KR20230074641A - 자가항체-매개 병태의 예방 또는 치료를 위한 화합물 - Google Patents
자가항체-매개 병태의 예방 또는 치료를 위한 화합물 Download PDFInfo
- Publication number
- KR20230074641A KR20230074641A KR1020237013947A KR20237013947A KR20230074641A KR 20230074641 A KR20230074641 A KR 20230074641A KR 1020237013947 A KR1020237013947 A KR 1020237013947A KR 20237013947 A KR20237013947 A KR 20237013947A KR 20230074641 A KR20230074641 A KR 20230074641A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acid
- peptide
- syndrome
- encephalitis
- acid sequence
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 197
- 230000001404 mediated effect Effects 0.000 title claims abstract description 15
- 238000011282 treatment Methods 0.000 title claims description 28
- 230000002265 prevention Effects 0.000 title claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 1092
- 241000282414 Homo sapiens Species 0.000 claims abstract description 673
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 127
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 118
- 150000001413 amino acids Chemical class 0.000 claims abstract description 107
- 229920001222 biopolymer Polymers 0.000 claims abstract description 87
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 54
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims abstract description 41
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims abstract description 41
- 210000002265 sensory receptor cell Anatomy 0.000 claims abstract description 38
- 206010057244 Post viral fatigue syndrome Diseases 0.000 claims abstract description 35
- 201000010046 Dilated cardiomyopathy Diseases 0.000 claims abstract description 25
- 206010063080 Postural orthostatic tachycardia syndrome Diseases 0.000 claims abstract description 24
- 201000011304 dilated cardiomyopathy 1A Diseases 0.000 claims abstract description 24
- 230000001363 autoimmune Effects 0.000 claims abstract description 21
- 230000002567 autonomic effect Effects 0.000 claims abstract description 13
- 230000001684 chronic effect Effects 0.000 claims abstract description 13
- 208000031976 Channelopathies Diseases 0.000 claims abstract description 11
- 208000019622 heart disease Diseases 0.000 claims abstract description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 66
- 206010014599 encephalitis Diseases 0.000 claims description 39
- 108010091867 peptide P Proteins 0.000 claims description 36
- 125000006850 spacer group Chemical group 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 30
- 230000002163 immunogen Effects 0.000 claims description 25
- 206010010904 Convulsion Diseases 0.000 claims description 24
- 102000034337 acetylcholine receptors Human genes 0.000 claims description 16
- 206010008025 Cerebellar ataxia Diseases 0.000 claims description 13
- 210000003403 autonomic nervous system Anatomy 0.000 claims description 13
- 208000012111 paraneoplastic syndrome Diseases 0.000 claims description 13
- 208000023275 Autoimmune disease Diseases 0.000 claims description 12
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 claims description 12
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 claims description 12
- 208000002033 Myoclonus Diseases 0.000 claims description 12
- 208000010325 limbic encephalitis Diseases 0.000 claims description 12
- 208000002552 acute disseminated encephalomyelitis Diseases 0.000 claims description 11
- 239000000539 dimer Substances 0.000 claims description 11
- 206010015037 epilepsy Diseases 0.000 claims description 11
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 10
- 208000000044 Amnesia Diseases 0.000 claims description 9
- 108010014494 beta-1 Adrenergic Receptors Proteins 0.000 claims description 9
- 208000011580 syndromic disease Diseases 0.000 claims description 9
- 108010009685 Cholinergic Receptors Proteins 0.000 claims description 8
- 208000026139 Memory disease Diseases 0.000 claims description 8
- 208000028017 Psychotic disease Diseases 0.000 claims description 8
- 208000024799 Thyroid disease Diseases 0.000 claims description 8
- 230000005856 abnormality Effects 0.000 claims description 8
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 claims description 8
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 claims description 8
- 208000010877 cognitive disease Diseases 0.000 claims description 8
- 230000006984 memory degeneration Effects 0.000 claims description 8
- 208000023060 memory loss Diseases 0.000 claims description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
- 206010001497 Agitation Diseases 0.000 claims description 7
- 208000028698 Cognitive impairment Diseases 0.000 claims description 7
- 208000000209 Isaacs syndrome Diseases 0.000 claims description 7
- 208000017281 Morvan syndrome Diseases 0.000 claims description 7
- 208000003926 Myelitis Diseases 0.000 claims description 7
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 claims description 7
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 claims description 7
- 206010072359 Neuromyotonia Diseases 0.000 claims description 7
- 208000003435 Optic Neuritis Diseases 0.000 claims description 7
- 230000037396 body weight Effects 0.000 claims description 7
- 230000003551 muscarinic effect Effects 0.000 claims description 7
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 6
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 6
- 206010003805 Autism Diseases 0.000 claims description 6
- 208000020706 Autistic disease Diseases 0.000 claims description 6
- 102100040794 Beta-1 adrenergic receptor Human genes 0.000 claims description 6
- 206010008748 Chorea Diseases 0.000 claims description 6
- 206010012735 Diarrhoea Diseases 0.000 claims description 6
- 208000014094 Dystonic disease Diseases 0.000 claims description 6
- 208000004547 Hallucinations Diseases 0.000 claims description 6
- 206010025280 Lymphocytosis Diseases 0.000 claims description 6
- 208000016285 Movement disease Diseases 0.000 claims description 6
- 206010028403 Mutism Diseases 0.000 claims description 6
- 206010052087 Oscillopsia Diseases 0.000 claims description 6
- 208000006199 Parasomnias Diseases 0.000 claims description 6
- 208000027089 Parkinsonian disease Diseases 0.000 claims description 6
- 206010034010 Parkinsonism Diseases 0.000 claims description 6
- 206010038910 Retinitis Diseases 0.000 claims description 6
- 206010072148 Stiff-Person syndrome Diseases 0.000 claims description 6
- 208000029560 autism spectrum disease Diseases 0.000 claims description 6
- 208000012601 choreatic disease Diseases 0.000 claims description 6
- 208000010118 dystonia Diseases 0.000 claims description 6
- 230000000632 dystonic effect Effects 0.000 claims description 6
- 201000002491 encephalomyelitis Diseases 0.000 claims description 6
- 230000005021 gait Effects 0.000 claims description 6
- 208000008795 neuromyelitis optica Diseases 0.000 claims description 6
- 231100000898 oscillopsia Toxicity 0.000 claims description 6
- 201000002859 sleep apnea Diseases 0.000 claims description 6
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 claims description 5
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims description 5
- 102000010180 Endothelin receptor Human genes 0.000 claims description 5
- 108050001739 Endothelin receptor Proteins 0.000 claims description 5
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 claims description 5
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 claims description 5
- 102000012740 beta Adrenergic Receptors Human genes 0.000 claims description 5
- 108010079452 beta Adrenergic Receptors Proteins 0.000 claims description 5
- 208000028329 epileptic seizure Diseases 0.000 claims description 5
- 201000003631 narcolepsy Diseases 0.000 claims description 5
- 208000004296 neuralgia Diseases 0.000 claims description 5
- 230000007971 neurological deficit Effects 0.000 claims description 5
- 208000021722 neuropathic pain Diseases 0.000 claims description 5
- 102000008873 Angiotensin II receptor Human genes 0.000 claims description 4
- 108050000824 Angiotensin II receptor Proteins 0.000 claims description 4
- 102000006395 Globulins Human genes 0.000 claims description 4
- 108010044091 Globulins Proteins 0.000 claims description 4
- 206010019233 Headaches Diseases 0.000 claims description 4
- 241000282412 Homo Species 0.000 claims description 4
- 231100000869 headache Toxicity 0.000 claims description 4
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 claims description 3
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 3
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 3
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 35
- 230000000926 neurological effect Effects 0.000 abstract description 11
- 208000035475 disorder Diseases 0.000 abstract description 6
- 230000002232 neuromuscular Effects 0.000 abstract description 4
- 235000001014 amino acid Nutrition 0.000 description 101
- 230000027455 binding Effects 0.000 description 78
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 69
- 239000012634 fragment Substances 0.000 description 53
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 51
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 47
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 42
- 235000018102 proteins Nutrition 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 40
- 108090000623 proteins and genes Proteins 0.000 description 40
- 102100021277 Beta-secretase 2 Human genes 0.000 description 36
- 238000002965 ELISA Methods 0.000 description 31
- 101710150190 Beta-secretase 2 Proteins 0.000 description 30
- 201000010099 disease Diseases 0.000 description 29
- 238000002347 injection Methods 0.000 description 29
- 239000007924 injection Substances 0.000 description 29
- 241000699670 Mus sp. Species 0.000 description 27
- 108010068380 arginylarginine Proteins 0.000 description 27
- 210000002381 plasma Anatomy 0.000 description 27
- 241001465754 Metazoa Species 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 102000014702 Haptoglobin Human genes 0.000 description 23
- 108050005077 Haptoglobin Proteins 0.000 description 23
- 239000000427 antigen Substances 0.000 description 23
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 22
- 108091007433 antigens Proteins 0.000 description 22
- 102000036639 antigens Human genes 0.000 description 22
- 238000001727 in vivo Methods 0.000 description 22
- 108010050848 glycylleucine Proteins 0.000 description 21
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 19
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 19
- 238000000338 in vitro Methods 0.000 description 19
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 18
- 239000000523 sample Substances 0.000 description 17
- 108060003951 Immunoglobulin Proteins 0.000 description 16
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 16
- 108010093581 aspartyl-proline Proteins 0.000 description 16
- 102000018358 immunoglobulin Human genes 0.000 description 16
- 108010031719 prolyl-serine Proteins 0.000 description 16
- 108010088751 Albumins Proteins 0.000 description 15
- 102000009027 Albumins Human genes 0.000 description 15
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 15
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 15
- 241000880493 Leptailurus serval Species 0.000 description 14
- 108010005233 alanylglutamic acid Proteins 0.000 description 14
- 238000003556 assay Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 13
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 13
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 13
- 239000002953 phosphate buffered saline Substances 0.000 description 13
- 108010009992 CD163 antigen Proteins 0.000 description 12
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 125000004122 cyclic group Chemical group 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 108010009298 lysylglutamic acid Proteins 0.000 description 12
- 108010053725 prolylvaline Proteins 0.000 description 12
- QVVDVENEPNODSI-BTNSXGMBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylidene Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QVVDVENEPNODSI-BTNSXGMBSA-N 0.000 description 11
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 11
- 239000002202 Polyethylene glycol Substances 0.000 description 11
- 238000013459 approach Methods 0.000 description 11
- 108010056582 methionylglutamic acid Proteins 0.000 description 11
- 229920001223 polyethylene glycol Polymers 0.000 description 11
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 230000009467 reduction Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 102000000185 SRCR domains Human genes 0.000 description 10
- 108050008568 SRCR domains Proteins 0.000 description 10
- 108010068265 aspartyltyrosine Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 10
- 108010078144 glutaminyl-glycine Proteins 0.000 description 10
- 239000013642 negative control Substances 0.000 description 10
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
- 102000004338 Transferrin Human genes 0.000 description 9
- 108090000901 Transferrin Proteins 0.000 description 9
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 9
- 210000004899 c-terminal region Anatomy 0.000 description 9
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 9
- 239000012581 transferrin Substances 0.000 description 9
- XPSGESXVBSQZPL-SRVKXCTJSA-N Arg-Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XPSGESXVBSQZPL-SRVKXCTJSA-N 0.000 description 8
- 108010069514 Cyclic Peptides Proteins 0.000 description 8
- 102000001189 Cyclic Peptides Human genes 0.000 description 8
- 108010065920 Insulin Lispro Proteins 0.000 description 8
- 241000283984 Rodentia Species 0.000 description 8
- MCDVZTRGHNXTGK-HJGDQZAQSA-N Thr-Met-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O MCDVZTRGHNXTGK-HJGDQZAQSA-N 0.000 description 8
- 108020000715 acetylcholine receptors Proteins 0.000 description 8
- 108010087924 alanylproline Proteins 0.000 description 8
- 108010060035 arginylproline Proteins 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 108010010147 glycylglutamine Proteins 0.000 description 8
- 108010037850 glycylvaline Proteins 0.000 description 8
- 238000001990 intravenous administration Methods 0.000 description 8
- 206010028417 myasthenia gravis Diseases 0.000 description 8
- 229940023041 peptide vaccine Drugs 0.000 description 8
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 8
- 108010061238 threonyl-glycine Proteins 0.000 description 8
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 7
- YRKJQKATZOTUEN-ACZMJKKPSA-N Cys-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N YRKJQKATZOTUEN-ACZMJKKPSA-N 0.000 description 7
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 7
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 7
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 7
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 7
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 7
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 7
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 7
- 108010092854 aspartyllysine Proteins 0.000 description 7
- 230000000779 depleting effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 108010064235 lysylglycine Proteins 0.000 description 7
- 108010038320 lysylphenylalanine Proteins 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 108010026333 seryl-proline Proteins 0.000 description 7
- 230000008685 targeting Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 6
- FEGOCLZUJUFCHP-CIUDSAMLSA-N Ala-Pro-Gln Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FEGOCLZUJUFCHP-CIUDSAMLSA-N 0.000 description 6
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 6
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 6
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- WVYJNPCWJYBHJG-YVNDNENWSA-N Glu-Ile-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O WVYJNPCWJYBHJG-YVNDNENWSA-N 0.000 description 6
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 6
- AIRUUHAOKGVJAD-JYJNAYRXSA-N Leu-Phe-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIRUUHAOKGVJAD-JYJNAYRXSA-N 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 6
- 108010047495 alanylglycine Proteins 0.000 description 6
- 108010013835 arginine glutamate Proteins 0.000 description 6
- 108010062796 arginyllysine Proteins 0.000 description 6
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 6
- 108010038633 aspartylglutamate Proteins 0.000 description 6
- 108010047857 aspartylglycine Proteins 0.000 description 6
- 230000009918 complex formation Effects 0.000 description 6
- 108010049041 glutamylalanine Proteins 0.000 description 6
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 6
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 6
- 108010087823 glycyltyrosine Proteins 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000007912 intraperitoneal administration Methods 0.000 description 6
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 6
- 108010084572 phenylalanyl-valine Proteins 0.000 description 6
- 108010051242 phenylalanylserine Proteins 0.000 description 6
- 108010077112 prolyl-proline Proteins 0.000 description 6
- 108010070643 prolylglutamic acid Proteins 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- WOJJIRYPFAZEPF-YFKPBYRVSA-N 2-[[(2s)-2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]propanoyl]amino]acetate Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)CN WOJJIRYPFAZEPF-YFKPBYRVSA-N 0.000 description 5
- CSEJMKNZDCJYGJ-XHNCKOQMSA-N Asp-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O CSEJMKNZDCJYGJ-XHNCKOQMSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 238000009007 Diagnostic Kit Methods 0.000 description 5
- 101150059079 EBNA1 gene Proteins 0.000 description 5
- PCKOTDPDHIBGRW-CIUDSAMLSA-N Gln-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N PCKOTDPDHIBGRW-CIUDSAMLSA-N 0.000 description 5
- HPCOBEHVEHWREJ-DCAQKATOSA-N Gln-Lys-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HPCOBEHVEHWREJ-DCAQKATOSA-N 0.000 description 5
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 5
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 5
- AQLHORCVPGXDJW-IUCAKERBSA-N Gly-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN AQLHORCVPGXDJW-IUCAKERBSA-N 0.000 description 5
- 108090000144 Human Proteins Proteins 0.000 description 5
- 102000003839 Human Proteins Human genes 0.000 description 5
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 5
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 5
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 5
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 5
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 5
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 5
- URHJPNHRQMQGOZ-RHYQMDGZSA-N Leu-Thr-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O URHJPNHRQMQGOZ-RHYQMDGZSA-N 0.000 description 5
- GPAHWYRSHCKICP-GUBZILKMSA-N Met-Glu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GPAHWYRSHCKICP-GUBZILKMSA-N 0.000 description 5
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 5
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 5
- SNVIOQXAHVORQM-WDSKDSINSA-N Ser-Gly-Gln Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O SNVIOQXAHVORQM-WDSKDSINSA-N 0.000 description 5
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 101150006914 TRP1 gene Proteins 0.000 description 5
- 108010041407 alanylaspartic acid Proteins 0.000 description 5
- 108010070944 alanylhistidine Proteins 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 108010008355 arginyl-glutamine Proteins 0.000 description 5
- 208000019479 dysautonomia Diseases 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 108010000761 leucylarginine Proteins 0.000 description 5
- 108010012581 phenylalanylglutamate Proteins 0.000 description 5
- 201000011461 pre-eclampsia Diseases 0.000 description 5
- 208000018290 primary dysautonomia Diseases 0.000 description 5
- 108010029020 prolylglycine Proteins 0.000 description 5
- 108010090894 prolylleucine Proteins 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 108010020532 tyrosyl-proline Proteins 0.000 description 5
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 4
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 4
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 4
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 4
- 206010061666 Autonomic neuropathy Diseases 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 102100024441 Dihydropyrimidinase-related protein 5 Human genes 0.000 description 4
- 108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 description 4
- CLPQUWHBWXFJOX-BQBZGAKWSA-N Gln-Gly-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O CLPQUWHBWXFJOX-BQBZGAKWSA-N 0.000 description 4
- VNTGPISAOMAXRK-CIUDSAMLSA-N Gln-Pro-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O VNTGPISAOMAXRK-CIUDSAMLSA-N 0.000 description 4
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 4
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 4
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 4
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 4
- GYXDQXPCPASCNR-NHCYSSNCSA-N His-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N GYXDQXPCPASCNR-NHCYSSNCSA-N 0.000 description 4
- 101001053479 Homo sapiens Dihydropyrimidinase-related protein 5 Proteins 0.000 description 4
- VOBYAKCXGQQFLR-LSJOCFKGSA-N Ile-Gly-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VOBYAKCXGQQFLR-LSJOCFKGSA-N 0.000 description 4
- ADDYYRVQQZFIMW-MNXVOIDGSA-N Ile-Lys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ADDYYRVQQZFIMW-MNXVOIDGSA-N 0.000 description 4
- 102000004310 Ion Channels Human genes 0.000 description 4
- 108090000862 Ion Channels Proteins 0.000 description 4
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 4
- AIPHUKOBUXJNKM-KKUMJFAQSA-N Lys-Cys-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O AIPHUKOBUXJNKM-KKUMJFAQSA-N 0.000 description 4
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 4
- 108010079364 N-glycylalanine Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 4
- 208000025966 Neurological disease Diseases 0.000 description 4
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 4
- DIFXZGPHVCIVSQ-CIUDSAMLSA-N Pro-Gln-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DIFXZGPHVCIVSQ-CIUDSAMLSA-N 0.000 description 4
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 4
- FHZJRBVMLGOHBX-GUBZILKMSA-N Pro-Pro-Asp Chemical compound OC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(O)=O FHZJRBVMLGOHBX-GUBZILKMSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 description 4
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 4
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 4
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 210000003719 b-lymphocyte Anatomy 0.000 description 4
- 108010016616 cysteinylglycine Proteins 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 4
- 108010077515 glycylproline Proteins 0.000 description 4
- 108010036413 histidylglycine Proteins 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 229940072221 immunoglobulins Drugs 0.000 description 4
- 238000003364 immunohistochemistry Methods 0.000 description 4
- 238000007918 intramuscular administration Methods 0.000 description 4
- 108010057821 leucylproline Proteins 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 108010005942 methionylglycine Proteins 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 4
- 238000001498 protein fragment complementation assay Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 108700004896 tripeptide FEG Proteins 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- PXKLCFFSVLKOJM-ACZMJKKPSA-N Ala-Asn-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXKLCFFSVLKOJM-ACZMJKKPSA-N 0.000 description 3
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 3
- VBRDBGCROKWTPV-XHNCKOQMSA-N Ala-Glu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N VBRDBGCROKWTPV-XHNCKOQMSA-N 0.000 description 3
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 3
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 3
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 3
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 3
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 3
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 3
- OVVUNXXROOFSIM-SDDRHHMPSA-N Arg-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O OVVUNXXROOFSIM-SDDRHHMPSA-N 0.000 description 3
- CTAPSNCVKPOOSM-KKUMJFAQSA-N Arg-Tyr-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O CTAPSNCVKPOOSM-KKUMJFAQSA-N 0.000 description 3
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 3
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 3
- BUVNWKQBMZLCDW-UGYAYLCHSA-N Asp-Asn-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BUVNWKQBMZLCDW-UGYAYLCHSA-N 0.000 description 3
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 3
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 3
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 3
- DINOVZWPTMGSRF-QXEWZRGKSA-N Asp-Pro-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O DINOVZWPTMGSRF-QXEWZRGKSA-N 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 3
- CEZSLNCYQUFOSL-BQBZGAKWSA-N Cys-Arg-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O CEZSLNCYQUFOSL-BQBZGAKWSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- SHAUZYVSXAMYAZ-JYJNAYRXSA-N Gln-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SHAUZYVSXAMYAZ-JYJNAYRXSA-N 0.000 description 3
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 3
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 3
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 3
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 3
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 3
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 3
- BUAKRRKDHSSIKK-IHRRRGAJSA-N Glu-Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BUAKRRKDHSSIKK-IHRRRGAJSA-N 0.000 description 3
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 3
- LGYCLOCORAEQSZ-PEFMBERDSA-N Glu-Ile-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O LGYCLOCORAEQSZ-PEFMBERDSA-N 0.000 description 3
- UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 3
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 3
- FGSGPLRPQCZBSQ-AVGNSLFASA-N Glu-Phe-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O FGSGPLRPQCZBSQ-AVGNSLFASA-N 0.000 description 3
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 3
- MWTGQXBHVRTCOR-GLLZPBPUSA-N Glu-Thr-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MWTGQXBHVRTCOR-GLLZPBPUSA-N 0.000 description 3
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 3
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 3
- RLFSBAPJTYKSLG-WHFBIAKZSA-N Gly-Ala-Asp Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O RLFSBAPJTYKSLG-WHFBIAKZSA-N 0.000 description 3
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 3
- ZQIMMEYPEXIYBB-IUCAKERBSA-N Gly-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN ZQIMMEYPEXIYBB-IUCAKERBSA-N 0.000 description 3
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 3
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 3
- CVFOYJJOZYYEPE-KBPBESRZSA-N Gly-Lys-Tyr Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CVFOYJJOZYYEPE-KBPBESRZSA-N 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- QZZIBQZLWBOOJH-PEDHHIEDSA-N Ile-Ile-Val Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)O QZZIBQZLWBOOJH-PEDHHIEDSA-N 0.000 description 3
- IOVUXUSIGXCREV-DKIMLUQUSA-N Ile-Leu-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IOVUXUSIGXCREV-DKIMLUQUSA-N 0.000 description 3
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 3
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 3
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 3
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 3
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 3
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 3
- DDVHDMSBLRAKNV-IHRRRGAJSA-N Leu-Met-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O DDVHDMSBLRAKNV-IHRRRGAJSA-N 0.000 description 3
- RRVCZCNFXIFGRA-DCAQKATOSA-N Leu-Pro-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RRVCZCNFXIFGRA-DCAQKATOSA-N 0.000 description 3
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 3
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 3
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 3
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 3
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 3
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 3
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- FRWZTWWOORIIBA-FXQIFTODSA-N Met-Asn-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FRWZTWWOORIIBA-FXQIFTODSA-N 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 108010066427 N-valyltryptophan Proteins 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- MPFGIYLYWUCSJG-AVGNSLFASA-N Phe-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MPFGIYLYWUCSJG-AVGNSLFASA-N 0.000 description 3
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 3
- BQMFWUKNOCJDNV-HJWJTTGWSA-N Phe-Val-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BQMFWUKNOCJDNV-HJWJTTGWSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 3
- LNLNHXIQPGKRJQ-SRVKXCTJSA-N Pro-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1 LNLNHXIQPGKRJQ-SRVKXCTJSA-N 0.000 description 3
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 3
- ZVEQWRWMRFIVSD-HRCADAONSA-N Pro-Phe-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@@H]3C(=O)O ZVEQWRWMRFIVSD-HRCADAONSA-N 0.000 description 3
- FYKUEXMZYFIZKA-DCAQKATOSA-N Pro-Pro-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FYKUEXMZYFIZKA-DCAQKATOSA-N 0.000 description 3
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 3
- KIDXAAQVMNLJFQ-KZVJFYERSA-N Pro-Thr-Ala Chemical compound C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(O)=O KIDXAAQVMNLJFQ-KZVJFYERSA-N 0.000 description 3
- 102100028120 Protein O-mannosyl-transferase 1 Human genes 0.000 description 3
- 101710093787 Protein O-mannosyl-transferase 1 Proteins 0.000 description 3
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 3
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 3
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 3
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 3
- XQAPEISNMXNKGE-FXQIFTODSA-N Ser-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CS)C(=O)O XQAPEISNMXNKGE-FXQIFTODSA-N 0.000 description 3
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 3
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 3
- DYEGLQRVMBWQLD-IXOXFDKPSA-N Ser-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CO)N)O DYEGLQRVMBWQLD-IXOXFDKPSA-N 0.000 description 3
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- YSXYEJWDHBCTDJ-DVJZZOLTSA-N Thr-Gly-Trp Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O YSXYEJWDHBCTDJ-DVJZZOLTSA-N 0.000 description 3
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 3
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 3
- SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 3
- WTRQBSSQBKRNKV-MNSWYVGCSA-N Trp-Thr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)[C@H](O)C)C(O)=O)C1=CC=C(O)C=C1 WTRQBSSQBKRNKV-MNSWYVGCSA-N 0.000 description 3
- YYLHVUCSTXXKBS-IHRRRGAJSA-N Tyr-Pro-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YYLHVUCSTXXKBS-IHRRRGAJSA-N 0.000 description 3
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 3
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 3
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 3
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 3
- JPBGMZDTPVGGMQ-ULQDDVLXSA-N Val-Tyr-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N JPBGMZDTPVGGMQ-ULQDDVLXSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 108010044940 alanylglutamine Proteins 0.000 description 3
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 3
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 3
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 3
- 102000016967 beta-1 Adrenergic Receptors Human genes 0.000 description 3
- 230000001588 bifunctional effect Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000001364 causal effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000009137 competitive binding Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 108010060199 cysteinylproline Proteins 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 108010060455 des-Tyr- beta-casomorphin Proteins 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 3
- 108010079547 glutamylmethionine Proteins 0.000 description 3
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 3
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 3
- 108010015792 glycyllysine Proteins 0.000 description 3
- 108010092114 histidylphenylalanine Proteins 0.000 description 3
- 108010018006 histidylserine Proteins 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 108010078274 isoleucylvaline Proteins 0.000 description 3
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 3
- 108010003700 lysyl aspartic acid Proteins 0.000 description 3
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 3
- 108010017391 lysylvaline Proteins 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000010208 microarray analysis Methods 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 3
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 3
- 230000036470 plasma concentration Effects 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 108091005725 scavenger receptor cysteine-rich superfamily Proteins 0.000 description 3
- 108010048818 seryl-histidine Proteins 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108010080629 tryptophan-leucine Proteins 0.000 description 3
- 108010073969 valyllysine Proteins 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SKPQXOSVPKPXML-ULQDDVLXSA-N 2-[[(2s)-1-[(2s)-3-phenyl-2-[[(2s)-pyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NCCC1)CC1=CC=CC=C1 SKPQXOSVPKPXML-ULQDDVLXSA-N 0.000 description 2
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 2
- 108060003345 Adrenergic Receptor Proteins 0.000 description 2
- 102000017910 Adrenergic receptor Human genes 0.000 description 2
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 2
- PIPTUBPKYFRLCP-NHCYSSNCSA-N Ala-Ala-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PIPTUBPKYFRLCP-NHCYSSNCSA-N 0.000 description 2
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 2
- LBJYAILUMSUTAM-ZLUOBGJFSA-N Ala-Asn-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LBJYAILUMSUTAM-ZLUOBGJFSA-N 0.000 description 2
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 2
- ZODMADSIQZZBSQ-FXQIFTODSA-N Ala-Gln-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZODMADSIQZZBSQ-FXQIFTODSA-N 0.000 description 2
- IFKQPMZRDQZSHI-GHCJXIJMSA-N Ala-Ile-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O IFKQPMZRDQZSHI-GHCJXIJMSA-N 0.000 description 2
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 2
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 2
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 2
- XUCHENWTTBFODJ-FXQIFTODSA-N Ala-Met-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O XUCHENWTTBFODJ-FXQIFTODSA-N 0.000 description 2
- DWYROCSXOOMOEU-CIUDSAMLSA-N Ala-Met-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DWYROCSXOOMOEU-CIUDSAMLSA-N 0.000 description 2
- RNHKOQHGYMTHFR-UBHSHLNASA-N Ala-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 RNHKOQHGYMTHFR-UBHSHLNASA-N 0.000 description 2
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 2
- IORKCNUBHNIMKY-CIUDSAMLSA-N Ala-Pro-Glu Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IORKCNUBHNIMKY-CIUDSAMLSA-N 0.000 description 2
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 2
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 2
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 2
- JJHBEVZAZXZREW-LFSVMHDDSA-N Ala-Thr-Phe Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O JJHBEVZAZXZREW-LFSVMHDDSA-N 0.000 description 2
- IETUUAHKCHOQHP-KZVJFYERSA-N Ala-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O IETUUAHKCHOQHP-KZVJFYERSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 2
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 2
- MUXONAMCEUBVGA-DCAQKATOSA-N Arg-Arg-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O MUXONAMCEUBVGA-DCAQKATOSA-N 0.000 description 2
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 2
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 2
- MFAMTAVAFBPXDC-LPEHRKFASA-N Arg-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O MFAMTAVAFBPXDC-LPEHRKFASA-N 0.000 description 2
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 2
- QAODJPUKWNNNRP-DCAQKATOSA-N Arg-Glu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QAODJPUKWNNNRP-DCAQKATOSA-N 0.000 description 2
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 2
- ZATRYQNPUHGXCU-DTWKUNHWSA-N Arg-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZATRYQNPUHGXCU-DTWKUNHWSA-N 0.000 description 2
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 2
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 2
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 2
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 2
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 2
- YLVGUOGAFAJMKP-JYJNAYRXSA-N Arg-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YLVGUOGAFAJMKP-JYJNAYRXSA-N 0.000 description 2
- PRLPSDIHSRITSF-UNQGMJICSA-N Arg-Phe-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PRLPSDIHSRITSF-UNQGMJICSA-N 0.000 description 2
- LFAUVOXPCGJKTB-DCAQKATOSA-N Arg-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N LFAUVOXPCGJKTB-DCAQKATOSA-N 0.000 description 2
- KSBHCUSPLWRVEK-ZLUOBGJFSA-N Asn-Asn-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KSBHCUSPLWRVEK-ZLUOBGJFSA-N 0.000 description 2
- FUHFYEKSGWOWGZ-XHNCKOQMSA-N Asn-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O FUHFYEKSGWOWGZ-XHNCKOQMSA-N 0.000 description 2
- BZMWJLLUAKSIMH-FXQIFTODSA-N Asn-Glu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BZMWJLLUAKSIMH-FXQIFTODSA-N 0.000 description 2
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 2
- IKLAUGBIDCDFOY-SRVKXCTJSA-N Asn-His-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O IKLAUGBIDCDFOY-SRVKXCTJSA-N 0.000 description 2
- UYXXMIZGHYKYAT-NHCYSSNCSA-N Asn-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)N)N UYXXMIZGHYKYAT-NHCYSSNCSA-N 0.000 description 2
- PNHQRQTVBRDIEF-CIUDSAMLSA-N Asn-Leu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)N PNHQRQTVBRDIEF-CIUDSAMLSA-N 0.000 description 2
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 2
- NCFJQJRLQJEECD-NHCYSSNCSA-N Asn-Leu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O NCFJQJRLQJEECD-NHCYSSNCSA-N 0.000 description 2
- RVHGJNGNKGDCPX-KKUMJFAQSA-N Asn-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N RVHGJNGNKGDCPX-KKUMJFAQSA-N 0.000 description 2
- PQKSVQSMTHPRIB-ZKWXMUAHSA-N Asn-Val-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O PQKSVQSMTHPRIB-ZKWXMUAHSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- NYLBGYLHBDFRHL-VEVYYDQMSA-N Asp-Arg-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NYLBGYLHBDFRHL-VEVYYDQMSA-N 0.000 description 2
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 2
- HRGGPWBIMIQANI-GUBZILKMSA-N Asp-Gln-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HRGGPWBIMIQANI-GUBZILKMSA-N 0.000 description 2
- GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 2
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 2
- WNGZKSVJFDZICU-XIRDDKMYSA-N Asp-Leu-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N WNGZKSVJFDZICU-XIRDDKMYSA-N 0.000 description 2
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 2
- ZVGRHIRJLWBWGJ-ACZMJKKPSA-N Asp-Ser-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZVGRHIRJLWBWGJ-ACZMJKKPSA-N 0.000 description 2
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 2
- NVXLFIPTHPKSKL-UBHSHLNASA-N Asp-Trp-Asn Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(O)=O)N)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 NVXLFIPTHPKSKL-UBHSHLNASA-N 0.000 description 2
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 2
- ALMIMUZAWTUNIO-BZSNNMDCSA-N Asp-Tyr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ALMIMUZAWTUNIO-BZSNNMDCSA-N 0.000 description 2
- 208000030767 Autoimmune encephalitis Diseases 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 102000006734 Beta-Globulins Human genes 0.000 description 2
- 108010087504 Beta-Globulins Proteins 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- 102000034573 Channels Human genes 0.000 description 2
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 2
- UKVGHFORADMBEN-GUBZILKMSA-N Cys-Arg-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UKVGHFORADMBEN-GUBZILKMSA-N 0.000 description 2
- GGIHYKLJUIZYGH-ZLUOBGJFSA-N Cys-Cys-Asp Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)N)C(=O)O GGIHYKLJUIZYGH-ZLUOBGJFSA-N 0.000 description 2
- KCPOQGRVVXYLAC-KKUMJFAQSA-N Cys-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CS)N KCPOQGRVVXYLAC-KKUMJFAQSA-N 0.000 description 2
- SRZZZTMJARUVPI-JBDRJPRFSA-N Cys-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N SRZZZTMJARUVPI-JBDRJPRFSA-N 0.000 description 2
- DQGIAOGALAQBGK-BWBBJGPYSA-N Cys-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N)O DQGIAOGALAQBGK-BWBBJGPYSA-N 0.000 description 2
- SAEVTQWAYDPXMU-KATARQTJSA-N Cys-Thr-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O SAEVTQWAYDPXMU-KATARQTJSA-N 0.000 description 2
- KXHAPEPORGOXDT-UWJYBYFXSA-N Cys-Tyr-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O KXHAPEPORGOXDT-UWJYBYFXSA-N 0.000 description 2
- KZZYVYWSXMFYEC-DCAQKATOSA-N Cys-Val-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KZZYVYWSXMFYEC-DCAQKATOSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- KJRXLVZYJJLUCV-DCAQKATOSA-N Gln-Arg-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O KJRXLVZYJJLUCV-DCAQKATOSA-N 0.000 description 2
- KCJJFESQRXGTGC-BQBZGAKWSA-N Gln-Glu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O KCJJFESQRXGTGC-BQBZGAKWSA-N 0.000 description 2
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 2
- SMLDOQHTOAAFJQ-WDSKDSINSA-N Gln-Gly-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SMLDOQHTOAAFJQ-WDSKDSINSA-N 0.000 description 2
- IWUFOVSLWADEJC-AVGNSLFASA-N Gln-His-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O IWUFOVSLWADEJC-AVGNSLFASA-N 0.000 description 2
- FTIJVMLAGRAYMJ-MNXVOIDGSA-N Gln-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O FTIJVMLAGRAYMJ-MNXVOIDGSA-N 0.000 description 2
- FTMLQFPULNGION-ZVZYQTTQSA-N Gln-Val-Trp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O FTMLQFPULNGION-ZVZYQTTQSA-N 0.000 description 2
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 2
- OJGLIOXAKGFFDW-SRVKXCTJSA-N Glu-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N OJGLIOXAKGFFDW-SRVKXCTJSA-N 0.000 description 2
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 2
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 2
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 2
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 2
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 2
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 2
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 2
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 2
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 2
- QIQABBIDHGQXGA-ZPFDUUQYSA-N Glu-Ile-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QIQABBIDHGQXGA-ZPFDUUQYSA-N 0.000 description 2
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 2
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 2
- ZWMYUDZLXAQHCK-CIUDSAMLSA-N Glu-Met-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O ZWMYUDZLXAQHCK-CIUDSAMLSA-N 0.000 description 2
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 2
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 2
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 2
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 2
- FVGOGEGGQLNZGH-DZKIICNBSA-N Glu-Val-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FVGOGEGGQLNZGH-DZKIICNBSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 2
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 2
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 2
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 2
- GVVKYKCOFMMTKZ-WHFBIAKZSA-N Gly-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CN GVVKYKCOFMMTKZ-WHFBIAKZSA-N 0.000 description 2
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 2
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 2
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 2
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 2
- COVXELOAORHTND-LSJOCFKGSA-N Gly-Ile-Val Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O COVXELOAORHTND-LSJOCFKGSA-N 0.000 description 2
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 2
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 2
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 2
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 2
- FXGRXIATVXUAHO-WEDXCCLWSA-N Gly-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN FXGRXIATVXUAHO-WEDXCCLWSA-N 0.000 description 2
- DBJYVKDPGIFXFO-BQBZGAKWSA-N Gly-Met-Ala Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O DBJYVKDPGIFXFO-BQBZGAKWSA-N 0.000 description 2
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 2
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 2
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- IMRNSEPSPFQNHF-STQMWFEESA-N Gly-Ser-Trp Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O IMRNSEPSPFQNHF-STQMWFEESA-N 0.000 description 2
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 2
- DKJWUIYLMLUBDX-XPUUQOCRSA-N Gly-Val-Cys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O DKJWUIYLMLUBDX-XPUUQOCRSA-N 0.000 description 2
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 2
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 2
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 2
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- JIUYRPFQJJRSJB-QWRGUYRKSA-N His-His-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)NCC(O)=O)C1=CN=CN1 JIUYRPFQJJRSJB-QWRGUYRKSA-N 0.000 description 2
- RLAOTFTXBFQJDV-KKUMJFAQSA-N His-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CN=CN1 RLAOTFTXBFQJDV-KKUMJFAQSA-N 0.000 description 2
- CKONPJHGMIDMJP-IHRRRGAJSA-N His-Val-His Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 CKONPJHGMIDMJP-IHRRRGAJSA-N 0.000 description 2
- 101001078385 Homo sapiens Haptoglobin Proteins 0.000 description 2
- 101000634526 Homo sapiens Nucleolar pre-ribosomal-associated protein 1 Proteins 0.000 description 2
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 2
- QIHJTGSVGIPHIW-QSFUFRPTSA-N Ile-Asn-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N QIHJTGSVGIPHIW-QSFUFRPTSA-N 0.000 description 2
- DFFTXLCCDFYRKD-MBLNEYKQSA-N Ile-Gly-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N DFFTXLCCDFYRKD-MBLNEYKQSA-N 0.000 description 2
- KOPIAUWNLKKELG-SIGLWIIPSA-N Ile-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N KOPIAUWNLKKELG-SIGLWIIPSA-N 0.000 description 2
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 2
- BKPPWVSPSIUXHZ-OSUNSFLBSA-N Ile-Met-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N BKPPWVSPSIUXHZ-OSUNSFLBSA-N 0.000 description 2
- XHBYEMIUENPZLY-GMOBBJLQSA-N Ile-Pro-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O XHBYEMIUENPZLY-GMOBBJLQSA-N 0.000 description 2
- IVXJIMGDOYRLQU-XUXIUFHCSA-N Ile-Pro-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O IVXJIMGDOYRLQU-XUXIUFHCSA-N 0.000 description 2
- CZWANIQKACCEKW-CYDGBPFRSA-N Ile-Pro-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N CZWANIQKACCEKW-CYDGBPFRSA-N 0.000 description 2
- HJDZMPFEXINXLO-QPHKQPEJSA-N Ile-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N HJDZMPFEXINXLO-QPHKQPEJSA-N 0.000 description 2
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 2
- KXUKTDGKLAOCQK-LSJOCFKGSA-N Ile-Val-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O KXUKTDGKLAOCQK-LSJOCFKGSA-N 0.000 description 2
- APQYGMBHIVXFML-OSUNSFLBSA-N Ile-Val-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N APQYGMBHIVXFML-OSUNSFLBSA-N 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 2
- HBJZFCIVFIBNSV-DCAQKATOSA-N Leu-Arg-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O HBJZFCIVFIBNSV-DCAQKATOSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 2
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 2
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 2
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 2
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 2
- QPXBPQUGXHURGP-UWVGGRQHSA-N Leu-Gly-Met Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N QPXBPQUGXHURGP-UWVGGRQHSA-N 0.000 description 2
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 2
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 2
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 2
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 2
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- UCNNZELZXFXXJQ-BZSNNMDCSA-N Leu-Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCNNZELZXFXXJQ-BZSNNMDCSA-N 0.000 description 2
- ZGUMORRUBUCXEH-AVGNSLFASA-N Leu-Lys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZGUMORRUBUCXEH-AVGNSLFASA-N 0.000 description 2
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 2
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 2
- GCXGCIYIHXSKAY-ULQDDVLXSA-N Leu-Phe-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GCXGCIYIHXSKAY-ULQDDVLXSA-N 0.000 description 2
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 2
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 2
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 2
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 2
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 2
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 2
- NTXYXFDMIHXTHE-WDSOQIARSA-N Leu-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 NTXYXFDMIHXTHE-WDSOQIARSA-N 0.000 description 2
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 2
- QYOXSYXPHUHOJR-GUBZILKMSA-N Lys-Asn-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYOXSYXPHUHOJR-GUBZILKMSA-N 0.000 description 2
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 2
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 2
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 2
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 2
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 2
- ZUGVARDEGWMMLK-SRVKXCTJSA-N Lys-Ser-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN ZUGVARDEGWMMLK-SRVKXCTJSA-N 0.000 description 2
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 2
- XATKLFSXFINPSB-JYJNAYRXSA-N Lys-Tyr-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O XATKLFSXFINPSB-JYJNAYRXSA-N 0.000 description 2
- OGAZPKJHHZPYFK-GARJFASQSA-N Met-Glu-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGAZPKJHHZPYFK-GARJFASQSA-N 0.000 description 2
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 2
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 2
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 2
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 102100029053 Nucleolar pre-ribosomal-associated protein 1 Human genes 0.000 description 2
- 101800004192 Peptide P1 Proteins 0.000 description 2
- 101800004191 Peptide P2 Proteins 0.000 description 2
- HXSUFWQYLPKEHF-IHRRRGAJSA-N Phe-Asn-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HXSUFWQYLPKEHF-IHRRRGAJSA-N 0.000 description 2
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 2
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 2
- RORUIHAWOLADSH-HJWJTTGWSA-N Phe-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 RORUIHAWOLADSH-HJWJTTGWSA-N 0.000 description 2
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 2
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 2
- GKRCCTYAGQPMMP-IHRRRGAJSA-N Phe-Ser-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O GKRCCTYAGQPMMP-IHRRRGAJSA-N 0.000 description 2
- LTAWNJXSRUCFAN-UNQGMJICSA-N Phe-Thr-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LTAWNJXSRUCFAN-UNQGMJICSA-N 0.000 description 2
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 2
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 2
- FUVBEZJCRMHWEM-FXQIFTODSA-N Pro-Asn-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FUVBEZJCRMHWEM-FXQIFTODSA-N 0.000 description 2
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 2
- HQVPQXMCQKXARZ-FXQIFTODSA-N Pro-Cys-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O HQVPQXMCQKXARZ-FXQIFTODSA-N 0.000 description 2
- SKICPQLTOXGWGO-GARJFASQSA-N Pro-Gln-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@@H]2C(=O)O SKICPQLTOXGWGO-GARJFASQSA-N 0.000 description 2
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 2
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 2
- SRBFGSGDNNQABI-FHWLQOOXSA-N Pro-Leu-Trp Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C(=O)[C@@H]1CCCN1 SRBFGSGDNNQABI-FHWLQOOXSA-N 0.000 description 2
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 2
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 2
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 2
- FNGOXVQBBCMFKV-CIUDSAMLSA-N Pro-Ser-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O FNGOXVQBBCMFKV-CIUDSAMLSA-N 0.000 description 2
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 2
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 2
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 2
- WVXQQUWOKUZIEG-VEVYYDQMSA-N Pro-Thr-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O WVXQQUWOKUZIEG-VEVYYDQMSA-N 0.000 description 2
- OFSZYRZOUMNCCU-BZSNNMDCSA-N Pro-Trp-Met Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(O)=O)C(=O)[C@@H]1CCCN1 OFSZYRZOUMNCCU-BZSNNMDCSA-N 0.000 description 2
- XRGIDCGRSSWCKE-SRVKXCTJSA-N Pro-Val-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O XRGIDCGRSSWCKE-SRVKXCTJSA-N 0.000 description 2
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 2
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 2
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 2
- FCRMLGJMPXCAHD-FXQIFTODSA-N Ser-Arg-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O FCRMLGJMPXCAHD-FXQIFTODSA-N 0.000 description 2
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 2
- DSSOYPJWSWFOLK-CIUDSAMLSA-N Ser-Cys-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O DSSOYPJWSWFOLK-CIUDSAMLSA-N 0.000 description 2
- MPPHJZYXDVDGOF-BWBBJGPYSA-N Ser-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CO MPPHJZYXDVDGOF-BWBBJGPYSA-N 0.000 description 2
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 2
- OJPHFSOMBZKQKQ-GUBZILKMSA-N Ser-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO OJPHFSOMBZKQKQ-GUBZILKMSA-N 0.000 description 2
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 2
- GZBKRJVCRMZAST-XKBZYTNZSA-N Ser-Glu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZBKRJVCRMZAST-XKBZYTNZSA-N 0.000 description 2
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 2
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 2
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 2
- ZOPISOXXPQNOCO-SVSWQMSJSA-N Ser-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CO)N ZOPISOXXPQNOCO-SVSWQMSJSA-N 0.000 description 2
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 2
- KCNSGAMPBPYUAI-CIUDSAMLSA-N Ser-Leu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KCNSGAMPBPYUAI-CIUDSAMLSA-N 0.000 description 2
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 2
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 2
- QUGRFWPMPVIAPW-IHRRRGAJSA-N Ser-Pro-Phe Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QUGRFWPMPVIAPW-IHRRRGAJSA-N 0.000 description 2
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 2
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 2
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 2
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 2
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 2
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 2
- 208000021386 Sjogren Syndrome Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- YLXAMFZYJTZXFH-OLHMAJIHSA-N Thr-Asn-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O YLXAMFZYJTZXFH-OLHMAJIHSA-N 0.000 description 2
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 2
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 2
- GCXFWAZRHBRYEM-NUMRIWBASA-N Thr-Gln-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O GCXFWAZRHBRYEM-NUMRIWBASA-N 0.000 description 2
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 2
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 2
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 2
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 2
- IJVNLNRVDUTWDD-MEYUZBJRSA-N Thr-Leu-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IJVNLNRVDUTWDD-MEYUZBJRSA-N 0.000 description 2
- WRQLCVIALDUQEQ-UNQGMJICSA-N Thr-Phe-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WRQLCVIALDUQEQ-UNQGMJICSA-N 0.000 description 2
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 2
- NJGMALCNYAMYCB-JRQIVUDYSA-N Thr-Tyr-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJGMALCNYAMYCB-JRQIVUDYSA-N 0.000 description 2
- NRFTYDWKWGJLAR-MELADBBJSA-N Tyr-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O NRFTYDWKWGJLAR-MELADBBJSA-N 0.000 description 2
- CDBXVDXSLPLFMD-BPNCWPANSA-N Tyr-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDBXVDXSLPLFMD-BPNCWPANSA-N 0.000 description 2
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 2
- QFXVAFIHVWXXBJ-AVGNSLFASA-N Tyr-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O QFXVAFIHVWXXBJ-AVGNSLFASA-N 0.000 description 2
- AEOFMCAKYIQQFY-YDHLFZDLSA-N Tyr-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AEOFMCAKYIQQFY-YDHLFZDLSA-N 0.000 description 2
- 108010064997 VPY tripeptide Proteins 0.000 description 2
- DNOOLPROHJWCSQ-RCWTZXSCSA-N Val-Arg-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DNOOLPROHJWCSQ-RCWTZXSCSA-N 0.000 description 2
- BYOHPUZJVXWHAE-BYULHYEWSA-N Val-Asn-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BYOHPUZJVXWHAE-BYULHYEWSA-N 0.000 description 2
- VUTHNLMCXKLLFI-LAEOZQHASA-N Val-Asp-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VUTHNLMCXKLLFI-LAEOZQHASA-N 0.000 description 2
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 2
- PMDOQZFYGWZSTK-LSJOCFKGSA-N Val-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C PMDOQZFYGWZSTK-LSJOCFKGSA-N 0.000 description 2
- APEBUJBRGCMMHP-HJWJTTGWSA-N Val-Ile-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 APEBUJBRGCMMHP-HJWJTTGWSA-N 0.000 description 2
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 2
- YMTOEGGOCHVGEH-IHRRRGAJSA-N Val-Lys-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O YMTOEGGOCHVGEH-IHRRRGAJSA-N 0.000 description 2
- WSUWDIVCPOJFCX-TUAOUCFPSA-N Val-Met-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N WSUWDIVCPOJFCX-TUAOUCFPSA-N 0.000 description 2
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 2
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 2
- ZHWZDZFWBXWPDW-GUBZILKMSA-N Val-Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O ZHWZDZFWBXWPDW-GUBZILKMSA-N 0.000 description 2
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 2
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 2
- 102000004111 amphiphysin Human genes 0.000 description 2
- 108090000686 amphiphysin Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001466 anti-adreneric effect Effects 0.000 description 2
- 230000002788 anti-peptide Effects 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 238000002617 apheresis Methods 0.000 description 2
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 2
- 108010036533 arginylvaline Proteins 0.000 description 2
- 230000029586 bacterial cell surface binding Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000004154 complement system Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 108010069495 cysteinyltyrosine Proteins 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000001723 extracellular space Anatomy 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 2
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 108010013759 hepatoglobin Proteins 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 108010028295 histidylhistidine Proteins 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 102000050796 human HP Human genes 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 229940027941 immunoglobulin g Drugs 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010053037 kyotorphin Proteins 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- -1 lipids) Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 2
- 108010090114 methionyl-tyrosyl-lysine Proteins 0.000 description 2
- 108010085203 methionylmethionine Proteins 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 210000000715 neuromuscular junction Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 2
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- ULARYIUTHAWJMU-UHFFFAOYSA-M sodium;1-[4-(2,5-dioxopyrrol-1-yl)butanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O ULARYIUTHAWJMU-UHFFFAOYSA-M 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 108010078580 tyrosylleucine Proteins 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PVGATNRYUYNBHO-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-(2,5-dioxopyrrol-1-yl)butanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O PVGATNRYUYNBHO-UHFFFAOYSA-N 0.000 description 1
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- PQFMROVJTOPVDF-JBDRJPRFSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O PQFMROVJTOPVDF-JBDRJPRFSA-N 0.000 description 1
- UDTXUDHDIVNHCL-AENUQYPBSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UDTXUDHDIVNHCL-AENUQYPBSA-N 0.000 description 1
- DKHHZKDYCNRLEJ-NVAZTIMOSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-amino-4-methylpentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl] Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O DKHHZKDYCNRLEJ-NVAZTIMOSA-N 0.000 description 1
- DAZBILQQVFBVPE-XKKUQSFHSA-N (2s)-4-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-4-amino-2-[[2-[[(2r)-2-[[(2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexan Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O)CCC1 DAZBILQQVFBVPE-XKKUQSFHSA-N 0.000 description 1
- BNIFSVVAHBLNTN-XKKUQSFHSA-N (2s)-4-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-4-amino-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexan Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O)CCC1 BNIFSVVAHBLNTN-XKKUQSFHSA-N 0.000 description 1
- JPOKAKNGULMYHZ-UILVTTEASA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-3-(4-hydroxyp Chemical compound C([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C1=CC=C(O)C=C1 JPOKAKNGULMYHZ-UILVTTEASA-N 0.000 description 1
- MUSGYEMSJUFFHT-UWABRSFTSA-N 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[[(2S,3S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-methylcarbamoyl]-25-(3-amino-3-oxopropyl)-7-(3-carbamimidamidopropyl)-10-(1H-imidazol-5-ylmethyl)-19-(1H-indol-3-ylmethyl)-13,17-dimethyl-28-[(1-methylindol-3-yl)methyl]-6,9,12,15,18,21,24,27,30,33-decaoxo-31-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-22-yl]acetic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O MUSGYEMSJUFFHT-UWABRSFTSA-N 0.000 description 1
- YEJQWBFDKKTPNO-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-methylbutanoic acid Chemical compound CC(C)C(N)C(=O)N1CCCC1C(=O)NCC(=O)NC(C(C)C)C(O)=O YEJQWBFDKKTPNO-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- ORJCWNHUOREFAT-UHFFFAOYSA-N 7,8-dimethylquinoxalino[2,3-f][1,10]phenanthroline Chemical compound C1=CC=C2N=C(C=3C(=NC=C(C=3C)C)C=3C4=CC=CN=3)C4=NC2=C1 ORJCWNHUOREFAT-UHFFFAOYSA-N 0.000 description 1
- 102000003678 AMPA Receptors Human genes 0.000 description 1
- 108090000078 AMPA Receptors Proteins 0.000 description 1
- 102100030913 Acetylcholine receptor subunit alpha Human genes 0.000 description 1
- 101710082042 Acetylcholine receptor subunit alpha Proteins 0.000 description 1
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 1
- KQFRUSHJPKXBMB-BHDSKKPTSA-N Ala-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 KQFRUSHJPKXBMB-BHDSKKPTSA-N 0.000 description 1
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- ZEXDYVGDZJBRMO-ACZMJKKPSA-N Ala-Asn-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N ZEXDYVGDZJBRMO-ACZMJKKPSA-N 0.000 description 1
- GORKKVHIBWAQHM-GCJQMDKQSA-N Ala-Asn-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GORKKVHIBWAQHM-GCJQMDKQSA-N 0.000 description 1
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 1
- NJIFPLAJSVUQOZ-JBDRJPRFSA-N Ala-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N NJIFPLAJSVUQOZ-JBDRJPRFSA-N 0.000 description 1
- XAGIMRPOEJSYER-CIUDSAMLSA-N Ala-Cys-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N XAGIMRPOEJSYER-CIUDSAMLSA-N 0.000 description 1
- XYKDZXKKYOOTGC-FXQIFTODSA-N Ala-Cys-Met Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)O)N XYKDZXKKYOOTGC-FXQIFTODSA-N 0.000 description 1
- VIGKUFXFTPWYER-BIIVOSGPSA-N Ala-Cys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N VIGKUFXFTPWYER-BIIVOSGPSA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- NKJBKNVQHBZUIX-ACZMJKKPSA-N Ala-Gln-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKJBKNVQHBZUIX-ACZMJKKPSA-N 0.000 description 1
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 1
- BVSGPHDECMJBDE-HGNGGELXSA-N Ala-Glu-His Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N BVSGPHDECMJBDE-HGNGGELXSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- UHMQKOBNPRAZGB-CIUDSAMLSA-N Ala-Glu-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N UHMQKOBNPRAZGB-CIUDSAMLSA-N 0.000 description 1
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- GRPHQEMIFDPKOE-HGNGGELXSA-N Ala-His-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GRPHQEMIFDPKOE-HGNGGELXSA-N 0.000 description 1
- CBCCCLMNOBLBSC-XVYDVKMFSA-N Ala-His-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CBCCCLMNOBLBSC-XVYDVKMFSA-N 0.000 description 1
- GRIFPSOFWFIICX-GOPGUHFVSA-N Ala-His-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GRIFPSOFWFIICX-GOPGUHFVSA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- OPZJWMJPCNNZNT-DCAQKATOSA-N Ala-Leu-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N OPZJWMJPCNNZNT-DCAQKATOSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- VHEVVUZDDUCAKU-FXQIFTODSA-N Ala-Met-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O VHEVVUZDDUCAKU-FXQIFTODSA-N 0.000 description 1
- IHRGVZXPTIQNIP-NAKRPEOUSA-N Ala-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)N IHRGVZXPTIQNIP-NAKRPEOUSA-N 0.000 description 1
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 1
- DRARURMRLANNLS-GUBZILKMSA-N Ala-Met-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O DRARURMRLANNLS-GUBZILKMSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 1
- MAZZQZWCCYJQGZ-GUBZILKMSA-N Ala-Pro-Arg Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MAZZQZWCCYJQGZ-GUBZILKMSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- JNLDTVRGXMSYJC-UVBJJODRSA-N Ala-Pro-Trp Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JNLDTVRGXMSYJC-UVBJJODRSA-N 0.000 description 1
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 1
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 1
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 1
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 1
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 1
- JPOQZCHGOTWRTM-FQPOAREZSA-N Ala-Tyr-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPOQZCHGOTWRTM-FQPOAREZSA-N 0.000 description 1
- ZCUFMRIQCPNOHZ-NRPADANISA-N Ala-Val-Gln Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N ZCUFMRIQCPNOHZ-NRPADANISA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 102000012002 Aquaporin 4 Human genes 0.000 description 1
- 108010036280 Aquaporin 4 Proteins 0.000 description 1
- GXCSUJQOECMKPV-CIUDSAMLSA-N Arg-Ala-Gln Chemical compound C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GXCSUJQOECMKPV-CIUDSAMLSA-N 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 1
- VWVPYNGMOCSSGK-GUBZILKMSA-N Arg-Arg-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O VWVPYNGMOCSSGK-GUBZILKMSA-N 0.000 description 1
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 1
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 1
- RWWPBOUMKFBHAL-FXQIFTODSA-N Arg-Asn-Cys Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(O)=O RWWPBOUMKFBHAL-FXQIFTODSA-N 0.000 description 1
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 1
- IIABBYGHLYWVOS-FXQIFTODSA-N Arg-Asn-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O IIABBYGHLYWVOS-FXQIFTODSA-N 0.000 description 1
- OZNSCVPYWZRQPY-CIUDSAMLSA-N Arg-Asp-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OZNSCVPYWZRQPY-CIUDSAMLSA-N 0.000 description 1
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 1
- AHPWQERCDZTTNB-FXQIFTODSA-N Arg-Cys-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N AHPWQERCDZTTNB-FXQIFTODSA-N 0.000 description 1
- QIWYWCYNUMJBTC-CIUDSAMLSA-N Arg-Cys-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QIWYWCYNUMJBTC-CIUDSAMLSA-N 0.000 description 1
- YWENWUYXQUWRHQ-LPEHRKFASA-N Arg-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O YWENWUYXQUWRHQ-LPEHRKFASA-N 0.000 description 1
- RYRQZJVFDVWURI-SRVKXCTJSA-N Arg-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N RYRQZJVFDVWURI-SRVKXCTJSA-N 0.000 description 1
- OBFTYSPXDRROQO-SRVKXCTJSA-N Arg-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCN=C(N)N OBFTYSPXDRROQO-SRVKXCTJSA-N 0.000 description 1
- LLZXKVAAEWBUPB-KKUMJFAQSA-N Arg-Gln-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLZXKVAAEWBUPB-KKUMJFAQSA-N 0.000 description 1
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 1
- OGUPCHKBOKJFMA-SRVKXCTJSA-N Arg-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N OGUPCHKBOKJFMA-SRVKXCTJSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- NXDXECQFKHXHAM-HJGDQZAQSA-N Arg-Glu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NXDXECQFKHXHAM-HJGDQZAQSA-N 0.000 description 1
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 1
- AQPVUEJJARLJHB-BQBZGAKWSA-N Arg-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N AQPVUEJJARLJHB-BQBZGAKWSA-N 0.000 description 1
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 1
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
- SLNCSSWAIDUUGF-LSJOCFKGSA-N Arg-His-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O SLNCSSWAIDUUGF-LSJOCFKGSA-N 0.000 description 1
- BMNVSPMWMICFRV-DCAQKATOSA-N Arg-His-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CN=CN1 BMNVSPMWMICFRV-DCAQKATOSA-N 0.000 description 1
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 1
- CRCCTGPNZUCAHE-DCAQKATOSA-N Arg-His-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CN=CN1 CRCCTGPNZUCAHE-DCAQKATOSA-N 0.000 description 1
- DGFXIWKPTDKBLF-AVGNSLFASA-N Arg-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N DGFXIWKPTDKBLF-AVGNSLFASA-N 0.000 description 1
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 1
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 1
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 1
- OOIMKQRCPJBGPD-XUXIUFHCSA-N Arg-Ile-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O OOIMKQRCPJBGPD-XUXIUFHCSA-N 0.000 description 1
- OFIYLHVAAJYRBC-HJWJTTGWSA-N Arg-Ile-Phe Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O OFIYLHVAAJYRBC-HJWJTTGWSA-N 0.000 description 1
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 1
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- NPAVRDPEFVKELR-DCAQKATOSA-N Arg-Lys-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NPAVRDPEFVKELR-DCAQKATOSA-N 0.000 description 1
- NYDIVDKTULRINZ-AVGNSLFASA-N Arg-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NYDIVDKTULRINZ-AVGNSLFASA-N 0.000 description 1
- INXWADWANGLMPJ-JYJNAYRXSA-N Arg-Phe-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CC1=CC=CC=C1 INXWADWANGLMPJ-JYJNAYRXSA-N 0.000 description 1
- FKQITMVNILRUCQ-IHRRRGAJSA-N Arg-Phe-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O FKQITMVNILRUCQ-IHRRRGAJSA-N 0.000 description 1
- KZXPVYVSHUJCEO-ULQDDVLXSA-N Arg-Phe-Lys Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 KZXPVYVSHUJCEO-ULQDDVLXSA-N 0.000 description 1
- BSYKSCBTTQKOJG-GUBZILKMSA-N Arg-Pro-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BSYKSCBTTQKOJG-GUBZILKMSA-N 0.000 description 1
- OVQJAKFLFTZDNC-GUBZILKMSA-N Arg-Pro-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O OVQJAKFLFTZDNC-GUBZILKMSA-N 0.000 description 1
- HGKHPCFTRQDHCU-IUCAKERBSA-N Arg-Pro-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O HGKHPCFTRQDHCU-IUCAKERBSA-N 0.000 description 1
- STHNZYKCJHWULY-AVGNSLFASA-N Arg-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O STHNZYKCJHWULY-AVGNSLFASA-N 0.000 description 1
- FVBZXNSRIDVYJS-AVGNSLFASA-N Arg-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N FVBZXNSRIDVYJS-AVGNSLFASA-N 0.000 description 1
- AWMAZIIEFPFHCP-RCWTZXSCSA-N Arg-Pro-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O AWMAZIIEFPFHCP-RCWTZXSCSA-N 0.000 description 1
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 1
- AIFHRTPABBBHKU-RCWTZXSCSA-N Arg-Thr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AIFHRTPABBBHKU-RCWTZXSCSA-N 0.000 description 1
- UZSQXCMNUPKLCC-FJXKBIBVSA-N Arg-Thr-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UZSQXCMNUPKLCC-FJXKBIBVSA-N 0.000 description 1
- YNSUUAOAFCVINY-OSUNSFLBSA-N Arg-Thr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YNSUUAOAFCVINY-OSUNSFLBSA-N 0.000 description 1
- MOGMYRUNTKYZFB-UNQGMJICSA-N Arg-Thr-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MOGMYRUNTKYZFB-UNQGMJICSA-N 0.000 description 1
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 1
- INOIAEUXVVNJKA-XGEHTFHBSA-N Arg-Thr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O INOIAEUXVVNJKA-XGEHTFHBSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- NVPHRWNWTKYIST-BPNCWPANSA-N Arg-Tyr-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 NVPHRWNWTKYIST-BPNCWPANSA-N 0.000 description 1
- QJWLLRZTJFPCHA-STECZYCISA-N Arg-Tyr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QJWLLRZTJFPCHA-STECZYCISA-N 0.000 description 1
- FOWOZYAWODIRFZ-JYJNAYRXSA-N Arg-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCN=C(N)N)N FOWOZYAWODIRFZ-JYJNAYRXSA-N 0.000 description 1
- QCTOLCVIGRLMQS-HRCADAONSA-N Arg-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O QCTOLCVIGRLMQS-HRCADAONSA-N 0.000 description 1
- KEZVOBAKAXHMOF-GUBZILKMSA-N Arg-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N KEZVOBAKAXHMOF-GUBZILKMSA-N 0.000 description 1
- ISVACHFCVRKIDG-SRVKXCTJSA-N Arg-Val-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O ISVACHFCVRKIDG-SRVKXCTJSA-N 0.000 description 1
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 1
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 1
- CPTXATAOUQJQRO-GUBZILKMSA-N Arg-Val-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O CPTXATAOUQJQRO-GUBZILKMSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- RZVVKNIACROXRM-ZLUOBGJFSA-N Asn-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N RZVVKNIACROXRM-ZLUOBGJFSA-N 0.000 description 1
- LEFKSBYHUGUWLP-ACZMJKKPSA-N Asn-Ala-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LEFKSBYHUGUWLP-ACZMJKKPSA-N 0.000 description 1
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 1
- VDCIPFYVCICPEC-FXQIFTODSA-N Asn-Arg-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O VDCIPFYVCICPEC-FXQIFTODSA-N 0.000 description 1
- GMRGSBAMMMVDGG-GUBZILKMSA-N Asn-Arg-Arg Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N GMRGSBAMMMVDGG-GUBZILKMSA-N 0.000 description 1
- CIBWFJFMOBIFTE-CIUDSAMLSA-N Asn-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N CIBWFJFMOBIFTE-CIUDSAMLSA-N 0.000 description 1
- ACRYGQFHAQHDSF-ZLUOBGJFSA-N Asn-Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ACRYGQFHAQHDSF-ZLUOBGJFSA-N 0.000 description 1
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 1
- NVGWESORMHFISY-SRVKXCTJSA-N Asn-Asn-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NVGWESORMHFISY-SRVKXCTJSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- WVCJSDCHTUTONA-FXQIFTODSA-N Asn-Asp-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WVCJSDCHTUTONA-FXQIFTODSA-N 0.000 description 1
- JZRLLSOWDYUKOK-SRVKXCTJSA-N Asn-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N JZRLLSOWDYUKOK-SRVKXCTJSA-N 0.000 description 1
- SPIPSJXLZVTXJL-ZLUOBGJFSA-N Asn-Cys-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O SPIPSJXLZVTXJL-ZLUOBGJFSA-N 0.000 description 1
- UPALZCBCKAMGIY-PEFMBERDSA-N Asn-Gln-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UPALZCBCKAMGIY-PEFMBERDSA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- JZDZLBJVYWIIQU-AVGNSLFASA-N Asn-Glu-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JZDZLBJVYWIIQU-AVGNSLFASA-N 0.000 description 1
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
- ODBSSLHUFPJRED-CIUDSAMLSA-N Asn-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N ODBSSLHUFPJRED-CIUDSAMLSA-N 0.000 description 1
- SXNJBDYEBOUYOJ-DCAQKATOSA-N Asn-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)N)N SXNJBDYEBOUYOJ-DCAQKATOSA-N 0.000 description 1
- SUEIIIFUBHDCCS-PBCZWWQYSA-N Asn-His-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SUEIIIFUBHDCCS-PBCZWWQYSA-N 0.000 description 1
- ANPFQTJEPONRPL-UGYAYLCHSA-N Asn-Ile-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O ANPFQTJEPONRPL-UGYAYLCHSA-N 0.000 description 1
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
- SPCONPVIDFMDJI-QSFUFRPTSA-N Asn-Ile-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O SPCONPVIDFMDJI-QSFUFRPTSA-N 0.000 description 1
- KHCNTVRVAYCPQE-CIUDSAMLSA-N Asn-Lys-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O KHCNTVRVAYCPQE-CIUDSAMLSA-N 0.000 description 1
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 1
- UYRPHDGXHKBZHJ-CIUDSAMLSA-N Asn-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N UYRPHDGXHKBZHJ-CIUDSAMLSA-N 0.000 description 1
- HZZIFFOVHLWGCS-KKUMJFAQSA-N Asn-Phe-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O HZZIFFOVHLWGCS-KKUMJFAQSA-N 0.000 description 1
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 1
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 1
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 1
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 1
- QUMKPKWYDVMGNT-NUMRIWBASA-N Asn-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QUMKPKWYDVMGNT-NUMRIWBASA-N 0.000 description 1
- YHXNKGKUDJCAHB-PBCZWWQYSA-N Asn-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O YHXNKGKUDJCAHB-PBCZWWQYSA-N 0.000 description 1
- XEGZSHSPQNDNRH-JRQIVUDYSA-N Asn-Tyr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XEGZSHSPQNDNRH-JRQIVUDYSA-N 0.000 description 1
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 1
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 1
- KBQOUDLMWYWXNP-YDHLFZDLSA-N Asn-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KBQOUDLMWYWXNP-YDHLFZDLSA-N 0.000 description 1
- QXNGSPZMGFEZNO-QRTARXTBSA-N Asn-Val-Trp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QXNGSPZMGFEZNO-QRTARXTBSA-N 0.000 description 1
- XEDQMTWEYFBOIK-ACZMJKKPSA-N Asp-Ala-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XEDQMTWEYFBOIK-ACZMJKKPSA-N 0.000 description 1
- XPGVTUBABLRGHY-BIIVOSGPSA-N Asp-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N XPGVTUBABLRGHY-BIIVOSGPSA-N 0.000 description 1
- HTOZUYZQPICRAP-BPUTZDHNSA-N Asp-Arg-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N HTOZUYZQPICRAP-BPUTZDHNSA-N 0.000 description 1
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 1
- RDRMWJBLOSRRAW-BYULHYEWSA-N Asp-Asn-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O RDRMWJBLOSRRAW-BYULHYEWSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 1
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 1
- KGAJCJXBEWLQDZ-UBHSHLNASA-N Asp-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N KGAJCJXBEWLQDZ-UBHSHLNASA-N 0.000 description 1
- PXLNPFOJZQMXAT-BYULHYEWSA-N Asp-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O PXLNPFOJZQMXAT-BYULHYEWSA-N 0.000 description 1
- FMWHSNJMHUNLAG-FXQIFTODSA-N Asp-Cys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FMWHSNJMHUNLAG-FXQIFTODSA-N 0.000 description 1
- DXQOQMCLWWADMU-ACZMJKKPSA-N Asp-Gln-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DXQOQMCLWWADMU-ACZMJKKPSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 1
- SPWXXPFDTMYTRI-IUKAMOBKSA-N Asp-Ile-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SPWXXPFDTMYTRI-IUKAMOBKSA-N 0.000 description 1
- XLILXFRAKOYEJX-GUBZILKMSA-N Asp-Leu-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLILXFRAKOYEJX-GUBZILKMSA-N 0.000 description 1
- RQHLMGCXCZUOGT-ZPFDUUQYSA-N Asp-Leu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RQHLMGCXCZUOGT-ZPFDUUQYSA-N 0.000 description 1
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 1
- MYOHQBFRJQFIDZ-KKUMJFAQSA-N Asp-Leu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYOHQBFRJQFIDZ-KKUMJFAQSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 1
- YTXCCDCOHIYQFC-GUBZILKMSA-N Asp-Met-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTXCCDCOHIYQFC-GUBZILKMSA-N 0.000 description 1
- VMVUDJUXJKDGNR-FXQIFTODSA-N Asp-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N VMVUDJUXJKDGNR-FXQIFTODSA-N 0.000 description 1
- LIJXJYGRSRWLCJ-IHRRRGAJSA-N Asp-Phe-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LIJXJYGRSRWLCJ-IHRRRGAJSA-N 0.000 description 1
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 1
- PWAIZUBWHRHYKS-MELADBBJSA-N Asp-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)O)N)C(=O)O PWAIZUBWHRHYKS-MELADBBJSA-N 0.000 description 1
- KOWYNSKRPUWSFG-IHPCNDPISA-N Asp-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CC(=O)O)N KOWYNSKRPUWSFG-IHPCNDPISA-N 0.000 description 1
- GPPIDDWYKJPRES-YDHLFZDLSA-N Asp-Phe-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GPPIDDWYKJPRES-YDHLFZDLSA-N 0.000 description 1
- LOEKZJRUVGORIY-CAMMJAKZSA-N Asp-Phe-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=CC=C1 LOEKZJRUVGORIY-CAMMJAKZSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- HJZLUGQGJWXJCJ-CIUDSAMLSA-N Asp-Pro-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJZLUGQGJWXJCJ-CIUDSAMLSA-N 0.000 description 1
- XUVTWGPERWIERB-IHRRRGAJSA-N Asp-Pro-Phe Chemical compound N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O XUVTWGPERWIERB-IHRRRGAJSA-N 0.000 description 1
- GGRSYTUJHAZTFN-IHRRRGAJSA-N Asp-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O GGRSYTUJHAZTFN-IHRRRGAJSA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 1
- OZBXOELNJBSJOA-UBHSHLNASA-N Asp-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N OZBXOELNJBSJOA-UBHSHLNASA-N 0.000 description 1
- GWWSUMLEWKQHLR-NUMRIWBASA-N Asp-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GWWSUMLEWKQHLR-NUMRIWBASA-N 0.000 description 1
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 1
- KBJVTFWQWXCYCQ-IUKAMOBKSA-N Asp-Thr-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KBJVTFWQWXCYCQ-IUKAMOBKSA-N 0.000 description 1
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 1
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 1
- LEYKQPDPZJIRTA-AQZXSJQPSA-N Asp-Trp-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LEYKQPDPZJIRTA-AQZXSJQPSA-N 0.000 description 1
- HCOQNGIHSXICCB-IHRRRGAJSA-N Asp-Tyr-Arg Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O HCOQNGIHSXICCB-IHRRRGAJSA-N 0.000 description 1
- NJLLRXWFPQQPHV-SRVKXCTJSA-N Asp-Tyr-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJLLRXWFPQQPHV-SRVKXCTJSA-N 0.000 description 1
- CZIVKMOEXPILDK-SRVKXCTJSA-N Asp-Tyr-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O CZIVKMOEXPILDK-SRVKXCTJSA-N 0.000 description 1
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 1
- OQMGSMNZVHYDTQ-ZKWXMUAHSA-N Asp-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N OQMGSMNZVHYDTQ-ZKWXMUAHSA-N 0.000 description 1
- UXRVDHVARNBOIO-QSFUFRPTSA-N Asp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)N UXRVDHVARNBOIO-QSFUFRPTSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 102100040499 Contactin-associated protein-like 2 Human genes 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 108060002063 Cyclotide Proteins 0.000 description 1
- AMRLSQGGERHDHJ-FXQIFTODSA-N Cys-Ala-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMRLSQGGERHDHJ-FXQIFTODSA-N 0.000 description 1
- FMDCYTBSPZMPQE-JBDRJPRFSA-N Cys-Ala-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMDCYTBSPZMPQE-JBDRJPRFSA-N 0.000 description 1
- NOCCABSVTRONIN-CIUDSAMLSA-N Cys-Ala-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CS)N NOCCABSVTRONIN-CIUDSAMLSA-N 0.000 description 1
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 1
- WVJHEDOLHPZLRV-CIUDSAMLSA-N Cys-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N WVJHEDOLHPZLRV-CIUDSAMLSA-N 0.000 description 1
- UUERSUCTHOZPMG-SRVKXCTJSA-N Cys-Asn-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UUERSUCTHOZPMG-SRVKXCTJSA-N 0.000 description 1
- IIGHQOPGMGKDMT-SRVKXCTJSA-N Cys-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N IIGHQOPGMGKDMT-SRVKXCTJSA-N 0.000 description 1
- BVFQOPGFOQVZTE-ACZMJKKPSA-N Cys-Gln-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O BVFQOPGFOQVZTE-ACZMJKKPSA-N 0.000 description 1
- KEBJBKIASQVRJS-WDSKDSINSA-N Cys-Gln-Gly Chemical compound C(CC(=O)N)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N KEBJBKIASQVRJS-WDSKDSINSA-N 0.000 description 1
- UDPSLLFHOLGXBY-FXQIFTODSA-N Cys-Glu-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDPSLLFHOLGXBY-FXQIFTODSA-N 0.000 description 1
- MUZAUPFGPMMZSS-GUBZILKMSA-N Cys-Glu-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N MUZAUPFGPMMZSS-GUBZILKMSA-N 0.000 description 1
- SBORMUFGKSCGEN-XHNCKOQMSA-N Cys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N)C(=O)O SBORMUFGKSCGEN-XHNCKOQMSA-N 0.000 description 1
- DZLQXIFVQFTFJY-BYPYZUCNSA-N Cys-Gly-Gly Chemical compound SC[C@H](N)C(=O)NCC(=O)NCC(O)=O DZLQXIFVQFTFJY-BYPYZUCNSA-N 0.000 description 1
- LBOLGUYQEPZSKM-YUMQZZPRSA-N Cys-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N LBOLGUYQEPZSKM-YUMQZZPRSA-N 0.000 description 1
- CUXIOFHFFXNUGG-HTFCKZLJSA-N Cys-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CS)N CUXIOFHFFXNUGG-HTFCKZLJSA-N 0.000 description 1
- WVLZTXGTNGHPBO-SRVKXCTJSA-N Cys-Leu-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O WVLZTXGTNGHPBO-SRVKXCTJSA-N 0.000 description 1
- SRIRHERUAMYIOQ-CIUDSAMLSA-N Cys-Leu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SRIRHERUAMYIOQ-CIUDSAMLSA-N 0.000 description 1
- VDUPGIDTWNQAJD-CIUDSAMLSA-N Cys-Lys-Cys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(O)=O VDUPGIDTWNQAJD-CIUDSAMLSA-N 0.000 description 1
- BNCKELUXXUYRNY-GUBZILKMSA-N Cys-Lys-Glu Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N BNCKELUXXUYRNY-GUBZILKMSA-N 0.000 description 1
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 1
- ABLQPNMKLMFDQU-BIIVOSGPSA-N Cys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CS)N)C(=O)O ABLQPNMKLMFDQU-BIIVOSGPSA-N 0.000 description 1
- YNJBLTDKTMKEET-ZLUOBGJFSA-N Cys-Ser-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O YNJBLTDKTMKEET-ZLUOBGJFSA-N 0.000 description 1
- IQXSTXKVEMRMMB-XAVMHZPKSA-N Cys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N)O IQXSTXKVEMRMMB-XAVMHZPKSA-N 0.000 description 1
- HPZAJRPYUIHDIN-BZSNNMDCSA-N Cys-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N HPZAJRPYUIHDIN-BZSNNMDCSA-N 0.000 description 1
- FCXJJTRGVAZDER-FXQIFTODSA-N Cys-Val-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O FCXJJTRGVAZDER-FXQIFTODSA-N 0.000 description 1
- MHYHLWUGWUBUHF-GUBZILKMSA-N Cys-Val-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N MHYHLWUGWUBUHF-GUBZILKMSA-N 0.000 description 1
- 108091008102 DNA aptamers Proteins 0.000 description 1
- 206010011968 Decreased immune responsiveness Diseases 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102100036966 Dipeptidyl aminopeptidase-like protein 6 Human genes 0.000 description 1
- 101710092625 Dipeptidyl aminopeptidase-like protein 6 Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006396 Ephrin-B2 Human genes 0.000 description 1
- 108010044090 Ephrin-B2 Proteins 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 108010020195 FLAG peptide Proteins 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 102000010451 Folate receptor alpha Human genes 0.000 description 1
- 108050001931 Folate receptor alpha Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102000027484 GABAA receptors Human genes 0.000 description 1
- 108091008681 GABAA receptors Proteins 0.000 description 1
- 241001669573 Galeorhinus galeus Species 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- INKFLNZBTSNFON-CIUDSAMLSA-N Gln-Ala-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O INKFLNZBTSNFON-CIUDSAMLSA-N 0.000 description 1
- MLZRSFQRBDNJON-GUBZILKMSA-N Gln-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MLZRSFQRBDNJON-GUBZILKMSA-N 0.000 description 1
- JSYULGSPLTZDHM-NRPADANISA-N Gln-Ala-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O JSYULGSPLTZDHM-NRPADANISA-N 0.000 description 1
- KWUSGAIFNHQCBY-DCAQKATOSA-N Gln-Arg-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O KWUSGAIFNHQCBY-DCAQKATOSA-N 0.000 description 1
- PRBLYKYHAJEABA-SRVKXCTJSA-N Gln-Arg-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O PRBLYKYHAJEABA-SRVKXCTJSA-N 0.000 description 1
- PHZYLYASFWHLHJ-FXQIFTODSA-N Gln-Asn-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PHZYLYASFWHLHJ-FXQIFTODSA-N 0.000 description 1
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 1
- LVNILKSSFHCSJZ-IHRRRGAJSA-N Gln-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LVNILKSSFHCSJZ-IHRRRGAJSA-N 0.000 description 1
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 1
- ZQPOVSJFBBETHQ-CIUDSAMLSA-N Gln-Glu-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZQPOVSJFBBETHQ-CIUDSAMLSA-N 0.000 description 1
- JEFZIKRIDLHOIF-BYPYZUCNSA-N Gln-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(O)=O JEFZIKRIDLHOIF-BYPYZUCNSA-N 0.000 description 1
- NSORZJXKUQFEKL-JGVFFNPUSA-N Gln-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)N)N)C(=O)O NSORZJXKUQFEKL-JGVFFNPUSA-N 0.000 description 1
- ICDIMQAMJGDHSE-GUBZILKMSA-N Gln-His-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O ICDIMQAMJGDHSE-GUBZILKMSA-N 0.000 description 1
- GQZDDFRXSDGUNG-YVNDNENWSA-N Gln-Ile-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O GQZDDFRXSDGUNG-YVNDNENWSA-N 0.000 description 1
- ZNTDJIMJKNNSLR-RWRJDSDZSA-N Gln-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N ZNTDJIMJKNNSLR-RWRJDSDZSA-N 0.000 description 1
- LGIKBBLQVSWUGK-DCAQKATOSA-N Gln-Leu-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LGIKBBLQVSWUGK-DCAQKATOSA-N 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 1
- IHSGESFHTMFHRB-GUBZILKMSA-N Gln-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O IHSGESFHTMFHRB-GUBZILKMSA-N 0.000 description 1
- LURQDGKYBFWWJA-MNXVOIDGSA-N Gln-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N LURQDGKYBFWWJA-MNXVOIDGSA-N 0.000 description 1
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 1
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 1
- DQLVHRFFBQOWFL-JYJNAYRXSA-N Gln-Lys-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)O DQLVHRFFBQOWFL-JYJNAYRXSA-N 0.000 description 1
- QKWBEMCLYTYBNI-GVXVVHGQSA-N Gln-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O QKWBEMCLYTYBNI-GVXVVHGQSA-N 0.000 description 1
- DOQUICBEISTQHE-CIUDSAMLSA-N Gln-Pro-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O DOQUICBEISTQHE-CIUDSAMLSA-N 0.000 description 1
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 1
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 1
- MQJDLNRXBOELJW-KKUMJFAQSA-N Gln-Pro-Phe Chemical compound N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O MQJDLNRXBOELJW-KKUMJFAQSA-N 0.000 description 1
- YPFFHGRJCUBXPX-NHCYSSNCSA-N Gln-Pro-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(O)=O YPFFHGRJCUBXPX-NHCYSSNCSA-N 0.000 description 1
- OKQLXOYFUPVEHI-CIUDSAMLSA-N Gln-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N OKQLXOYFUPVEHI-CIUDSAMLSA-N 0.000 description 1
- BYKZWDGMJLNFJY-XKBZYTNZSA-N Gln-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)O BYKZWDGMJLNFJY-XKBZYTNZSA-N 0.000 description 1
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 1
- NHMRJKKAVMENKJ-WDCWCFNPSA-N Gln-Thr-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NHMRJKKAVMENKJ-WDCWCFNPSA-N 0.000 description 1
- XFHMVFKCQSHLKW-HJGDQZAQSA-N Gln-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O XFHMVFKCQSHLKW-HJGDQZAQSA-N 0.000 description 1
- HLRLXVPRJJITSK-IFFSRLJSSA-N Gln-Thr-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HLRLXVPRJJITSK-IFFSRLJSSA-N 0.000 description 1
- NSEKYCAADBNQFE-XIRDDKMYSA-N Gln-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(N)=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 NSEKYCAADBNQFE-XIRDDKMYSA-N 0.000 description 1
- VYOILACOFPPNQH-UMNHJUIQSA-N Gln-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N VYOILACOFPPNQH-UMNHJUIQSA-N 0.000 description 1
- FHPXTPQBODWBIY-CIUDSAMLSA-N Glu-Ala-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHPXTPQBODWBIY-CIUDSAMLSA-N 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- WOMUDRVDJMHTCV-DCAQKATOSA-N Glu-Arg-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOMUDRVDJMHTCV-DCAQKATOSA-N 0.000 description 1
- KEBACWCLVOXFNC-DCAQKATOSA-N Glu-Arg-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O KEBACWCLVOXFNC-DCAQKATOSA-N 0.000 description 1
- WOSRKEJQESVHGA-CIUDSAMLSA-N Glu-Arg-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O WOSRKEJQESVHGA-CIUDSAMLSA-N 0.000 description 1
- SYDJILXOZNEEDK-XIRDDKMYSA-N Glu-Arg-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O SYDJILXOZNEEDK-XIRDDKMYSA-N 0.000 description 1
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 description 1
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 1
- VAZZOGXDUQSVQF-NUMRIWBASA-N Glu-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)O VAZZOGXDUQSVQF-NUMRIWBASA-N 0.000 description 1
- NTBDVNJIWCKURJ-ACZMJKKPSA-N Glu-Asp-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NTBDVNJIWCKURJ-ACZMJKKPSA-N 0.000 description 1
- NADWTMLCUDMDQI-ACZMJKKPSA-N Glu-Asp-Cys Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N NADWTMLCUDMDQI-ACZMJKKPSA-N 0.000 description 1
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 1
- PBFGQTGPSKWHJA-QEJZJMRPSA-N Glu-Asp-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PBFGQTGPSKWHJA-QEJZJMRPSA-N 0.000 description 1
- CYHBMLHCQXXCCT-AVGNSLFASA-N Glu-Asp-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CYHBMLHCQXXCCT-AVGNSLFASA-N 0.000 description 1
- FLQAKQOBSPFGKG-CIUDSAMLSA-N Glu-Cys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FLQAKQOBSPFGKG-CIUDSAMLSA-N 0.000 description 1
- ZZIFPJZQHRJERU-WDSKDSINSA-N Glu-Cys-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O ZZIFPJZQHRJERU-WDSKDSINSA-N 0.000 description 1
- RQNYYRHRKSVKAB-GUBZILKMSA-N Glu-Cys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O RQNYYRHRKSVKAB-GUBZILKMSA-N 0.000 description 1
- GFLQTABMFBXRIY-GUBZILKMSA-N Glu-Gln-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GFLQTABMFBXRIY-GUBZILKMSA-N 0.000 description 1
- XHWLNISLUFEWNS-CIUDSAMLSA-N Glu-Gln-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XHWLNISLUFEWNS-CIUDSAMLSA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 1
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 1
- NUSWUSKZRCGFEX-FXQIFTODSA-N Glu-Glu-Cys Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(O)=O NUSWUSKZRCGFEX-FXQIFTODSA-N 0.000 description 1
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 1
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 1
- YLJHCWNDBKKOEB-IHRRRGAJSA-N Glu-Glu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YLJHCWNDBKKOEB-IHRRRGAJSA-N 0.000 description 1
- LSPKYLAFTPBWIL-BYPYZUCNSA-N Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(O)=O LSPKYLAFTPBWIL-BYPYZUCNSA-N 0.000 description 1
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 1
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 1
- ZCOJVESMNGBGLF-GRLWGSQLSA-N Glu-Ile-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZCOJVESMNGBGLF-GRLWGSQLSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 1
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 1
- HQOGXFLBAKJUMH-CIUDSAMLSA-N Glu-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N HQOGXFLBAKJUMH-CIUDSAMLSA-N 0.000 description 1
- PMSMKNYRZCKVMC-DRZSPHRISA-N Glu-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)N PMSMKNYRZCKVMC-DRZSPHRISA-N 0.000 description 1
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 1
- UDEPRBFQTWGLCW-CIUDSAMLSA-N Glu-Pro-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O UDEPRBFQTWGLCW-CIUDSAMLSA-N 0.000 description 1
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 1
- DCBSZJJHOTXMHY-DCAQKATOSA-N Glu-Pro-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DCBSZJJHOTXMHY-DCAQKATOSA-N 0.000 description 1
- DAHLWSFUXOHMIA-FXQIFTODSA-N Glu-Ser-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O DAHLWSFUXOHMIA-FXQIFTODSA-N 0.000 description 1
- VNCNWQPIQYAMAK-ACZMJKKPSA-N Glu-Ser-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O VNCNWQPIQYAMAK-ACZMJKKPSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- TWYSSILQABLLME-HJGDQZAQSA-N Glu-Thr-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TWYSSILQABLLME-HJGDQZAQSA-N 0.000 description 1
- BDISFWMLMNBTGP-NUMRIWBASA-N Glu-Thr-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O BDISFWMLMNBTGP-NUMRIWBASA-N 0.000 description 1
- LWYUQLZOIORFFJ-XKBZYTNZSA-N Glu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O LWYUQLZOIORFFJ-XKBZYTNZSA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 1
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 1
- YOTHMZZSJKKEHZ-SZMVWBNQSA-N Glu-Trp-Lys Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CCC(O)=O)=CNC2=C1 YOTHMZZSJKKEHZ-SZMVWBNQSA-N 0.000 description 1
- SFKMXFWWDUGXRT-NWLDYVSISA-N Glu-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N)O SFKMXFWWDUGXRT-NWLDYVSISA-N 0.000 description 1
- PMSDOVISAARGAV-FHWLQOOXSA-N Glu-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 PMSDOVISAARGAV-FHWLQOOXSA-N 0.000 description 1
- KXRORHJIRAOQPG-SOUVJXGZSA-N Glu-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KXRORHJIRAOQPG-SOUVJXGZSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 1
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- 102100035857 Glutamate decarboxylase 2 Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- WJZLEENECIOOSA-WDSKDSINSA-N Gly-Asn-Gln Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O WJZLEENECIOOSA-WDSKDSINSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 1
- XEJTYSCIXKYSHR-WDSKDSINSA-N Gly-Asp-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN XEJTYSCIXKYSHR-WDSKDSINSA-N 0.000 description 1
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 1
- RPLLQZBOVIVGMX-QWRGUYRKSA-N Gly-Asp-Phe Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RPLLQZBOVIVGMX-QWRGUYRKSA-N 0.000 description 1
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 1
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 1
- QGZSAHIZRQHCEQ-QWRGUYRKSA-N Gly-Asp-Tyr Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QGZSAHIZRQHCEQ-QWRGUYRKSA-N 0.000 description 1
- YZACQYVWLCQWBT-BQBZGAKWSA-N Gly-Cys-Arg Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YZACQYVWLCQWBT-BQBZGAKWSA-N 0.000 description 1
- MQVNVZUEPUIAFA-WDSKDSINSA-N Gly-Cys-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)CN MQVNVZUEPUIAFA-WDSKDSINSA-N 0.000 description 1
- SABZDFAAOJATBR-QWRGUYRKSA-N Gly-Cys-Phe Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SABZDFAAOJATBR-QWRGUYRKSA-N 0.000 description 1
- BPQYBFAXRGMGGY-LAEOZQHASA-N Gly-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN BPQYBFAXRGMGGY-LAEOZQHASA-N 0.000 description 1
- JUGQPPOVWXSPKJ-RYUDHWBXSA-N Gly-Gln-Phe Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JUGQPPOVWXSPKJ-RYUDHWBXSA-N 0.000 description 1
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 1
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 1
- BEQGFMIBZFNROK-JGVFFNPUSA-N Gly-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)O BEQGFMIBZFNROK-JGVFFNPUSA-N 0.000 description 1
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 1
- GDOZQTNZPCUARW-YFKPBYRVSA-N Gly-Gly-Glu Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O GDOZQTNZPCUARW-YFKPBYRVSA-N 0.000 description 1
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 1
- QITBQGJOXQYMOA-ZETCQYMHSA-N Gly-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QITBQGJOXQYMOA-ZETCQYMHSA-N 0.000 description 1
- ADZGCWWDPFDHCY-ZETCQYMHSA-N Gly-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 ADZGCWWDPFDHCY-ZETCQYMHSA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- SXJHOPPTOJACOA-QXEWZRGKSA-N Gly-Ile-Arg Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SXJHOPPTOJACOA-QXEWZRGKSA-N 0.000 description 1
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 1
- UESJMAMHDLEHGM-NHCYSSNCSA-N Gly-Ile-Leu Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O UESJMAMHDLEHGM-NHCYSSNCSA-N 0.000 description 1
- FCKPEGOCSVZPNC-WHOFXGATSA-N Gly-Ile-Phe Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FCKPEGOCSVZPNC-WHOFXGATSA-N 0.000 description 1
- YIFUFYZELCMPJP-YUMQZZPRSA-N Gly-Leu-Cys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O YIFUFYZELCMPJP-YUMQZZPRSA-N 0.000 description 1
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 1
- FHQRLHFYVZAQHU-IUCAKERBSA-N Gly-Lys-Gln Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O FHQRLHFYVZAQHU-IUCAKERBSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- MHZXESQPPXOING-KBPBESRZSA-N Gly-Lys-Phe Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MHZXESQPPXOING-KBPBESRZSA-N 0.000 description 1
- MDKCBHZLQJZOCJ-STQMWFEESA-N Gly-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)CN MDKCBHZLQJZOCJ-STQMWFEESA-N 0.000 description 1
- WDXLKVQATNEAJQ-BQBZGAKWSA-N Gly-Pro-Asp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WDXLKVQATNEAJQ-BQBZGAKWSA-N 0.000 description 1
- NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 description 1
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 1
- GAAHQHNCMIAYEX-UWVGGRQHSA-N Gly-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GAAHQHNCMIAYEX-UWVGGRQHSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- YABRDIBSPZONIY-BQBZGAKWSA-N Gly-Ser-Met Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O YABRDIBSPZONIY-BQBZGAKWSA-N 0.000 description 1
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 1
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 1
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 1
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 1
- JKSMZVCGQWVTBW-STQMWFEESA-N Gly-Trp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O JKSMZVCGQWVTBW-STQMWFEESA-N 0.000 description 1
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 1
- YDIDLLVFCYSXNY-RCOVLWMOSA-N Gly-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN YDIDLLVFCYSXNY-RCOVLWMOSA-N 0.000 description 1
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- IZVICCORZOSGPT-JSGCOSHPSA-N Gly-Val-Tyr Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IZVICCORZOSGPT-JSGCOSHPSA-N 0.000 description 1
- 102000011714 Glycine Receptors Human genes 0.000 description 1
- 108010076533 Glycine Receptors Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000003807 Graves Disease Diseases 0.000 description 1
- 208000015023 Graves' disease Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- ZNPRMNDAFQKATM-LKTVYLICSA-N His-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZNPRMNDAFQKATM-LKTVYLICSA-N 0.000 description 1
- TVQGUFGDVODUIF-LSJOCFKGSA-N His-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CN=CN1)N TVQGUFGDVODUIF-LSJOCFKGSA-N 0.000 description 1
- PDSUIXMZYNURGI-AVGNSLFASA-N His-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CN=CN1 PDSUIXMZYNURGI-AVGNSLFASA-N 0.000 description 1
- TTZAWSKKNCEINZ-AVGNSLFASA-N His-Arg-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O TTZAWSKKNCEINZ-AVGNSLFASA-N 0.000 description 1
- YJBMLTVVVRJNOK-SRVKXCTJSA-N His-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N YJBMLTVVVRJNOK-SRVKXCTJSA-N 0.000 description 1
- LMMPTUVWHCFTOT-GARJFASQSA-N His-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O LMMPTUVWHCFTOT-GARJFASQSA-N 0.000 description 1
- LBHOVGUGOBINDL-KKUMJFAQSA-N His-Asp-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O LBHOVGUGOBINDL-KKUMJFAQSA-N 0.000 description 1
- JFFAPRNXXLRINI-NHCYSSNCSA-N His-Asp-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JFFAPRNXXLRINI-NHCYSSNCSA-N 0.000 description 1
- AASLOGQZZKZWKH-SRVKXCTJSA-N His-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AASLOGQZZKZWKH-SRVKXCTJSA-N 0.000 description 1
- LBCAQRFTWMMWRR-CIUDSAMLSA-N His-Cys-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O LBCAQRFTWMMWRR-CIUDSAMLSA-N 0.000 description 1
- SWSVTNGMKBDTBM-DCAQKATOSA-N His-Gln-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SWSVTNGMKBDTBM-DCAQKATOSA-N 0.000 description 1
- KNNSUUOHFVVJOP-GUBZILKMSA-N His-Glu-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N KNNSUUOHFVVJOP-GUBZILKMSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- JBSLJUPMTYLLFH-MELADBBJSA-N His-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CN=CN3)N)C(=O)O JBSLJUPMTYLLFH-MELADBBJSA-N 0.000 description 1
- MPXGJGBXCRQQJE-MXAVVETBSA-N His-Ile-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O MPXGJGBXCRQQJE-MXAVVETBSA-N 0.000 description 1
- SKOKHBGDXGTDDP-MELADBBJSA-N His-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N SKOKHBGDXGTDDP-MELADBBJSA-N 0.000 description 1
- VUUFXXGKMPLKNH-BZSNNMDCSA-N His-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N VUUFXXGKMPLKNH-BZSNNMDCSA-N 0.000 description 1
- HYWZHNUGAYVEEW-KKUMJFAQSA-N His-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N HYWZHNUGAYVEEW-KKUMJFAQSA-N 0.000 description 1
- WHKLDLQHSYAVGU-ACRUOGEOSA-N His-Phe-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WHKLDLQHSYAVGU-ACRUOGEOSA-N 0.000 description 1
- XJFITURPHAKKAI-SRVKXCTJSA-N His-Pro-Gln Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C1=CN=CN1 XJFITURPHAKKAI-SRVKXCTJSA-N 0.000 description 1
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 1
- FHKZHRMERJUXRJ-DCAQKATOSA-N His-Ser-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 FHKZHRMERJUXRJ-DCAQKATOSA-N 0.000 description 1
- JMSONHOUHFDOJH-GUBZILKMSA-N His-Ser-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 JMSONHOUHFDOJH-GUBZILKMSA-N 0.000 description 1
- UOYGZBIPZYKGSH-SRVKXCTJSA-N His-Ser-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N UOYGZBIPZYKGSH-SRVKXCTJSA-N 0.000 description 1
- GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- FFKJUTZARGRVTH-KKUMJFAQSA-N His-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O FFKJUTZARGRVTH-KKUMJFAQSA-N 0.000 description 1
- UPJODPVSKKWGDQ-KLHWPWHYSA-N His-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O UPJODPVSKKWGDQ-KLHWPWHYSA-N 0.000 description 1
- SWBUZLFWGJETAO-KKUMJFAQSA-N His-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O SWBUZLFWGJETAO-KKUMJFAQSA-N 0.000 description 1
- WSAILOWUJZEAGC-DCAQKATOSA-N His-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N WSAILOWUJZEAGC-DCAQKATOSA-N 0.000 description 1
- FBOMZVOKCZMDIG-XQQFMLRXSA-N His-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N FBOMZVOKCZMDIG-XQQFMLRXSA-N 0.000 description 1
- 101000929495 Homo sapiens Adenosine deaminase Proteins 0.000 description 1
- 101000959437 Homo sapiens Beta-2 adrenergic receptor Proteins 0.000 description 1
- 101000749877 Homo sapiens Contactin-associated protein-like 2 Proteins 0.000 description 1
- 101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 101000620451 Homo sapiens Leucine-rich glioma-inactivated protein 1 Proteins 0.000 description 1
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
- 101001094820 Homo sapiens Paraneoplastic antigen Ma2 Proteins 0.000 description 1
- YKRYHWJRQUSTKG-KBIXCLLPSA-N Ile-Ala-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKRYHWJRQUSTKG-KBIXCLLPSA-N 0.000 description 1
- JRHFQUPIZOYKQP-KBIXCLLPSA-N Ile-Ala-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O JRHFQUPIZOYKQP-KBIXCLLPSA-N 0.000 description 1
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 1
- QLRMMMQNCWBNPQ-QXEWZRGKSA-N Ile-Arg-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)N QLRMMMQNCWBNPQ-QXEWZRGKSA-N 0.000 description 1
- DMHGKBGOUAJRHU-UHFFFAOYSA-N Ile-Arg-Pro Natural products CCC(C)C(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O DMHGKBGOUAJRHU-UHFFFAOYSA-N 0.000 description 1
- FJWYJQRCVNGEAQ-ZPFDUUQYSA-N Ile-Asn-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N FJWYJQRCVNGEAQ-ZPFDUUQYSA-N 0.000 description 1
- ZZHGKECPZXPXJF-PCBIJLKTSA-N Ile-Asn-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZZHGKECPZXPXJF-PCBIJLKTSA-N 0.000 description 1
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 1
- DCQMJRSOGCYKTR-GHCJXIJMSA-N Ile-Asp-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O DCQMJRSOGCYKTR-GHCJXIJMSA-N 0.000 description 1
- LDRALPZEVHVXEK-KBIXCLLPSA-N Ile-Cys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N LDRALPZEVHVXEK-KBIXCLLPSA-N 0.000 description 1
- HOLOYAZCIHDQNS-YVNDNENWSA-N Ile-Gln-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HOLOYAZCIHDQNS-YVNDNENWSA-N 0.000 description 1
- ZGGWRNBSBOHIGH-HVTMNAMFSA-N Ile-Gln-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZGGWRNBSBOHIGH-HVTMNAMFSA-N 0.000 description 1
- KUHFPGIVBOCRMV-MNXVOIDGSA-N Ile-Gln-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N KUHFPGIVBOCRMV-MNXVOIDGSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- IXEFKXAGHRQFAF-HVTMNAMFSA-N Ile-Glu-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N IXEFKXAGHRQFAF-HVTMNAMFSA-N 0.000 description 1
- SPQWWEZBHXHUJN-KBIXCLLPSA-N Ile-Glu-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O SPQWWEZBHXHUJN-KBIXCLLPSA-N 0.000 description 1
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 1
- LNJLOZYNZFGJMM-DEQVHRJGSA-N Ile-His-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N LNJLOZYNZFGJMM-DEQVHRJGSA-N 0.000 description 1
- KYLIZSDYWQQTFM-PEDHHIEDSA-N Ile-Ile-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N KYLIZSDYWQQTFM-PEDHHIEDSA-N 0.000 description 1
- YNMQUIVKEFRCPH-QSFUFRPTSA-N Ile-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O)N YNMQUIVKEFRCPH-QSFUFRPTSA-N 0.000 description 1
- DMSVBUWGDLYNLC-IAVJCBSLSA-N Ile-Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DMSVBUWGDLYNLC-IAVJCBSLSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- PKGGWLOLRLOPGK-XUXIUFHCSA-N Ile-Leu-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PKGGWLOLRLOPGK-XUXIUFHCSA-N 0.000 description 1
- TWYOYAKMLHWMOJ-ZPFDUUQYSA-N Ile-Leu-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O TWYOYAKMLHWMOJ-ZPFDUUQYSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 description 1
- HPCFRQWLTRDGHT-AJNGGQMLSA-N Ile-Leu-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O HPCFRQWLTRDGHT-AJNGGQMLSA-N 0.000 description 1
- FCWFBHMAJZGWRY-XUXIUFHCSA-N Ile-Leu-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N FCWFBHMAJZGWRY-XUXIUFHCSA-N 0.000 description 1
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 1
- DSDPLOODKXISDT-XUXIUFHCSA-N Ile-Leu-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O DSDPLOODKXISDT-XUXIUFHCSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- RCMNUBZKIIJCOI-ZPFDUUQYSA-N Ile-Met-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RCMNUBZKIIJCOI-ZPFDUUQYSA-N 0.000 description 1
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 1
- KTTMFLSBTNBAHL-MXAVVETBSA-N Ile-Phe-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N KTTMFLSBTNBAHL-MXAVVETBSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- LRAUKBMYHHNADU-DKIMLUQUSA-N Ile-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CC=CC=C1 LRAUKBMYHHNADU-DKIMLUQUSA-N 0.000 description 1
- FGBRXCZYVRFNKQ-MXAVVETBSA-N Ile-Phe-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N FGBRXCZYVRFNKQ-MXAVVETBSA-N 0.000 description 1
- XQLGNKLSPYCRMZ-HJWJTTGWSA-N Ile-Phe-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)O)N XQLGNKLSPYCRMZ-HJWJTTGWSA-N 0.000 description 1
- VISRCHQHQCLODA-NAKRPEOUSA-N Ile-Pro-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N VISRCHQHQCLODA-NAKRPEOUSA-N 0.000 description 1
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 1
- FBGXMKUWQFPHFB-JBDRJPRFSA-N Ile-Ser-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N FBGXMKUWQFPHFB-JBDRJPRFSA-N 0.000 description 1
- NAFIFZNBSPWYOO-RWRJDSDZSA-N Ile-Thr-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N NAFIFZNBSPWYOO-RWRJDSDZSA-N 0.000 description 1
- KBDIBHQICWDGDL-PPCPHDFISA-N Ile-Thr-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N KBDIBHQICWDGDL-PPCPHDFISA-N 0.000 description 1
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 1
- RTSQPLLOYSGMKM-DSYPUSFNSA-N Ile-Trp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)O)N RTSQPLLOYSGMKM-DSYPUSFNSA-N 0.000 description 1
- FXJLRZFMKGHYJP-CFMVVWHZSA-N Ile-Tyr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FXJLRZFMKGHYJP-CFMVVWHZSA-N 0.000 description 1
- REXAUQBGSGDEJY-IGISWZIWSA-N Ile-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N REXAUQBGSGDEJY-IGISWZIWSA-N 0.000 description 1
- GVEODXUBBFDBPW-MGHWNKPDSA-N Ile-Tyr-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 GVEODXUBBFDBPW-MGHWNKPDSA-N 0.000 description 1
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 1
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 1
- UYODHPPSCXBNCS-XUXIUFHCSA-N Ile-Val-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C UYODHPPSCXBNCS-XUXIUFHCSA-N 0.000 description 1
- NJGXXYLPDMMFJB-XUXIUFHCSA-N Ile-Val-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N NJGXXYLPDMMFJB-XUXIUFHCSA-N 0.000 description 1
- YHFPHRUWZMEOIX-CYDGBPFRSA-N Ile-Val-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)N YHFPHRUWZMEOIX-CYDGBPFRSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022557 Intermediate uveitis Diseases 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- PBCHMHROGNUXMK-DLOVCJGASA-N Leu-Ala-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 PBCHMHROGNUXMK-DLOVCJGASA-N 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- CNNQBZRGQATKNY-DCAQKATOSA-N Leu-Arg-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N CNNQBZRGQATKNY-DCAQKATOSA-N 0.000 description 1
- KSZCCRIGNVSHFH-UWVGGRQHSA-N Leu-Arg-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O KSZCCRIGNVSHFH-UWVGGRQHSA-N 0.000 description 1
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 1
- CUXRXAIAVYLVFD-ULQDDVLXSA-N Leu-Arg-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUXRXAIAVYLVFD-ULQDDVLXSA-N 0.000 description 1
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 1
- BAJIJEGGUYXZGC-CIUDSAMLSA-N Leu-Asn-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N BAJIJEGGUYXZGC-CIUDSAMLSA-N 0.000 description 1
- RFUBXQQFJFGJFV-GUBZILKMSA-N Leu-Asn-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RFUBXQQFJFGJFV-GUBZILKMSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- PPBKJAQJAUHZKX-SRVKXCTJSA-N Leu-Cys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC(C)C PPBKJAQJAUHZKX-SRVKXCTJSA-N 0.000 description 1
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 1
- CQGSYZCULZMEDE-SRVKXCTJSA-N Leu-Gln-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CQGSYZCULZMEDE-SRVKXCTJSA-N 0.000 description 1
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 1
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 1
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- QJUWBDPGGYVRHY-YUMQZZPRSA-N Leu-Gly-Cys Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N QJUWBDPGGYVRHY-YUMQZZPRSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- UCDHVOALNXENLC-KBPBESRZSA-N Leu-Gly-Tyr Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UCDHVOALNXENLC-KBPBESRZSA-N 0.000 description 1
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 1
- AUBMZAMQCOYSIC-MNXVOIDGSA-N Leu-Ile-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O AUBMZAMQCOYSIC-MNXVOIDGSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- LIINDKYIGYTDLG-PPCPHDFISA-N Leu-Ile-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LIINDKYIGYTDLG-PPCPHDFISA-N 0.000 description 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- PPQRKXHCLYCBSP-IHRRRGAJSA-N Leu-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N PPQRKXHCLYCBSP-IHRRRGAJSA-N 0.000 description 1
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- JLWZLIQRYCTYBD-IHRRRGAJSA-N Leu-Lys-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JLWZLIQRYCTYBD-IHRRRGAJSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 1
- ARRIJPQRBWRNLT-DCAQKATOSA-N Leu-Met-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ARRIJPQRBWRNLT-DCAQKATOSA-N 0.000 description 1
- MJTOYIHCKVQICL-ULQDDVLXSA-N Leu-Met-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MJTOYIHCKVQICL-ULQDDVLXSA-N 0.000 description 1
- JVTYXRRFZCEPPK-RHYQMDGZSA-N Leu-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)N)O JVTYXRRFZCEPPK-RHYQMDGZSA-N 0.000 description 1
- YESNGRDJQWDYLH-KKUMJFAQSA-N Leu-Phe-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N YESNGRDJQWDYLH-KKUMJFAQSA-N 0.000 description 1
- SYRTUBLKWNDSDK-DKIMLUQUSA-N Leu-Phe-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYRTUBLKWNDSDK-DKIMLUQUSA-N 0.000 description 1
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 1
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- FYPWFNKQVVEELI-ULQDDVLXSA-N Leu-Phe-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 FYPWFNKQVVEELI-ULQDDVLXSA-N 0.000 description 1
- XWEVVRRSIOBJOO-SRVKXCTJSA-N Leu-Pro-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O XWEVVRRSIOBJOO-SRVKXCTJSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 1
- UCXQIIIFOOGYEM-ULQDDVLXSA-N Leu-Pro-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCXQIIIFOOGYEM-ULQDDVLXSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- KZZCOWMDDXDKSS-CIUDSAMLSA-N Leu-Ser-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KZZCOWMDDXDKSS-CIUDSAMLSA-N 0.000 description 1
- IWMJFLJQHIDZQW-KKUMJFAQSA-N Leu-Ser-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IWMJFLJQHIDZQW-KKUMJFAQSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 1
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 1
- CNWDWAMPKVYJJB-NUTKFTJISA-N Leu-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CNWDWAMPKVYJJB-NUTKFTJISA-N 0.000 description 1
- IDGRADDMTTWOQC-WDSOQIARSA-N Leu-Trp-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IDGRADDMTTWOQC-WDSOQIARSA-N 0.000 description 1
- UIIMIKFNIYPDJF-WDSOQIARSA-N Leu-Trp-Met Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)[C@@H](N)CC(C)C)=CNC2=C1 UIIMIKFNIYPDJF-WDSOQIARSA-N 0.000 description 1
- LFXSPAIBSZSTEM-PMVMPFDFSA-N Leu-Trp-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LFXSPAIBSZSTEM-PMVMPFDFSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- WUHBLPVELFTPQK-KKUMJFAQSA-N Leu-Tyr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O WUHBLPVELFTPQK-KKUMJFAQSA-N 0.000 description 1
- ISSAURVGLGAPDK-KKUMJFAQSA-N Leu-Tyr-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O ISSAURVGLGAPDK-KKUMJFAQSA-N 0.000 description 1
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- QQXJROOJCMIHIV-AVGNSLFASA-N Leu-Val-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O QQXJROOJCMIHIV-AVGNSLFASA-N 0.000 description 1
- MSFITIBEMPWCBD-ULQDDVLXSA-N Leu-Val-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MSFITIBEMPWCBD-ULQDDVLXSA-N 0.000 description 1
- 102100022275 Leucine-rich glioma-inactivated protein 1 Human genes 0.000 description 1
- 206010061225 Limb injury Diseases 0.000 description 1
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
- RVOMPSJXSRPFJT-DCAQKATOSA-N Lys-Ala-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVOMPSJXSRPFJT-DCAQKATOSA-N 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 1
- ZTPWXNOOKAXPPE-DCAQKATOSA-N Lys-Arg-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N ZTPWXNOOKAXPPE-DCAQKATOSA-N 0.000 description 1
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 1
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 1
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 1
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 1
- QUYCUALODHJQLK-CIUDSAMLSA-N Lys-Asp-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O QUYCUALODHJQLK-CIUDSAMLSA-N 0.000 description 1
- OVIVOCSURJYCTM-GUBZILKMSA-N Lys-Asp-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O OVIVOCSURJYCTM-GUBZILKMSA-N 0.000 description 1
- CFVQPNSCQMKDPB-CIUDSAMLSA-N Lys-Cys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N CFVQPNSCQMKDPB-CIUDSAMLSA-N 0.000 description 1
- XFBBBRDEQIPGNR-KATARQTJSA-N Lys-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N)O XFBBBRDEQIPGNR-KATARQTJSA-N 0.000 description 1
- MRWXLRGAFDOILG-DCAQKATOSA-N Lys-Gln-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRWXLRGAFDOILG-DCAQKATOSA-N 0.000 description 1
- DRCILAJNUJKAHC-SRVKXCTJSA-N Lys-Glu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DRCILAJNUJKAHC-SRVKXCTJSA-N 0.000 description 1
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- DKTNGXVSCZULPO-YUMQZZPRSA-N Lys-Gly-Cys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CS)C(O)=O DKTNGXVSCZULPO-YUMQZZPRSA-N 0.000 description 1
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 1
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 1
- DAOSYIZXRCOKII-SRVKXCTJSA-N Lys-His-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O DAOSYIZXRCOKII-SRVKXCTJSA-N 0.000 description 1
- WOEDRPCHKPSFDT-MXAVVETBSA-N Lys-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N WOEDRPCHKPSFDT-MXAVVETBSA-N 0.000 description 1
- HQXSFFSLXFHWOX-IXOXFDKPSA-N Lys-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N)O HQXSFFSLXFHWOX-IXOXFDKPSA-N 0.000 description 1
- SLQJJFAVWSZLBL-BJDJZHNGSA-N Lys-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN SLQJJFAVWSZLBL-BJDJZHNGSA-N 0.000 description 1
- OJDFAABAHBPVTH-MNXVOIDGSA-N Lys-Ile-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O OJDFAABAHBPVTH-MNXVOIDGSA-N 0.000 description 1
- QBEPTBMRQALPEV-MNXVOIDGSA-N Lys-Ile-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN QBEPTBMRQALPEV-MNXVOIDGSA-N 0.000 description 1
- IVFUVMSKSFSFBT-NHCYSSNCSA-N Lys-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN IVFUVMSKSFSFBT-NHCYSSNCSA-N 0.000 description 1
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 1
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 1
- ZJWIXBZTAAJERF-IHRRRGAJSA-N Lys-Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZJWIXBZTAAJERF-IHRRRGAJSA-N 0.000 description 1
- AHFOKDZWPPGJAZ-SRVKXCTJSA-N Lys-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)N AHFOKDZWPPGJAZ-SRVKXCTJSA-N 0.000 description 1
- PYFNONMJYNJENN-AVGNSLFASA-N Lys-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PYFNONMJYNJENN-AVGNSLFASA-N 0.000 description 1
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 1
- KJIXWRWPOCKYLD-IHRRRGAJSA-N Lys-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N KJIXWRWPOCKYLD-IHRRRGAJSA-N 0.000 description 1
- VSTNAUBHKQPVJX-IHRRRGAJSA-N Lys-Met-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O VSTNAUBHKQPVJX-IHRRRGAJSA-N 0.000 description 1
- ZZHPLPSLBVBWOA-WDSOQIARSA-N Lys-Met-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N ZZHPLPSLBVBWOA-WDSOQIARSA-N 0.000 description 1
- AZOFEHCPMBRNFD-BZSNNMDCSA-N Lys-Phe-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 AZOFEHCPMBRNFD-BZSNNMDCSA-N 0.000 description 1
- IPTUBUUIFRZMJK-ACRUOGEOSA-N Lys-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 IPTUBUUIFRZMJK-ACRUOGEOSA-N 0.000 description 1
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 1
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 1
- MGKFCQFVPKOWOL-CIUDSAMLSA-N Lys-Ser-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N MGKFCQFVPKOWOL-CIUDSAMLSA-N 0.000 description 1
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 1
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- CUHGAUZONORRIC-HJGDQZAQSA-N Lys-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N)O CUHGAUZONORRIC-HJGDQZAQSA-N 0.000 description 1
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 1
- SEZADXQOJJTXPG-VFAJRCTISA-N Lys-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N)O SEZADXQOJJTXPG-VFAJRCTISA-N 0.000 description 1
- VVURYEVJJTXWNE-ULQDDVLXSA-N Lys-Tyr-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O VVURYEVJJTXWNE-ULQDDVLXSA-N 0.000 description 1
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 1
- RPWQJSBMXJSCPD-XUXIUFHCSA-N Lys-Val-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O RPWQJSBMXJSCPD-XUXIUFHCSA-N 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- MUYQDMBLDFEVRJ-LSJOCFKGSA-N Met-Ala-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 MUYQDMBLDFEVRJ-LSJOCFKGSA-N 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- DTICLBJHRYSJLH-GUBZILKMSA-N Met-Ala-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O DTICLBJHRYSJLH-GUBZILKMSA-N 0.000 description 1
- AHZNUGRZHMZGFL-GUBZILKMSA-N Met-Arg-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCNC(N)=N AHZNUGRZHMZGFL-GUBZILKMSA-N 0.000 description 1
- YNOVBMBQSQTLFM-DCAQKATOSA-N Met-Asn-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O YNOVBMBQSQTLFM-DCAQKATOSA-N 0.000 description 1
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 1
- DBOMZJOESVYERT-GUBZILKMSA-N Met-Asn-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N DBOMZJOESVYERT-GUBZILKMSA-N 0.000 description 1
- OHMKUHXCDSCOMT-QXEWZRGKSA-N Met-Asn-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHMKUHXCDSCOMT-QXEWZRGKSA-N 0.000 description 1
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 1
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 1
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 1
- CNUPMMXDISGXMU-CIUDSAMLSA-N Met-Cys-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O CNUPMMXDISGXMU-CIUDSAMLSA-N 0.000 description 1
- OBCRZLRPJFNLAN-DCAQKATOSA-N Met-His-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O OBCRZLRPJFNLAN-DCAQKATOSA-N 0.000 description 1
- TZHFJXDKXGZHEN-IHRRRGAJSA-N Met-His-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O TZHFJXDKXGZHEN-IHRRRGAJSA-N 0.000 description 1
- RVYDCISQIGHAFC-ZPFDUUQYSA-N Met-Ile-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O RVYDCISQIGHAFC-ZPFDUUQYSA-N 0.000 description 1
- QZPXMHVKPHJNTR-DCAQKATOSA-N Met-Leu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O QZPXMHVKPHJNTR-DCAQKATOSA-N 0.000 description 1
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 1
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 description 1
- HAQLBBVZAGMESV-IHRRRGAJSA-N Met-Lys-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O HAQLBBVZAGMESV-IHRRRGAJSA-N 0.000 description 1
- VAGCEUUEMMXFEX-GUBZILKMSA-N Met-Met-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O VAGCEUUEMMXFEX-GUBZILKMSA-N 0.000 description 1
- HUURTRNKPBHHKZ-JYJNAYRXSA-N Met-Phe-Val Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 HUURTRNKPBHHKZ-JYJNAYRXSA-N 0.000 description 1
- BJPQKNHZHUCQNQ-SRVKXCTJSA-N Met-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)N BJPQKNHZHUCQNQ-SRVKXCTJSA-N 0.000 description 1
- XPVCDCMPKCERFT-GUBZILKMSA-N Met-Ser-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XPVCDCMPKCERFT-GUBZILKMSA-N 0.000 description 1
- GMMLGMFBYCFCCX-KZVJFYERSA-N Met-Thr-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMMLGMFBYCFCCX-KZVJFYERSA-N 0.000 description 1
- SQPZCTBSLIIMBL-BPUTZDHNSA-N Met-Trp-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CO)C(=O)O)N SQPZCTBSLIIMBL-BPUTZDHNSA-N 0.000 description 1
- CQRGINSEMFBACV-WPRPVWTQSA-N Met-Val-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O CQRGINSEMFBACV-WPRPVWTQSA-N 0.000 description 1
- JACMWNXOOUYXCD-JYJNAYRXSA-N Met-Val-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JACMWNXOOUYXCD-JYJNAYRXSA-N 0.000 description 1
- 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 101000930477 Mus musculus Albumin Proteins 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 208000035959 Narcolepsy type 1 Diseases 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 102100021310 Neurexin-3 Human genes 0.000 description 1
- 101710203763 Neurexin-3 Proteins 0.000 description 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 1
- 208000029067 Neuromyelitis optica spectrum disease Diseases 0.000 description 1
- 108010065395 Neuropep-1 Proteins 0.000 description 1
- 206010071323 Neuropsychiatric syndrome Diseases 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 208000004056 Orthostatic intolerance Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 102100034574 P protein Human genes 0.000 description 1
- 101710181008 P protein Proteins 0.000 description 1
- 102100035467 Paraneoplastic antigen Ma2 Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 1
- JVTMTFMMMHAPCR-UBHSHLNASA-N Phe-Ala-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JVTMTFMMMHAPCR-UBHSHLNASA-N 0.000 description 1
- WSXKXSBOJXEZDV-DLOVCJGASA-N Phe-Ala-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@H](C)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 WSXKXSBOJXEZDV-DLOVCJGASA-N 0.000 description 1
- AJOKKVTWEMXZHC-DRZSPHRISA-N Phe-Ala-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 AJOKKVTWEMXZHC-DRZSPHRISA-N 0.000 description 1
- GNUCSNWOCQFMMC-UFYCRDLUSA-N Phe-Arg-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 GNUCSNWOCQFMMC-UFYCRDLUSA-N 0.000 description 1
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 1
- AWAYOWOUGVZXOB-BZSNNMDCSA-N Phe-Asn-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 AWAYOWOUGVZXOB-BZSNNMDCSA-N 0.000 description 1
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- DJPXNKUDJKGQEE-BZSNNMDCSA-N Phe-Asp-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DJPXNKUDJKGQEE-BZSNNMDCSA-N 0.000 description 1
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 1
- FSPGBMWPNMRWDB-AVGNSLFASA-N Phe-Cys-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N FSPGBMWPNMRWDB-AVGNSLFASA-N 0.000 description 1
- LXUJDHOKVUYHRC-KKUMJFAQSA-N Phe-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N LXUJDHOKVUYHRC-KKUMJFAQSA-N 0.000 description 1
- VJEZWOSKRCLHRP-MELADBBJSA-N Phe-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O VJEZWOSKRCLHRP-MELADBBJSA-N 0.000 description 1
- VLZGUAUYZGQKPM-DRZSPHRISA-N Phe-Gln-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VLZGUAUYZGQKPM-DRZSPHRISA-N 0.000 description 1
- KOUUGTKGEQZRHV-KKUMJFAQSA-N Phe-Gln-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KOUUGTKGEQZRHV-KKUMJFAQSA-N 0.000 description 1
- IDUCUXTUHHIQIP-SOUVJXGZSA-N Phe-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O IDUCUXTUHHIQIP-SOUVJXGZSA-N 0.000 description 1
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 1
- CDQCFGOQNYOICK-IHRRRGAJSA-N Phe-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDQCFGOQNYOICK-IHRRRGAJSA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- FIRWJEJVFFGXSH-RYUDHWBXSA-N Phe-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 FIRWJEJVFFGXSH-RYUDHWBXSA-N 0.000 description 1
- CSDMCMITJLKBAH-SOUVJXGZSA-N Phe-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O CSDMCMITJLKBAH-SOUVJXGZSA-N 0.000 description 1
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 1
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- HBGFEEQFVBWYJQ-KBPBESRZSA-N Phe-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HBGFEEQFVBWYJQ-KBPBESRZSA-N 0.000 description 1
- KRYSMKKRRRWOCZ-QEWYBTABSA-N Phe-Ile-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KRYSMKKRRRWOCZ-QEWYBTABSA-N 0.000 description 1
- GXDPQJUBLBZKDY-IAVJCBSLSA-N Phe-Ile-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GXDPQJUBLBZKDY-IAVJCBSLSA-N 0.000 description 1
- DVOCGBNHAUHKHJ-DKIMLUQUSA-N Phe-Ile-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O DVOCGBNHAUHKHJ-DKIMLUQUSA-N 0.000 description 1
- GHNVJQZQYKNTDX-HJWJTTGWSA-N Phe-Ile-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O GHNVJQZQYKNTDX-HJWJTTGWSA-N 0.000 description 1
- BYAIIACBWBOJCU-URLPEUOOSA-N Phe-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BYAIIACBWBOJCU-URLPEUOOSA-N 0.000 description 1
- NRKNYPRRWXVELC-NQCBNZPSSA-N Phe-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)N NRKNYPRRWXVELC-NQCBNZPSSA-N 0.000 description 1
- YKUGPVXSDOOANW-KKUMJFAQSA-N Phe-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKUGPVXSDOOANW-KKUMJFAQSA-N 0.000 description 1
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- ZIQQNOXKEFDPBE-BZSNNMDCSA-N Phe-Lys-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N ZIQQNOXKEFDPBE-BZSNNMDCSA-N 0.000 description 1
- DOXQMJCSSYZSNM-BZSNNMDCSA-N Phe-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O DOXQMJCSSYZSNM-BZSNNMDCSA-N 0.000 description 1
- GPSMLZQVIIYLDK-ULQDDVLXSA-N Phe-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O GPSMLZQVIIYLDK-ULQDDVLXSA-N 0.000 description 1
- SZYBZVANEAOIPE-UBHSHLNASA-N Phe-Met-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O SZYBZVANEAOIPE-UBHSHLNASA-N 0.000 description 1
- CBENHWCORLVGEQ-HJOGWXRNSA-N Phe-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CBENHWCORLVGEQ-HJOGWXRNSA-N 0.000 description 1
- CZQZSMJXFGGBHM-KKUMJFAQSA-N Phe-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O CZQZSMJXFGGBHM-KKUMJFAQSA-N 0.000 description 1
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 1
- IPFXYNKCXYGSSV-KKUMJFAQSA-N Phe-Ser-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N IPFXYNKCXYGSSV-KKUMJFAQSA-N 0.000 description 1
- RAGOJJCBGXARPO-XVSYOHENSA-N Phe-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RAGOJJCBGXARPO-XVSYOHENSA-N 0.000 description 1
- OLZVAVSJEUAOHI-UNQGMJICSA-N Phe-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O OLZVAVSJEUAOHI-UNQGMJICSA-N 0.000 description 1
- SHUFSZDAIPLZLF-BEAPCOKYSA-N Phe-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O SHUFSZDAIPLZLF-BEAPCOKYSA-N 0.000 description 1
- MSSXKZBDKZAHCX-UNQGMJICSA-N Phe-Thr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O MSSXKZBDKZAHCX-UNQGMJICSA-N 0.000 description 1
- YCEWAVIRWNGGSS-NQCBNZPSSA-N Phe-Trp-Ile Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)C1=CC=CC=C1 YCEWAVIRWNGGSS-NQCBNZPSSA-N 0.000 description 1
- VFDRDMOMHBJGKD-UFYCRDLUSA-N Phe-Tyr-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N VFDRDMOMHBJGKD-UFYCRDLUSA-N 0.000 description 1
- AGTHXWTYCLLYMC-FHWLQOOXSA-N Phe-Tyr-Glu Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 AGTHXWTYCLLYMC-FHWLQOOXSA-N 0.000 description 1
- ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 1
- VDTYRPWRWRCROL-UFYCRDLUSA-N Phe-Val-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VDTYRPWRWRCROL-UFYCRDLUSA-N 0.000 description 1
- MWQXFDIQXIXPMS-UNQGMJICSA-N Phe-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O MWQXFDIQXIXPMS-UNQGMJICSA-N 0.000 description 1
- GAMLAXHLYGLQBJ-UFYCRDLUSA-N Phe-Val-Tyr Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)O)C(C)C)CC1=CC=CC=C1 GAMLAXHLYGLQBJ-UFYCRDLUSA-N 0.000 description 1
- 101710177166 Phosphoprotein Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 208000024842 Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG Diseases 0.000 description 1
- 101800001357 Potential peptide Proteins 0.000 description 1
- 102400000745 Potential peptide Human genes 0.000 description 1
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 1
- FZHBZMDRDASUHN-NAKRPEOUSA-N Pro-Ala-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(O)=O FZHBZMDRDASUHN-NAKRPEOUSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- LCRSGSIRKLXZMZ-BPNCWPANSA-N Pro-Ala-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LCRSGSIRKLXZMZ-BPNCWPANSA-N 0.000 description 1
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 1
- BNBBNGZZKQUWCD-IUCAKERBSA-N Pro-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 BNBBNGZZKQUWCD-IUCAKERBSA-N 0.000 description 1
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 1
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 1
- ZSKJPKFTPQCPIH-RCWTZXSCSA-N Pro-Arg-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZSKJPKFTPQCPIH-RCWTZXSCSA-N 0.000 description 1
- JARJPEMLQAWNBR-GUBZILKMSA-N Pro-Asp-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JARJPEMLQAWNBR-GUBZILKMSA-N 0.000 description 1
- NGNNPLJHUFCOMZ-FXQIFTODSA-N Pro-Asp-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 NGNNPLJHUFCOMZ-FXQIFTODSA-N 0.000 description 1
- KIGGUSRFHJCIEJ-DCAQKATOSA-N Pro-Asp-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O KIGGUSRFHJCIEJ-DCAQKATOSA-N 0.000 description 1
- GDXZRWYXJSGWIV-GMOBBJLQSA-N Pro-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 GDXZRWYXJSGWIV-GMOBBJLQSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- LCWXSALTPTZKNM-CIUDSAMLSA-N Pro-Cys-Glu Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O LCWXSALTPTZKNM-CIUDSAMLSA-N 0.000 description 1
- OLTFZQIYCNOBLI-DCAQKATOSA-N Pro-Cys-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O OLTFZQIYCNOBLI-DCAQKATOSA-N 0.000 description 1
- OHQFMEIJLZQXHB-GUBZILKMSA-N Pro-Cys-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 OHQFMEIJLZQXHB-GUBZILKMSA-N 0.000 description 1
- LSIWVWRUTKPXDS-DCAQKATOSA-N Pro-Gln-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LSIWVWRUTKPXDS-DCAQKATOSA-N 0.000 description 1
- SNIPWBQKOPCJRG-CIUDSAMLSA-N Pro-Gln-Cys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O SNIPWBQKOPCJRG-CIUDSAMLSA-N 0.000 description 1
- UPJGUQPLYWTISV-GUBZILKMSA-N Pro-Gln-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UPJGUQPLYWTISV-GUBZILKMSA-N 0.000 description 1
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 1
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 1
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 1
- SSWJYJHXQOYTSP-SRVKXCTJSA-N Pro-His-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O SSWJYJHXQOYTSP-SRVKXCTJSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- JRQCDSNPRNGWRG-AVGNSLFASA-N Pro-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]2CCCN2 JRQCDSNPRNGWRG-AVGNSLFASA-N 0.000 description 1
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- VTFXTWDFPTWNJY-RHYQMDGZSA-N Pro-Leu-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VTFXTWDFPTWNJY-RHYQMDGZSA-N 0.000 description 1
- SUENWIFTSTWUKD-AVGNSLFASA-N Pro-Leu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SUENWIFTSTWUKD-AVGNSLFASA-N 0.000 description 1
- YAZNFQUKPUASKB-DCAQKATOSA-N Pro-Lys-Cys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O YAZNFQUKPUASKB-DCAQKATOSA-N 0.000 description 1
- XQPHBAKJJJZOBX-SRVKXCTJSA-N Pro-Lys-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O XQPHBAKJJJZOBX-SRVKXCTJSA-N 0.000 description 1
- ABSSTGUCBCDKMU-UWVGGRQHSA-N Pro-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 ABSSTGUCBCDKMU-UWVGGRQHSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- SMFQZMGHCODUPQ-ULQDDVLXSA-N Pro-Lys-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SMFQZMGHCODUPQ-ULQDDVLXSA-N 0.000 description 1
- AJBQTGZIZQXBLT-STQMWFEESA-N Pro-Phe-Gly Chemical compound C([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 AJBQTGZIZQXBLT-STQMWFEESA-N 0.000 description 1
- WHNJMTHJGCEKGA-ULQDDVLXSA-N Pro-Phe-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WHNJMTHJGCEKGA-ULQDDVLXSA-N 0.000 description 1
- XYAFCOJKICBRDU-JYJNAYRXSA-N Pro-Phe-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O XYAFCOJKICBRDU-JYJNAYRXSA-N 0.000 description 1
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 1
- SXJOPONICMGFCR-DCAQKATOSA-N Pro-Ser-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O SXJOPONICMGFCR-DCAQKATOSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- AJJDPGVVNPUZCR-RHYQMDGZSA-N Pro-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1)O AJJDPGVVNPUZCR-RHYQMDGZSA-N 0.000 description 1
- RMJZWERKFFNNNS-XGEHTFHBSA-N Pro-Thr-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMJZWERKFFNNNS-XGEHTFHBSA-N 0.000 description 1
- HOJUNFDJDAPVBI-BZSNNMDCSA-N Pro-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H]3CCCN3 HOJUNFDJDAPVBI-BZSNNMDCSA-N 0.000 description 1
- DLZBBDSPTJBOOD-BPNCWPANSA-N Pro-Tyr-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O DLZBBDSPTJBOOD-BPNCWPANSA-N 0.000 description 1
- CWZUFLWPEFHWEI-IHRRRGAJSA-N Pro-Tyr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O CWZUFLWPEFHWEI-IHRRRGAJSA-N 0.000 description 1
- BVTYXOFTHDXSNI-IHRRRGAJSA-N Pro-Tyr-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 BVTYXOFTHDXSNI-IHRRRGAJSA-N 0.000 description 1
- FZXSYIPVAFVYBH-KKUMJFAQSA-N Pro-Tyr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O FZXSYIPVAFVYBH-KKUMJFAQSA-N 0.000 description 1
- DYJTXTCEXMCPBF-UFYCRDLUSA-N Pro-Tyr-Phe Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O DYJTXTCEXMCPBF-UFYCRDLUSA-N 0.000 description 1
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100024952 Protein CBFA2T1 Human genes 0.000 description 1
- 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 description 1
- 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101710204410 Scaffold protein Proteins 0.000 description 1
- 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 102000012066 Septin 5 Human genes 0.000 description 1
- 108050002582 Septin 5 Proteins 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 1
- NLQUOHDCLSFABG-GUBZILKMSA-N Ser-Arg-Arg Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NLQUOHDCLSFABG-GUBZILKMSA-N 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- WXUBSIDKNMFAGS-IHRRRGAJSA-N Ser-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXUBSIDKNMFAGS-IHRRRGAJSA-N 0.000 description 1
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 1
- CNIIKZQXBBQHCX-FXQIFTODSA-N Ser-Asp-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O CNIIKZQXBBQHCX-FXQIFTODSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- BYIROAKULFFTEK-CIUDSAMLSA-N Ser-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO BYIROAKULFFTEK-CIUDSAMLSA-N 0.000 description 1
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- HEQPKICPPDOSIN-SRVKXCTJSA-N Ser-Asp-Tyr Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HEQPKICPPDOSIN-SRVKXCTJSA-N 0.000 description 1
- XSYJDGIDKRNWFX-SRVKXCTJSA-N Ser-Cys-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XSYJDGIDKRNWFX-SRVKXCTJSA-N 0.000 description 1
- XWCYBVBLJRWOFR-WDSKDSINSA-N Ser-Gln-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O XWCYBVBLJRWOFR-WDSKDSINSA-N 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 1
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 1
- FYUIFUJFNCLUIX-XVYDVKMFSA-N Ser-His-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O FYUIFUJFNCLUIX-XVYDVKMFSA-N 0.000 description 1
- MOQDPPUMFSMYOM-KKUMJFAQSA-N Ser-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N MOQDPPUMFSMYOM-KKUMJFAQSA-N 0.000 description 1
- CAOYHZOWXFFAIR-CIUDSAMLSA-N Ser-His-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CAOYHZOWXFFAIR-CIUDSAMLSA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- BKZYBLLIBOBOOW-GHCJXIJMSA-N Ser-Ile-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O BKZYBLLIBOBOOW-GHCJXIJMSA-N 0.000 description 1
- HBTCFCHYALPXME-HTFCKZLJSA-N Ser-Ile-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HBTCFCHYALPXME-HTFCKZLJSA-N 0.000 description 1
- DOSZISJPMCYEHT-NAKRPEOUSA-N Ser-Ile-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O DOSZISJPMCYEHT-NAKRPEOUSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- SRKMDKACHDVPMD-SRVKXCTJSA-N Ser-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N SRKMDKACHDVPMD-SRVKXCTJSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 1
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 1
- RQXDSYQXBCRXBT-GUBZILKMSA-N Ser-Met-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RQXDSYQXBCRXBT-GUBZILKMSA-N 0.000 description 1
- KJKQUQXDEKMPDK-FXQIFTODSA-N Ser-Met-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O KJKQUQXDEKMPDK-FXQIFTODSA-N 0.000 description 1
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 1
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 1
- RWDVVSKYZBNDCO-MELADBBJSA-N Ser-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N)C(=O)O RWDVVSKYZBNDCO-MELADBBJSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- FLONGDPORFIVQW-XGEHTFHBSA-N Ser-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FLONGDPORFIVQW-XGEHTFHBSA-N 0.000 description 1
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- FZXOPYUEQGDGMS-ACZMJKKPSA-N Ser-Ser-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZXOPYUEQGDGMS-ACZMJKKPSA-N 0.000 description 1
- GYDFRTRSSXOZCR-ACZMJKKPSA-N Ser-Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O GYDFRTRSSXOZCR-ACZMJKKPSA-N 0.000 description 1
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 1
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- QNBVFKZSSRYNFX-CUJWVEQBSA-N Ser-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N)O QNBVFKZSSRYNFX-CUJWVEQBSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- STIAINRLUUKYKM-WFBYXXMGSA-N Ser-Trp-Ala Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 STIAINRLUUKYKM-WFBYXXMGSA-N 0.000 description 1
- SDFUZKIAHWRUCS-QEJZJMRPSA-N Ser-Trp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N SDFUZKIAHWRUCS-QEJZJMRPSA-N 0.000 description 1
- BCAVNDNYOGTQMQ-AAEUAGOBSA-N Ser-Trp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(O)=O BCAVNDNYOGTQMQ-AAEUAGOBSA-N 0.000 description 1
- GSCVDSBEYVGMJQ-SRVKXCTJSA-N Ser-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)O GSCVDSBEYVGMJQ-SRVKXCTJSA-N 0.000 description 1
- YXGCIEUDOHILKR-IHRRRGAJSA-N Ser-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CO)N YXGCIEUDOHILKR-IHRRRGAJSA-N 0.000 description 1
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 1
- SYCFMSYTIFXWAJ-DCAQKATOSA-N Ser-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N SYCFMSYTIFXWAJ-DCAQKATOSA-N 0.000 description 1
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 1
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- ODRUTDLAONAVDV-IHRRRGAJSA-N Ser-Val-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ODRUTDLAONAVDV-IHRRRGAJSA-N 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 108050009621 Synapsin Proteins 0.000 description 1
- 102000001435 Synapsin Human genes 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 102100040347 TAR DNA-binding protein 43 Human genes 0.000 description 1
- 101710150875 TAR DNA-binding protein 43 Proteins 0.000 description 1
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 1
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 1
- IRKWVRSEQFTGGV-VEVYYDQMSA-N Thr-Asn-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IRKWVRSEQFTGGV-VEVYYDQMSA-N 0.000 description 1
- PAOYNIKMYOGBMR-PBCZWWQYSA-N Thr-Asn-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O PAOYNIKMYOGBMR-PBCZWWQYSA-N 0.000 description 1
- SKHPKKYKDYULDH-HJGDQZAQSA-N Thr-Asn-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SKHPKKYKDYULDH-HJGDQZAQSA-N 0.000 description 1
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 1
- VXMHQKHDKCATDV-VEVYYDQMSA-N Thr-Asp-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VXMHQKHDKCATDV-VEVYYDQMSA-N 0.000 description 1
- KZUJCMPVNXOBAF-LKXGYXEUSA-N Thr-Cys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KZUJCMPVNXOBAF-LKXGYXEUSA-N 0.000 description 1
- WLDUCKSCDRIVLJ-NUMRIWBASA-N Thr-Gln-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O WLDUCKSCDRIVLJ-NUMRIWBASA-N 0.000 description 1
- VUVCRYXYUUPGSB-GLLZPBPUSA-N Thr-Gln-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O VUVCRYXYUUPGSB-GLLZPBPUSA-N 0.000 description 1
- FHDLKMFZKRUQCE-HJGDQZAQSA-N Thr-Glu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHDLKMFZKRUQCE-HJGDQZAQSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- SHOMROOOQBDGRL-JHEQGTHGSA-N Thr-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SHOMROOOQBDGRL-JHEQGTHGSA-N 0.000 description 1
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 1
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 1
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 1
- FKIGTIXHSRNKJU-IXOXFDKPSA-N Thr-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CN=CN1 FKIGTIXHSRNKJU-IXOXFDKPSA-N 0.000 description 1
- UDNVOQMPQBEITB-MEYUZBJRSA-N Thr-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UDNVOQMPQBEITB-MEYUZBJRSA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- URPSJRMWHQTARR-MBLNEYKQSA-N Thr-Ile-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O URPSJRMWHQTARR-MBLNEYKQSA-N 0.000 description 1
- AHOLTQCAVBSUDP-PPCPHDFISA-N Thr-Ile-Lys Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O AHOLTQCAVBSUDP-PPCPHDFISA-N 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- KRDSCBLRHORMRK-JXUBOQSCSA-N Thr-Lys-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O KRDSCBLRHORMRK-JXUBOQSCSA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- JWQNAFHCXKVZKZ-UVOCVTCTSA-N Thr-Lys-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWQNAFHCXKVZKZ-UVOCVTCTSA-N 0.000 description 1
- UJQVSMNQMQHVRY-KZVJFYERSA-N Thr-Met-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UJQVSMNQMQHVRY-KZVJFYERSA-N 0.000 description 1
- WRUWXBBEFUTJOU-XGEHTFHBSA-N Thr-Met-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)N)O WRUWXBBEFUTJOU-XGEHTFHBSA-N 0.000 description 1
- MEBDIIKMUUNBSB-RPTUDFQQSA-N Thr-Phe-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MEBDIIKMUUNBSB-RPTUDFQQSA-N 0.000 description 1
- NWECYMJLJGCBOD-UNQGMJICSA-N Thr-Phe-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O NWECYMJLJGCBOD-UNQGMJICSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 1
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- YGCDFAJJCRVQKU-RCWTZXSCSA-N Thr-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O YGCDFAJJCRVQKU-RCWTZXSCSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- XZUBGOYOGDRYFC-XGEHTFHBSA-N Thr-Ser-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O XZUBGOYOGDRYFC-XGEHTFHBSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- QYDKSNXSBXZPFK-ZJDVBMNYSA-N Thr-Thr-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYDKSNXSBXZPFK-ZJDVBMNYSA-N 0.000 description 1
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 1
- VGNLMPBYWWNQFS-ZEILLAHLSA-N Thr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O VGNLMPBYWWNQFS-ZEILLAHLSA-N 0.000 description 1
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
- QJIODPFLAASXJC-JHYOHUSXSA-N Thr-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O QJIODPFLAASXJC-JHYOHUSXSA-N 0.000 description 1
- GRIUMVXCJDKVPI-IZPVPAKOSA-N Thr-Thr-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GRIUMVXCJDKVPI-IZPVPAKOSA-N 0.000 description 1
- FBQHKSPOIAFUEI-OWLDWWDNSA-N Thr-Trp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O FBQHKSPOIAFUEI-OWLDWWDNSA-N 0.000 description 1
- ZEJBJDHSQPOVJV-UAXMHLISSA-N Thr-Trp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZEJBJDHSQPOVJV-UAXMHLISSA-N 0.000 description 1
- REJRKTOJTCPDPO-IRIUXVKKSA-N Thr-Tyr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O REJRKTOJTCPDPO-IRIUXVKKSA-N 0.000 description 1
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 1
- AVYVKJMBNLPWRX-WFBYXXMGSA-N Trp-Ala-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 AVYVKJMBNLPWRX-WFBYXXMGSA-N 0.000 description 1
- PEYSVKMXSLPQRU-FJHTZYQYSA-N Trp-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O PEYSVKMXSLPQRU-FJHTZYQYSA-N 0.000 description 1
- QNMIVTOQXUSGLN-SZMVWBNQSA-N Trp-Arg-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QNMIVTOQXUSGLN-SZMVWBNQSA-N 0.000 description 1
- SCQBNMKLZVCXNX-ZFWWWQNUSA-N Trp-Arg-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)N SCQBNMKLZVCXNX-ZFWWWQNUSA-N 0.000 description 1
- IBBBOLAPFHRDHW-BPUTZDHNSA-N Trp-Asn-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N IBBBOLAPFHRDHW-BPUTZDHNSA-N 0.000 description 1
- DVAAUUVLDFKTAQ-VHWLVUOQSA-N Trp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N DVAAUUVLDFKTAQ-VHWLVUOQSA-N 0.000 description 1
- OENGVSDBQHHGBU-QEJZJMRPSA-N Trp-Glu-Asn Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OENGVSDBQHHGBU-QEJZJMRPSA-N 0.000 description 1
- DVIIYMVCSUQOJG-QEJZJMRPSA-N Trp-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DVIIYMVCSUQOJG-QEJZJMRPSA-N 0.000 description 1
- OBAMASZCXDIXSS-SZMVWBNQSA-N Trp-Glu-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N OBAMASZCXDIXSS-SZMVWBNQSA-N 0.000 description 1
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 1
- HQJOVVWAPQPYDS-ZFWWWQNUSA-N Trp-Gly-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQJOVVWAPQPYDS-ZFWWWQNUSA-N 0.000 description 1
- RXEQOXHCHQJMSO-IHPCNDPISA-N Trp-His-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O RXEQOXHCHQJMSO-IHPCNDPISA-N 0.000 description 1
- YDTKYBHPRULROG-LTHWPDAASA-N Trp-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N YDTKYBHPRULROG-LTHWPDAASA-N 0.000 description 1
- CXPJPTFWKXNDKV-NUTKFTJISA-N Trp-Leu-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CXPJPTFWKXNDKV-NUTKFTJISA-N 0.000 description 1
- CMXACOZDEJYZSK-XIRDDKMYSA-N Trp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N CMXACOZDEJYZSK-XIRDDKMYSA-N 0.000 description 1
- WKCFCVBOFKEVKY-HSCHXYMDSA-N Trp-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N WKCFCVBOFKEVKY-HSCHXYMDSA-N 0.000 description 1
- CCZXBOFIBYQLEV-IHPCNDPISA-N Trp-Leu-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O CCZXBOFIBYQLEV-IHPCNDPISA-N 0.000 description 1
- UKWSFUSPGPBJGU-VFAJRCTISA-N Trp-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O UKWSFUSPGPBJGU-VFAJRCTISA-N 0.000 description 1
- KRCPXGSWDOGHAM-XIRDDKMYSA-N Trp-Lys-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O KRCPXGSWDOGHAM-XIRDDKMYSA-N 0.000 description 1
- PWPJLBWYRTVYQS-PMVMPFDFSA-N Trp-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PWPJLBWYRTVYQS-PMVMPFDFSA-N 0.000 description 1
- XOLLWQIBBLBAHQ-WDSOQIARSA-N Trp-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O XOLLWQIBBLBAHQ-WDSOQIARSA-N 0.000 description 1
- KBKTUNYBNJWFRL-UBHSHLNASA-N Trp-Ser-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 KBKTUNYBNJWFRL-UBHSHLNASA-N 0.000 description 1
- UIRPULWLRODAEQ-QEJZJMRPSA-N Trp-Ser-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 UIRPULWLRODAEQ-QEJZJMRPSA-N 0.000 description 1
- YXSSXUIBUJGHJY-SFJXLCSZSA-N Trp-Thr-Phe Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)[C@H](O)C)C(O)=O)C1=CC=CC=C1 YXSSXUIBUJGHJY-SFJXLCSZSA-N 0.000 description 1
- VRTMYQGKPQZAPO-SBCJRHGPSA-N Trp-Trp-Ile Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VRTMYQGKPQZAPO-SBCJRHGPSA-N 0.000 description 1
- ZPZNQAZHMCLTOA-PXDAIIFMSA-N Trp-Tyr-Ile Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 ZPZNQAZHMCLTOA-PXDAIIFMSA-N 0.000 description 1
- BABINGWMZBWXIX-BPUTZDHNSA-N Trp-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BABINGWMZBWXIX-BPUTZDHNSA-N 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- KSVMDJJCYKIXTK-IGNZVWTISA-N Tyr-Ala-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 KSVMDJJCYKIXTK-IGNZVWTISA-N 0.000 description 1
- KDGFPPHLXCEQRN-STECZYCISA-N Tyr-Arg-Ile Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KDGFPPHLXCEQRN-STECZYCISA-N 0.000 description 1
- JBBYKPZAPOLCPK-JYJNAYRXSA-N Tyr-Arg-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O JBBYKPZAPOLCPK-JYJNAYRXSA-N 0.000 description 1
- DYEGCOJHFNJBKB-UFYCRDLUSA-N Tyr-Arg-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 DYEGCOJHFNJBKB-UFYCRDLUSA-N 0.000 description 1
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 1
- OEVJGIHPQOXYFE-SRVKXCTJSA-N Tyr-Asn-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OEVJGIHPQOXYFE-SRVKXCTJSA-N 0.000 description 1
- PEVVXUGSAKEPEN-AVGNSLFASA-N Tyr-Asn-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PEVVXUGSAKEPEN-AVGNSLFASA-N 0.000 description 1
- VTFWAGGJDRSQFG-MELADBBJSA-N Tyr-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O VTFWAGGJDRSQFG-MELADBBJSA-N 0.000 description 1
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 1
- UABYBEBXFFNCIR-YDHLFZDLSA-N Tyr-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UABYBEBXFFNCIR-YDHLFZDLSA-N 0.000 description 1
- MOCXXGZHHSPNEJ-AVGNSLFASA-N Tyr-Cys-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O MOCXXGZHHSPNEJ-AVGNSLFASA-N 0.000 description 1
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 1
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 1
- HVHJYXDXRIWELT-RYUDHWBXSA-N Tyr-Glu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O HVHJYXDXRIWELT-RYUDHWBXSA-N 0.000 description 1
- LMLBOGIOLHZXOT-JYJNAYRXSA-N Tyr-Glu-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O LMLBOGIOLHZXOT-JYJNAYRXSA-N 0.000 description 1
- SLCSPPCQWUHPPO-JYJNAYRXSA-N Tyr-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SLCSPPCQWUHPPO-JYJNAYRXSA-N 0.000 description 1
- OSMTVLSRTQDWHJ-JBACZVJFSA-N Tyr-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 OSMTVLSRTQDWHJ-JBACZVJFSA-N 0.000 description 1
- UNUZEBFXGWVAOP-DZKIICNBSA-N Tyr-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UNUZEBFXGWVAOP-DZKIICNBSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- AKLNEFNQWLHIGY-QWRGUYRKSA-N Tyr-Gly-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)O AKLNEFNQWLHIGY-QWRGUYRKSA-N 0.000 description 1
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 1
- JKUZFODWJGEQAP-KBPBESRZSA-N Tyr-Gly-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O JKUZFODWJGEQAP-KBPBESRZSA-N 0.000 description 1
- ILTXFANLDMJWPR-SIUGBPQLSA-N Tyr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N ILTXFANLDMJWPR-SIUGBPQLSA-N 0.000 description 1
- HHFMNAVFGBYSAT-IGISWZIWSA-N Tyr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HHFMNAVFGBYSAT-IGISWZIWSA-N 0.000 description 1
- OHOVFPKXPZODHS-SJWGOKEGSA-N Tyr-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N OHOVFPKXPZODHS-SJWGOKEGSA-N 0.000 description 1
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 1
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 1
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 1
- WOAQYWUEUYMVGK-ULQDDVLXSA-N Tyr-Lys-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOAQYWUEUYMVGK-ULQDDVLXSA-N 0.000 description 1
- BYAKMYBZADCNMN-JYJNAYRXSA-N Tyr-Lys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O BYAKMYBZADCNMN-JYJNAYRXSA-N 0.000 description 1
- NKMFRGPKTIEXSK-ULQDDVLXSA-N Tyr-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NKMFRGPKTIEXSK-ULQDDVLXSA-N 0.000 description 1
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 1
- VXFXIBCCVLJCJT-JYJNAYRXSA-N Tyr-Pro-Pro Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O VXFXIBCCVLJCJT-JYJNAYRXSA-N 0.000 description 1
- GQVZBMROTPEPIF-SRVKXCTJSA-N Tyr-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GQVZBMROTPEPIF-SRVKXCTJSA-N 0.000 description 1
- BCOBSVIZMQXKFY-KKUMJFAQSA-N Tyr-Ser-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O BCOBSVIZMQXKFY-KKUMJFAQSA-N 0.000 description 1
- XUIOBCQESNDTDE-FQPOAREZSA-N Tyr-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XUIOBCQESNDTDE-FQPOAREZSA-N 0.000 description 1
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 1
- NZBSVMQZQMEUHI-WZLNRYEVSA-N Tyr-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NZBSVMQZQMEUHI-WZLNRYEVSA-N 0.000 description 1
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 1
- JHDZONWZTCKTJR-KJEVXHAQSA-N Tyr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JHDZONWZTCKTJR-KJEVXHAQSA-N 0.000 description 1
- ZYVAAYAOTVJBSS-GMVOTWDCSA-N Tyr-Trp-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O ZYVAAYAOTVJBSS-GMVOTWDCSA-N 0.000 description 1
- YMZYSCDRTXEOKD-IHPCNDPISA-N Tyr-Trp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N YMZYSCDRTXEOKD-IHPCNDPISA-N 0.000 description 1
- LVILBTSHPTWDGE-PMVMPFDFSA-N Tyr-Trp-Lys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=C(O)C=C1 LVILBTSHPTWDGE-PMVMPFDFSA-N 0.000 description 1
- LYPKCSYAKLTBHJ-ILWGZMRPSA-N Tyr-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)C(=O)O LYPKCSYAKLTBHJ-ILWGZMRPSA-N 0.000 description 1
- GPLTZEMVOCZVAV-UFYCRDLUSA-N Tyr-Tyr-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 GPLTZEMVOCZVAV-UFYCRDLUSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 1
- JFAWZADYPRMRCO-UBHSHLNASA-N Val-Ala-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JFAWZADYPRMRCO-UBHSHLNASA-N 0.000 description 1
- ZLFHAAGHGQBQQN-AEJSXWLSSA-N Val-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZLFHAAGHGQBQQN-AEJSXWLSSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 1
- IVXJODPZRWHCCR-JYJNAYRXSA-N Val-Arg-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IVXJODPZRWHCCR-JYJNAYRXSA-N 0.000 description 1
- CVUDMNSZAIZFAE-TUAOUCFPSA-N Val-Arg-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N CVUDMNSZAIZFAE-TUAOUCFPSA-N 0.000 description 1
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 1
- VMRFIKXKOFNMHW-GUBZILKMSA-N Val-Arg-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N VMRFIKXKOFNMHW-GUBZILKMSA-N 0.000 description 1
- GXAZTLJYINLMJL-LAEOZQHASA-N Val-Asn-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N GXAZTLJYINLMJL-LAEOZQHASA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 1
- XQVRMLRMTAGSFJ-QXEWZRGKSA-N Val-Asp-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XQVRMLRMTAGSFJ-QXEWZRGKSA-N 0.000 description 1
- KXUKIBHIVRYOIP-ZKWXMUAHSA-N Val-Asp-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N KXUKIBHIVRYOIP-ZKWXMUAHSA-N 0.000 description 1
- ZQGPWORGSNRQLN-NHCYSSNCSA-N Val-Asp-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZQGPWORGSNRQLN-NHCYSSNCSA-N 0.000 description 1
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 1
- ZSZFTYVFQLUWBF-QXEWZRGKSA-N Val-Asp-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N ZSZFTYVFQLUWBF-QXEWZRGKSA-N 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 1
- LHADRQBREKTRLR-DCAQKATOSA-N Val-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N LHADRQBREKTRLR-DCAQKATOSA-N 0.000 description 1
- XJFXZQKJQGYFMM-GUBZILKMSA-N Val-Cys-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)O)N XJFXZQKJQGYFMM-GUBZILKMSA-N 0.000 description 1
- CFSSLXZJEMERJY-NRPADANISA-N Val-Gln-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O CFSSLXZJEMERJY-NRPADANISA-N 0.000 description 1
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- FOADDSDHGRFUOC-DZKIICNBSA-N Val-Glu-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N FOADDSDHGRFUOC-DZKIICNBSA-N 0.000 description 1
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 1
- RKIGNDAHUOOIMJ-BQFCYCMXSA-N Val-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 RKIGNDAHUOOIMJ-BQFCYCMXSA-N 0.000 description 1
- NXRAUQGGHPCJIB-RCOVLWMOSA-N Val-Gly-Asn Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O NXRAUQGGHPCJIB-RCOVLWMOSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- OPGWZDIYEYJVRX-AVGNSLFASA-N Val-His-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N OPGWZDIYEYJVRX-AVGNSLFASA-N 0.000 description 1
- DHINLYMWMXQGMQ-IHRRRGAJSA-N Val-His-His Chemical compound C([C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 DHINLYMWMXQGMQ-IHRRRGAJSA-N 0.000 description 1
- ZTKGDWOUYRRAOQ-ULQDDVLXSA-N Val-His-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N ZTKGDWOUYRRAOQ-ULQDDVLXSA-N 0.000 description 1
- JPPXDMBGXJBTIB-ULQDDVLXSA-N Val-His-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N JPPXDMBGXJBTIB-ULQDDVLXSA-N 0.000 description 1
- CPGJELLYDQEDRK-NAKRPEOUSA-N Val-Ile-Ala Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O CPGJELLYDQEDRK-NAKRPEOUSA-N 0.000 description 1
- FTKXYXACXYOHND-XUXIUFHCSA-N Val-Ile-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O FTKXYXACXYOHND-XUXIUFHCSA-N 0.000 description 1
- JZWZACGUZVCQPS-RNJOBUHISA-N Val-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N JZWZACGUZVCQPS-RNJOBUHISA-N 0.000 description 1
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 1
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 1
- ZZGPVSZDZQRJQY-ULQDDVLXSA-N Val-Leu-Phe Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O ZZGPVSZDZQRJQY-ULQDDVLXSA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 1
- WMRWZYSRQUORHJ-YDHLFZDLSA-N Val-Phe-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WMRWZYSRQUORHJ-YDHLFZDLSA-N 0.000 description 1
- MJOUSKQHAIARKI-JYJNAYRXSA-N Val-Phe-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 MJOUSKQHAIARKI-JYJNAYRXSA-N 0.000 description 1
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 1
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- MIKHIIQMRFYVOR-RCWTZXSCSA-N Val-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)N)O MIKHIIQMRFYVOR-RCWTZXSCSA-N 0.000 description 1
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- QZKVWWIUSQGWMY-IHRRRGAJSA-N Val-Ser-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QZKVWWIUSQGWMY-IHRRRGAJSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- SUGRIIAOLCDLBD-ZOBUZTSGSA-N Val-Trp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SUGRIIAOLCDLBD-ZOBUZTSGSA-N 0.000 description 1
- LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
- VTIAEOKFUJJBTC-YDHLFZDLSA-N Val-Tyr-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VTIAEOKFUJJBTC-YDHLFZDLSA-N 0.000 description 1
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 1
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 1
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 1
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 1
- NLNCNKIVJPEFBC-DLOVCJGASA-N Val-Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O NLNCNKIVJPEFBC-DLOVCJGASA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 102100025330 Voltage-dependent P/Q-type calcium channel subunit alpha-1A Human genes 0.000 description 1
- 101710202674 Voltage-dependent P/Q-type calcium channel subunit alpha-1A Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 230000001270 agonistic effect Effects 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010078114 alanyl-tryptophyl-alanine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000002502 anti-myelin effect Effects 0.000 description 1
- 230000001405 anti-neuronal effect Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 230000007234 antiinflammatory process Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 108010021908 aspartyl-aspartyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 230000037424 autonomic function Effects 0.000 description 1
- 210000003192 autonomic ganglia Anatomy 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000006720 chronic neuroinflammation Effects 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 206010061811 demyelinating polyneuropathy Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000002121 endocytic effect Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 208000028327 extreme fatigue Diseases 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 108010071602 haptoglobin-hemoglobin complex Proteins 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000016178 immune complex formation Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000002650 immunosuppressive therapy Methods 0.000 description 1
- 230000006057 immunotolerant effect Effects 0.000 description 1
- 230000002637 immunotoxin Effects 0.000 description 1
- 239000002596 immunotoxin Substances 0.000 description 1
- 229940051026 immunotoxin Drugs 0.000 description 1
- 231100000608 immunotoxin Toxicity 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 108010056777 interleukin-2 (59-72) Proteins 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003093 intracellular space Anatomy 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- IUPKBWSKNCAQJQ-JYYYXURSSA-N kisspeptin 234 Chemical compound C([C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(C)=O)C)C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CC=CC=C1 IUPKBWSKNCAQJQ-JYYYXURSSA-N 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 201000010901 lateral sclerosis Diseases 0.000 description 1
- 108010009932 leucyl-alanyl-glycyl-valine Proteins 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 108010077372 mast cell degranulating peptide Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
- 108700023046 methionyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- CSHFHJNMIMPJST-HOTGVXAUSA-N methyl (2s)-2-[[(2s)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoate Chemical compound NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)CC1=CC=CC=C1 CSHFHJNMIMPJST-HOTGVXAUSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000005264 motor neuron disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000004461 narcolepsy 1 Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 101800002712 p27 Proteins 0.000 description 1
- 238000002888 pairwise sequence alignment Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 108010026901 peptide 106 Proteins 0.000 description 1
- 108010009779 peptide 32 Proteins 0.000 description 1
- 108010013933 peptide 399 Proteins 0.000 description 1
- 108010011990 peptide 74 Proteins 0.000 description 1
- YYCZLGUOLIWZAW-GVETXGJZSA-N peptide 75 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C1=CC=CC=C1 YYCZLGUOLIWZAW-GVETXGJZSA-N 0.000 description 1
- 108010012038 peptide 78 Proteins 0.000 description 1
- 229940125863 peptide 78 Drugs 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 1
- 108010065135 phenylalanyl-phenylalanyl-phenylalanine Proteins 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229940076376 protein agonist Drugs 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 108010078070 scavenger receptors Proteins 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 208000005809 status epilepticus Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940126577 synthetic vaccine Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 108010060175 trypsinogen activation peptide Proteins 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 210000004981 tumor-associated macrophage Anatomy 0.000 description 1
- 108010029599 tyrosyl-glutamyl-tryptophan Proteins 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/644—Transferrin, e.g. a lactoferrin or ovotransferrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Electroluminescent Light Sources (AREA)
- Flanged Joints, Insulating Joints, And Other Joints (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 근육통성 뇌척수염/만성 피로 증후군(ME/CFS), 체위 기립성 빈맥 증후군 (POTS), 자가면역 자율신경절병증(AAG), 특발성 확장성 심근병증(IDC) 및 만성 샤가스 심장병(cChHD) 및 기타 신경학적, 신경근 및 신경정신학적 장애, 특히 자가면역 채널병증과 같은 자가항체-매개 병태와 관련된 목적하지 않은 항체의 제거를 위한 화합물을 제공한다. 상기 화합물은 생물중합체 스캐폴드 및 6-13개 아미노산의 서열 길이를 갖는 적어도 2개의 펩타이드를 포함하며, 여기서 각각의 펩타이드는 독립적으로 인간 신경수용체의 아미노산 서열의 6-아미노산 단편을 포함하고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다. 또한, 상기 화합물을 포함하는 약제학적 조성물, 및 상기 언급된 병태를 개선 또는 치료하는 방법이 제공된다.
Description
본 발명의 분야는 근육통성 뇌척수염/만성 피로 증후군(ME/CFS), 체위 기립성 빈맥 증후군 (POTS), 자가면역 자율신경절병증(AAG), 특발성 확장성 심근병증(IDC) 및 만성 샤가스 심장병(cChHD) 및 기타 신경학적, 신경근 및 신경정신학적 장애와 같은 자가항체-매개 병태의 치료요법에 관한 것이다.
신경 수용체는 신경학적 자가면역 질환에서 질병을 유발하는 자가항체에 대한 특수한 부류의 표적을 나타낸다. 말초 자율 신경계에 영향을 미치는 질병과 관련하여 이러한 자가 에피토프는 다양한 신경면역학적 병태와 관련하여 특별한 관심을 받았다. 신경근 접합부의 구조, 말초 및 중추 신경수용체, 자율신경계의 수용체 또는 채널 단백질에 대한 자가면역 원인으로 채널병증이라고 하는 채널 기능 장애를 일으키는 자가항체에 대한 종합적인 리뷰가 발표되었다(Vincent 2020; Golden 등, 2019 및 Kim, 2014). 중요한 것은 말초에 있는 신경수용체에 대한 질병 유발 항체 부류의 병원성 중요성에 대한 인식이 높아지고 있다는 것이다. 동시에, 중추 및 말초 신경계의 신경 표면 및 시냅스에서 질병 관련 자가항원의 풍부한 스펙트럼이 나타나고 있다(Zong 등, 2017; Meyer 등, 2018).
자율신경계를 방해하는 항체는 예를 들어 자가 면역 뇌염, 신경 퇴행성 질환, 다발성 경화증뿐만 아니라 부종양성 증후군(paraneoplastic syndromes) 또는 심부전 을 포함하는 많은 신경면역학적 병태와 관련이 있다. 항체와 자가항체는 또한 채널 단백질을 표적으로 삼을 수 있다(즉, 채널 병증 유발). 이러한 유형의 자가항체의 역할에 대한 완전한 기능적 및 기계론적 이해는 아직 없지만 치료적 제거가 유용하고 유망한 치료 전략임을 뒷받침하는 증거가 늘어나고 있다. 일반적으로 자율 신경계의 구성 요소에 대한 몇 가지 다른 유형의 자가 항체는 자율 기능의 일반적인 기능 장애를 설명하는 자율신경실조증(또는 자율신경계이상)과 관련이 있는 것으로 나타났다. 자율신경실조증은 심장, 장, 방광, 뇌, 혈관, 동공, 땀샘 등과 같은 여러 주요 기관 시스템을 포함하는 복잡하고 이질적인 임상 증상이다(Thornton 등, 2017). 이는 Low & Engstrom, 2017 에서도 검토되었다.
자율신경실조증은 또한 자가면역 자율신경절병증(Nakane 등, 2018), Lambert-Eaton 근무력증 증후군(Vincent 2020), 변연계 뇌염 또는 Morvan 증후군(Masood 2021), 자율 신경병증, 뇌염 및 자율신경 이상증의 다양한 기타 징후(Golden 등, 2019; 및 Kaur 등, 2021 검토)과 같은 관련 임상 병태가 있는 부종양성 증후군(paraneoplastic syndromes)에서도 발견된다. McKeon(McKeon 등, 2016)은 자가항체 및 자가면역 자율신경 장애(자가면역 자율신경절병증, 부신생물성 자율신경병증, 급성 자율신경 및 감각 신경병증 포함)의 역할을 설명한다.
본 발명의 초점은 주로 특히 말초 자율신경계에 대한 자가항체와 관련된 자율신경장애 관련 병태의 하위 그룹에 있다.
말초 자율 신경계와 관련된 가장 관련성 높은 질병 중 하나는 만성 피로 증후군(Chronic fatigue syndrome)/근육통성 뇌병증(Myalgic encephalopathy)(CFS/ME, "ME/CFS"라고도 함)이며; Sotzny 등, 2018 또는 Cortes Rivera 등, 2019를 참조한다.
ME/CFS는 환자가 일반적으로 심한 피로, 수면 문제 및 스트레스 불내성으로 인해 일상 활동을 수행할 수 있는 능력을 상실하는 복합적인 다중 전신 병태이며, 이는 사회 생활 및 직업 활동에 큰 영향을 미친다. 과도한 소모와 심한 피로는 일반적으로 인지 장애 및 기타 여러 증상과 결합된다. 면역학적, 유전적, 감염적 요인이 다원인 병인에 기여할 수 있다고 생각된다. 현재까지 표준화된 진단, 잘 검증된 바이오마커, 적절한 치료법이나 약물이 존재하지 않는다. ME/CFS의 치료는 본질적으로 대증 치료요법으로 제한된다. 수많은 연구에서 자율신경계에 대한 자가항체가 ME/CFS에서 원인 역할을 할 수 있음을 뒷받침한다(Sotzny 등, 2018 검토). 놀랍게도, 체외 면역성분채집술에 의한 항체의 일반적인 제거는 항신경수용체 항체를 고갈시킬 수 있으며 이는 병태의 임상적 개선과 상관관계가 있을 수 있다(Scheibenbogen 등, 2018). ME/CFS 환자에서 임상 증상과 항아드레날린성 및 항콜린성 자가항체의 존재 사이의 연관성은 Bynke 등, 2020에 의해 추가로 확증되었다.
중요한 것은 체위 기립성 빈맥 증후군(POTS)이 관련 병태라는 것이다[Zhao 등, 2020, Ruzieh 등, 2017]. ME/CFS로서 이는 항아드레날린성 및 무스카린성 수용체 자가항체와 관련이 있다(Gunning 등, 2019). POTS는 일반적으로 만성 기립성 조절장애 및 다양한 기타 합병증으로 나타난다. 특징은 일반적으로 기립 시 심박수의 강력한 증가이며, 종종 시야 흐림, 정신 혼탁, 가슴 불편함 및 기타 이질적인 자율신경계 이상과 결합된다 (f. ex. Jacob 등, 2020, 및 인용 참조). 자율신경계의 신경수용체에 대한 자가항체의 원인이 되는 역할에 대한 기계적 증거는 수용체 단백질에 대한 자가항체가 포함된 환자 혈청으로 M3 AChR의 시험관내 기능적 차단에 의해 제공되었다[Palma 등, 2020]. 이러한 유형의 항신경세포 자가항체에 대한 원인이 되는 역할의 다른 예는 만성 심부전에서도 발견되었다(Nagatomo 등, 2014).
복합부위 통증 증후군(CRPS)은 수족 손상 또는 수술 후 통증 병태이며 자율신경수용체에 대한 자가항체와 관련이 있다. 다시, 항-GPCR 항체는 자가면역 질환인 쇼그렌 증후군의 자율신경 기능 장애에도 기능적으로 할당되었다(Shoenfeld 등, 2020 검토). 자가면역 자율신경절병증에서 자가항체의 역할이 설명되었다(Nakane 등, 2018).
신경절 아세틸콜린 수용체 항체가 여러 류마티스성 자가면역 질환(쇼그렌 증후군, 전신 경화증, 류마티스 관절염 및 전신성 홍반성 루푸스 포함)에서 역할을 한다는 증거가 발표되었다(Imamura 등, 2020).
특발성 확장 심근 병증(IDC)은 일반적으로 좌심실 또는 이중 심실 확장 및 심근 수축 장애를 특징으로하는 원발성 심근 질환으로 간주된다. Wallukat 및 Muller(Wallukat 등, 2002; Muller 등, 2000)는 베타-1 아드레날린성 수용체에 대한 자가항체가 IDC 환자에서 비선택적으로 제거될 수 있다는 임상 증거를 제공했다. Schimke 등, 2005는 IDC 환자의 면역분리채집법에 의한 항-베타-1 아드레날린성 수용체 자가항체의 면역흡착을 보여, 산화 스트레스를 감소시키고 심장 성능을 향상시켰다. Matsui 등, 1997은 G-단백질 결합 수용체에서 유도된 펩타이드가 면역화된 토끼에서 형태학적 심근병증 변화를 유도할 수 있음을 보여주었다. Bornholz 등, 2014는 진단 및 바이오마커 목적을 위한 베타-1 아드레날린성 자가항체 사용에 대한 논의를 제공한다.
만성 샤가스 심장 질환(cChHD)은 일반적으로 트리파노소마 크루지 감염의 만성 징후이며, 일반적으로 리보솜 P 단백질의 C-말단 영역에 대한 높은 항체 수준을 특징으로 힌다. Labovsky 등, 2007은 cChHD 환자에서 베타-1-아드레날린성 수용체에 대한 자가항체를 보여주었다.
Dungen 등, 2020은 베타-1 아드레날린성 수용체 자가항체와 심장 질환의 관계에 대한 개요를 제공한다.
이러한 자가항체의 병원성 역할은 ME/CFS 환자의 임상적 개선이 관찰될 수 있는 면역성분채집술을 포함한 B 세포 고갈 또는 기타 면역억제 치료요법의 결과에 의해 뒷받침된다(Scheibenbogen 등, 2018; Kim 등, 2020). 또한 혈장 교환 치료요법은 POTS에서 수행되었으며(Wells 등, 2020), IVIG 치료요법, 혈장 교환 및 리툭시맙 치료를 포함한 여러 Ig 고갈 접근법은 이러한 질병에서 자가항체의 원인 역할을 뒷받침한다.
그러나 일반적인 면역억제 또는 비선택적 항체 고갈, 예를 들어 B 세포 고갈 또는 면역성분채집술은 불편하고 스트레스가 많으며 다수의 목적하지 않은 부작용 및 높은 비용과 관련이 있다.
따라서 본 발명의 목적은 바람직하게는 ME/CFS, POTS, AAG, IDC 및 cChHD로부터 선택되는 자가항체-매개 병태의 치료를 위한 화합물 및 방법을 제공하는 것이며, 이는 위에 기술된 기존 치료요법의 하나 이상의 단점을 해결하고/하거나 개선된 치료 결과를 초래한다.
본 발명은 생물중합체(biopolymer) 스캐폴드와 6-13개 아미노산의 서열 길이를 갖는 적어도 2개의 펩타이드를 포함하는 (일반적으로 항체, 특히 인간 개체에 존재하는, 바람직하게는 ME/CFS, POTS, AAG, IDC, 및 cChHD 또는 본원에 언급된 다른 병태로부터 선택되는 자가항체-매개 병태와 관련된 항체의 제거 또는 고갈을 위한) 화합물을 제공하고,
여기서 각각의 펩타이드는 독립적으로 다음으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 (바람직하게는 (바람직하게는 인간) 신경수용체의) 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 훨씬 더 바람직하게는 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고:
P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6, Q9Y6J6, P48058, P55087, Q9BPU6, P52799, P15328, Q05329, Q16653, Q9Y4C0, Q5F0I5, Q99719, P17600, Q13148, P01266, P07202, 및 Q9Y6A1, (바람직하게는 하기 표 1, 표 2 또는 표 3, 특히 표 1 또는 표 3으로부터 선택된 UniProt 접근 코드에 의해 식별됨),
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 더 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다.
또한, 본 발명은 본 발명에 따른 화합물 및 적어도 하나의 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물을 제공한다.
한 측면에서, 이 약제학적 조성물은 개체, 바람직하게는 인간 개체에서, 바람직하게는 ME/CFS, POTS, AAG, IDC, cChHD, 변연계 뇌염(limbic encephalitis), 또는 부종양 선조체 뇌염(paraneoplastic striatal encephalitis), 또는 항-mGluR1 뇌염, 또는 항-mGluR5 뇌염, 또는 급성 파종성 뇌척수염(ADEM), 또는 NMDAR 뇌염과 같은 뇌염, 부종양 증후군(paraneoplastic syndrome), 강직 증후군(stiff man syndrome), 자가 면역 채널 병증(autoimmune channelopathies), 시신경 척수염(neuromyelitis optica), 신경 근육 긴장(neuromyotonia), 모르반증후군(Morvan's syndrome), 신경병성 통증, 척수염, 시신경염, 망막염, 파킨슨증, 무도병(chorea), 정신병, 디스토니아(dystonia), 무언증(mutism), 운동 장애, 착란(confusion), 환각, 전구 설사(prodromal diarrhoea), 기억 상실, 과흥분(hyperexcitability), 뇌염 정신과 증후군(encephalitis psychiatric syndrome), 기면증, 자폐 스펙트럼 장애(autism spectrum disorders), 발작, 간질 발작 상태, 만성 간질, 근간대 경련(myoclonus), 뇌척수염(encephalomyelitis), 근간대 경련(myoclonus), 사건수면증(parasomnia), 수면 무호흡증(sleep apnoea), 인지 장애, 보행 이상, 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 부종양 증후군(paraneoplastic syndrome), 소뇌 운동 실조증(cerebellar ataxia), 자폐증, 뚜렛, ADHD, 소뇌 운동 실조증(cerebellar ataxia), 진동시(oscillopsia), 근 위축성 측삭 경화증 (ALS), 갑상선 장애 및 신경학적 결손 및 림프구증가증(HaNDL)을 동반한 두통에서 선택된, 자가항체-매개 병태의 예방 또는 치료에 사용하기 위한 것이다.
위에서 설명한 바와 같이, 신경수용체 또는 막 채널 단백질에 대한 자가항체가 ME/CFS, POTS, AAG, IDC 및 cChHD에서 원인이 되는 역할을 한다는 것을 뒷받침하는 수많은 연구가 있다. 예를 들어, Bynke 등은 ME/CFS 환자에서 아드레날린성 및 무스카린성 수용체에 대한 증가된 항체 수준의 일반적인 패턴이 있음을 발견했다(Bynke 등, 2020). 특히, 베타-1 및 베타-2 아드레날린성 수용체뿐만 아니라 M3 및 M4 무스카린성 아세틸콜린 수용체에 대한 자가항체 수준의 상당한 증가가 관찰되었다. Scheibenbogenet 등은 또한 ME/CFS 환자에서 특히 베타-2 아드레날린성 수용체, M3 및 M4 무스카린성 아세틸콜린 수용체에 대한 상승된 자가항체를 관찰했다(Scheibenbogen 등, 2020).면역 흡착에 의한 일반적인 항체 고갈은 자가 항체를 제거하는 데 효과적이며 ME/CFS 환자의 임상적 개선으로 이어지는 것으로 나타났다.
그러나, 본 발명 이전에는 질병 유발 항체를 특이적으로 표적화하는 선택적 접근법이 없었다. 비특이적 항체 고갈 또는 면역억제는 매우 불편하고 다수의 바람직하지 않은 부작용을 수반한다.
본 발명의 과정에서, 생체 내에서 신경수용체에 대한 이러한 항체를 고갈(또는 제거)할 수 있고 따라서 ME/CFS, POTS, AAG, IDC 및 cChHD 및 본원에 언급된 기타 조건과 같은 자가항체-매개 병태의 예방 또는 치료에 사용하기에 적합한 화합물이 개발되었다.
또한, 놀랍게도 본 발명에서도 사용되는 접근법이 개체에서 바람직하지 않은 항체의 역가를 감소시키는데 특히 효과적이라는 것이 밝혀졌다. 특히, 이 화합물은 생체 내 모델에서 선택성, 역가 감소 기간 및/또는 역가 감소 수준과 관련하여 특히 우수한 결과를 달성하였다(실험예 참조). 더욱이 이 접근법은 24시간 이내에 항체 제거를 허용하는 것으로 밝혀졌다.
하기 상세한 설명은 명시적으로 제외되지 않는 한 본 발명의 상기 측면 모두에 관한 것이다.
일반적으로, 항체는 세균, 바이러스, 진균 또는 기생충을 포함하는 외부 유기체에 의한 감염으로부터의 보호를 제공하는, 체액성 면역계의 필수 구성 성분이다. 그러나, 자가면역 질환, 기관 이식(organ transplantation), 수혈(blood transfusion) 또는, 생물분자 약물 또는 유전자 전달 벡터(gene delivery vector)의 투여시를 포함하는 - 특정의 상황하에서, 항체는 환자 자신의 신체(또는 바로 투여된 외부 조직 또는 세포 또는 생물분자 약물 또는 벡터)를 표적화함으로써, 유해하거나 질환을 유발하는 실체가 될 수 있다. 특정의 항체는 또한 진단 영상용 프로브(probe)를 방해할 수 있다. 이하에서, 이러한 항체는 일반적으로 "목적하지 않은 항체(undesired antibody)" 또는 "바람직하지 않은 항체(undesirable antibody)"로 지칭된다.
거의 예외없이, 목적하지 않은 항체의 선택적인 제거는 임상 실시에 도달하지 않았다. 이는 현재 매우 적은 증상(indications)에 한정된다: 선택적인 항체 제거에 대한 공지된 기술 중 하나(광범위하게 확립되어 있지 않다고 해도)는 면역채집술(immunoapheresis)이다. 면역채집술(이는 면역글로불린을 제거한다)과는 대조적으로, 선택적인 면역채집술은 이의 항원 결합 부위에 대한 선택적인 결합을 기반으로 목적하지 않은 항체를 고갈시킬 체외의, 선택적인 항체-흡수제 카트릿지(antibody-absorber cartridge)를 통한 혈장의 여과를 포함한다. 선택적인 면역채집술은 예를 들면, ABO-양립할 수 없는 이식(ABO-incompatible transplantation) 전에 또는 수혈의학의 처방과 관련하여 혈액으로부터 항-A 또는 항-B 항체를 제거하는데 사용되어 왔다(Teschner 등). 선택적인 채집술은 또한 다른 처방, 예를 들면, 신경면역학적 처방(Tetala 등) 또는 중증 근무력증(myasthenia gravis)(Lazaridis 등)에서 실험적으로 적용되었으나, 임상 실무에서 아직 확인되지 않고 있다. 선택적인 면역채집술이 단지 주저하며 적용되는 한가지 이유는 이것이 비용 집약적이고 전문화된 의학적 보호를 필요로하는 복잡한 중재 과정이라는 사실이다. 더욱이, 목적하지 않은 항체를 신속하게 및 효율적으로 고갈시키는 방법이 선행 기술에 알려져 있지 않다.
채집술(apheresis)과는 별도로, 모리모토(Morimoto) 등은 펩타이드 및 펩티도미메틱 리간드(peptidomimetic ligand), 예를 들면, FLAG 펩타이드의 면역글로불린-결합 친화성을 증진시키기 위한 일반적으로 적용가능한 다가 스캐폴드(miltivalent scaffold)로서의 덱스트란을 개시하고 있다. 제WO 2011/130324 A1호는 세포 손상의 예방용 화합물에 관한 것이다. 제EP 3 059 244 A1호는 C-met 단백질 효능제에 관한 것이다.
언급한 바와 같이, 채집술은 체외적으로 적용된다. 대조적으로, 또한 바람직하지 않은 항체를 고갈시키기 위한 수개의 접근법이, 대부분이 자가항체 또는 항-약물 항체를 포함하는 특정의 자가면역 질환과 관련하여, 선행 기술에서 제안되었다:
'로렌츠(Lorentz) 등'은 적혈구를 항원-특이적인 T 세포의 고갈을 유발하는 면역허용원성 페이로드를 사용하여 반응계내(in situ)에서 충전시키는 기술을 개시하고 있다. 이는 모델 항원에 대해 목적하지 않은 체액성 반응의 감소를 궁극적으로 초래하는 것으로 추정된다. 유사한 시도는 피쉐샤(Pishesha) 등에 제안되어 있다. 이러한 시도에서, 적혈구는 표면에 공유결합으로 결합된 펩타이드-항원 작제물로 생체외(ex vivo)에서 로딩되고 일반적인 면역내성 유도를 위해 동물 모델로 재주사된다.
제WO 92/13558 A1호는 면역원의 특이적인 B 세포 결합능을 지니고, 개체에게 도입된 경우, 면역원에 대해 체액성 아네르기(humoral anergy)를 유도하는 안정한 비면역원성 중합체 및 면역원의 유사체의 접합체(conjugate)에 관한 것이다. 따라서, 이러한 접합체는 외부- 또는 자가-면역원에 의해 유발된 항체-매개된 병리학을 치료하는데 유용한 것으로 개시되어 있다. 이와 관련하여, 또한 제EP 0 498 658 A2호를 참고한다.
탓데오(Taddeo) 등은 오브알부민(ovalbumin) 모델 항원에 융합된 항-CD138 항체 유도체를 사용하여 항체를 생산하는 혈장 세포를 선택적으로 고갈시킴으로써 모델 항원에 대해 항체를 발현하는 이러한 세포내에서 선택적으로 시험관내(in vitro)에서 수용체 가교결합 및 세포 자살을 유도하는 것을 개시하고 있다.
Apitope International NV(벨기에)는 현재 내성을 유발함으로써, 항체 반응을 억제하는 항원 제시 세포(antigen presenting cell)로부터 공-자극성 분자의 낮은 수준의 발현을 초래할 수 있는 가용성의 면역허용원성 T-세포 에피토프 펩타이드를 개발 중에 있다(참고: 예컨대, Jansson 등). 이러한 생성물(product)은 현재 예컨대, 다발경화증(multiple sclerosis), 그레이브스 질환(Grave's disease), 중간 포도막염(intermediate uveitis), 및 다른 자가면역 병태(autoimmune condition) 뿐만 아니라 인자 VIII 내성에 있어서, 전임상 및 조기 임상 평가 하에 있다.
유사하게, 문헌 [Selecta Biosciences, Inc. (USA)]은 현재 소위 합성 백신 입자(Synthetic Vaccine Particles)(SVPs)에 의한 내성 유도 전략을 추구하고 있다. SVP-라파마이신은 조절성 T 세포를 선택적으로 유도함을 통해 목적하지 않은 항체 생산을 방지함으로써 내성을 유도하는 것으로 제안되어 있다(참고: Mazor 등)
민고찌(Mingozzi) 등은 항체를 흡수하지만 표적 세포로 도입할 수 없는 데코이(decoy) 아데노-관련 바이러스(adeno-associated virus)(AAV) 캡시드를 개시하고 있다.
제WO 2015/136027 Al호는 항-MAG(myelin-associated glycoprotein) IgM 항체에 결합하는 최소의 사람 천연 킬러-1(Human Natural Killer-1)(HNK-1) 에피토프를 제시하는 탄수화물 리간드, 및 진단시 뿐만 아니라 항-MAG 신경병증(neuropathy)의 치료를 위한 이의 용도를 개시하고 있다. 제WO 2017/046172 Al호는 신경학적 질환과 관련된 항-글리칸 항체에 의해 결합된 신경계의 글리코스핑고리피드(glycosphingolipid)가 포함하는 당에피토프를 모사(mimicking)하는 추가의 탄수화물 리간드 및 모이어티(moiety)를 개시하고 있다. 이러한 문헌은 또한 진단뿐만 아니라 항-글리칸 항체와 관련된 신경학적 질환의 치료를 위한 이러한 탄수화물 리간드/모이어티(moiety)의 용도에 관한 것이다.
제US 2004/0258683 Al호는 전신 홍반 루푸스(systemic lupus erythematosus)(SLE), 예를 들면, 신장 SLE를 치료하는 방법 및 SLE를 지닌 개체에서 신장 플래어(renal flare)의 위험을 감소시키는 방법을 개시하고 있다. 신장 SLE를 포함하는 SLE를 치료하고 SLE를 지닌 개체에서 신장 플래어의 위험을 감소시키는 하나의 개시된 방법은 항-이중 가닥 DNA(dsDNA) 항체, 예를 들면, 에피토프-제시 담체(epitope-presenting carrier) 또는 에피토프-제시 원자가 플랫폼 분자 (epitope-presenting valency platform molecule) 형태에서와 같은 dsDNA 에피토프를 개인에게 투여함을 포함한다.
미국 특허 제5,637,454호는 자가면역 질환의 검정 및 치료에 관한 것이다. 치료에 사용된 제제는 확인된 항원성의, 분자 미미크리 서열(molecular mimicry sequence)에 대해 상동성인 펩타이드를 포함할 수 있다. 이러한 펩타이드는 환자에게 전달되어 특수한 특이성을 지닌 순환하는 항체의 양을 감소시킬 수 있음이 개시되어 있다.
제US 2007/0026396 A1호는 감기-내성을 유발하는, 항체에 대해 지시된 펩타이드, 및 이의 용도에 관한 것이다. 개시된 펩타이드를 사용함으로써, 목적하지 않은 자가항체의 생체내 또는 생체외 중화가 가능함이 교시되어 있다. 비교가능한 접근법은 제WO 1992/014150 A1호 또는 제WO 1998/030586 A2호에 개시되어 있다.
제WO 2018/102668 A1호는 질환-유발 또는 달리 목적하지 않은 항체의 선택적인 분해를 위한 융합 단백질을 개시하고 있다. 융합 단백질("Seldeg"로 명명됨)은 거의 중성 pH에서 세포 표면 수용체 또는 다른 세포 표면 분자에 특이적으로 결합하는 표적화 구성성분, 및 표적화 구성성분에 직접 또는 간접적으로 융합된 항원 구성성분을 포함한다. 또한 표적 항원-특이적인 항체에 특이적으로 결합하도록 구성된 항원 구성성분을 갖는 Seldeg를 환자에게 투여함으로써 환자로부터 표적 항원-특이적인 항체를 고갈시키는 방법이 개시되어 있다.
제WO 2015/181393 A1호는 해바라기 트립신 억제제(sunflower_trypsin-inhibitor-)(SFTI-) 및 사이클로타이드-기반 스캐폴드(cyclotide-based 스캐폴드) 내로 이식된 펩타이드에 관한 것이다. 이러한 펩타이드, 예를 들면, 류마티스 관절염(rheumatoid arthritis)에서 자가항체를 차단하고 염증(inflammation) 및 통증(pain)을 억제하는 것으로 밝혀진 SFTI 스캐폴드 내로 이식된 시트룰린화된 (citrullinated) 피브리노겐 서열은 자가면역 질환에 효과적인 것으로 개시되어 있다. 이러한 스캐폴드는 비-면역원성인 것으로 개시되어 있다.
에를랜드슨(Erlandsson) 등은 항-이디오타입 항체(anti-idiotypic antibody) 및 이의 유도체를 생체내(in vivo)에서 청소하는 것(clearing)을 개시하고 있다.
Berlin Cures Holding AG(독일)는 고 투여량에서 자가항체의 항원 결합 영역에 대한 경쟁적 결합에 의해 자가항체를 차단하는 것으로 제안된 확장성 심근병증(dilated cardiomyopathy) 및 다른 GPCR-자가항체 관련 질환(GPCR-autoantibody related disease)의 치료를 위한 정맥내 광범위한 스펙트럼의 중화제 DNA 압타머(neutralizer DNA aptamer)(참고: 예컨대, 제WO 2016/020377 A1호 및 제 WO 2012/000889 A1호)를 제시하였다. 일반적으로, 압타머는 아직 돌파구를 달성하지 않았으며 여전히 임상 개발의 예비 단계에 있다. 주요 관심은 여전히 생물안정성 및 생이용가능성, 구속, 예를 들면, 뉴클레아제 민감성, 독성, 작은 크기 및 신장 청소(renal clearance)이다. 선택적인 항체 길항제로서 이의 용도와 관련된 특수한 문제는 선천성 면역 반응을 자극하는 이의 경향성이다.
제WO 00/33887 A2호는 항체, 특히 질환-관련된 항체의 순환 수준을 감소시키는 방법을 개시하고 있다. 방법은 유효량의 에피토프-제시 담체를 개체에게 투여함을 개시하고 있다. 또한, 에피토프-제시 담체를 사용하는 항체의 순환하는 수준을 감소시키기 위한 생체외 방법이 개시되어있다.
제US 6,022,544 A호는 포유동물에게 고 분자량 면역자극성 분자가 없는 비-면역원성 작제물을 투여함으로써 포유동물에서 목적하지 않은 항체 반응을 감소시키는 방법에 관한 것이다. 작제물(contruct)은 약제학적으로 허용되는 비-면역원성 담체에 결합된 B 세포 막 면역글로불린 수용체 에피토프의 적어도 2개의 카피를 함유하는 것으로 개시되어 있다.
그러나, 선행 기술에 개시된 체내적으로 바람직하지 않은 항체를 고갈시키려는 접근법은 많은 단점을 갖는다. 특히, 이들 중 어느 것도 정식 임상용으로 승인되지 않았다.
본 발명의 화합물에 대하여, 상기 신경전달물질은 자율신경계의 신경수용체인 것이 바람직하고, 보다 바람직하게는 무스카린성 및 니코틴성 콜린성 수용체, 알파- 및 베타-아드레날린성 수용체, 세로토닌 수용체, 안지오텐신- 및 엔도텔린 수용체로 구성된 군으로부터 선택되는 신경수용체이고; 가장 바람직하게는 베타-1 아드레날린성 수용체, 베타-2 아드레날린성 수용체, M3 무스카린성 아세틸콜린 수용체 및 M4 무스카린성 아세틸콜린 수용체로 구성된 군으로부터 선택된 신경수용체이다. 모든 경우에, 신경수용체는 인간 신경수용체인 것이 바람직하다.
바람직하게는, (본 발명의 화합물에 의해 포함된) 적어도 2개의 펩타이드 각각은 독립적으로 다음으로 구성된 군에서 선택된 UniProt 접근 코드로 식별되는 (바람직하게는 자율신경계의 신경수용체의) 아미노산 서열 중 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13-아미노산 단편(선호도가 높은 순서대로)을 포함한다: P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1; P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, 및 P48664.
상기 아미노산 서열이 무스카린성 및 니코틴성 콜린성 수용체, 알파- 및 베타-아드레날린성 수용체, 세로토닌 수용체, 안지오텐신- 및 엔도텔린 수용체로 구성된 군으로부터 선택된 신경수용체의 아미노산 서열인 경우 더욱 바람직하다.
특히 바람직하게는, 상기 아미노산 서열은 P08588, P07550, P20309 및 P08173으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되며 (바람직하게는 베타-1 아드레날린성 수용체, 베타-2 아드레날린성 수용체, M3 무스카린성 아세틸콜린 수용체 및 M4 무스카린성 아세틸콜린 수용체로 구성된 군으로부터 선택된 신경수용체의) 아미노산 서열이다.
전술한 단락에 개시된 바람직한 아미노산 서열(신경전달물질 및/또는 UniProt 접근 번호와 관련하여)의 정의 뿐만 아니라 상기 본원에 개시된 발명의 요약은 본 발명의 화합물(이하 예를 들어 P, P1, P2, Pa-j로 지정됨)에 포함된 펩타이드의 모든 정의에 대한 바람직한 구체예로서 동일하게 적용된다.
많은 신경계, 신경근계 및 신경정신과적 장애가 자가항체와 연관되거나 그에 의해 유발된다는 것은 잘 알려져 있다. 신경근 접합부(예를들어, 중증 근무력증의 니코틴성 아세틸콜린 수용체에 대한 항체)를 표적으로 하는 자가항체의 질병 유발 효과가 발견된 이후 유사한 병인학적 특징을 가진 여러 패러다임이 기술되었다.
많은 경우 임상에서 상관관계와 연관성이 나타났으며, 이러한 사례 중 일부는 예를 들어 Giannoccaro 등, 2020에서 검토한 바와 같이 인간 자가항체(자가면역 혈청, 클로닝된 항체, 능동 면역화에 의해 직접 유도)의 병원성 효과가 입증된 동물 모델을 사용하여 기능적 개념 증명이 확립되었다.
본 발명의 과정에서, 인간 기증자(ME/CFS 환자 포함)의 혈청은 인간 단백질에 대한 자가항체의 파라토프, 특히 신경학적, 신경근 및 신경정신 장애에 관여하는 수용체 및 이온 채널 또는 기타 막 채널에 결합할 수 있는 펩타이드에 대해 스크리닝되었다(특히 실시예 12 및 하기 표 1 뿐만 아니라 예를 들어 표 2 참조). 발견된 펩타이드 또는 이의 단편은 본 발명의 화합물의 형태로 투여될 때 환자에서 질병 유발 자가항체를 고갈시키는데 적합하다.
몇 가지 신경학적 또는 신경정신과적 질환 병태 또는 증후군은 하나 또는 여러 가지 일반적인 자가항체 표적(즉, 자가항원)과 연관될 수 있다. 자가항원은 신경수용체 및 막 채널(자가면역 채널병증과 관련됨)의 경우와 같이 반드시 세포외 공간에 위치할 필요는 없다 - 많은 자가항체는 실제로 아래에 나열된 바와 같이 세포내 항원과 연관되어 있다. 중요한 것은 신경면역학적 증상의 연관성이 종양, 신경퇴행성 질환 또는 자가면역 질환과 같은 다양한 병태에서 발견된다는 것이다. 본 발명은 상응하는 자가항원이 세포외 또는 세포내 공간에 위치하는지 여부에 관계없이 이러한 자가항체를 제거하는 해결책을 제공한다. 본원에 개시된 신경수용체 및 다른 단백질로부터 유래된 펩타이드는 펩타이드가 단백질 사슬의 세포외 부분 또는 세포내 부분으로부터 유래되었는지 여부에 관계없이 자가항체에 대한 결합 모이어티를 제공한다. 또한, 본 발명에서 제공하는 펩타이드 식별 전략은 전체 "천연" 에피토프 구조가 아닌 부분적인 에피토프 구조만을 나타내는 펩타이드 히트를 생성할 수 있습니다 - 본 발명의 선형 또는 환형 펩타이드가 그 자체로 전체 에피토프를 모방할 필요는 없다(사실, 본 발명의 화합물의 임의의 잠재적인 면역원성을 추가로 감소시키기 위해 부분적 에피토프만을 나타내는 것이 바람직하다). 다시 말해, 본 발명의 펩타이드의 목적은 신경학적 또는 신경정신과적 질병에 관여하는 자가항체의 유형과 같은 목적하지 않은 질병 유발 항체에 결합하는 것이다(특히 하기 표 1-3 참조).
펩타이드 # | 서열번호 | 펩타이드 | 그룹 I | 그룹 II | 그룹 III | 단백질 ( UniProt ) |
1 | 45 | GQPGAQRMYKQ | X | X | X | O00555 |
2 | 46 | HLPDDDKTPMS | X | X | X | O00555 |
3 | 47 | PGAQRMYKQSM | X | X | X | O00555 |
4 | 48 | PPLNHTVVQVN | X | X | X | O00555 |
5 | 49 | QILTGEDWNEV | X | X | X | O00555 |
6 | 50 | RSHRASERSLG | X | X | X | O00555 |
7 | 51 | SSPAPLGGQET | X | X | X | O43497 |
8 | 52 | EKKRRNLMLDDVIA | X | X | X | O43497 |
9 | 53 | LNCITIAMERPKID | X | X | X | O43497 |
10 | 54 | RRLEKKRRNLMLDD | X | X | X | O43497 |
11 | 55 | CNYSETGPPEPPYS | X | X | X | O43525 |
12 | 56 | LSSFLVYLVEKDVP | X | X | X | O43525 |
13 | 57 | VVVEGSGRVADVIA | X | X | X | O94759 |
14 | 58 | ASAGGAKILGVLRV | X | X | X | O95180 |
15 | 59 | ELGADEEQRVPYPA | X | X | X | O95180 |
16 | 60 | SGDPPLGDQKP | X | X | X | O95180 |
17 | 61 | FEPLDLGVPSGDPF | X | X | X | O95180 |
18 | 62 | LINVDEVNQIVTTN | X | X | X | P02708 |
19 | 63 | SLRSPHTHSMA | X | X | X | P07510 |
20 | 64 | GRTGHGLRRSS | X | X | X | P07550 |
21 | 65 | LGPVVCDLWLALDY | X | X | X | P08172 |
22 | 66 | VSPSLVQGRIVKPN | X | X | X | P08172 |
23 | 67 | YWPLGPVVCDLWLA | X | X | X | P08172 |
24 | 68 | IKVNRQLQTVN | X | X | X | P08173 |
25 | 69 | DPKCCDFVTNR | X | X | X | P08588 |
26 | 70 | KCCDFVTNRAY | X | X | X | P08588 |
27 | 71 | MSLASADLVMG | X | X | X | P08588 |
28 | 72 | EFSAEETEETF | X | X | X | P08912 |
29 | 73 | PGEEFSAEETEETF | X | X | X | P08912 |
30 | 74 | SPGEEFSAEETEET | X | X | X | P08912 |
31 | 75 | EETEETF | X | X | X | P08912 |
32 | 76 | PGEEFSAEETEET | X | X | X | P08912 |
33 | 77 | NLYTTYL | X | X | X | P11229 |
34 | 78 | EKLFSGY | X | X | X | P11230 |
35 | 79 | FYLPLLVMLFV | X | X | X | P13945 |
36 | 80 | HSKGLQILGQTLKA | X | X | X | P16389 |
37 | 81 | QVWLLFEYPESSGP | X | X | X | P16389 |
38 | 82 | VLITSLAILVF | X | X | X | P17787 |
39 | 83 | AKLPALASVASARE | X | X | X | P18089 |
40 | 84 | ALPNSGQGQKE | X | X | X | P18089 |
41 | 85 | WAALPNSGQGQKEG | X | X | X | P18089 |
42 | 86 | ALPNSGQGQKEGV | X | X | X | P18089 |
43 | 87 | GQGQKEG | X | X | X | P18089 |
44 | 88 | AVTGVNKIELPQFS | X | X | X | P18505 |
45 | 89 | ATLVMPFSLANELM | X | X | X | P18825 |
46 | 90 | VMPFSLANELMAYW | X | X | X | P18825 |
47 | 91 | CNKTFRTTFKM | X | X | X | P20309 |
48 | 92 | SSDSWNNNDAA | X | X | X | P20309 |
49 | 93 | APQSLLTMEEI | X | X | X | P25098 |
50 | 94 | GEAPQSLLTME | X | X | X | P25098 |
51 | 95 | TISERWQQEVA | X | X | X | P25098 |
52 | 96 | APQSLLTMEEIQS | X | X | X | P25098 |
53 | 97 | EGEAPQSLLTMEE | X | X | X | P25098 |
54 | 98 | GEAPQSLLTMEEI | X | X | X | P25098 |
55 | 99 | PQSLLTMEEIQSV | X | X | X | P25098 |
56 | 100 | QSLLTMEEIQSVE | X | X | X | P25098 |
57 | 101 | SLLTMEEIQSVEE | X | X | X | P25098 |
58 | 102 | GVGVFLAAFILMA | X | X | X | P25100 |
59 | 103 | LLRCQCRRRRRRR | X | X | X | P25100 |
60 | 104 | VGVRHSL | X | X | X | P25100 |
61 | 105 | YTIMTAHFHLKRKI | X | X | X | P31644 |
62 | 106 | GSARITVSKDQ | X | X | X | P35348 |
63 | 107 | GMASAKTKTHFSV | X | X | X | P35348 |
64 | 108 | LKSGLKTDKSDSE | X | X | X | P35348 |
65 | 109 | CRGRGRRRRRRRRR | X | X | X | P35368 |
66 | 110 | CQCRGRGRRRRRR | X | X | X | P35368 |
67 | 111 | CRGRGRRRRRRRR | X | X | X | P35368 |
68 | 112 | GRGRRRRRRRRRL | X | X | X | P35368 |
69 | 113 | QCRGRGRRRRRRR | X | X | X | P35368 |
70 | 114 | RGRGRRRRRRRRR | X | X | X | P35368 |
71 | 115 | RGRRRRRRRRRLG | X | X | X | P35368 |
72 | 116 | CTPCKENEYVFDEY | X | X | X | P41594 |
73 | 117 | NTQNFKPAPATNTQ | X | X | X | P42263 |
74 | 118 | TTRSITDPTDPVDY | X | X | X | P43146 |
75 | 119 | DQLDFWESGEW | X | X | X | P43681 |
76 | 120 | ELPPPDQPSPC | X | X | X | P43681 |
77 | 121 | PPPDQPSPCKC | X | X | X | P43681 |
78 | 122 | SVKEDWKYVAMVID | X | X | X | P43681 |
79 | 123 | AELPPPDQPSPCK | X | X | X | P43681 |
80 | 124 | HSAELPPPDQPSP | X | X | X | P43681 |
81 | 125 | PDQPSPC | X | X | X | P43681 |
82 | 126 | PPDQPSP | X | X | X | P43681 |
83 | 127 | SAELPPPDQPSPC | X | X | X | P43681 |
84 | 128 | LPSTCLQKVEEQPE | X | X | X | Q00975 |
85 | 129 | SAKPLTRYMPQ | X | X | X | Q00975 |
86 | 130 | IVLALEQHLPDGDK | X | X | X | Q00975 |
87 | 131 | AMDILNMVFTGVFT | X | X | X | Q01668 |
88 | 132 | KAAQTMSTSAP | X | X | X | Q01668 |
89 | 133 | KHDREPQRRSS | X | X | X | Q01668 |
90 | 134 | QAKAAQTMSTS | X | X | X | Q01668 |
91 | 135 | IYIPFPEDDSNSTN | X | X | X | Q01668 |
92 | 136 | QHSPEAACPPTAGT | X | X | X | Q03721 |
93 | 137 | ASPPRRASSVG | X | X | X | Q04844 |
94 | 138 | PEVRCCVDAVN | X | X | X | Q04844 |
95 | 139 | PRLRHVLLELL | X | X | X | Q04844 |
96 | 140 | FIWDSAVLEFEASQ | X | X | X | Q05586 |
97 | 141 | LFLQKLPKLLC | X | X | X | Q05901 |
98 | 142 | SIIVTVFVINV | X | X | X | Q05901 |
99 | 143 | TLSIIVTVFVI | X | X | X | Q05901 |
100 | 144 | LFENADGRFEGSL | X | X | X | Q05901 |
101 | 145 | GVYNQPPPQPFPGD | X | X | X | Q07001 |
102 | 146 | LEEDREAVRREAER | X | X | X | Q08289 |
103 | 147 | KFKTTHAPPGDTLV | X | X | X | Q12809 |
104 | 148 | AGESTFANNKSSVP | X | X | X | Q13224 |
105 | 149 | EMSAGESTFANNKS | X | X | X | Q13224 |
106 | 150 | GNIEGNAAKRRKQQ | X | X | X | Q13224 |
107 | 151 | LGAAMALSLITFIC | X | X | X | Q13224 |
108 | 152 | SKHSQLSDLYGKFS | X | X | X | Q13224 |
109 | 153 | IGTDIVATVENEEP | X | X | X | Q13698 |
110 | 154 | CYFIGTDIVATVEN | X | X | X | Q13698 |
111 | 155 | FGKFCPHRVACKRL | X | X | X | Q13698 |
112 | 156 | AGYPSTVSTVE | X | X | X | Q13936 |
113 | 157 | FAQDPKFIEVT | X | X | X | Q13936 |
114 | 158 | GQFAQDPKFIE | X | X | X | Q13936 |
115 | 159 | PQPVPTLRLEGVES | X | X | X | Q13936 |
116 | 160 | QGSTTATRPPR | X | X | X | Q13936 |
117 | 161 | SSNRERHVPMCEDL | X | X | X | Q13936 |
118 | 162 | ALAHEDCPAIDQPA | X | X | X | Q14003 |
119 | 163 | GAAHVHGIVFEDNV | X | X | X | Q14957 |
120 | 164 | HVHGIVFEDNVDTE | X | X | X | Q14957 |
121 | 165 | PHMQKALEGVHYIA | X | X | X | Q15822 |
122 | 166 | EVAITQLANVDEVN | X | X | X | Q15825 |
123 | 167 | HCHKSNELATS | X | X | X | Q15825 |
124 | 168 | VDMNDFWENSE | X | X | X | Q15825 |
125 | 169 | WTYDKAEIDLL | X | X | X | Q15825 |
126 | 170 | LGRSNTIGSAP | X | X | X | Q15878 |
127 | 171 | MEPSSLPQEII | X | X | X | Q15878 |
128 | 172 | LFPVAFAGFNLVYW | X | X | X | Q16445 |
129 | 173 | RPGFGGAVTEVKTD | X | X | X | Q16445 |
130 | 174 | GAVMNKLLTMG | X | X | X | Q8IZS8 |
131 | 175 | RLTIAKQTVSS | X | X | X | Q8IZS8 |
132 | 176 | DMNFDFDLYIVGDG | X | X | X | Q8TCU5 |
133 | 177 | IEHPFVFTREVDDE | X | X | X | Q8TCU5 |
134 | 178 | YEWKSPFGLTPKGR | X | X | X | Q8TCU5 |
135 | 179 | ITIIFNKFSHFYRR | X | X | X | Q96KK3 |
136 | 180 | DDEDLAAKRLGIED | X | X | X | Q96PR1 |
137 | 181 | LSPPPRAPPLSPGP | X | X | X | Q96PR1 |
138 | 182 | ESEGEKENSTNDPE | X | X | X | Q9NS40 |
139 | 183 | ESLCSIRRASSVHD | X | X | X | Q9NS40 |
140 | 184 | LSFESEGEKENSTN | X | X | X | Q9NS40 |
141 | 185 | RSRESLCSIRRASS | X | X | X | Q9NS40 |
142 | 186 | SPTKESCSPSEADD | X | X | X | Q9NS40 |
143 | 187 | TLSDDDYVNVASFN | X | X | X | Q9NY47 |
144 | 188 | DEEGRGGAGGGGAG | X | X | X | Q9P0X4 |
145 | 189 | GGAGGGGDTEGGLC | X | X | X | Q9P0X4 |
146 | 190 | GRGGAGGGGAG | X | X | X | Q9P0X4 |
147 | 191 | RSPSWAADRSKDPP | X | X | X | Q9P0X4 |
148 | 192 | WGRSAAWASRR | X | X | X | Q9P0X4 |
149 | 193 | ASPSRDVSPMG | X | X | X | Q9UBN1 |
150 | 194 | GSWTYNGNQVD | X | X | X | Q9UGM1 |
151 | 195 | TDKVLNVTLQITLS | X | X | X | Q9UGM1 |
152 | 196 | VLFVYDVGESCLS | X | X | X | Q9UGM1 |
153 | 197 | FSRSYSELKEQQQR | X | X | X | Q9UJ96 |
154 | 198 | FQATWAVNNGIDTT | X | X | X | Q9ULD8 |
155 | 199 | KFFKNALNLIDLMS | X | X | X | Q9ULS6 |
156 | 200 | PRRHRRPRRVIARY | X | X | X | Q9UN88 |
157 | 201 | SRDASPVGIKGFNT | X | X | X | Q9Y698 |
158 | 202 | ILYAGNDRWTSDPR | X | X | A6NGN9 | |
159 | 203 | SWGSKIAPVYQQEE | X | X | O00222 | |
160 | 204 | FEQGKKSVTAPKFI | X | X | O00222 | |
161 | 205 | GKKSVTAPKFISPA | X | X | O00222 | |
162 | 206 | SVTAPKFISPASQL | X | X | O00222 | |
163 | 207 | ALMAHESGLKE | X | X | O00555 | |
164 | 208 | ARKPDHTTVDI | X | X | O00555 | |
165 | 209 | ASVAYENALRVFNI | X | X | O00555 | |
166 | 210 | DCRGKYLLYEKNEV | X | X | O00555 | |
167 | 211 | GADKQQMDAEL | X | X | O00555 | |
168 | 212 | GKYLLYEKNEV | X | X | O00555 | |
169 | 213 | GSYLRNGWNVM | X | X | O00555 | |
170 | 214 | HHGYYRGSDYD | X | X | O00555 | |
171 | 215 | LFIVVFALLGM | X | X | O00555 | |
172 | 216 | LGMQLFGGQFN | X | X | O00555 | |
173 | 217 | LRLLRIFKVTKYWA | X | X | O00555 | |
174 | 218 | LSGEFAKERER | X | X | O00555 | |
175 | 219 | MAHESGLKESP | X | X | O00555 | |
176 | 220 | NPDPLPKKEEE | X | X | O00555 | |
177 | 221 | NYTLLNVFLAIAVD | X | X | O00555 | |
178 | 222 | QGGQPGAQRMY | X | X | O00555 | |
179 | 223 | REALYNEMDPD | X | X | O00555 | |
180 | 224 | RPHVSYSPVIR | X | X | O00555 | |
181 | 225 | RTPLMFQRMEP | X | X | O00555 | |
182 | 226 | SAAPHGSLGHA | X | X | O00555 | |
183 | 227 | SGILTRECGNE | X | X | O00555 | |
184 | 228 | SLKNVFNILIV | X | X | O00555 | |
185 | 229 | TPRPHVSYSPV | X | X | O00555 | |
186 | 230 | TVFQILTGEDWNEV | X | X | O00555 | |
187 | 231 | VILAEDETDGE | X | X | O00555 | |
188 | 232 | YLTRDSSILGP | X | X | O00555 | |
189 | 233 | GGALMAHESGLKES | X | X | O00555 | |
190 | 234 | AAFMIQEEYVDTVS | X | X | O15399 | |
191 | 235 | APTSRSLEDLSSCP | X | X | O15399 | |
192 | 236 | PLWSRYGRFLQPVD | X | X | O15399 | |
193 | 237 | PQPLPSPAYPAPRP | X | X | O15399 | |
194 | 238 | QLQVIFEVLEEYDW | X | X | O15399 | |
195 | 239 | VIFEVLEEYDWTSF | X | X | O15399 | |
196 | 240 | YTANLAAFMIQEEY | X | X | O15399 | |
197 | 241 | ESQPLLGPGAGGAG | X | X | O15399 | |
198 | 242 | DPQIPLAEMEALSL | X | X | O43497 | |
199 | 243 | FIFIFSILGMHLFG | X | X | O43497 | |
200 | 244 | KGAINFDNIGY | X | X | O43497 | |
201 | 245 | NHNPWMLLYFISFL | X | X | O43497 | |
202 | 246 | PCEGLGRHATFRNF | X | X | O43497 | |
203 | 247 | PWMLLYFISFLLIV | X | X | O43497 | |
204 | 248 | PYCARAGAGEV | X | X | O43497 | |
205 | 249 | SPSLDGDGDRKKCL | X | X | O43497 |
206 | 250 | VHHLVHHHHHHHHH | X | X | O43497 | |
207 | 251 | VRFLSNASTLA | X | X | O43497 | |
208 | 252 | CGLDYEAYNSSSNT | X | X | O43497 | |
209 | 253 | GAAGGGGDGGGGGG | X | X | O43525 | |
210 | 254 | GGGGDGGGGGGGAA | X | X | O43525 | |
211 | 255 | KARRAAGAAGGGGD | X | X | O43525 | |
212 | 256 | RAAGAAGGGGDGGG | X | X | O43525 | |
213 | 257 | YGDKTPKTWEGRLI | X | X | O43525 | |
214 | 258 | FARLPPYRYRFRRR | X | X | O60359 | |
215 | 259 | DFELYLVGDGKYGA | X | X | O60391 | |
216 | 260 | TGRLLMNLWAIFCL | X | X | O60391 | |
217 | 261 | KEETAEAEPSGPEV | X | X | O60391 | |
218 | 262 | EKRLGTPPGGGGAG | X | X | O60741 | |
219 | 263 | FWIIHPYSDFRFYW | X | X | O60741 | |
220 | 264 | LGTPPGGGGAGAKE | X | X | O60741 | |
221 | 265 | LLQDFPPDCWVSLN | X | X | O60741 | |
222 | 266 | LPADMRQKIHDYYE | X | X | O60741 | |
223 | 267 | MVGNLVIIPVGITF | X | X | O60741 | |
224 | 268 | PSAILSPCSYTTAV | X | X | O60741 | |
225 | 269 | TNLTREVRPLSASQ | X | X | O60741 | |
226 | 270 | TPQPSAILSPCSYT | X | X | O60741 | |
227 | 271 | YEHRYQGKIFDEEN | X | X | O60741 | |
228 | 272 | IQHGVAGVITKSSK | X | X | O60741 | |
229 | 273 | CGGILETTLVE | X | X | O60840 | |
230 | 274 | EEEEEEEEEEE | X | X | O60840 | |
231 | 275 | EEEEEEEEEEEEEE | X | X | O60840 | |
232 | 276 | GADMEEEEEEEEEE | X | X | O60840 | |
233 | 277 | HHGQPVWLTQIQEY | X | X | O60840 | |
234 | 278 | HSSAISVVKILRVL | X | X | O60840 | |
235 | 279 | IVAYGLVLHPS | X | X | O60840 | |
236 | 280 | IVDIAVTEVNN | X | X | O60840 | |
237 | 281 | LGMQLFGGKFNFDQ | X | X | O60840 | |
238 | 282 | LPASDTGSMTE | X | X | O60840 | |
239 | 283 | LYSDEESILSRFDE | X | X | O60840 | |
240 | 284 | MEEDLRGYLDWITQ | X | X | O60840 | |
241 | 285 | MEEEEEEEEEEEEE | X | X | O60840 | |
242 | 286 | PHQYRVWATVN | X | X | O60840 | |
243 | 287 | QENEGLVPGVEKEE | X | X | O60840 | |
244 | 288 | SAMMALFTVSTFEG | X | X | O60840 | |
245 | 289 | SHASLPASDTG | X | X | O60840 | |
246 | 290 | TCDTEEEEEEG | X | X | O60840 | |
247 | 291 | EGSGRVADVIAQVA | X | X | O94759 | |
248 | 292 | AESLDPRPLRP | X | X | O95180 | |
249 | 293 | ASVRTRKHTFGQRC | X | X | O95180 | |
250 | 294 | ATFCTLLMLFIFIF | X | X | O95180 | |
251 | 295 | DNVATFCTLLMLFI | X | X | O95180 | |
252 | 296 | DPYEKIPHVVGEHG | X | X | O95180 | |
253 | 297 | DTGDTVPDRKN | X | X | O95180 | |
254 | 298 | GVPSGDPFLDG | X | X | O95180 | |
255 | 299 | HAYLQSSWNLLDGL | X | X | O95180 | |
256 | 300 | KRRGLYLTVPQCPL | X | X | O95180 | |
257 | 301 | PGSPQRRAQQR | X | X | O95180 | |
258 | 302 | AEPALGARRKKKMS | X | X | O95180 | |
259 | 303 | GADEEQRVPYPALA | X | X | O95180 | |
260 | 304 | AGLVLGSEHETRLV | X | X | P02708 | |
261 | 305 | DEVNQIVTTNV | X | X | P02708 | |
262 | 306 | GLQLIQLINVDEVN | X | X | P02708 | |
263 | 307 | IQLINVDEVNQ | X | X | P02708 | |
264 | 308 | YCEIIVTHFPF | X | X | P02708 | |
265 | 309 | HSEENKAPESEELE | X | X | P06213 | |
266 | 310 | PAKMLLDPAAPAQE | X | X | P07510 | |
267 | 311 | ILIVVNA | X | X | P07510 | |
268 | 312 | SHFDNGNEEWFLV | X | X | P07510 | |
269 | 313 | AINCYANETCCDFF | X | X | P07550 | |
270 | 314 | DNIDSQGRNCSTND | X | X | P07550 | |
271 | 315 | DSQGRNCSTND | X | X | P07550 | |
272 | 316 | HDVTQERDEVW | X | X | P07550 | |
273 | 317 | AITSPFKYQSLLT | X | X | P07550 | |
274 | 318 | IDSQGRNCSTNDS | X | X | P07550 | |
275 | 319 | KYQSLLT | X | X | P07550 | |
276 | 320 | NIDSQGRNCSTND | X | X | P07550 | |
277 | 321 | DLIIGVFSMNL | X | X | P08172 | |
278 | 322 | IGVFSMNLYTLYTV | X | X | P08172 | |
279 | 323 | IVGVRTVEDGE | X | X | P08172 | |
280 | 324 | KSDSCTPTNTTVEV | X | X | P08172 | |
281 | 325 | MNNSTNSSNNS | X | X | P08172 | |
282 | 326 | TSLGHSKDENSKQT | X | X | P08172 | |
283 | 327 | MNNSTNS | X | X | P08172 | |
284 | 328 | MNNSTNSSNNSLA | X | X | P08172 | |
285 | 329 | NNSTNSSNNSLAL | X | X | P08172 | |
286 | 330 | TQDENTVSTSLGH | X | X | P08172 | |
287 | 331 | KEKKAKTLAFL | X | X | P08173 | |
288 | 332 | PATELSTTEAT | X | X | P08173 | |
289 | 333 | GSATQNT | X | X | P08173 | |
290 | 334 | YTVYIIKGYWPLG | X | X | P08173 | |
291 | 335 | APAPPPGPPRP | X | X | P08588 | |
292 | 336 | ERRFLGGPARP | X | X | P08588 | |
293 | 337 | NGGAAADSDSSLDE | X | X | P08588 | |
294 | 338 | YNDPKCCDFVT | X | X | P08588 | |
295 | 339 | AITSPFRYQSLLT | X | X | P08588 | |
296 | 340 | RYQSLLT | X | X | P08588 | |
297 | 341 | DYVASNASVMNLLV | X | X | P08912 | |
298 | 342 | EETEETFVKAE | X | X | P08912 | |
299 | 343 | GEEFSAEETEE | X | X | P08912 | |
300 | 344 | LVGKRTVPLDE | X | X | P08912 | |
301 | 345 | AEETEET | X | X | P08912 | |
302 | 346 | AEETEETFVKAET | X | X | P08912 | |
303 | 347 | CSSYPSSEDEDKP | X | X | P08912 | |
304 | 348 | EETEETFVKAETE | X | X | P08912 | |
305 | 349 | GEEFSAEETEETF | X | X | P08912 | |
306 | 350 | LFRSCLRCPRPTL | X | X | P08912 | |
307 | 351 | LGYWLCYVNSTVN | X | X | P08912 | |
308 | 352 | SAEETEE | X | X | P08912 | |
309 | 353 | TKAEKRKPAHRAL | X | X | P08912 | |
310 | 354 | YPSSEDEDKPATD | X | X | P08912 | |
311 | 355 | IYLALDVLFCT | X | X | P08913 | |
312 | 356 | VATLVIPFSLANEV | X | X | P08913 | |
313 | 357 | AALQGSETPGKGGG | X | X | P11229 | |
314 | 358 | ETENRARELAALQG | X | X | P11229 | |
315 | 359 | LVLISFKVNTE | X | X | P11229 | |
316 | 360 | PRSSPNTVKRP | X | X | P11229 | |
317 | 361 | QKPRGKEQLAK | X | X | P11229 | |
318 | 362 | PTKKGRD | X | X | P11229 |
319 | 363 | PGALLML | X | X | P11230 | |
320 | 364 | WTFIIFTSVGTLV | X | X | P11230 | |
321 | 365 | VLVWVVSAAVS | X | X | P13945 | |
322 | 366 | YGALVTK | X | X | P13945 | |
323 | 367 | GKTRTSLKTMSRRK | X | X | P14416 | |
324 | 368 | DIVAIIPYFITLGT | X | X | P16389 | |
325 | 369 | ENEFQRQVWLLFEY | X | X | P16389 | |
326 | 370 | EYPESSGPARIIAI | X | X | P16389 | |
327 | 371 | IGVILFSSAVYFAE | X | X | P16389 | |
328 | 372 | QSTSFTDPFFIVET | X | X | P16389 | |
329 | 373 | QEGVNNSNEDFREE | X | X | P16389 | |
330 | 374 | TWTLKKLPLSLSFL | X | X | P16473 | |
331 | 375 | NNGGVSRVSPVSRG | X | X | P17658 | |
332 | 376 | FRSWTYDRTEIDLV | X | X | P17787 | |
333 | 377 | LDDFTPSGEWDIVA | X | X | P17787 | |
334 | 378 | LPPAIYKSACK | X | X | P17787 | |
335 | 379 | NVWLTQEWEDY | X | X | P17787 | |
336 | 380 | RHHCARQRLRLRRR | X | X | P17787 | |
337 | 381 | WTYDRTEIDLV | X | X | P17787 | |
338 | 382 | AEEEEEEEEEE | X | X | P18089 | |
339 | 383 | ASVASAREVNG | X | X | P18089 | |
340 | 384 | DEAEEEEEEEE | X | X | P18089 | |
341 | 385 | DEAEEEEEEEEEEE | X | X | P18089 | |
342 | 386 | EAEEEEEEEEE | X | X | P18089 | |
343 | 387 | EDEAEEEEEEE | X | X | P18089 | |
344 | 388 | EEECEPQAVPV | X | X | P18089 | |
345 | 389 | EEEEEEEEECE | X | X | P18089 | |
346 | 390 | EEEEEEEEEEC | X | X | P18089 | |
347 | 391 | EEEEEEEEEEEECE | X | X | P18089 | |
348 | 392 | GQGQKEGVCGA | X | X | P18089 | |
349 | 393 | LPNSGQGQKEG | X | X | P18089 | |
350 | 394 | PNSGQGQKEGV | X | X | P18089 | |
351 | 395 | SGQGQKEGVCG | X | X | P18089 | |
352 | 396 | SPEDEAEEEEEEEE | X | X | P18089 | |
353 | 397 | AALPNSGQGQKEG | X | X | P18089 | |
354 | 398 | CIILTVWLIAAVI | X | X | P18089 | |
355 | 399 | LPNSGQGQKEGVC | X | X | P18089 | |
356 | 400 | PNSGQGQKEGVCG | X | X | P18089 | |
357 | 401 | QGQKEGV | X | X | P18089 | |
358 | 402 | SGQGQKE | X | X | P18089 | |
359 | 403 | STGEKEE | X | X | P18089 | |
360 | 404 | ACMMDLRRYPLDEQ | X | X | P18505 | |
361 | 405 | EIRNETSGSEVLTS | X | X | P18505 | |
362 | 406 | AQAREKRFTFV | X | X | P18825 | |
363 | 407 | AAALAVA | X | X | P18825 | |
364 | 408 | AVLTSRA | X | X | P18825 | |
365 | 409 | RRSFKHILFRRRR | X | X | P18825 | |
366 | 410 | RSFKHILFRRRRR | X | X | P18825 | |
367 | 411 | DSWNNND | X | X | P20309 | |
368 | 412 | LQQQSMKRSNRRK | X | X | P20309 | |
369 | 413 | VVPGDHLLEPEVAD | X | X | P22001 | |
370 | 414 | EEEEEEEEEEGRFY | X | X | P22459 | |
371 | 415 | ESLCAKEEKCQGKG | X | X | P22459 | |
372 | 416 | HCSDLMPSGSEEKI | X | X | P22459 | |
373 | 417 | KKQIWLLFEYPESS | X | X | P22459 | |
374 | 418 | SSSLGDKSEYLEME | X | X | P22459 | |
375 | 419 | HDPQSSRGSRRRRR | X | X | P22459 | |
376 | 420 | QSSRGSRRRRRQRS | X | X | P22459 | |
377 | 421 | GPKEPAPKGRGAQR | X | X | P22460 | |
378 | 422 | LRYFDPLRNEYFFD | X | X | P22460 | |
379 | 423 | LYALCLDTSRETDL | X | X | P22460 | |
380 | 424 | MAVCLLFVFSALLE | X | X | P23415 | |
381 | 425 | FTMTLYLRHYWKDE | X | X | P24046 | |
382 | 426 | GVDVQVESLDSISE | X | X | P24046 | |
383 | 427 | WKDERLSFPSTNNL | X | X | P24046 | |
384 | 428 | APQSLLTMEEIQSV | X | X | P25098 | |
385 | 429 | EARPLVEFYEE | X | X | P25098 | |
386 | 430 | EGEAPQSLLTMEEI | X | X | P25098 | |
387 | 431 | EIQSVEETQIKERK | X | X | P25098 | |
388 | 432 | FCLNHLEEARPLVE | X | X | P25098 | |
389 | 433 | LEEARPLVEFY | X | X | P25098 | |
390 | 434 | LLLKIRGGKQFILQ | X | X | P25098 | |
391 | 435 | NHLEEARPLVEFYE | X | X | P25098 | |
392 | 436 | QKYPPPLIPPRGEV | X | X | P25098 | |
393 | 437 | QSLLTMEEIQS | X | X | P25098 | |
394 | 438 | QVPPDLFQPYIEEI | X | X | P25098 | |
395 | 439 | SDKFTRFCQWK | X | X | P25098 | |
396 | 440 | SLLTMEEIQSVEET | X | X | P25098 | |
397 | 441 | TVFDTINAETDRLE | X | X | P25098 | |
398 | 442 | AMEKSKA | X | X | P25098 | |
399 | 443 | EAPQSLLTMEEIQ | X | X | P25098 | |
400 | 444 | EIQSVEETQIKER | X | X | P25098 | |
401 | 445 | ETQIKER | X | X | P25098 | |
402 | 446 | GEGEAPQSLLTME | X | X | P25098 | |
403 | 447 | QSLLTME | X | X | P25098 | |
404 | 448 | RGEGEAPQSLLTM | X | X | P25098 | |
405 | 449 | SLLTMEE | X | X | P25098 | |
406 | 450 | VHRIIGRGGFGEV | X | X | P25098 | |
407 | 451 | WRGEGEAPQSLLT | X | X | P25098 | |
408 | 452 | IMTERKAAAILALL | X | X | P25100 | |
409 | 453 | LLKFSREKKAAKTL | X | X | P25100 | |
410 | 454 | LLRCQCRRRRR | X | X | P25100 | |
411 | 455 | LLSVSFEGPRPDSS | X | X | P25100 | |
412 | 456 | LRLLRCQCRRRRRR | X | X | P25100 | |
413 | 457 | RRRRRRRPLWR | X | X | P25100 | |
414 | 458 | CRRRRRRRPLWRV | X | X | P25100 | |
415 | 459 | LRCQCRRRRRRRP | X | X | P25100 | |
416 | 460 | LRLLRCQCRRRRR | X | X | P25100 | |
417 | 461 | QCRRRRRRRPLWR | X | X | P25100 | |
418 | 462 | RCQCRRRRRRRPL | X | X | P25100 | |
419 | 463 | RLLRCQCRRRRRR | X | X | P25100 | |
420 | 464 | YPAIMTERKAAAI | X | X | P25100 | |
421 | 465 | EIIPSSSKVIPLIG | X | X | P30532 | |
422 | 466 | RSHVDRYFTQKEET | X | X | P30532 | |
423 | 467 | LKQEWTDYRLT | X | X | P30926 | |
424 | 468 | LMTPTASMDDF | X | X | P30926 | |
425 | 469 | MFVCVLGTVGL | X | X | P30926 | |
426 | 470 | QLSLAQLISVN | X | X | P30926 |
427 | 471 | RPATSSSQLIS | X | X | P30926 | |
428 | 472 | SKSPAGSTPVAIPR | X | X | P30926 | |
429 | 473 | STHTMAPWVKRCFL | X | X | P30926 | |
430 | 474 | VCVLGTVGLFL | X | X | P30926 | |
431 | 475 | YEVSVYTNLIV | X | X | P30926 | |
432 | 476 | SEGPYAA | X | X | P30926 | |
433 | 477 | AEHRLFERLFEDYN | X | X | P32297 | |
434 | 478 | ERLFEDYNEIIRP | X | X | P32297 | |
435 | 479 | LNQYDLLGHVVGTE | X | X | P34903 | |
436 | 480 | ETKTYNSVSKVDKI | X | X | P34903 | |
437 | 481 | AAKTLGIVVGCFVL | X | X | P35348 | |
438 | 482 | GGSGMASAKTK | X | X | P35348 | |
439 | 483 | ILLGVILGGLILFG | X | X | P35348 | |
440 | 484 | TFYRISKTDGV | X | X | P35348 | |
441 | 485 | YRISKTDGVCE | X | X | P35348 | |
442 | 486 | DQSSCTTARVRSK | X | X | P35348 | |
443 | 487 | CQCRGRGRRRRRRR | X | X | P35368 | |
444 | 488 | LGCQCRGRGRRRRR | X | X | P35368 | |
445 | 489 | LSLCAISIDRYIGV | X | X | P35368 | |
446 | 490 | QCRGRGRRRRRRRR | X | X | P35368 | |
447 | 491 | RGRGRRRRRRR | X | X | P35368 | |
448 | 492 | RGRGRRRRRRRRRL | X | X | P35368 | |
449 | 493 | RHDSGPLFTFKLLT | X | X | P35368 | |
450 | 494 | GCQCRGRGRRRRR | X | X | P35368 | |
451 | 495 | GRRRRRRRRRLGG | X | X | P35368 | |
452 | 496 | RRRRRRRLGGCAY | X | X | P35368 | |
453 | 497 | RRRRRRRRLGGCA | X | X | P35368 | |
454 | 498 | RRRRRRRRRLGGC | X | X | P35368 | |
455 | 499 | DEKNQVLTTNI | X | X | P36544 | |
456 | 500 | AQEVASTLASSPPS | X | X | P37088 | |
457 | 501 | GRGAQEVASTLASS | X | X | P37088 | |
458 | 502 | ETAAEILKQILFMG | X | X | P39086 | |
459 | 503 | GVSCVLFVIARFTP | X | X | P39086 | |
460 | 504 | KPLLKEMKKGKEFY | X | X | P39086 | |
461 | 505 | RIGGIFETVENEPV | X | X | P39086 | |
462 | 506 | ALVTKTNRIARILA | X | X | P41594 | |
463 | 507 | MEPPDIMHDYPSIR | X | X | P41594 | |
464 | 508 | CEKGQIKVIRKGEV | X | X | P41594 | |
465 | 509 | ANQFEGNDRYEGYC | X | X | P42261 | |
466 | 510 | FNSLWFSLGAFMQQ | X | X | P42261 | |
467 | 511 | GIRKIGYWNEDDKF | X | X | P42261 | |
468 | 512 | HVCFITPSFPVDTS | X | X | P42261 | |
469 | 513 | LTVERMVSPIESAE | X | X | P42261 | |
470 | 514 | PCMSHSSGMPLGAT | X | X | P42261 | |
471 | 515 | RKSKGKYAYLLEST | X | X | P42261 | |
472 | 516 | ERLVVVDCESERLN | X | X | P42261 | |
473 | 517 | MRSAEPSVFVRTTA | X | X | P42262 | |
474 | 518 | SRAEAKRMKVAKNA | X | X | P42262 | |
475 | 519 | IAVYEKMWSYMKSA | X | X | P42263 | |
476 | 520 | KIAVYEKMWSYMKS | X | X | P42263 | |
477 | 521 | PYEWHLEDNNEEPR | X | X | P42263 | |
478 | 522 | WEKFVYLYDTERGF | X | X | P42263 | |
479 | 523 | NFKPAPATNTQNYA | X | X | P42263 | |
480 | 524 | RVRKSKGKFAFLLE | X | X | P42263 | |
481 | 525 | LHRQNEEPVFSKDG | X | X | P42658 | |
482 | 526 | LYSANTVGNFNRQC | X | X | P42658 | |
483 | 527 | APSRTIPTACVRPT | X | X | P43146 | |
484 | 528 | DPTDPVDYYPLLDD | X | X | P43146 | |
485 | 529 | SITDPTDPVDYYPL | X | X | P43146 | |
486 | 530 | DQLPPQQPLEA | X | X | P43681 | |
487 | 531 | DVVLVRFGLSIAQL | X | X | P43681 | |
488 | 532 | HSRVDQLDFWE | X | X | P43681 | |
489 | 533 | PDQPSPCKCTC | X | X | P43681 | |
490 | 534 | RVDQLDFWESG | X | X | P43681 | |
491 | 535 | SAELPPPDQPS | X | X | P43681 | |
492 | 536 | ELPPPDQPSPCKC | X | X | P43681 | |
493 | 537 | NTHSAELPPPDQP | X | X | P43681 | |
494 | 538 | PPPDQPSPCKCTC | X | X | P43681 | |
495 | 539 | RIFLWMFIIVCLL | X | X | P43681 | |
496 | 540 | THSAELPPPDQPS | X | X | P43681 | |
497 | 541 | NMQFLLFVFLVWDP | X | X | P47869 | |
498 | 542 | SVQVAPDGSRLNQY | X | X | P47869 | |
499 | 543 | CALAGVLTIAMPVP | X | X | P48547 | |
500 | 544 | HFDYDPRADEFFFD | X | X | P48547 | |
501 | 545 | LSGLSSKAAKDVLG | X | X | P48547 | |
502 | 546 | PVPVIVNNFGMYYS | X | X | P48547 | |
503 | 547 | VFAHILNYYRTGKL | X | X | P48547 | |
504 | 548 | WLAEPDAHSHFDYD | X | X | P48547 | |
505 | 549 | CQARQFRTFHHPTY | X | X | P51172 | |
506 | 550 | KDNGVTPGEKMLTV | X | X | P51787 | |
507 | 551 | TYEQLTVPRRGPDE | X | X | P51787 | |
508 | 552 | ERPTGWKCFVYHFA | X | X | P51787 | |
509 | 553 | KCFVYHFAVFLIVL | X | X | P51787 | |
510 | 554 | NFLERPTGWKCFVY | X | X | P51787 | |
511 | 555 | TGWKCFVYHFAVFL | X | X | P51787 | |
512 | 556 | AAAWSILQQFL | X | X | P54289 | |
513 | 557 | QWREDFASNEV | X | X | P54289 | |
514 | 558 | SCFQHLVQANV | X | X | P54289 | |
515 | 559 | VDVSGSVSGLT | X | X | P54289 | |
516 | 560 | YDVRRRPWYIQ | X | X | P54289 | |
517 | 561 | LEETITQARYSETL | X | X | P54289 | |
518 | 562 | GSPLPPGAPLPGPG | X | X | P56696 | |
519 | 563 | PRTSAEDAPSEEVA | X | X | P56696 | |
520 | 564 | APRAELVALTAVQS | X | X | P56696 | |
521 | 565 | DITSDYHSPVDHED | X | X | P56696 | |
522 | 566 | AAEAPEGVDPP | X | X | Q00975 | |
523 | 567 | CLSPTNLLRRF | X | X | Q00975 | |
524 | 568 | DFVVVLTGILATAG | X | X | Q00975 | |
525 | 569 | EMDPEERLRFA | X | X | Q00975 | |
526 | 570 | FIMAMIALNTV | X | X | Q00975 | |
527 | 571 | GPDGEPQPGLE | X | X | Q00975 | |
528 | 572 | GPTGCRRERER | X | X | Q00975 | |
529 | 573 | PGPHPQGSGSV | X | X | Q00975 | |
530 | 574 | QGPSPGYRMEL | X | X | Q00975 | |
531 | 575 | RARGGGAGGAG | X | X | Q00975 | |
532 | 576 | RARGGGAGGAGGPG | X | X | Q00975 | |
533 | 577 | RGGGAGGAGGP | X | X | Q00975 | |
534 | 578 | RQKSSTSLSNGGAI | X | X | Q00975 |
535 | 579 | RRGPDGEPQPG | X | X | Q00975 | |
536 | 580 | TDAEPVGDFPC | X | X | Q00975 | |
537 | 581 | YKRLVRMNMPISNE | X | X | Q00975 | |
538 | 582 | YSEMDPEERLR | X | X | Q00975 | |
539 | 583 | GGERARGGGAGGAG | X | X | Q00975 | |
540 | 584 | ACISIVEWKPF | X | X | Q01668 | |
541 | 585 | AKSNPEECRGL | X | X | Q01668 | |
542 | 586 | ALLGNHVNHVN | X | X | Q01668 | |
543 | 587 | ECLRRQSSQEE | X | X | Q01668 | |
544 | 588 | EIRRAISCDLQDDE | X | X | Q01668 | |
545 | 589 | ESVNTENVSGE | X | X | Q01668 | |
546 | 590 | ETESVNTENVS | X | X | Q01668 | |
547 | 591 | GALLGNHVNHVNSD | X | X | Q01668 | |
548 | 592 | GLGRYARDPKFVSA | X | X | Q01668 | |
549 | 593 | GRYARDPKFVS | X | X | Q01668 | |
550 | 594 | IGVQLFKGKFYRCT | X | X | Q01668 | |
551 | 595 | IIVAFFMMNIFVGF | X | X | Q01668 | |
552 | 596 | ILLAIFANCVALAI | X | X | Q01668 | |
553 | 597 | LGNHVNHVNSD | X | X | Q01668 | |
554 | 598 | LPYVALLIAML | X | X | Q01668 | |
555 | 599 | LTISSEHYNQPDWL | X | X | Q01668 | |
556 | 600 | NLADAESLNTA | X | X | Q01668 | |
557 | 601 | PFPEDDSNSTN | X | X | Q01668 | |
558 | 602 | SETESVNTENVSGE | X | X | Q01668 | |
559 | 603 | TSMPTSETESVNTE | X | X | Q01668 | |
560 | 604 | FVIVTFQEQGEKEY | X | X | Q01668 | |
561 | 605 | PFPEDDSNSTNHNL | X | X | Q01668 | |
562 | 606 | SRRWRRWNRFNRRR | X | X | Q01668 | |
563 | 607 | WSEYDPEAKGRIKH | X | X | Q01668 | |
564 | 608 | ARQGSWEDEEE | X | X | Q02641 | |
565 | 609 | EDEEEDYEEEL | X | X | Q02641 | |
566 | 610 | EEEDYEEELTD | X | X | Q02641 | |
567 | 611 | GDNSSSSLGDV | X | X | Q02641 | |
568 | 612 | LGRNKNELEGW | X | X | Q02641 | |
569 | 613 | NSAYTELGDSC | X | X | Q02641 | |
570 | 614 | PGSRNSAYTEL | X | X | Q02641 | |
571 | 615 | QGSWEDEEEDY | X | X | Q02641 | |
572 | 616 | SQEIPMEVFDP | X | X | Q02641 | |
573 | 617 | SRNSAYTELGD | X | X | Q02641 | |
574 | 618 | SRNSAYTELGDSCV | X | X | Q02641 | |
575 | 619 | SWEDEEEDYEE | X | X | Q02641 | |
576 | 620 | YNPSPGDEVPV | X | X | Q02641 | |
577 | 621 | YPPSQEIPMEVFDP | X | X | Q02641 | |
578 | 622 | CPADVCGPLFEEEL | X | X | Q03721 | |
579 | 623 | ITSVHFRREVETEP | X | X | Q03721 | |
580 | 624 | NKPPSKTCLKEEMA | X | X | Q03721 | |
581 | 625 | DDFGGIETLRV | X | X | Q04844 | |
582 | 626 | GKTINKIDIDTEAY | X | X | Q04844 | |
583 | 627 | SLNEKEETLTT | X | X | Q04844 | |
584 | 628 | KIQLNATSVTHKPN | X | X | Q05586 | |
585 | 629 | PFGRFKVNSEEEEE | X | X | Q05586 | |
586 | 630 | VPPYSHQSSVWFEM | X | X | Q05586 | |
587 | 631 | IPCLGLSFLTVLVF | X | X | Q05901 | |
588 | 632 | IVTVFVINVHH | X | X | Q05901 | |
589 | 633 | CLFVVTPVMVV | X | X | Q07001 | |
590 | 634 | GANFIVNHMRD | X | X | Q07001 | |
591 | 635 | NQPPPQPFPGD | X | X | Q07001 | |
592 | 636 | PPPQPFPGDPY | X | X | Q07001 | |
593 | 637 | CLFVVTPVMVVGT | X | X | Q07001 | |
594 | 638 | DVSLEEDREAVRRE | X | X | Q08289 | |
595 | 639 | EKFNNDWWIGR | X | X | Q08289 | |
596 | 640 | HTPPYDVVPSMRPV | X | X | Q08289 | |
597 | 641 | YVEPKEDYSHDHVD | X | X | Q08289 | |
598 | 642 | TTVIYNSNIFTDPF | X | X | Q09470 | |
599 | 643 | IAEQEGNQKGEQAT | X | X | Q09470 | |
600 | 644 | FMACEELPPGAPEL | X | X | Q12809 | |
601 | 645 | GESPSSGPSSPESS | X | X | Q12809 | |
602 | 646 | LRLVRVARKLDRYS | X | X | Q12809 | |
603 | 647 | KFSYIPEAKASCYG | X | X | Q12879 | |
604 | 648 | LLVLPALLVWRGPA | X | X | Q12879 | |
605 | 649 | NSTNEGMNVKKCCK | X | X | Q12879 | |
606 | 650 | PSFTIGKAIWLLWG | X | X | Q12879 | |
607 | 651 | PSGLISVSYDDWDY | X | X | Q12879 | |
608 | 652 | LRISRQHSYDNIVD | X | X | Q12879 | |
609 | 653 | HSYDNIVDKPRELD | X | X | Q12879 | |
610 | 654 | KLSGKKSSLFPQGL | X | X | Q12879 | |
611 | 655 | MSLIKEAHWEGLTG | X | X | Q13002 | |
612 | 656 | IPVSFEWSNDSSVI | X | X | Q13018 | |
613 | 657 | SDRTPVVSSFLDNT | X | X | Q13018 | |
614 | 658 | TIKDEAENAFLLEE | X | X | Q13018 | |
615 | 659 | AMALSLITFICEHL | X | X | Q13224 | |
616 | 660 | APWEKNLTNVEWED | X | X | Q13224 | |
617 | 661 | ASVMLNIMEEYDWY | X | X | Q13224 | |
618 | 662 | EGNAAKRRKQQYKD | X | X | Q13224 | |
619 | 663 | ETEEQEDDHLSIVT | X | X | Q13224 | |
620 | 664 | FPTGLISVSYDEWD | X | X | Q13224 | |
621 | 665 | GVPAPWEKNLTNVE | X | X | Q13224 | |
622 | 666 | HMFEMSAGESTFAN | X | X | Q13224 | |
623 | 667 | IENSFVGWELEEVL | X | X | Q13224 | |
624 | 668 | QFGPSIEQQASVML | X | X | Q13224 | |
625 | 669 | SRREFDEIELAYRR | X | X | Q13224 | |
626 | 670 | RERLPKARVVVCFC | X | X | Q13255 | |
627 | 671 | SAMCYSALVTKTNR | X | X | Q13255 | |
628 | 672 | ADFPGDDEEDEPEI | X | X | Q13698 | |
629 | 673 | DIVATVENEEP | X | X | Q13698 | |
630 | 674 | FIGTDIVATVE | X | X | Q13698 | |
631 | 675 | GSLDQHQGSQE | X | X | Q13698 | |
632 | 676 | GTDIVATVENE | X | X | Q13698 | |
633 | 677 | IDEFESNVNEV | X | X | Q13698 | |
634 | 678 | KLCDPESDYAPGEE | X | X | Q13698 | |
635 | 679 | KLMAFKARGYFGDP | X | X | Q13698 | |
636 | 680 | LLIQKALVRGGLGT | X | X | Q13698 | |
637 | 681 | TDLSKMTEEEC | X | X | Q13698 | |
638 | 682 | TGQALADACQMEPE | X | X | Q13698 | |
639 | 683 | TSMKLLDQVIPPIG | X | X | Q13698 | |
640 | 684 | YPSADFPGDDEEDE | X | X | Q13698 | |
641 | 685 | DIVATVENEEPSPC | X | X | Q13698 | |
642 | 686 | PDKSEEEKSTMAKK | X | X | Q13698 |
643 | 687 | AAIDAARQAKLMGS | X | X | Q13936 | |
644 | 688 | DAARQAKLMGSAGN | X | X | Q13936 | |
645 | 689 | EGLGQFAQDPKFIE | X | X | Q13936 | |
646 | 690 | GQFAQDPKFIEVTT | X | X | Q13936 | |
647 | 691 | GWPPQPVPTLR | X | X | Q13936 | |
648 | 692 | GWPPQPVPTLRLEG | X | X | Q13936 | |
649 | 693 | IVTFQEQGEQE | X | X | Q13936 | |
650 | 694 | LETGHGRQCQN | X | X | Q13936 | |
651 | 695 | LRRDSGSAGTQAHC | X | X | Q13936 | |
652 | 696 | PPQPVPTLRLE | X | X | Q13936 | |
653 | 697 | QDPKFIEVTTQ | X | X | Q13936 | |
654 | 698 | QPVPTLRLEGV | X | X | Q13936 | |
655 | 699 | SMNAEENSRIS | X | X | Q13936 | |
656 | 700 | VACKRLVSMNM | X | X | Q13936 | |
657 | 701 | YPSTVSTVEGH | X | X | Q13936 | |
658 | 702 | PRPAGYPSTVSTVE | X | X | Q13936 | |
659 | 703 | YIPFPEDDSNATNS | X | X | Q13936 | |
660 | 704 | FPEDDSNATNSNLE | X | X | Q13936 | |
661 | 705 | LLYRSIDSHTEDKG | X | X | Q13936 | |
662 | 706 | CPAIDQPAMSPEDK | X | X | Q14003 | |
663 | 707 | ENITNVEVETEPFL | X | X | Q14003 | |
664 | 708 | ESPPPPPLPPQQQQ | X | X | Q14003 | |
665 | 709 | HEDCPAIDQPAMSP | X | X | Q14003 | |
666 | 710 | IPGAPPENITNVEV | X | X | Q14003 | |
667 | 711 | PNYCKPDPPPPPPP | X | X | Q14003 | |
668 | 712 | ERIGADPDDILGSN | X | X | Q14003 | |
669 | 713 | VKSVQPGEVCCWLC | X | X | Q14416 | |
670 | 714 | AEKDEDDTKFKSIP | X | X | Q14721 | |
671 | 715 | FPGPCTWRRISSLE | X | X | Q14957 | |
672 | 716 | FVAYCSREEAEVLF | X | X | Q14957 | |
673 | 717 | GIVFEDNVDTEAVA | X | X | Q14957 | |
674 | 718 | KRVRGVWNGMIGEV | X | X | Q14957 | |
675 | 719 | LAAFMIQEQYIDTV | X | X | Q14957 | |
676 | 720 | PATFPVGLISVVTE | X | X | Q14957 | |
677 | 721 | PCTWRRISSLESEV | X | X | Q14957 | |
678 | 722 | PLEIQPLTVGVNTT | X | X | Q14957 | |
679 | 723 | LEIQPLTVGVNTTN | X | X | Q14957 | |
680 | 724 | VEEEDRWACAG | X | X | Q15822 | |
681 | 725 | GSWTYDKAEID | X | X | Q15825 | |
682 | 726 | IGSKVDMNDFW | X | X | Q15825 | |
683 | 727 | KSSCPMDITFF | X | X | Q15825 | |
684 | 728 | QLANVDEVNQI | X | X | Q15825 | |
685 | 729 | SKVDMNDFWEN | X | X | Q15825 | |
686 | 730 | YNCCEEIYTDITYS | X | X | Q15825 | |
687 | 731 | APMFQRMEPSS | X | X | Q15878 | |
688 | 732 | EEETLTFEAAV | X | X | Q15878 | |
689 | 733 | GSAPPLRHSWQMPN | X | X | Q15878 | |
690 | 734 | GTNKGRDIKTI | X | X | Q15878 | |
691 | 735 | HRACFMNNSGILEG | X | X | Q15878 | |
692 | 736 | ITMEGWTTVLY | X | X | Q15878 | |
693 | 737 | KNAPMFQRMEP | X | X | Q15878 | |
694 | 738 | MMKYYSAPCTYELA | X | X | Q15878 | |
695 | 739 | QCITMEGWTTV | X | X | Q15878 | |
696 | 740 | QELTKDEQEEEEAF | X | X | Q15878 | |
697 | 741 | QQEAGGGEAVV | X | X | Q15878 | |
698 | 742 | RERGRSKERKHLLS | X | X | Q15878 | |
699 | 743 | SPLKEAEIREDEEE | X | X | Q15878 | |
700 | 744 | TDPSSMRRSFSTIR | X | X | Q15878 | |
701 | 745 | PMRLVNFPMDGHAC | X | X | Q16445 | |
702 | 746 | ALSRGHGKYFF | X | X | Q8IZS8 | |
703 | 747 | DGAHGLLDPYN | X | X | Q8IZS8 | |
704 | 748 | ESLNKVFVDNF | X | X | Q8IZS8 | |
705 | 749 | IMLITDGAVDTYDT | X | X | Q8IZS8 | |
706 | 750 | PELRLLYEEGK | X | X | Q8IZS8 | |
707 | 751 | PGIKWEPDENG | X | X | Q8IZS8 | |
708 | 752 | TIAKQTVSSIL | X | X | Q8IZS8 | |
709 | 753 | TTVAMPVFSKQ | X | X | Q8IZS8 | |
710 | 754 | VDKGKRVLVMTNDY | X | X | Q8IZS8 | |
711 | 755 | RIAKIDSYSRIFFP | X | X | Q8N1C3 | |
712 | 756 | KFRSARYSRSLSTE | X | X | Q8TAE7 | |
713 | 757 | RTFEEPTSSLAAQI | X | X | Q8TAE7 | |
714 | 758 | FIMDKALLDYEVSI | X | X | Q8TCU5 | |
715 | 759 | IPSTMNCMEVETTN | X | X | Q8TCU5 | |
716 | 760 | QRLHRAINTSFIEE | X | X | Q8TCU5 | |
717 | 761 | DAFIMDKALLDYEV | X | X | Q8TCU5 | |
718 | 762 | KTKRVEKRSNVGPR | X | X | Q8TCU5 | |
719 | 763 | ETECFFVEPDEPFH | X | X | Q8TDD5 | |
720 | 764 | GGGGGGGGGAG | X | X | Q8WXS5 | |
721 | 765 | GLAGAGGGGGGAVG | X | X | Q8WXS5 | |
722 | 766 | SNIIGVIVYIS | X | X | Q8WXS5 | |
723 | 767 | VAAGLAGAGGGGGG | X | X | Q8WXS5 | |
724 | 768 | RLPSYRFRYRRRSR | X | X | Q8WXS5 | |
725 | 769 | FSSRERRSFTEIDT | X | X | Q92953 | |
726 | 770 | KEQMNEELRREAET | X | X | Q92953 | |
727 | 771 | RSFTEIDTGDDEDF | X | X | Q92953 | |
728 | 772 | SADDNHLSPSRWKW | X | X | Q92953 | |
729 | 773 | VCDDYNLNENEYFF | X | X | Q92953 | |
730 | 774 | CDDYDEAAREFYFD | X | X | Q96KK3 | |
731 | 775 | LRSLGATLKHSYRE | X | X | Q96KK3 | |
732 | 776 | VSEASLETSRETSQ | X | X | Q96KK3 | |
733 | 777 | VYCSDGFCELAGFA | X | X | Q96L42 | |
734 | 778 | IRVSRSNSPKTKQE | X | X | Q96L42 | |
735 | 779 | SPICTRGSSSRNKK | X | X | Q96L42 | |
736 | 780 | TLPGTRLALLASSE | X | X | Q96PR1 | |
737 | 781 | LEGKANGGLVDGEV | X | X | Q96RP8 | |
738 | 782 | CGPSVRPVPAW | X | X | Q9GZZ6 | |
739 | 783 | DRFFLAIFFSM | X | X | Q9GZZ6 | |
740 | 784 | FFLAIFFSMAL | X | X | Q9GZZ6 | |
741 | 785 | QSRPPELSPSPQSP | X | X | Q9GZZ6 | |
742 | 786 | RPPELSPSPQS | X | X | Q9GZZ6 | |
743 | 787 | LSPSPQS | X | X | Q9GZZ6 | |
744 | 788 | LYLWIRQ | X | X | Q9GZZ6 | |
745 | 789 | QGHASYILEAPASN | X | X | Q9H252 | |
746 | 790 | GSQNSMGAGPCAPG | X | X | Q9H252 | |
747 | 791 | LGPQFPSKGYSLLG | X | X | Q9H252 | |
748 | 792 | YSAAFLLSDQDESR | X | X | Q9H252 | |
749 | 793 | KDRTHNVTEKVTQV | X | X | Q9NS40 | |
750 | 794 | ENSTNDPEDSADTI | X | X | Q9NS40 | |
751 | 795 | GEKENSTNDPEDSA | X | X | Q9NS40 | |
752 | 796 | RECGYSCSPLNVVD | X | X | Q9NS40 | |
753 | 797 | YSEYGAAVLMLLMC | X | X | Q9NS40 | |
754 | 798 | SRPDVMQKPCTCDF | X | X | Q9NS40 | |
755 | 799 | GRRTLRPAVVG | X | X | Q9NY47 | |
756 | 800 | LDFLDAELEDE | X | X | Q9NY47 | |
757 | 801 | LDNHGYVFKPPHQD | X | X | Q9NY47 | |
758 | 802 | RTLRPAVVGVK | X | X | Q9NY47 |
759 | 803 | RTLVKSLDERY | X | X | Q9NY47 | |
760 | 804 | TRRPTSGPPRP | X | X | Q9NY47 | |
761 | 805 | VTLDFLDAELEDEN | X | X | Q9NY47 | |
762 | 806 | REYCKDLNASDNNT | X | X | Q9NY47 | |
763 | 807 | LYGLIYHSWFQADP | X | X | Q9NY47 | |
764 | 808 | DFFYHPETQQYFFD | X | X | Q9NZV8 | |
765 | 809 | LIPEIIGDCCYEEY | X | X | Q9NZV8 | |
766 | 810 | RYPDTLLGSSERDF | X | X | Q9NZV8 | |
767 | 811 | VTMTTLGYGDMVPK | X | X | Q9NZV8 | |
768 | 812 | ANRSYSDEDQSSSN | X | X | Q9P0X4 | |
769 | 813 | DATPHTLVQPI | X | X | Q9P0X4 | |
770 | 814 | DNGIMGCHEIP | X | X | Q9P0X4 | |
771 | 815 | DRGEDEEEIDY | X | X | Q9P0X4 | |
772 | 816 | ELGKEEEEEEQ | X | X | Q9P0X4 | |
773 | 817 | FYHCLGVDTRN | X | X | Q9P0X4 | |
774 | 818 | GGAGGGGAGSE | X | X | Q9P0X4 | |
775 | 819 | GKFYHCLGVDT | X | X | Q9P0X4 | |
776 | 820 | GMHIFGCKFSL | X | X | Q9P0X4 | |
777 | 821 | GRGGAGGGGAGSEH | X | X | Q9P0X4 | |
778 | 822 | LFKGKFYHCLGVDT | X | X | Q9P0X4 | |
779 | 823 | NRVPSMRILVN | X | X | Q9P0X4 | |
780 | 824 | QEVQLAETEAF | X | X | Q9P0X4 | |
781 | 825 | QPIPATLASDP | X | X | Q9P0X4 | |
782 | 826 | RQATGSDTSLD | X | X | Q9P0X4 | |
783 | 827 | RQATGSDTSLDASP | X | X | Q9P0X4 | |
784 | 828 | SLRGLRAHQRS | X | X | Q9P0X4 | |
785 | 829 | SMRILVNLLLD | X | X | Q9P0X4 | |
786 | 830 | SPSSSAGSLQTTLE | X | X | Q9P0X4 | |
787 | 831 | TAVSPDPENFL | X | X | Q9P0X4 | |
788 | 832 | TGSDTSLDASPSSS | X | X | Q9P0X4 | |
789 | 833 | LVQPIPATLASDPA | X | X | Q9P0X4 | |
790 | 834 | PYARMPSYRYRRRR | X | X | Q9UBN1 | |
791 | 835 | RMPSYRYRRRRSRS | X | X | Q9UBN1 | |
792 | 836 | EWEVHGMPAVKNVI | X | X | Q9UGM1 | |
793 | 837 | LSDFIEDVEWE | X | X | Q9UGM1 | |
794 | 838 | VLNVTLQITLSQIK | X | X | Q9UGM1 | |
795 | 839 | VLYNKADDESSEPV | X | X | Q9UGM1 | |
796 | 840 | DESSEPV | X | X | Q9UGM1 | |
797 | 841 | LLLKRRSSFYIVN | X | X | Q9UGM1 | |
798 | 842 | TFGSWTYNGNQVD | X | X | Q9UGM1 | |
799 | 843 | AIRNGVNRNSAIIG | X | X | Q9UHC6 | |
800 | 844 | GDNSDYDYSALSCT | X | X | Q9UIX4 | |
801 | 845 | QPEDRRRRIIINVG | X | X | Q9UIX4 | |
802 | 846 | SDYDYSALSCTSDA | X | X | Q9UIX4 | |
803 | 847 | TREFGLLLLFLCVA | X | X | Q9UIX4 | |
804 | 848 | FHTFSRSYSELKEQ | X | X | Q9UJ96 | |
805 | 849 | RLRACRGHDDLLRV | X | X | Q9UJ96 | |
806 | 850 | RVCDDYDVSRDEFF | X | X | Q9UJ96 | |
807 | 851 | LGAGGGSAEVDTSS | X | X | Q9ULD8 | |
808 | 852 | PDLSPRVVDGIEDG | X | X | Q9ULD8 | |
809 | 853 | TAPRPRLGGRGRPG | X | X | Q9ULD8 | |
810 | 854 | SAMRSCDFGDGMKE | X | X | Q9ULS6 | |
811 | 855 | RSCDFGDGMKEVPS | X | X | Q9ULS6 | |
812 | 856 | ILKFQVQREVNSYL | X | X | Q9UN88 | |
813 | 857 | QPRRHRRPRRVIAR | X | X | Q9UN88 | |
814 | 858 | DLSPRIVDGIEDSG | X | X | Q9UQ05 | |
815 | 859 | IEDSGSTAEAPSFR | X | X | Q9UQ05 | |
816 | 860 | DKTLPSITEAESGA | X | X | Q9UQ05 | |
817 | 861 | ASPVGIKGFNTLPS | X | X | Q9Y698 | |
818 | 862 | LAVHMFIDRHK | X | X | Q9Y698 | |
819 | 863 | DASPVGIKGFNTLP | X | X | Q9Y698 | |
820 | 864 | AVNFNGSAGTPVTF | X | O00222 | ||
821 | 865 | CEGYNYQVDELSCE | X | O00222 | ||
822 | 866 | CSRDTYALEQSLTF | X | O00222 | ||
823 | 867 | ESGVEAFTQISREI | X | O00222 | ||
824 | 868 | FNGSAGTPVTFNEN | X | O00222 | ||
825 | 869 | GHFLWIGSDSWGSK | X | O00222 | ||
826 | 870 | IAQSQKIPREPRPG | X | O00222 | ||
827 | 871 | IFEQGKKSVTAPKF | X | O00222 | ||
828 | 872 | ILPKRASIDGFDRY | X | O00222 | ||
829 | 873 | KLIQKGNDRPNGEV | X | O00222 | ||
830 | 874 | KSVTAPKFISPASQ | X | O00222 | ||
831 | 875 | NNRRNVWFAEFWEE | X | O00222 | ||
832 | 876 | NQSGHFLWIGSDSW | X | O00222 | ||
833 | 877 | QGKKSVTAPKFISP | X | O00222 | ||
834 | 878 | RMSTIDGKELLGYI | X | O00222 | ||
835 | 879 | IDQINKDPDLLSNI | X | O00222 | ||
836 | 880 | QSAEKMYIQTTTLT | X | O00222 | ||
837 | 881 | AEVQSEIERIF | X | O00305 | ||
838 | 882 | AKRSVLNNPSK | X | O00305 | ||
839 | 883 | ISITRVTADISLAK | X | O00305 | ||
840 | 884 | RPSDSDVSLEE | X | O00305 | ||
841 | 885 | SEIERIFELAR | X | O00305 | ||
842 | 886 | SLAEVQSEIER | X | O00305 | ||
843 | 887 | YPLVEEDYPDSYQD | X | O00305 | ||
844 | 888 | AANQKLALQKAKEV | X | O00555 | ||
845 | 889 | AGGSGPPQQQQ | X | O00555 | ||
846 | 890 | AGGSGPPQQQQQQQ | X | O00555 | ||
847 | 891 | AKPLTRHMPQN | X | O00555 | ||
848 | 892 | ALEQHLPDDDKTPM | X | O00555 | ||
849 | 893 | ALYNEMDPDER | X | O00555 | ||
850 | 894 | ANAQELTKDEQEEE | X | O00555 | ||
851 | 895 | ARDREWKKYEFHYD | X | O00555 | ||
852 | 896 | ARGGEGEGEGP | X | O00555 | ||
853 | 897 | ARTMALYNPIPVRQ | X | O00555 | ||
854 | 898 | ASERSLGRYTDVDT | X | O00555 | ||
855 | 899 | ASREALYNEMDPDE | X | O00555 | ||
856 | 900 | AVDNLANAQEL | X | O00555 | ||
857 | 901 | DEDSDEDEFQI | X | O00555 | ||
858 | 902 | DEGTPPTNFDT | X | O00555 | ||
859 | 903 | DHHAREGSLEQPGF | X | O00555 | ||
860 | 904 | DPQENRNNNTN | X | O00555 | ||
861 | 905 | DRARDPSGSAGLDA | X | O00555 | ||
862 | 906 | EEEKKEEEEDD | X | O00555 | ||
863 | 907 | EEKKEEEEDDRGED | X | O00555 | ||
864 | 908 | EGPYGRESDHH | X | O00555 | ||
865 | 909 | EPYSESDDDWC | X | O00555 | ||
866 | 910 | EQDRTPLMFQRMEP | X | O00555 | ||
867 | 911 | EQEEEEAANQK | X | O00555 | ||
868 | 912 | EQGPPTDMPNS | X | O00555 | ||
869 | 913 | EVAEVSPLSAA | X | O00555 |
870 | 914 | EVILAEDETDGEQR | X | O00555 | ||
871 | 915 | EVKARDREWKKYEF | X | O00555 | ||
872 | 916 | EYLTRDSSILG | X | O00555 | ||
873 | 917 | FDTFPAAIMTV | X | O00555 | ||
874 | 918 | FEKDCRGKYLL | X | O00555 | ||
875 | 919 | FEYLTRDSSIL | X | O00555 | ||
876 | 920 | FFIYAIIGMQV | X | O00555 | ||
877 | 921 | FLKLRRQQQIE | X | O00555 | ||
878 | 922 | FVAVIMDNFEY | X | O00555 | ||
879 | 923 | GALMAHESGLKESP | X | O00555 | ||
880 | 924 | GPPQQQQQQQQ | X | O00555 | ||
881 | 925 | GRESDHHAREG | X | O00555 | ||
882 | 926 | GSDYDEADGPG | X | O00555 | ||
883 | 927 | GSGPPQQQQQQ | X | O00555 | ||
884 | 928 | GSGVPVSGPNLSTT | X | O00555 | ||
885 | 929 | HHHHHHHHHHPPPP | X | O00555 | ||
886 | 930 | HHHHHHHPPPPDKD | X | O00555 | ||
887 | 931 | HHHHHHPPPPD | X | O00555 | ||
888 | 932 | HHHHPPPPDKD | X | O00555 | ||
889 | 933 | HHLDEYVRVWAEYD | X | O00555 | ||
890 | 934 | HYLPMEGQGRA | X | O00555 | ||
891 | 935 | IDVEDEDSDED | X | O00555 | ||
892 | 936 | IQQDLGRQDPP | X | O00555 | ||
893 | 937 | KDEQEEEEAAN | X | O00555 | ||
894 | 938 | KGGADKQQMDA | X | O00555 | ||
895 | 939 | KGGADKQQMDAELR | X | O00555 | ||
896 | 940 | KKEEEKKEEEE | X | O00555 | ||
897 | 941 | KPCDKNSGILT | X | O00555 | ||
898 | 942 | LAEDETDGEQR | X | O00555 | ||
899 | 943 | LFGNYTLLNVFLAI | X | O00555 | ||
900 | 944 | LGVLSGEFAKERER | X | O00555 | ||
901 | 945 | LIFAIIGLEFY | X | O00555 | ||
902 | 946 | LRALRLLRIFKVTK | X | O00555 | ||
903 | 947 | LRPLKTIKRLPKLK | X | O00555 | ||
904 | 948 | LSTTRPIQQDL | X | O00555 | ||
905 | 949 | LTKDEQEEEEA | X | O00555 | ||
906 | 950 | LTRDSSILGPH | X | O00555 | ||
907 | 951 | MAGAYDAPPPV | X | O00555 | ||
908 | 952 | NIGIDVEDEDSDED | X | O00555 | ||
909 | 953 | PLMFQRMEPPS | X | O00555 | ||
910 | 954 | PLPKKEEEKKEEEE | X | O00555 | ||
911 | 955 | PLSAANMSIAV | X | O00555 | ||
912 | 956 | PNAPRNNVLRYFDY | X | O00555 | ||
913 | 957 | PNSQSVEMREM | X | O00555 | ||
914 | 958 | PQQQQQQQQQQ | X | O00555 | ||
915 | 959 | PQQQQQQQQQQQQQ | X | O00555 | ||
916 | 960 | PTNFDTFPAAIMTV | X | O00555 | ||
917 | 961 | PYGRESDHHAR | X | O00555 | ||
918 | 962 | QILTGEDWNEVMYD | X | O00555 | ||
919 | 963 | QQQQQQQQQQA | X | O00555 | ||
920 | 964 | QQQQQQQQQQQ | X | O00555 | ||
921 | 965 | RDGYSDSEHYLPME | X | O00555 | ||
922 | 966 | RDRSHRASERS | X | O00555 | ||
923 | 967 | RMRFYIRRMVK | X | O00555 | ||
924 | 968 | RRMRFYIRRMVKTQ | X | O00555 | ||
925 | 969 | RRQQQIERELNGYM | X | O00555 | ||
926 | 970 | RTPLMFQRMEPPSP | X | O00555 | ||
927 | 971 | RYHDRARDPSGSAG | X | O00555 | ||
928 | 972 | SDSEHYLPMEG | X | O00555 | ||
929 | 973 | SEHYLPMEGQG | X | O00555 | ||
930 | 974 | SGKPCDKNSGILTR | X | O00555 | ||
931 | 975 | SGLKESPSWVT | X | O00555 | ||
932 | 976 | SGPPQQQQQQQQQQ | X | O00555 | ||
933 | 977 | SLFSLECVLKV | X | O00555 | ||
934 | 978 | SPEQGPPTDMP | X | O00555 | ||
935 | 979 | SPLSAANMSIAVKE | X | O00555 | ||
936 | 980 | STDPGPMLAIPAMA | X | O00555 | ||
937 | 981 | TGTWSPEQGPPTDM | X | O00555 | ||
938 | 982 | TRPYFHSSFNCFDC | X | O00555 | ||
939 | 983 | VEDEDSDEDEF | X | O00555 | ||
940 | 984 | VFQILTGEDWNEVM | X | O00555 | ||
941 | 985 | VIKPGTSFGISVLR | X | O00555 | ||
942 | 986 | WAEYDPAAWGRMPY | X | O00555 | ||
943 | 987 | YNPIPVRQNCLTVN | X | O00555 | ||
944 | 988 | YRGSDYDEADG | X | O00555 | ||
945 | 989 | YSDSEHYLPMEGQG | X | O00555 | ||
946 | 990 | DNFEYLTRDSSILG | X | O00555 | ||
947 | 991 | DGPGSGGGEEAMAG | X | O00555 | ||
948 | 992 | DPQENRNNNTNKSR | X | O00555 | ||
949 | 993 | EDSDEDEFQITEHN | X | O00555 | ||
950 | 994 | GIDVEDEDSDEDEF | X | O00555 | ||
951 | 995 | GNIGIDVEDEDSDE | X | O00555 | ||
952 | 996 | LMAHESGLKESPSW | X | O00555 | ||
953 | 997 | LVVDPQENRNNNTN | X | O00555 | ||
954 | 998 | MDNFEYLTRDSSIL | X | O00555 | ||
955 | 999 | NAQELTKDEQEEEE | X | O00555 | ||
956 | 1000 | PKKEEEKKEEEEDD | X | O00555 | ||
957 | 1001 | VEDEDSDEDEFQIT | X | O00555 | ||
958 | 1002 | GICFSFVFGALLEY | X | O00591 | ||
959 | 1003 | STVACDMDLAKYPM | X | O14764 | ||
960 | 1004 | DEQECMLDLESYGY | X | O14764 | ||
961 | 1005 | KKQKAKVKVSRPRA | X | O14764 | ||
962 | 1006 | TTELMNFKSAGQFP | X | O14764 | ||
963 | 1007 | KDNKGYCAQYRGEV | X | O15146 | ||
964 | 1008 | LYCCRRRKQWKNKK | X | O15146 | ||
965 | 1009 | QECSPGVVPTPIPI | X | O15146 | ||
966 | 1010 | ELLPGVRLGARLLD | X | O15303 | ||
967 | 1011 | SVIDYEEQRTVDPE | X | O15303 | ||
968 | 1012 | AREEAEPVFRAAEE | X | O15399 | ||
969 | 1013 | DLALLQFLGDDEIE | X | O15399 | ||
970 | 1014 | DNMAGVFYMLLVAM | X | O15399 |
971 | 1015 | ERSEIVDFSVPFVE | X | O15399 | ||
972 | 1016 | GGAGGPGGGLGGAR | X | O15399 | ||
973 | 1017 | IRLLFCAREEAEPV | X | O15399 | ||
974 | 1018 | LADGFHRYYGPIEP | X | O15399 | ||
975 | 1019 | LLGPGAGGAGGTGG | X | O15399 | ||
976 | 1020 | PGAGGAGGTGGAGG | X | O15399 | ||
977 | 1021 | PSPSDSEDSESLGG | X | O15399 | ||
978 | 1022 | PWWFADFPYPYAER | X | O15399 | ||
979 | 1023 | SQPLLGPGAGGAGG | X | O15399 | ||
980 | 1024 | SRYGRFLQPVDDTQ | X | O15399 | ||
981 | 1025 | SYTANLAAFMIQEE | X | O15399 | ||
982 | 1026 | TEQQLQVIFEVLEE | X | O15399 | ||
983 | 1027 | TQHLTVATLEERPF | X | O15399 | ||
984 | 1028 | ALLQFLGDDEIEML | X | O15399 | ||
985 | 1029 | GDDEIEMLERLWLS | X | O15399 | ||
986 | 1030 | GPGAGGAGGTGGAG | X | O15399 | ||
987 | 1031 | IDLALLQFLGDDEI | X | O15399 | ||
988 | 1032 | KKIDGVWNGMIGEV | X | O15399 | ||
989 | 1033 | PLLGPGAGGAGGTG | X | O15399 | ||
990 | 1034 | QFLGDDEIEMLERL | X | O15399 | ||
991 | 1035 | VWVMMFVMCLTVVA | X | O15399 | ||
992 | 1036 | NLFDTAEVYAAGKA | X | O43448 | ||
993 | 1037 | ANKSESEPDFF | X | O43497 | ||
994 | 1038 | AQRPLRRQAAIRTD | X | O43497 | ||
995 | 1039 | AWIAIFQVITLEGW | X | O43497 | ||
996 | 1040 | CVTLGMFRPCEDIA | X | O43497 | ||
997 | 1041 | DFFSPSLDGDGDRK | X | O43497 | ||
998 | 1042 | DGDRKKCLALVSLG | X | O43497 | ||
999 | 1043 | DRKNFDSLLWAIVT | X | O43497 | ||
1000 | 1044 | DSCPYCARAGAGEV | X | O43497 | ||
1001 | 1045 | DSKDPLASGPPDSM | X | O43497 | ||
1002 | 1046 | DTLPMLGNVLL | X | O43497 | ||
1003 | 1047 | EAELEAELELE | X | O43497 | ||
1004 | 1048 | ELTNALEISNIVFT | X | O43497 | ||
1005 | 1049 | ENFHKCRQHQEEEE | X | O43497 | ||
1006 | 1050 | EWELKLMDELA | X | O43497 | ||
1007 | 1051 | FAALGVELFGDLEC | X | O43497 | ||
1008 | 1052 | FIIFGILGVQLFKG | X | O43497 | ||
1009 | 1053 | FVLTAQFVLVN | X | O43497 | ||
1010 | 1054 | FYHADCHLEPV | X | O43497 | ||
1011 | 1055 | GAGEVELADREMPD | X | O43497 | ||
1012 | 1056 | GDLLPPGGQEE | X | O43497 | ||
1013 | 1057 | GERRSLLSGEG | X | O43497 | ||
1014 | 1058 | GGSDPQIPLAE | X | O43497 | ||
1015 | 1059 | GIMIAILVNTL | X | O43497 | ||
1016 | 1060 | GLDYEAYNSSSNTT | X | O43497 | ||
1017 | 1061 | GQESQDEEESSEEE | X | O43497 | ||
1018 | 1062 | HPTDRQLFDTISLL | X | O43497 | ||
1019 | 1063 | HSPLGSPFLWPGVE | X | O43497 | ||
1020 | 1064 | IPLAEMEALSL | X | O43497 | ||
1021 | 1065 | KEAKEEAELEAELE | X | O43497 | ||
1022 | 1066 | KKRRNLMLDDVIAS | X | O43497 | ||
1023 | 1067 | KLLKMAVGMRALLD | X | O43497 | ||
1024 | 1068 | KMAVGMRALLDTVM | X | O43497 | ||
1025 | 1069 | LARALRPDDPPLDG | X | O43497 | ||
1026 | 1070 | LDGDGDRKKCLALV | X | O43497 | ||
1027 | 1071 | LDYEAYNSSSN | X | O43497 | ||
1028 | 1072 | LKYLVYILRKAARR | X | O43497 | ||
1029 | 1073 | LMTFGNYVLFN | X | O43497 | ||
1030 | 1074 | LNIPPGPYSSM | X | O43497 | ||
1031 | 1075 | LPACCLERDSW | X | O43497 | ||
1032 | 1076 | LVHHHHHHHHHYHL | X | O43497 | ||
1033 | 1077 | LVTLLLDTLPM | X | O43497 | ||
1034 | 1078 | MDAHSFYNFIYFIL | X | O43497 | ||
1035 | 1079 | MFVGVVVENFHKCR | X | O43497 | ||
1036 | 1080 | MRILVTLLLDTLPM | X | O43497 | ||
1037 | 1081 | NYIFTAVFLAE | X | O43497 | ||
1038 | 1082 | PPETRSSLELD | X | O43497 | ||
1039 | 1083 | PQIPLAEMEAL | X | O43497 | ||
1040 | 1084 | PSGERRSLLSGEGQ | X | O43497 | ||
1041 | 1085 | PSLGGSDPQIPLAE | X | O43497 | ||
1042 | 1086 | QEDWNKVLYNG | X | O43497 | ||
1043 | 1087 | QSGSVLSVHSQPAD | X | O43497 | ||
1044 | 1088 | RARLPACCLERDSW | X | O43497 | ||
1045 | 1089 | RLEKKRRNLMLDDV | X | O43497 | ||
1046 | 1090 | RLRRLEKKRRNLML | X | O43497 | ||
1047 | 1091 | RLSVHHLVHHHHHH | X | O43497 | ||
1048 | 1092 | RQHQEEEEARRREE | X | O43497 | ||
1049 | 1093 | SLEWELKLMDE | X | O43497 | ||
1050 | 1094 | SPEIQDRDANGSRR | X | O43497 | ||
1051 | 1095 | SRFRLLVHHLC | X | O43497 | ||
1052 | 1096 | SVLSVHSQPAD | X | O43497 | ||
1053 | 1097 | VGSGKVYPTVH | X | O43497 | ||
1054 | 1098 | VIDILVSMVSDSGT | X | O43497 | ||
1055 | 1099 | VLYNGMASTSS | X | O43497 | ||
1056 | 1100 | WSAYIFPPQSR | X | O43497 | ||
1057 | 1101 | YEAYNSSSNTT | X | O43497 | ||
1058 | 1102 | ALGVELFGDLECDE | X | O43497 | ||
1059 | 1103 | ASGRLARALRPDDP | X | O43497 | ||
1060 | 1104 | DYEAYNSSSNTTCV | X | O43497 | ||
1061 | 1105 | FFVCQGEDTRNITN | X | O43497 | ||
1062 | 1106 | FGDLECDETHPCEG | X | O43497 | ||
1063 | 1107 | FILLIIVGSFFMIN | X | O43497 | ||
1064 | 1108 | GNVLLLCFFVFFIF | X | O43497 | ||
1065 | 1109 | KRLRRLEKKRRNLM | X | O43497 | ||
1066 | 1110 | LRAINRVPSMRILV | X | O43497 | ||
1067 | 1111 | NIGYAWIAIFQVIT | X | O43497 | ||
1068 | 1112 | PAPCPGPEPNWGKG | X | O43497 | ||
1069 | 1113 | RRREEKRLRRLEKK | X | O43497 | ||
1070 | 1114 | SETKQRESQLMREQ | X | O43497 | ||
1071 | 1115 | AAAGDEERKVGLAP | X | O43525 | ||
1072 | 1116 | DAIEESPSKEPKPV | X | O43525 | ||
1073 | 1117 | DRGYGNDFPIEDMI | X | O43525 | ||
1074 | 1118 | DTDPFTPSGSMPLS | X | O43525 | ||
1075 | 1119 | ELERSPSGFSISQD | X | O43525 | ||
1076 | 1120 | GDEERKVGLAPGDV | X | O43525 | ||
1077 | 1121 | GGGAANPAGGDAAA | X | O43525 | ||
1078 | 1122 | SITRDSDTPLSLMS | X | O43525 | ||
1079 | 1123 | TIICNYSETGPPEP | X | O43525 | ||
1080 | 1124 | DQSMMGKFVKVERQ | X | O43525 | ||
1081 | 1125 | EELERSPSGFSISQ | X | O43525 | ||
1082 | 1126 | EVDAQGEEMKEEFE | X | O43525 | ||
1083 | 1127 | HALVFLIVLGCLIL | X | O43525 | ||
1084 | 1128 | MMGKFVKVERQVQD | X | O43525 | ||
1085 | 1129 | RYKGWRGRLKFARK | X | O43525 | ||
1086 | 1130 | VRILQFRLYKKKFK | X | O43525 | ||
1087 | 1131 | DLHSTWQYYERTVT | X | O43526 | ||
1088 | 1132 | GEDIVDDKSCPCEF | X | O43526 |
1089 | 1133 | ARLPPYRYRFRRRS | X | O60359 | ||
1090 | 1134 | KESLHNNPANR | X | O60359 | ||
1091 | 1135 | TFARLPPYRYR | X | O60359 | ||
1092 | 1136 | FPEDADYEQDTAEY | X | O60359 | ||
1093 | 1137 | IDHFPEDADYEQDT | X | O60359 | ||
1094 | 1138 | YRYRFRRRSSSRST | X | O60359 | ||
1095 | 1139 | AEDTPFDFELYLVG | X | O60391 | ||
1096 | 1140 | AQVQPKRALLPAPV | X | O60391 | ||
1097 | 1141 | DLLERLAEDTPFDF | X | O60391 | ||
1098 | 1142 | EPSGPEVEQQQQQQ | X | O60391 | ||
1099 | 1143 | ERLAEDTPFDFELY | X | O60391 | ||
1100 | 1144 | FEELSGIHDPKLHH | X | O60391 | ||
1101 | 1145 | GEHAFFRLALPRIR | X | O60391 | ||
1102 | 1146 | GPEVEQQQQQQDQP | X | O60391 | ||
1103 | 1147 | KMVPCGKRVFAVTE | X | O60391 | ||
1104 | 1148 | LVRRGQLLAQLGDS | X | O60391 | ||
1105 | 1149 | NAFIMDKSLLDYEV | X | O60391 | ||
1106 | 1150 | QPKRALLPAPVNCG | X | O60391 | ||
1107 | 1151 | SYTANLAAVMVGDK | X | O60391 | ||
1108 | 1152 | TPFDFELYLVGDGK | X | O60391 | ||
1109 | 1153 | EGPVWLCSYGRPPA | X | O60391 | ||
1110 | 1154 | EGSKEETAEAEPSG | X | O60391 | ||
1111 | 1155 | EHPFVFARDPDEDG | X | O60391 | ||
1112 | 1156 | EPPEGSKEETAEAE | X | O60391 | ||
1113 | 1157 | LCQALVPPGVAALL | X | O60391 | ||
1114 | 1158 | LRKCCYGYCIDLLE | X | O60391 | ||
1115 | 1159 | QQQQQQDQPTAPEG | X | O60391 | ||
1116 | 1160 | TAGLPPGLLALGEV | X | O60391 | ||
1117 | 1161 | ENILNELNDPLREE | X | O60741 | ||
1118 | 1162 | ESSSVLNTDPDAEK | X | O60741 | ||
1119 | 1163 | GGGEEPAGGFEDAE | X | O60741 | ||
1120 | 1164 | GGGGGGGGGGGGEE | X | O60741 | ||
1121 | 1165 | IHPYSDFRFYWDLI | X | O60741 | ||
1122 | 1166 | KVDGGGGGGGGGGG | X | O60741 | ||
1123 | 1167 | LIMMVGNLVIIPVG | X | O60741 | ||
1124 | 1168 | LNDPLREEIVNFNC | X | O60741 | ||
1125 | 1169 | LYSLSVDNFNEVLE | X | O60741 | ||
1126 | 1170 | RTGTVNEDSSEIIL | X | O60741 | ||
1127 | 1171 | RYQGKIFDEENILN | X | O60741 | ||
1128 | 1172 | SLSHSNLHSPSPST | X | O60741 | ||
1129 | 1173 | SQPPQTQPQQPSPQ | X | O60741 | ||
1130 | 1174 | SVLNTDPDAEKPRF | X | O60741 | ||
1131 | 1175 | TAGFWIIHPYSDFR | X | O60741 | ||
1132 | 1176 | TATSLSHSNLHSPS | X | O60741 | ||
1133 | 1177 | YPMMRRAFETVAID | X | O60741 | ||
1134 | 1178 | DGGGGGGGGGGGGE | X | O60741 | ||
1135 | 1179 | EGGGKPNSSSNSRD | X | O60741 | ||
1136 | 1180 | FKVDGGGGGGGGGG | X | O60741 | ||
1137 | 1181 | FRTGTVNEDSSEII | X | O60741 | ||
1138 | 1182 | GGGGGGGGGGEEPA | X | O60741 | ||
1139 | 1183 | IFDEENILNELNDP | X | O60741 | ||
1140 | 1184 | QGKIFDEENILNEL | X | O60741 | ||
1141 | 1185 | QSQPPQTQPQQPSP | X | O60741 | ||
1142 | 1186 | SVCFKVDGGGGGGG | X | O60741 | ||
1143 | 1187 | ADMEEEEEEEE | X | O60840 | ||
1144 | 1188 | ALGVYIPFPED | X | O60840 | ||
1145 | 1189 | ALTCDTEEEEE | X | O60840 | ||
1146 | 1190 | ASLPASDTGSM | X | O60840 | ||
1147 | 1191 | CKRLVAMNMPL | X | O60840 | ||
1148 | 1192 | CVALGVYIPFPEDD | X | O60840 | ||
1149 | 1193 | DEDEEEGALAS | X | O60840 | ||
1150 | 1194 | DEFKRIWSEYD | X | O60840 | ||
1151 | 1195 | DEVIPPPDEEEVTV | X | O60840 | ||
1152 | 1196 | DTEEEEEEGQE | X | O60840 | ||
1153 | 1197 | DWITQAEELDMEDP | X | O60840 | ||
1154 | 1198 | DYAFTSIFTVE | X | O60840 | ||
1155 | 1199 | EDEEVPDRLSY | X | O60840 | ||
1156 | 1200 | EEEEEEEEEEEEGA | X | O60840 | ||
1157 | 1201 | EEEEEEEEEEG | X | O60840 | ||
1158 | 1202 | EEEEEEEEGAG | X | O60840 | ||
1159 | 1203 | EEEEGQEGVEE | X | O60840 | ||
1160 | 1204 | EEEEGQEGVEEEDE | X | O60840 | ||
1161 | 1205 | EEGQEGVEEED | X | O60840 | ||
1162 | 1206 | EEVPDRLSYLD | X | O60840 | ||
1163 | 1207 | EGADMEEEEEE | X | O60840 | ||
1164 | 1208 | ELDKNQRQCVEYAL | X | O60840 | ||
1165 | 1209 | EPSPANGAGPGPEW | X | O60840 | ||
1166 | 1210 | EQVEYVFLVIF | X | O60840 | ||
1167 | 1211 | ESILSRFDEED | X | O60840 | ||
1168 | 1212 | ETQGDEDEEEG | X | O60840 | ||
1169 | 1213 | EVIPPPDEEEV | X | O60840 | ||
1170 | 1214 | FACIGVQLFKGKFY | X | O60840 | ||
1171 | 1215 | FDNFFFAMLTVFQC | X | O60840 | ||
1172 | 1216 | FDYAFTSIFTVEIL | X | O60840 | ||
1173 | 1217 | GILETTLVEVG | X | O60840 | ||
1174 | 1218 | GSIVDIAVTEVNNG | X | O60840 | ||
1175 | 1219 | GVYIPFPEDDS | X | O60840 | ||
1176 | 1220 | GYLDWITQAEELDM | X | O60840 | ||
1177 | 1221 | IMKTRVCRRLR | X | O60840 | ||
1178 | 1222 | IPPPDEEEVTV | X | O60840 | ||
1179 | 1223 | ITQAEELDMED | X | O60840 | ||
1180 | 1224 | KIKTEGNLEQA | X | O60840 | ||
1181 | 1225 | KLLDEVIPPPDEEE | X | O60840 | ||
1182 | 1226 | KQEIADACRLT | X | O60840 | ||
1183 | 1227 | KQQMEEDLRGYLDW | X | O60840 | ||
1184 | 1228 | KRLVAMNMPLN | X | O60840 | ||
1185 | 1229 | LGSDMEAEEDP | X | O60840 | ||
1186 | 1230 | LISFGIHSSAISVV | X | O60840 | ||
1187 | 1231 | LLVLFVIIIYAIIG | X | O60840 | ||
1188 | 1232 | LRIVIKKIWKR | X | O60840 | ||
1189 | 1233 | MALFTVSTFEG | X | O60840 | ||
1190 | 1234 | MEEEEEEEEEE | X | O60840 | ||
1191 | 1235 | MLCAFLIINLFVAV | X | O60840 | ||
1192 | 1236 | MSESEGGKDTTPEP | X | O60840 | ||
1193 | 1237 | MTETQGDEDEE | X | O60840 | ||
1194 | 1238 | NATLFALVRTS | X | O60840 | ||
1195 | 1239 | NLEQVEYVFLV | X | O60840 | ||
1196 | 1240 | PFPEDDSNTAN | X | O60840 | ||
1197 | 1241 | QAEELDMEDPS | X | O60840 | ||
1198 | 1242 | QDAMGYELPWV | X | O60840 | ||
1199 | 1243 | QGTSSLYSDEE | X | O60840 | ||
1200 | 1244 | QYRVWATVNSA | X | O60840 |
1201 | 1245 | RLTLDEMDNAASDL | X | O60840 | ||
1202 | 1246 | RNNNFQTFPQAVLL | X | O60840 | ||
1203 | 1247 | RREGADMEEEE | X | O60840 | ||
1204 | 1248 | RREGADMEEEEEEE | X | O60840 | ||
1205 | 1249 | RVCRRLRRANR | X | O60840 | ||
1206 | 1250 | SHASLPASDTGSMT | X | O60840 | ||
1207 | 1251 | SLPASDTGSMTETQ | X | O60840 | ||
1208 | 1252 | STSSHASLPASDTG | X | O60840 | ||
1209 | 1253 | TFEGWPALLYKAID | X | O60840 | ||
1210 | 1254 | TGSMTETQGDEDEE | X | O60840 | ||
1211 | 1255 | TNRRRGRLRWF | X | O60840 | ||
1212 | 1256 | TQAEELDMEDPSAD | X | O60840 | ||
1213 | 1257 | TSSLYSDEESILSR | X | O60840 | ||
1214 | 1258 | VASAQRSPRAL | X | O60840 | ||
1215 | 1259 | VEYVFLVIFTVETV | X | O60840 | ||
1216 | 1260 | VVPKEKVVPIP | X | O60840 | ||
1217 | 1261 | WATPPQRGRLL | X | O60840 | ||
1218 | 1262 | YFLGSDMEAEE | X | O60840 | ||
1219 | 1263 | YIPFPEDDSNT | X | O60840 | ||
1220 | 1264 | YLDWITQAEEL | X | O60840 | ||
1221 | 1265 | YLGRSSGPLRT | X | O60840 | ||
1222 | 1266 | YVFLVIFTVET | X | O60840 | ||
1223 | 1267 | ARREGADMEEEEEE | X | O60840 | ||
1224 | 1268 | DMEEEEEEEEEEEE | X | O60840 | ||
1225 | 1269 | DTEEEEEEGQEGVE | X | O60840 | ||
1226 | 1270 | EEEEEEE | X | O60840 | ||
1227 | 1271 | EEEEEEEEEEEEEG | X | O60840 | ||
1228 | 1272 | EEEEEEEEEEGAGG | X | O60840 | ||
1229 | 1273 | EEEEEEEGAGGVEL | X | O60840 | ||
1230 | 1274 | EEEEEGQEGVEEED | X | O60840 | ||
1231 | 1275 | EEGQEGVEEEDEKD | X | O60840 | ||
1232 | 1276 | EGADMEEEEEEEEE | X | O60840 | ||
1233 | 1277 | FDEEDLGDEMACVH | X | O60840 | ||
1234 | 1278 | FYATFLIQDYFRKF | X | O60840 | ||
1235 | 1279 | LDWITQAEELDMED | X | O60840 | ||
1236 | 1280 | LTCDTEEEEEEGQE | X | O60840 | ||
1237 | 1281 | NTFDALIVVGSIVD | X | O60840 | ||
1238 | 1282 | QCLQRQGSCEDLPI | X | O60840 | ||
1239 | 1283 | RIVIKKIWKRMKQK | X | O60840 | ||
1240 | 1284 | RLRRANRVLRARCR | X | O60840 | ||
1241 | 1285 | RQALTCDTEEEEEE | X | O60840 | ||
1242 | 1286 | SDEESILSRFDEED | X | O60840 | ||
1243 | 1287 | VYIPFPEDDSNTAN | X | O60840 | ||
1244 | 1288 | CDGDNDCEDDSDEQ | X | O75096 | ||
1245 | 1289 | CDGDNDCGDHSDED | X | O75096 | ||
1246 | 1290 | DDDCGDWSDESDCS | X | O75096 | ||
1247 | 1291 | DNDCEDDSDEQDCP | X | O75096 | ||
1248 | 1292 | DNDCGDHSDEDGCI | X | O75096 | ||
1249 | 1293 | KKEGGPDHNYTKEK | X | O75096 | ||
1250 | 1294 | NLDGSERKVLINTD | X | O75096 | ||
1251 | 1295 | GPGTLHTIDNATTN | X | O94759 | ||
1252 | 1296 | KYVRVSQDTPSSVI | X | O94759 | ||
1253 | 1297 | LENGVQLKEFVTWD | X | O94759 | ||
1254 | 1298 | LEPLSTIQYNVVDG | X | O94759 | ||
1255 | 1299 | LSTIQYNVVDGLRD | X | O94759 | ||
1256 | 1300 | VCEEMRQLFYDPDE | X | O94759 | ||
1257 | 1301 | ADEEQRVPYPALAA | X | O95180 | ||
1258 | 1302 | ADGGLSVLRTF | X | O95180 | ||
1259 | 1303 | AELDAEIELEM | X | O95180 | ||
1260 | 1304 | AGTPLGSVASV | X | O95180 | ||
1261 | 1305 | AIVLLSLMGITLEE | X | O95180 | ||
1262 | 1306 | AIVPLEPPESEPPM | X | O95180 | ||
1263 | 1307 | APHPRPLQEVE | X | O95180 | ||
1264 | 1308 | ASAPHPRPLQE | X | O95180 | ||
1265 | 1309 | ATGMRALLDTV | X | O95180 | ||
1266 | 1310 | ATGMRALLDTVVQA | X | O95180 | ||
1267 | 1311 | CEGPDTRNISTKAQ | X | O95180 | ||
1268 | 1312 | CGERESLLSGE | X | O95180 | ||
1269 | 1313 | CTLLMLFIFIFSIL | X | O95180 | ||
1270 | 1314 | DAELDAEIELEMAQ | X | O95180 | ||
1271 | 1315 | DEDKTSVHFEEDFH | X | O95180 | ||
1272 | 1316 | DKTSVHFEEDF | X | O95180 | ||
1273 | 1317 | DLFITFIICVN | X | O95180 | ||
1274 | 1318 | DLGVPSGDPFL | X | O95180 | ||
1275 | 1319 | DPAEPGEKTPV | X | O95180 | ||
1276 | 1320 | EAEASDPADEE | X | O95180 | ||
1277 | 1321 | EDAAELDDDSEDSC | X | O95180 | ||
1278 | 1322 | EGSGAGGDPAA | X | O95180 | ||
1279 | 1323 | EPPESEPPMPV | X | O95180 | ||
1280 | 1324 | EPTEGSGAGGDPAA | X | O95180 | ||
1281 | 1325 | ERRRRSTFPSP | X | O95180 | ||
1282 | 1326 | ERVFLSVSNYIFTA | X | O95180 | ||
1283 | 1327 | EVEMETYGAGT | X | O95180 | ||
1284 | 1328 | FFLRIDSHREDAAE | X | O95180 | ||
1285 | 1329 | FGILGVQLFKGKFY | X | O95180 | ||
1286 | 1330 | FIFLNCVTIALERP | X | O95180 | ||
1287 | 1331 | FLRPYYQTEEGEEN | X | O95180 | ||
1288 | 1332 | FVTFVLVAQFVLVN | X | O95180 | ||
1289 | 1333 | GAIVPLEPPES | X | O95180 | ||
1290 | 1334 | GEENPFICSSR | X | O95180 | ||
1291 | 1335 | GIMMAILVNTL | X | O95180 | ||
1292 | 1336 | GSELGVSPSESPAA | X | O95180 | ||
1293 | 1337 | HADCHIEGPQERAR | X | O95180 | ||
1294 | 1338 | HNGAINFDNIGYAW | X | O95180 | ||
1295 | 1339 | ILGMHLFGCKFSLK | X | O95180 | ||
1296 | 1340 | KRLRRLERRRR | X | O95180 | ||
1297 | 1341 | KTSVHFEEDFHKLR | X | O95180 | ||
1298 | 1342 | LDPAEPGEKTPVRP | X | O95180 | ||
1299 | 1343 | LGVQLFKGKFYYCE | X | O95180 | ||
1300 | 1344 | LQSSWNLLDGLLVL | X | O95180 | ||
1301 | 1345 | LSPPLIMCTAATPM | X | O95180 | ||
1302 | 1346 | LSPRGTARSPS | X | O95180 | ||
1303 | 1347 | MCTAATPMPTP | X | O95180 | ||
1304 | 1348 | MFALEMLLKLLACG | X | O95180 |
1305 | 1349 | MGRLWVTFSGKLRR | X | O95180 | ||
1306 | 1350 | MHLFGCKFSLKTDT | X | O95180 | ||
1307 | 1351 | PAESCASLQIPLAV | X | O95180 | ||
1308 | 1352 | PASAPHPRPLQEVE | X | O95180 | ||
1309 | 1353 | PEAEPALGARRKKK | X | O95180 | ||
1310 | 1354 | PEPGACDTRLVRAG | X | O95180 | ||
1311 | 1355 | PLEPPESEPPMPVG | X | O95180 | ||
1312 | 1356 | PLIMCTAATPMPTP | X | O95180 | ||
1313 | 1357 | PSPGRGPPDAE | X | O95180 | ||
1314 | 1358 | QESPGARDAPNLVA | X | O95180 | ||
1315 | 1359 | QVVALPSDFFL | X | O95180 | ||
1316 | 1360 | RASSSGAIVPLEPP | X | O95180 | ||
1317 | 1361 | SAVQGQGPGHRQRR | X | O95180 | ||
1318 | 1362 | SCASLQIPLAVSSP | X | O95180 | ||
1319 | 1363 | SHREDAAELDDDSE | X | O95180 | ||
1320 | 1364 | SLQIPLAVSSPARS | X | O95180 | ||
1321 | 1365 | SNPHNGAINFDNIG | X | O95180 | ||
1322 | 1366 | SPPSPGRGPPD | X | O95180 | ||
1323 | 1367 | TLGMFRPCEDV | X | O95180 | ||
1324 | 1368 | TRNISTKAQCR | X | O95180 | ||
1325 | 1369 | VALMTFGNYVL | X | O95180 | ||
1326 | 1370 | YTQPQAEGVGAARN | X | O95180 | ||
1327 | 1371 | AAELDDDSEDSCCL | X | O95180 | ||
1328 | 1372 | AGRHTASVHHLVYH | X | O95180 | ||
1329 | 1373 | APGEPGWMGRLWVT | X | O95180 | ||
1330 | 1374 | AYTQPQAEGVGAAR | X | O95180 | ||
1331 | 1375 | CKFSLKTDTGDTVP | X | O95180 | ||
1332 | 1376 | CSSRRDNGMQKCSH | X | O95180 | ||
1333 | 1377 | GMHLFGCKFSLKTD | X | O95180 | ||
1334 | 1378 | GPEAEPALGARRKK | X | O95180 | ||
1335 | 1379 | LDLGVPSGDPFLDG | X | O95180 | ||
1336 | 1380 | LLKMATGMRALLDT | X | O95180 | ||
1337 | 1381 | PDSRRGSSSSGDPP | X | O95180 | ||
1338 | 1382 | QRCVSSRPAAPGGE | X | O95180 | ||
1339 | 1383 | QSRWRKKVDPSAVQ | X | O95180 | ||
1340 | 1384 | SATPAPGGGADDPV | X | O95180 | ||
1341 | 1385 | TFGQRCVSSRPAAP | X | O95180 | ||
1342 | 1386 | TILPSGVGSGKGST | X | O95180 | ||
1343 | 1387 | VPLEPPESEPPMPV | X | O95180 | ||
1344 | 1388 | WNRLDFFIVVAGMM | X | O95180 | ||
1345 | 1389 | YHHHHHHHHHYHFS | X | O95180 | ||
1346 | 1390 | FLENIVRRSNDTNF | X | O95259 | ||
1347 | 1391 | PYDVINAFENVDEV | X | O95259 | ||
1348 | 1392 | AYFLCLLSALLLTE | X | O95970 | ||
1349 | 1393 | DHILLGVFMLV | X | P02708 | ||
1350 | 1394 | DQESNNAAAEW | X | P02708 | ||
1351 | 1395 | EIIVTHFPFDE | X | P02708 | ||
1352 | 1396 | ETMKSDQESNNAAA | X | P02708 | ||
1353 | 1397 | GLVLGSEHETR | X | P02708 | ||
1354 | 1398 | GSVVAINPESDQPD | X | P02708 | ||
1355 | 1399 | KSDQESNNAAA | X | P02708 | ||
1356 | 1400 | KVLLQYTGHIT | X | P02708 | ||
1357 | 1401 | LVLYNNADGDFAIV | X | P02708 | ||
1358 | 1402 | NVIIPCLLFSF | X | P02708 | ||
1359 | 1403 | QDKKIFTEDID | X | P02708 | ||
1360 | 1404 | QLIQLINVDEV | X | P02708 | ||
1361 | 1405 | RPVEDHRQVVE | X | P02708 | ||
1362 | 1406 | SAGLVLGSEHE | X | P02708 | ||
1363 | 1407 | SIIITVIVINTHHR | X | P02708 | ||
1364 | 1408 | SYCEIIVTHFPFDE | X | P02708 | ||
1365 | 1409 | VFVIASIIITV | X | P02708 | ||
1366 | 1410 | VINTHHRSPST | X | P02708 | ||
1367 | 1411 | VNVIIPCLLFSFLT | X | P02708 | ||
1368 | 1412 | VPLFSHLQNEQ | X | P02708 | ||
1369 | 1413 | YNNADGDFAIVKFT | X | P02708 | ||
1370 | 1414 | CCPDTPYLDITYH | X | P02708 | ||
1371 | 1415 | CPDTPYLDITYHF | X | P02708 | ||
1372 | 1416 | FLLVIVE | X | P02708 | ||
1373 | 1417 | GLQLIQLINVDEV | X | P02708 | ||
1374 | 1418 | GSVVAINPESDQP | X | P02708 | ||
1375 | 1419 | HSVTYSCCPDTPY | X | P02708 | ||
1376 | 1420 | INVDEVNQIVTTN | X | P02708 | ||
1377 | 1421 | KRPSREKQDKKIF | X | P02708 | ||
1378 | 1422 | LQLIQLINVDEVN | X | P02708 | ||
1379 | 1423 | LSNFMESGEWVIK | X | P02708 | ||
1380 | 1424 | NVDEVNQIVTTNV | X | P02708 | ||
1381 | 1425 | NVIIPCLLFSFLT | X | P02708 | ||
1382 | 1426 | PDTPYLDITY | X | P02708 | ||
1383 | 1427 | SCCPDTPYLDITY | X | P02708 | ||
1384 | 1428 | SVVAINPESDQPD | X | P02708 | ||
1385 | 1429 | TYSCCPDTPYLDI | X | P02708 | ||
1386 | 1430 | VCIIGTLAVFAGR | X | P02708 | ||
1387 | 1431 | VTYSCCPDTPYLD | X | P02708 | ||
1388 | 1432 | YSCCPDTPYLDIT | X | P02708 | ||
1389 | 1433 | AAAAPLLVAVAALL | X | P06213 | ||
1390 | 1434 | APESEELEMEFEDM | X | P06213 | ||
1391 | 1435 | CSISVTYFPFD | X | P07510 | ||
1392 | 1436 | DGQTIEWIFID | X | P07510 | ||
1393 | 1437 | DPNLRPAERDS | X | P07510 | ||
1394 | 1438 | EERLLADLMQN | X | P07510 | ||
1395 | 1439 | FDNGNEEWFLV | X | P07510 | ||
1396 | 1440 | IFQSQTYSTNEIDL | X | P07510 | ||
1397 | 1441 | KMLLDPAAPAQ | X | P07510 | ||
1398 | 1442 | LAVCLGAQGRNQEE | X | P07510 | ||
1399 | 1443 | LGAQGRNQEER | X | P07510 | ||
1400 | 1444 | LLDPAAPAQEA | X | P07510 | ||
1401 | 1445 | LSQEDGQTIEW | X | P07510 | ||
1402 | 1446 | LTNLISLNEREEAL | X | P07510 | ||
1403 | 1447 | NQEERLLADLM | X | P07510 | ||
1404 | 1448 | NRVPALPFPGD | X | P07510 | ||
1405 | 1449 | NYDPNLRPAER | X | P07510 | ||
1406 | 1450 | PAKMLLDPAAP | X | P07510 | ||
1407 | 1451 | PDIVLENNVDG | X | P07510 | ||
1408 | 1452 | PDIVLENNVDGVFE | X | P07510 | ||
1409 | 1453 | QTIEWIFIDPE | X | P07510 | ||
1410 | 1454 | RHQQSHFDNGNEEW | X | P07510 | ||
1411 | 1455 | SHFDNGNEEWF | X | P07510 | ||
1412 | 1456 | SKYLTFLLVVT | X | P07510 |
1413 | 1457 | SQTYSTNEIDL | X | P07510 | ||
1414 | 1458 | VDGVFEVALYC | X | P07510 | ||
1415 | 1459 | VPALPFPGDPR | X | P07510 | ||
1416 | 1460 | VWRPDIVLENNVDG | X | P07510 | ||
1417 | 1461 | AALEKLE | X | P07510 | ||
1418 | 1462 | DIVLENNVDGVFE | X | P07510 | ||
1419 | 1463 | ETSQAVP | X | P07510 | ||
1420 | 1464 | FQSQTYSTNEIDL | X | P07510 | ||
1421 | 1465 | HFDNGNEEWFLVG | X | P07510 | ||
1422 | 1466 | HYNRVPALPFPGD | X | P07510 | ||
1423 | 1467 | LLLAVCLGAQGRN | X | P07510 | ||
1424 | 1468 | LQLSQEDGQTIEW | X | P07510 | ||
1425 | 1469 | LSLFICG | X | P07510 | ||
1426 | 1470 | LVAKKVPETSQAV | X | P07510 | ||
1427 | 1471 | QWQRQGLVAAALE | X | P07510 | ||
1428 | 1472 | RQGLVAAALEKLE | X | P07510 | ||
1429 | 1473 | STNEIDL | X | P07510 | ||
1430 | 1474 | TIEWIFIDPEAFT | X | P07510 | ||
1431 | 1475 | VLENNVDGVFEVA | X | P07510 | ||
1432 | 1476 | VVNAVVV | X | P07510 | ||
1433 | 1477 | WQRQGLVAAALEK | X | P07510 | ||
1434 | 1478 | APDHDVTQERDEVW | X | P07550 | ||
1435 | 1479 | CYANETCCDFF | X | P07550 | ||
1436 | 1480 | DSQGRNCSTNDSLL | X | P07550 | ||
1437 | 1481 | FAITSPFKYQSLLT | X | P07550 | ||
1438 | 1482 | NFWCEFWTSIDVLC | X | P07550 | ||
1439 | 1483 | NGYSSNGNTGEQSG | X | P07550 | ||
1440 | 1484 | QEKENKLLCEDLPG | X | P07550 | ||
1441 | 1485 | QGRNCSTNDSL | X | P07550 | ||
1442 | 1486 | CLKEHKALKTLGI | X | P07550 | ||
1443 | 1487 | DNIDSQGRNCSTN | X | P07550 | ||
1444 | 1488 | DSQGRNCSTNDSL | X | P07550 | ||
1445 | 1489 | FCLKEHKALKTLG | X | P07550 | ||
1446 | 1490 | GRNCSTN | X | P07550 | ||
1447 | 1491 | IASSIVS | X | P07550 | ||
1448 | 1492 | NCSTNDS | X | P07550 | ||
1449 | 1493 | RNCSTND | X | P07550 | ||
1450 | 1494 | SLLTKNKARVIIL | X | P07550 | ||
1451 | 1495 | TVPSDNI | X | P07550 | ||
1452 | 1496 | VLAIVFG | X | P07550 | ||
1453 | 1497 | YQSLLTK | X | P07550 | ||
1454 | 1498 | AIAAFYLPVIIMTV | X | P08172 | ||
1455 | 1499 | APRDPVTENCV | X | P08172 | ||
1456 | 1500 | CAPCIPNTVWT | X | P08172 | ||
1457 | 1501 | DSCTPTNTTVE | X | P08172 | ||
1458 | 1502 | GRIVKPNNNNMPSS | X | P08172 | ||
1459 | 1503 | INTFCAPCIPNTVW | X | P08172 | ||
1460 | 1504 | ISFDRYFCVTKPLT | X | P08172 | ||
1461 | 1505 | IVKPNNNNMPSSDD | X | P08172 | ||
1462 | 1506 | KQNIVARKIVKMTK | X | P08172 | ||
1463 | 1507 | KVNRHLQTVNN | X | P08172 | ||
1464 | 1508 | LFWQFIVGVRTVED | X | P08172 | ||
1465 | 1509 | LIISFDRYFCV | X | P08172 | ||
1466 | 1510 | LVQGRIVKPNNNNM | X | P08172 | ||
1467 | 1511 | MNNSTNSSNNSLAL | X | P08172 | ||
1468 | 1512 | MVSIKVNRHLQTVN | X | P08172 | ||
1469 | 1513 | NSTNSSNNSLA | X | P08172 | ||
1470 | 1514 | PAILFWQFIVG | X | P08172 | ||
1471 | 1515 | PCIPNTVWTIG | X | P08172 | ||
1472 | 1516 | PVTENCVQGEE | X | P08172 | ||
1473 | 1517 | QFIVGVRTVED | X | P08172 | ||
1474 | 1518 | QGRIVKPNNNNMPS | X | P08172 | ||
1475 | 1519 | QNIVARKIVKMTKQ | X | P08172 | ||
1476 | 1520 | SRIKKDKKEPV | X | P08172 | ||
1477 | 1521 | SVMNLLIISFD | X | P08172 | ||
1478 | 1522 | TENCVQGEEKE | X | P08172 | ||
1479 | 1523 | TENCVQGEEKESSN | X | P08172 | ||
1480 | 1524 | TFCAPCIPNTVWTI | X | P08172 | ||
1481 | 1525 | TPKSDSCTPTNTTV | X | P08172 | ||
1482 | 1526 | TVEVVGSSGQNGDE | X | P08172 | ||
1483 | 1527 | VCDLWLALDYV | X | P08172 | ||
1484 | 1528 | VLVAGSLSLVTIIG | X | P08172 | ||
1485 | 1529 | VSIKVNRHLQTVNN | X | P08172 | ||
1486 | 1530 | WPLGPVVCDLW | X | P08172 | ||
1487 | 1531 | IVKMTKQPAKKKP | X | P08172 | ||
1488 | 1532 | KIVKMTKQPAKKK | X | P08172 | ||
1489 | 1533 | LFWQFIVGVRTVE | X | P08172 | ||
1490 | 1534 | NNNNMPSSDDGLE | X | P08172 | ||
1491 | 1535 | NNSTNSS | X | P08172 | ||
1492 | 1536 | NSTNSSN | X | P08172 | ||
1493 | 1537 | NSTNSSNNSLALT | X | P08172 | ||
1494 | 1538 | RKIVKMTKQPAKK | X | P08172 | ||
1495 | 1539 | SRASKSRIKKDKK | X | P08172 | ||
1496 | 1540 | STNSSNNSLALTS | X | P08172 | ||
1497 | 1541 | TNSSNNS | X | P08172 | ||
1498 | 1542 | VKPNNNNMPSSDD | X | P08172 | ||
1499 | 1543 | WTIGYWL | X | P08172 | ||
1500 | 1544 | YINSTIN | X | P08172 | ||
1501 | 1545 | AFYLPVVIMTV | X | P08173 | ||
1502 | 1546 | AKTLAFLKSPL | X | P08173 | ||
1503 | 1547 | EATTPAMPAPP | X | P08173 | ||
1504 | 1548 | EMVFIATVTGS | X | P08173 | ||
1505 | 1549 | ETVEMVFIATVTGS | X | P08173 | ||
1506 | 1550 | LSIKVNRQLQTVNN | X | P08173 | ||
1507 | 1551 | LSTTEATTPAMPAP | X | P08173 | ||
1508 | 1552 | NRYETVEMVFIATV | X | P08173 | ||
1509 | 1553 | TVEMVFIATVT | X | P08173 | ||
1510 | 1554 | VNRQLQTVNNY | X | P08173 | ||
1511 | 1555 | WTPYNVMVLVN | X | P08173 | ||
1512 | 1556 | AKTLAFL | X | P08173 | ||
1513 | 1557 | DKDTSNE | X | P08173 | ||
1514 | 1558 | KDTSNES | X | P08173 | ||
1515 | 1559 | LYTVYIIKGYWPL | X | P08173 | ||
1516 | 1560 | RNQVRKKRQMAAR | X | P08173 | ||
1517 | 1561 | RYETVEMVFIATV | X | P08173 | ||
1518 | 1562 | SATQNTK | X | P08173 | ||
1519 | 1563 | YETVEMVFIATVT | X | P08173 | ||
1520 | 1564 | EYGSFFCELWTSVD | X | P08588 |
1521 | 1565 | LAITSPFRYQSLLT | X | P08588 | ||
1522 | 1566 | LVALREQKALK | X | P08588 | ||
1523 | 1567 | PGAASDDDDDD | X | P08588 | ||
1524 | 1568 | PPSPSPSPVPA | X | P08588 | ||
1525 | 1569 | RARARGLVCTV | X | P08588 | ||
1526 | 1570 | SFFCELWTSVD | X | P08588 | ||
1527 | 1571 | VWAISALVSFL | X | P08588 | ||
1528 | 1572 | WEYGSFFCELW | X | P08588 | ||
1529 | 1573 | ARLLEPW | X | P08588 | ||
1530 | 1574 | ARLLVPA | X | P08588 | ||
1531 | 1575 | DVVGATPPARLLE | X | P08588 | ||
1532 | 1576 | LPPASES | X | P08588 | ||
1533 | 1577 | PPARLLE | X | P08588 | ||
1534 | 1578 | QQWTAGMGLLMAL | X | P08588 | ||
1535 | 1579 | RLLCCARRAARRR | X | P08588 | ||
1536 | 1580 | SFFCELWTSVDVL | X | P08588 | ||
1537 | 1581 | RAARFRIRKTVKKV | X | P08908 | ||
1538 | 1582 | AQRERNQASWS | X | P08912 | ||
1539 | 1583 | CLRCPRPTLAQRER | X | P08912 | ||
1540 | 1584 | CWQYLVGKRTV | X | P08912 | ||
1541 | 1585 | DSYHNATTVNG | X | P08912 | ||
1542 | 1586 | EDEDKPATDPV | X | P08912 | ||
1543 | 1587 | GEEFSAEETEETFV | X | P08912 | ||
1544 | 1588 | GKRTVPLDECQ | X | P08912 | ||
1545 | 1589 | GTPVNHQPLER | X | P08912 | ||
1546 | 1590 | KPATDPVLQVV | X | P08912 | ||
1547 | 1591 | KRTKDLADLQGSDS | X | P08912 | ||
1548 | 1592 | LGYWLCYVNSTVNP | X | P08912 | ||
1549 | 1593 | NLLVISFDRYF | X | P08912 | ||
1550 | 1594 | PICYALCNRTF | X | P08912 | ||
1551 | 1595 | QGKESPGEEFSAEE | X | P08912 | ||
1552 | 1596 | QYLVGKRTVPLDEC | X | P08912 | ||
1553 | 1597 | RKTFKMLLLCRWKK | X | P08912 | ||
1554 | 1598 | TEETFVKAETE | X | P08912 | ||
1555 | 1599 | TLAQRERNQAS | X | P08912 | ||
1556 | 1600 | TVNGTPVNHQPLER | X | P08912 | ||
1557 | 1601 | WALGSLACDLW | X | P08912 | ||
1558 | 1602 | AETEKSD | X | P08912 | ||
1559 | 1603 | ALFRSCLRCPRPT | X | P08912 | ||
1560 | 1604 | ASWSSSRRSTSTT | X | P08912 | ||
1561 | 1605 | DPVLQVV | X | P08912 | ||
1562 | 1606 | EEFSAEETEETFV | X | P08912 | ||
1563 | 1607 | EFSAEETEETFVK | X | P08912 | ||
1564 | 1608 | FKMLLLCRWKKKK | X | P08912 | ||
1565 | 1609 | FRSCLRCPRPTLA | X | P08912 | ||
1566 | 1610 | FSAEETEETFVKA | X | P08912 | ||
1567 | 1611 | GKRTVPLDECQIQ | X | P08912 | ||
1568 | 1612 | GYWLCYVNSTVNP | X | P08912 | ||
1569 | 1613 | KMLLLCRWKKKKV | X | P08912 | ||
1570 | 1614 | KPAHRALFRSCLR | X | P08912 | ||
1571 | 1615 | LYTTYILMGRWAL | X | P08912 | ||
1572 | 1616 | SPGEEFSAEETEE | X | P08912 | ||
1573 | 1617 | SSYPSSEDEDKPA | X | P08912 | ||
1574 | 1618 | SYPSSEDEDKPAT | X | P08912 | ||
1575 | 1619 | TCSSYPSSEDEDK | X | P08912 | ||
1576 | 1620 | VNSTVNP | X | P08912 | ||
1577 | 1621 | YVNSTVN | X | P08912 | ||
1578 | 1622 | YWLCYVNSTVNPI | X | P08912 | ||
1579 | 1623 | AWCEIYLALDV | X | P08913 | ||
1580 | 1624 | DSLPRRGPGAT | X | P08913 | ||
1581 | 1625 | HAERPPGPRRPERG | X | P08913 | ||
1582 | 1626 | ISLDRYWSITQAIE | X | P08913 | ||
1583 | 1627 | KFFFWFGYCNSSLN | X | P08913 | ||
1584 | 1628 | LALDVLFCTSSIVH | X | P08913 | ||
1585 | 1629 | PMGSLQPDAGN | X | P08913 | ||
1586 | 1630 | PPGGTERRPNG | X | P08913 | ||
1587 | 1631 | SSDHAERPPGPRRP | X | P08913 | ||
1588 | 1632 | SSIVHLCAISLDRY | X | P08913 | ||
1589 | 1633 | TERRPNGLGPE | X | P08913 | ||
1590 | 1634 | VHLCAISLDRY | X | P08913 | ||
1591 | 1635 | YTIFNHDFRRA | X | P08913 | ||
1592 | 1636 | ALDLEES | X | P08913 | ||
1593 | 1637 | ATLVIPFSLANEV | X | P08913 | ||
1594 | 1638 | DFRRAFK | X | P08913 | ||
1595 | 1639 | FSLANEV | X | P08913 | ||
1596 | 1640 | GAEAEPL | X | P08913 | ||
1597 | 1641 | AYSWKEEEEED | X | P11229 | ||
1598 | 1642 | CKDCVPETLWELGY | X | P11229 | ||
1599 | 1643 | CVPETLWELGYWLC | X | P11229 | ||
1600 | 1644 | GSEVVIKMPMV | X | P11229 | ||
1601 | 1645 | GYWLCYVNSTINPM | X | P11229 | ||
1602 | 1646 | KQPPRSSPNTVKRP | X | P11229 | ||
1603 | 1647 | LLQAYSWKEEEEED | X | P11229 | ||
1604 | 1648 | LQAYSWKEEEE | X | P11229 | ||
1605 | 1649 | NLLVLISFKVNTEL | X | P11229 | ||
1606 | 1650 | SEGEEPGSEVV | X | P11229 | ||
1607 | 1651 | SWKEEEEEDEG | X | P11229 | ||
1608 | 1652 | EEEEEDE | X | P11229 | ||
1609 | 1653 | EEEEEDEGSMESL | X | P11229 | ||
1610 | 1654 | KEEEEED | X | P11229 | ||
1611 | 1655 | LLQAYSW | X | P11229 | ||
1612 | 1656 | QAYSWKEEEEEDE | X | P11229 | ||
1613 | 1657 | RPLSYRAKRTPRR | X | P11229 | ||
1614 | 1658 | SLTSSEG | X | P11229 | ||
1615 | 1659 | WKEEEEE | X | P11229 | ||
1616 | 1660 | GLGPDGQGHQE | X | P11230 | ||
1617 | 1661 | LKRPKPERDLMPEP | X | P11230 | ||
1618 | 1662 | YLDLEWTDYRLSWD | X | P11230 | ||
1619 | 1663 | AVALLPELREVVS | X | P11230 | ||
1620 | 1664 | CTMVFSS | X | P11230 | ||
1621 | 1665 | HEGTFIE | X | P11230 | ||
1622 | 1666 | LAPGVRG | X | P11230 | ||
1623 | 1667 | SYSYDSSEVSLQT | X | P11230 | ||
1624 | 1668 | TPGALLM | X | P11230 | ||
1625 | 1669 | WTFIIFT | X | P11230 | ||
1626 | 1670 | ATGCELWTSVD | X | P13945 | ||
1627 | 1671 | GLIMGTFTLCW | X | P13945 | ||
1628 | 1672 | LPTLAPNTANT | X | P13945 | ||
1629 | 1673 | RALGGPSLVPG | X | P13945 | ||
1630 | 1674 | SRSLAPAPVGT | X | P13945 | ||
1631 | 1675 | VDRYLAVTNPL | X | P13945 | ||
1632 | 1676 | VGADAEAQRCHSNP | X | P13945 | ||
1633 | 1677 | RYGALVT | X | P13945 | ||
1634 | 1678 | IKIYIVLRRRRKRV | X | P14416 | ||
1635 | 1679 | LVYIKIYIVLRRRR | X | P14416 | ||
1636 | 1680 | HGLHSTPDSPAKPE | X | P14416 |
1637 | 1681 | IVLRRRRKRVNTKR | X | P14416 | ||
1638 | 1682 | KIYIVLRRRRKRVN | X | P14416 | ||
1639 | 1683 | MPNGKTRTSLKTMS | X | P14416 | ||
1640 | 1684 | RRRRKRVNTKRSSR | X | P14416 | ||
1641 | 1685 | VYIKIYIVLRRRRK | X | P14416 | ||
1642 | 1686 | AVCYAFVFSALIEF | X | P14867 | ||
1643 | 1687 | ECPMHLEDFPMDAH | X | P14867 | ||
1644 | 1688 | KVAYATAMDWFIAV | X | P14867 | ||
1645 | 1689 | YFVIQTYLPCIMTV | X | P14867 | ||
1646 | 1690 | FTKRGYAWDGKSVV | X | P14867 | ||
1647 | 1691 | FNVYIESDAWQEKD | X | P15382 | ||
1648 | 1692 | AILYYYQSGGRLRR | X | P16389 | ||
1649 | 1693 | DENEDMHGSGVTFH | X | P16389 | ||
1650 | 1694 | DYMEIQEGVNNSNE | X | P16389 | ||
1651 | 1695 | EDMHGSGVTFHTYS | X | P16389 | ||
1652 | 1696 | EGVNNSNEDFREEN | X | P16389 | ||
1653 | 1697 | EIQEGVNNSNEDFR | X | P16389 | ||
1654 | 1698 | EMFREDEGYIKEEE | X | P16389 | ||
1655 | 1699 | FRIFKLSRHSKGLQ | X | P16389 | ||
1656 | 1700 | FYELGEEAMEMFRE | X | P16389 | ||
1657 | 1701 | ISIVSFCLETLPIF | X | P16389 | ||
1658 | 1702 | KLSRHSKGLQILGQ | X | P16389 | ||
1659 | 1703 | PQDTYDPEADHECC | X | P16389 | ||
1660 | 1704 | MEIQEGVNNSNEDF | X | P16389 | ||
1661 | 1705 | SDYMEIQEGVNNSN | X | P16389 | ||
1662 | 1706 | VNNSNEDFREENLK | X | P16389 | ||
1663 | 1707 | FLHLTRADLSYPSH | X | P16473 | ||
1664 | 1708 | YVFFEEQEDEIIGF | X | P16473 | ||
1665 | 1709 | EYPESSGPARGIAI | X | P17658 | ||
1666 | 1710 | GGSFFTDPFFLVET | X | P17658 | ||
1667 | 1711 | GVSRVSPVSRGSQE | X | P17658 | ||
1668 | 1712 | LAAPGEVRGPEGEQ | X | P17658 | ||
1669 | 1713 | LRATDNGLGKPDFP | X | P17658 | ||
1670 | 1714 | PVSRGSQEEEEDED | X | P17658 | ||
1671 | 1715 | QEEEEDEDDSYTFH | X | P17658 | ||
1672 | 1716 | REDEGCLPEGGEDE | X | P17658 | ||
1673 | 1717 | RGSQEEEEDEDDSY | X | P17658 | ||
1674 | 1718 | SQPFQRQVWLLFEY | X | P17658 | ||
1675 | 1719 | STLGGSFFTDPFFL | X | P17658 | ||
1676 | 1720 | ERLVINISGLRFET | X | P17658 | ||
1677 | 1721 | RSEKSLTLAAPGEV | X | P17658 | ||
1678 | 1722 | SQEEEEDEDDSYTF | X | P17658 | ||
1679 | 1723 | YFAEADDDDSLFPS | X | P17658 | ||
1680 | 1724 | ACKIEVKHFPF | X | P17787 | ||
1681 | 1725 | AGAFGAEPAPV | X | P17787 | ||
1682 | 1726 | CARQRLRLRRR | X | P17787 | ||
1683 | 1727 | CGEKMTLCISV | X | P17787 | ||
1684 | 1728 | EKMTLCISVLL | X | P17787 | ||
1685 | 1729 | GPVALLLGFGL | X | P17787 | ||
1686 | 1730 | ISVHEREQIMTTNV | X | P17787 | ||
1687 | 1731 | KVRLPSKHIWLPDV | X | P17787 | ||
1688 | 1732 | MTTNVWLTQEWEDY | X | P17787 | ||
1689 | 1733 | PPAIYKSACKI | X | P17787 | ||
1690 | 1734 | QRLRLRRRQREREG | X | P17787 | ||
1691 | 1735 | RLRRRQREREG | X | P17787 | ||
1692 | 1736 | RQRLRLRRRQR | X | P17787 | ||
1693 | 1737 | RSWTYDRTEID | X | P17787 | ||
1694 | 1738 | VASLDDFTPSGEWD | X | P17787 | ||
1695 | 1739 | VHEREQIMTTN | X | P17787 | ||
1696 | 1740 | VSLAQLISVHEREQ | X | P17787 | ||
1697 | 1741 | WTYDRTEIDLVLKS | X | P17787 | ||
1698 | 1742 | YDRTEIDLVLK | X | P17787 | ||
1699 | 1743 | CARQRLRLRRRQR | X | P17787 | ||
1700 | 1744 | GAEPAPV | X | P17787 | ||
1701 | 1745 | GLAGAFGAEPAPV | X | P17787 | ||
1702 | 1746 | HHCARQRLRLRRR | X | P17787 | ||
1703 | 1747 | ISVHEREQIMTTN | X | P17787 | ||
1704 | 1748 | NAVVSYD | X | P17787 | ||
1705 | 1749 | RHHCARQRLRLRR | X | P17787 | ||
1706 | 1750 | AAITFLILFTI | X | P18089 | ||
1707 | 1751 | ASPEDEAEEEE | X | P18089 | ||
1708 | 1752 | CGASPEDEAEEEEE | X | P18089 | ||
1709 | 1753 | EEEEEECEPQAVPV | X | P18089 | ||
1710 | 1754 | EEEEEEECEPQ | X | P18089 | ||
1711 | 1755 | EEEEEEEECEP | X | P18089 | ||
1712 | 1756 | EEEEEEEEECEPQA | X | P18089 | ||
1713 | 1757 | GASPEDEAEEE | X | P18089 | ||
1714 | 1758 | PEDEAEEEEEE | X | P18089 | ||
1715 | 1759 | SGQGQKEGVCGASP | X | P18089 | ||
1716 | 1760 | SPEDEAEEEEE | X | P18089 | ||
1717 | 1761 | STGEKEEGETP | X | P18089 | ||
1718 | 1762 | AEEEEEE | X | P18089 | ||
1719 | 1763 | AEEEEEEEEEEEE | X | P18089 | ||
1720 | 1764 | DEAEEEEEEEEEE | X | P18089 | ||
1721 | 1765 | EAEEEEE | X | P18089 | ||
1722 | 1766 | EAEEEEEEEEEEE | X | P18089 | ||
1723 | 1767 | EDEAEEEEEEEEE | X | P18089 | ||
1724 | 1768 | EEEEECE | X | P18089 | ||
1725 | 1769 | EEEEEEC | X | P18089 | ||
1726 | 1770 | EEEEEEEECEPQA | X | P18089 | ||
1727 | 1771 | EEEEEEEEECEPQ | X | P18089 | ||
1728 | 1772 | EEEEEEEEEECEP | X | P18089 | ||
1729 | 1773 | EEEEEEEEEEECE | X | P18089 | ||
1730 | 1774 | EEEEEEEEEEEEC | X | P18089 | ||
1731 | 1775 | GEKEEGE | X | P18089 | ||
1732 | 1776 | GQKEGVC | X | P18089 | ||
1733 | 1777 | IILTVWLIAAVIS | X | P18089 | ||
1734 | 1778 | IYTIFNQ | X | P18089 | ||
1735 | 1779 | NSGQGQKEGVCGA | X | P18089 | ||
1736 | 1780 | PEDEAEEEEEEEE | X | P18089 | ||
1737 | 1781 | RALPPSWAALPNS | X | P18089 | ||
1738 | 1782 | RAQLTRE | X | P18089 | ||
1739 | 1783 | RGRPQCK | X | P18089 | ||
1740 | 1784 | SPEDEAEEEEEEE | X | P18089 | ||
1741 | 1785 | TGEKEEG | X | P18089 | ||
1742 | 1786 | TIFNQDF | X | P18089 | ||
1743 | 1787 | VNGHSKSTGEKEE | X | P18089 | ||
1744 | 1788 | WAALPNSGQGQKE | X | P18089 | ||
1745 | 1789 | ETLPKIPYVKAIDI | X | P18505 | ||
1746 | 1790 | IDVASIDMVSEVNM | X | P18505 | ||
1747 | 1791 | LRPDFGGPPVDVGM | X | P18505 | ||
1748 | 1792 | PLDEQNCTLEIESY | X | P18505 |
1749 | 1793 | VCCAHSTNEPSNMS | X | P18505 | ||
1750 | 1794 | AARVALGITTVLTM | X | P18505 | ||
1751 | 1795 | GCFVFVFLALLEYA | X | P18505 | ||
1752 | 1796 | YDIRLRPDFGGPPV | X | P18505 | ||
1753 | 1797 | ATHLQERDEEYGYE | X | P18507 | ||
1754 | 1798 | DAECQLQLHNFPMD | X | P18507 | ||
1755 | 1799 | DAVPARTSLGITTV | X | P18507 | ||
1756 | 1800 | KKNPAPTIDIRPRS | X | P18507 | ||
1757 | 1801 | KVSYVTAMDLFVSV | X | P18507 | ||
1758 | 1802 | LDGKDCASFFCCFE | X | P18507 | ||
1759 | 1803 | LIHTDMYVNSIGPV | X | P18507 | ||
1760 | 1804 | NFPMDEHSCPLEFS | X | P18507 | ||
1761 | 1805 | NTTEVVKTTSGDYV | X | P18507 | ||
1762 | 1806 | SNRKPSKDKDKKKK | X | P18507 | ||
1763 | 1807 | KPSKDKDKKKKNPA | X | P18507 | ||
1764 | 1808 | VLYTLRLTIDAECQ | X | P18507 | ||
1765 | 1809 | AAAGPNASGAGERG | X | P18825 | ||
1766 | 1810 | ADVEPDESSAAAER | X | P18825 | ||
1767 | 1811 | ANASGASWGPPRGQ | X | P18825 | ||
1768 | 1812 | APPPADVEPDE | X | P18825 | ||
1769 | 1813 | GAAYPQCGLND | X | P18825 | ||
1770 | 1814 | HCAPPPADVEPDES | X | P18825 | ||
1771 | 1815 | IAVLTSRALRA | X | P18825 | ||
1772 | 1816 | ILFRRRRRGFR | X | P18825 | ||
1773 | 1817 | IVFTVVGNVLV | X | P18825 | ||
1774 | 1818 | LIMGLVYARIY | X | P18825 | ||
1775 | 1819 | PADVEPDESSA | X | P18825 | ||
1776 | 1820 | PCLIMGLVYAR | X | P18825 | ||
1777 | 1821 | PDGAAYPQCGLNDE | X | P18825 | ||
1778 | 1822 | PFSLANELMAY | X | P18825 | ||
1779 | 1823 | PPPADVEPDES | X | P18825 | ||
1780 | 1824 | PPPADVEPDESSAA | X | P18825 | ||
1781 | 1825 | RRGALRRGGRR | X | P18825 | ||
1782 | 1826 | AAAERRRRRGALR | X | P18825 | ||
1783 | 1827 | AAERRRRRGALRR | X | P18825 | ||
1784 | 1828 | AAGPNAS | X | P18825 | ||
1785 | 1829 | AAVVGFL | X | P18825 | ||
1786 | 1830 | AERRRRR | X | P18825 | ||
1787 | 1831 | AERRRRRGALRRG | X | P18825 | ||
1788 | 1832 | AGERGSG | X | P18825 | ||
1789 | 1833 | FRRSFKHILFRRR | X | P18825 | ||
1790 | 1834 | GFLIVFT | X | P18825 | ||
1791 | 1835 | KHILFRRRRRGFR | X | P18825 | ||
1792 | 1836 | LFRRRRR | X | P18825 | ||
1793 | 1837 | NASGAGE | X | P18825 | ||
1794 | 1838 | PFFFSYSLYGICR | X | P18825 | ||
1795 | 1839 | RRRGALRRGGRRR | X | P18825 | ||
1796 | 1840 | RRRRARSSVCRRK | X | P18825 | ||
1797 | 1841 | RRRRGALRRGGRR | X | P18825 | ||
1798 | 1842 | RRRRRGALRRGGR | X | P18825 | ||
1799 | 1843 | SFKHILFRRRRRG | X | P18825 | ||
1800 | 1844 | SRALRAP | X | P18825 | ||
1801 | 1845 | SRRRRARSSVCRR | X | P18825 | ||
1802 | 1846 | YRVAKLRTRTLSE | X | P18825 | ||
1803 | 1847 | AASLENSASSDEED | X | P20309 | ||
1804 | 1848 | CYINSTVNPVC | X | P20309 | ||
1805 | 1849 | DNLQVPEEELG | X | P20309 | ||
1806 | 1850 | FSKLPIQLESAVDT | X | P20309 | ||
1807 | 1851 | LACDLWLAIDY | X | P20309 | ||
1808 | 1852 | LERKADKLQAQ | X | P20309 | ||
1809 | 1853 | LGNLACDLWLAIDY | X | P20309 | ||
1810 | 1854 | LPIQLESAVDT | X | P20309 | ||
1811 | 1855 | LQVPEEELGMV | X | P20309 | ||
1812 | 1856 | PLFPNISSSWI | X | P20309 | ||
1813 | 1857 | TAIAAFYMPVT | X | P20309 | ||
1814 | 1858 | TFGTAIAAFYMPVT | X | P20309 | ||
1815 | 1859 | TTKRAGVMIGLAWV | X | P20309 | ||
1816 | 1860 | VDTAKTSDVNS | X | P20309 | ||
1817 | 1861 | WLCYINSTVNP | X | P20309 | ||
1818 | 1862 | ELAGLQA | X | P20309 | ||
1819 | 1863 | IFHKRAP | X | P20309 | ||
1820 | 1864 | INSTVNP | X | P20309 | ||
1821 | 1865 | NSTVNPV | X | P20309 | ||
1822 | 1866 | QQQSMKRSNRRKY | X | P20309 | ||
1823 | 1867 | QSMKRSN | X | P20309 | ||
1824 | 1868 | RPLTYRAKRTTKR | X | P20309 | ||
1825 | 1869 | TKRKRMSLVKEKK | X | P20309 | ||
1826 | 1870 | YINSTVN | X | P20309 | ||
1827 | 1871 | FKTGNSTATCTTNN | X | P22001 | ||
1828 | 1872 | GRELPPDMTVVPGD | X | P22001 | ||
1829 | 1873 | AAAAAAVAAATAAV | X | P22459 | ||
1830 | 1874 | ATAAVEGSGGSGGG | X | P22459 | ||
1831 | 1875 | CTSHDPQSSRGSRR | X | P22459 | ||
1832 | 1876 | EEEEEEEGRFYYSE | X | P22459 | ||
1833 | 1877 | EEEEGRFYYSEDDH | X | P22459 | ||
1834 | 1878 | FREDEGFVREEEDR | X | P22459 | ||
1835 | 1879 | FYYSEDDHGDECSY | X | P22459 | ||
1836 | 1880 | GVKESLCAKEEKCQ | X | P22459 | ||
1837 | 1881 | KILRELSEEEEDEE | X | P22459 | ||
1838 | 1882 | LLKFREDEGFVREE | X | P22459 | ||
1839 | 1883 | QLGEEALLKFREDE | X | P22459 | ||
1840 | 1884 | SEEKILRELSEEEE | X | P22459 | ||
1841 | 1885 | SFPHCSDLMPSGSE | X | P22459 | ||
1842 | 1886 | SGHTIFNDPFFIVE | X | P22459 | ||
1843 | 1887 | SSTSSSLGDKSEYL | X | P22459 | ||
1844 | 1888 | TIFNDPFFIVETVC | X | P22459 | ||
1845 | 1889 | TQYFDPLRNEYFFD | X | P22459 | ||
1846 | 1890 | VSGLRFETQMKTLA | X | P22459 | ||
1847 | 1891 | EEDEEEEEEEEEEG | X | P22459 | ||
1848 | 1892 | RELSEEEEDEEEEE | X | P22459 | ||
1849 | 1893 | SEEEEDEEEEEEEE | X | P22459 | ||
1850 | 1894 | RGSRRRRRQRSEKK | X | P22459 | ||
1851 | 1895 | RRRRRQRSEKKKAH | X | P22459 |
1852 | 1896 | ELPRPRRPPPEDEE | X | P22460 | ||
1853 | 1897 | ENGGAMTVRGGDEA | X | P22460 | ||
1854 | 1898 | FDRNRPSFDGILYY | X | P22460 | ||
1855 | 1899 | LLPRTLADPFFIVE | X | P22460 | ||
1856 | 1900 | LPPLPEELPRPRRP | X | P22460 | ||
1857 | 1901 | LSDGPKEPAPKGRG | X | P22460 | ||
1858 | 1902 | PLEKCNVKAKSNVD | X | P22460 | ||
1859 | 1903 | RETDHEEPAVLKEE | X | P22460 | ||
1860 | 1904 | SLDVFADEIRFYQL | X | P22460 | ||
1861 | 1905 | TFELLVRFFACPSK | X | P22460 | ||
1862 | 1906 | TVGYGDMRPITVGG | X | P22460 | ||
1863 | 1907 | EEEEGDPGLGTVED | X | P22460 | ||
1864 | 1908 | PEDEEEEGDPGLGT | X | P22460 | ||
1865 | 1909 | VNVSLDVFADEIRF | X | P22460 | ||
1866 | 1910 | AKDGISVKGANNSN | X | P23415 | ||
1867 | 1911 | ANNSNTTNPPPAPS | X | P23415 | ||
1868 | 1912 | CLLFVFSALLEYAA | X | P23415 | ||
1869 | 1913 | GISVKGANNSNTTN | X | P23415 | ||
1870 | 1914 | VKGANNSNTTNPPP | X | P23415 | ||
1871 | 1915 | DFSMRPGFGGPAIP | X | P24046 | ||
1872 | 1916 | DSLKTDERISLSQF | X | P24046 | ||
1873 | 1917 | GFGGPAIPVGVDVQ | X | P24046 | ||
1874 | 1918 | GKVLYSLRVTVTAM | X | P24046 | ||
1875 | 1919 | MRPGFGGPAIPVGV | X | P24046 | ||
1876 | 1920 | QPDGKVLYSLRVTV | X | P24046 | ||
1877 | 1921 | TLYLRHYWKDERLS | X | P24046 | ||
1878 | 1922 | VQVESLDSISEVDM | X | P24046 | ||
1879 | 1923 | WVPDMFFVHSKRSF | X | P24046 | ||
1880 | 1924 | CSLEIESYAYTEDD | X | P24046 | ||
1881 | 1925 | ERLSFPSTNNLSMT | X | P24046 | ||
1882 | 1926 | SLEEKQSCLKFKAN | X | P24530 | ||
1883 | 1927 | AADAFDIGSFDEED | X | P25098 | ||
1884 | 1928 | AFDIGSFDEED | X | P25098 | ||
1885 | 1929 | DLFQPYIEEIC | X | P25098 | ||
1886 | 1930 | DRLEARKKAKN | X | P25098 | ||
1887 | 1931 | EEARPLVEFYEEIK | X | P25098 | ||
1888 | 1932 | EEERVARSREIFDS | X | P25098 | ||
1889 | 1933 | FQKFIESDKFT | X | P25098 | ||
1890 | 1934 | GEGEAPQSLLT | X | P25098 | ||
1891 | 1935 | HKTKDKHEIDR | X | P25098 | ||
1892 | 1936 | LLTMEEIQSVE | X | P25098 | ||
1893 | 1937 | LPDSFSPELRSLLE | X | P25098 | ||
1894 | 1938 | NHLEEARPLVE | X | P25098 | ||
1895 | 1939 | QNLRGDVFQKFIES | X | P25098 | ||
1896 | 1940 | QQEVAETVFDTINA | X | P25098 | ||
1897 | 1941 | RPLVEFYEEIK | X | P25098 | ||
1898 | 1942 | SFSPELRSLLE | X | P25098 | ||
1899 | 1943 | SVEETQIKERK | X | P25098 | ||
1900 | 1944 | TMEEIQSVEET | X | P25098 | ||
1901 | 1945 | WRGEGEAPQSLLTM | X | P25098 | ||
1902 | 1946 | YLEDRGEVTFE | X | P25098 | ||
1903 | 1947 | AAEIILG | X | P25098 | ||
1904 | 1948 | APQSLLT | X | P25098 | ||
1905 | 1949 | EEERVARSREIFD | X | P25098 | ||
1906 | 1950 | EIQSVEE | X | P25098 | ||
1907 | 1951 | ERVARSREIFDSY | X | P25098 | ||
1908 | 1952 | GRGGFGE | X | P25098 | ||
1909 | 1953 | GYMAPEV | X | P25098 | ||
1910 | 1954 | HPFSKSA | X | P25098 | ||
1911 | 1955 | IGRGGFG | X | P25098 | ||
1912 | 1956 | IPPRGEV | X | P25098 | ||
1913 | 1957 | IQSVEETQIKERK | X | P25098 | ||
1914 | 1958 | ISERWQQEVAETV | X | P25098 | ||
1915 | 1959 | KYPPPLIPPRGEV | X | P25098 | ||
1916 | 1960 | LEDRGEV | X | P25098 | ||
1917 | 1961 | LTMNDFS | X | P25098 | ||
1918 | 1962 | PQSLLTM | X | P25098 | ||
1919 | 1963 | QSVEETQIKERKC | X | P25098 | ||
1920 | 1964 | RGGFGEV | X | P25098 | ||
1921 | 1965 | RVARSREIFDSYI | X | P25098 | ||
1922 | 1966 | SVMQKYLEDRGEV | X | P25098 | ||
1923 | 1967 | ALTALPDPDPE | X | P25100 | ||
1924 | 1968 | APSSGDAPPGAPLA | X | P25100 | ||
1925 | 1969 | CQCRRRRRRRP | X | P25100 | ||
1926 | 1970 | CRRRRRRRPLW | X | P25100 | ||
1927 | 1971 | DPEPPGTPEMQAPV | X | P25100 | ||
1928 | 1972 | ERGKASEVVLR | X | P25100 | ||
1929 | 1973 | FRDLLSVSFEG | X | P25100 | ||
1930 | 1974 | LRCQCRRRRRR | X | P25100 | ||
1931 | 1975 | LRCQCRRRRRRRPL | X | P25100 | ||
1932 | 1976 | MQAPVASRRKPPSA | X | P25100 | ||
1933 | 1977 | PLLGWKEPVPPDER | X | P25100 | ||
1934 | 1978 | QCRRRRRRRPL | X | P25100 | ||
1935 | 1979 | QDCAPSSGDAPPGA | X | P25100 | ||
1936 | 1980 | RCQCRRRRRRR | X | P25100 | ||
1937 | 1981 | WRASTSGLRQDCAP | X | P25100 | ||
1938 | 1982 | CQCRRRRRRRPLW | X | P25100 | ||
1939 | 1983 | CRRRRRR | X | P25100 | ||
1940 | 1984 | EVAEGATCQAYEL | X | P25100 | ||
1941 | 1985 | FLRLLRCQCRRRR | X | P25100 | ||
1942 | 1986 | FSREKKAAKTLAI | X | P25100 | ||
1943 | 1987 | GATCQAYELADYS | X | P25100 | ||
1944 | 1988 | LCCTASILSLCTI | X | P25100 | ||
1945 | 1989 | PEMQAPV | X | P25100 | ||
1946 | 1990 | RRRRRRPLWRVYG | X | P25100 | ||
1947 | 1991 | RRRRRRR | X | P25100 | ||
1948 | 1992 | RRRRRRRPLWRVY | X | P25100 | ||
1949 | 1993 | SATMEVL | X | P25100 | ||
1950 | 1994 | VIFWLGY | X | P25100 | ||
1951 | 1995 | VLCWFPFFFVLPL | X | P25100 | ||
1952 | 1996 | VVCCAQSVNDPGNM | X | P28472 | ||
1953 | 1997 | LYWKNGDESLKTDE | X | P28476 | ||
1954 | 1998 | QTCSLELESYAYTD | X | P28476 | ||
1955 | 1999 | CTIDVTFFPFD | X | P30532 | ||
1956 | 2000 | DQDVDKRDFFD | X | P30532 | ||
1957 | 2001 | GLSFLTVLVFY | X | P30532 | ||
1958 | 2002 | HEDSLLKDLFQDYE | X | P30532 | ||
1959 | 2003 | PSDSVWTPDIVLFD | X | P30532 |
1960 | 2004 | QDVDKRDFFDNGEW | X | P30532 | ||
1961 | 2005 | QKEETESGSGP | X | P30532 | ||
1962 | 2006 | RDFFDNGEWEI | X | P30532 | ||
1963 | 2007 | SVWTPDIVLFDNAD | X | P30532 | ||
1964 | 2008 | SWTYDGSQVDIILE | X | P30532 | ||
1965 | 2009 | TKTVIRYNGTVTWT | X | P30532 | ||
1966 | 2010 | AISQLVDVDEKNQ | X | P30532 | ||
1967 | 2011 | RYNGTVT | X | P30532 | ||
1968 | 2012 | TYSFVIKRLPLFY | X | P30532 | ||
1969 | 2013 | VTYSFVIKRLPLF | X | P30532 | ||
1970 | 2014 | DFIIKRKPLFY | X | P30926 | ||
1971 | 2015 | MRRAPSLVLFFLVA | X | P30926 | ||
1972 | 2016 | NEREQIMTTNV | X | P30926 | ||
1973 | 2017 | SLAQLISVNER | X | P30926 | ||
1974 | 2018 | TSPSNFYGNSM | X | P30926 | ||
1975 | 2019 | VFMFVCVLGTV | X | P30926 | ||
1976 | 2020 | DFIIKRKPLFYTI | X | P30926 | ||
1977 | 2021 | ISVNEREQIMTTN | X | P30926 | ||
1978 | 2022 | LISVNEREQIMTT | X | P30926 | ||
1979 | 2023 | ECPMQLEDFPMDAH | X | P31644 | ||
1980 | 2024 | GMFSGFIMIKNLLL | X | P31644 | ||
1981 | 2025 | ISAECPMQLEDFPM | X | P31644 | ||
1982 | 2026 | KKREVILNKSTNAF | X | P31644 | ||
1983 | 2027 | MNLSSHFGFSQMPT | X | P31644 | ||
1984 | 2028 | SGFIMIKNLLLFCI | X | P31644 | ||
1985 | 2029 | DGKKALEAAKIKKK | X | P31644 | ||
1986 | 2030 | EVILNKSTNAFTTG | X | P31644 | ||
1987 | 2031 | ASEAEHRLFERLFE | X | P32297 | ||
1988 | 2032 | DIKYNCCEEIY | X | P32297 | ||
1989 | 2033 | ERLFEDYNEIIRPV | X | P32297 | ||
1990 | 2034 | HHRRIKISNFSANL | X | P32297 | ||
1991 | 2035 | HRLFERLFEDY | X | P32297 | ||
1992 | 2036 | IRPVANVSDPV | X | P32297 | ||
1993 | 2037 | KIDVTYFPFDY | X | P32297 | ||
1994 | 2038 | MSQLVKVDEVN | X | P32297 | ||
1995 | 2039 | PVANVSDPVIIHFE | X | P32297 | ||
1996 | 2040 | RLFERLFEDYNEII | X | P32297 | ||
1997 | 2041 | VARASEAEHRLFER | X | P32297 | ||
1998 | 2042 | VDEVNQIMETN | X | P32297 | ||
1999 | 2043 | VDEVNQIMETNLWL | X | P32297 | ||
2000 | 2044 | CCEEIYPDITYSL | X | P32297 | ||
2001 | 2045 | CEEIYPDITYSLY | X | P32297 | ||
2002 | 2046 | DKTKALLKYTGEV | X | P32297 | ||
2003 | 2047 | ENMKAQN | X | P32297 | ||
2004 | 2048 | EVSMSQLVKVDEV | X | P32297 | ||
2005 | 2049 | IAENMKAQNEAKE | X | P32297 | ||
2006 | 2050 | LFERLFEDYNEII | X | P32297 | ||
2007 | 2051 | LKYTGEV | X | P32297 | ||
2008 | 2052 | RLFEDYNEIIRPV | X | P32297 | ||
2009 | 2053 | YSLYIRRLPLFYT | X | P32297 | ||
2010 | 2054 | AECPMHLEDFPMDV | X | P34903 | ||
2011 | 2055 | DSPTETKTYNSVSK | X | P34903 | ||
2012 | 2056 | IFTRILDRLLDGYD | X | P34903 | ||
2013 | 2057 | LYTMRLTIHAECPM | X | P34903 | ||
2014 | 2058 | PMHLEDFPMDVHAC | X | P34903 | ||
2015 | 2059 | TETKTYNSVSKVDK | X | P34903 | ||
2016 | 2060 | VVGTEIIRSSTGEY | X | P34903 | ||
2017 | 2061 | GQGESRRQEPGDFV | X | P34903 | ||
2018 | 2062 | SPTETKTYNSVSKV | X | P34903 | ||
2019 | 2063 | GLCIISIDRYI | X | P35348 | ||
2020 | 2064 | IDRYIGVSYPL | X | P35348 | ||
2021 | 2065 | IGPLFGWRQPAPED | X | P35348 | ||
2022 | 2066 | LKTDKSDSEQVTLR | X | P35348 | ||
2023 | 2067 | LTSTVLPFSAIFEV | X | P35348 | ||
2024 | 2068 | VLCWLPFFLVMPIG | X | P35348 | ||
2025 | 2069 | ITVSKDQSSCTTA | X | P35348 | ||
2026 | 2070 | PSETVFK | X | P35348 | ||
2027 | 2071 | ANGQPGFKSNMPLA | X | P35368 | ||
2028 | 2072 | ASILSLCAISIDRY | X | P35368 | ||
2029 | 2073 | CQCRGRGRRRR | X | P35368 | ||
2030 | 2074 | CRGRGRRRRRR | X | P35368 | ||
2031 | 2075 | DKECGVTEEPF | X | P35368 | ||
2032 | 2076 | GCQCRGRGRRRRRR | X | P35368 | ||
2033 | 2077 | GRGRRRRRRRR | X | P35368 | ||
2034 | 2078 | GRGRRRRRRRRRLG | X | P35368 | ||
2035 | 2079 | GRRRRRRRRRL | X | P35368 | ||
2036 | 2080 | LCWLPFFIALPLGS | X | P35368 | ||
2037 | 2081 | LSLCAISIDRY | X | P35368 | ||
2038 | 2082 | PCSSKEFKRAFVRI | X | P35368 | ||
2039 | 2083 | QCRGRGRRRRR | X | P35368 | ||
2040 | 2084 | RGRRRRRRRRR | X | P35368 | ||
2041 | 2085 | RILGCQCRGRGRRR | X | P35368 | ||
2042 | 2086 | RRRRRRRRRLG | X | P35368 | ||
2043 | 2087 | SIDRYIGVRYS | X | P35368 | ||
2044 | 2088 | ANFTGPNQTSSNS | X | P35368 | ||
2045 | 2089 | FTGPNQTSSNSTL | X | P35368 | ||
2046 | 2090 | GRRRRRR | X | P35368 | ||
2047 | 2091 | LGCQCRGRGRRRR | X | P35368 | ||
2048 | 2092 | NFTGPNQTSSNST | X | P35368 | ||
2049 | 2093 | QTSSNST | X | P35368 | ||
2050 | 2094 | RRRRRRLGGCAYT | X | P35368 | ||
2051 | 2095 | SFTVLPFSAALEV | X | P35368 | ||
2052 | 2096 | TGPNQTSSNSTLP | X | P35368 | ||
2053 | 2097 | CVPTPDSGVVCGRM | X | P36544 | ||
2054 | 2098 | DHYLQWNVSEY | X | P36544 | ||
2055 | 2099 | DISGYIPNGEW | X | P36544 | ||
2056 | 2100 | EGDPDLAKILE | X | P36544 | ||
2057 | 2101 | ELVKNYNPLER | X | P36544 | ||
2058 | 2102 | EVRYIANRFRCQDE | X | P36544 | ||
2059 | 2103 | FSLSLLQIMDVDEK | X | P36544 | ||
2060 | 2104 | GEDKVRPACQHKQR | X | P36544 | ||
2061 | 2105 | GIFKSSCYIDV | X | P36544 | ||
2062 | 2106 | HGGQPPEGDPD | X | P36544 | ||
2063 | 2107 | LERPVANDSQP | X | P36544 | ||
2064 | 2108 | LHGGQPPEGDPDLA | X | P36544 | ||
2065 | 2109 | LQMQEADISGY | X | P36544 | ||
2066 | 2110 | MLLVAEIMPAT | X | P36544 | ||
2067 | 2111 | MSAPNFVEAVS | X | P36544 | ||
2068 | 2112 | PACQHKQRRCSLAS | X | P36544 | ||
2069 | 2113 | SGYIPNGEWDL | X | P36544 | ||
2070 | 2114 | SLSLLQIMDVD | X | P36544 | ||
2071 | 2115 | SVPLIAQYFASTMI | X | P36544 | ||
2072 | 2116 | TVYFSLSLLQIMDV | X | P36544 | ||
2073 | 2117 | VKNYNPLERPV | X | P36544 | ||
2074 | 2118 | VTVIVLQYHHHDPD | X | P36544 | ||
2075 | 2119 | YIANRFRCQDE | X | P36544 | ||
2076 | 2120 | YNPLERPVANDSQP | X | P36544 |
2077 | 2121 | DEKNQVLTTNIWL | X | P36544 | ||
2078 | 2122 | DILLYNS | X | P36544 | ||
2079 | 2123 | EKISLGI | X | P36544 | ||
2080 | 2124 | ERFYECCKEPYPD | X | P36544 | ||
2081 | 2125 | IPGKRSE | X | P36544 | ||
2082 | 2126 | KISLGIT | X | P36544 | ||
2083 | 2127 | KNYNPLE | X | P36544 | ||
2084 | 2128 | VKTVRFP | X | P36544 | ||
2085 | 2129 | YFSLSLLQIMDVD | X | P36544 | ||
2086 | 2130 | PEPAAPQQPTAEEE | X | P37088 | ||
2087 | 2131 | YGNCYTFNDKNNSN | X | P37088 | ||
2088 | 2132 | ACDQLALGVAALFG | X | P39086 | ||
2089 | 2133 | ACLGVSCVLFVIAR | X | P39086 | ||
2090 | 2134 | AEILKQILFMGMMT | X | P39086 | ||
2091 | 2135 | ALSTRIVGGIWWFF | X | P39086 | ||
2092 | 2136 | FEASRRACDQLALG | X | P39086 | ||
2093 | 2137 | FGPSHSSSVSAVQS | X | P39086 | ||
2094 | 2138 | GYCLDLLKELSNIL | X | P39086 | ||
2095 | 2139 | IDNPHVSSIIEKWS | X | P39086 | ||
2096 | 2140 | IFETVENEPVNVEE | X | P39086 | ||
2097 | 2141 | LKEMKKGKEFYVIF | X | P39086 | ||
2098 | 2142 | LLMESTSIEYVTQR | X | P39086 | ||
2099 | 2143 | LLNIDNPHVSSIIE | X | P39086 | ||
2100 | 2144 | LNSFWFGVGALMQQ | X | P39086 | ||
2101 | 2145 | PLYGNDRFEGYCLD | X | P39086 | ||
2102 | 2146 | QLALGVAALFGPSH | X | P39086 | ||
2103 | 2147 | SDKPLYGNDRFEGY | X | P39086 | ||
2104 | 2148 | SLQCHRHKPWRLGP | X | P39086 | ||
2105 | 2149 | TVENEPVNVEELAF | X | P39086 | ||
2106 | 2150 | GIFETVENEPVNVE | X | P39086 | ||
2107 | 2151 | NIKIKIRQLPSGNK | X | P39086 | ||
2108 | 2152 | RLLNIDNPHVSSII | X | P39086 | ||
2109 | 2153 | ARPRSPSPISTLSH | X | P41594 | ||
2110 | 2154 | CKENEYVFDEYTCK | X | P41594 | ||
2111 | 2155 | CMFVPKVYIILAKP | X | P41594 | ||
2112 | 2156 | CWTCTPCKENEYVF | X | P41594 | ||
2113 | 2157 | EFIRDSLISSEEEE | X | P41594 | ||
2114 | 2158 | ESRGLGAGAGAGGS | X | P41594 | ||
2115 | 2159 | FSVSLSATVALGCM | X | P41594 | ||
2116 | 2160 | GLGAGAGAGGSAGG | X | P41594 | ||
2117 | 2161 | IKLQSPDVKWFDDY | X | P41594 | ||
2118 | 2162 | IMNFKEMGKDYFDY | X | P41594 | ||
2119 | 2163 | QARAMVDIVKRYNW | X | P41594 | ||
2120 | 2164 | RPETNHRNPWFQEF | X | P41594 | ||
2121 | 2165 | PCKENEYVFDEYTC | X | P41594 | ||
2122 | 2166 | PQENSKYNKTCNSS | X | P41594 | ||
2123 | 2167 | RILAGSKKKICTKK | X | P41594 | ||
2124 | 2168 | RTDDDVPSLHSEPV | X | P41594 | ||
2125 | 2169 | WPTDDLTGCDLIPV | X | P41594 | ||
2126 | 2170 | AAEKNWQVTAVNIL | X | P42261 | ||
2127 | 2171 | APLTITLVREEVID | X | P42261 | ||
2128 | 2172 | FEEGRDQTTSDQSN | X | P42261 | ||
2129 | 2173 | GAFMQQGCDISPRS | X | P42261 | ||
2130 | 2174 | KGKYAYLLESTMNE | X | P42261 | ||
2131 | 2175 | KHDGIRKIGYWNED | X | P42261 | ||
2132 | 2176 | KIGYWNEDDKFVPA | X | P42261 | ||
2133 | 2177 | KKNANQFEGNDRYE | X | P42261 | ||
2134 | 2178 | KYAYLLESTMNEYI | X | P42261 | ||
2135 | 2179 | LNKFKESGANVTGF | X | P42261 | ||
2136 | 2180 | PLTITLVREEVIDF | X | P42261 | ||
2137 | 2181 | SAEPSVFVRTTEEG | X | P42261 | ||
2138 | 2182 | SKGKYAYLLESTMN | X | P42261 | ||
2139 | 2183 | SRFSPYEWHSEEFE | X | P42261 | ||
2140 | 2184 | VRKSKGKYAYLLES | X | P42261 | ||
2141 | 2185 | YAYLLESTMNEYIE | X | P42261 | ||
2142 | 2186 | YWNEDDKFVPAATD | X | P42261 | ||
2143 | 2187 | EHAAFRFALSQLTE | X | P42261 | ||
2144 | 2188 | VIDFSKPFMSLGIS | X | P42261 | ||
2145 | 2189 | AIFGFYDKKSVNTI | X | P42262 | ||
2146 | 2190 | IESAEDLSKQTEIA | X | P42262 | ||
2147 | 2191 | INPSSSQNSQNFAT | X | P42262 | ||
2148 | 2192 | LKKERRVILDCERD | X | P42262 | ||
2149 | 2193 | MLVALIEFCYKSRA | X | P42262 | ||
2150 | 2194 | NHEMLEGNERYEGY | X | P42262 | ||
2151 | 2195 | NPAVPWGQGVEIER | X | P42262 | ||
2152 | 2196 | PIESAEDLSKQTEI | X | P42262 | ||
2153 | 2197 | PYEWHTEEFEDGRE | X | P42262 | ||
2154 | 2198 | RFSPYEWHTEEFED | X | P42262 | ||
2155 | 2199 | ALHTSFVTPSFPTD | X | P42263 | ||
2156 | 2200 | ERYEGYCVDLAYEI | X | P42263 | ||
2157 | 2201 | FAFLLESTMNEYIE | X | P42263 | ||
2158 | 2202 | FVYLYDTERGFSIL | X | P42263 | ||
2159 | 2203 | GFSILQAIMEAAVQ | X | P42263 | ||
2160 | 2204 | LGLLGHSHGGFPNT | X | P42263 | ||
2161 | 2205 | NITGFQIVNNENPM | X | P42263 | ||
2162 | 2206 | PFSDQQISNDSASS | X | P42263 | ||
2163 | 2207 | RIKYKLSIVGDGKY | X | P42263 | ||
2164 | 2208 | RKSKGKFAFLLEST | X | P42263 | ||
2165 | 2209 | RQEKRYLIDCEVER | X | P42263 | ||
2166 | 2210 | SIVGDGKYGARDPE | X | P42263 | ||
2167 | 2211 | SKGKFAFLLESTMN | X | P42263 | ||
2168 | 2212 | SRGVYAIFGFYDQM | X | P42263 | ||
2169 | 2213 | TQNFKPAPATNTQN | X | P42263 | ||
2170 | 2214 | VTPSFPTDADVQFV | X | P42263 | ||
2171 | 2215 | YKLSIVGDGKYGAR | X | P42263 | ||
2172 | 2216 | KFAFLLESTMNEYI | X | P42263 | ||
2173 | 2217 | VRKSKGKFAFLLES | X | P42263 | ||
2174 | 2218 | GKFAFLLESTMNEY | X | P42263 | ||
2175 | 2219 | DGRKFFFIRAIPQG | X | P42658 | ||
2176 | 2220 | ENDLDESQVPDQPS | X | P43146 | ||
2177 | 2221 | LDESQVPDQPSSLH | X | P43146 | ||
2178 | 2222 | NPLLPPPMSAIEPK | X | P43146 | ||
2179 | 2223 | VPDLSTPMLPPVGV | X | P43146 | ||
2180 | 2224 | ADHLKAEDTDF | X | P43681 | ||
2181 | 2225 | CCAEIYPDITY | X | P43681 | ||
2182 | 2226 | DAVGTYNTRKY | X | P43681 | ||
2183 | 2227 | EDTDFSVKEDW | X | P43681 | ||
2184 | 2228 | FWESGEWVIVD | X | P43681 | ||
2185 | 2229 | GTYNTRKYECCAEI | X | P43681 | ||
2186 | 2230 | KKLFSGYNKWSRPV | X | P43681 | ||
2187 | 2231 | KSPSDQLPPQQPLE | X | P43681 | ||
2188 | 2232 | LDFWESGEWVI | X | P43681 | ||
2189 | 2233 | LLLMKRPSVVK | X | P43681 | ||
2190 | 2234 | LMKRPSVVKDN | X | P43681 | ||
2191 | 2235 | NVTSIRIPSEL | X | P43681 | ||
2192 | 2236 | RKYECCAEIYP | X | P43681 |
2193 | 2237 | RSRSIQYCVPR | X | P43681 | ||
2194 | 2238 | RWDPADYENVT | X | P43681 | ||
2195 | 2239 | SCSIDVTFFPFDQQ | X | P43681 | ||
2196 | 2240 | TGLLRASSHVETRA | X | P43681 | ||
2197 | 2241 | VGLFLPPWLAG | X | P43681 | ||
2198 | 2242 | YECCAEIYPDI | X | P43681 | ||
2199 | 2243 | YNKWSRPVANISDV | X | P43681 | ||
2200 | 2244 | ADGQAAGALASRN | X | P43681 | ||
2201 | 2245 | LPPPDQP | X | P43681 | ||
2202 | 2246 | LPPPDQPSPCKCT | X | P43681 | ||
2203 | 2247 | PPPDQPS | X | P43681 | ||
2204 | 2248 | SIQYCVPRDDAAP | X | P43681 | ||
2205 | 2249 | TPPAIYK | X | P43681 | ||
2206 | 2250 | WDPADYE | X | P43681 | ||
2207 | 2251 | DDGTLLYTMRLTVQ | X | P47869 | ||
2208 | 2252 | GLGDSITEVFTNIY | X | P47869 | ||
2209 | 2253 | MHLEDFPMDAHSCP | X | P47869 | ||
2210 | 2254 | SRLNQYDLLGQSIG | X | P47869 | ||
2211 | 2255 | VMIQNNAYAVAVAN | X | P47869 | ||
2212 | 2256 | VQAECPMHLEDFPM | X | P47869 | ||
2213 | 2257 | AVCAQSVNDPSNMS | X | P47870 | ||
2214 | 2258 | LMGCFVFVFMALLE | X | P47870 | ||
2215 | 2259 | TLEIKNEMATSEAV | X | P47870 | ||
2216 | 2260 | VNDPSNMSLVKETV | X | P47870 | ||
2217 | 2261 | DLARVPANSTSNIL | X | P48167 | ||
2218 | 2262 | DIYVTSFGPVSDVE | X | P48169 | ||
2219 | 2263 | NKESVPARTVFGIT | X | P48169 | ||
2220 | 2264 | TGKLSATPPPSAPP | X | P48169 | ||
2221 | 2265 | VCLNESPGQNQKEE | X | P48169 | ||
2222 | 2266 | AGVLTIAMPVPVIV | X | P48547 | ||
2223 | 2267 | AHSHFDYDPRADEF | X | P48547 | ||
2224 | 2268 | ALAGVLTIAMPVPV | X | P48547 | ||
2225 | 2269 | CPADVCGPLYEEEL | X | P48547 | ||
2226 | 2270 | DTCPLAQEEILEIN | X | P48547 | ||
2227 | 2271 | DVCGPLYEEELAFW | X | P48547 | ||
2228 | 2272 | EVGLSGLSSKAAKD | X | P48547 | ||
2229 | 2273 | GALCALAGVLTIAM | X | P48547 | ||
2230 | 2274 | HILNYYRTGKLHCP | X | P48547 | ||
2231 | 2275 | KLHCPADVCGPLYE | X | P48547 | ||
2232 | 2276 | LAGVLTIAMPVPVI | X | P48547 | ||
2233 | 2277 | LCALAGVLTIAMPV | X | P48547 | ||
2234 | 2278 | SLAMAKQKLPKKKK | X | P48547 | ||
2235 | 2279 | KQKLPKKKKKHIPR | X | P48547 | ||
2236 | 2280 | SHFDYDPRADEFFF | X | P48547 | ||
2237 | 2281 | YSLAMAKQKLPKKK | X | P48547 | ||
2238 | 2282 | FKQFKTQYSTRVVT | X | P48664 | ||
2239 | 2283 | RTENGSEPGASMPP | X | P48664 | ||
2240 | 2284 | TLQEMLSFEETVPV | X | P48664 | ||
2241 | 2285 | EITIGAEPKETTED | X | P49418 | ||
2242 | 2286 | LFTMQTDQSMICNL | X | P49418 | ||
2243 | 2287 | QDAGWLVGVKESDW | X | P49418 | ||
2244 | 2288 | FRNFTSATQALTEW | X | P51168 | ||
2245 | 2289 | GEPYSPCTVNGSEV | X | P51168 | ||
2246 | 2290 | NYDSLRLQPLDVIE | X | P51168 | ||
2247 | 2291 | EEEYNPFLVSSTGA | X | P51170 | ||
2248 | 2292 | GLQVILYINEEEYN | X | P51170 | ||
2249 | 2293 | ILYINEEEYNPFLV | X | P51170 | ||
2250 | 2294 | INEEEYNPFLVSST | X | P51170 | ||
2251 | 2295 | LQVILYINEEEYNP | X | P51170 | ||
2252 | 2296 | QVPLEKKINMSYSA | X | P51170 | ||
2253 | 2297 | RPGITHGVGLVLRV | X | P51172 | ||
2254 | 2298 | DAVNESGRVEFGSY | X | P51787 | ||
2255 | 2299 | GARLNRVEDKVTQL | X | P51787 | ||
2256 | 2300 | HITCDPPEERRLDH | X | P51787 | ||
2257 | 2301 | SYADALWWGVVTVT | X | P51787 | ||
2258 | 2302 | PKKSVVVKKKKFKL | X | P51787 | ||
2259 | 2303 | SPKPKKSVVVKKKK | X | P51787 | ||
2260 | 2304 | FNRQIPAAASLIQT | X | P51787 | ||
2261 | 2305 | QKHFNRQIPAAASL | X | P51787 | ||
2262 | 2306 | QLEDACEHLAEYLE | X | P54284 | ||
2263 | 2307 | QCPPESFDVILDEN | X | P54284 | ||
2264 | 2308 | CGNCSRIFHGEKLM | X | P54289 | ||
2265 | 2309 | CSRIFHGEKLMNTN | X | P54289 | ||
2266 | 2310 | DCKRNSDVMDC | X | P54289 | ||
2267 | 2311 | DDFVNVASFNS | X | P54289 | ||
2268 | 2312 | DIKRLTPRFTL | X | P54289 | ||
2269 | 2313 | ENPETYEDSFY | X | P54289 | ||
2270 | 2314 | FRTLVKSQDERYID | X | P54289 | ||
2271 | 2315 | FTLCPNGYYFAIDP | X | P54289 | ||
2272 | 2316 | GEKLMNTNLIFIMV | X | P54289 | ||
2273 | 2317 | GRFFGEIDPSL | X | P54289 | ||
2274 | 2318 | IEDANFGRQIS | X | P54289 | ||
2275 | 2319 | IFHGEKLMNTNLIF | X | P54289 | ||
2276 | 2320 | IFIMVESKGTCPCD | X | P54289 | ||
2277 | 2321 | IPSIGAIRINTQEY | X | P54289 | ||
2278 | 2322 | LCPNGYYFAID | X | P54289 | ||
2279 | 2323 | LIGPSSEEPFPSAV | X | P54289 | ||
2280 | 2324 | PNGYYFAIDPN | X | P54289 | ||
2281 | 2325 | QEYLDVLGRPM | X | P54289 | ||
2282 | 2326 | QIGRFFGEIDP | X | P54289 | ||
2283 | 2327 | RIKPVFIEDANFGR | X | P54289 | ||
2284 | 2328 | SLSKQSCITEQ | X | P54289 | ||
2285 | 2329 | SSEEPFPSAVT | X | P54289 | ||
2286 | 2330 | TLSDDDFVNVASFN | X | P54289 | ||
2287 | 2331 | TLTLFQSLLIG | X | P54289 | ||
2288 | 2332 | TLVKSQDERYI | X | P54289 | ||
2289 | 2333 | VCFDNNVLEDY | X | P54289 | ||
2290 | 2334 | VEMEDDDFTAS | X | P54289 | ||
2291 | 2335 | VKSQDERYIDK | X | P54289 |
2292 | 2336 | DYCNDLKISDNNTE | X | P54289 | ||
2293 | 2337 | HGEKLMNTNLIFIM | X | P54289 | ||
2294 | 2338 | PDNFEESGYTFIAP | X | P54289 | ||
2295 | 2339 | TLKPDNFEESGYTF | X | P54289 | ||
2296 | 2340 | VLNELNWTSALDEV | X | P54289 | ||
2297 | 2341 | ALLGISFFALPAGI | X | P56696 | ||
2298 | 2342 | CVIDFIVFVASVAV | X | P56696 | ||
2299 | 2343 | ELVALTAVQSEQGE | X | P56696 | ||
2300 | 2344 | HQELANECLLILEF | X | P56696 | ||
2301 | 2345 | LANECLLILEFVMI | X | P56696 | ||
2302 | 2346 | MIVVFGLEYIVRVW | X | P56696 | ||
2303 | 2347 | PRAELVALTAVQSE | X | P56696 | ||
2304 | 2348 | PSKQHLAPPTMPTS | X | P56696 | ||
2305 | 2349 | QTLSISRSVSTNMD | X | P56696 | ||
2306 | 2350 | RIRMGSSQRRTGPS | X | P56696 | ||
2307 | 2351 | YQCELTVDDIMPAV | X | P56696 | ||
2308 | 2352 | AELVALTAVQSEQG | X | P56696 | ||
2309 | 2353 | VALTAVQSEQGEAG | X | P56696 | ||
2310 | 2354 | EYFLEPEINLVTEN | X | P62955 | ||
2311 | 2355 | LEPEINLVTENTEN | X | P62955 | ||
2312 | 2356 | CFVFCFCALLEFAV | X | P78334 | ||
2313 | 2357 | IAICFVFCFCALLE | X | P78334 | ||
2314 | 2358 | KCQKEAKRSSADKG | X | P78348 | ||
2315 | 2359 | KRSSADKGVALSLD | X | P78348 | ||
2316 | 2360 | AAETQPVTDAS | X | Q00975 | ||
2317 | 2361 | AAETQPVTDASPMK | X | Q00975 | ||
2318 | 2362 | AEEVMLAEEDRNAE | X | Q00975 | ||
2319 | 2363 | AGPREAESGEE | X | Q00975 | ||
2320 | 2364 | ALEQHLPDGDKTPM | X | Q00975 | ||
2321 | 2365 | ASCEALYSEMDPEE | X | Q00975 | ||
2322 | 2366 | CAVGSPFARAS | X | Q00975 | ||
2323 | 2367 | CEALYSEMDPE | X | Q00975 | ||
2324 | 2368 | CRGQYLDYEKEEVE | X | Q00975 | ||
2325 | 2369 | CRRERERRQER | X | Q00975 | ||
2326 | 2370 | DEFIRVWAEYDPAA | X | Q00975 | ||
2327 | 2371 | EATVVPSGNVD | X | Q00975 | ||
2328 | 2372 | ETQPVTDASPM | X | Q00975 | ||
2329 | 2373 | FYDAPYEYELM | X | Q00975 | ||
2330 | 2374 | GPGGGERARGGGAG | X | Q00975 | ||
2331 | 2375 | GPLGEATVVPS | X | Q00975 | ||
2332 | 2376 | ITRRGPDGEPQ | X | Q00975 | ||
2333 | 2377 | KELERDCRGQYLDY | X | Q00975 | ||
2334 | 2378 | KHSVDATYEEQ | X | Q00975 | ||
2335 | 2379 | KQNCFTVNRSLFVF | X | Q00975 | ||
2336 | 2380 | LCEGDTECREY | X | Q00975 | ||
2337 | 2381 | LFGGQFNFQDE | X | Q00975 | ||
2338 | 2382 | LGEATVVPSGN | X | Q00975 | ||
2339 | 2383 | LPDGDKTPMSE | X | Q00975 | ||
2340 | 2384 | LTFEEAVATNS | X | Q00975 | ||
2341 | 2385 | LTKDEEEMEEA | X | Q00975 | ||
2342 | 2386 | MKFYDAPYEYE | X | Q00975 | ||
2343 | 2387 | MPRLAAETQPV | X | Q00975 | ||
2344 | 2388 | NAQELTKDEEE | X | Q00975 | ||
2345 | 2389 | PDEMTVGKVYA | X | Q00975 | ||
2346 | 2390 | PEAAEAPEGVD | X | Q00975 | ||
2347 | 2391 | PLVVELGRDGA | X | Q00975 | ||
2348 | 2392 | PVGDFPCGKEA | X | Q00975 | ||
2349 | 2393 | RDCRGQYLDYE | X | Q00975 | ||
2350 | 2394 | REPRRHRAHRH | X | Q00975 | ||
2351 | 2395 | RLCEGDTECREYWP | X | Q00975 | ||
2352 | 2396 | RPPLERGHSTEIPV | X | Q00975 | ||
2353 | 2397 | RRGPDGEPQPGLES | X | Q00975 | ||
2354 | 2398 | RVAYKRLVRMNMPI | X | Q00975 | ||
2355 | 2399 | SADMDGAPSSA | X | Q00975 | ||
2356 | 2400 | SERGRGPGPEG | X | Q00975 | ||
2357 | 2401 | SFYFIVLTLFGNYT | X | Q00975 | ||
2358 | 2402 | SLEKGPSLSAD | X | Q00975 | ||
2359 | 2403 | SSSSSEKQRFY | X | Q00975 | ||
2360 | 2404 | SVSWGTQRTQD | X | Q00975 | ||
2361 | 2405 | TGCRRERERRQ | X | Q00975 | ||
2362 | 2406 | THLCSTTPDRP | X | Q00975 | ||
2363 | 2407 | VFLRQKSSTSLSNG | X | Q00975 | ||
2364 | 2408 | VLKHSVDATYE | X | Q00975 | ||
2365 | 2409 | VLMMKFYDAPYEYE | X | Q00975 | ||
2366 | 2410 | VMLTGPLGEATVVP | X | Q00975 | ||
2367 | 2411 | VRFGDELGGRY | X | Q00975 | ||
2368 | 2412 | VYAALMIFDFY | X | Q00975 | ||
2369 | 2413 | YKRLVRMNMPI | X | Q00975 | ||
2370 | 2414 | GGAIQNQESGIKES | X | Q00975 | ||
2371 | 2415 | GIKIIALGFVFHKG | X | Q00975 | ||
2372 | 2416 | HHHRCHRRRDRKQR | X | Q00975 | ||
2373 | 2417 | NLANAQELTKDEEE | X | Q00975 | ||
2374 | 2418 | QERRQPSSSSSEKQ | X | Q00975 | ||
2375 | 2419 | RNVTRMGSQPPDPN | X | Q00975 | ||
2376 | 2420 | SSSSSEKQRFYSCD | X | Q00975 | ||
2377 | 2421 | ALAIYIPFPED | X | Q01668 | ||
2378 | 2422 | ANCVALAIYIPFPE | X | Q01668 | ||
2379 | 2423 | CLAMQHYEQSKMFN | X | Q01668 | ||
2380 | 2424 | CLGEQEYFSSEECY | X | Q01668 | ||
2381 | 2425 | CQAISKSKLSRRWR | X | Q01668 | ||
2382 | 2426 | CVALAIYIPFPEDD | X | Q01668 | ||
2383 | 2427 | DACDLTIDEME | X | Q01668 | ||
2384 | 2428 | DDDSPVCYDSRRSP | X | Q01668 | ||
2385 | 2429 | DDSNSTNHNLE | X | Q01668 | ||
2386 | 2430 | DDYREEDEDKD | X | Q01668 | ||
2387 | 2431 | DEEPDPGRDEEDLA | X | Q01668 | ||
2388 | 2432 | DFGPGYSDEEP | X | Q01668 | ||
2389 | 2433 | DIFILLAIFANCVA | X | Q01668 | ||
2390 | 2434 | DPESDYNPGEE | X | Q01668 | ||
2391 | 2435 | DPYPPCDVPVGEEE | X | Q01668 | ||
2392 | 2436 | DVPVGEEEEEE | X | Q01668 | ||
2393 | 2437 | DVPVGEEEEEEEED | X | Q01668 | ||
2394 | 2438 | EDKDPYPPCDVPVG | X | Q01668 | ||
2395 | 2439 | EEEEEDEPEVP | X | Q01668 |
2396 | 2440 | EEEEEEEDEPE | X | Q01668 | ||
2397 | 2441 | EEEEEEEDEPEVPA | X | Q01668 | ||
2398 | 2442 | EEPDPGRDEED | X | Q01668 | ||
2399 | 2443 | EKVEYAFLIIFTVE | X | Q01668 | ||
2400 | 2444 | EPEETKREEED | X | Q01668 | ||
2401 | 2445 | EQEYFSSEECY | X | Q01668 | ||
2402 | 2446 | EQEYFSSEECYEDD | X | Q01668 | ||
2403 | 2447 | ESDYNPGEEYT | X | Q01668 | ||
2404 | 2448 | ETESVNTENVSGEG | X | Q01668 | ||
2405 | 2449 | EVPAGPRPRRI | X | Q01668 | ||
2406 | 2450 | EYFSSEECYED | X | Q01668 | ||
2407 | 2451 | FGIQSSAISVV | X | Q01668 | ||
2408 | 2452 | FLEDDDSPVCY | X | Q01668 | ||
2409 | 2453 | FNFECLRRQSSQEE | X | Q01668 | ||
2410 | 2454 | FQCITMEGWTDVLY | X | Q01668 | ||
2411 | 2455 | FRNTILGYFDY | X | Q01668 | ||
2412 | 2456 | GCHKLINHHIF | X | Q01668 | ||
2413 | 2457 | GEEEEEEEEDE | X | Q01668 | ||
2414 | 2458 | GGEEGKRNTSMPTS | X | Q01668 | ||
2415 | 2459 | GYSDEEPDPGRDEE | X | Q01668 | ||
2416 | 2460 | HPQGFLEDDDS | X | Q01668 | ||
2417 | 2461 | HVNSDRRDSLQ | X | Q01668 | ||
2418 | 2462 | IADACDLTIDEMES | X | Q01668 | ||
2419 | 2463 | ILNMVFTGVFTVEM | X | Q01668 | ||
2420 | 2464 | ILYKDGDVDSP | X | Q01668 | ||
2421 | 2465 | IPFPEDDSNSTNHN | X | Q01668 | ||
2422 | 2466 | IVAEEDPAPCA | X | Q01668 | ||
2423 | 2467 | KGKFYRCTDEAKSN | X | Q01668 | ||
2424 | 2468 | KQRSADSLVEA | X | Q01668 | ||
2425 | 2469 | KRQQYAKSKKQGNS | X | Q01668 | ||
2426 | 2470 | KSKLSRRWRRW | X | Q01668 | ||
2427 | 2471 | KVTIDDYREED | X | Q01668 | ||
2428 | 2472 | LEEDLKGYLDW | X | Q01668 | ||
2429 | 2473 | LFILYKDGDVD | X | Q01668 | ||
2430 | 2474 | LKMTTFGAFLH | X | Q01668 | ||
2431 | 2475 | LQDDEPEETKREEE | X | Q01668 | ||
2432 | 2476 | LQDFGPGYSDEEPD | X | Q01668 | ||
2433 | 2477 | LREKQQLEEDL | X | Q01668 | ||
2434 | 2478 | LSRRWRRWNRFNRR | X | Q01668 | ||
2435 | 2479 | LTIDEMESAASTLL | X | Q01668 | ||
2436 | 2480 | MMKKMQHQRQQQAD | X | Q01668 | ||
2437 | 2481 | MPTSETESVNTENV | X | Q01668 | ||
2438 | 2482 | MVFTGVFTVEM | X | Q01668 | ||
2439 | 2483 | NKVTIDDYREEDED | X | Q01668 | ||
2440 | 2484 | NMKEKIAPIPE | X | Q01668 | ||
2441 | 2485 | NMKEKIAPIPEGSA | X | Q01668 | ||
2442 | 2486 | NSDRRDSLQQT | X | Q01668 | ||
2443 | 2487 | PCDVPVGEEEE | X | Q01668 | ||
2444 | 2488 | PDPGRDEEDLADEM | X | Q01668 | ||
2445 | 2489 | PEDDSNSTNHN | X | Q01668 | ||
2446 | 2490 | PEDDSNSTNHNLEK | X | Q01668 | ||
2447 | 2491 | PPASDTEKPLFPPA | X | Q01668 | ||
2448 | 2492 | PPCDVPVGEEEEEE | X | Q01668 | ||
2449 | 2493 | PTSETESVNTENVS | X | Q01668 | ||
2450 | 2494 | PVGEEEEEEEE | X | Q01668 | ||
2451 | 2495 | QGFLEDDDSPV | X | Q01668 | ||
2452 | 2496 | QKLREKQQLEE | X | Q01668 | ||
2453 | 2497 | QLFKGKFYRCTDEA | X | Q01668 | ||
2454 | 2498 | QTVLSWQAAID | X | Q01668 | ||
2455 | 2499 | QVPTSTNANLNNAN | X | Q01668 | ||
2456 | 2500 | RAVIKKIWKKT | X | Q01668 | ||
2457 | 2501 | RGLFILYKDGDVDS | X | Q01668 | ||
2458 | 2502 | RSDSGDEQLPT | X | Q01668 | ||
2459 | 2503 | SELNMKEKIAPIPE | X | Q01668 | ||
2460 | 2504 | SQRKRQQYAKSKKQ | X | Q01668 | ||
2461 | 2505 | SRRSPRRRLLP | X | Q01668 | ||
2462 | 2506 | SSKQTVLSWQAAID | X | Q01668 | ||
2463 | 2507 | TESVNTENVSGEGE | X | Q01668 | ||
2464 | 2508 | TETILVELEIM | X | Q01668 | ||
2465 | 2509 | TIDDYREEDED | X | Q01668 | ||
2466 | 2510 | TSETESVNTEN | X | Q01668 | ||
2467 | 2511 | VETFLKIIAYG | X | Q01668 | ||
2468 | 2512 | VGEEEEEEEEDEPE | X | Q01668 | ||
2469 | 2513 | VIKKIWKKTSM | X | Q01668 | ||
2470 | 2514 | WITQAEDIDPE | X | Q01668 | ||
2471 | 2515 | YAFLIIFTVET | X | Q01668 | ||
2472 | 2516 | YAFTAIFTVEI | X | Q01668 | ||
2473 | 2517 | YFDYAFTAIFTVEI | X | Q01668 | ||
2474 | 2518 | YFRDPHCLGEQEYF | X | Q01668 | ||
2475 | 2519 | SMPTSETESVNTEN | X | Q01668 | ||
2476 | 2520 | AEDIDPENEEEGGE | X | Q01668 | ||
2477 | 2521 | CDLQDDEPEETKRE | X | Q01668 | ||
2478 | 2522 | EDDSNSTNHNLEKV | X | Q01668 | ||
2479 | 2523 | ESVNTENVSGEGEN | X | Q01668 | ||
2480 | 2524 | GEEEEEEEEDEPEV | X | Q01668 | ||
2481 | 2525 | IDDYREEDEDKDPY | X | Q01668 | ||
2482 | 2526 | ITQAEDIDPENEEE | X | Q01668 | ||
2483 | 2527 | LLDQVVPPAGDDEV | X | Q01668 | ||
2484 | 2528 | PASDTEKPLFPPAG | X | Q01668 | ||
2485 | 2529 | PCDVPVGEEEEEEE | X | Q01668 | ||
2486 | 2530 | QDFGPGYSDEEPDP | X | Q01668 | ||
2487 | 2531 | QGFLEDDDSPVCYD | X | Q01668 | ||
2488 | 2532 | RLFRVMRLVKLLSR | X | Q01668 | ||
2489 | 2533 | RQQYAKSKKQGNSS | X | Q01668 | ||
2490 | 2534 | VPPAGDDEVTVGKF | X | Q01668 | ||
2491 | 2535 | VPVGEEEEEEEEDE | X | Q01668 | ||
2492 | 2536 | GFLQEFSKEERDPV | X | Q02246 | ||
2493 | 2537 | GVSSSEMNVTWEPV | X | Q02246 | ||
2494 | 2538 | QLNLAAEDTRLFAP | X | Q02246 | ||
2495 | 2539 | SGLSGGGGAPGELI | X | Q02246 | ||
2496 | 2540 | TFTWTLDDFPIDFD | X | Q02246 | ||
2497 | 2541 | AQCPPEMFDIILDE | X | Q02641 | ||
2498 | 2542 | DACEHLAEYLEAYW | X | Q02641 | ||
2499 | 2543 | DMETDPSEGPG | X | Q02641 | ||
2500 | 2544 | EEDYEEELTDNRNR | X | Q02641 | ||
2501 | 2545 | EKLAQCPPEMFDII | X | Q02641 | ||
2502 | 2546 | GRFKRSDGSTSSDT | X | Q02641 | ||
2503 | 2547 | PPARQGSWEDE | X | Q02641 | ||
2504 | 2548 | PQGKYSKRKGRFKR | X | Q02641 | ||
2505 | 2549 | QGPYLASGDQPLER | X | Q02641 | ||
2506 | 2550 | RGPYPPSQEIPMEV | X | Q02641 | ||
2507 | 2551 | TPPARQGSWEDEEE | X | Q02641 | ||
2508 | 2552 | YLASGDQPLER | X | Q02641 | ||
2509 | 2553 | ARQGSWEDEEEDYE | X | Q02641 | ||
2510 | 2554 | DADTPGSRNSAYTE | X | Q02641 | ||
2511 | 2555 | EDEEEDYEEELTDN | X | Q02641 | ||
2512 | 2556 | GSWEDEEEDYEEEL | X | Q02641 | ||
2513 | 2557 | NVGYNPSPGDEVPV | X | Q02641 | ||
2514 | 2558 | RNKARYCAEGGGPV | X | Q02641 | ||
2515 | 2559 | TPGSRNSAYTELGD | X | Q02641 |
2516 | 2560 | KRSDGSTSSDTTSN | X | Q02641 | ||
2517 | 2561 | ADVCGPLFEEELTF | X | Q03721 | ||
2518 | 2562 | LRDLPLQHSPEAAC | X | Q03721 | ||
2519 | 2563 | RREVETEPILTYIE | X | Q03721 | ||
2520 | 2564 | HCPADVCGPLFEEE | X | Q03721 | ||
2521 | 2565 | CCPDTLDFVKNLLN | X | Q03721 | ||
2522 | 2566 | DHTDFKNIPIGFWW | X | Q03721 | ||
2523 | 2567 | EELTFWGIDETDVE | X | Q03721 | ||
2524 | 2568 | FLVRIVCCPDTLDF | X | Q03721 | ||
2525 | 2569 | KQKLPKKRKKHVPR | X | Q03721 | ||
2526 | 2570 | LFEEELTFWGIDET | X | Q03721 | ||
2527 | 2571 | TLEFLVRIVCCPDT | X | Q03721 | ||
2528 | 2572 | AGGQKCTVSIN | X | Q04844 | ||
2529 | 2573 | ALVLFSVGSSLIFL | X | Q04844 | ||
2530 | 2574 | AYTENGEWAID | X | Q04844 | ||
2531 | 2575 | AYTENGEWAIDFCP | X | Q04844 | ||
2532 | 2576 | CCVDAVNFVAE | X | Q04844 | ||
2533 | 2577 | DTEAYTENGEWAID | X | Q04844 | ||
2534 | 2578 | IFRSQTYNAEEVEF | X | Q04844 | ||
2535 | 2579 | LGVLLLLGLLG | X | Q04844 | ||
2536 | 2580 | NNYDPGSRPVREPE | X | Q04844 | ||
2537 | 2581 | PPRRASSVGLL | X | Q04844 | ||
2538 | 2582 | SQTYNAEEVEF | X | Q04844 | ||
2539 | 2583 | TYNAEEVEFTF | X | Q04844 | ||
2540 | 2584 | VCAVEVTYFPFDWQ | X | Q04844 | ||
2541 | 2585 | VDAVNFVAEST | X | Q04844 | ||
2542 | 2586 | VGLLLRAEELILKK | X | Q04844 | ||
2543 | 2587 | VRCCVDAVNFV | X | Q04844 | ||
2544 | 2588 | VRCCVDAVNFVAES | X | Q04844 | ||
2545 | 2589 | KKPRSELVFEGQR | X | Q04844 | ||
2546 | 2590 | LGAAAPEVRCCVD | X | Q04844 | ||
2547 | 2591 | LGLLGRGVGKNEE | X | Q04844 | ||
2548 | 2592 | NAEEVEFTFAVDN | X | Q04844 | ||
2549 | 2593 | TENGEWAIDFCPG | X | Q04844 | ||
2550 | 2594 | TLTTSVW | X | Q04844 | ||
2551 | 2595 | YSLIIRR | X | Q04844 | ||
2552 | 2596 | ERESKAEKVLQFDP | X | Q05586 | ||
2553 | 2597 | FSWGVLLNSGIGEG | X | Q05586 | ||
2554 | 2598 | GETEKPRGYQMSTR | X | Q05586 | ||
2555 | 2599 | GINDPRLRNPSDKF | X | Q05586 | ||
2556 | 2600 | GSWKIQLNATSVTH | X | Q05586 | ||
2557 | 2601 | LHAFIWDSAVLEFE | X | Q05586 | ||
2558 | 2602 | LLEERESKAEKVLQ | X | Q05586 | ||
2559 | 2603 | MLYLLDRFSPFGRF | X | Q05586 | ||
2560 | 2604 | NDHFTPTPVSYTAG | X | Q05586 | ||
2561 | 2605 | PLTINNERAQYIEF | X | Q05586 | ||
2562 | 2606 | RFKVNSEEEEEDAL | X | Q05586 | ||
2563 | 2607 | RRSSKDTSTGGGRG | X | Q05586 | ||
2564 | 2608 | SDDHEGRAAQKRLE | X | Q05586 | ||
2565 | 2609 | FDPGTKNVTALLME | X | Q05586 | ||
2566 | 2610 | KLHAFIWDSAVLEF | X | Q05586 | ||
2567 | 2611 | SEEEEEDALTLSSA | X | Q05586 | ||
2568 | 2612 | LPDFMLVLIVL | X | Q05901 | ||
2569 | 2613 | SSSTYHPMAPW | X | Q05901 | ||
2570 | 2614 | TVFVINVHHRSSST | X | Q05901 | ||
2571 | 2615 | VLFENADGRFE | X | Q05901 | ||
2572 | 2616 | KEESQPV | X | Q05901 | ||
2573 | 2617 | LIVLGIPSSATTG | X | Q05901 | ||
2574 | 2618 | YFGLKISQLVDVD | X | Q05901 | ||
2575 | 2619 | ARRPPASSEQAQQE | X | Q07001 | ||
2576 | 2620 | IIRRKPLFYII | X | Q07001 | ||
2577 | 2621 | LGYISKAEEYF | X | Q07001 | ||
2578 | 2622 | NQPPPQPFPGDPYS | X | Q07001 | ||
2579 | 2623 | NVDPRAPLDSP | X | Q07001 | ||
2580 | 2624 | PASSEQAQQEL | X | Q07001 | ||
2581 | 2625 | PPASSEQAQQELFN | X | Q07001 | ||
2582 | 2626 | PPQPFPGDPYSYNV | X | Q07001 | ||
2583 | 2627 | PQPFPGDPYSY | X | Q07001 | ||
2584 | 2628 | PSPGALVRRSSSLG | X | Q07001 | ||
2585 | 2629 | QNCSLKFSSLK | X | Q07001 | ||
2586 | 2630 | RRKPLFYIINI | X | Q07001 | ||
2587 | 2631 | VEWIIIDPEGF | X | Q07001 | ||
2588 | 2632 | VRRSSSLGYISKAE | X | Q07001 | ||
2589 | 2633 | FSSLKYT | X | Q07001 | ||
2590 | 2634 | IRRKPLFYIINIL | X | Q07001 | ||
2591 | 2635 | NYNEEKDSWNRVA | X | Q07001 | ||
2592 | 2636 | PFPGDPYSYNVQD | X | Q07001 | ||
2593 | 2637 | VYNQPPPQPFPGD | X | Q07001 | ||
2594 | 2638 | AEEEPSVEPVK | X | Q08289 | ||
2595 | 2639 | DACEHLADYLEAYW | X | Q08289 | ||
2596 | 2640 | DREAVRREAERQAQ | X | Q08289 | ||
2597 | 2641 | GTSRGLSRQET | X | Q08289 | ||
2598 | 2642 | HKSKDRYCEKDGEV | X | Q08289 | ||
2599 | 2643 | QLEDACEHLADYLE | X | Q08289 | ||
2600 | 2644 | RKSTPPSSAID | X | Q08289 | ||
2601 | 2645 | RSGTSRGLSRQ | X | Q08289 | ||
2602 | 2646 | STPPSSAIDID | X | Q08289 | ||
2603 | 2647 | HDHVDHYASHRDHN | X | Q08289 | ||
2604 | 2648 | PTLASNSQGSQGDQ | X | Q08289 | ||
2605 | 2649 | VDHYASHRDHNHRD | X | Q08289 | ||
2606 | 2650 | ELGEEAMEKFREDE | X | Q09470 | ||
2607 | 2651 | KSEYMEIEEDMNNS | X | Q09470 | ||
2608 | 2652 | MFSEEIKFYELGEE | X | Q09470 | ||
2609 | 2653 | MSGENVDEASAAPG | X | Q09470 | ||
2610 | 2654 | MTVMSGENVDEASA | X | Q09470 | ||
2611 | 2655 | PLDMFSEEIKFYEL | X | Q09470 | ||
2612 | 2656 | SAAPGHPQDGSYPR | X | Q09470 | ||
2613 | 2657 | SNIFTDPFFIVETL | X | Q09470 | ||
2614 | 2658 | AAQIAQALLGAEER | X | Q12809 | ||
2615 | 2659 | ALLALTARESSVRS | X | Q12809 | ||
2616 | 2660 | CELCGYSRAEVMQR | X | Q12809 | ||
2617 | 2661 | ENCAVIYCNDGFCE | X | Q12809 | ||
2618 | 2662 | FDLLIFGSGSEELI | X | Q12809 | ||
2619 | 2663 | FLCLVDVVPVKNED | X | Q12809 | ||
2620 | 2664 | GEPLMEDCEKSSDT | X | Q12809 | ||
2621 | 2665 | IPGSPGSTELEGGF | X | Q12809 | ||
2622 | 2666 | KLPALLALTARESS | X | Q12809 | ||
2623 | 2667 | LIAHWLACIWYAIG | X | Q12809 | ||
2624 | 2668 | LQADICLHLNRSLL | X | Q12809 | ||
2625 | 2669 | LTSVGFGNVSPNTN | X | Q12809 | ||
2626 | 2670 | LVRVARKLDRYSEY | X | Q12809 | ||
2627 | 2671 | RDDLLEVLDMYPEF | X | Q12809 |
2628 | 2672 | RRRTDKDTEQPGEV | X | Q12809 | ||
2629 | 2673 | SPGSTELEGGFSRQ | X | Q12809 | ||
2630 | 2674 | SSVRSGGAGGAGAP | X | Q12809 | ||
2631 | 2675 | MIPGSPGSTELEGG | X | Q12809 | ||
2632 | 2676 | PALLALTARESSVR | X | Q12809 | ||
2633 | 2677 | PQEGPTRRLSLPGQ | X | Q12809 | ||
2634 | 2678 | PYSAAFLLKETEEG | X | Q12809 | ||
2635 | 2679 | SRQRKRKLSFRRRT | X | Q12809 | ||
2636 | 2680 | ASCYGQMERPEVPM | X | Q12879 | ||
2637 | 2681 | DQYKLYSKHFTLKD | X | Q12879 | ||
2638 | 2682 | EAKASCYGQMERPE | X | Q12879 | ||
2639 | 2683 | FTGVCSDRPGLLFS | X | Q12879 | ||
2640 | 2684 | GKAPHGPSFTIGKA | X | Q12879 | ||
2641 | 2685 | IYDAAVLNYKAGRD | X | Q12879 | ||
2642 | 2686 | KAIWLLWGLVFNNS | X | Q12879 | ||
2643 | 2687 | KEFPSGLISVSYDD | X | Q12879 | ||
2644 | 2688 | KFVKINNSTNEGMN | X | Q12879 | ||
2645 | 2689 | LAKGKAPHGPSFTI | X | Q12879 | ||
2646 | 2690 | LALLQFVGDGEMEE | X | Q12879 | ||
2647 | 2691 | LISVSYDDWDYSLE | X | Q12879 | ||
2648 | 2692 | LWLTGICHNEKNEV | X | Q12879 | ||
2649 | 2693 | NSVPVQNPKGTTSK | X | Q12879 | ||
2650 | 2694 | PHGPSFTIGKAIWL | X | Q12879 | ||
2651 | 2695 | PVQNPKGTTSKIMV | X | Q12879 | ||
2652 | 2696 | TIGKAIWLLWGLVF | X | Q12879 | ||
2653 | 2697 | VFNNSVPVQNPKGT | X | Q12879 | ||
2654 | 2698 | WGLVFNNSVPVQNP | X | Q12879 | ||
2655 | 2699 | WLLWGLVFNNSVPV | X | Q12879 | ||
2656 | 2700 | PCRKFVKINNSTNE | X | Q12879 | ||
2657 | 2701 | AAAMALSLITFIWE | X | Q12879 | ||
2658 | 2702 | SNRRVYKKMPSIES | X | Q12879 | ||
2659 | 2703 | TLPENVDFPDPYQD | X | Q12879 | ||
2660 | 2704 | GNGCPEEESKEASA | X | Q13002 | ||
2661 | 2705 | WWRGNGCPEEESKE | X | Q13002 | ||
2662 | 2706 | FAHIEEENFVNELL | X | Q13018 | ||
2663 | 2707 | FGAHLASFAHIEEE | X | Q13018 | ||
2664 | 2708 | DEAENAFLLEELFA | X | Q13018 | ||
2665 | 2709 | STVLDSMSFEAAHE | X | Q13018 | ||
2666 | 2710 | AKSRREFDEIELAY | X | Q13224 | ||
2667 | 2711 | ALDFIRRESSVYDI | X | Q13224 | ||
2668 | 2712 | CEENLFSDYISEVE | X | Q13224 | ||
2669 | 2713 | DGIAIITTAASDML | X | Q13224 | ||
2670 | 2714 | DSKIQNQLKKLQSP | X | Q13224 | ||
2671 | 2715 | EEQEDDHLSIVTLE | X | Q13224 | ||
2672 | 2716 | ELEEVLLLDMSLDD | X | Q13224 | ||
2673 | 2717 | EQEDDHLSIVTLEE | X | Q13224 | ||
2674 | 2718 | ESSMFFQFGPSIEQ | X | Q13224 | ||
2675 | 2719 | IDILKKISKSVKFT | X | Q13224 | ||
2676 | 2720 | ILQLFGDGEMEELE | X | Q13224 | ||
2677 | 2721 | IRSDVSDISTHTVT | X | Q13224 | ||
2678 | 2722 | KYYVWPRMCPETEE | X | Q13224 | ||
2679 | 2723 | LFGDGEMEELEALW | X | Q13224 | ||
2680 | 2724 | LIVSAVAVFVFEYF | X | Q13224 | ||
2681 | 2725 | NLAAFMIQEEYVDQ | X | Q13224 | ||
2682 | 2726 | PTGLISVSYDEWDY | X | Q13224 | ||
2683 | 2727 | QASVMLNIMEEYDW | X | Q13224 | ||
2684 | 2728 | SAKSRREFDEIELA | X | Q13224 | ||
2685 | 2729 | SEHSFIPEPKSSCY | X | Q13224 | ||
2686 | 2730 | SFVGWELEEVLLLD | X | Q13224 | ||
2687 | 2731 | SGVPAPWEKNLTNV | X | Q13224 | ||
2688 | 2732 | SPSAFLEPFSADVW | X | Q13224 | ||
2689 | 2733 | SQKSPPSIGIAVIL | X | Q13224 | ||
2690 | 2734 | VWPRMCPETEEQED | X | Q13224 | ||
2691 | 2735 | WEKNLTNVEWEDRS | X | Q13224 | ||
2692 | 2736 | YNNPPCEENLFSDY | X | Q13224 | ||
2693 | 2737 | FSPVGYNRCLADGR | X | Q13224 | ||
2694 | 2738 | IELAYRRRPPRSPD | X | Q13224 | ||
2695 | 2739 | EETPLFLAEPALPK | X | Q13255 | ||
2696 | 2740 | ENPNFKRICTGNES | X | Q13255 | ||
2697 | 2741 | GLRSLYPPPPPPQH | X | Q13255 | ||
2698 | 2742 | KLQSPEVRSFDDYF | X | Q13255 | ||
2699 | 2743 | MLDIVKRYNWTYVS | X | Q13255 | ||
2700 | 2744 | MPILSYPSIKEVYL | X | Q13255 | ||
2701 | 2745 | PGNGLRSLYPPPPP | X | Q13255 | ||
2702 | 2746 | STKTLYNVEEEEDA | X | Q13255 | ||
2703 | 2747 | TACKENEYVQDEFT | X | Q13255 | ||
2704 | 2748 | VQLTLVVTLIIMEP | X | Q13255 | ||
2705 | 2749 | NTEEDELEEEEEDL | X | Q13255 | ||
2706 | 2750 | REGNTEEDELEEEE | X | Q13255 | ||
2707 | 2751 | TLYNVEEEEDAQPI | X | Q13255 | ||
2708 | 2752 | CTYYAFKTRNVPAN | X | Q13255 | ||
2709 | 2753 | DIPQIAYSATSIDL | X | Q13255 | ||
2710 | 2754 | EDELEEEEEDLQAA | X | Q13255 | ||
2711 | 2755 | GLSSAMCYSALVTK | X | Q13255 | ||
2712 | 2756 | RKLRERLPKARVVV | X | Q13255 | ||
2713 | 2757 | FDTAEVYAAGKAEV | X | Q13303 | ||
2714 | 2758 | VFANRPDPNTPMEE | X | Q13303 | ||
2715 | 2759 | GAIQVLPKLSSSII | X | Q13303 | ||
2716 | 2760 | PKLSSSIIHEIDSI | X | Q13303 | ||
2717 | 2761 | QVLPKLSSSIIHEI | X | Q13303 | ||
2718 | 2762 | SSSIIHEIDSILGN | X | Q13303 | ||
2719 | 2763 | VDVVFANRPDPNTP | X | Q13303 | ||
2720 | 2764 | ALADACQMEPEEVE | X | Q13698 | ||
2721 | 2765 | DACQMEPEEVE | X | Q13698 | ||
2722 | 2766 | DFEDTEVRRSNFDN | X | Q13698 | ||
2723 | 2767 | DIGFTSVFTVE | X | Q13698 | ||
2724 | 2768 | DVILSEIDTFL | X | Q13698 | ||
2725 | 2769 | EASSFFIFSPTNKI | X | Q13698 | ||
2726 | 2770 | EHFRKFMKRQEEYY | X | Q13698 | ||
2727 | 2771 | EIEMEEMESPV | X | Q13698 | ||
2728 | 2772 | EKAVPIPEASS | X | Q13698 | ||
2729 | 2773 | FAEIEMEEMES | X | Q13698 | ||
2730 | 2774 | FRCTDLSKMTEEEC | X | Q13698 |
2731 | 2775 | GFTSVFTVEIV | X | Q13698 | ||
2732 | 2776 | GGLYCLGGGCGNVD | X | Q13698 | ||
2733 | 2777 | HFRKFMKRQEE | X | Q13698 | ||
2734 | 2778 | IEMEEMESPVFLED | X | Q13698 | ||
2735 | 2779 | IILLTIFANCVALA | X | Q13698 | ||
2736 | 2780 | KDPYPSADFPGDDE | X | Q13698 | ||
2737 | 2781 | KLLDQVIPPIGDDE | X | Q13698 | ||
2738 | 2782 | LADACQMEPEE | X | Q13698 | ||
2739 | 2783 | LDEFKAIWAEYDPE | X | Q13698 | ||
2740 | 2784 | LQFAEIEMEEM | X | Q13698 | ||
2741 | 2785 | LRHREWVHSDFHFD | X | Q13698 | ||
2742 | 2786 | LRKACISIVEWKPF | X | Q13698 | ||
2743 | 2787 | LSPRPRPLAEL | X | Q13698 | ||
2744 | 2788 | LYCLGGGCGNV | X | Q13698 | ||
2745 | 2789 | MSWITQGEVMDVED | X | Q13698 | ||
2746 | 2790 | NCVALAVYLPMPED | X | Q13698 | ||
2747 | 2791 | PLQFAEIEMEEMES | X | Q13698 | ||
2748 | 2792 | QALADACQMEP | X | Q13698 | ||
2749 | 2793 | QVIPPIGDDEV | X | Q13698 | ||
2750 | 2794 | RCTDLSKMTEE | X | Q13698 | ||
2751 | 2795 | RYDFEDTEVRR | X | Q13698 | ||
2752 | 2796 | SADFPGDDEED | X | Q13698 | ||
2753 | 2797 | SDYAPGEEYTCGTN | X | Q13698 | ||
2754 | 2798 | TFEGWPQLLYKAID | X | Q13698 | ||
2755 | 2799 | VATVENEEPSP | X | Q13698 | ||
2756 | 2800 | VFSSVHYEREF | X | Q13698 | ||
2757 | 2801 | VTFQEQGETEY | X | Q13698 | ||
2758 | 2802 | WPQLLYKAIDS | X | Q13698 | ||
2759 | 2803 | YAPGEEYTCGT | X | Q13698 | ||
2760 | 2804 | YCLGGGCGNVDPDE | X | Q13698 | ||
2761 | 2805 | DPESDYAPGEEYTC | X | Q13698 | ||
2762 | 2806 | ATVENEEPSPCART | X | Q13698 | ||
2763 | 2807 | GKFFRCTDLSKMTE | X | Q13698 | ||
2764 | 2808 | VHYEREFPEETETP | X | Q13698 | ||
2765 | 2809 | AESLTSAQKEEEEE | X | Q13936 | ||
2766 | 2810 | AGNATISTVSS | X | Q13936 | ||
2767 | 2811 | AGYPSTVSTVEGHG | X | Q13936 | ||
2768 | 2812 | AQDPKFIEVTTQEL | X | Q13936 | ||
2769 | 2813 | CKGNYITYKDGEVD | X | Q13936 | ||
2770 | 2814 | CKRLVSMNMPL | X | Q13936 | ||
2771 | 2815 | CLTLKNPIRRA | X | Q13936 | ||
2772 | 2816 | CSDSSKQTEAE | X | Q13936 | ||
2773 | 2817 | CVRARGRPSEEELQ | X | Q13936 | ||
2774 | 2818 | DMTIEEMESAADNI | X | Q13936 | ||
2775 | 2819 | EDEEEPEMPVG | X | Q13936 | ||
2776 | 2820 | EDEGMDEEKPR | X | Q13936 | ||
2777 | 2821 | ETESVNTENVA | X | Q13936 | ||
2778 | 2822 | FDIVFTTIFTIEIA | X | Q13936 | ||
2779 | 2823 | GGPSFPGMLVCIYF | X | Q13936 | ||
2780 | 2824 | GGSSAARRVRP | X | Q13936 | ||
2781 | 2825 | GSAGNATISTV | X | Q13936 | ||
2782 | 2826 | GSIVDIAITEVNPA | X | Q13936 | ||
2783 | 2827 | GSRGWPPQPVPTLR | X | Q13936 | ||
2784 | 2828 | HRISKSKFSRYWRR | X | Q13936 | ||
2785 | 2829 | KLMGSAGNATISTV | X | Q13936 | ||
2786 | 2830 | LFTVEMILKLIAFK | X | Q13936 | ||
2787 | 2831 | LTIFANCVALAIYI | X | Q13936 | ||
2788 | 2832 | LTSAQKEEEEE | X | Q13936 | ||
2789 | 2833 | MDEEKPRNMSMPTS | X | Q13936 | ||
2790 | 2834 | MHKTCYNQEGIADV | X | Q13936 | ||
2791 | 2835 | MVPSQAGAPGRQFH | X | Q13936 | ||
2792 | 2836 | NYITYKDGEVD | X | Q13936 | ||
2793 | 2837 | PEDDSNATNSN | X | Q13936 | ||
2794 | 2838 | PETTGEEDEEE | X | Q13936 | ||
2795 | 2839 | PHHLDEFKRIWAEY | X | Q13936 | ||
2796 | 2840 | PLSPAIRVQEVAWK | X | Q13936 | ||
2797 | 2841 | PVGPRPRPLSE | X | Q13936 | ||
2798 | 2842 | QKEEEEEKERK | X | Q13936 | ||
2799 | 2843 | QRKRQQYGKPK | X | Q13936 | ||
2800 | 2844 | RNMSMPTSETESVN | X | Q13936 | ||
2801 | 2845 | SAQKEEEEEKE | X | Q13936 | ||
2802 | 2846 | SITADGESPPA | X | Q13936 | ||
2803 | 2847 | SKQTEAECKGN | X | Q13936 | ||
2804 | 2848 | SRGWPPQPVPT | X | Q13936 | ||
2805 | 2849 | STEMLSYQDDENRQ | X | Q13936 | ||
2806 | 2850 | STGSNANINNA | X | Q13936 | ||
2807 | 2851 | STQRKRQQYGK | X | Q13936 | ||
2808 | 2852 | TADGESPPATK | X | Q13936 | ||
2809 | 2853 | TFDNFPQSLLT | X | Q13936 | ||
2810 | 2854 | TFTPSSYSSTGSNA | X | Q13936 | ||
2811 | 2855 | TGEEDEEEPEMPVG | X | Q13936 | ||
2812 | 2856 | TIEIALKILGNADY | X | Q13936 | ||
2813 | 2857 | TIFTNLILFFILLS | X | Q13936 | ||
2814 | 2858 | TTGEEDEEEPE | X | Q13936 | ||
2815 | 2859 | VEYLFLIIFTVEAF | X | Q13936 | ||
2816 | 2860 | VGRDWPWIYFV | X | Q13936 | ||
2817 | 2861 | VNSTYFEYLMFVLI | X | Q13936 | ||
2818 | 2862 | VSLMVPSQAGAPGR | X | Q13936 | ||
2819 | 2863 | WDGPKHGITNFDNF | X | Q13936 | ||
2820 | 2864 | YFEYLMFVLIL | X | Q13936 | ||
2821 | 2865 | YFSDPWNVFDF | X | Q13936 | ||
2822 | 2866 | YKVWYVVNSTYFEY | X | Q13936 | ||
2823 | 2867 | YLFLIIFTVEA | X | Q13936 | ||
2824 | 2868 | YPNPETTGEEDEEE | X | Q13936 | ||
2825 | 2869 | YTCSDSSKQTE | X | Q13936 | ||
2826 | 2870 | TESVNTENVAGGDI | X | Q13936 | ||
2827 | 2871 | TSETESVNTENVAG | X | Q13936 | ||
2828 | 2872 | DDSNATNSNLERVE | X | Q13936 | ||
2829 | 2873 | APGEPCPLAQEEVI | X | Q14003 | ||
2830 | 2874 | ASPIPGAPPENITN | X | Q14003 | ||
2831 | 2875 | CKPDPPPPPPPHPH | X | Q14003 | ||
2832 | 2876 | DGGLDDEAGAGGGG | X | Q14003 | ||
2833 | 2877 | DVCGPLFEEELGFW | X | Q14003 | ||
2834 | 2878 | LCFQDAGGGAGGPP | X | Q14003 | ||
2835 | 2879 | LDDEAGAGGGGLDG | X | Q14003 | ||
2836 | 2880 | LKRLCFQDAGGGAG | X | Q14003 | ||
2837 | 2881 | PDDILGSNHTYFKN | X | Q14003 | ||
2838 | 2882 | PPPQPPESPPPPPL | X | Q14003 | ||
2839 | 2883 | RGRQGASKQQPAPP | X | Q14003 |
2840 | 2884 | SNHTYFKNIPIGFW | X | Q14003 | ||
2841 | 2885 | APPENITNVEVETE | X | Q14003 | ||
2842 | 2886 | DAEEALDSFEAPDP | X | Q14003 | ||
2843 | 2887 | RFDYDPGADEFFFD | X | Q14003 | ||
2844 | 2888 | YYAERIGADPDDIL | X | Q14003 | ||
2845 | 2889 | FDAPFRPADTHNEV | X | Q14416 | ||
2846 | 2890 | GPAKKVLTLEGDLV | X | Q14416 | ||
2847 | 2891 | DSLLEVCDDYSLDD | X | Q14721 | ||
2848 | 2892 | DYWGIDEIYLESCC | X | Q14721 | ||
2849 | 2893 | EAETLREREGEEFD | X | Q14721 | ||
2850 | 2894 | ELGLLILFLAMGIM | X | Q14721 | ||
2851 | 2895 | EMCALSFSQELDYW | X | Q14721 | ||
2852 | 2896 | EPMEIVRSKACSRR | X | Q14721 | ||
2853 | 2897 | KGPSGQEKCKLENH | X | Q14721 | ||
2854 | 2898 | MNMKDAFARSIEMM | X | Q14721 | ||
2855 | 2899 | RDCNTHDSLLEVCD | X | Q14721 | ||
2856 | 2900 | RLNVGGLAHEVLWR | X | Q14721 | ||
2857 | 2901 | SAAQSKPKEELEME | X | Q14721 | ||
2858 | 2902 | SFWWATITMTTVGY | X | Q14721 | ||
2859 | 2903 | SGQEKCKLENHISP | X | Q14721 | ||
2860 | 2904 | TSSLPPEPMEIVRS | X | Q14721 | ||
2861 | 2905 | VEAVCIAWFTMEYL | X | Q14721 | ||
2862 | 2906 | YSLDDNEYFFDRHP | X | Q14721 | ||
2863 | 2907 | CDDYSLDDNEYFFD | X | Q14721 | ||
2864 | 2908 | LEVCDDYSLDDNEY | X | Q14721 | ||
2865 | 2909 | DVVFANRPDSNTPM | X | Q14722 | ||
2866 | 2910 | KMTSHVVNEIDNIL | X | Q14722 | ||
2867 | 2911 | VLPKMTSHVVNEID | X | Q14722 | ||
2868 | 2912 | FANRPDSNTPMEEI | X | Q14722 | ||
2869 | 2913 | PCCWTCEPCDGYQY | X | Q14831 | ||
2870 | 2914 | PELNVQKRKRSFKA | X | Q14831 | ||
2871 | 2915 | CWICIPCEPYEYLA | X | Q14832 | ||
2872 | 2916 | FGDGMGRYNVFNFQ | X | Q14832 | ||
2873 | 2917 | AALVRRAPQPPGRP | X | Q14957 | ||
2874 | 2918 | APVFVAYCSREEAE | X | Q14957 | ||
2875 | 2919 | CLTVVAITVFMFEY | X | Q14957 | ||
2876 | 2920 | DMVTTAGVSSSLDR | X | Q14957 | ||
2877 | 2921 | FMIQEQYIDTVSGL | X | Q14957 | ||
2878 | 2922 | IQPLTVGVNTTNPS | X | Q14957 | ||
2879 | 2923 | KLRHSVPNSSQLDF | X | Q14957 | ||
2880 | 2924 | LTVGVNTTNPSSLL | X | Q14957 | ||
2881 | 2925 | NEKNEVMSSKLDID | X | Q14957 | ||
2882 | 2926 | PAPAGDCRVHPGPV | X | Q14957 | ||
2883 | 2927 | PEPSPTGWGPPDGG | X | Q14957 | ||
2884 | 2928 | QLQVLFKVLEEYDW | X | Q14957 | ||
2885 | 2929 | RLLDVVTLELGPGG | X | Q14957 | ||
2886 | 2930 | RPFLPLFPELEDLP | X | Q14957 | ||
2887 | 2931 | RSGRPFLPLFPELE | X | Q14957 | ||
2888 | 2932 | SQTHVPILSISGGS | X | Q14957 | ||
2889 | 2933 | SVVTESWRLSLRQK | X | Q14957 | ||
2890 | 2934 | VKFNQRSVEDALTS | X | Q14957 | ||
2891 | 2935 | ATFPVGLISVVTES | X | Q14957 | ||
2892 | 2936 | FLGDGETQKLETVW | X | Q14957 | ||
2893 | 2937 | QPLTVGVNTTNPSS | X | Q14957 | ||
2894 | 2938 | VWLSGICQNEKNEV | X | Q14957 | ||
2895 | 2939 | AEEREVVVEEEDRW | X | Q15822 | ||
2896 | 2940 | AKIDLEQMEQTVDL | X | Q15822 | ||
2897 | 2941 | ALLQEGELLLS | X | Q15822 | ||
2898 | 2942 | ASGPKAEALLQEGE | X | Q15822 | ||
2899 | 2943 | CKMKFGSWTYD | X | Q15822 | ||
2900 | 2944 | FRGYNRWARPV | X | Q15822 | ||
2901 | 2945 | IDLEQMEQTVD | X | Q15822 | ||
2902 | 2946 | LESNVDAEEREVVV | X | Q15822 | ||
2903 | 2947 | LMNRPPPPVEL | X | Q15822 | ||
2904 | 2948 | NVDAEEREVVV | X | Q15822 | ||
2905 | 2949 | NVDAEEREVVVEEE | X | Q15822 | ||
2906 | 2950 | REVVVEEEDRW | X | Q15822 | ||
2907 | 2951 | RWNPTDFGNIT | X | Q15822 | ||
2908 | 2952 | WLLMNRPPPPVELC | X | Q15822 | ||
2909 | 2953 | AEALLQE | X | Q15822 | ||
2910 | 2954 | ALLQEGE | X | Q15822 | ||
2911 | 2955 | ALLQEGELLLSPH | X | Q15822 | ||
2912 | 2956 | GASGPKAEALLQE | X | Q15822 | ||
2913 | 2957 | VPPAIYKSSCSID | X | Q15822 | ||
2914 | 2958 | CEEIYTDITYS | X | Q15825 | ||
2915 | 2959 | CFHCHKSNELA | X | Q15825 | ||
2916 | 2960 | DGIETLRVPAD | X | Q15825 | ||
2917 | 2961 | DLLIIGSKVDM | X | Q15825 | ||
2918 | 2962 | EIDLLIIGSKV | X | Q15825 | ||
2919 | 2963 | ITQLANVDEVN | X | Q15825 | ||
2920 | 2964 | ITQLANVDEVNQIM | X | Q15825 | ||
2921 | 2965 | LANVDEVNQIMETN | X | Q15825 | ||
2922 | 2966 | LRWDPMEYDGI | X | Q15825 | ||
2923 | 2967 | NLWLRHIWNDY | X | Q15825 | ||
2924 | 2968 | PAIFKSSCPMDITF | X | Q15825 | ||
2925 | 2969 | SEHSPEVEDVI | X | Q15825 | ||
2926 | 2970 | TLSIVVTVFVL | X | Q15825 | ||
2927 | 2971 | VHFEVAITQLANVD | X | Q15825 | ||
2928 | 2972 | WTPPAIFKSSCPMD | X | Q15825 | ||
2929 | 2973 | YDKAEIDLLII | X | Q15825 | ||
2930 | 2974 | YKLRWDPMEYD | X | Q15825 | ||
2931 | 2975 | DMNDFWENSEWEI | X | Q15825 | ||
2932 | 2976 | ENVSDPV | X | Q15825 | ||
2933 | 2977 | EVAITQLANVDEV | X | Q15825 | ||
2934 | 2978 | LANVDEV | X | Q15825 | ||
2935 | 2979 | NLIIPCLFISFLT | X | Q15825 | ||
2936 | 2980 | QFIRPVENVSDPV | X | Q15825 | ||
2937 | 2981 | VAITQLANVDEVN | X | Q15825 | ||
2938 | 2982 | VQFIAEN | X | Q15825 | ||
2939 | 2983 | AAVATSLGRSN | X | Q15878 | ||
2940 | 2984 | ACFMNNSGILE | X | Q15878 | ||
2941 | 2985 | ADDGQFQERQSLEP | X | Q15878 | ||
2942 | 2986 | AEIREDEEEVE | X | Q15878 | ||
2943 | 2987 | AKEPTIQEERAQDL | X | Q15878 | ||
2944 | 2988 | AKEVSPMSAPN | X | Q15878 | ||
2945 | 2989 | ALEQHLPEDDKTPM | X | Q15878 | ||
2946 | 2990 | ALEVLRRATIK | X | Q15878 | ||
2947 | 2991 | APNMPSIERDR | X | Q15878 | ||
2948 | 2992 | CEPDTTAPSGQ | X | Q15878 | ||
2949 | 2993 | DEFVRVWAEYD | X | Q15878 | ||
2950 | 2994 | DSHASDCGEEE | X | Q15878 | ||
2951 | 2995 | EDEEEVEKKKQ | X | Q15878 | ||
2952 | 2996 | EPYLALHEDSH | X | Q15878 |
2953 | 2997 | EQGDKMMEECS | X | Q15878 | ||
2954 | 2998 | FMNNSGILEGF | X | Q15878 | ||
2955 | 2999 | FRDLWNILDFV | X | Q15878 | ||
2956 | 3000 | FRPGTSFGISV | X | Q15878 | ||
2957 | 3001 | GDKMMEECSLE | X | Q15878 | ||
2958 | 3002 | GDSDQSRNRQGTPV | X | Q15878 | ||
2959 | 3003 | GQFQERQSLEP | X | Q15878 | ||
2960 | 3004 | GWPQVLQHSVDVTE | X | Q15878 | ||
2961 | 3005 | HGAKEPTIQEE | X | Q15878 | ||
2962 | 3006 | HHLDEFVRVWAEYD | X | Q15878 | ||
2963 | 3007 | HNQPQWLTHLL | X | Q15878 | ||
2964 | 3008 | IAASSIALAAEDPV | X | Q15878 | ||
2965 | 3009 | KDEQEEEEAFN | X | Q15878 | ||
2966 | 3010 | KEAEIREDEEE | X | Q15878 | ||
2967 | 3011 | KEAEIREDEEEVEK | X | Q15878 | ||
2968 | 3012 | KRLVLMNMPVA | X | Q15878 | ||
2969 | 3013 | KVAYKRLVLMNMPV | X | Q15878 | ||
2970 | 3014 | KVKKQRQQLEE | X | Q15878 | ||
2971 | 3015 | LGATWNWLYFI | X | Q15878 | ||
2972 | 3016 | LGLALEKFEEE | X | Q15878 | ||
2973 | 3017 | LPYLQQDPVSG | X | Q15878 | ||
2974 | 3018 | LVLMNMPVAED | X | Q15878 | ||
2975 | 3019 | MSFLKLFRAAR | X | Q15878 | ||
2976 | 3020 | PNGHYRRRRRGGPG | X | Q15878 | ||
2977 | 3021 | PPLRHSWQMPN | X | Q15878 | ||
2978 | 3022 | PSLYRRPRAIE | X | Q15878 | ||
2979 | 3023 | QPQWLTHLLYY | X | Q15878 | ||
2980 | 3024 | QSRSPSEGRSQ | X | Q15878 | ||
2981 | 3025 | QWLTHLLYYAE | X | Q15878 | ||
2982 | 3026 | RSPSEGRSQTP | X | Q15878 | ||
2983 | 3027 | SPMSAPNMPSI | X | Q15878 | ||
2984 | 3028 | SPPLGLGKRCP | X | Q15878 | ||
2985 | 3029 | TTESTSVTVAIPDV | X | Q15878 | ||
2986 | 3030 | VHHNQPQWLTH | X | Q15878 | ||
2987 | 3031 | VLTEQEPEGSS | X | Q15878 | ||
2988 | 3032 | VQPSNHGIYLP | X | Q15878 | ||
2989 | 3033 | WHFVVSPSFEY | X | Q15878 | ||
2990 | 3034 | YKRLVLMNMPVAED | X | Q15878 | ||
2991 | 3035 | EQKNAPMFQRMEPS | X | Q15878 | ||
2992 | 3036 | AIPDVDPLVDSTVV | X | Q15878 | ||
2993 | 3037 | HRQSQRRSRHRRVR | X | Q15878 | ||
2994 | 3038 | IFDFITVIGSITEI | X | Q15878 | ||
2995 | 3039 | LAEENKNAGTSALE | X | Q15878 | ||
2996 | 3040 | QALESNNACLTESS | X | Q15878 | ||
2997 | 3041 | RARHRQSQRRSRHR | X | Q15878 | ||
2998 | 3042 | TEQEPEGSSEQALL | X | Q15878 | ||
2999 | 3043 | ADCPMRLVNFPMDG | X | Q16445 | ||
3000 | 3044 | AGFNLVYWVVYLSK | X | Q16445 | ||
3001 | 3045 | IKSNTGEYVIMTVY | X | Q16445 | ||
3002 | 3046 | WLCIILWLENALGK | X | Q16445 | ||
3003 | 3047 | RAPILQSTPVTPPP | X | Q16445 | ||
3004 | 3048 | IFFEALNYETIEQK | X | Q16515 | ||
3005 | 3049 | TIEQKKAYEVAALL | X | Q16515 | ||
3006 | 3050 | TISHTVNVPLQTTL | X | Q16515 | ||
3007 | 3051 | DSTTYAHFLFNAFD | X | Q6PIL6 | ||
3008 | 3052 | YAQNSTKRSIKERL | X | Q6PIL6 | ||
3009 | 3053 | ISSKVPKAEYIPTI | X | Q6X4W1 | ||
3010 | 3054 | SLVSNGCYEGSLSE | X | Q6X4W1 | ||
3011 | 3055 | AGYWNEYERFVP | X | P42263 | ||
3012 | 3056 | FSPYEWHLEDNNEE | X | P42263 | ||
3013 | 3057 | YEWHLEDNNEEPRD | X | P42263 | ||
3014 | 3058 | NYNSVDLSEVEWED | X | Q7Z3S7 | ||
3015 | 3059 | AHGLLDPYNAF | X | Q8IZS8 | ||
3016 | 3060 | DQGPVLMTTVAMPV | X | Q8IZS8 | ||
3017 | 3061 | DTLGDDDFFNIIAY | X | Q8IZS8 | ||
3018 | 3062 | DVLRNAMVNRK | X | Q8IZS8 | ||
3019 | 3063 | EFDADLQYEYF | X | Q8IZS8 | ||
3020 | 3064 | EPDENGVIAFDCRN | X | Q8IZS8 | ||
3021 | 3065 | FFNIIAYNEEL | X | Q8IZS8 | ||
3022 | 3066 | FRGNVTIEEGL | X | Q8IZS8 | ||
3023 | 3067 | GDDDFFNIIAYNEE | X | Q8IZS8 | ||
3024 | 3068 | GSFVYSIPFSTGPV | X | Q8IZS8 | ||
3025 | 3069 | IMLITDGAVDT | X | Q8IZS8 | ||
3026 | 3070 | KEYEKDVAIEE | X | Q8IZS8 | ||
3027 | 3071 | KEYEKDVAIEEIDG | X | Q8IZS8 | ||
3028 | 3072 | LALNKSENSDK | X | Q8IZS8 | ||
3029 | 3073 | LPQAQKLTDDQGPV | X | Q8IZS8 | ||
3030 | 3074 | LRNAMVNRKTG | X | Q8IZS8 | ||
3031 | 3075 | LVDVSGSMKGLRLT | X | Q8IZS8 | ||
3032 | 3076 | NERDKDGNFLE | X | Q8IZS8 | ||
3033 | 3077 | NIIAYNEELHYVEP | X | Q8IZS8 | ||
3034 | 3078 | NNLPVNISLSD | X | Q8IZS8 | ||
3035 | 3079 | NYSSVDLSEVE | X | Q8IZS8 | ||
3036 | 3080 | PVLMTTVAMPV | X | Q8IZS8 | ||
3037 | 3081 | QLVKKLAKNMEEMF | X | Q8IZS8 | ||
3038 | 3082 | QYPGIKWEPDE | X | Q8IZS8 | ||
3039 | 3083 | SILDTLGDDDFFNI | X | Q8IZS8 | ||
3040 | 3084 | SQAIMLITDGAVDT | X | Q8IZS8 | ||
3041 | 3085 | THPELRLLYEE | X | Q8IZS8 | ||
3042 | 3086 | TSLALNKSENS | X | Q8IZS8 | ||
3043 | 3087 | TVSSILDTLGDDDF | X | Q8IZS8 | ||
3044 | 3088 | VIDQEHDVVWTEAY | X | Q8IZS8 | ||
3045 | 3089 | VSEDYTQTGDF | X | Q8IZS8 | ||
3046 | 3090 | YWTSLALNKSENSD | X | Q8IZS8 | ||
3047 | 3091 | EAYWTSLALNKSEN | X | Q8IZS8 | ||
3048 | 3092 | LALNKSENSDKGVE | X | Q8IZS8 | ||
3049 | 3093 | WTSLALNKSENSDK | X | Q8IZS8 | ||
3050 | 3094 | AECYLQLHNFPMDE | X | Q8N1C3 | ||
3051 | 3095 | GNCVDKADDEDDED | X | Q8N1C3 | ||
3052 | 3096 | LHLGNCVDKADDED | X | Q8N1C3 | ||
3053 | 3097 | TISGDYVIMTIFFD | X | Q8N1C3 | ||
3054 | 3098 | YLQLHNFPMDEHSC | X | Q8N1C3 | ||
3055 | 3099 | VDKADDEDDEDLTV | X | Q8N1C3 | ||
3056 | 3100 | CASTLPDWRNAAAD | X | Q8TAE7 | ||
3057 | 3101 | LEVCDDYDRERNEY | X | Q8TAE7 | ||
3058 | 3102 | RDVLEVCDDYDRER | X | Q8TAE7 |
3059 | 3103 | RMRRTFEEPTSSLA | X | Q8TAE7 | ||
3060 | 3104 | RSERDVLEVCDDYD | X | Q8TAE7 | ||
3061 | 3105 | CDDYDRERNEYFFD | X | Q8TAE7 | ||
3062 | 3106 | SARYSRSLSTEFLN | X | Q8TAE7 | ||
3063 | 3107 | IFEITTQFGVMPPE | X | Q8TCU5 | ||
3064 | 3108 | IPLPPRRRELPALR | X | Q8TCU5 | ||
3065 | 3109 | LDAFIMDKALLDYE | X | Q8TCU5 | ||
3066 | 3110 | NNFFIWNLQHDPMG | X | Q8TCU5 | ||
3067 | 3111 | PFVFTREVDDEGLC | X | Q8TCU5 | ||
3068 | 3112 | QELQLAVSRKTELE | X | Q8TCU5 | ||
3069 | 3113 | QLGIRIHQDIPLPP | X | Q8TCU5 | ||
3070 | 3114 | RSQVIDFTSPFFST | X | Q8TCU5 | ||
3071 | 3115 | RWVLGDSQNVEELR | X | Q8TCU5 | ||
3072 | 3116 | TMNCMEVETTNLTS | X | Q8TCU5 | ||
3073 | 3117 | TNGKADSLNVSRNS | X | Q8TCU5 | ||
3074 | 3118 | ADSLNVSRNSVMQE | X | Q8TCU5 | ||
3075 | 3119 | NGKADSLNVSRNSV | X | Q8TCU5 | ||
3076 | 3120 | DIDPEIETECFFVE | X | Q8TDD5 | ||
3077 | 3121 | ECLFSLINGDDMFA | X | Q8TDD5 | ||
3078 | 3122 | CDDYDEDSQEFFFD | X | Q8TDN1 | ||
3079 | 3123 | EEIVQLCDDYDEDS | X | Q8TDN1 | ||
3080 | 3124 | DLRRFARSALNLVD | X | Q8TDN2 | ||
3081 | 3125 | EEDEDGEEEDQWKD | X | Q8TDN2 | ||
3082 | 3126 | KDDLAEEDQQAGEV | X | Q8TDN2 | ||
3083 | 3127 | RRSWSYRPWNTTEN | X | Q8TDN2 | ||
3084 | 3128 | AAGGAGGGGGGGGG | X | Q8WXS5 | ||
3085 | 3129 | AGLAGAGGGGG | X | Q8WXS5 | ||
3086 | 3130 | DTDYDHDSAEY | X | Q8WXS5 | ||
3087 | 3131 | FGGAAGGAGGGGGG | X | Q8WXS5 | ||
3088 | 3132 | GAGGGGGGAVG | X | Q8WXS5 | ||
3089 | 3133 | GAGGGGGGGGGAGA | X | Q8WXS5 | ||
3090 | 3134 | GGGGGAGAERD | X | Q8WXS5 | ||
3091 | 3135 | GGGGGGGGAGAERD | X | Q8WXS5 | ||
3092 | 3136 | HFPEDTDYDHD | X | Q8WXS5 | ||
3093 | 3137 | INHFPEDTDYD | X | Q8WXS5 | ||
3094 | 3138 | LYTRALICNTTNLT | X | Q8WXS5 | ||
3095 | 3139 | NHFPEDTDYDHDSA | X | Q8WXS5 | ||
3096 | 3140 | PSYRFRYRRRS | X | Q8WXS5 | ||
3097 | 3141 | RALICNTTNLT | X | Q8WXS5 | ||
3098 | 3142 | RGVCVKINHFP | X | Q8WXS5 | ||
3099 | 3143 | RLPSYRFRYRR | X | Q8WXS5 | ||
3100 | 3144 | SDLLKAGGGAG | X | Q8WXS5 | ||
3101 | 3145 | VTVTVTGPPAP | X | Q8WXS5 | ||
3102 | 3146 | YRFRYRRRSRS | X | Q8WXS5 | ||
3103 | 3147 | YTRALICNTTN | X | Q8WXS5 | ||
3104 | 3148 | AILRLPSYRFRYRR | X | Q8WXS5 | ||
3105 | 3149 | EPGPKRDEEKKNHY | X | Q8WXS5 | ||
3106 | 3150 | FRYRRRSRSSSRSS | X | Q8WXS5 | ||
3107 | 3151 | HFPEDTDYDHDSAE | X | Q8WXS5 | ||
3108 | 3152 | KINHFPEDTDYDHD | X | Q8WXS5 | ||
3109 | 3153 | SYRFRYRRRSRSSS | X | Q8WXS5 | ||
3110 | 3154 | CNTHESLLEVCDDY | X | Q92953 | ||
3111 | 3155 | DDEDFLELPGAREE | X | Q92953 | ||
3112 | 3156 | DGTLEYAPVDITVN | X | Q92953 | ||
3113 | 3157 | ERPSAYEEEIEMEE | X | Q92953 | ||
3114 | 3158 | HQKKEQMNEELRRE | X | Q92953 | ||
3115 | 3159 | LFPFSSRERRSFTE | X | Q92953 | ||
3116 | 3160 | NFKENRGSAPQTPP | X | Q92953 | ||
3117 | 3161 | RERRSFTEIDTGDD | X | Q92953 | ||
3118 | 3162 | SAYEEEIEMEEVVC | X | Q92953 | ||
3119 | 3163 | TEIDTGDDEDFLEL | X | Q92953 | ||
3120 | 3164 | CDDYNLNENEYFFD | X | Q92953 | ||
3121 | 3165 | SFTSCATDFTETER | X | Q92953 | ||
3122 | 3166 | SIDSFTSCATDFTE | X | Q92953 | ||
3123 | 3167 | ASEEQARRLCDDYD | X | Q96KK3 | ||
3124 | 3168 | AVRNSNHQEFEDLL | X | Q96KK3 | ||
3125 | 3169 | FEDLLSSIDGVSEA | X | Q96KK3 | ||
3126 | 3170 | RRLCDDYDEAAREF | X | Q96KK3 | ||
3127 | 3171 | ARYGAARCGRLRRR | X | Q96KK3 | ||
3128 | 3172 | ASLETSRETSQEGQ | X | Q96KK3 | ||
3129 | 3173 | IDGVSEASLETSRE | X | Q96KK3 | ||
3130 | 3174 | DEEEEEEGEEEEAV | X | Q96L42 | ||
3131 | 3175 | DLSPRIVDGIEDGN | X | Q96L42 | ||
3132 | 3176 | EEEEGEEEEAVSLS | X | Q96L42 | ||
3133 | 3177 | HQPCLHLQTGGAAY | X | Q96L42 | ||
3134 | 3178 | IEDGNSSEESQTFD | X | Q96L42 | ||
3135 | 3179 | IVEDEEEEEEGEEE | X | Q96L42 | ||
3136 | 3180 | LEYFQTTWSVNNGI | X | Q96L42 | ||
3137 | 3181 | LPSIVEDEEEEEEG | X | Q96L42 | ||
3138 | 3182 | MQKSCSCKFLFGVE | X | Q96L42 | ||
3139 | 3183 | NKRLPSIVEDEEEE | X | Q96L42 | ||
3140 | 3184 | NNTLGGPSIRSAYI | X | Q96L42 | ||
3141 | 3185 | PEYAHKFVEDIQHD | X | Q96L42 | ||
3142 | 3186 | PRIVDGIEDGNSSE | X | Q96L42 | ||
3143 | 3187 | RLLRLLQKLDRYSQ | X | Q96L42 | ||
3144 | 3188 | SCSCKFLFGVETNE | X | Q96L42 | ||
3145 | 3189 | SSLTSVGFGNVSAN | X | Q96L42 | ||
3146 | 3190 | VDGIEDGNSSEESQ | X | Q96L42 | ||
3147 | 3191 | VSRSNSPKTKQEID | X | Q96L42 | ||
3148 | 3192 | EEEEEEGEEEEAVS | X | Q96L42 | ||
3149 | 3193 | GSWNQEGMASASTK | X | Q96L42 | ||
3150 | 3194 | KIFSICTMLIGALM | X | Q96L42 | ||
3151 | 3195 | NLPGSWNQEGMASA | X | Q96L42 | ||
3152 | 3196 | PSIVEDEEEEEEGE | X | Q96L42 | ||
3153 | 3197 | SLTSVGFGNVSANT | X | Q96L42 | ||
3154 | 3198 | SVGFGNVSANTDAE | X | Q96L42 | ||
3155 | 3199 | VEDEEEEEEGEEEE | X | Q96L42 | ||
3156 | 3200 | ADVCGPLFEEELAF | X | Q96PR1 | ||
3157 | 3201 | APPLSPGPGGCFEG | X | Q96PR1 | ||
3158 | 3202 | DLAAKRLGIEDAAG | X | Q96PR1 | ||
3159 | 3203 | PLFEEELAFWGIDE | X | Q96PR1 | ||
3160 | 3204 | PSPPPLSPPPRAPP | X | Q96PR1 | ||
3161 | 3205 | QYEIETDPALTYVE | X | Q96PR1 | ||
3162 | 3206 | TPDLIGGDPGDDED | X | Q96PR1 | ||
3163 | 3207 | LRFETRARTLGRFP | X | Q96RP8 | ||
3164 | 3208 | YWQEFEDTCVYECL | X | Q99928 | ||
3165 | 3209 | DSTDASSIEDNEDI | X | Q9BQ31 | ||
3166 | 3210 | SEFQNEDGEVDDPV | X | Q9BQ31 | ||
3167 | 3211 | CHEDWKRLARV | X | Q9GZZ6 |
3168 | 3212 | HYCGPSVRPVP | X | Q9GZZ6 | ||
3169 | 3213 | ILIMNLHYCGPSVR | X | Q9GZZ6 | ||
3170 | 3214 | PELSPSPQSPE | X | Q9GZZ6 | ||
3171 | 3215 | PVPAWARALLL | X | Q9GZZ6 | ||
3172 | 3216 | QEALLHHVATIANT | X | Q9GZZ6 | ||
3173 | 3217 | RGAAASLADFV | X | Q9GZZ6 | ||
3174 | 3218 | RGEPCGQSRPPELS | X | Q9GZZ6 | ||
3175 | 3219 | TLYLWIRQEWT | X | Q9GZZ6 | ||
3176 | 3220 | ILIMNLHYCGPSV | X | Q9GZZ6 | ||
3177 | 3221 | MDERNQV | X | Q9GZZ6 | ||
3178 | 3222 | PPELSPSPQSPEG | X | Q9GZZ6 | ||
3179 | 3223 | QSRPPELSPSPQS | X | Q9GZZ6 | ||
3180 | 3224 | RPPELSPSPQSPE | X | Q9GZZ6 | ||
3181 | 3225 | RPVPAWARALLLG | X | Q9GZZ6 | ||
3182 | 3226 | RRRAAAY | X | Q9GZZ6 | ||
3183 | 3227 | SPSPQSP | X | Q9GZZ6 | ||
3184 | 3228 | SRPPELSPSPQSP | X | Q9GZZ6 | ||
3185 | 3229 | TYGCCSEPYPDVT | X | Q9GZZ6 | ||
3186 | 3230 | VRPRGAA | X | Q9GZZ6 | ||
3187 | 3231 | VRPVPAWARALLL | X | Q9GZZ6 | ||
3188 | 3232 | WARALLL | X | Q9GZZ6 | ||
3189 | 3233 | YLWIRQE | X | Q9GZZ6 | ||
3190 | 3234 | RVSSDLSRILQLLQ | X | Q9H252 | ||
3191 | 3235 | SNDLALVPIASETT | X | Q9H252 | ||
3192 | 3236 | VFTPYSAAFLLSDQ | X | Q9H252 | ||
3193 | 3237 | AVSRLAQALLGAEE | X | Q9H252 | ||
3194 | 3238 | FTPYSAAFLLSDQD | X | Q9H252 | ||
3195 | 3239 | KHRSSSTTEIEIIA | X | Q9H252 | ||
3196 | 3240 | VAILGKNDIFGEPV | X | Q9H252 | ||
3197 | 3241 | QSHPETLFKSIPQS | X | Q9H3M0 | ||
3198 | 3242 | VLAILPFYVSLTLT | X | Q9H3M0 | ||
3199 | 3243 | IRIMKFHVAKRKFK | X | Q9NR82 | ||
3200 | 3244 | PFECEQTSDYQSPV | X | Q9NR82 | ||
3201 | 3245 | AFRGASKGCLRALA | X | Q9NS40 | ||
3202 | 3246 | DLHKIQREDLLEVL | X | Q9NS40 | ||
3203 | 3247 | EDPDVVVIDSSKHS | X | Q9NS40 | ||
3204 | 3248 | FNHIKSSLLGSTSD | X | Q9NS40 | ||
3205 | 3249 | GIGKASGLDFEETV | X | Q9NS40 | ||
3206 | 3250 | GLDFEETVPTSGRM | X | Q9NS40 | ||
3207 | 3251 | GLHRHVSDPGLPGK | X | Q9NS40 | ||
3208 | 3252 | GTIIRKFEGQNKKF | X | Q9NS40 | ||
3209 | 3253 | IIAPKVKDRTHNVT | X | Q9NS40 | ||
3210 | 3254 | KASGLDFEETVPTS | X | Q9NS40 | ||
3211 | 3255 | LDRYSEYGAAVLML | X | Q9NS40 | ||
3212 | 3256 | LQKQTTVVPPAYSM | X | Q9NS40 | ||
3213 | 3257 | LQLLQKQTTVVPPA | X | Q9NS40 | ||
3214 | 3258 | NFRTTYVNQNEEVV | X | Q9NS40 | ||
3215 | 3259 | QTTVVPPAYSMVTA | X | Q9NS40 | ||
3216 | 3260 | REDLLEVLDMYPEF | X | Q9NS40 | ||
3217 | 3261 | RRASSVHDIEGFGV | X | Q9NS40 | ||
3218 | 3262 | SSSFISSIDDEQKP | X | Q9NS40 | ||
3219 | 3263 | VNISGPLDHSSPKR | X | Q9NS40 | ||
3220 | 3264 | VVPPAYSMVTAGSE | X | Q9NS40 | ||
3221 | 3265 | YCNDGFCEMTGFSR | X | Q9NS40 | ||
3222 | 3266 | GISETESDLTYGEV | X | Q9NS40 | ||
3223 | 3267 | KKNSSPPSSDKTII | X | Q9NS40 | ||
3224 | 3268 | KSRSSSFISSIDDE | X | Q9NS40 | ||
3225 | 3269 | IAQIAQALLGSEER | X | Q9NS40 | ||
3226 | 3270 | QEQLNRLESQMTTD | X | Q9NS40 | ||
3227 | 3271 | EENFKQIYSQFFPQ | X | Q9NS61 | ||
3228 | 3272 | GRKESLSDSRDLDG | X | Q9NS61 | ||
3229 | 3273 | SLSGVLVIALPVPV | X | Q9NSA2 | ||
3230 | 3274 | LGYTLKSCASELGF | X | Q9NSA2 | ||
3231 | 3275 | SLLSSCCPRRAKRR | X | Q9NSA2 | ||
3232 | 3276 | ARTCGASRPGP | X | Q9NY47 | ||
3233 | 3277 | DAELDDPESED | X | Q9NY47 | ||
3234 | 3278 | DALLRPLELEN | X | Q9NY47 | ||
3235 | 3279 | DDDYVNVASFN | X | Q9NY47 | ||
3236 | 3280 | DMVIIVDVSGS | X | Q9NY47 | ||
3237 | 3281 | EDVERGSKASTLRL | X | Q9NY47 | ||
3238 | 3282 | ELDDPESEDVE | X | Q9NY47 | ||
3239 | 3283 | FEKYNWPNRTV | X | Q9NY47 | ||
3240 | 3284 | HAQRLTNTNLL | X | Q9NY47 | ||
3241 | 3285 | HQDALLRPLEL | X | Q9NY47 | ||
3242 | 3286 | KADAELDDPES | X | Q9NY47 | ||
3243 | 3287 | KAHRWQDNIKEEDI | X | Q9NY47 | ||
3244 | 3288 | LGANGYVFAID | X | Q9NY47 | ||
3245 | 3289 | PTVADFLNLAWWTS | X | Q9NY47 | ||
3246 | 3290 | QIPTDIYKGSTVIL | X | Q9NY47 | ||
3247 | 3291 | RWQDNIKEEDIVYY | X | Q9NY47 | ||
3248 | 3292 | SSPKDMVIIVDVSG | X | Q9NY47 | ||
3249 | 3293 | TCGASRPGPAR | X | Q9NY47 | ||
3250 | 3294 | WARRLEQEVDG | X | Q9NY47 | ||
3251 | 3295 | YRRGPHICFDY | X | Q9NY47 | ||
3252 | 3296 | YVFKPPHQDAL | X | Q9NY47 | ||
3253 | 3297 | YVNVASFNEKAQPV | X | Q9NY47 | ||
3254 | 3298 | CKDLNASDNNTEFL | X | Q9NY47 | ||
3255 | 3299 | TLVKSLDERYIDEV | X | Q9NY47 | ||
3256 | 3300 | LEDLQDLDSLDTEK | X | Q9NZQ8 | ||
3257 | 3301 | DTLLGSSERDFFYH | X | Q9NZV8 | ||
3258 | 3302 | EQVFEESCMEVATV | X | Q9NZV8 | ||
3259 | 3303 | ETQQYFFDRDPDIF | X | Q9NZV8 | ||
3260 | 3304 | FEESCMEVATVNRP | X | Q9NZV8 | ||
3261 | 3305 | HECISAYDEELAFF | X | Q9NZV8 | ||
3262 | 3306 | KTTNHEFVDEQVFE | X | Q9NZV8 | ||
3263 | 3307 | NHEFVDEQVFEESC | X | Q9NZV8 | ||
3264 | 3308 | PFARAAAIGWMPVA | X | Q9NZV8 | ||
3265 | 3309 | YHPETQQYFFDRDP | X | Q9NZV8 | ||
3266 | 3310 | YPRHECISAYDEEL | X | Q9NZV8 | ||
3267 | 3311 | YVTTAIISIPTPPV | X | Q9NZV8 | ||
3268 | 3312 | KRRAQKKARLARIR | X | Q9NZV8 | ||
3269 | 3313 | LDTACVMIFTVEYL | X | Q9NZV8 | ||
3270 | 3314 | LVMTDNEDVSGAFV | X | Q9NZV8 | ||
3271 | 3315 | YIGLVMTDNEDVSG | X | Q9NZV8 | ||
3272 | 3316 | AGGGGAGSEHS | X | Q9P0X4 | ||
3273 | 3317 | ANYRWVHHKYN | X | Q9P0X4 | ||
3274 | 3318 | DATPHTLVQPIPAT | X | Q9P0X4 | ||
3275 | 3319 | DEEEIDYTLCF | X | Q9P0X4 | ||
3276 | 3320 | DEGRHLGSRHCQTL | X | Q9P0X4 | ||
3277 | 3321 | DNRDSVDLAELVPA | X | Q9P0X4 | ||
3278 | 3322 | DRGDRGEDEEEIDY | X | Q9P0X4 | ||
3279 | 3323 | DRGEDEEEIDYTLC | X | Q9P0X4 | ||
3280 | 3324 | DSSQAPPSPFS | X | Q9P0X4 | ||
3281 | 3325 | DVYKPDWCEVREDW | X | Q9P0X4 | ||
3282 | 3326 | ECCLSKDDVYD | X | Q9P0X4 | ||
3283 | 3327 | EDGASSELGKEEEE | X | Q9P0X4 | ||
3284 | 3328 | EDQSSSNIEEF | X | Q9P0X4 | ||
3285 | 3329 | EEEEEEQADGA | X | Q9P0X4 | ||
3286 | 3330 | FNPVRSWLKHDSSQ | X | Q9P0X4 |
3287 | 3331 | GAGGGGAGSEHSET | X | Q9P0X4 | ||
3288 | 3332 | GASSELGKEEE | X | Q9P0X4 | ||
3289 | 3333 | GEDEEEIDYTL | X | Q9P0X4 | ||
3290 | 3334 | GKEEEEEEQAD | X | Q9P0X4 | ||
3291 | 3335 | GKFYHCLGVDTRNI | X | Q9P0X4 | ||
3292 | 3336 | GSLQTTLEDSLTLS | X | Q9P0X4 | ||
3293 | 3337 | GSSAGGEDEAD | X | Q9P0X4 | ||
3294 | 3338 | KDPPGRAPLPM | X | Q9P0X4 | ||
3295 | 3339 | KEAQEDAEMDAELE | X | Q9P0X4 | ||
3296 | 3340 | KFSLRTDTGDTVPD | X | Q9P0X4 | ||
3297 | 3341 | KMGDRGDRGEDEEE | X | Q9P0X4 | ||
3298 | 3342 | LDAVAVDQQPV | X | Q9P0X4 | ||
3299 | 3343 | LDSSGDPKLCPIPM | X | Q9P0X4 | ||
3300 | 3344 | LEGELTIIDNL | X | Q9P0X4 | ||
3301 | 3345 | LERPQIEAGSTERI | X | Q9P0X4 | ||
3302 | 3346 | LTSLFCPPPPP | X | Q9P0X4 | ||
3303 | 3347 | LVALGSRKSSV | X | Q9P0X4 | ||
3304 | 3348 | MKHLDDSNKEA | X | Q9P0X4 | ||
3305 | 3349 | MRVGDLGECFFPLS | X | Q9P0X4 | ||
3306 | 3350 | NFLCEMEEIPF | X | Q9P0X4 | ||
3307 | 3351 | PAPGHEDCNGRMPS | X | Q9P0X4 | ||
3308 | 3352 | PDASSPLLPMPAEF | X | Q9P0X4 | ||
3309 | 3353 | PENFLCEMEEI | X | Q9P0X4 | ||
3310 | 3354 | PGLEEPLDGAD | X | Q9P0X4 | ||
3311 | 3355 | PRRALGPPAPA | X | Q9P0X4 | ||
3312 | 3356 | PSPFSPDASSP | X | Q9P0X4 | ||
3313 | 3357 | QEDAEMDAELELEM | X | Q9P0X4 | ||
3314 | 3358 | RGLRAHQRSHS | X | Q9P0X4 | ||
3315 | 3359 | RGPGGAGGGGD | X | Q9P0X4 | ||
3316 | 3360 | RILVNLLLDTL | X | Q9P0X4 | ||
3317 | 3361 | RSAAWASRRSS | X | Q9P0X4 | ||
3318 | 3362 | SAERGGGARVC | X | Q9P0X4 | ||
3319 | 3363 | SDRSSSILLGD | X | Q9P0X4 | ||
3320 | 3364 | SGDPKLCPIPMTPN | X | Q9P0X4 | ||
3321 | 3365 | SLFCPPPPPPA | X | Q9P0X4 | ||
3322 | 3366 | SLTSLFCPPPPPPA | X | Q9P0X4 | ||
3323 | 3367 | SPDASSPLLPM | X | Q9P0X4 | ||
3324 | 3368 | SSELGKEEEEE | X | Q9P0X4 | ||
3325 | 3369 | SSPLLPMPAEF | X | Q9P0X4 | ||
3326 | 3370 | TPHTLVQPIPA | X | Q9P0X4 | ||
3327 | 3371 | TVASYAEPGDCYEE | X | Q9P0X4 | ||
3328 | 3372 | VIFQVITLEGWVEI | X | Q9P0X4 | ||
3329 | 3373 | VTLGMYQPCDDMDC | X | Q9P0X4 | ||
3330 | 3374 | VYDFGAGRQDL | X | Q9P0X4 | ||
3331 | 3375 | YNGLDAVAVDQQPV | X | Q9P0X4 | ||
3332 | 3376 | ASSELGKEEEEEEQ | X | Q9P0X4 | ||
3333 | 3377 | LNSDRSSSILLGDD | X | Q9P0X4 | ||
3334 | 3378 | SYSDEDQSSSNIEE | X | Q9P0X4 | ||
3335 | 3379 | AFSLNSDRSSSILL | X | Q9P0X4 | ||
3336 | 3380 | DNLSGSIFHHYSSP | X | Q9P0X4 | ||
3337 | 3381 | DRSSSILLGDDLSL | X | Q9P0X4 | ||
3338 | 3382 | HDKQEVQLAETEAF | X | Q9P0X4 | ||
3339 | 3383 | MHIFGCKFSLRTDT | X | Q9P0X4 | ||
3340 | 3384 | SGSIFHHYSSPAGC | X | Q9P0X4 | ||
3341 | 3385 | AHICNGTNLTM | X | Q9UBN1 | ||
3342 | 3386 | FGALSFIVAETVGV | X | Q9UBN1 | ||
3343 | 3387 | GHCFRINHFPE | X | Q9UBN1 | ||
3344 | 3388 | LTTAGAFAAFS | X | Q9UBN1 | ||
3345 | 3389 | LYSSAHICNGTNLT | X | Q9UBN1 | ||
3346 | 3390 | NHFPEDNDYDH | X | Q9UBN1 | ||
3347 | 3391 | PSRDVSPMGLK | X | Q9UBN1 | ||
3348 | 3392 | RMPSYRYRRRR | X | Q9UBN1 | ||
3349 | 3393 | VAETVGVLAVN | X | Q9UBN1 | ||
3350 | 3394 | YWLYSSAHICN | X | Q9UBN1 | ||
3351 | 3395 | EDNDYDHDSSEYLL | X | Q9UBN1 | ||
3352 | 3396 | HFPEDNDYDHDSSE | X | Q9UBN1 | ||
3353 | 3397 | RINHFPEDNDYDHD | X | Q9UBN1 | ||
3354 | 3398 | SYRYRRRRSRSSSR | X | Q9UBN1 | ||
3355 | 3399 | SFAFAAISFLLTES | X | Q9UF02 | ||
3356 | 3400 | SSEASLQMNSNYPA | X | Q9UF02 | ||
3357 | 3401 | AYLTWDRDQYD | X | Q9UGM1 | ||
3358 | 3402 | CLSPHHSRERD | X | Q9UGM1 | ||
3359 | 3403 | DFIEDVEWEVH | X | Q9UGM1 | ||
3360 | 3404 | DFIEDVEWEVHGMP | X | Q9UGM1 | ||
3361 | 3405 | DIVLYNKADDE | X | Q9UGM1 | ||
3362 | 3406 | DLSDFIEDVEWEVH | X | Q9UGM1 | ||
3363 | 3407 | DLVWRPDIVLY | X | Q9UGM1 | ||
3364 | 3408 | DSGDLSDFIED | X | Q9UGM1 | ||
3365 | 3409 | DSGDLSDFIEDVEW | X | Q9UGM1 | ||
3366 | 3410 | EDYSNALRPVEDTD | X | Q9UGM1 | ||
3367 | 3411 | FQLMVAEIMPA | X | Q9UGM1 | ||
3368 | 3412 | GDLSDFIEDVE | X | Q9UGM1 | ||
3369 | 3413 | IATMALITASTALT | X | Q9UGM1 | ||
3370 | 3414 | LTKVYSKLPESNLK | X | Q9UGM1 | ||
3371 | 3415 | PAITKSSCVVD | X | Q9UGM1 | ||
3372 | 3416 | PHWARVVILKY | X | Q9UGM1 | ||
3373 | 3417 | QKLFNDLFEDY | X | Q9UGM1 | ||
3374 | 3418 | RDHLTKVYSKLPES | X | Q9UGM1 | ||
3375 | 3419 | TVFQLMVAEIMPAS | X | Q9UGM1 | ||
3376 | 3420 | VHGMPAVKNVISYG | X | Q9UGM1 | ||
3377 | 3421 | VLRYDGLITWD | X | Q9UGM1 | ||
3378 | 3422 | VVDVTYFPFDN | X | Q9UGM1 | ||
3379 | 3423 | AITKSSC | X | Q9UGM1 | ||
3380 | 3424 | DFIEDVE | X | Q9UGM1 | ||
3381 | 3425 | DLSDFIEDVEWEV | X | Q9UGM1 | ||
3382 | 3426 | DSGDLSDFIEDVE | X | Q9UGM1 | ||
3383 | 3427 | GAEARPV | X | Q9UGM1 | ||
3384 | 3428 | GDLSDFIEDVEWE | X | Q9UGM1 | ||
3385 | 3429 | LTFGSWTYNGNQV | X | Q9UGM1 |
3386 | 3430 | LYNKADDESSEPV | X | Q9UGM1 | ||
3387 | 3431 | SFLAPLS | X | Q9UGM1 | ||
3388 | 3432 | SGDLSDFIEDVEW | X | Q9UGM1 | ||
3389 | 3433 | YNGNQVD | X | Q9UGM1 | ||
3390 | 3434 | ASMDQISAITDSAE | X | Q9UHC6 | ||
3391 | 3435 | DQISAITDSAEYCE | X | Q9UHC6 | ||
3392 | 3436 | HTSVMTGSLLDDHH | X | Q9UHC6 | ||
3393 | 3437 | IYGHTSVMTGSLLD | X | Q9UHC6 | ||
3394 | 3438 | LPYRFRNKKMKTLK | X | Q9UHC6 | ||
3395 | 3439 | MQAAPRAGCGAALL | X | Q9UHC6 | ||
3396 | 3440 | NGVNRNSAIIGGVI | X | Q9UHC6 | ||
3397 | 3441 | SSRVDNAPDQQNSH | X | Q9UHC6 | ||
3398 | 3442 | VDNAPDQQNSHPDL | X | Q9UHC6 | ||
3399 | 3443 | VYSASMDQISAITD | X | Q9UHC6 | ||
3400 | 3444 | CDDYDVTCNEFFFD | X | Q9UIX4 | ||
3401 | 3445 | DASFHPAFLPQRQA | X | Q9UIX4 | ||
3402 | 3446 | EEFAEMVEREEEDD | X | Q9UIX4 | ||
3403 | 3447 | LLPGDNSDYDYSAL | X | Q9UIX4 | ||
3404 | 3448 | LLREMCALSFQEEL | X | Q9UIX4 | ||
3405 | 3449 | LNVCDDYDVTCNEF | X | Q9UIX4 | ||
3406 | 3450 | MVERPHSGLPGKVF | X | Q9UIX4 | ||
3407 | 3451 | NLSVSTLPSLREEE | X | Q9UIX4 | ||
3408 | 3452 | TNFDDILNVCDDYD | X | Q9UIX4 | ||
3409 | 3453 | TPGQVVALSSILSG | X | Q9UIX4 | ||
3410 | 3454 | EEEEQGHCSQMCHN | X | Q9UIX4 | ||
3411 | 3455 | EFPLTRLGQLKACT | X | Q9UIX4 | ||
3412 | 3456 | MVEREEEDDALDSE | X | Q9UIX4 | ||
3413 | 3457 | RVMFRRAQFLIKTK | X | Q9UIX4 | ||
3414 | 3458 | DDYDVSRDEFFFDR | X | Q9UJ96 | ||
3415 | 3459 | ECSPKCRSLFVLET | X | Q9UJ96 | ||
3416 | 3460 | GHDDLLRVCDDYDV | X | Q9UJ96 | ||
3417 | 3461 | HSATATEDSSQGPD | X | Q9UJ96 | ||
3418 | 3462 | PLARLERLRACRGH | X | Q9UJ96 | ||
3419 | 3463 | TERGAQGSPARALG | X | Q9UJ96 | ||
3420 | 3464 | LLLFLCVAMALFAP | X | Q9UJ96 | ||
3421 | 3465 | RALGPRGRLQRGRR | X | Q9UJ96 | ||
3422 | 3466 | RRCAREFGLLLLFL | X | Q9UJ96 | ||
3423 | 3467 | VCDDYDVSRDEFFF | X | Q9UJ96 | ||
3424 | 3468 | ASTSGLLQPLCVDT | X | Q9ULD8 | ||
3425 | 3469 | FDLLHAFKVNVYFG | X | Q9ULD8 | ||
3426 | 3470 | FWCLLDVIPIKNEK | X | Q9ULD8 | ||
3427 | 3471 | GIEDGCGSDQPKFS | X | Q9ULD8 | ||
3428 | 3472 | NTLMSTLEEKETDG | X | Q9ULD8 | ||
3429 | 3473 | PRRTAPRPRLGGRG | X | Q9ULD8 | ||
3430 | 3474 | RRRYGRARSKGFNA | X | Q9ULD8 | ||
3431 | 3475 | RTTFVSKSGQVVFA | X | Q9ULD8 | ||
3432 | 3476 | TVSPAPADEPSSPL | X | Q9ULD8 | ||
3433 | 3477 | TWAVNNGIDTTELL | X | Q9ULD8 | ||
3434 | 3478 | VCDLAVEVLFILDI | X | Q9ULD8 | ||
3435 | 3479 | VVDGIEDGCGSDQP | X | Q9ULD8 | ||
3436 | 3480 | YITSLYFALSSLTS | X | Q9ULD8 | ||
3437 | 3481 | LLDVIPIKNEKGEV | X | Q9ULD8 | ||
3438 | 3482 | DLCSEPSTPASPPP | X | Q9ULD8 | ||
3439 | 3483 | KHKLNKGVFGEKPN | X | Q9ULD8 | ||
3440 | 3484 | LNFRTTFVSKSGQV | X | Q9ULD8 | ||
3441 | 3485 | ATVSMTTVGYGDVV | X | Q9ULS6 | ||
3442 | 3486 | AYTIEKEENEGLAT | X | Q9ULS6 | ||
3443 | 3487 | FQIPDSQGNPGEDP | X | Q9ULS6 | ||
3444 | 3488 | GNFRRQLWLALDNP | X | Q9ULS6 | ||
3445 | 3489 | HSREAILELCDDYD | X | Q9ULS6 | ||
3446 | 3490 | STTSSFDEILAFYN | X | Q9ULS6 | ||
3447 | 3491 | VFSFSQEIEYWGIN | X | Q9ULS6 | ||
3448 | 3492 | CDDYDDVQREFYFD | X | Q9ULS6 | ||
3449 | 3493 | LELCDDYDDVQREF | X | Q9ULS6 | ||
3450 | 3494 | ACSLDLHKFPMDKQ | X | Q9UN88 | ||
3451 | 3495 | AQAPLASPESLGSL | X | Q9UN88 | ||
3452 | 3496 | FYSRGPRRQPRRHR | X | Q9UN88 | ||
3453 | 3497 | ILVCLFFVFLSLLE | X | Q9UN88 | ||
3454 | 3498 | KCDTNSTWGLNDDE | X | Q9UN88 | ||
3455 | 3499 | RGPRRQPRRHRRPR | X | Q9UN88 | ||
3456 | 3500 | PRRQPRRHRRPRRV | X | Q9UN88 | ||
3457 | 3501 | QREVNSYLVQVYWP | X | Q9UN88 | ||
3458 | 3502 | CIWYVIGRREMEAN | X | Q9UQ05 | ||
3459 | 3503 | EICFYRKDGSAFWC | X | Q9UQ05 | ||
3460 | 3504 | ELRHIMGLLQARLG | X | Q9UQ05 | ||
3461 | 3505 | HKALEGHQEHRAEI | X | Q9UQ05 | ||
3462 | 3506 | KTLPSITEAESGAE | X | Q9UQ05 | ||
3463 | 3507 | LEGHQEHRAEICFY | X | Q9UQ05 | ||
3464 | 3508 | LPRPLKQRMLEYFQ | X | Q9UQ05 | ||
3465 | 3509 | NLRQGSDTSGLSRF | X | Q9UQ05 | ||
3466 | 3510 | PSITEAESGAEPGG | X | Q9UQ05 | ||
3467 | 3511 | REILQLPLFGAASR | X | Q9UQ05 | ||
3468 | 3512 | RPSPELASEAEEVK | X | Q9UQ05 | ||
3469 | 3513 | VDGIEDSGSTAEAP | X | Q9UQ05 | ||
3470 | 3514 | VHRLPRPLKQRMLE | X | Q9UQ05 | ||
3471 | 3515 | GDALQAHYYVCSGS | X | Q9UQ05 | ||
3472 | 3516 | LPSITEAESGAEPG | X | Q9UQ05 | ||
3473 | 3517 | PYNVCFSGDDDTPI | X | Q9UQ05 | ||
3474 | 3518 | SDIAVEMLFILDII | X | Q9UQ05 | ||
3475 | 3519 | SQPRSESLGSSSDK | X | Q9UQ05 | ||
3476 | 3520 | GSDSSDSELELSTV | X | Q9Y2W7 | ||
3477 | 3521 | SSTAPQGSDSSDSE | X | Q9Y2W7 | ||
3478 | 3522 | ASPVGIKGFNT | X | Q9Y698 | ||
3479 | 3523 | FYFGALSFIIA | X | Q9Y698 | ||
3480 | 3524 | GIKGFNTLPST | X | Q9Y698 | ||
3481 | 3525 | KGFNTLPSTEISMY | X | Q9Y698 | ||
3482 | 3526 | LLFMGGLCIAASEF | X | Q9Y698 | ||
3483 | 3527 | PEDADYEADTAEYF | X | Q9Y698 | ||
3484 | 3528 | RIPSYRYRYQRRSR | X | Q9Y698 | ||
3485 | 3529 | SLHSNTANRRT | X | Q9Y698 | ||
3486 | 3530 | VHMFIDRHKQL | X | Q9Y698 | ||
3487 | 3531 | VLAVHMFIDRHKQL | X | Q9Y698 | ||
3488 | 3532 | WLYSRGVCKTKSVS | X | Q9Y698 | ||
3489 | 3533 | IKGFNTLPSTEISM | X | Q9Y698 | ||
3490 | 3534 | LLTTVGAFAAFSLM | X | Q9Y698 | ||
3491 | 3535 | PVGIKGFNTLPSTE | X | Q9Y698 | ||
3492 | 3536 | SFYFGALSFIIAEM | X | Q9Y698 |
신경학적 또는 신경정신과적 병태와 관련된 상위 자가항원의 광범위한 목록이 아래 표 2에 제공된다. 예를 들어, Pruss 2021; Garza 등 2021; Giannoccaro 등 2018; Gardoni 등 2021를 참조한다. 또한 Hansen & Timaus, 2021은 정신과적 병태, 가장 중요하게는 정신 증후군(psychiatric syndromes) 및 관련 질병을 동반한 자가면역 뇌염의 자가항체에 특별히 초점을 맞춘 검토를 제공한다. Galli 등, 2020은 부종양(paraneoplastic) 질환에서 자가항체의 역할에 대한 리뷰를 제공한다. Ma2[Ta], Hu, Ri, Yo, CV2/CRMP5, 암피피신(amphiphysin), GAD65 및 항핵(antinuclear) 항원(ANA)과 같은 세포내 항원 또는 신경계 질환의 맥락에서 TG, TPO 또는 TRAK와 같은 갑상선 조직 항원도 관련이 있다.
하기 표 3은 표 1로부터의 선택이고 본 발명의 과정에서 수행된 자가항체 스크리닝에서 발견된 표 2의 상위 자가항원에 기초한 펩타이드를 열거한다.
자가항원 ( autoantigen ) | UniProt | 관련 질병 또는 증상 |
아세틸콜린 수용체 서브유닛 알파 (Acetylcholine receptor subunit alpha) | P02708 | 중증 근무력증(Myasthenia Gravis) |
AMPA 수용체 (글루타메이트 수용체) | P42262, P42261, P42263, P48058 | 번연계 뇌염(limbic encephalitis), 발작(seizures), 기억상실(memory loss) |
암피피신(Amphiphysin) | P49418 | 번연계 뇌염(limbic encephalitis), 부종양 증후군(paraneoplastic syndr.), 강직 증후군(stiff man syndr.) |
아쿠아포린-4(Aquaporin-4) | P55087 | 시신경 척수염 (neuromyelitis optica (NMOSD)), MS |
CASPR2 | Q9UHC6 | LGI1-like, 신경근육긴장증(neuromyotonia), 모르반 증후군(Morvan's syndrome), 신경병증성 통증( neuropathic pain) |
CV2/CRMP5 | Q9BPU6 | 부종양 선조체 뇌염(Paraneoplastic striatal encephalitis), 척수염(myelitis), 시신경염(optic neuritis) 및 망막염(retinitis) |
D2R | P14416 | 파킨슨증(Parkinsonism), 무도병(chorea), 정신병(psychosis), 디스토니아(dystonia), 무언증(mutism), 정신과 증후군(psychiatric syndr), 운동 장애(movement disorders) |
DPPX | P42658 | 뇌염(encephalitis), 착란(Confusion), 환각(hallucinations), 전구 설사(prodromal diarrhoea), 기억상실(memory loss), 과흥분(hyperexcitability) |
에프린(ephrin)-B2 | P52799 | 정신과 증후군(encephalitis psychiatric syndrome) |
엽산 수용체 알파 (Folate receptor alpha) | P15328 | 자폐 스펙트럼 장애(autism spectrum disorders) |
GABAA 수용체 | P14867, P47869, P34903, P48169, P31644, Q16445 | 발작(seizures), 뇌전증중첩증(status epilepticus), 정신병(psychosis), |
GABAB 수용체 | P18505, P47870, P28472 | 번연계 뇌염(limbic encephalitis), 발작(seizures), 기억상실(memory loss) |
GAD65 | Q05329 | 뇌염(encephalitis); 발작(seizures) 및 만성 간질(chronic epilepsy ) |
글라이신 수용체(Glycine receptor) | P23415 | 뇌척수염(encephalomyelitis), 강직(rigidity), 근육간대경련(myoclonus), 발작(seizures), 강직 증후군(stiff person syndrome) |
IgLON5 | A6NGN9 | 사건수면증(parasomnia), 수면무호흡증(sleep apnoea), 인지기능장애(cognitive impairment), 보행 이상(gait abnormalities) |
LGI1 | O95970 | Limbic encephalitis (발작, 인지기능장애), 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 신경 근육 긴장(neuromyotonia) |
Ma2[Ta] | PNMA2 | 부종양 증후군(paraneoplastic syndrome) |
mGluR1 | Q13255 | 항-mGluR1 뇌염, 소뇌 운동 실조증(cerebellar ataxia) |
mGluR5 | P41594 | 복잡한 신경 정신병 증후군(neuropsychiatric syndrome)과 관련된 항-mGluR5 뇌염 |
MOG | Q16653 | 시신경염(optic neuritis), 척수염(myelitis), ADEM |
MuSK | O15146 | 중증 근무력증(Myasthenia Gravis) |
뉴렉신(Neurexin) 3α | Q9Y4C0 | 뇌염 (NMDAR 뇌염) |
NMDAR | Q05586, Q12879, Q13224, Q14957, O15399, Q8TCU5, Q5F0I5 | 뇌염(encephalitis), 정신병(psychosis), 기억상실(amnesia), 행동이상(behavioural abnormalities), 발작(seizures), 자율신경장애(dysautonomia), 자폐증(autism), 뚜렛(Tourette), ADHD |
셉틴(Septin) 5 | Q99719 | 소뇌성운동실조증(Cerebellar ataxia),동요시(oscillopsia) |
시냅신(Synapsin) | P17600 | 번연계 뇌염(limbic encephalitis) |
TDP-43 | Q13148 | ALS |
TG (thyroid) | P01266 | 갑상선 장애(thyroid disorder) |
TPO (thyroid) | P07202 | 갑상선 장애(thyroid disorder) |
TRAK (thyroid) | P16473 | 갑상선 장애(thyroid disorder) |
VGKC | Q09470 | 번연계 뇌염(limbic encephalitis) |
전압 의존적 P/Q형 칼슘 채널 서브유닛 알파-1A | O00555, Q13936, Q00975, Q01668, Q15878, O60840, O43497, O95180, Q9P0X4 | 신경학적 결손 및 림프구증가증을 동반한 두통(HaNDL) |
펩타이드 # | 펩타이드 서열 | 단백질 ( UniProt ) |
1 | GQPGAQRMYKQ | O00555 |
7 | SSPAPLGGQET | O43497 |
14 | ASAGGAKILGVLRV | O95180 |
18 | LINVDEVNQIVTTN | P02708 |
44 | AVTGVNKIELPQFS | P18505 |
61 | YTIMTAHFHLKRKI | P31644 |
72 | CTPCKENEYVFDEY | P41594 |
73 | NTQNFKPAPATNTQ | P42263 |
84 | LPSTCLQKVEEQPE | Q00975 |
87 | AMDILNMVFTGVFT | Q01668 |
96 | FIWDSAVLEFEASQ | Q05586 |
104 | AGESTFANNKSSVP | Q13224 |
112 | AGYPSTVSTVE | Q13936 |
119 | GAAHVHGIVFEDNV | Q14957 |
126 | LGRSNTIGSAP | Q15878 |
128 | LFPVAFAGFNLVYW | Q16445 |
132 | DMNFDFDLYIVGDG | Q8TCU5 |
144 | DEEGRGGAGGGGAG | Q9P0X4 |
158 | ILYAGNDRWTSDPR | A6NGN9 |
190 | AAFMIQEEYVDTVS | O15399 |
229 | CGGILETTLVE | O60840 |
323 | GKTRTSLKTMSRRK | P14416 |
330 | TWTLKKLPLSLSFL | P16473 |
380 | MAVCLLFVFSALLE | P23415 |
435 | LNQYDLLGHVVGTE | P34903 |
465 | ANQFEGNDRYEGYC | P42261 |
473 | MRSAEPSVFVRTTA | P42262 |
481 | LHRQNEEPVFSKDG | P42658 |
497 | NMQFLLFVFLVWDP | P47869 |
598 | TTVIYNSNIFTDPF | Q09470 |
603 | KFSYIPEAKASCYG | Q12879 |
626 | RERLPKARVVVCFC | Q13255 |
799 | AIRNGVNRNSAIIG | Q9UHC6 |
963 | KDNKGYCAQYRGEV | O15146 |
1348 | AYFLCLLSALLLTE | O95970 |
1642 | AVCYAFVFSALIEF | P14867 |
1952 | VVCCAQSVNDPGNM | P28472 |
2213 | AVCAQSVNDPSNMS | P47870 |
2218 | DIYVTSFGPVSDVE | P48169 |
2241 | EITIGAEPKETTED | P49418 |
상기 표 1-3 및 실시예 12에 기술된 발견에 비추어 볼 때, 특히 바람직한 구체예는 본 발명의 화합물에 관한 것이며, 여기서 적어도 하나의 펩타이드에 대해(바람직하게는 펩타이드 각각에 대해), 상기 아미노산 단편은 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다.
또 다른 바람직한 예에 따르면, 본 발명의 화합물에 사용되는 펩타이드(예를 들어, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는 서열번호 45-3536, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 더 바람직하게는 최대 1개의 아미노산이 독립적으로 다른 임의의 아미노산으로 치환된다.
다른 바람직한 구현예에 따르면, 본 발명의 화합물의 적어도 2개의 펩타이드의 각각의 아미노산 서열은 동일하다. 즉, 적어도 두 개의 펩타이드가 동일하다.
기면증(Narcolepsy) 1형은 또 다른 자가항체 관련 질병이다(예를들어, Vuorela 등, 2021 참조). 관련된 자가항원은 단백질-O-만노실트랜스퍼라제 1(POMT1), UniProt 접근 번호 Q9Y6A1인 것으로 밝혀졌다. 보다 구체적으로, 발견된 하나의 자가에피토프(autoepitope)는 UniProt 수탁 번호 Q9Y6A1의 잔기 697-711에 위치했다. 따라서, POMT1은 본 발명의 특히 바람직한 표적이다. 훨씬 더 바람직하게는, 상기 아미노산 단편은 UniProt 수탁 번호 Q9Y6A1의 잔기 697-711의 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속 아미노산을 포함하고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다.
본 발명의 전체 맥락에서, 바람직하게는, 적어도 2개의 펩타이드는 펩타이드 P1 및 펩타이드 P2를 포함하고, 여기서 P1 및 P2는 독립적으로 상기 개시된 바와 같은(표시된 신경수용체 및/또는 UniProt 등록 번호에 의해) 아미노산 서열의 6-, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 훨씬 더 바람직하게는 11-, 특히 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고, 여기서 P1 및 P2는 펩타이드 이량체 P1 - S - P2의 형태로 존재하고, 여기서 S는 비-펩타이드 스페이서이고, 여기서 펩타이드 이량체는 바람직하게는 링커를 통해 생물중합체 스캐폴드에 공유 결합된다.
본 발명의 화합물의 바람직한 구체예는 다음을 포함하는 화합물에 관한 것으로,
- 생물중합체 스캐폴드(biopolymer scaffold) 및 적어도
- 하기 화학식의 제1의 펩타이드 n-머(peptide n-mer):
P ( - S - P ) (n-1) 및
- 하기 화학식의 제2의 펩타이드 n-머:
P ( -
S -
P )
(n-1)
;
여기서, 각 경우에 독립적으로 P는 펩타이드고 S는 비-펩타이드 스페이서이고,
여기서, 각각의 펩타이드 n-머에 대해 독립적으로, n은 적어도 1, 바람직하게는 적어도 2, 더 바람직하게는 적어도 3, 특히 적어도 4의 정수이고,
여기서 각각의 펩타이드 n-머는 바람직하게는 각각 링커를 통해 생물중합체 스캐폴드에 결합된다. 이 문맥에서 "P"는 각각의 경우 독립적으로 본 발명의 화합물의 적어도 2개의 펩타이드 및/또는 상기 정의된 P1 및 P2에 대해 개시된 것과 동일한 방식으로 정의된다.
본 발명에 사용된 생물중합체 스캐폴드는 포유동물 생물중합체, 예를 들면, 사람 생물중합체, 비-사람 영장류 생물중합체, 양(sheep) 생물중합체, 돼지 생물중합체, 개 생물중합체 또는 설치류 생물중합체일 수 있다. 특히, 생물중합체 스캐폴드는 단백질, 특히 (비-변형된 또는 이의 아미노산 서열과 관련하여 비-변형된) 혈장 단백질이다. 바람직하게는, 생물중합체 스캐폴드는 포유동물 단백질, 예를 들면, 사람 단백질, 비-사람 영장류 단백질, 양 단백질, 돼지 단백질, 개 단백질 또는 설치류 단백질이다. 전형적으로, 생물중합체 스캐폴드는 바람직하게는 건강한(사람) 개인의 혈장내에서 순환하고 예컨대, 효율적으로 스캐빈징(scavenging)되거나 스캐빈징 수용체(scavenging receptor)에 의해 재순환될 수 있는, 예컨대, 골수 세포 또는 간 동모양 혈관 내피 세포에 존재하는 비-면역원성 및/또는 비-독성 단백질이다(참고: Sorensen 등, 2015).
특수한 선호도에 따라서, 생물중합체 스캐폴드는 바람직하게는 면역글로불린, 알파-글로불린, 알파2-글로불린 및 베타-글로불린, 특히 면역글로불린 G, 헤파토글로빈 및 트랜스페린으로 구성된 군으로부터 선택된, (바람직하게는 사람) 글로불린이다. 특히 헤파토글로빈은, 실시예 5 내지 9에 나타낸 바와 같은, 수 개의 유리한 특성, 특히 유리한 안전성 프로파일을 갖는다.
생물중합체 스캐폴드는 또한 (바람직하게는 사람) 알부민, 헤모펙신, 알파-1-항트립신, C1 에스테라제 억제제, 락토페린 또는 전술한 단백질, 예를 들면, 글로불린 모두의 비-면역원성(즉, 치료될 개체에서 비-면역원성) 단편일 수 있다.
또 다른 선호도에서, 생물중합체 스캐폴드는 항-CD163 항체(즉, CD163 단백질에 특이적인 항체) 또는 이의 CD163-결합 단편이다.
사람 CD163(Cluster of Differentiation 163)은 리간드 결합을 담당하는 9개의 스캐빈저 수용체 시스테인 풍부(scavenger receptor cysteine-rich, SRCR) 도메인으로 구성된 세포외 부분을 가지는 130kDa 막 당단백질(이전에는 M130이라고 함) 및 프로토타입 클래스 I 스캐빈저 수용체이다. CD163은 대식세포 및 단핵구에 존재하는 세포내 이입 수용체(endocytic receptor)이며, 혈액에서 헤모글로빈/합토글로빈 복합체를 제거하지만 항염증 과정과 상처 치유에도 역할을 한다. CD163의 가장 높은 발현 수준은 조직 대식세포(예: 간의 쿠퍼 세포)와 비장 및 골수의 특정 대식세포에서 발견된다. 조직 및 세포 특이적인 발현과 바람직하지 않은 항체의 고갈과는 전혀 관련이 없기 때문에, CD163은 예컨대, 면역독소, 리포좀 또는 기타 치료 화합물 부류의 약물 전달을 위한 대식세포 표적으로 간주된다(Skytthe 등, 2020).
모노클로날 항-CD163 항체 및 이들이 결합하는 SRCR 도메인은 예를 들어 Madsen 등, 2004, 특히 도 7에 개시되어 있다. 추가의 항-CD163 항체 및 이의 단편은 예를 들어 제WO 2002/032941 A2호 또는 제WO 2011/039510 A2호에 개시되어 있다. 도메인 특이적 항체, 예를 들어 모노클로날 항체(mAb) EDhu1를 사용하여 적어도 2개의 구조적으로 다른 리간드 결합 부위가 매핑되었다 (Madsen 등, 2004 참조). 이 항체는 CD163의 세 번째 SRCR에 결합하고 CD163에 결합하는 헤모글로빈/합토글로빈과 경쟁한다. SRCR 도메인 1, 3, 7 및 9를 각각 표적으로 하는 Mac2-158, KiM8, GHI/61 및 RM3/1을 포함하여 CD163의 다른 도메인에 대한 수많은 다른 항체가 이전에 문헌에 기술되었다. 또한, 보존된 박테리아 결합 부위가 매핑되었고 특정 항체가 박테리아 결합을 억제할 수 있지만 헤모글로빈/합토글로빈 복합체 결합은 억제할 수 없으며 그 반대도 가능하다는 것이 입증되었다. 이는 CD163의 다양한 결합 방식과 리간드 상호작용을 지시한다 (Fabriek 등, 2009; 또한, 그 인용 참조).
바람직하지 않은 항체의 고갈과는 전혀 관련이 없이, 그의 생리학적 특성 때문에 CD163은 세포 특이적 약물 전달의 표적으로 제안되었다. 종양 관련 대식세포는 현재 CD163 표적화의 잠재적 이점이 탐구되는 주요 표적 중 하나이다. 놀랍게도, 수많은 종양 및 악성종양이 CD163 발현 수준과 상관관계가 있는 것으로 나타났으며, 이는 종양 치료를 위한 이 표적의 사용을 뒷받침한다. 다른 제안된 응용에는 만성 염증 및 신경염증에서 항약물 결합체(ADC)에 의한 CD163 표적화가 포함된다 (Skytthe 등, 2020에서 검토됨). 따라서, 특히 덱사메타손 또는 스텔스 리포솜 접합체를 사용한 ADC에 의한 CD163 표적화는 현재 연구되고 있는 치료 원리를 나타낸다(Graversen 등, 2012; Etzerodt 등, 2012).
이러한 맥락에서, 항-CD163 항체가 생체 내에서 적용될 때 엔도사이토시스(endocytosis)에 의해 신속하게 내재화될 수 있음을 나타내는 참고 문헌이 있다. 이는 예를 들어 mAB Ed-2(Dijkstra 등, 1985; Graversen 등, 2012) 또는 mAB Mac2-158/KN2/NRY(Granfeldt 등, 2013)에 대해 나타났다. 본 발명(특정 실시예 섹션 참조)의 과정에서 이루어진 관찰과 조합된 이러한 관찰에 기초하여, 항-CD163 항체 및 CD163-결합은 바람직하지 않은 항체의 고갈/제거를 위한 매우 적합한 생물중합체 스캐폴드인 것으로 밝혀졌다.
수많은 항-CD163 항체 및 이의 CD163-결합 단편이 당업계에 공지되어 있다(예를 들어 상기 참조). 이들은 본 발명의 생물중합체 스캐폴드로 사용하기에 적합하다. 예를 들어, 본원 또는 제WO 2011/039510 A2호(본원에 참조로 포함됨)에 언급된 임의의 항-CD163 항체 또는 이의 단편은 본 발명에서 생체중합체 스캐폴드로 사용될 수 있다. 바람직하게는, 본 발명 화합물의 생물중합체 스캐폴드는 제WO 2011/039510 A2호에 개시된 항체 Mac2-48, Mac2-158, 5C6-FAT, BerMac3, 또는 E10B10이고, 특히 제WO 2011/039510 A2호에 개시된 사람화 Mac2-48 또는 Mac2-158이다.
바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 11-13으로 구성된 군으로부터 선택되는 하나 이상의 상보성 결정 영역(CDR) 서열을 포함하는 중쇄 가변(VH) 영역을 포함한다.
추가로 또는 이에 대안적으로, 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 14-16으로 구성된 군 또는 제WO 2011/039510 A2호의 서열번호 17-19로 구성된 군으로부터 선택되는 하나 이상의 CDR 서열을 포함하는 경쇄 가변(VL) 영역을 포함한다.
추가의 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 20의 아미노산 서열을 포함하거나 이로 구성된 중쇄 가변(VH) 영역을 포함한다.
추가로 또는 이에 대안적으로, 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 21의 아미노산 서열을 포함하거나 이로 구성된 경쇄 가변(VL) 영역을 포함한다.
추가의 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 22의 아미노산 서열을 포함하거나 이로 구성된 중쇄 가변(VH) 영역을 포함한다.
추가로 또는 이에 대안적으로, 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 23의 아미노산 서열을 포함하거나 이로 구성된 경쇄 가변(VL) 영역을 포함한다.
추가의 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 24의 아미노산 서열을 포함하거나 이로 구성된 중쇄 가변(VH) 영역을 포함한다.
추가로 또는 이에 대안적으로, 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 제WO 2011/039510 A2호의 서열번호 25의 아미노산 서열을 포함하거나 이로 구성된 경쇄 가변(VL) 영역을 포함한다.
본 발명의 맥락에서, 항-CD163 항체는 사람화 항체 또는 사람 항체, 비사람 영장류 항체, 양 항체, 돼지 항체, 개 항체 또는 설치류 항체와 같은 포유동물 항체일 수 있다. 구현예에서, 항-CD163 항체는 모노클로날일 수 있다.
선호도에 따라서, 항-CD163 항체는 IgG, IgA, IgD, IgE 및 IgM에서 선택된다.
추가의 선호도에 따라서, CD163-결합 단편은 Fab, Fab', F(ab)2, Fv, 단일 사슬 항체, 나노바디 및 항원 결합 도메인으로부터 선택된다.
CD163 아미노산 서열은 예를 들어 제WO 2011/039510 A2호(여기에 참조로 포함됨)에 개시되어 있다. 본 발명의 맥락에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 바람직하게는 사람 CD163에 대해 특이적이고, 특히 제WO 2011/039510 A2호의 서열번호 28-31 중 어느 하나의 아미노산 서열을 갖는다.
추가의 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 CD163의 세포외 영역 (예를 들어, 사람 CD163의 경우: UniProt Q86VB7의 아미노산 42-1050, 서열 버전 2)에 대해, 바람직하게는 CD163의 SRCR 도메인에 대해, 보다 바람직하게는 CD163의 SRCR 도메인 1-9 (예를 들어 사람 CD163의 경우: 각각 UniProt Q86VB7의 아미노산 51-152, 159-259, 266-366, 373-473, 478-578, 583-683, 719-819, 824-926 및 929-1029, 서열버전 2) 중 어느 하나에 대해, 심지어 보다 바람직하게는 CD163의 SRCR 도메인 1-3 (예를 들어, 사람 CD163에 경우, 각각 UniProt Q86VB7의 아미노산 51-152, 159-259, 266-366 및 373-473, 서열 버전 2) 중 어느 하나에 대해, 특히 CD163의 SRCR 도메인 1 (특히, 제WO 2011/039510 A2호의 서열번호 1-8 중 어느 하나의 아미노산 서열, 특히 제WO 2011/039510 A2호의 서열번호 1)에 대해 특이적이다.
특정 선호도에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 (바람직하게는 사람) CD163에 대한 결합에 대해 (바람직하게는 사람) 헤모글로빈-합토글로빈 복합체 (예컨대, ELISA에서)와 경쟁할 수 있다.
또 다른 특정 선호도에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 사람 CD163에 대한 결합에 대해 본원에 개시된 임의의 항-사람 CD163 mAb, 특히 제WO 2011/039510 A2호에 개시된 바와 같은 Mac2-48 또는 Mac2-158과 경쟁할 수 있다.
심지어 또 다른 특정 선호도에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 사람 CD163에 결합하기 위해
DVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYIT
YSGITNYNPSLKSQISITRDTSKNQFFLQLNSVTTEDTATYYCVSGTYYFDYW
GQGTTLTVSS (서열번호 1) 아미노산 서열로 구성된 중쇄 가변(VH) 영역 및
SVVMTQTPKSLLISIGDRVTITCKASQSVSSDVAWFQQKPGQSPKPLIYYASNRY
TGVPDRFTGSGYGTDFTFTISSVQAEDLAVYFCGQDYTSPRTFGGGTKLEIKRA (서열번호 2)의 아미노산 서열로 구성된 경쇄 가변(VL) 영역을 가지는 항체와 (예컨대, ELISA에서) 경쟁할 수 있다.
경쟁적 결합 실험(예를 들어 ELISA를 기반으로 함)에 대한 상세한 사항은 당업자에게 공지되어 있고 예를 들어 제WO 2011/039510 A2호(본원에 참조로 포함됨)에 개시되어 있다.
본 발명의 과정에서, 제WO 2011/039510 호에 개시된 바와 같은 항체 E10B10 및 Mac2-158의 에피토프는 환형 펩타이드 어레이를 사용하는 미세 맵핑에 의해 맵핑되었고, 여기서 펩타이드는 CD163으로부터 유래되었다. 이들 에피토프는 본 발명의 화합물의 항-CD163 항체(또는 이의 CD163-결합 단편)의 결합에 특히 적합하다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 CSGRVEVKVQEEWGTVCNNGWSMEA(서열번호 3) 또는 이의 7 내지 24개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 GRVEVKVQEEW (서열번호 4), WGTVCNNGWS (서열번호 5) 또는 WGTVCNNGW (서열번호 6)를 포함한다. 보다 바람직하게는, 이 펩타이드는 EWGTVCNNGWSME (서열번호 7), QEEWGTVCNNGWS (서열번호 8), WGTVCNNGWSMEA (서열번호 9), EEWGTVCNNGWSM (서열번호 10), VQEEWGTVCNNGW (서열번호 11), EWGTVCNNGW (서열번호 12) 및 WGTVCNNGWS (서열번호 5)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 EWGTVCNNGWSME (서열번호 7), QEEWGTVCNNGWS (서열번호 8), WGTVCNNGWSMEA (서열번호 9), EEWGTVCNNGWSM (서열번호 10), VQEEWGTVCNNGW (서열번호 11), EWGTVCNNGW (서열번호 12) 및 WGTVCNNGWS (서열번호 5)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD 163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 DHVSCRGNESALWDCKHDGWG (서열번호 13) 또는 이의 7 내지 20개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 ESALW (서열번호 14) 또는 ALW을 포함한다. 보다 바람직하게는, 이 펩타이드는 ESALWDC (서열번호 15), RGNESALWDC (서열번호 16), SCRGNESALW (서열번호 17), VSCRGNESALWDC (서열번호 18), ALWDCKHDGW (서열번호 19), DHVSCRGNESALW (서열번호 20), CRGNESALWD (서열번호 21), NESALWDCKHDGW (서열번호 22) 및 ESALWDCKHDGWG (서열번호 23)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 ESALWDC (서열번호 15), RGNESALWDC (서열번호 16), SCRGNESALW (서열번호 17), VSCRGNESALWDC (서열번호 18), ALWDCKHDGW (서열번호 19), DHVSCRGNESALW (서열번호 20), CRGNESALWD (서열번호 21), NESALWDCKHDGW (서열번호 22) 및 ESALWDCKHDGWG (서열번호 23)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD 163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 SSLGGTDKELRLVDGENKCS (서열번호 24) 또는 이의 7 내지 19개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 SSLGGTDKELR (서열번호 25) 또는 SSLGG (서열번호 26)을 포함한다. 보다 바람직하게는, 이 펩타이드는 SSLGGTDKELR (서열번호 25), SSLGGTDKEL (서열번호 28), SSLGGTDKE (서열번호 29), SSLGGTDK (서열번호 30), SSLGGTD (서열번호 31), SSLGGT (서열번호 32) 및 SSLGG (서열번호 26)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 SSLGGTDKELR (서열번호 25), SSLGGTDKEL (서열번호 28), SSLGGTDKE (서열번호 29), SSLGGTDK (서열번호 30), SSLGGTD (서열번호 31), SSLGGT (서열번호 32) 및 SSLGG (서열번호 26)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
경쟁적 결합 실험(예를 들어 ELISA를 기반으로 함)에 대한 상세한 사항은 당업자에게 공지되어 있고 예를 들어 제WO 2011/039510 A2호(본원에 참조로 포함됨)에 개시되어 있다.
본 발명의 과정에서, 제WO 2011/039510 호에 개시된 바와 같은 항체 E10B10 및 Mac2-158의 에피토프는 환형 펩타이드 어레이를 사용하는 미세 맵핑에 의해 맵핑되었고, 여기서 펩타이드는 CD163으로부터 유래되었다. 이들 에피토프는 본 발명의 화합물의 항-CD163 항체(또는 이의 CD163-결합 단편)의 결합에 특히 적합하다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 CSGRVEVKVQEEWGTVCNNGWSMEA(서열번호 3) 또는 이의 7 내지 24개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 GRVEVKVQEEW (서열번호 4), WGTVCNNGWS (서열번호 5) 또는 WGTVCNNGW (서열번호 6)를 포함한다. 보다 바람직하게는, 이 펩타이드는 EWGTVCNNGWSME (서열번호 7), QEEWGTVCNNGWS (서열번호 8), WGTVCNNGWSMEA (서열번호 9), EEWGTVCNNGWSM (서열번호 10), VQEEWGTVCNNGW (서열번호 11), EWGTVCNNGW (서열번호 12) 및 WGTVCNNGWS (서열번호 5)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 EWGTVCNNGWSME (서열번호 7), QEEWGTVCNNGWS (서열번호 8), WGTVCNNGWSMEA (서열번호 9), EEWGTVCNNGWSM (서열번호 10), VQEEWGTVCNNGW (서열번호 11), EWGTVCNNGW (서열번호 12) 및 WGTVCNNGWS (서열번호 5)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD 163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 DHVSCRGNESALWDCKHDGWG (서열번호 13) 또는 이의 7 내지 20개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 ESALW (서열번호 14) 또는 ALW을 포함한다. 보다 바람직하게는, 이 펩타이드는 ESALWDC (서열번호 15), RGNESALWDC (서열번호 16), SCRGNESALW (서열번호 17), VSCRGNESALWDC (서열번호 18), ALWDCKHDGW (서열번호 19), DHVSCRGNESALW (서열번호 20), CRGNESALWD (서열번호 21), NESALWDCKHDGW (서열번호 22) 및 ESALWDCKHDGWG (서열번호 23)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 ESALWDC (서열번호 15), RGNESALWDC (서열번호 16), SCRGNESALW (서열번호 17), VSCRGNESALWDC (서열번호 18), ALWDCKHDGW (서열번호 19), DHVSCRGNESALW (서열번호 20), CRGNESALWD (서열번호 21), NESALWDCKHDGW (서열번호 22) 및 ESALWDCKHDGWG (서열번호 23)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
따라서, 특히 바람직한 구현예에서, 항-CD163 항체 또는 이의 CD 163-결합 단편은 7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드에 특이적이며, 여기서 펩타이드는 아미노산 서열 SSLGGTDKELRLVDGENKCS (서열번호 24) 또는 이의 7 내지 19개 아미노산 단편을 포함한다. 바람직하게는, 이 펩타이드는 아미노산 서열 SSLGGTDKELR (서열번호 25) 또는 SSLGG (서열번호 26)을 포함한다. 보다 바람직하게는, 이 펩타이드는 SSLGGTDKELR (서열번호 25), SSLGGTDKEL (서열번호 28), SSLGGTDKE (서열번호 29), SSLGGTDK (서열번호 30), SSLGGTD (서열번호 31), SSLGGT (서열번호 32) 및 SSLGG (서열번호 26)로부터 선택되는 아미노산 서열을 포함한다. 심지어 보다 바람직하게는, 이 펩타이드는 SSLGGTDKELR (서열번호 25), SSLGGTDKEL (서열번호 28), SSLGGTDKE (서열번호 29), SSLGGTDK (서열번호 30), SSLGGTD (서열번호 31), SSLGGT (서열번호 32) 및 SSLGG (서열번호 26)로부터 선택되는 아미노산 서열로 구성되고, 임의로 N-말단 및/또는 C-말단 시스테인 잔기를 갖는다.
펩타이드(또는 펩타이드 n-머)는 바람직하게는 예를 들면, 아민-대-설프하이드릴 링커 및 이작용성 NHS-PEG-말레이미드 링커 또는 당해 분야에 공지된 다른 링커와 같이 당해 분야에 공지된 (비-면역원성) 링커를 통해 생물중합체 스캐폴드에 공유결합으로 접합(또는 공유결합으로 결합)된다. 대안적으로, 펩타이드(또는 펩타이드 n-머)는 예컨대, 단백질과 펩타이드(이는 또한 본원에서 "링커"로 지칭된다) 사이의 이황화물 결합의 형성에 의해, 또는 비-공유결합성 조립 기술, 자발적 이소펩타이드 결합 형성, 또는 유전 코드 확장 기술을 통한 생체-직교 화학용 비천연 아미노산을 사용하여 에피토프 담체 스캐폴드(epitope carrier scaffold)에 결합시킬 수 있다(참고: Howarth 등 2018 및 Lim 등 2016).
본 발명의 화합물은 예컨대, 하나 또는 수개의 상이한 펩타이드(이는 본원에 개시된 바와 같이 펩타이드 n-머의 상이한 형태로 존재할 수 있다)의 적어도 2개, 바람직하게는 3 내지 40개 카피를 포함할 수 있다. 화합물은 1개 유형의 에피토프성 펩타이드(epitopic peptide)(다시 말해서: 항체-결합 펩타이드 또는 파라토프-결합 펩타이드) 중 하나의 유형을 포함할 수 있지만, 하나의 생물중합체 스캐폴드 분자에 결합된 에피토프성 펩타이드의 다양성은 예컨대, 8개 이하의 상이한 에피토프성 펩타이드의 혼합물일 수 있다.
전형적으로, 본 발명에 존재하는 펩타이드는 선택된 목적하지 않은 항체에 특이적으로 결합하므로, 이의 서열을 일반적으로 선택하여 최적화함으로써 이는 특이적인 결합을 제공하여 혈액으로부터 목적하지 않은 항체 고갈의 선택성을 보장한다. 이러한 목적을 위해, 상기 펩타이드의 펩타이드 서열은 전형적으로 전체 에피토프 서열 또는 목적하지 않는 항체 에피토프의 부위에 상응한다. 본 발명에 사용된 펩타이드는 1개, 2개 또는 3개 이하의 아미노산 위치를 교환하고, 예컨대, 고갈시킬 필요가 있는 목적하지 않은 항체에 대한 결합 친화성을 조절하도록 함으로써 추가로 최적화시킬 수 있다. 증가된 결합 친화성을 지닌 "미모토프(mimotopes)를 제공할 수 있고 당해 분야에 공지된 이러한 단일 또는 다수의 아미노산 치환 전략이 파아지 디스플레이 전략 (phage display strategies) 또는 펩타이드 미세배열(peptide microarray)을 사용하여 앞서 개발되었다. 다시 말해서, 본 발명에 사용된 펩타이드는 목적하지 않은 항체의 천연 에피토프 서열과 완전히 동일하지 않아야만 한다.
전형적으로, 본 발명의 화합물에 사용된 펩타이드(예컨대, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는 포유동물 단백질 속에 일반적으로 존재하는 20개 아미노산 중 하나 이상으로 구성된다. 또한, 펩타이드에 사용된 아미노산 레퍼토리는 해독후 변형된 아미노산으로 확장되어, 예컨대, 단백질의 항원성, 예를 들면, 해독후 변형 (post translational modifications), 특히 산화성 해독후 변형(참고: 예컨대, Ryan 2014) 또는 펩타이드 골격에 대한 변형(참고: 예컨대, Muller 2018), 또는 비-천연 아미노산에 대한 변형(참고: 예컨대, Meister 등, 2018)에 영향을 미칠 수 있다. 이러한 변형은 또한 펩타이드에서 사용되어, 예컨대, 펩타이드와 목적하지 않은 항체의 가변 영역 사이의 결합 상호작용 및 특이성을 조정할 수 있다. 특히, 에피토프(및 따라서 본 발명의 화합물에 사용된 펩타이드)는 또한 예를 들면, 자가면역 질환에서와 같이 시트룰린(citrulline)을 함유할 수 있다. 또한, 펩타이드 서열내로 변형을 도입시킴으로써 HLA 분자에 대한 결합 성향을 감소시킬 수 있거나, 안정성 및 물리화학적 특성이 개선될 수 있거나 목적하지 않은 항체에 대한 친화성이 증가될 수 있다.
많은 경우에, 고갈시켜야 하는 목적하지 않은 항체는 올리고- 또는 폴리클로날(예컨대, 자가항체, ADA 또는 동종항체는 전형적으로 폴리- 또는 올리고 클로날이다)이고, 목적하지 않은(폴리클로날) 항체 에피토프는 표적 분자의 보다 큰 에피토프성 영역을 포함한다. 이러한 상황을 조정하기 위하여, 본 발명의 화합물은 2개 또는 수개의 에피토프성 펩타이드(다시 말해서: 항체-결합 펩타이드 또는 파라토프-결합 펩타이드)의 혼합물을 포함함으로써, 목적하지 않은 항체의 폴리클로날성(polyclonality) 또는 올리고클로날성(oligoclonality)을 조정하도록 한다.
본 발명의 이러한 폴리-에피토프성 화합물은 목적하지 않은 항체를 효과적으로 고갈시킬 수 있고 목적하지 않은 항체의 에피토프가 보다 큰 아미노산 서열 범위로 연장되는 경우에 모노-에피포트성 화합물보다 흔히 더 효과적이다.
이는 본 발명의 화합물에 사용된 펩타이드를 설계하여 이것이 고갈될 목적하지 않은 항체의 가변 영역에 의해 특이적으로 인식되도록 설계하는 경우에 유리하다. 본 발명에 사용된 펩타이드의 서열은 예컨대, 목적하지 않은 항체에서 미세한 에피토프 맵핑 기술(즉, 에피토프 웍스(epitope walks), 펩타이드 고갈 맵핑, 예를 들면, Carter 등, 2004, 및 Hansen 등, 2013에 기술된 바와 같은 펩타이드 배열을 사용한 아미노산 치환 스캐닝)을 적용함으로써 선택할 수 있다.
또한 본 발명에 사용된 펩타이드가 임의의 HLA 제I 부류 또는 HLA 제II 부류 분자(즉, 치료될 개체, 예컨대 사람의)에 결합하지 않아, 생체내에서 T-세포 수용체를 통한 제시(presentation) 및 자극을 방지함으로서 면역 반응을 유도하는 것이 매우 바람직하다. 항원-특이적인 면역학적 내성화 접근법과는 대조적으로 임의의 억제성(또는 자극성) T-세포 반응을 포함시키는 것은 일반적으로 바람직하지 않다. 따라서, T-세포 에피토프 활성을 가능한 한 최대로 피하기 위하여, 본 발명의 화합물의 펩타이드(예컨대, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는 바람직하게는 다음의 특성 중 하나 이상을 충족한다:
- 본 발명의 화합물에 사용된 펩타이드가 HLA 제II 부류 또는 제I 부류 분자에 결합할 가능성을 감소시키기 위하여, 펩타이드(예컨대, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는, 6 내지 13개 아미노산 길이가 바람직하다.
- 이러한 펩타이드가 HLA 제II 부류 또는 제I 부류 분자에 결합하는 가능성을 추가로 감소시키기 위하여, HLA 결합 예측 알고리즘, 예를 들면, NetMHCII-2.3(참고: Jensen 등 2018)에 의해 후보물 펩타이드 서열을 시험하는 것이 바람직하다. 바람직하게는, 본 발명의 화합물에 사용된 펩타이드(예컨대, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는 적어도 500 nM의 (예측된) HLA 결합(IC50)을 갖는다. 보다 바람직하게는, HLA 결합(IC50)은 1000 nM 이상, 특히 2000 nM 이상이다(참고: 예컨대, Peters 등 2006). HLA 제I 부류 결합의 경향성을 감소시키기 위하여, NetMHCpan 4.0을 또한 예측에 적용시킬 수 있다(Jurtz 등 2017).
- 이러한 펩타이드가 HLA 제I 부류 분자에 결합할 가능성을 추가로 감소시키기 위하여, 문헌: 에 따라 10%의 배경 수준으로 설정할 수 있다. 바람직하게는, 따라서, 본 발명의 화합물에 사용된 펩타이드(예컨대, 펩타이드 P 또는 Pa 또는 Pb 또는 P1 또는 P2)는 NetMHCpan 알고리즘에 따라 3 이상, 바람직하게는 5 이상, 보다 바람직하게는 10 이상의 순위 값%(%Rank value)를 갖는다.
- 이러한 펩타이드가 HLA 제II 부류 분자에 결합할 가능성을 추가로 감소시키기 위하여, 당해 분야에서 일반적으로 사용된 시험관내 HLA-결합 검정, 예를 들면, 리폴딩 검정(refolding assay), iTopia, 펩타이드 구제 검정(peptide rescuing assay) 또는 배열-기반 펩타이드 결합 검정(array-based peptide binding assay)을 수행하는 것이 유리하다. 대안적으로, 또는 이외에, 예컨대, Gfeller 등 2016에 고찰된 바와 같이, LC-MS 기반 분석을 사용할 수 있다.
목적하지 않은 항체의 역가의 보다 강력한 감소를 위해, 본 발명에 사용된 펩타이드를 환형화(circularization)시키는 것이 바람직하다(참고: 또한 실시예 4). 따라서, 바람직한 구현예에서, 적어도 하나의 경우의 P는 환형화된 펩타이드이다. 바람직하게는 모든 경우의 P의 적어도 10%는 환형화된 펩타이드이거나, 보다 바람직하게는 모든 경우의 P의 적어도 25%는 환형화된 펩타이드이거나, 여전히 보다 바람직하게는 P의 모든 환형화된 경우의 적어도 50%는 환형화된 펩타이드이거나, 심지어 보다 바람직하게는 모든 경우의 P의 적어도 75%는 환형화된 펩타이드이거나, 여전히 심지어 보다 바람직하게는 모든 경우의 P의 적어도 90%는 환형화된 펩타이드이거나 심지어 모든 경우의 P의 적어도 95%는 환형화된 펩타이드이고, 특히 P의 모든 경우은 환형화된 펩타이드이다. 수개의 일반적인 기술이 펩타이드의 환형화에 이용가능하다(참고: 예컨대, Ong 등 2017). 본원에 사용된 바와 같은 "환형화된 펩타이드"는 예컨대 문헌(참고: Ong 등)에 개시된 바와 같이, 펩타이드 자체가 환형화된 것으로 이해될 수 있음은 말할 필요가 없다(그리고, 예컨대, 서열 길이가 13개 아미노산 보다 긴 환형 스캐폴드에서 이식되지 않음). 이러한 펩타이드는 또한 본원에서 사이클로펩타이드로 지칭될 수 있다.
또한, 본 발명의 바람직한 구현예에서, 사용된 스캐폴드의 양에 대해 목적하지 않은 항체의 역가의 보다 강력한 감소를 위해, 독립적으로, 펩타이드 n-머 각각에 대해, n은 적어도 2, 보다 바람직하게는 적어도 3, 특히 적어도 4이다. 일반적으로, 제조 공정에서 복잡성을 피하기 위하여, 독립적으로 각각의 펩타이드 n-머에 대해, n은 10 미만, 바람직하게는 9 미만, 보다 바람직하게는 8 미만, 심지어 보다 바람직하게는 7 미만, 여전히 심지어 보다 바람직하게는 6 미만, 특히 5 미만이다. 목적하지 않은 항체의 2가 결합을 통한 보다 높은 항원항체결합력(avidity)으로부터 유리하기 위해, 펩타이드 n-머 각각에 대해, n이 2인 것이 매우 바람직하다.
목적하지 않은 항체의 다가 결합을 위해, 펩타이드 이량체 또는 n_머가 소수성의, 구조적으로 유연하고, 면역학적으로 불활성이며, 무독성이고 임상적으로 승인된 스페이서, 예를 들면, (헤테로-)이작용성 및 -삼작용성 폴리에틸렌글리콜(PEG) 스페이서 (예컨대, NHS-PEG-말레이미드)에 의해 이격되어 있는 것이 유리하다 - 광범위한 PEG 쇄가 이용가능하며 PEG는 FDA에 의해 승인되어 있다. PEG 링커의 대안, 예를 들면, 면역학적으로 불활성이고 무독성인 합성 중합체 또는 글리칸이 또한 적합하다. 따라서, 본 발명의 맥락에서, 스페이서(예컨대, 스페이서 S)는 바람직하게는 PEG 분자 또는 글리칸으로부터 선택된다. 예를 들면, 스페이서, 예를 들어, PEG가 펩타이드 합성 동안 도입될 수 있다. 이러한 스페이서(예컨대, PEG 스페이서)는 예컨대, 10000 달톤의 분자량을 가질 수 있다. 명백하게, 본 발명의 맥락 내에서, 링커 각각을 통한 생물중합체 스캐폴드에 대한 펩타이드 n-머의 공유결합성 결합은 예를 들면, 링커를 펩타이드 n-머의 스페이서(예컨대, 펩타이드 n-머의 펩타이드 대신에)에 직접 결합시킴으로써 달성할 수 있다.
바람직하게는, 펩타이드 n-머 각각은 바람직하게는 링커 각각을 통해 생물중합체 스캐폴드에 공유결합으로 결합된다.
본원에 사용된 바와 같이, 링커는 예컨대, 디설파이드 브릿지(difulphide bridge) 및 PEG 분자로부터 선택될 수 있다.
본 발명의 화합물의 추가의 바람직한 구현예에 따르면, P 중 적어도 한 번은 Pa이고/이거나 P 중 적어도 한 번은 Pb이다(여기서 Pa 및 Pb는 각각 독립적으로 P 및/또는 P1 및 P2에 대해 상기 정의된 바와 같은 펩타이드다). 바람직하게는, 각 경우에 독립적으로 P는 Pa 또는 Pb이다.
또한, 제1의 펩타이드 n-머에서, P의 각각의 경우이 Pa이고, 제2의 펩타이드 n-머에서, P의 각각의 경우가 Pb인 것이 바람직하다. 대안적으로, 또는 이외에, Pa 및/또는 Pb는 환형화되어 있다.
항체 역가를 감소시키기 위해서는 2가 결합이 특히 적합하다. 따라서, 바람직한 구현예에서,
제1의 펩타이드 n-머는 P a - S - P a 이고 제2의 펩타이드 n-머는 P a - S - P a 이거나;
제1의 펩타이드 n-머는 P a - S - P a 이고 제2의 펩타이드 n-머는 P b - S - P b 이거나;
제1의 펩타이드 n-머는 P b - S - P b 이고 제2의 펩타이드 n-머는 P b - S - P b 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P a - S - P b 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P a - S - P a 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P b - S - P b 이다.
특히 효능을 증가시키기 위하여, 특히 자가면역 질환(일반적으로 다클론 항체에 기초함, 상기 참조)에서, 바람직한 구현예에서 제1의 펩타이드 n-머는 제2의 펩타이드 n-머와는 상이하다. 유사한 이유로, 바람직하게는, 펩타이드 Pa는 펩타이드 Pb와는 상이하고, 바람직하게는 여기서 펩타이드 Pa 및 펩타이드 Pb는 동일한 항원의 2개의 상이한 에피토프 또는 동일한 에피토프의 2개의 상이한 에피토프 부분이다.
특히 폴리클로날 항체의 보다 우수한 표적화를 위해, 펩타이드 Pa 및 펩타이드 Pb가 동일한 아미노산 서열 단편을 동일한 아미노산 단편을 포함하는 경우가 유리하며, 여기서, 아미노산 서열 단편은 적어도 2개의 아미노산, 바람직하게는 적어도 3개의 아미노산, 보다 바람직하게는 적어도 4개의 아미노산, 여전히 보다 바람직하게는 적어도 5개의 아미노산, 심지어 보다 바람직하게는 적어도 6개의 아미노산, 여전히 심지어 보다 바람직하게는 적어도 7개의 아미노산, 특히 적어도 8개의 아미노산 또는 심지어 적어도 9개의 아미노산의 길이를 갖는다.
또한, 사용된 스캐폴드의 양에 대해 목적하지 않은 항체의 역가의 보다 강력한 감소를 위해, 화합물은 다수의 상기 제1의 펩타이드 n-머(예컨대, 10개 또는 20개 또는 30개 이하) 및/또는 다수의 상기 제2의 펩타이드 n-머(예컨대, 10개 또는 20개 또는 30개 이하)를 포함한다.
사용된 스캐폴드의 양에 대해 목적하지 않은 항체 역가의 더 강력한 감소를 위해, 화합물은 또한 적어도
하기 화학식의 제3의 펩타이드 n-머(n-mer):
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pc이고, 여기서 Pc는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pc는 환형이고;
바람직하게는 하기 화학식의 제4의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pd이고, 여기서 Pd는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pd는 환형이고;
바람직하게는 하기 화학식의 제5의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pe이고, 여기서 Pe는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pe는 환형이고;
바람직하게는 하기 화학식의 제6의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pf이고, 여기서 Pf는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pf는 환형이고;
바람직하게는 하기 화학식의 제7의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pg이고, 여기서 Pg는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pg는 환형이고;
바람직하게는 하기 화학식의 제8의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Ph이고, 여기서 Ph는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Ph는 환형이고;
바람직하게는 하기 화학식의 제9의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pi이고, 여기서 Pi는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pi는 환형이고;
바람직하게는 하기 화학식의 제10의 펩타이드 n-머:
P ( ― S ― P ) (n-1) ,
여기서, 각 경우에 독립적으로, P는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해)에 개시된 바와 같이 정의된 펩타이드고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pj이고, 여기서 Pj는 본원에서 상기(예를 들어, P, P1, P2 및/또는 Pa에 대해) 개시된 바와 같이 정의된 펩타이드고,
보다 바람직하게는 여기서 Pj는 환형인 것; 을 포함할 수 있다.
펩타이드 Pc-Pj는 펩타이드 Pa 및 Pb(및/또는 펩타이드 P, P1, P2)에 대해 본원에 개시된 것과 동일한 특징(예를 들어, 서열) 중 하나 이상을 가질 수 있다. P, P1 및 P2에 대해 본원에 개시된 모든 바람직한 특징은 또한 펩타이드 Pa-Pj의 바람직한 특징이다. 또한 상기 나타낸 바와 같이, 본 발명의 화합물이 포유동물, 바람직하게는 사람, 비-사람 영장류, 양, 돼지, 개 또는 설치류 내에서 비-면역원성인 경우가 매우 바람직하다.
본 발명의 맥락에서, 비-면역원성 화합물은 바람직하게는 생물중합체 스캐폴드(이것이 단백질인 경우) 및/또는 펩타이드(펩타이드 n-머의)가 NetMHCII-2.3 알고리즘에 의해 예측된 것으로서 HLA-DRB1_0101에 대해 100 nM 초과, 바람직하게는 500 nM 초과, 심지어 보다 바람직하게는 1000 nM 초과, 특히 2000 nM 초과의 IC50을 갖는 화합물이다. NetMHCII-2.3 알고리즘은 본원에 참고로 포함된 문헌: Jensen 등에 기술되어 있다. 알고리즘은 http://www.cbs.dtu.dk/services/NetMHCII-2.3/ 하에 공공 이용가능하다. 심지어 보다 바람직하게는, 비-면역원성 화합물(또는 약제학적 조성물)은 생체내에서 어떠한 HLA 및/또는 MHC 분자에도 결합하지 않는다(예컨대, 포유동물 내에서, 바람직하게는 사람에서, 비-사람 영장류에서, 양에서, 돼지에서, 개에서 또는 설치류에서; 또는 치료할 개체에서).
추가의 선호도에 따라서, 화합물은 개체내, 바람직하게는 개체의 혈류내에서 적어도 하나의 항체의 체내 제거(또는 체내 고갈)용 및/또는 개체내, 바람직하게는 개체의 혈류내에서 적어도 하나의 항체의 역가의 감소용이다. 바람직하게는 상기 항체는 (인간) 신경수용체, 바람직하게는 자율신경계의 (인간) 신경수용체 보다 바람직하게는 무스카린성 및 니코틴성 콜린성 수용체, 알파- 및 베타-아드레날린성 수용체, 세로토닌 수용체, 안지오텐신- 및 엔도텔린 수용체로 구성된 군으로부터 선택되는 (인간) 신경수용체; 가장 바람직하게는 베타-1 아드레날린성 수용체, 베타-2 아드레날린성 수용체, M3 무스카린 아세틸콜린 수용체 및 M4 무스카린 아세틸콜린 수용체로 구성된 군으로부터 선택되는 (인간) 신경수용체; 에 특이적인 항체이며, 바람직하게는 (본 발명의 화합물에 포함된 펩타이드의 맥락에서) 상기 본원에 개시된 UniProt 접근 번호에 의해 정의된다.
일 양태에서, 본 발명은 본 발명의 화합물 및 적어도 하나의 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물에 관한 것이다.
구현예에서, 조성물은 복강내, 피하, 근육내 및/또는 정맥내 투여를 위해 제조한다. 특히, 조성물은 반복된 투여용이다(이는 전형적으로 비-면역원성 (non-immunogenic)이기 때문이다).
바람직하게는, 조성물 속의 펩타이드 (예를들어 P 또는 Pa 또는 Pb) 대 생물중합체 스캐폴드의 몰 비는 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 심지어 보다 바람직하게는 5:1 내지 70:1, 여전히 심지어 보다 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1이다.
다른 양태에서, 본 발명의 화합물 및/또는 약제학적 조성물은 치료요법에 사용하기 위한 것이다.
바람직하게는, 화합물 및/또는 약제학적 조성물은 개체에서 ME/CFS의 예방 또는 치료에 사용하기 위한 것이다.
추가로 바람직하게는, 화합물 및/또는 제약 조성물은 개체에서 POTS의 예방 또는 치료에 사용하기 위한 것이다.
더욱 바람직하게는, 화합물 및/또는 약제학적 조성물은 개체에서 AAG의 예방 또는 치료에 사용하기 위한 것이다.
더욱 바람직하게는, 화합물 및/또는 약제학적 조성물은 개체에서 IDC의 예방 또는 치료에 사용하기 위한 것이다.
더욱 바람직하게는, 화합물 및/또는 약제학적 조성물은 개체에서 cChHD의 예방 또는 치료에 사용하기 위한 것이다.
또 다른 선호도에서, 화합물 및/또는 약제학적 조성물은 개체에서 변연계 뇌염 또는 부종양 선조체 뇌염(paraneoplastic striatal encephalitis) 또는 항-mGluR1 뇌염 또는 항-mGluR5 뇌염 또는 급성 파종성 뇌척수염(ADEM) 또는 NMDAR 뇌염과 같은 뇌염, 부종양 증후군(paraneoplastic syndrome), 강직 증후군(stiff man syndrome), 자가 면역 채널 병증(autoimmune channelopathies), 시신경 척수염(neuromyelitis optica), 신경 근육 긴장(neuromyotonia), 모르반증후군(Morvan's syndrome), 신경병성 통증, 척수염, 시신경염, 망막염, 파킨슨증, 무도병(chorea), 정신병, 디스토니아(dystonia), 무언증(mutism), 운동 장애, 착란(confusion), 환각, 전구 설사(prodromal diarrhoea), 기억 상실, 과흥분(hyperexcitability), 뇌염 정신과 증후군(encephalitis psychiatric syndrome), 기면증, 자폐 스펙트럼 장애(autism spectrum disorders), 발작, 간질 발작 상태, 만성 간질, 근간대 경련(myoclonus), 뇌척수염(encephalomyelitis), 근간대 경련(myoclonus), 사건수면증(parasomnia), 수면 무호흡증(sleep apnoea), 인지 장애, 보행 이상(gait abnormalities), 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 부종양 증후군(paraneoplastic syndrome), 소뇌 운동 실조증(cerebellar ataxia), 자폐증, 뚜렛, ADHD, 소뇌 운동 실조증(cerebellar ataxia), 진동시(oscillopsia), 근 위축성 측삭 경화증 (ALS), 갑상선 장애 및 신경학적 결손 및 림프구증가증(HaNDL) 의 예방 또는 치료에 사용하기 위한 것이다.
본 발명의 과정에서, 본 발명의 화합물에 의해 저하되는 바람직하지 않은 항체의 생체내 동역학은 전형적으로 매우 빠르며, 때때로 바람직하지 않은 항체의 완만한 반동이 뒤따른다는 것이 밝혀졌다. 따라서 화합물(또는 화합물을 포함하는 약제학적 조성물)은 96시간 범위 내, 바람직하게는 72시간 범위 내, 보다 바람직하게는 48시간 범위 내, 심지어 보다 바람직하게는 36시간 범위 내, 심지어 보다 바람직하게는 24시간 범위 내, 특히 18시간 범위 내 또는 심지어 12시간 범위 내에서 2회 이상 투여되는 경우가 특히 바람직하다.
구현예에서, 본 발명의 화합물의 펩타이드(예를 들어, 펩타이드 P, P1, P2, 또는 펩타이드 Pa 및/또는 펩타이드 Pb)의 적어도 하나의 발생에 특이적인 하나 이상의 항체가 개체에 존재하며, 바람직하게는 여기서 상기 항체는 본원에서 상기 정의된 바와 같은 신경수용체에 대해 특이적이다.
조성물이 개체에서 비-면역원성인 것이 매우 바람직하다(예컨대, 이는 보조제 또는 선천성 또는 적응성 면역계(adaptive immune system)를 자극시키는 면역자극성 물질, 예컨대, 보조제 또는 T-세포 에피토프를 포함하지 않는다).
본 발명의 조성물은 개체의 체중 kg당 화합물을 1 내지 1000 mg, 바람직하게는 2 내지 500 mg, 보다 바람직하게는 3 내지 250 mg, 심지어 보다 바람직하게는 4 내지 100 mg, 특히 5 내지 50 mg의 용량으로 투여될 수 있고, 바람직하게는 여기서 조성물은 반복적으로 투여된다. 이러한 투여는 복강내, 피하, 근육내 또는 정맥내일 수 있다.
한 측면에서, 본 발명은 이를 필요로 하는 개체에서, 바람직하게는 CFS/ME, POTS, AAG, IDC, 및 cChHD 및 변연계 뇌염 또는 부종양 선조체 뇌염(paraneoplastic striatal encephalitis) 또는 항-mGluR1 뇌염 또는 항-mGluR5 뇌염 또는 급성 파종성 뇌척수염(ADEM) 또는 NMDAR 뇌염과 같은 뇌염, 부종양 증후군(paraneoplastic syndrome), 강직 증후군(stiff man syndrome), 자가 면역 채널 병증(autoimmune channelopathies), 시신경 척수염(neuromyelitis optica), 신경 근육 긴장(neuromyotonia), 모르반증후군(Morvan's syndrome), 신경병성 통증, 척수염, 시신경염, 망막염, 파킨슨증, 무도병(chorea), 정신병, 디스토니아(dystonia), 무언증(mutism), 운동 장애, 착란(confusion), 환각, 전구 설사(prodromal diarrhoea), 기억 상실, 과흥분(hyperexcitability), 뇌염 정신과 증후군(encephalitis psychiatric syndrome), 기면증, 자폐 스펙트럼 장애(autism spectrum disorders), 발작, 간질 발작 상태, 만성 간질, 근간대 경련(myoclonus), 뇌척수염(encephalomyelitis), 근간대 경련(myoclonus), 사건수면증(parasomnia), 수면 무호흡증(sleep apnoea), 인지 장애, 보행 이상(gait abnormalities), 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 부종양 증후군(paraneoplastic syndrome), 소뇌 운동 실조증(cerebellar ataxia), 자폐증, 뚜렛, ADHD, 소뇌 운동 실조증(cerebellar ataxia), 진동시(oscillopsia), 근 위축성 측삭 경화증 (ALS), 갑상선 장애 및 신경학적 결손 및 림프구증가증(HaNDL)으로부터 선택되는 자가항체-매개 병태(condition)를 개선 또는 치료하는 방법에 관한 것이며,
본 발명의 약제학적 조성물을 수득하는 단계; 및
약제학적 조성물의 유효량을 개인에게 투여하는 단계를 포함한다. 개체에서 CFS/ME, POTS, AAG, IDC, 및 cChHD 및 본원에 개시된 다른 병태로부터 선택되는 자가항체-매개 병태,의 예방 또는 치료에 사용하기 위한 화합물 및/또는 약제학적 조성물에 대해 개시된 모든 바람직한 특징은 또한 이 방법에 적용된다.
추가 측면에서, 본 발명은 개체에 존재하는 하나 이상의 항체를 제거(또는 고갈)하는 방법에 관한 것으로,
본원에 정의된 바와 같은 약제학적 조성물을 수득하는 단계(여기서, 조성물은 개체에서 비-면역원성이고 여기서 개체내에 존재하는 하나 이상의 항체는 적어도 하나의 경우의 P에 대해, 또는 펩타이드 Pa 및/또는 펩타이드 Pb에 대해 특이적이다); 및
개체에게 약제학적 조성물을 투여하는 단계(특히 반복적으로 투여, 예컨대, 적어도 2회, 바람직하게는 적어도 3회, 보다 바람직하게는 적어도 5회 투여)를 포함한다.
바람직하게는, 하나 이상의 항체는 신경수용체, 바람직하게는 상기 본원에서 정의된 바와 같은 신경수용체에 특이적이다.
바람직하게는, 생물중합체 스캐폴드는 개체와 관련하여 자기유래 (autologous)이고, 바람직하게는 여기서 생물중합체 스캐폴드는 자기유래 단백질이다(즉, 개체가 마우스인 경우 쥐 알부민이 사용된다).
추가 측면에서, 본 발명은 펩타이드에 관한 것이며, 여기서 펩타이드는 본 발명의 화합물의 적어도 2개의 펩타이드, P, P1, P2, Pa 또는 Pb 중 임의의 하나에 대해 본원에 개시된 바와 같이 정의된다.
바람직하게는, 펩타이드는 다음으로 구성된 군에서 선택된 UniProt 접근 코드로 식별되는 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 훨씬 더 바람직하게는 아미노산 서열의 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고: P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6, Q9Y6J6, P48058, P55087, Q9BPU6, P52799, P15328, Q05329, Q16653, Q9Y4C0, Q5F0I5, Q99719, P17600, Q13148, P01266, Q9Y6A1, Q9Y6A1,및 P07202, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다.
훨씬 더 바람직하게는, 상기 아미노산 단편은 서열번호 45-3536(단, 상기 아미노산 서열의 UniProt 접근 코드 및 표 1에 주어진 서열번호의 UniProt 접근 코드는 동일), 바람직하게는 서열번호 45-863 중 어느 하나(단, 상기 아미노산 서열의 UniProt 접근 코드와 표 1에 제공된 서열번호의 UniProt 접근 코드는 동일), 특히 서열번호 45-201 중 어느 하나(단, 상기 아미노산 서열의 UniProt 접근 코드와 표 1에 제공된 서열번호의 UniProt 접근 코드는 동일) 중 어느 하나로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된다.
특정 구현예에서, 이러한 펩타이드는 본원에 개시된 것과 같은 자가항체-매개 병태의 진단 유형화 및 분석을 위한 프로브로서 사용될 수 있다. 펩타이드는 예를 들어 진단용 자가항체 매개 병태 타이핑 또는 스크리닝 장치나 키트 또는 절차의 일부로, 동반 진단으로, 환자 계층화를 위해 또는 치료 과정에서 자가항체 수준을 모니터링하기 위해 사용된다.
추가의 양태에서, 본 발명은
- 샘플을 본원에 개시된 바와 같이 정의된 펩타이드(예컨대, P, P1, P2, Pa, 또는 Pb에 대해)와 접촉시키는 단계, 및
- 샘플 내 자기항체의 존재 및/또는 농도를 검출하는 단계를 포함하는 생물학적 샘플에서 자가항체를 검출 및/또는 정량화하는 방법에 관한 것이다.
당업자는 생물학적 샘플에서 항체를 검출 및/또는 정량화하는 방법에 익숙하다. 이 방법은 예를 들어 샌드위치 분석, 바람직하게는 ELISA(enzyme-linked immunosorbent assay) 또는 SPR(surface plasmon resonance) 분석일 수 있다.
바람직하게는, 펩타이드(특히 적어도 10개, 보다 바람직하게는 적어도 100개, 훨씬 더 바람직하게는 적어도 1000개, 특히 적어도 10000개의 본 발명의 상이한 펩타이드)는 고체 지지체, 바람직하게는 ELISA 플레이트 또는 SPR 칩 또는 전기화학, 형광, 자기, 전자, 중력 또는 광학 생체변환기를 갖춘 바이오센서 기반 진단 장치 상에 고정된다. 대안적으로 또는 이에 더하여, 펩타이드(특히 적어도 10개, 보다 바람직하게는 적어도 100개, 훨씬 더 바람직하게는 적어도 1000개, 특히 적어도 10000개의 본 발명의 상이한 펩타이드)는 리포터 또는 단백질 단편 보완 분석(PCA)에 적합한 리포터 단편과 같은 리포터 단편에 커플링될 수 있다; 예컨대, Li 등, 2019, 또는 Kanulainen 등, 2021 참조.
바람직하게는, 샘플은 포유동물, 바람직하게는 사람으로부터 수득된다. 바람직하게는 샘플은 혈액 샘플, 바람직하게는 전혈, 혈청 또는 혈장 샘플이다.
본 발명은 또한 진단 분석, 바람직하게는 상기 본원에 개시된 바와 같은, 바람직하게는 ELISA에서, 본원에 개시된 바와 같이 정의된 펩타이드(예컨대, P, P1, P2, Pa, 또는 Pb에 대한)의 용도에 관한 것이다.
본 발명의 추가의 양태는 바람직하게는 고체 지지체 상에 고정된, 본원에 개시된 바와 같이 정의된 펩타이드(예컨대, P, P1, P2, Pa, 또는 Pb에 대한)를 포함하는 진단 장치에 관한 것이다. 바람직하게는, 고체 지지체는 ELISA 플레이트 또는 표면 플라즈몬 공명 칩이다. 다른 바람직한 예에서, 진단 장치는 전기화학적, 형광, 자기, 전자, 중량 측정 또는 광학 생체변환기를 갖는 바이오센서 기반 진단 장치이다.
또 다른 바람직한 구현예에서, 진단 장치는 측면 유동 분석이다(lateral flow assay).
본 발명은 또한 본원에 개시된 바와 같이 정의된 (예컨대, P, P1, P2, Pa 또는 Pb) 펩타이드를 포함하는 진단 키트, 바람직하게는 본원에 정의된 바와 같은 진단 장치에 관한 것이다. 바람직하게는 진단 키트는 버퍼, 시약, 설명서의 그룹에서 선택된 하나 이상을 추가로 포함한다. 바람직하게는 진단 키트는 ELISA 키트이다.
추가의 양태는 본원에 개시된 바와 같이 정의된 펩타이드(예를 들어, P, P1, P2, Pa 또는 Pb에 대해)를 포함하는 채집 장치에 관한 것이다. 바람직하게는 펩타이드는 고체 담체 상에 고정된다. 채집 장치가 본원에 개시된 바와 같이 정의된(예를 들어, P, P1, P2, Pa 또는 Pb에 대해) 적어도 2개, 바람직하게는 적어도 3개, 보다 바람직하게는 적어도 4개의 상이한 펩타이드를 포함하는 경우 특히 바람직하다. 바람직한 구현예에서 고체 담체는 본 발명의 화합물을 포함한다.
바람직하게는, 고체 담체는 혈액 또는 혈장 흐름과 접촉할 수 있다. 바람직하게는, 고체 담체는 멸균되고 발열원이 없는(pyrogen-free) 컬럼이다.
본 발명의 맥락에서, 개선된 생물이용능(bioavailability)을 위해, 본 발명의 화합물은 25℃에서 적어도 0.1 μg/ml, 바람직하게는 적어도 1 μg/ml, 보다 바람직하게는 적어도 10 μg/ml, 심지어 보다 바람직하게는 적어도 100 μg/ml, 특히 적어도 1000 μg/ml의 수중 용해도를 갖는 것이 바람직하다.
본원에 사용된 바와 같은 용어 "예방하는" 또는 "예방"은 환자 또는 대상체 또는 개체가 이러한 질환 상태(disease state) 또는 병태(condition)에 걸릴 위험에 취약하게 되는 경우, 환자 또는 대상체에서의 발생으로부터 질환 상태 또는 병태를 완벽하게 또는 거의 완벽하게 또는 적어도 (바람직하게는 유의적인) 정도로 정지시키는 것을 의미한다.
본 발명의 약제학적 조성물은 바람직하게는 (전형적으로 수성) 액제, (전형적으로 수성) 현탁제(suspension) 또는 (전형적으로 수성) 유제(emulsion)로서 제공된다. 본 발명의 약제학적 조성물에 적합한 부형제는 당해 분야의 기술자에게 공지되어 있고, 본 명세서의 판독시, 예를 들면, 물(특히 주사용수), 염수, 링커액(Ringer's solution), 덱스트로즈 용액, 완충제, 행크 용액(Hank solution), 비히클 형성 화합물(예컨대, 지질), 고정 오일(fixed oil), 에틸 올레이트, 염수 중 5% 덱스트로즈, 등장성 및 화학 안정성을 향상시키는 물질, 완충제 및 방부제이다. 다른 적합한 부형제는 환자(또는 개체)에 대해 유해한 환자(또는 개체)에서 항체의 생산을 자체적으로 유도하지 않는 임의의 화합물이다. 예에는 잘 견딜 수 있는 단백질, 다당류, 폴리락트산, 폴리글리콜산, 중합체성 아미노산 및 아미노산 공중합체가 있다. 이러한 약제학적 조성물은 (약물로서) 당해 분야의 기술자에게 공지된 적절한 과정을 통해(본 명세서의 판독시) 이를 필요로 하는 환자 또는 개체(즉, 본원에서 언급한 질환 또는 병태를 갖거나 이로 발전할 위험을 가진 환자 또는 개체)에게 투여될 수 있다. 상기 약제학적 조성물의 바람직한 투여 경로는 특히 복강내, 피하, 근육내 및/또는 정맥내 투여를 통한 비경구 투여이다. 비경구 투여를 위해, 본 발명의 약제학적 조성물은 바람직하게는 상기 정의한 약제학적으로 허용되는 부형제와 함께 제형화된, 주사가능한 투여량 단위형, 예컨대, 액제(전형적으로 수성 액제), 현탁제 또는 유제로서 제공된다. 그러나, 투여량 및 투여방법은 치료될 개체 환자 또는 개체에 의존한다. 상기 약제학적 조성물은 다른 생물학적 투여량 요법(regimen)으로부터 공지된 임의의 적합한 투여량으로 투여될 수 있거나 주어진 개체에 대해 구체적으로 평가 및 최적화될 수 있다. 예를 들면, 활성제는 약제학적 조성물 속에 1 mg 내지 10 g, 바람직하게는 50 mg 내지 2 g, 특히 100 mg 내지 1 g의 양으로 존재할 수 있다. 일반적인 투여량은 또한 환자의 체중 kg을 기반으로 측정할 수 있고, 예를 들면, 바람직한 투여량은 0.1 mg 내지 100 mg/kg 체중, 특히 1 내지 10 mg/kg 체중(투여 기간 당)의 범위이다. 투여는 예컨대, 1일 1회, 격일에 1회, 주당 1회 또는 2주당 1회일 수 있다. 본 발명의 약제학적 조성물의 바람직한 투여 방식은 비경구 투여이므로, 본 발명에 따른 약제학적 조성물은 바람직하게는 액체이거나 멸균, 탈이온화 또는 증류수 또는 멸균 등장성 인산염 완충된 염수(PBS)와 같은 액체 속에 용해될 준비가 되어 있다. 바람직하게는, 이러한 조성물 1000 μg(무수 중량)은 0.1 내지 990 μg, 바람직하게는 1 내지 900μg, 보다 바람직하게는 10 내지 200μg의 화합물, 및 임의로 1 내지 500 μg, 바람직하게는 1 내지 100 μg, 보다 바람직하게는 5 내지 15 μg(완충제) 염(바람직하게는 최종 용적으로 등장성 완충제를 수득하기 위하여), 및 임의로 0.1 내지 999.9 μg, 바람직하게는 100 내지 999.9 μg, 보다 바람직하게는 200 내지 999 μg의 다른 부형제를 포함하거나 이로 이루어진다. 바람직하게는, 이러한 무수 조성물 100 mg은 멸균된, 탈이온수/증류수 또는 멸균 등장성 인산염 완충된 염수(PBS) 속에 용해되어 0.1 내지 100 ml, 바람직하게는 0.5 내지 20 ml, 보다 바람직하게는 1 내지 10 ml의 최종 용적을 생성한다.
본원에 기술된 활성제 및 약물이 염 형태(즉, 활성제의 약제학적으로 허용되능 염)로 또한 투여될 수 있음은 기술자에게 명백하다. 따라서, 본원의 활성제의 임의의 언급은 또한 이의 임의의 약제학적으로 허용되는 염 형태를 포함할 수 있다.
본 발명의 화합물에 대해 사용된 펩타이드의 화학적 합성 방법은 당해 분야에 잘 공지되어 있다. 물론, 재조합 방법을 사용하여 펩타이드를 생산하는 것이 또한 가능하다. 펩타이드는 미생물, 예를 들면,세균, 효모 또는 진균, 진핵 세포, 예를 들면, 포유동물 또는 곤충 세포, 또는 재조합 바이러스 벡터, 예를 들면, 아데노바이러스, 폭스바이러스, 헤르페스바이러스, 심리키 포레스트 바이러스(Simliki forest virus), 바쿨로바이러스, 신드비스 바이러스(sindbis virus) 또는 센다이 바이러스(sendai virus)에서 생산될 수 있다. 펩타이드를 생산하기에 적합한 세균은 이. 콜라이(E. coli), 비. 서브틸리스(B. subtilis) 또는 이러한 펩타이드를 발현할 수 있는 임의의 다른 세균을 포함한다. 본 발명의 펩타이드를 발현하기에 적합한 효모 세균은 사카로마이세스 세레비지아에(Saccharomyces cerevisiae), 시크조사카로마이세스 폼베(Schizosaccharomyces pombe), 칸디다(Candida), 피키아파스토리스(Pichiapastoris) 또는 펩타이드를 발현할 수 있는 임의의 다른 효모를 포함한다. 상응하는 수단 및 방법은 당해 분야에 잘 공지되어 있다. 또한, 재조합적으로 생산된 펩타이드를 단리 및 정제하는 방법은 당해 분야에 잘 공지되어 있고 예컨대, 겔 여과, 친화성 크로마토그래피, 이온 교환 크로마토그래피 등을 포함한다.
유리하게는, 시스테인 잔기를 N- 및/또는 C-말단에서 펩타이드에 가하여 특히 생물중합체 스캐폴드에 대한 커플링을 촉진시킨다.
상기 펩타이드의 단리를 용이하게 하기 위하여, 융합 폴리펩타이드를 제조할 수 있고 여기서 펩타이드는 친화성 크로마토그래피에 의한 단리를 가능하도록 하는 이종 폴리펩타이드에 해독적으로 융합(공유결합으로 연결)된다. 대표적인 이종 폴리펩타이드는 His-Tag(예컨대, His6; 6 히스티딘 잔기), GST-Tag(글루타티온-S-트랜스퍼라제) 등이다. 융합 폴리펩타이드는 펩타이드의 정제를 촉진할 뿐만 아니라 정제 단계 동안 펩타이드의 분해를 방지할 수 있다. 정제 후 이종 폴리펩타이드를 제거하는 것이 요구되는 경우, 융합 폴리펩타이드는 펩타이드와 이종 폴리펩타이드 사이의 접합(junction)에서 절단 부위를 포함할 수 있다. 절단 부위는 이러한 부위에서 아미노산 서열에 대해 특이적인 효소(예컨대, 프로테아제)로 절단되는 아미노산 서열로 이루어질 수 있다.
생물중합체 스캐폴드에 펩타이드/펩타이드 n-머를 연결(예컨대, 헤테로이작용성 화합물, 예를 들면, GMBS 및 물론 또한 문헌: "Bioconjugate Techniques", Greg T. Hermanson에 기술된 바와 같은 다른 것)시키는데 사용되거나 본 발명의 맥락에서 펩타이드에 스페이스를 접합시키는데 사용된 커플링/접합 화학은 또한 당해 분야의 기술자에게 공지된 반응으로부터 선택될 수 있다. 생물중합체 스캐폴드 자체는 재조합작으로 생산될 수 있거나 천연 공급원으로부터 수득될 수 있다.
여기서, "분자 B에 대해 특이적인 분자 A"에서와 같이 용어 "~에 대해 특이적인"은 분자 A가 개체의 체(body)내 다른 분자와 비교하여 분자 B에 대한 결합 선호도를 갖는다. 전형적으로, 이는 분자 A(예를 들면, 항체)는 (즉, 보다 더 강한") 1000 nM 미만, 바람직하게는 100 nM 미만, 보다 바람직하게는 50 nM 미만, 심지어 보다 바람직하게는 10 nM 미만, 특히 5 nM 미만인 분자 B(예를 들면, 항원, 특이적으로 이의 결합 에피토프)와 관련하여 해리 상수(또한 "친화성"으로 불림)를 갖는다.
여기서, "UniProt"은 Universal Protein Resource를 지칭한다. UniProt은 단백질 서열에 대한 포괄적인 자원 및 주석 데이타이다. UniProt는 유럽 생물정보 협회(European Bioinformatics Institute)(EMBL-EBI), SIB 스위스 생물정보 협회(SIB Swiss Institute)와 단백질 정보 자원(Protein Information Resource)(PIR) 사이의 공동 작업체이다. 3개의 협회에 걸쳐 100명 이상의 사람들이 상이한 업무, 예를 들면, 데이타베이스 큐레이션(database curation), 소프트웨어 개발 및 지원(software development and support)을 통해 포함된다. Website: https://www.uniprot.org/
UniProt 데이타베이스내 기입은 이의 수탁 코드(본원에서 예컨대, "UniProt 수탁 코드" 또는 요약하면 "UniProt"에 이은 수탁 코드로 지칭됨), 일반적으로 6개의 영숫자 문자(alphanumeric letter)의 코드(예컨대, "Q1HVF7")에 의해 확인된다. 달리 구체화되지 않는 경우, 본원에 사용된 수탁 코드는 UniProt의 단백질 지식베이스(UniProtKB)내 기입을 지칭한다. 달리 기술하지 않는 한, 본원에 지칭된 모든 기입에 대한 UniProt 데이타베이스 상태는 2020년 9월 22일부터이다(UniProt/UniProtKB Release 2020_04).
본원의 맥락에서, 서열 변이체(UniProt에서 "천연 변이체"로서 지정됨)는 UniProt 데이타베이스 기입을 지칭하는 경우 명확하게 포함된다.
참고 폴리펩타이드 또는 단백질 서열와 관련하여 "아미노산 서열 동일성(sequence identity) 퍼센트(%)" 또는 "X% 동일한"(예를 들면, "70% 동일한")은 필요한 경우 최대 서열 동일성 퍼센트를 달성하기 위하여, 서열을 정렬하고 갭(gap)을 도입한 후, 및 서열 동일성의 부분으로서 임의의 보존적 치환을 고려하지 않고, 참고 폴리펩타이드 서열내 아미노산 잔기와 동일한 후보물 서열내 아미노산 잔기의 퍼센트로 정의된다. 아미노산 서열 동일성 퍼센트를 측정할 목적을 위한 정렬은 당해 분야의 기술내 다양한 방식으로, 예를 들면, 공공 이용가능한 컴퓨터 소프트웨어, 예를 들면, BLAST, BLAST-2, ALIGN, ALIGN-2, Megalign(DNASTAR) 또는 EMBOSS 소프트웨어 패키지의 "니들(needle)" 쌍식 서열 정렬 적용을 사용하여 달성할 수 있다. 당해 분야의 기술자는 서열을 정렬하기에 적절한 매개변수, 예를 들면, 비교하는 서열의 전체 길이에 걸쳐 최대 정렬을 달성하는데 요구되는 임의의 알고리즘을 측정할 수 있다. 그러나, 본원의 목적을 위해, 아미노산 서열 동일성 값%는 EMBOSS 소트트웨어 패키지(European Molecular Biology Laboratory로부터 공공 이용가능함; Rice 등, 2000)의 컴퓨터 프로그램 "니들"의 서열 정렬을 사용하여 계산한다.
니들 프로그램(needle program)은 웹 사이트 http://www.ebi.ac.uk/Tools/psa/emboss_needle/하에 수탁되거나 http://emboss.sourceforge.net/로부터 EMBOSS 패키지의 부분으로서 국소 설치를 위해 다운로드된다. 이는 많은 널리 사용된 Linux 같은 UNIX 운용 시스템에서 작동한다.
2개의 단백질 서열을 정렬하기 위하여, 니들 프로그램은 바람직하게는 다음의 매개변수로 작동한다:
명령행(Commandline): needle -auto -stdout -asequence SEQUENCE_FILE_A -bsequence SEQUENCE_FILE_B -datafile EBLOSUM62 -gapopen 10.0 -gapextend 0.5 -endopen 10.0 -endextend 0.5 -aformat3 pair -sprotein1 -sprotein2 (Align_format: pair Report_file: stdout)
주어진 아미노산 서열 B(이는 대안적으로 주어진 아미노산 서열 B에 대해, 이와, 또는 이에 대해 특정의 아미노산 서열 동일성%를 갖거나 이를 포함하는 주어진 아미노산 서열 A로서 대안적으로 표현될 수 있다)에 대해, 이와 함께, 또는 이에 대해 주어진 아미노산 서열 A의 아미노산 서열 동일성%는 다음과 같이 계산된다:
분획 X/Y 100배
여기서 X는 A 및 B의 이러한 프로그램 정렬에서 서열 정렬 프로그램 니들에 의한 동일한 매치로 기록된 아미노산 잔기의 수이고, 여기서 Y는 B에서 아미노산 잔기의 총 수이다. 아미노산 서열 A의 길이가 아미노산 서열 B의 길이와 동일하지 않을 경우, B에 대한 A의 아미노산 서열 동일성%는 A에 대한 B의 아미노산 서열 동일성%와 동일하지 않을 것임이 인식될 것이다. "A의 서열이 B의 전체 서열에 대해 N% 이상 동일한 경우, Y는 B의 전체 서열 길이이다(즉, B에서 아미노산 잔기의 전체 수). 구체적으로 달리 기술하지 않는 한, 본원에 사용된 아미노산 서열 동일성 값의 모든 %는 니들 컴퓨터 프로그램을 사용한 바로 위 단락에 기술된 바와 같이 수득된다.
본 발명은 또한 다음의 구현예에 관한 것이다:
구현예 1. 생물중합체(biopolymer) 스캐폴드 및 6-13개 아미노산의 서열 길이를 갖는 2개 이상의 펩타이드를 포함하는 화합물로서,
여기서 각각의 펩타이드는 독립적으로 다음으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는, 바람직하게는 (바람직하게는 인간) 신경수용체의 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 훨씬 더 바람직하게는 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고:
P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6, Q9Y6J6, P48058, P55087, Q9BPU6, P52799, P15328, Q05329, Q16653, Q9Y4C0, Q5F0I5, Q99719, P17600, Q13148, P01266, P07202, 및 Q9Y6A1, (바람직하게는 하기 표 1, 표 2 또는 표 3, 특히 표 1 또는 표 3에서 선택된 UniProt 접근 코드에 의해 식별됨),
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환되는 화합물.
구현예 2. 구현예 1의 화합물로서,
여기서 상기 아미노산 서열은 다음으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 바람직하게는 자율신경계의 (바람직하게는 인간) 신경수용체의 아미노산 서열인, 화합물: P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1; P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, 및 P48664.
구현예 3. 구현예 1 또는 2의 화합물로서, 여기서 상기 아미노산 서열은 무스카린성 및 니코틴성 콜린성 수용체, 알파- 및 베타-아드레날린성 수용체, 세로토닌 수용체, 안지오텐신- 및 엔도텔린 수용체로 구성된 군으로부터 선택되는 (바람직하게는 인간) 신경수용체의 아미노산 서열인, 화합물.
구현예 4. 구현예 1 내지 3 중 어느 하나의 화합물로서, 여기서 상기 아미노산 서열은 P08588, P07550, P20309 및 P08173으로 구성된 군에서 선택된 UniProt 접근 코드로 식별되며, 바람직하게는 베타-1 아드레날린성 수용체, 베타-2 아드레날린성 수용체, M3 무스카린 아세틸콜린 수용체 및 M4 무스카린 아세틸콜린 수용체로 구성된 군으로부터 선택되는 (바람직하게는 인간) 신경수용체의 아미노산 서열인, 화합물.
구현예 5. 구현예 1 내지 4 중 어느 하나의 화합물로서, 여기서 상기 아미노산 서열은 하기로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 아미노산 서열인, 화합물: P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086 및 P48664.
구현예 6. 구현예 1 내지 4 중 어느 하나의 화합물로서, 여기서 상기 아미노산 서열은 하기로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 아미노산 서열인, 화합물: P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6 및 Q9Y6J6.
구현예 7. 구현예 1 내지 4 중 어느 하나의 화합물로서, 여기서 상기 아미노산 서열은 하기로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 아미노산 서열인, 화합물: O00555, O43497, O95180, P02708, P18505, P31644, P41594, P42263, Q00975, Q01668, Q05586, Q13224, Q13936, Q14957, Q15878, Q16445, Q8TCU5, Q9P0X4, A6NGN9, O15399, O60840, P14416, P16473, P23415, P34903, P42261, P42262, P42658, P47869, Q09470, Q12879, Q13255, Q9UHC6, O15146, O95970, P14867, P28472, P47870, P48169, 및 P49418.
구현예 8. 구현예 1 내지 4 중 어느 하나의 화합물, 여기서 상기 아미노산 서열은 하기로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는 아미노산 서열인, 화합물: P02708, P18505, P31644, P41594, P42263, Q05586, Q13224, Q13936, Q14957, Q16445, Q8TCU5, O15399, P14416, P23415, P34903, P42261, P42262, P47869, Q12879, Q13255, P14867, P28472, P47870, 및 P48169.
구현예 9. 구현예 1 내지 8 중 어느 하나의 화합물로서, 여기서 적어도 하나의 펩타이드(바람직하게는 각각의 펩타이드)에 대해, 상기 아미노산 단편은 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나(단, 상기 아미노산 서열의 UniProt 접근 코드와 표 1에 제공된 서열번호의 UniProt 접근 코드는 동일함), 특히 서열번호 45-201 중 어느 하나(단, 상기 아미노산 서열의 UniProt 접근 코드와 표 1에 제공된 서열번호의 UniProt 접근 코드는 동일함)로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고(단, 상기 아미노산 서열의 UniProt 접근 코드와 표 1에 기재된 서열번호 의 UniProt 접근 코드는 동일함), 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된, 화합물.
구현예 10. 구현예 1 내지 9 중 어느 하나의 화합물로서, 여기서, 적어도 하나의 펩타이드에 대해(바람직하게는 각각의 펩타이드에 대해), 상기 아미노산 단편은 표 3에 열거된 서열의 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고(단, 상기 아미노산의 UniProt 접근 코드는 표 3에 나열된 상기 서열의 UniProt 접근 코드는 동일), 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된, 화합물.
구현예 11. 구현예 1 내지 10 중 어느 하나의 화합물로서, 상기 단편의 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
구현예 12. 구현예 1 내지 10 중 어느 하나의 화합물로서, 상기 단편의 3개의 아미노산은 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
구현예 13. 구현예 1 내지 10 중 어느 하나의 화합물로서, 상기 단편의 2개의 아미노산은 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
구현예 14. 구현예 1 내지 10 중 어느 하나의 화합물로서, 상기 단편의 1개의 아미노산은 임의의 다른 아미노산으로 치환되는 화합물.
구현예 15. 구현예 1 내지 14 중 어느 하나의 화합물로서, 상기 생물중합체 스캐폴드는 인간 단백질인 화합물.
구현예 16.
구현예 1 내지 15 중 어느 하나의 화합물로서, 여기서 적어도 2개의 펩타이드는 펩타이드 P1 및 펩타이드 P2를 포함하고, 여기서 P1 및 P2는 독립적으로 구현예 1 내지 14 중 어느 하나에 정의된 아미노산 서열의 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 특히 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고, 여기서 P1 및 P2는 펩타이드 이량체 P1-S-P2의 형태로 존재하며, 여기서 S는 비-펩타이드 스페이서이고, 여기서 펩타이드 이량체는 바람직하게는 링커를 통해 생물중합체 스캐폴드에 공유 결합된 화합물.
구현예 17.
구현예 1 내지 16 중 어느 하나의 화합물로서, 여기서 상기 생물중합체 스캐폴드는 인간 글로불린 및 인간 알부민으로부터 선택되는 화합물.
구현예 18. 구현예 1 내지 17 중 어느 하나의 화합물로서, 적어도 2개의 펩타이드 중 적어도 하나는 환형화된 화합물.
구현예 19. 구현예 1 내지 18 중 어느 하나의 화합물로서, 적어도 2개의 펩타이드 각각은 환형화된 화합물.
구현예 20. 구현예 1 내지 19 중 어느 하나의 화합물로서, 상기 화합물은 인간에서 비-면역원성인 화합물.
구현예 21. 구현예 1 내지 20 중 어느 하나의 화합물로서, 상기 생물중합체 스캐폴드는 인간 트랜스페린 및 인간 알부민으로부터 선택되는 화합물.
구현예 22.
- 생물중합체 스캐폴드(biopolymer scaffold) 및 적어도
- 하기 화학식의 제1의 펩타이드 n-머(peptide n-mer):
P ( - S - P ) (n-1) 및
- 하기 화학식의 제2의 펩타이드 n-머:
P ( -
S -
P )
(n-1)
를 포함하는 화합물, 바람직하게는 구현예 1 내지 21 중 어느 하나의 화합물 로서,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서(non-peptide spacer)이고,
여기서 각각의 펩타이드 n-머에 대해 독립적으로, n은 적어도 1, 바람직하게는 적어도 2, 보다 바람직하게는 적어도 3, 특히 적어도 4의 정수이고,
여기서 펩타이드 n-머 각각은, 바람직하게는 링커(linker) 각각을 통해, 생물중합체 스캐폴드에 결합된 화합물.
구현예 23. 구현예 22의 화합물로서, 여기서 P의 적어도 하나의 경우는 환형화된 펩타이드이거나, 바람직하게는 여기서 모든 경우의 P의 적어도 10%는 환형화된 펩타이드이거나, 보다 바람직하게는 여기서 모든 경우의 P의 적어도 25%는 환형화된 펩타이드이거나, 여전히 보다 바람직하게는 여기서 모든 경우의 P의 적어도 50%는 환형화된 펩타이드이거나, 심지어 보다 바람직하게는 여기서 모든 경우의 P의 적어도 75%는 환형화된 펩타이드이거나, 여전히 심지어 보다 바람직하게는 여기서 P의 모든 경우의 적어도 90%는 환형화된 펩타이드이거나 심지어 여기서 모든 경우의 P의 적어도 95%는 환형화된 펩타이드이고, 특히 여기서 P의 모든 경우는 환형화된 펩타이드인 화합물.
구현예 24. 구현예 22 또는 23의 화합물로서, 여기서, 각각의 펩타이드 n-머에 대해 독립적으로, n은 적어도 2, 보다 바람직하게는 적어도 3, 특히 적어도 4인 화합물.
구현예 25. 구현예 22 내지 24 중 어느 하나의 화합물로서, 여기서, 펩타이드 n-머 각각에 대해 독립적으로, n은 10 미만, 바람직하게는 9 미만, 보다 바람직하게는 8 미만, 심지어 보다 바람직하게는 7 미만, 여전히 심지어 보다 바람직하게는 6 미만, 특히 5 미만인 화합물.
구현예 26. 구현예 22 내지 25 중 어느 하나의 화합물로서, 여기서, 각각의 펩타이드 n-머에 대해 n은 2인 화합물.
구현예 27. 구현예 22 내지 26 중 어느 하나의 화합물로서, 여기서, P의 적어도 1회 경우는 Pa이고/이거나 P의 적어도 1회 경우는 Pb이고,
여기서 Pa 및 Pb는 각각 독립적으로 구현예 1 내지 14 중 어느 하나에 정의된 펩타이드인 화합물.
구현예 28. 구현예 22 내지 27 중 어느 하나의 화합물로서, 여기서, 각각의 경우에 독립적으로, P는 Pa 또는 Pb인 화합물.
구현예 29. 구현예 22 내지 28 중 어느 하나의 화합물로서, 여기서, 제1의 펩타이드 n-머에서, P의 각각의 경우는 Pa이고, 제2의 펩타이드 n-머에서, P의 각각의 경우는 Pb인 화합물.
구현예 30. 구현예 22 내지 29 중 어느 하나의 화합물로서, 여기서
제1의 펩타이드 n-머는 P a - S - P a 이고 제2의 펩타이드 n-머는 P a - S - P a 이거나;
제1의 펩타이드 n-머는 P a - S - P a 이고 제2의 펩타이드 n-머는 P b - S - P b 이거나;
제1의 펩타이드 n-머는 P a - S - P a 이고 제2의 펩타이드 n-머는 P b - S - P b 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P a - S - P b 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P a - S - P a 이거나;
제1의 펩타이드 n-머는 P a - S - P b 이고 제2의 펩타이드 n-머는 P b - S - P b 인 화합물.
구현예 31. - 생물중합체 스캐폴드 및 적어도
- 화학식 P a - S - P a 또는 P a - S - P b 의 펩타이드 이량체인 제1의 펩타이드 n-머를 포함하는 화합물로서,
여기서 Pa 및 Pb는 각각 독립적으로 구현예 1 내지 14 중 어느 하나에서 정의된 바와 같은 펩타이드이고, S는 비- 펩타이드 스페이서이고,
여기서 제1의 펩타이드 n-머는, 바람직하게는 링커를 통해, 생물중합체 스캐폴드에 결합된 화합물.
구현예 32. 구현예 31의 화합물로서, 화학식 P b - S - P b 또는 P a - S - P b 의 펩타이드 이량체인 제2의 펩타이드 n-머를 추가로 포함하고,
여기서 제2의 펩타이드 n-머는 바람직하게는 링커를 통해 생물중합체 스캐폴드에 결합된 화합물.
구현예 33. 구현예 22 내지 30 및 32 중 어느 하나의 화합물로서, 여기서 제1의 펩타이드 n-머는 제2의 펩타이드 n-머와는 상이한 화합물.
구현예 34. 구현예 27 내지 33 중 어느 하나의 화합물로서, 여기서 펩타이드 Pa는 펩타이드 Pb와 상이하고, 바람직하게는 여기서 펩타이드 Pa 및 펩타이드 Pb는 동일한 항원의 2개의 상이한 에피토프 또는 동일한 에피토프의 2개의 상이한 에피토프 부분인 화합물.
구현예 35. 구현예 27 내지 34 중 어느 하나의 화합물로서, 여기서 펩타이드 Pa 및 펩타이드 Pb는 동일한 아미노산 서열 단편을 포함하고, 여기서 아미노산 서열 단편은 적어도 2개의 아미노산, 바람직하게는 적어도 3개의 아미노산, 보다 바람직하게는 적어도 4개의 아미노산, 여전히 보다 바람직하게는 적어도 5개의 아미노산, 심지어 보다 바람직하게는 적어도 6개의 아미노산, 여전히 심지어 보다 바람직하게는 적어도 7개의 아미노산, 특히 적어도 8개의 아미노산 또는 심지어 적어도 9개의 아미노산의 길이를 갖는 화합물.
구현예 36. 구현예 27 내지 35 중 어느 하나의 화합물로서, 여기서 Pa 및/또는 Pb가 환형화된 화합물.
구현예 37. 구현예 27 내지 36 중 어느 하나의 화합물로서, 여기서 화합물이 다수의 상기 제1의 펩타이드 n-머 및/또는 다수의 상기 제2의 펩타이드 n-머를 포함하는 화합물.
구현예 38. 구현예 1 내지 37 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 단백질, 바람직하게는 포유동물 단백질, 예를 들면, 사람 단백질, 비-사람 영장류 단백질, 양(sheep) 단백질, 돼지 단백질, 개 단백질 또는 설치류 단백질인 화합물.
구현예 39. 구현예 1 내지 38 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 글로불린인 화합물.
구현예 40. 구현예 1 내지 39 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 면역글로불린, 알파1-글로불린, 알파2-글로불린 및 베타-글로불린으로 구성된 군으로부터 선택된 화합물.
구현예 41. 구현예 1 내지 40 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 면역글로불린 G, 합토글로빈(haptoglobin) 및 트랜스페린으로 구성된 군으로부터 선택된 화합물.
구현예 42. 구현예 1 내지 41 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 합토글로빈인 화합물.
구현예 43. 구현예 1 내지 38 중 어느 하나의 화합물로서, 여기서 생물중합체 스캐폴드가 알부민인 화합물.
구현예 44. 구현예 38의 화합물로서, 여기서 생물중합체 스캐폴드는 항-CD163 항체(즉, CD163 단백질에 특이적인 항체) 또는 이의 CD163-결합 단편인 화합물.
구현예 45. 구현예 44의 화합물로서, 여기서 항-CD163 항체 또는 이의 CD163-결합 단편은 사람 CD163에 특이적 및/또는 CD163의 세포외 영역, 바람직하게는 CD163의 SRCR 도메인, 보다 바람직하게는 CD163의 SRCR 도메인 1-9 중 어느 하나, 심지어 보다 바람직하게는 CD163의 SRCR 도메인 1-3 중 어느 하나, 특히 CD163의 SRCR 도메인 1에 특이적인 화합물.
구현예 46. 구현예 44 또는 45의 화합물로서, 여기서 항-CD163 항체 또는 이의 CD163-결합 단편은:
7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드로, 여기서 상기 펩타이드는 아미노산 서열 CSGRVEVKVQEEWGTVCNNGWSMEA (서열번호 3) 또는 이의 7 내지 24개 아미노산 단편을 포함하거나;
7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드로, 여기서 상기 펩타이드는 아미노산 서열 DHVSCRGNESALWDCKHDGWG(서열번호 13) 또는 이의 7 내지 20개 아미노산 단편을 포함하거나; 또는
7 내지 25개, 바람직하게는 8 내지 20개, 심지어 보다 바람직하게는 9 내지 15개, 특히 10 내지 13개의 아미노산으로 구성된 펩타이드로, 여기서 상기 펩타이드는 아미노산 서열 SSLGGTDKELRLVDGENKCS(서열번호 24) 또는 이의 7 내지 19개의 아미노산 단편을 포함하는 펩타이드 중 하나에 특이적인 화합물.
구현예 47. 구현예 44 또는 45의 화합물로서, 여기서 항-CD163 항체 또는 이의 CD163-결합 단편이 아미노산 서열 ESALW(서열번호 14) 또는 ALW를 포함하는 펩타이드에 대해 특이적인 화합물.
구현예 48. 구현예 44 또는 45의 화합물로서, 여기서 항-CD163 항체 또는 이의 CD163-결합 단편은 아미노산 서열 GRVEVKVQEEW (서열번호 4), WGTVCNNGWS (서열번호 5) 또는 WGTVCNNGW (서열번호 6)을 포함하는 펩타이드에 특이적인 화합물.
구현예 49. 구현예 44 또는 45의 화합물로서, 여기서 항-CD163 항체 또는 그의 CD163-결합 단편은 아미노산 서열 SSLGGTDKELR(서열번호 25) 또는 SSLGG(서열번호 26)를 포함하는 펩타이드에 특이적인 화합물.
구현예 50. 구현예 1 내지 49 중 어느 하나의 화합물로서, 여기서 화합물은 포유동물, 바람직하게는 인간, 비인간 영장류, 양, 돼지, 개 또는 설치류에서 비-면역원성인 화합물.
구현예 51. 구현예 1 내지 50 중 어느 하나의 화합물로서, 여기서 화합물은 개체, 바람직하게는 개체의 혈류에서 적어도 하나의 항체의 체내 제거(또는 체내 고갈) 및/또는 개체, 바람직하게는 개체의 혈류에서 적어도 하나의 항체의 역가 감소를 위한 것인 화합물.
구현예 52. 구현예 1 내지 51 중 어느 하나의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제3의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pc이고, 여기서 Pc는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pc는 환형화된 화합물.
구현예 53. 구현예 52의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제4의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pd이고, 여기서 Pd는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pd는 환형화된 화합물.
구현예 54. 구현예 53의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제5의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pe이고, 여기서 Pe는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pe는 환형화된 화합물.
구현예 55. 구현예 54의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제6의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pf이고, 여기서 Pf는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pf는 환형화된 화합물.
구현예 56. 구현예 55의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제7의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pg이고, 여기서 Pg는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pg는 환형화된 화합물.
구현예 57. 구현예 56의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제8의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Ph이고, 여기서 Ph는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Ph는 환형화된 화합물.
구현예 58. 구현예 57의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제9의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pi이고, 여기서 Pi는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pi는 환형화된 화합물.
구현예 59. 구현예 58의 화합물로서, 여기서 상기 화합물은 적어도
하기 화학식의 제10의 펩타이드 n-머(peptide n-mer):
P ( ― S ― P ) (n-1)
를 더 포함하고,
여기서, 각 경우에 독립적으로, P는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고, S는 비-펩타이드 스페이서이고,
바람직하게는 여기에서 P의 각각의 경우는 Pj이고, 여기서 Pj는 구현예 1 내지 14 중 어느 하나에 정의된 바와 같은 펩타이드이고,
바람직하게 여기서 Pj는 환형화된 화합물.
구현예 60. 구현예 22 내지 59 중 어느 하나의 화합물로서, 여기서 펩타이드 n-머 각각은 바람직하게는 각각 링커를 통해 생물중합체 스캐폴드에 공유 결합된 화합물.
구현예 61. 구현예 1 내지 60 중 어느 하나의 화합물로서, 여기서 링커 중 적어도 하나는 이황화 가교(disulphide bridges) 및 PEG 분자로부터 선택되는 화합물.
구현예 62. 구현예 1 내지 61 중 어느 하나의 화합물로서, 여기서 스페이서 S 중 적어도 하나는 PEG 분자 또는 글리칸으로부터 선택되는 화합물.
구현예 63. 구현예 1 내지 62 중 어느 하나의 화합물로서, 제1 펩타이드 n-머는 P a - S - P b 이고 제2 펩타이드 n-머는 P a - S - P b 인 화합물.
구현예 64. 구현예 1 내지 63 중 어느 하나의 화합물로서, 펩타이드 Pa 및 펩타이드 Pb는 동일한 아미노산 서열 단편을 포함하고, 여기서 아미노산 서열 단편은 적어도 5개 아미노산, 더욱 더 바람직하게는 적어도 6개의 아미노산, 훨씬 더 바람직하게는 적어도 7개의 아미노산, 특히 적어도 8개의 아미노산 또는 심지어 적어도 9개의 아미노산의 길이를 갖는, 화합물.
구현예 65. 구현예 1 내지 64 중 어느 하나의 화합물로서, 여기서 화합물은 (인간) 신경수용체에 특이적인 항체의 제거(또는 고갈)를 위한 것이며, 바람직하게는 여기서 신경수용체는 구현예 1 내지 8 중 어느 하나에서 정의된 바와 같은, 화합물.
구현예 66. 구현예 1 내지 65 중 어느 하나의 화합물 및 적어도 하나의 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물.
구현예 67. 구현예 66의 약제학적 조성물로서, 여기서 상기 조성물 중 펩타이드 대 스캐폴드의 몰비가 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 보다 더 바람직하게는 5:1 내지 70:1, 훨씬 더 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1인 약제학적 조성물.
구현예 68. 구현예 66 또는 67의 약제학적 조성물로서, 여기서 조성물이 복강내, 피하, 근육내 및/또는 정맥내 투여를 위해 제조되고/되거나, 여기서 조성물이 반복된 투여용인 약제학적 조성물.
구현예 69. 구현예 66 내지 68 중 어느 하나의 약제학적 조성물, 또는 구현예 22 내지 65 중 어느 하나의 화합물로서, 여기서 조성물 중 펩타이드 P 대 생물중합체 스캐폴드의 몰비는 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 보다 더 바람직하게는 5:1 내지 70:1, 훨씬 더 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1인 약제학적 조성물 또는 화합물.
구현예 70. 구현예 66 내지 69 중 어느 하나의 약제학적 조성물 또는 구현예 27 내지 65 중 어느 하나의 화합물로서, 조성물 내 펩타이드 Pa 대 생물중합체 스캐폴드의 몰비는 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 심지어 보다 바람직하게는 5:1 내지 70:1, 여전히 심지어 보다 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1인 약제학적 조성물 또는 화합물.
구현예 71. 구현예 66 내지 70 중 어느 하나의 약제학적 조성물, 또는 구현예 27 내지 65 중 어느 하나의 화합물로서, 여기서 조성물 속의 펩타이드 Pb 대 생물중합체 스캐폴드의 몰 비가 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 심지어 보다 바람직하게는 5:1 내지 70:1, 여전히 심지어 보다 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1인 약제학적 조성물 또는 화합물.
구현예 72. 구현예 66 내지 71 중 어느 하나의 약제학적 조성물로서, 치료요법에 사용하기 위한, 조성물.
구현예 73. 구현예 66 내지 71 중 어느 하나의 약제학적 조성물로서, 개체에서, 바람직하게는 근육통성 뇌척수염/만성 피로 증후군(ME/CFS), 체위 기립성 빈맥 증후군 (POTS), 자가면역 자율신경절병증(AAG), 특발성 확장성 심근병증(IDC) 및 만성 샤가스 심장병(cChHD) 또는 변연계 뇌염(limbic encephalitis), 또는 부종양 선조체 뇌염(paraneoplastic striatal encephalitis), 또는 항-mGluR1 뇌염, 또는 항-mGluR5 뇌염, 또는 급성 파종성 뇌척수염(ADEM), 또는 NMDAR 뇌염과 같은 뇌염, 부종양 증후군(paraneoplastic syndrome), 강직 증후군(stiff man syndrome), 자가 면역 채널 병증(autoimmune channelopathies), 시신경 척수염(neuromyelitis optica), 신경 근육 긴장(neuromyotonia), 모르반증후군(Morvan's syndrome), 신경병성 통증, 척수염, 시신경염, 망막염, 파킨슨증, 무도병(chorea), 정신병, 디스토니아(dystonia), 무언증(mutism), 운동 장애, 착란(confusion), 환각, 전구 설사(prodromal diarrhoea), 기억 상실, 과흥분(hyperexcitability), 뇌염 정신과 증후군(encephalitis psychiatric syndrome), 기면증, 자폐 스펙트럼 장애(autism spectrum disorders), 발작, 간질 발작 상태, 만성 간질, 근간대 경련(myoclonus), 뇌척수염(encephalomyelitis), 근간대 경련(myoclonus), 사건수면증(parasomnia), 수면 무호흡증(sleep apnoea), 인지 장애, 보행 이상, 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 부종양 증후군(paraneoplastic syndrome), 소뇌 운동 실조증(cerebellar ataxia), 자폐증, 뚜렛, ADHD, 소뇌 운동 실조증(cerebellar ataxia), 진동시(oscillopsia), 근 위축성 측삭 경화증 (ALS), 갑상선 장애 및 신경학적 결손 및 림프구증가증(HaNDL)을 동반한 두통으로부터 선택되는 자가항체-매개 병태의 예방 또는 치료에 사용하기 위한, 조성물.
구현예 74. 구현예 72 또는 73에 따라 사용하기 위한 약제학적 조성물로서, 여기서 약제학적 조성물은 96시간 범위 내, 바람직하게는 72시간 범위 내, 더 바람직하게는 48시간 범위 내, 훨씬 더 바람직하게는 36시간 범위 내, 훨씬 더 바람직하게는 24시간 범위 내, 특히 18시간 범위 내 또는 심지어 12시간 범위 내에 적어도 2회 투여되는, 조성물.
구현예 75.
구현예 72 내지 74 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 여기서 상기 조성물은 개체의 체중 kg당 화합물 1-1000 mg, 바람직하게는 2-500 mg, 보다 바람직하게는 3-250 mg, 훨씬 더 바람직하게는 4-100 mg, 특히 5-50 mg의 용량으로 투여되는 약제학적 조성물.
구현예 76.
구현예 72 내지 75 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 여기서 상기 조성물은 복강내, 피하, 근육내 또는 정맥내 투여되는, 조성물.
구현예 77.
구현예 72 내지 76 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 여기에서 하나 이상의 항체는 펩타이드 P의 적어도 하나의 경우에 대해, 또는 펩타이드 Pa 및/또는 펩타이드 Pb에 대해 특이적인 개체에 존재하는, 조성물.
구현예 78.
구현예 72 내지 77 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 하나 이상의 항체가 개체에 존재하는, 조성물.
구현예 79. 구현예 72 내지 78 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 여기서 상기 조성물은 개체에서 비면역원성인, 조성물.
구현예 80. 구현예 72 내지 79 중 어느 하나에 따라 사용하기 위한 약제학적 조성물로서, 여기서 상기 조성물은 개체의 체중 kg당 화합물 1-1000 mg, 바람직하게는 2-500 mg, 보다 바람직하게는 3-250 mg, 훨씬 더 바람직하게는 4-100 mg, 특히 5-50 mg의 용량으로 투여되는, 조성물.
구현예 81.
이를 필요로 하는 개체에서 CFS/ME, POTS, AAG, IDC 및 cChHD로부터 선택된 자가항체-매개 병태를 개선 또는 치료하는 방법으로서,
구현예 66 내지 71 중 어느 하나에 정의된 약제학적 조성물을 수득하는 단계; 및
상기 약제학적 조성물의 유효량을 개체게 투여하는 단계를 포함하는 방법.
구현예 82.
구현예 81에 따른 방법으로서, 여기서 상기 방법은 구현예 72 내지 80 중 어느 하나에서와 같이 정의되는, 방법.
구현예 83. 구현예 66 내지 71 중 어느 하나에서 정의한 바와 같은 약제학적 조성물을 수득하는 단계; 및
약제학적 조성물을 개체에게 투여하는 단계를 포함하는, 개체에 존재하는 하나 이상의 항체의 제거(또는 고갈) 방법으로서, 여기서 조성물은 개체에서 비-면역원성이고, 여기서 개체에 존재하는 하나 이상의 항체가 적어도 하나의 경우의 P에 대해, 또는 펩타이드 Pa 및/또는 펩타이드 Pb에 대해 특이적인, 방법.
구현예 84. 구체예 83의 방법으로서, 여기서 하나 이상의 항체는 신경수용체에 특이적이며, 바람직하게는 신경수용체는 구현예 1 내지 8 중 어느 하나에서와 같이 정의되는, 방법.
구현예 85. 구현예 83 또는 84의 방법으로서, 여기서 개체가 비-사람 동물, 바람직하게는 비-사람 영장류, 양, 돼지, 개 또는 설치류, 특히 마우스인, 방법.
구현예 86. 구현예 83 내지 85의 방법으로서, 여기서 생물중합체 스캐폴드가 개체와 관련하여 자가이고, 바람직하게는 여기서 생물중합체 스캐폴드가 자가 단백질인, 방법.
구현예 87. 구현예 83 내지 86 중 어느 하나의 방법으로서, 여기서 조성물이 복강내, 피하, 근육내 또는 정맥내 투여되는, 방법.
구현예 88. (바람직하게는 6-13개 아미노산의 서열 길이를 갖는) 펩타이드로서,
여기서 상기 펩타이드는 다음으로 구성된 군에서 선택된 UniProt 접근 코드로 식별되는 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 훨씬 더 바람직하게는 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고:
P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6, Q9Y6J6, P48058, P55087, Q9BPU6, P52799, P15328, Q05329, Q16653, Q9Y4C0, Q5F0I5, Q99719, P17600, Q13148, P01266, Q9Y6A1 및 P07202,
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된, 펩타이드.
구현예 89. 구현예 88의 펩타이드로서, 상기 펩타이드는 구현예 1 내지 14 중 어느 하나에서와 같이 추가로 정의되는, 펩타이드.
구현예 90. 펩타이드로서, 바람직하게는 7-14개 아미노산의 서열 길이를 갖고, 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열 중 적어도 7개 또는 심지어 적어도 8개, 보다 더 바람직하게는 적어도 9개, 훨씬 더 바람직하게는 적어도 10개, 더욱 더 바람직하게는 적어도 11개, 특히 적어도 12개 또는 심지어 13개의 연속 아미노산을 포함, 바람직하게는 구성되고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된, 펩타이드.
구현예 91. 펩타이드로서, 바람직하게는 7-14개 아미노산의 서열 길이를 갖고, 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열을 포함, 바람직하게는 구성되고, 임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환된, 펩타이드.
구현예 92. 구현예 88 내지 91 중 어느 하나의 펩타이드로서, 선형 또는 환형인 펩타이드.
구현예 93. - 샘플을 구현예 88 내지 92의 펩타이드와 접촉시키는 단계, 및
- 샘플 내 자가항체의 존재 및/또는 농도를 검출하는 단계;를 포함하는
생물학적 샘플에서 자가항체를 검출 및/또는 정량하는 방법.
구현예 94. 구현예 93의 방법에 있어서, 펩타이드는 고체 지지체, 특히 전기화학, 형광, 자기, 전자, 중력 또는 광학 생체변환기를 갖는 바이오센서 기반 진단 장치 상에 고정 및/또는 펩타이드는 리포터 또는 리포터 단편, 예컨대 PCA에 적합한 리포터 단편에 커플링된, 방법.
구현예 95. 구현예 93 또는 94에 있어서, 상기 방법이 샌드위치 검정, 바람직하게는 효소 결합 면역흡착 검정(ELISA)인 방법.
구현예 96. 구현예 93 내지 95 중 어느 하나에 있어서, 상기 샘플은 포유동물, 바람직하게는 사람으로부터 얻어지는 방법.
구현예 97. 구현예 93 내지 96 중 어느 하나에 있어서, 샘플이 혈액 샘플, 바람직하게는 전혈, 혈청 또는 혈장인 방법.
구현예 98. 구현예 88 내지 92에 따른 펩타이드의 효소 결합 면역흡착 검정(ELISA)에서의 용도로, 바람직하게는 구현예 93 내지 97 중 어느 하나에 정의된 방법을 위한 용도.
구현예 99. 구현예 88 내지 92 중 어느 하나에 따른 펩타이드를 포함하는 진단 장치로서, 여기서 상기 펩타이드는 고체 지지체 상에 고정 및/또는 펩타이드는 리포터 또는 리포터 단편, 예컨대 PCA에 적합한 리포터 단편에 커플링된, 진단 장치.
구현예 100. 구현예 99에 따른 진단 장치로서, 고체 지지체가 ELISA 플레이트 또는 표면 플라즈몬 공명 칩인, 진단 장치.
구현예 101. 구현예 99에 따른 진단 장치로서, 상기 진단 장치는 전기화학적, 형광, 자기, 전자, 중력 또는 광학 생체변환기를 갖는 측면 흐름 분석 장치 또는 바이오센서 기반 진단 장치인, 진단 장치.
구현예 102. 진단 키트로서, 구현예 88 내지 92중 어느 하나에 따른 펩타이드, 바람직하게는 구현예 99 내지 101 중 어느 하나에 따른 진단 장치, 및 바람직하게는 완충제, 시약, 설명서의 그룹으로부터 선택되는 하나 이상을 포함하는, 진단 키트.
구현예 103. 채집 장치로서, 구현예 88 내지 92에 따른 펩타이드를 포함하는 채집 장치(apheresis device)로, 바람직하게는 고체 담체 상에 고정된, 채집 장치.
구현예 104. 구현예 103에 따른 채집 장치로서, 고체 담체가 혈액 또는 혈장 흐름과 접촉할 수 있는, 채집 장치.
구현예 105. 고체 담체가 구현예 1 내지 65 중 어느 하나에 따른 화합물을 포함하는, 구현예 95 또는 96에 따른, 채집 장치.
구현예 106. 구현예 103 내지 105 중 어느 하나에 따른 채집 장치로서, 고체 담체가 멸균되고 발열원이 없는 컬럼인, 채집 장치.
구현예 107. 구현예 103 내지 106 중 어느 하나에 따른 채집 장치로서, 상기 채집 장치는 구현예 88 내지 92에 따른 적어도 2개, 바람직하게는 적어도 3개, 보다 바람직하게는 적어도 4개의 상이한 펩타이드를 포함하는, 채집 장치.
본 발명을 이에 한정되지 않는, 다음의 도면 및 실시예로 추가로 나타낸다. 다음의 도면 및 실시예의 맥락에서, 본 발명의 접근법이 기반으로 하는 화합물은 또한 "선택적인 항체 고갈 화합물"(SADC)로 지칭된다.
도 1: SADC는 목적하지 않은 항체의 역가를 성공적으로 감소시킨다. 각각의 화합물은 정의된 항원에 대해 펩타이드 면역화에 의해 예비-면역화된 Balb/c 마우스내로 복강내 투여함으로써 0 시점에 적용시켰다. 각각의 상부 패널(top panel)은 상응하는 항체를 검출하는 표준 ELISA에 따라 OD 값(y_축)에 대한 항-펩타이드 역가(0.5x 희석 단계; X-축은 log(X) 희석을 나타낸다)를 나타낸다. 각각의 하부 패널은 각각의 본 발명의 화합물 주사 전 역가(즉, -48h 및 -24h에서의 역가) 및 각각의 본 발명의 화합물 적용 후(즉, 주사 후 +24h, +48h 및 +72h째 역가; x-축에 나타냄) LogIC50(y-축)를 나타낸다. (A) EBNA1(전자간증과 관련됨)에 대해 지시된 항체에 결합하는 생물중합체 스캐폴드로서 알부민을 지닌 화합물. 마우스를 EBNA-1 모델 에피토프를 수반하는 펩타이드 백신으로 예비-면역화시켰다. (B) 사람 AChR 단백질 MIR(중중 근무력증과 관련됨)로부터 유래된 펩타이드에 대해 지시된 항체에 결합하는 생물중합체 스캐폴드로서 알부민을 지닌 화합물. 마우스를 AChR MIR 모델 에피토르를 수반하는 펩타이드 백신으로 예비-면역화시켰다. (C) EBNA1(전자간증과 관련됨)에 대해 지시된 항체에 결합하는 생물중 합체 스캐폴드로서 면역글로불린을 지닌 화합물. 마우스를 EBNA-1 모델 에피토프를 수반하는 펩타이드 백신으로 예비-면역화시켰다. (D) EBNA1(전자간증과 관련됨)에 대해 지시된 항체에 결합하는 생물중합체 스캐폴드로서 합토글로빈을 지닌 화합물. 마우스를 EBNA-1 모델 에피토프를 수반하는 펩타이드 백신으로 예비-면역화시켰다. (E) 패널 C에 나타낸 실험에서 사용된 EBNA1에 대해 지시된 항체에 결합하는 동일한 면역글로불린-기반 본 발명의 화합물을 사용한 선택성의 증명. 마우스를 관련되지 않은 아미노산 서열로 예비-면역화시켰다. 역가 감소는 발생하지 않았고, 이는 화합물의 선택성을 입증하였다.
도 2: SADC는 비-면역원성이고 마우스 내로 반복된 주사 후 항체 형성을 유도하지 않는다. 동물 C1-C4 뿐만 아니라 동물 C5-C8을 2개의 상이한 본 발명의 화합물로 복강내 처리하였다. 대조군 동물 C를 사람 AChR 단백질 MIR로부터 유래된 KLH-펩타이드로 예방접종하였다. 1:100의 희석에서 표준 ELISA에 의한 항체 역가 검출을 위해, BSA-접합된 펩타이드 프로브 T3-1, T9-1 및 E005(회색 바아, 그래프에서 나타낸 바와 같음)를 각각 사용하여, 백신-처리된 대조군 동물 C(y-축, OD450 nm)와 비교하는 경우, 항체 유도가 본 발명의 화합물로 처리한 동물에서 부재하였음이 입증될 수 있다.
도 3: 1가 또는 2가 펩타이드의 다중 카피를 수반하는 SADC를 사용한 항체의 성공적인 시험관내 고갈. 1가 또는 2가 펩타이드를 지닌 SADC는 항체를 흡수함으로써 이를 고갈시키는데 매우 적합하였다. "1가"는 펩타이드 단량체가 생물중합체 스캐폴드(즉, n=1)에 결합함을 의미하는 반면, "2가"는 펩타이드 이량체가 생물중합체 스캐폴드(즉, n=2)에 결합함을 의미한다. 본 경우에, 2가 펩타이드는 "단독2가 (homodivalent)"인데, 즉, SADC의 펩타이드 n-머는 E006 - 스페이서 - E006)이다.
도 4: 다양한 SADC 생물중합체 스캐폴드를 사용한 마우스에서 신속하고 선택적인 항체 고갈. 모의 처리된(mock treated) 대조군 그룹 SADC-CTL(관련되지 않은 펩타이드 함유)과 비교하는 경우 처리된 그룹은 이미 24 시간째에 신속하고 확실한 항체 감소를 나타내었다(특히 SADC-TF). 알부민 스캐폴 - SADC - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 5: SADC 주사 후 24시간째에 이의 펩타이드 모이어티를 통한 혈장 속의 SADC의 검출. 합토글로빈-스캐폴드-기반 SADC(SADC-HP 및 SADC-CTL)는 SADC-ALB, SADC-IG oder SADC-TF와 같은 다른 생물중합체 스캐폴드를 지닌 SADC보다 장점을 나타내는 비교적 보다 짧은 혈장 반감기를 나타내었다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 6: SADC 주사 후 24시간째에 혈장 속에서 SADC-IgG 복합체의 검출. 합토글로빈 기반 SADC는 다른 생물중합체 스캐폴드를 지닌 SADC와 비교하는 경우 가속화된 청소(clearance)에 처리하였다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 7: SADC-IgG 복합체 형성의 시험관내 분석. 동물 SADC-TF 및 -ALB는 강력한 신호 및 항원-항체 평형으로부터 항원 과다로의 이전으로 인해 1000ng/ml SADC-TF의 경우에 급격한 신호 저하에 의해 반영되는 것으로서 명백한 면역복합체 형성 및 C1q에 대한 결합을 나타내었다. 대조적으로, SADC-HP 또는 SADC-IG를 사용한 시험관내 면역복합체 형성은 존재하는 검정에서 측정시 훨씬 덜 효율적이었다. 이러한 발견은 합토글로빈 스캐폴드가 보체 시스템을 활성화시키기 위한 감소된 경향성(propensity)으로 인하여 다른 SADC 생물중합체 스캐폴드보다 유리하다는 발견을 확증한다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 8: 시험관내에서 SADC에 의한 IgG 포획의 측정. SADC-HP는 SADC-TF 또는 SADC-ALB과 비교하는 경우 시험관내에서 현저히 적은 항체 결합능을 나타내었다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 9: 항-CD163-항체 기반 생물중합체 스캐폴드의 혈액 청소. 마우스 모델에서, mAb E10B10(뮤린 CD163에 특이적)은 mAb Mac2-158(사람 CD163에 특이적이지만 뮤린 CD163에 특이적이지 않으므로 이 실험에서 음성 대조군으로 사용됨)보다 순환에서 심지어 더 빠르게 청소된다.
도 2: SADC는 비-면역원성이고 마우스 내로 반복된 주사 후 항체 형성을 유도하지 않는다. 동물 C1-C4 뿐만 아니라 동물 C5-C8을 2개의 상이한 본 발명의 화합물로 복강내 처리하였다. 대조군 동물 C를 사람 AChR 단백질 MIR로부터 유래된 KLH-펩타이드로 예방접종하였다. 1:100의 희석에서 표준 ELISA에 의한 항체 역가 검출을 위해, BSA-접합된 펩타이드 프로브 T3-1, T9-1 및 E005(회색 바아, 그래프에서 나타낸 바와 같음)를 각각 사용하여, 백신-처리된 대조군 동물 C(y-축, OD450 nm)와 비교하는 경우, 항체 유도가 본 발명의 화합물로 처리한 동물에서 부재하였음이 입증될 수 있다.
도 3: 1가 또는 2가 펩타이드의 다중 카피를 수반하는 SADC를 사용한 항체의 성공적인 시험관내 고갈. 1가 또는 2가 펩타이드를 지닌 SADC는 항체를 흡수함으로써 이를 고갈시키는데 매우 적합하였다. "1가"는 펩타이드 단량체가 생물중합체 스캐폴드(즉, n=1)에 결합함을 의미하는 반면, "2가"는 펩타이드 이량체가 생물중합체 스캐폴드(즉, n=2)에 결합함을 의미한다. 본 경우에, 2가 펩타이드는 "단독2가 (homodivalent)"인데, 즉, SADC의 펩타이드 n-머는 E006 - 스페이서 - E006)이다.
도 4: 다양한 SADC 생물중합체 스캐폴드를 사용한 마우스에서 신속하고 선택적인 항체 고갈. 모의 처리된(mock treated) 대조군 그룹 SADC-CTL(관련되지 않은 펩타이드 함유)과 비교하는 경우 처리된 그룹은 이미 24 시간째에 신속하고 확실한 항체 감소를 나타내었다(특히 SADC-TF). 알부민 스캐폴 - SADC - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 5: SADC 주사 후 24시간째에 이의 펩타이드 모이어티를 통한 혈장 속의 SADC의 검출. 합토글로빈-스캐폴드-기반 SADC(SADC-HP 및 SADC-CTL)는 SADC-ALB, SADC-IG oder SADC-TF와 같은 다른 생물중합체 스캐폴드를 지닌 SADC보다 장점을 나타내는 비교적 보다 짧은 혈장 반감기를 나타내었다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 6: SADC 주사 후 24시간째에 혈장 속에서 SADC-IgG 복합체의 검출. 합토글로빈 기반 SADC는 다른 생물중합체 스캐폴드를 지닌 SADC와 비교하는 경우 가속화된 청소(clearance)에 처리하였다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 7: SADC-IgG 복합체 형성의 시험관내 분석. 동물 SADC-TF 및 -ALB는 강력한 신호 및 항원-항체 평형으로부터 항원 과다로의 이전으로 인해 1000ng/ml SADC-TF의 경우에 급격한 신호 저하에 의해 반영되는 것으로서 명백한 면역복합체 형성 및 C1q에 대한 결합을 나타내었다. 대조적으로, SADC-HP 또는 SADC-IG를 사용한 시험관내 면역복합체 형성은 존재하는 검정에서 측정시 훨씬 덜 효율적이었다. 이러한 발견은 합토글로빈 스캐폴드가 보체 시스템을 활성화시키기 위한 감소된 경향성(propensity)으로 인하여 다른 SADC 생물중합체 스캐폴드보다 유리하다는 발견을 확증한다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 8: 시험관내에서 SADC에 의한 IgG 포획의 측정. SADC-HP는 SADC-TF 또는 SADC-ALB과 비교하는 경우 시험관내에서 현저히 적은 항체 결합능을 나타내었다. 알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC.
도 9: 항-CD163-항체 기반 생물중합체 스캐폴드의 혈액 청소. 마우스 모델에서, mAb E10B10(뮤린 CD163에 특이적)은 mAb Mac2-158(사람 CD163에 특이적이지만 뮤린 CD163에 특이적이지 않으므로 이 실험에서 음성 대조군으로 사용됨)보다 순환에서 심지어 더 빠르게 청소된다.
실시예 1-10은 항체의 선택적 제거를 입증하는 SADC의 일반적인 작동 원리에 관한 것이다. 실시예 11은 CFS/ME, POTS, AAG, IDC, 및 cChHD에 대한 이 치료 개념의 특정 적용에 관한 것이다.
실시예
1:
SADC는
목적하지 않은 항체의
역가를
효과적으로 감소시킨다.
동물 모델: 사람 처방에서 환형의 목적하지 않은 항체의 측정가능한 역가를 지닌 생체내 모델을 제공하기 위하여, BALB/c 마우스를 확립된 하람 자가항원 또는 항-약물 항체로부터 유래된 KLH-접합된 펩타이드 백신을 사용한 표준 실험 예방접종을 사용하여 면역화시켰다. 표준 펩타이드 ELISA에 의한 역가 평가 후, 면역화된 동물을 상응하는 시험 SADC로 처리하여 SADC 처리에 의한 선택적인 항체 저하를 입증하였다. 모든 실험을 상응하는 동물 윤리에 의한 안내에 따라 수행하였다.
모델 항원을 사용한 마우스의 면역화: 암컷 BALB/c 마우스(8 내지 10주령)는 Janvier(프랑스)가 제공하였으며, 12시간 광/12시간 암 주기 하에 유지시키고 사료 및 물을 자유로이 접근하도록 하였다. 면역화는 2주 간격으로 3회 주사한 KLH 담체-접합된 펩타이드 백신의 피하 적용에 의해 수행하였다. KLH 접합체를, 바이러스 항원(EBNA-1)과 내인성 사람 수용체 항원, 즉, 자간전증과 관련된 것으로 밝혀진(Elliott 등), 태반 GPR50 단백질 사이의 분자 모조품(mimicry)에 대한 예를 나타낸, 펩타이드 T3-2(서열번호 33: CGRPQKRPSCIGCKG)를 사용하여 생성시켰다. 이러한 접근법의 일반화를 확립하기 위하여, 자가면역 병태 중증 근무력증으로부터 유래된 보다 큰 항원성 펩타이드를 사람 자가에피토프를 사용한 마우스의 면역화에 사용하였다. 펩타이드 T3-2와 유사하게, 동물을 질환의 병리학에 근본 역활을 하는 사람 AChR 단백질의 MIR(주요 면역원성 영역)으로부터 유래된 펩타이드 T1-1(서열번호 34: LKWNPDDYGGVKKIHIPSEKGC)으로 면역화시켰다(Luo 등). T1-1 펩타이드는 마우스를 사람 AChR 자가항원의 대용 부분 모델 에피토프를 사용하여 면역화시키기 위해 사용하였다. 펩타이드 T8-1(서열번호 35: DHTLYTPYHTHPG)을 사용하여 대조군 마우스를 면역화시킴으로써 시스템의 선택성의 입증을 위한 대조군 역가를 제공하였다. 백신 접합체 제조를 위해, KLH 담체(Sigma)를 설포-GMBS(제품 번호 22324 Thermo)로 제조업자의 지시에 따라 활성화시킨 후, N- 또는 C-말단적으로 시스테이닐화된(cysteinylated) 펩타이드 T3-2 및 T1-1 중의 하나를 첨가하고 Alhydrogel®을 최종 첨가한 후 동물의 옆구리에 주사하였다. 백신 T3-2 및 T1-1에 대한 용량은 용량당 1%의 최종 농도에서 Alhydrogel®(InvivoGen VAC-Alu-250)을 함유하는 주사 당 100μg의 용적 속에 15ul의 접합체이었다.
환형 SADC의 생성: T3-2 및 T1-1 면역화된 마우스의 DSDC에 의한 선택적인 항체 저하 활성을 시험하기 위하여, SADC를 생물중합체 스캐폴드로서 마우스 혈청 알부민(MSA) 또는 마우스 면역글로불린(마우스-Ig)을 사용하여 제조함으로써 마우스에서 어떠한 면역 반응도 유도하지 않을, 자가 생물중합체 스캐폴드를 생성시키거나, 생물중합체 스캐폴드(이는 72시간내 1회 주사 후 동종면역 반응을 유도하지 않았다)로서 비-자가 사람 합토글로빈을 생성시켰다. N-말단으로 시스테이닐화된 SADC 펩타이드 E049(서열번호 36: GRPQKRPSCIG) 및/또는 C-말단으로 시스테이닐화된 SADC 펩타이드 E006(서열번호 37: VKKIHIPSEKG)를 스캐폴드에 설포-GMBS(제품 번호 22324 Thermo)-활성화된 MSA(Sigma; 제품 번호 A3559) 또는 -마우스-Ig(Sigma, I5381) 또는 -사람 합토글로빈(Sigma H0138)을 사용하여 제조업자의 설명서에 따라 연결시킴으로써, 상응하는 생물중합체 스캐폴드의 라이신에 공유결합으로 부착된, MSA-, Ig- 및 합토글로빈-기반 SADC를 제공하였다. 이작용성 아민-대-설프하이드릴 가교 결합제를 통해 라이신에 대한 시스테이닐화된 펩타이드의 접합 외에도, 첨가된 시스테이닐화된 SADC 펩타이드의 부위를 알부민 스캐폴드 단백질의 시스테인의 설프하이드릴 그룹과 반응시켰으며, 이는 접합체를 DTT로 처리한 다음 유리 펩타이드를 진량 분광법 또는 유리 펩타이드를 검출하는 임의의 다른 분석 방법을 사용한 후속적인 검출로 검출할 수 있다. 최종적으로, 이러한 SADC 접합체는 물에 대해 Pur-A-Lyzer™(Sigma)을 사용하여 투석하고 후속적으로 동결건조시켰다. 동결건조된 물질은 동물에게 주사하기 전에 PBS 속에 재현탁시켰다.
SADC의 생체내 기능 시험: 환형 SADC, SADC-E049 및 SADC-E006을 펩타이드 백신 T3-2(EBNA-1 모델 에피토프 수반) 및 펩타이드 백신 T1-1(AChR MIR 모델 에피토프 수반)로 미리 면역화시킨 마우스 내로 복강내 주사하였다(i.p.; 사람 및 보다 큰 동물에서 의도된 정맥내 적용을 위한 대용품으로서). 적용된 용량은 50μl의 PBS 용적 속에 30μg의 SADC 접합체이었다. 채혈은 복강내 SADC 주사 전(-48h, -24h) 및 후(+24h, +48h, +72h 등) 각각에 모세관 미세-헤마토크릿 튜브(capillary micro-hematocrit tube)를 사용하여, 턱밑 정맥 천자(submandibular vein puncture)로 수행하였다. ELISA 분석(하기 참고)을 사용하여, 환형 SADC 둘 다는 나타낸 동물 모델에서 적어도 72시간에 걸쳐 역가를 명확하게 감소시킬 수 있음이 밝혀졌다. 따라서, SADC를 사용하여 생체내에서 역가를 효과적으로 감소시킬 수 있다고 결론지을 수 있다.
역가 분석: 펩타이드 ELISA를 BSA-커플링된 펩타이드(30nM, PBS 속에 용해시킴)로 실온에서 1시간 동안 코팅시킨 96-웰 플레이트(Nunc Medisorp 플레이트; Thermofisher, 제품 번호 467320)를 사용하여 표준 과정에 따라 수행하고 적절한 완충액과 함께 진탕(차단 완충액, 1% BSA, 1x PBS; 세척 완충액, 1xPBS/0.1% 트윈; 희석 완충액, 1xPBS / 0.1% BSA /0.1% 트윈)시키면서 수행하였다. 혈청 항온 처리(PBS 속에서 1:50로 출발하는 희석; 전형적으로 1:3 또는 1:2 적정 단계로)한 후, 결합된 항체를 Jackson immunoresearch (115-035-008)로부터 서양고추냉이 퍼옥시다제-접합된 염소 항-마우스 IgG(Fc)를 사용하여 검출하였다. 반응을 정지시킨 후, 플레이트를 450nm에서 20분 동안 TMB를 사용하여 측정하였다. EC50은 4-매개변수 로지스틱 회귀 모델(4-parameter logistic regression model)(GraphPad Prism)을 지닌 곡선 핏팅(curve fitting)을 사용하여 제조업자가 추천한 과정에 따라 판독물 값으로부터 계산하였다. 상한치 및 하한치에 대한 제한 매개변수(constraining parameter)를 상응하게 설정하여 R2 >0.98의 커브 핏팅 품질 수준(curve fitting quality level)을 설정하였다.
도 1a는 자간전증에서 자가항체 및 모조품에 대한 모델로서(Elliott 등), EBNA1에 대해 지시된 항원에 결합하는 환형 알부민-기반 SADC 후보물의 생체내 선택적인 혈장-저하 활성에 대해 마우스 모델에서 생체내 개념 증명을 나타낸다. 이러한 마우스 실험을 위해, 마우스 알부민을 사용하여, 외부 종(foreign species)으로부터의 단백질에 대한 어떠한 반응도 피하였다. 항체 역가를 표준 펩타이드 예방접종에 의해 6개월령 Balb/c 마우스에서 유도하였다. 하부 패널은 SADC 주사 전(즉, -48h 및 -24h에서의 역가) 역가 LogIC50(y-축)이 SADC 적용 후(즉, 주사 후 +24h, +48h 및 +72h에서의 역가; x-축에 나타냄) 역가 LogIC50보다 더 높았음을 입증한다.
유사한 실시예를 상이한 질환 처방을 위한 펩타이드 항체 결합 모이어티의 대안적인 예를 사용하여, 도 1b에 나타낸다. 중증 근무력증에서의 상황을 모사하기 위하여 사람 AChR 단백질 MIR 영역(Luo 등)으로부터 유래된 상이한 펩타이드로 예비-면역화시킨 마우스 모델에서 알부민-기반 SADC의 항체 저하 활성. AChR-MIR 영역에 대해 유도된 항체 역가를 중증 근무력증에서 유발 역활을 하는 것으로 공지된 항-AChR-MIR 자가항체에 대한 대리물로서 사용하였다(참고: Vincent 등). 명확한 역가 감소가 SADC 적용 후 관찰되었다.
도 1c 및 1d는 대안적인 생물중합체 스캐폴드를 포함하는 SADC 변이 체의 기능성을 입증한다. 구체적으로, 도 1c는 면역글로불린 스캐폴드가 성공적으로 사용될 수 있는 반면, 도 1d는 SADC를 작제하기 위한 합토글로빈-스캐폴드의 사용을 입증한다. 예 둘 다는 공유결합으로 결합된 실시예 펩타이드 E049를 수반하는, SADC에 의한 선택적인 항체 저하에 대한 생체내 개념 증명을 나타낸다.
자가 스캐폴드 단백질이 바람직할 수 있지만 합토글로빈-기반 SADC를 대리물로서 사람 합토글로빈을 사용하여 생성시켰다. 항-사람-합토글로빈 항체의 형성을 피하기 위하여, 비-자가 스캐폴드 합토글로빈의 마우스 당 단지 1회 단일 SADC 주사를 본 실험 조건을 위해 사용하였다. 예측한 바와 같이, 본 실험 조건(즉, 1회 적용) 하에서, 본 대리물 합토글로빈 동족체에 대해 항체 반응성은 관찰되지 않았다.
도 1e는 SADC 시스템의 선택성을 입증한다. 펩타이드 E049를 수반하는 면역글로불린-기반 SADC(즉, 도 1c와 동일함)는 관련되지 않은, 비관련성 아미노산 서열, 지정된 펩타이드 T8-1(서열번호 35: DHTLYTPYHTHPG)을 사용한 펩타이드에 의해 유도된 Ig-역가를 감소시킬 수 없다. 실시예는 시스템의 선택성에 대한 생체내 개념 증명을 나타낸다. 상단 패널은 표준 ELISA에 따라 OD 값(y-축)에 대한 항-펩타이드 T8-1 역가(1:50로부터 1:102400까지의 0,5x 희석 단계; X-축은 log(X) 희석을 나타낸다)를 나타낸다. T8-1-역가는 적용 후 SADC-Ig-E049의 투여에 의해 영향받지 않는다. 하단 패널은 SADC 주사 전(즉, -48h 및 -24h에서 역가) 초기 역가 LogIC50(y-축)가 SADC 적용 후(즉, 역가 +24h, +48h 및 +72h; x-축에서 나타낸 바와 같음) 역가 LogIC50과 비교하는 경우 SADC-Ig-E049의 투여(화살표)에 의해 영향받지 않음으로써, 시스템의 선택성을 증명함을 입증한다.
실시예
2:
SADC의
면역원성.
SADC의 면역원성을 배제시키기 위하여, 환형 후보물 SADC를 반복된 주사시 항체를 유도하는 이의 경향성에 대해 시험하였다. 펩타이드 T3-1 및 T9-1을 당해 시험을 위해 사용하였다. T3-1은 이에 대해 작용성 자가항체가 전-자간증 동물 모델에서 형성된 안지오텐신 수용체의 참고 에피토프로부터 유래된 10개 아미노산 펩타이드이고(Zhou 등); T9-1은 사람 IFN 감마의 참고 항-약물 항체 에피토프로부터 유래된 12개 아미노산 펩타이드이다(Lin 등). 이러한 대조군 SADC 접합체를 8 내지 10주령에서 출발하여 나이브(naive), 비-면역화된 암컷 BALB/c 마우스내로 복강내에 2주마다 8회 주사하였다.
동물 C1 내지 C4를 SADC T3-1으로 복강내 처리하였다(실시예 1에 기술된 바와 같음). 동물 C5 내지 C8을 펩타이드 T9-1을 수반하는 SADC를 사용하여 복강내 처리하였다. ELISA 분석을 위한 참고 신호로서, KLH-펩타이드 T1-1(AChR_MIR로부터 유래됨, 실시예 1에서 설명됨)로 3회 예방접종시킨 대조군 동물로부터의 혈장을 사용하였다. 1:100의 희석에서 표준 ELISA에 의한 항체 역가 검출에 대해, BSA-접합된 펩타이드 프로브 T3-1, T9-1 및 E005(서열번호 38: GGVKKIHIPSEK)을 각각 사용하여, 백신-처리된 대조군 동물 C와 비교하는 경우, 항체 유도가 SADC-처리된 동물에서 부재하였음을 입증할 수 있다(참고: 도 2). 3번째 백신 주사 후 1주째(대조군 동물 C) 및 2주 간격으로 마지막 8회의 연속적인 SADC 주사 후(동물 C1 내지 C8) 각각 후 혈장을 턱밑 혈액 수집으로 수득하였다. 따라서, SADC는 비-면역원성이고 마우스내로 반복된 주사 후 항체 형성을 유도하지 않음이 입증되었다.
실시예
3: 1가
또는 2가
펩타이드의
다수 카피를 수반하는
SADC를
사용한 항체의 성공적인
시험관내
고갈.
E006-KLH(KLH에 접합된, C-말단 시스테인을 지닌 VKKIHIPSEKG(서열번호 37) 예방접종된 마우스의 혈장을 희석 완충액(PBS + 0.1% w/v BSA + 0.1% 트윈(Tween) 20) 속에 1:3200으로 희석시키고 음성 대조군으로서 2.5 μg/ml(250 ng/웰)의 SADC 또는 5 μg/ml(500 ng/웰)의 알부민으로 코팅시킨 미세역가 플레이트의 단일 웰에서 4회 연속적으로(10분/웰) 항온처리(100 μl, 실온)하였다.
SADC 코팅된 웰에서 항온처리 전 및 후에 존재하는 유리되고, 결합되지 않은 항체의 양을 측정하기 위하여, 50 μl의 희석된 혈청을 고갈 전 및 후에 취하고 표준 ELISA에 의해 E006-BSA 코팅된 플레이트(10 nM 펩타이드)를 사용하여 정량화하고 염소 항 마우스 IgG 바이오(Southern Biotech, 1:2000로 희석시킴)로 희석시켰다. 후속적으로, 바이오티닐화된 항체를 스트렙타비딘-HRP(Thermo Scientific, 1:5000으로 희석시킴)으로 기질로서 TMB를 사용하여 검출하였다. 신호의 발달은 0.5 M 황산으로 정지시켰다.
ELISA를 OD450nm(y-축)에서 측정하였다. 결과적으로, 항체는 C-말단 시스테인을 지닌 펩타이드 E006(서열 VKKIHIPSEKGC, 서열번호 39)을 함유하는 코팅된 1가- 또는 2가 SADC에 의해 효율적으로 흡착되었다(전 = 고갈된 출발 물질 없음; 1가는 SADC 표면에 나타난 펩타이드에 상응한다; 음성 대조군은 알부민이었다; x-축에 나타냄). 도 3 참고. ("1가"는 펩타이드 단량체가 생물중합체 스캐폴드에 결합함을 의미(즉, n=1)하는 반면 "2가"는 펩타이드 이량체가 생물중합체 스캐폴드에 결합함을 의미(즉, n=2)한다. 본 경우에, 2가 펩타이드는 "단독2가"이었는데, 즉 SADC의 펩타이드 n-머는 E006 - S - E006이다.)
이는 1가 또는 2가 펩타이드를 지닌 SADC가 항체를 흡착시킴으로써 이를 고갈시키는데 매우 적합함을 입증한다.
실시예
4:
미모토프
-기반
SADC의
생성
야생형 또는 변형된 펩타이드 아미노산 서열로부터 유래된 선형 및 환형 펩타이드를 특정 에피토프에 대해 해로운, 질병-유발 또는 달리 원치 않는 항체의 선택적인 제거를 위한 특이적인 SADC의 작제를 위해 사용할 수 있다. 특수한 에피토프의 경우에, 선형 펩타이드 또는 구속된 펩타이드, 예를 들면, 에피토프의 일부 또는 이의 변이체를 함유하는 사이클로펩타이드(여기서, 예를 들면, 하나 또는 수개의 아미노산은 치환되거나 화학적으로 변형되어 항체(미모토프)에 대한 친화성을 증진시켰다)는 SADC를 작제하는데 사용될 수 있다. 펩타이드 스크린은 질병-유발 자가항체에 대해 최적화된 친화성을 지닌 펩타이드를 확인하는 목표로 수행될 수 있다. 구조적 또는 화학적 펩타이드 변형의 유연성(flexibility)은 HLA에 대한 펩타이드 결합의 면역원성의 위험 및 따라서 원치않은 면역 자극 위험을 최소화시키기 위한 해결책을 제공하였다.
따라서, 야생형 뿐만 아니라 변형된 선형 및 환형 펩타이드 서열은 자가면역 질환과 관련된 공지된 에피토프로부터 유도되었다. 다양한 길이 및 위치의 펩타이드는 아미노산 치환에 의해 시스템적으로 추정되었고 펩타이드 배열에서 합성되었다. 이는 이러한 서열로부터 유래된 60000개의 환형 및 선형의 야생형 및 미모토프 펩타이드의 스크리닝을 허용하였다. 펩타이드 배열은 자가면역 질환에 관여하는 것으로 알려진 자가항체와 함께 배양되었다. 따라서, 이러한 자가항체를 사용하여 60000개의 펩타이드를 스크리닝하였고 100개의 환형 및 100개의 선형 펩타이드 히트(hit)를 자가항체에 대한 이들의 상대적인 결합 강도를 기반으로 선택하였다. 이러한 200개 펩타이드 중에서, 51개의 서열은 선형 펩타이드 그룹과 환형 펩타이드 그룹 사이에서 동일하였다. 확인된 가장 우수한 펩타이드 모두는 원래의 서열 각각에 대해 정렬하는 경우 적어도 하나의 아미노산 치환을 가졌고 따라서 미모토프로 고려된다. 보다 높은 결합 강도가 환형화된 펩타이드로 달성될 수 있음이 밝혀졌다.
이러한 새로이 확인된 펩타이드, 우선적으로 높은 상대적 결합 값을 가진 펩타이드는 이 특정 에피토프에 대한 자가항체를 제거할 수 있는 SADC를 생성하거나 그들의 서열에 기초하여 추가의 미모토프 및 유도체를 개발하는 데 사용된다.
실시예
5: 다양한
SADC
생물중합체
스캐폴드를
사용한 마우스에서의 신속하고, 선택적인 항체 고갈.
10 μg의 모델 목적하지 않은 항체 mAB 항 V5(Thermo Scientific)를 암컷 Balb/c 마우스(처리 그룹 당 5마리; 9 내지 11주령)에게 복강내 주사한 다음 초기 항체 투여 후 48시간째에 50 μg의 SADC(결합된 표적화된 V5 펩타이드를 지닌 상이한 생물중합체 스캐폴드, 하기 참고)를 정맥내 주사하였다. 턱밑 정맥으로부터 24시간 간격에서 혈액을 수집하였다. 0 hr 시점에 대한 혈액 샘플을 SADC 투여 직전에 취하였다.
혈액을 SADC 투여 후 120시간 시점까지 24시간마다 수집하였다(x-축). SADC 투여 후 혈장 항-V5 IgG 수준의 쇠퇴 및 감소를 코팅된 V5-펩타이드-BSA(펩타이드 서열 IPNPLLGLDC - 서열번호 40)와 함께 표준 ELISA 과정을 사용하여 항 V5 역가 판독 및 도 4에 나타낸 바와 같은 염소 항 마우스 IgG 바이오(Southern Biotech, diluted 1:2000)에 의한 검출로 측정하였다. 또한, SADC 수준(참고: 실시예 6) 및 면역복합체 형성(참고: 실시예 7)을 분석하였다.
EC50[OD450] 값을 4 매개변수 로지스틱 곡선 핏팅을 사용하여 측정하고 초기 수준(0 시점에서 1로 설정)과 이후 시점(x-축) 사이의 상대적인 신호 쇠퇴를 EC50 값의 비(y-축, 배 신호 감소 EC50)로서 계산하였다. 모든 SADC 펩타이드는 SADC의 직접적인 검출을 위한 태그 및 혈장 샘플로부터의 면역복합체를 함유하였고; SADC에 사용된 펩타이드 서열은: IPNPLLGLDGGSGDYKDDDDKGK(서열번호 41)-(BiotinAca)GC(알부민 스캐폴드 - SADC-ALB를 지닌 SADC, 면역글로불린 스캐폴드 - SADC-IG를 지닌 SADC, 합토글로빈 스캐폴드 - SADC-HP를 지닌 SADC, 및 트랜스페린 스캐폴드 - SADC-TF를 지닌 SADC) 및 음성 대조군 SADC로서 관련되지 않은 펩타이드 VKKIHIPSEKGGSGDYKDDDDKGK(서열번호 42)-(BiotinAca)GC(SADC-CTR)이었다.
5마리 동물의 상이한 처리 그룹에 대한 SADC 스캐폴드는 검정색/회색 음영으로 나타낸다(참고: 도 4의 삽도(inset)).
처리된 그룹은 모조물 처리된 대조군 그룹 SADC-CTL과 비교하는 경우 24 시간째에 이미 신속하고 명백한 항체 감소를 나타내었다(특히 SADC-TF). SADC-CTR은, 이의 펩타이드 서열이 투여된 항 V5 항체에 의해 인식되지 않으므로 항체 저하 활성을 가지지 않기 때문에 정상 항체에 대한 참고로 사용하였다. 따라서, SADC-CTR의 쇠퇴를 추세선(trend line)으로 표시하여 처리된 동물과 모조물 처리된 동물 사이의 항체 수준 차이를 강조하였다.
이러한 실험 조건 하에서 선택적인 항체 저하의 효능을 측정하기 위하여, 2원 ANOVA 시험을 SADC 투여 48시간 후 던네트 다중 비교 시험(Dunnett's multiple comparison test)을 사용하여 수행하였고, 항체 EC50은 SADC-CTR 참고 그룹(추세선)과 비교하여 모든 SADC 그룹에서 크게 유의적으로 감소하였다(p<0.0001). SADC 투여 120 시간째에, 항체 감소는 SADC-ALB 및 SADC-TF 그룹에서 매우 유의적이었고(둘 다 p<0.0001) SADC-HP 그룹에서 유의적(p=0.0292)이었으나, SADC-IG 그룹은 SADC 투여 120 시간 후 EC50 감소를 항한 경향성(p = 0.0722)을 나타내었다. 물론, 선택적인 항체 감소가 SADC 투여 후 모든 시험한 시점에서 SADC-ALB 및 SADC-TF 그룹에서 매우 유의적(p<0.0001)이었다.
모든 SADC 생물중합체 스캐폴드는 항체 수준을 선택적으로 감소시킬 수 있었다고 결론지어진다. 역가 감소는 SADC-ALB 및 SADC-TF로 가장 명확하며 항체 수준의 재결합 또는 재순환은 마지막 시점을 향해 검출되지 않았고, 이는 목적하지 않은 항체가 의도된 바와 같이 분해됨을 시사한다.
실시예
6:
SADC
주사 후 24시간째에 혈장 속에서
SADC의
검출
Balb/c 마우스내로 정맥내 주사 후 24시간째에 상이한 SADC 변이체의 혈장 수준. SADC-ALB, -IG, -HP, -TF의 혈장 수준(y-축) 및 음성 대조군 SADC-CTR의 혈장 수준(x-축)의 측정을 실시예 5에 이미 기술된 동물로부터의 혈장에서 검출하였다. 주사된 혈장 SADC 수준은 표준 ELISA로 검출하였으며 이에 의해 SADC가 스트렙타비딘 코팅된 플레이트(Thermo Scientific)와 함께 이의 펩타이드의 이들의 바이오틴 모이어티를 통해 포획되었다. 포획된 SADC는 Flag-태그된 펩타이드를 검출하는 마우스 항 Flag-HRP 항체(Thermo Scientific, 1:2,000 희석됨)로 검출하였다(참고: 또한 실시예 7):
50 μg의 SADC를 정맥내 주사한 후 혈액 속에서 대략 25 μg/ml의 이론적 양을 추정할 때, SADC의 검출가능한 양은 SADC 주사 후 24시간 째에, SADC-ALB 또는 SADC-IG의 경우 799 내지 623 ng/ml 및 SADC-TF의 경우 대략 5000 ng/ml 이하의 범위이었다. 그러나, 놀랍게도 및 대조적으로, SADC-HP 및 대조군 SADC-CTR(이는 또한 SADC-HP 변이체이나, 당해 경우에 관련되지 않은 음성 대조군 펩타이드 E006를 수반한다, 참고: 앞서의 실시예)은 주사 후 24시간째에 순환으로부터 완전히 사라졌고, 더 이상 검출될 수 없었다. 도 5를 참고한다.
이는 본 실시예에서 시험한 합토글로빈 스캐폴드-기반 SADC 둘 다(즉, SADC-HP 및 SADC-CTR)가 면역복합체 형성의 생체내 위험으로 인한 보체 의존성 혈관 및 신장 손상에 있어서 이의 잠재적인 역활과 관련하여 SADC, 예를 들면, SADC-ALB, SADC-IG 또는 SADC-TF보다 장점을 나타내는 비교적 보다 짧은 혈장 반감기를 나타냄을 입증한다. SADC-HP의 다른 장점은 신속한 치료학적 효과가 요구되는 경우에 혈액으로부터 이의 원치않는 표적 항체의 가속화된 청소율이다. 이러한 결과는 합토글로빈-기반 SADC 스캐폴드(SADC-HP 및 SADC-CTR로 나타낸 바와 같음)가 SADC-결합 항체가 혈액 속에 존재하는 여부와 상관없이, 혈액으로부터의 신속한 청소에 적용됨으로써 바람직하지 않은 면역복합체 형성을 최소화하고 신속하고 효율적인 청소를 나타냄을 입증한다. 따라서 본 실시예에서 합토글로빈-기반 SADC, 예를 들면, SADC-HP는 둘 다 주사후 24시간째에 완전히 청소된 SADC-HP 또는 SADC-CTR과는 대조적으로, 기술된 조건 하에서 주사 후 둘 다 24시간째까지 여전히 검출가능한, SADC-TF 또는 SADC-ALB에 의해 입증되는 바와 같이, 다른 SADC 생물중합체 스캐폴드보다 치료학적으로 관련된 장점을 제공한다.
실시예
7:
SADC
주사 후 24시간째에 혈장 속에서
SADC
-
IgG
복합체의 검출
생체내에서 SADC에 결합된 IgG의 양을 측정하기 위하여, 10 μg의 항 V5 IgG(Thermo Scientific)의 정맥내 주사에 이어 항체 주사 후 24시간째에 정맥내 투여된 SADC-ALB, -HP, -TF 및 -CTR(50 μg)의 주사 후, 혈장을, SADC 주사 후 24시간째에, 턱밑 정맥으로부터 수집하고, 이의 바이오티닐화된 SADC-V5-펩타이드 IPNPLLGLDGGSGDYKDDDDKGK(서열번호 41)(BiotinAca)GC를 통해 또는 SADC-CTR의 경우 음성 대조군 펩타이드 VKKIHIPSEKGGSGDYKDDDDKGK(서열번호 42)(BiotinAca)GC]를 통해 혈장으로부터 SADC를 포획하기 위해 스트렙타비딘 플레이트 상에서 항온처리하였다. 스트렙타비딘-포획된 SADC에 결합된 IgG는 SADC 주사 후 24시간째에 혈장 속에 존재하는 SADC-항체 복합체의 검출을 위한 염소 항 마우스 IgG HRP 항체 (Jackson Immuno Research, 1:2,000으로 희석됨)를 사용한 ELISA로 검출하였다. 처리되지 않은 동물로부터의 음성 대조군 혈청에 대해 수득된 OD450nm 값(y-축)을 배경 보정(background correction)을 위해 시험 그룹의 OD450nm 값(x-축)으로부터 감하였다.
도 6에 나타낸 바와 같이, 명백한 항-V5 항체 신호가 SADC-ALB 및 SADC-TF 주사된 마우스의 경우에 관찰되었지만(검정색 바아는, 5마리의 평균 값인, 1:25의 희석에서 배경 보정된 OD 값을 나타낸다; 표준 편차 오차 바아(standard deviation error bar)), 항체 신호는 SADC-HP 또는 대조군 SADC-CTR 주사된 동물에서 검출할 수 없었다(SADC-CTR은 임의의 항 V5 항체에 의해 인식되지 않는 관련없는 펩타이드 바이오-FLG-E006[VKKIHIPSEKGGSGDYKDDDDKGK(서열번호 42)(BiotinAca)GC]를 수반하는 음성 대조군이다). 이는 SADC의 정맥내 적용 후 24 시간째에 혈장 속에서 검출가능한 양의 SADC-HP/IgG 복합체의 부재를 입증한다.
따라서, SADC-HP는 SADC-ALB 또는 SADC-TF와 비교하는 경우 항 V5 예비-주사된 마우스에서 가속화된 청소(clearance)에 적용된다.
실시예
8:
SADC
-면역글로불린 복합체 형성의
시험관내
분석
SADC-항체 복합체 형성을 PBS +0.1% w/v BSA + 0.1% v/v 트윈20 속에서 증가하는 농도의 SADC-ALB, -IG, -HP, -TF 및 -CTR과 함께 1 μg/ml의 사람 항 V5 항체(항 V5 에피토프 태그 [SV5-P-K], 사람 IgG3, 절대 항체)를 실온에서 2 시간 동안 예비-항온처리하여 시험관내에서 면역복합체가 형성되도록 함으로써 분석하였다. 복합체 형성 후, 샘플을 10 μg/ml의 사람 C1q(CompTech)로 미리 코팅된 ELISA 플레이트에서 실온에서 1시간 동안 항온처리함으로써, 시험관내 형성된 면역 복합체의 포획이 가능하도록 하였다. 복합체를 ELISA에 의해 항 사람 IgG(Fab 특이적인)-퍼옥시다제(Sigma, 1:1,000로 희석됨)를 사용하여 후속적으로 검출하였다. OD450 nm에서 측정된 신호(y-축)는 시험관내에서 항체-SADC 복합체 형성을 반영한다.
도 7에 나타낸 바와 같이, SADC-TF 및 -ALB는 항원-항체 평형으로부터 항원 과다로의 이전으로 인하여 1000ng/ml SADC-TF의 경우에 강력한 신호 및 급격한 신호 저하로 반영되는 바와 같이 명백한 면역복합체 형성 및 C1q에 대한 결합을 나타내었다. 대조적으로, SADC-HP 또는 SADC-IG를 사용한 시험관내 면역 복합체 형성은 본 검정에서 측정한 경우 훨씬 덜 효율적이었다.
생체내 데이타(앞서의 실시예)와 함께, 이러한 발견은 합토글로빈 스캐폴드가 보체 시스템을 활성화시키기 위한 감소된 경향성으로 인하여 다른 SADC 생물중합체 스캐폴드보다 유리하다는 발견을 제공한다. 대조적으로, SADC-TF 또는 SADC-ALB는 보다 높은 복잡성을 나타내므로, 전통적인 보체 경로의 개시와 함께 C1 복합체를 활성화시키는 특정 위험을 수반한다(이러한 위험은 그러나, 일부 설정에 서 견디어질 수 있다).
실시예
9:
시험관내에서
SADC에
의한
IgG
포획의 측정
앞서의 실시예와 유사하게, 증가하는 양의 SADC(x-축에 나타냄)와 함께 1 μg/ml의 마우스 항 V5 항체(Thermo Scientific)를 사용하여 면역복합체를 시험관내에서 형성하도록 하였다. SADC-항체 복합체를 스트렙타비딘 코팅된 ELISA 플레이트에서 바이오티닐화된 SADC-펩타이드를 통해 포획한 다음(참고: 앞서의 실시예), 항 마우스 IgG-HRP(Jackson Immuno Research, 1:2,000으로 희석됨)를 사용하여 결합된 항-V5를 검출하였다.
이러한 검정 조건 하에서, SADC-HP는 SADC-TF 또는 SADC-ALB와 비교하는 경우 시험관내에서 현저히 적은 항체 결합능을 나타내었다(참고: 도 8, A). SADC에서 IgG 검출에 대해 계산된 EC50 값은 SADC-TF, -ALB 및 -HP의 경우 각각 7.0 ng/ml, 27.9 ng/ml 및 55.5 ng/ml이었다(참고: 도 8, B).
이러한 시험관내 발견은 SADC-HP가 원치않는 항체의 고갈을 위한 이의 치료학적 사용과 관련하여 안전성 장점으로서 고려되는 SADC-TF 또는 SADC-ALB와 비교하는 경우 보다 적은 면역복합체 형성능을 가진다는 관찰(참고: 앞서의 실시예)과 일치한다.
실시예
10: 항 CD163 항체 기반
SADC
생물중합체
스캐폴드의
생체 내 기능
항-마우스-CD163 mAB E10B10의 신속한 생체 내 혈액 제거(제WO 2011/039510 A2호에 개시됨). mAB E10B10은 마우스 IgG2a 백본으로 재합성되었다. 50 μg mAb E10B10 및 Mac2-158 (제WO 2011/039510 A2호에 개시된 바와 같이 사람-특이적 항-CD163 mAb, 마우스 CD163에 결합하지 않기 때문에 이 실시예에서 음성 대조군으로 사용됨)을 마우스에 정맥 내 주입하고 ELISA에서 12, 24, 36, 48, 72, 96 시간 후에 측정하여 혈액 제거율을 결정하였다.
직접적인 비교를 위해 둘 다 마우스 IgG2a 아이소타입으로 표현되었지만, E10B10은 마우스 CD163에 결합하는 반면 Mac2-158은 사람 특이적이므로, mAb E10B10은 도 9에 나타낸 바와 같이 대조군 mAb Mac2-158 보다 심지어 더 빠르게 순환계에서 제거되었다.
결론적으로 항-CD163 항체는 제거 프로파일 때문에 SADC 스캐폴드로 매우 적합하다. 이러한 스캐폴드가 있는 SADC는 바람직하지 않은 항체를 순환에서 빠르게 제거한다.
상세한 방법: 50ug의 바이오티닐화 모노클로날 항체 E10B10 및 바이오티닐화 Mac2-158을 마우스로 정맥 내 주사하고 12, 24, 36, 48, 72, 96시간 후에 ELISA로 측정하여 제거율을 결정하였다: 스트렙타비딘 플레이트를 실온에서 1시간 동안 PBS + 0.1% BSA + 0.1% Tween20에 희석된 혈장 샘플과 함께 인큐베이션하였다 (50 ㎕/웰). 세척 후(PBS + 0.1% Tween20으로 3회), 결합된 비오티닐화 항체는 1:1000 희석된 항-마우스 IgG+IgM-HRP 항체로 검출되었다. 세척 후, TMB 기질을 첨가하고 TMB 정지 용액으로 기질의 현상을 정지시켰다. OD450nm의 신호를 측정하였다. EC50 는 제한된 곡선 및 최소 제곱 회귀를 사용한 4 매개변수 곡선 피팅을 사용하여 비선형 회귀로 계산되었다. 시점 T12에서의 EC50 값(항체 주입 후 처음 측정된 시점임)을 100%로 설정하고, 다른 모든 EC50 값을 T12에서의 수준과 비교하였다.
실시예
11: ME/
CFS
, POTS,
AAG
, IDC 및
cChHD
환자에
SADC의
투여
본질적으로 실시예 1에 기술된 바와 같이 SADC를 제조하고, 생물중합체 스캐폴드로서 인간 트랜스페린을 사용한다.
N-말단 시스테닐화 펩타이드 RATHQEAINCYA(서열번호 43) 및 YANETC(서열번호 44), 둘 다 인간 베타-2 아드레날린성 수용체의 두 번째 세포외 루프로부터 유도되며 (UniProt 접근 코드 P07550; 참조: Magnusson 등, 1989), 설포-GMBS-활성화 인간 트랜스페린(sulfo-GMBS-activated human transferrin)을 사용하여 스캐폴드에 연결되어, 해당 생물중합체 스캐폴드의 라이신에 공유적으로(covalently) 부착되는 해당 시스테닐화된 펩타이드와 함께 트랜스페린 기반 SADC를 제공한다. 이러한 SADC 접합체는 PBS에서 정제 및 재현탁된다.
3명의 ME/CFS 환자에게 재현탁된 SADC 접합체를 각각 150mg, 250mg 및 500mg 정맥 투여하여 환자의 혈장에서 베타-2 아드레날린성 수용체에 대한 자가항체를 감소시켜 ME/CFS 증상을 개선한다. POTS 환자 3명, AAG 환자 3명, IDC 환자 3명, cChHD 환자 3명에 대해 동일한 절차를 수행한다.
실시예
12:
자가항체
결합
펩타이드에
대한
펩타이드
마이크로어레이
스크리닝
자가항체에 의해 인식되는 항원성 단백질 서열로부터 펩타이드 스트레치(stretch)를 확인하기 위해, 7 내지 14개의 아미노산 서열 길이를 가진 72886개의 환형(및 정도는 덜하지만 선형인) 펩타이드(184개의 인간 신경수용체 및 신경학적 또는 신경정신과적 병태에 관여하는 단백질에서 유래)를 포함하는 마이크로어레이에서 펩타이드에 대한 자가항체 스크리닝이 수행되었다. IgG는 단백질 G 정제를 통해 30명의 인간 기증자(ME/CFS 환자 포함)로부터 얻은 혈액으로부터 준비되었다. 각 IgG 샘플을 펩타이드 마이크로어레이와 함께 배양하고 Ig 결합 신호를 형광으로 검출했다. 어레이 상의 펩타이드에 대한 모든 항체 결합 신호는 배경을 빼고 각 샘플에 대해 순위를 매겼고, (UniProt에서 얻은) 상응하는 단백질 기원 서열을 가진 각 기증자에 대한 각각의 상위 250개 펩타이드 히트(hit)의 중복 제거된 집합체(deduplicated aggregate)가 컴파일되었다(그룹 III으로 지정됨). 또한, 각 기증자에 대한 각각의 상위 50개 펩타이드 히트의 중복 제거된 집합체가 컴파일되어 그룹 II로 지정되었다. 마지막으로, 각 기증자에 대한 각각의 상위 50개 펩타이드 히트의 중복 제거된 집합체가 수집되어 그룹 I로 지정되었다.
전체적으로 그룹 I에는 157개의 개별 펩타이드 히트가 포함되어 있고 그룹 II에는 819개의 개별 펩타이드 히트가 포함되어 있으며 그룹 III에는 3492개의 개별 펩타이드 히트가 포함되어 있다. 분명히, 그룹 I은 그룹 II의 하위 집합이고 그룹 III의 하위 집합이다. 그룹 I-III는 스크리닝된 모든 펩타이드의 각각 0,2%, 1,1% 및 4.8%에 해당한다.
그룹 I-III에 속하는 펩타이드 히트는 위의 일반적인 설명에서 표 1에 나열되어 있다.
따라서, 나열된 모든 펩타이드, 바람직하게는 그룹 II에 속하는, 보다 더 바람직하게는 그룹 I에 속하는 펩타이드는, (임의로 더 짧은) 펩타이드 서열이 본 발명에 따른 항체 고갈을 위해 유래될 수 있는 서열을 제공한다. 또한, 표 1의 펩타이드가 유래된 단백질(바람직하게는 그룹 II, 보다 바람직하게는 그룹 I)의 다른 펩타이드 서열(또는 단편)도 본 발명에 따른 SADC에 사용하기에 매우 적합하다. 이들 펩타이드 및 이의 단편은 또한 진단 또는 예측 목적을 위한 자가항체 프로파일링에 매우 적합하다.
실시예
13: 선형
펩타이드만을
기반으로 하는
자가항체
결합
펩타이드에
대한
펩타이드
마이크로어레이
스크리닝
실시예 12와 유사한 방식으로, 인간 기증자로부터의 혈액 샘플을 본원에 열거된 인간 신경수용체로부터의 62개의 선형 펩타이드의 선택만을 기초로 하는 펩타이드 마이크로어레이로 스크리닝하였다. 이 스크리닝은 52개의 양성 IgG 결합 히트(hit), 즉 확인된 자가항원 히트(hit)를 제공했다.
[비특허문헌]
Armstrong, Jonathan K. "The occurrence, induction, specificity and potential effect of antibodies against poly (ethylene glycol)." Pegylated protein drugs: Basic science and clinical applications. Birkhauser Basel, 2009. 147-168.
Bornholz, Beatrice, 등 "Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease." Autoimmunity Reviews 13.9 (2014): 954-962.
Bynke, Annie, 등 "Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients-A validation study in plasma and cerebrospinal fluid from two Swedish cohorts." Brain, Behavior, & Immunity-Health 7 (2020): 100107.
Carter, John Mark, 및 Larry Loomis-Price. "B cell epitope mapping using synthetic peptides." Current protocols in immunology 60.1 (2004): 9-4.
Cortes Rivera, Mateo, 등 "Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review." Diagnostics 9.3 (2019): 91.
Dijkstra, C. D., 등 "The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3." Microenvironments in the Lymphoid System. Springer, Boston, MA, 1985. 409-419.
Dngen, Hans-Dirk, 등 "β1-Adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications." Circulation: Heart Failure 13.1 (2020): e006155.
Elliott, Serra E., 등 "A pre-eclampsia-associated Epstein-Barr virus antibody cross-reacts with placental GPR50." Clinical Immunology 168 (2016): 64-71.
Erlandsson, Ann, 등 "In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives." Molecular immunology 43.6 (2006): 599-606.
Etzerodt, Anders, 등 "Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163." Journal of controlled release 160.1 (2012): 72-80.
Fabriek, Babs O., 등 "The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria." Blood 113.4 (2009): 887-892.
Galli, Jonathan, 및 John Greenlee. "Paraneoplastic diseases of the central nervous system." F1000Research 9 (2020).
Garces, Jorge Carlos, 등 "Antibody-mediated rejection: a review." The Ochsner Journal 17.1 (2017): 46.
Gardoni, Fabrizio, 등 "NMDA and AMPA receptor autoantibodies in brain disorders: from molecular mechanisms to clinical features." Cells 10.1 (2021): 77.
Garza, Madeline, 및 Amanda L. Piquet. "Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia." Frontiers in Neurology (2021): 1451.
Gazarian, Karlen, 등 "Mimotope peptides selected from phage display combinatorial library by serum antibodies of pigs experimentally infected with Taenia solium as leads to developing diagnostic antigens for human neurocysticercosis." Peptides 38.2 (2012): 381-388.
Gfeller, David, 등 "Current tools for predicting cancer-specific T cell immunity." Oncoimmunology 5.7 (2016): e1177691.
Giannoccaro, Maria Pia, Sukhvir K. Wright, 및 Angela Vincent. "In vivo mechanisms of antibody-mediated neurological disorders: animal models and potential implications." Frontiers in neurology 10 (2020): 1394.
Golden, Elisabeth P., 및 Steven Vernino. "Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances." Clinical Autonomic Research 29.3 (2019): 277-288.
Granfeldt, Asger, 등 "Targeting dexamethasone to macrophages in a porcine endotoxemic model." Critical Care Medicine 41.11 (2013): e309-e318.
Graversen, Jonas H., 등 "Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone." Molecular Therapy 20.8 (2012): 1550-1558.
Gunning III, William T., 등 "Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies." Journal of the American Heart Association 8.18 (2019): e013602.
Gurda, Brittney L., 등 "Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8." Journal of virology 86.15 (2012): 7739-7751.
Hansen, Lajla Bruntse, Soren Buus, 및 Claus Schafer-Nielsen. "Identification and mapping of linear antibody epitopes in human serum albumin using high-density peptide arrays." PLoS One 8.7 (2013): e68902.
Hansen, Niels, 및 Charles Timaus. "Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge." Journal of Neural Transmission 128.1 (2021): 1-14.
Homma, Masayuki, 등 "A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells." Neurotherapeutics 14.1 (2017): 191-198.
Howard Jr, James F. "Myasthenia gravis: the role of complement at the neuromuscular junction." Annals of the New York Academy of Sciences 1412.1 (2018): 113-128.
Howarth, M., & Brune, K. D. (2018). New routes and opportunities for modular construction of particulate vaccines: stick, click and glue. Frontiers in immunology, 9, 1432.
Imamura, Michie, 등 "Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases." International journal of molecular sciences 21.4 (2020): 1332.
Jacob, Giris, 등 "Vagal and sympathetic function in neuropathic postural tachycardia syndrome." Hypertension 73.5 (2019): 1087-1096.
Jansson, Liselotte, 등 "Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice." Endocrinology 159.9 (2018): 3446-3457.
Jensen, Kamilla Kjaergaard, 등 "Improved methods for predicting peptide binding affinity to MHC class II molecules." Immunology 154.3 (2018): 394-406.
Jurtz, Vanessa, 등 "NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data." The Journal of Immunology 199.9 (2017): 3360-3368.
Kainulainen, Markus H., 등 "High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay." Scientific reports 11.1 (2021): 1-9.
Kaur, Divpreet, 등 "Autonomic neuropathies." Muscle & Nerve 63.1 (2021): 10-21. Epub 2020 Sep 14.
Kim, Do-Young, 등 "Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)." Journal of translational medicine 18.1 (2020): 1-12.
Kim, June-Bum. "Channelopathies." Korean journal of pediatrics 57.1 (2014): 1.
Zeynep, 등 "Predicting T cell recognition of MHC class I restricted neoepitopes." Oncoimmunology 7.11 (2018): e1492508.
Labovsky, Vivian, 등 "Anti-β1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease." Clinical & Experimental Immunology 148.3 (2007): 440-449.
Lazaridis, Konstantinos, 등 "Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis." Journal of neuroimmunology 312 (2017): 24-30.
Leung, Nicki YH, 등 "Screening and identification of mimotopes of the major shrimp allergen tropomyosin using one-bead-one-compound peptide libraries." Cellular & molecular immunology 14.3 (2017): 308-318.
Li, Peipei, Li Wang, 및 Li-jun Di. "Applications of protein fragment complementation assays for analyzing biomolecular interactions and biochemical networks in living cells." Journal of proteome research 18.8 (2019): 2987-2998.
Lim, Sung In, 및 Inchan Kwon. "Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids." Critical reviews in biotechnology 36.5 (2016): 803-815.
Lin, Chia-Hao, 등 "Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease." Nature medicine 22.9 (2016): 994.
Lorentz, Kristen M., 등 "Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase." Science advances 1.6 (2015): e1500112.
Low PA, Engstrom JW. Disorders of the autonomic nervous system. In: Kasper D, Fauci A, Hauser S, 등, eds. Harrison's Principles of Internal Medicine. 19th ed. New York (2017)
Luo, Jie, 등 "Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity." Journal of Neuroscience 29.44 (2009): 13898-13908.
Luo, Jie, 및 Jon Lindstrom. "AChR-specific immunosuppressive therapy of myasthenia gravis." Biochemical pharmacology 97.4 (2015): 609-619.
Madsen, Mette, 등 "Molecular Characterization of the Haptoglobin· Hemoglobin Receptor CD163 ligand binding properties of the scavenger receptor cysteine-rich domain region." Journal of Biological Chemistry 279.49 (2004): 51561-51567.
Magnusson, Y., 등 "Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors." Clinical and experimental immunology 78.1 (1989): 42.
Majowicz, Anna, 등 "Seroprevalence of pre-existing NABs against AAV1, 2, 5, 6 and 8 in the South African Hemophilia B patient population." (2019): 3353-3353.
Masood 등, "Morvan syndrome", In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Matsui, Shinobu, 등 "Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits." Journal of molecular and cellular cardiology 29.2 (1997): 641-655.
Mazor, Ronit, 등 "Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity." Proceedings of the National Academy of Sciences 115.4 (2018): E733-E742.
McKeon, Andrew, 및 Eduardo E. Benarroch. "Autoimmune autonomic disorders." Handbook of clinical neurology 133 (2016): 405-416.
Meister, Daniel, S. Maryamdokht Taimoory, 및 John F. Trant. "Unnatural amino acids improve affinity and modulate immunogenicity: Developing peptides to treat MHC type II autoimmune disorders." Peptide Science 111.1 (2019): e24058.
Meyer, Carlotta, 및 Harald Heidecke. "Antibodies against GPCR." Front Biosci (Landmark Ed) 23.552 (2018): 2177-2194.
Mingozzi, Federico, 등 "Overcoming preexisting humoral immunity to AAV using capsid decoys." Science translational medicine 5.194 (2013): 194ra92-194ra92.
Mingozzi, Federico, 및 Katherine A. High. "Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape." Annual review of virology 4 (2017): 511-534.
Morimoto et. al., Bioconjugate Chemistry 25 (8) (2014): 1479-1491
Moussa, Ehab M., 등 "Immunogenicity of therapeutic protein aggregates." Journal of pharmaceutical sciences 105.2 (2016): 417-430.
ller, Johannes, 등 "Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy." Circulation 101.4 (2000): 385-391.
Muller, Manuel M. "Post-translational modifications of protein backbones: unique functions, mechanisms, and challenges." Biochemistry 57.2 (2017): 177-185.
Nagatomo, Yuji, 및 WH Wilson Tang. "Autoantibodies and cardiovascular dysfunction: cause or consequence?." Current heart failure reports 11.4 (2014): 500-508.
Nakane, Shunya, 등 "Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment." Expert review of neurotherapeutics 18.12 (2018): 953-965.
Siang Ong, Yong, 등 "Recent advances in synthesis and identification of cyclic peptides for bioapplications." Current topics in medicinal chemistry 17.20 (2017): 2302-2318.
Palma, Jose-Alberto, 등 "Autoantibodies blocking M3 muscarinic receptors cause postganglionic cholinergic dysautonomia." Annals of neurology 88.6 (2020): 1237-1243.
Peters, Bjoern, 등 "A community resource benchmarking predictions of peptide binding to MHC-I molecules." PLoS computational biology 2.6 (2006): e65.
Pishesha, Novalia, 등 "Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease." Proceedings of the National Academy of Sciences (2017): 201701746.
Rey 등, Clinical Immunology 96 (3) (2000): 269-279
Rice 등, EMBOSS: the European Molecular Biology Open Software Suite, Trends Genet. 2000 Jun;16(6):276-7
Ruff, Robert L., 및 Robert P. Lisak. "Nature and action of antibodies in myasthenia gravis." Neurologic clinics 36.2 (2018): 275-291.
Rummler, Silke, 등 "Current techniques for AB0-incompatible living donor liver transplantation." World journal of transplantation 6.3 (2016): 548.
Runcie, Karie, 등 "Bi-specific and tri-specific antibodies-the next big thing in solid tumor therapeutics." Molecular Medicine 24.1 (2018): 50.
Ruzieh, Mohammed, 등 "The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review." Scandinavian Cardiovascular Journal 51.5 (2017): 243-247.
Ryan, Brent J., Ahuva Nissim, 및 Paul G. Winyard. "Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases." Redox biology 2 (2014): 715-724.
Scheibenbogen, Carmen, 등 "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME." PLoS One 13.3 (2018): e0193672.
Schimke, Ingolf, 등 "Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study." Journal of Clinical Apheresis: The Official Journal of the American Society for Apheresis 20.3 (2005): 137-142.
Shanmugam, Arulkumaran, 등 "Identification of PSA peptide mimotopes using phage display peptide library." Peptides 32.6 (2011): 1097-1102.
Shoenfeld, Yehuda, 등 "Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy." Clinical Immunology 214 (2020): 108384.
Skytthe, Maria K., Jonas Heilskov Graversen, and Søren K. Moestrup. "Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases." International Journal of Molecular Sciences 21.15 (2020): 5497.
Sørensen, Karen Kristine, 등 "Liver sinusoidal endothelial cells." Comprehensive Physiology 5.4 (2011): 1751-1774.
Sotzny, Franziska, 등 "Myalgic encephalomyelitis/chronic fatigue syndrome-evidence for an autoimmune disease." Autoimmunity reviews 17.6 (2018): 601-609.
Spiess, Christoph, Qianting Zhai, 및 Paul J. Carter. "Alternative molecular formats and therapeutic applications for bispecific antibodies." Molecular immunology 67.2 (2015): 95-106.
Taddeo, Adriano, 등 "Selection and depletion of plasma cells based on the specificity of the secreted antibody." European journal of immunology 45.1 (2015): 317-319.
Teschner, Sven, 등 "ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption." Journal of clinical apheresis 27.2 (2012): 51-60.
Tetala, Kishore KR, 등 "Selective depletion of neuropathy-related antibodies from human serum by monolithic affinity columns containing ganglioside mimics." Journal of medicinal chemistry 54.10 (2011): 3500-3505.
Thornton, Kristen, 및 Marlon O. Mitchell. "Autonomic dysfunction: A guide for FPs." Journal of Family Practice 66.9 (2017): 539-544.
Vincent, Angela, 등 "Serological and experimental studies in different forms of myasthenia gravis." Annals of the New York Academy of Sciences 1413.1 (2018): 143-153.
Vincent, Angela. "Antibodies and receptors: from neuromuscular junction to central nervous system." Neuroscience 439 (2020): 48-61.
Vuorela, A., 등 "Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1." Nature communications 12.1 (2021): 1-17.
Wallukat, Gerd, 등 "Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT 1 receptor." The Journal of clinical investigation 103.7 (1999): 945-952.
Wallukat, G., J. Mller, 및 R. Hetzer. "Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy: Letter to the editor." N Engl J Med 347.22 (2002): 1806.
Wells, Rachel, 등 "Plasma exchange therapy in postural tachycardia syndrome: a novel long-term approach?." The American journal of medicine 133.4 (2020): e157-e159.
Zhao, Sean, 및 Vu H. Tran. "Postural Orthostatic Tachycardia Syndrome." StatPearls [Internet]. StatPearls Publishing, 2020.
Zhou, Cissy C., 등 "Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice." Nature medicine 14.8 (2008): 855.
Zong, Shenghua, 등 "Neuronal surface autoantibodies in neuropsychiatric disorders: are there implications for depression?." Frontiers in immunology 8 (2017): 752.
SEQUENCE LISTING
<110> Ablevia biotech GmbH
<120> Compound for the prevention or treatment of autoantibody-mediated conditions
<130> R 78304
<160> 3536
<150> EP 20197934.1
<151> 2020-09-23
<170> BiSSAP 1.3
<210> 1
<211> 116
<212> PRT
<213> Artificial Sequence
<220>
<223> heavy chain variable (VH) region
<400> 1
Asp Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
1 5 10 15
Ser Leu Ser Leu Thr Cys Thr Val Thr Gly Tyr Ser Ile Thr Ser Asp
20 25 30
Tyr Ala Trp Asn Trp Ile Arg Gln Phe Pro Gly Asn Lys Leu Glu Trp
35 40 45
Met Gly Tyr Ile Thr Tyr Ser Gly Ile Thr Asn Tyr Asn Pro Ser Leu
50 55 60
Lys Ser Gln Ile Ser Ile Thr Arg Asp Thr Ser Lys Asn Gln Phe Phe
65 70 75 80
Leu Gln Leu Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys
85 90 95
Val Ser Gly Thr Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr Leu
100 105 110
Thr Val Ser Ser
115
<210> 2
<211> 109
<212> PRT
<213> Artificial Sequence
<220>
<223> light chain variable (VL) region
<400> 2
Ser Val Val Met Thr Gln Thr Pro Lys Ser Leu Leu Ile Ser Ile Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Ser Ser Asp
20 25 30
Val Ala Trp Phe Gln Gln Lys Pro Gly Gln Ser Pro Lys Pro Leu Ile
35 40 45
Tyr Tyr Ala Ser Asn Arg Tyr Thr Gly Val Pro Asp Arg Phe Thr Gly
50 55 60
Ser Gly Tyr Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Val Gln Ala
65 70 75 80
Glu Asp Leu Ala Val Tyr Phe Cys Gly Gln Asp Tyr Thr Ser Pro Arg
85 90 95
Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala
100 105
<210> 3
<211> 25
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 3
Cys Ser Gly Arg Val Glu Val Lys Val Gln Glu Glu Trp Gly Thr Val
1 5 10 15
Cys Asn Asn Gly Trp Ser Met Glu Ala
20 25
<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 4
Gly Arg Val Glu Val Lys Val Gln Glu Glu Trp
1 5 10
<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 5
Trp Gly Thr Val Cys Asn Asn Gly Trp Ser
1 5 10
<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 6
Trp Gly Thr Val Cys Asn Asn Gly Trp
1 5
<210> 7
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 7
Glu Trp Gly Thr Val Cys Asn Asn Gly Trp Ser Met Glu
1 5 10
<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 8
Gln Glu Glu Trp Gly Thr Val Cys Asn Asn Gly Trp Ser
1 5 10
<210> 9
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 9
Trp Gly Thr Val Cys Asn Asn Gly Trp Ser Met Glu Ala
1 5 10
<210> 10
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 10
Glu Glu Trp Gly Thr Val Cys Asn Asn Gly Trp Ser Met
1 5 10
<210> 11
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 11
Val Gln Glu Glu Trp Gly Thr Val Cys Asn Asn Gly Trp
1 5 10
<210> 12
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 12
Glu Trp Gly Thr Val Cys Asn Asn Gly Trp
1 5 10
<210> 13
<211> 21
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 13
Asp His Val Ser Cys Arg Gly Asn Glu Ser Ala Leu Trp Asp Cys Lys
1 5 10 15
His Asp Gly Trp Gly
20
<210> 14
<211> 5
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 14
Glu Ser Ala Leu Trp
1 5
<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 15
Glu Ser Ala Leu Trp Asp Cys
1 5
<210> 16
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 16
Arg Gly Asn Glu Ser Ala Leu Trp Asp Cys
1 5 10
<210> 17
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 17
Ser Cys Arg Gly Asn Glu Ser Ala Leu Trp
1 5 10
<210> 18
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 18
Val Ser Cys Arg Gly Asn Glu Ser Ala Leu Trp Asp Cys
1 5 10
<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 19
Ala Leu Trp Asp Cys Lys His Asp Gly Trp
1 5 10
<210> 20
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 20
Asp His Val Ser Cys Arg Gly Asn Glu Ser Ala Leu Trp
1 5 10
<210> 21
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 21
Cys Arg Gly Asn Glu Ser Ala Leu Trp Asp
1 5 10
<210> 22
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 22
Asn Glu Ser Ala Leu Trp Asp Cys Lys His Asp Gly Trp
1 5 10
<210> 23
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 23
Glu Ser Ala Leu Trp Asp Cys Lys His Asp Gly Trp Gly
1 5 10
<210> 24
<211> 20
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 24
Ser Ser Leu Gly Gly Thr Asp Lys Glu Leu Arg Leu Val Asp Gly Glu
1 5 10 15
Asn Lys Cys Ser
20
<210> 25
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 25
Ser Ser Leu Gly Gly Thr Asp Lys Glu Leu Arg
1 5 10
<210> 26
<211> 5
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 26
Ser Ser Leu Gly Gly
1 5
<210> 27
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 27
Ser Ser Leu Gly Gly Thr Asp Lys Glu Leu Arg
1 5 10
<210> 28
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 28
Ser Ser Leu Gly Gly Thr Asp Lys Glu Leu
1 5 10
<210> 29
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 29
Ser Ser Leu Gly Gly Thr Asp Lys Glu
1 5
<210> 30
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 30
Ser Ser Leu Gly Gly Thr Asp Lys
1 5
<210> 31
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 31
Ser Ser Leu Gly Gly Thr Asp
1 5
<210> 32
<211> 6
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 32
Ser Ser Leu Gly Gly Thr
1 5
<210> 33
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 33
Cys Gly Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly Cys Lys Gly
1 5 10 15
<210> 34
<211> 22
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 34
Leu Lys Trp Asn Pro Asp Asp Tyr Gly Gly Val Lys Lys Ile His Ile
1 5 10 15
Pro Ser Glu Lys Gly Cys
20
<210> 35
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 35
Asp His Thr Leu Tyr Thr Pro Tyr His Thr His Pro Gly
1 5 10
<210> 36
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 36
Gly Arg Pro Gln Lys Arg Pro Ser Cys Ile Gly
1 5 10
<210> 37
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 37
Val Lys Lys Ile His Ile Pro Ser Glu Lys Gly
1 5 10
<210> 38
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 38
Gly Gly Val Lys Lys Ile His Ile Pro Ser Glu Lys
1 5 10
<210> 39
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 39
Val Lys Lys Ile His Ile Pro Ser Glu Lys Gly Cys
1 5 10
<210> 40
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 40
Ile Pro Asn Pro Leu Leu Gly Leu Asp Cys
1 5 10
<210> 41
<211> 23
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 41
Ile Pro Asn Pro Leu Leu Gly Leu Asp Gly Gly Ser Gly Asp Tyr Lys
1 5 10 15
Asp Asp Asp Asp Lys Gly Lys
20
<210> 42
<211> 24
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 42
Val Lys Lys Ile His Ile Pro Ser Glu Lys Gly Gly Ser Gly Asp Tyr
1 5 10 15
Lys Asp Asp Asp Asp Lys Gly Lys
20
<210> 43
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 43
Arg Ala Thr His Gln Glu Ala Ile Asn Cys Tyr Ala
1 5 10
<210> 44
<211> 6
<212> PRT
<213> Artificial Sequence
<220>
<223> peptide
<400> 44
Tyr Ala Asn Glu Thr Cys
1 5
<210> 45
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1
<400> 45
Gly Gln Pro Gly Ala Gln Arg Met Tyr Lys Gln
1 5 10
<210> 46
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2
<400> 46
His Leu Pro Asp Asp Asp Lys Thr Pro Met Ser
1 5 10
<210> 47
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3
<400> 47
Pro Gly Ala Gln Arg Met Tyr Lys Gln Ser Met
1 5 10
<210> 48
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 4
<400> 48
Pro Pro Leu Asn His Thr Val Val Gln Val Asn
1 5 10
<210> 49
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 5
<400> 49
Gln Ile Leu Thr Gly Glu Asp Trp Asn Glu Val
1 5 10
<210> 50
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 6
<400> 50
Arg Ser His Arg Ala Ser Glu Arg Ser Leu Gly
1 5 10
<210> 51
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 7
<400> 51
Ser Ser Pro Ala Pro Leu Gly Gly Gln Glu Thr
1 5 10
<210> 52
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 8
<400> 52
Glu Lys Lys Arg Arg Asn Leu Met Leu Asp Asp Val Ile Ala
1 5 10
<210> 53
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 9
<400> 53
Leu Asn Cys Ile Thr Ile Ala Met Glu Arg Pro Lys Ile Asp
1 5 10
<210> 54
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 10
<400> 54
Arg Arg Leu Glu Lys Lys Arg Arg Asn Leu Met Leu Asp Asp
1 5 10
<210> 55
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 11
<400> 55
Cys Asn Tyr Ser Glu Thr Gly Pro Pro Glu Pro Pro Tyr Ser
1 5 10
<210> 56
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 12
<400> 56
Leu Ser Ser Phe Leu Val Tyr Leu Val Glu Lys Asp Val Pro
1 5 10
<210> 57
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 13
<400> 57
Val Val Val Glu Gly Ser Gly Arg Val Ala Asp Val Ile Ala
1 5 10
<210> 58
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 14
<400> 58
Ala Ser Ala Gly Gly Ala Lys Ile Leu Gly Val Leu Arg Val
1 5 10
<210> 59
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 15
<400> 59
Glu Leu Gly Ala Asp Glu Glu Gln Arg Val Pro Tyr Pro Ala
1 5 10
<210> 60
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 16
<400> 60
Ser Gly Asp Pro Pro Leu Gly Asp Gln Lys Pro
1 5 10
<210> 61
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 17
<400> 61
Phe Glu Pro Leu Asp Leu Gly Val Pro Ser Gly Asp Pro Phe
1 5 10
<210> 62
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 18
<400> 62
Leu Ile Asn Val Asp Glu Val Asn Gln Ile Val Thr Thr Asn
1 5 10
<210> 63
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 19
<400> 63
Ser Leu Arg Ser Pro His Thr His Ser Met Ala
1 5 10
<210> 64
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 20
<400> 64
Gly Arg Thr Gly His Gly Leu Arg Arg Ser Ser
1 5 10
<210> 65
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 21
<400> 65
Leu Gly Pro Val Val Cys Asp Leu Trp Leu Ala Leu Asp Tyr
1 5 10
<210> 66
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 22
<400> 66
Val Ser Pro Ser Leu Val Gln Gly Arg Ile Val Lys Pro Asn
1 5 10
<210> 67
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 23
<400> 67
Tyr Trp Pro Leu Gly Pro Val Val Cys Asp Leu Trp Leu Ala
1 5 10
<210> 68
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 24
<400> 68
Ile Lys Val Asn Arg Gln Leu Gln Thr Val Asn
1 5 10
<210> 69
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 25
<400> 69
Asp Pro Lys Cys Cys Asp Phe Val Thr Asn Arg
1 5 10
<210> 70
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 26
<400> 70
Lys Cys Cys Asp Phe Val Thr Asn Arg Ala Tyr
1 5 10
<210> 71
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 27
<400> 71
Met Ser Leu Ala Ser Ala Asp Leu Val Met Gly
1 5 10
<210> 72
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 28
<400> 72
Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe
1 5 10
<210> 73
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 29
<400> 73
Pro Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe
1 5 10
<210> 74
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 30
<400> 74
Ser Pro Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr
1 5 10
<210> 75
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 31
<400> 75
Glu Glu Thr Glu Glu Thr Phe
1 5
<210> 76
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 32
<400> 76
Pro Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr
1 5 10
<210> 77
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 33
<400> 77
Asn Leu Tyr Thr Thr Tyr Leu
1 5
<210> 78
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 34
<400> 78
Glu Lys Leu Phe Ser Gly Tyr
1 5
<210> 79
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 35
<400> 79
Phe Tyr Leu Pro Leu Leu Val Met Leu Phe Val
1 5 10
<210> 80
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 36
<400> 80
His Ser Lys Gly Leu Gln Ile Leu Gly Gln Thr Leu Lys Ala
1 5 10
<210> 81
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 37
<400> 81
Gln Val Trp Leu Leu Phe Glu Tyr Pro Glu Ser Ser Gly Pro
1 5 10
<210> 82
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 38
<400> 82
Val Leu Ile Thr Ser Leu Ala Ile Leu Val Phe
1 5 10
<210> 83
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 39
<400> 83
Ala Lys Leu Pro Ala Leu Ala Ser Val Ala Ser Ala Arg Glu
1 5 10
<210> 84
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 40
<400> 84
Ala Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu
1 5 10
<210> 85
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 41
<400> 85
Trp Ala Ala Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly
1 5 10
<210> 86
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 42
<400> 86
Ala Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly Val
1 5 10
<210> 87
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 43
<400> 87
Gly Gln Gly Gln Lys Glu Gly
1 5
<210> 88
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 44
<400> 88
Ala Val Thr Gly Val Asn Lys Ile Glu Leu Pro Gln Phe Ser
1 5 10
<210> 89
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 45
<400> 89
Ala Thr Leu Val Met Pro Phe Ser Leu Ala Asn Glu Leu Met
1 5 10
<210> 90
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 46
<400> 90
Val Met Pro Phe Ser Leu Ala Asn Glu Leu Met Ala Tyr Trp
1 5 10
<210> 91
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 47
<400> 91
Cys Asn Lys Thr Phe Arg Thr Thr Phe Lys Met
1 5 10
<210> 92
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 48
<400> 92
Ser Ser Asp Ser Trp Asn Asn Asn Asp Ala Ala
1 5 10
<210> 93
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 49
<400> 93
Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile
1 5 10
<210> 94
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 50
<400> 94
Gly Glu Ala Pro Gln Ser Leu Leu Thr Met Glu
1 5 10
<210> 95
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 51
<400> 95
Thr Ile Ser Glu Arg Trp Gln Gln Glu Val Ala
1 5 10
<210> 96
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 52
<400> 96
Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile Gln Ser
1 5 10
<210> 97
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 53
<400> 97
Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr Met Glu Glu
1 5 10
<210> 98
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 54
<400> 98
Gly Glu Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile
1 5 10
<210> 99
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 55
<400> 99
Pro Gln Ser Leu Leu Thr Met Glu Glu Ile Gln Ser Val
1 5 10
<210> 100
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 56
<400> 100
Gln Ser Leu Leu Thr Met Glu Glu Ile Gln Ser Val Glu
1 5 10
<210> 101
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 57
<400> 101
Ser Leu Leu Thr Met Glu Glu Ile Gln Ser Val Glu Glu
1 5 10
<210> 102
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 58
<400> 102
Gly Val Gly Val Phe Leu Ala Ala Phe Ile Leu Met Ala
1 5 10
<210> 103
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 59
<400> 103
Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 104
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 60
<400> 104
Val Gly Val Arg His Ser Leu
1 5
<210> 105
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 61
<400> 105
Tyr Thr Ile Met Thr Ala His Phe His Leu Lys Arg Lys Ile
1 5 10
<210> 106
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 62
<400> 106
Gly Ser Ala Arg Ile Thr Val Ser Lys Asp Gln
1 5 10
<210> 107
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 63
<400> 107
Gly Met Ala Ser Ala Lys Thr Lys Thr His Phe Ser Val
1 5 10
<210> 108
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 64
<400> 108
Leu Lys Ser Gly Leu Lys Thr Asp Lys Ser Asp Ser Glu
1 5 10
<210> 109
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 65
<400> 109
Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 110
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 66
<400> 110
Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg
1 5 10
<210> 111
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 67
<400> 111
Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 112
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 68
<400> 112
Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu
1 5 10
<210> 113
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 69
<400> 113
Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 114
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 70
<400> 114
Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 115
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 71
<400> 115
Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly
1 5 10
<210> 116
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 72
<400> 116
Cys Thr Pro Cys Lys Glu Asn Glu Tyr Val Phe Asp Glu Tyr
1 5 10
<210> 117
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 73
<400> 117
Asn Thr Gln Asn Phe Lys Pro Ala Pro Ala Thr Asn Thr Gln
1 5 10
<210> 118
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 74
<400> 118
Thr Thr Arg Ser Ile Thr Asp Pro Thr Asp Pro Val Asp Tyr
1 5 10
<210> 119
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 75
<400> 119
Asp Gln Leu Asp Phe Trp Glu Ser Gly Glu Trp
1 5 10
<210> 120
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 76
<400> 120
Glu Leu Pro Pro Pro Asp Gln Pro Ser Pro Cys
1 5 10
<210> 121
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 77
<400> 121
Pro Pro Pro Asp Gln Pro Ser Pro Cys Lys Cys
1 5 10
<210> 122
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 78
<400> 122
Ser Val Lys Glu Asp Trp Lys Tyr Val Ala Met Val Ile Asp
1 5 10
<210> 123
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 79
<400> 123
Ala Glu Leu Pro Pro Pro Asp Gln Pro Ser Pro Cys Lys
1 5 10
<210> 124
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 80
<400> 124
His Ser Ala Glu Leu Pro Pro Pro Asp Gln Pro Ser Pro
1 5 10
<210> 125
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 81
<400> 125
Pro Asp Gln Pro Ser Pro Cys
1 5
<210> 126
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 82
<400> 126
Pro Pro Asp Gln Pro Ser Pro
1 5
<210> 127
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 83
<400> 127
Ser Ala Glu Leu Pro Pro Pro Asp Gln Pro Ser Pro Cys
1 5 10
<210> 128
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 84
<400> 128
Leu Pro Ser Thr Cys Leu Gln Lys Val Glu Glu Gln Pro Glu
1 5 10
<210> 129
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 85
<400> 129
Ser Ala Lys Pro Leu Thr Arg Tyr Met Pro Gln
1 5 10
<210> 130
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 86
<400> 130
Ile Val Leu Ala Leu Glu Gln His Leu Pro Asp Gly Asp Lys
1 5 10
<210> 131
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 87
<400> 131
Ala Met Asp Ile Leu Asn Met Val Phe Thr Gly Val Phe Thr
1 5 10
<210> 132
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 88
<400> 132
Lys Ala Ala Gln Thr Met Ser Thr Ser Ala Pro
1 5 10
<210> 133
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 89
<400> 133
Lys His Asp Arg Glu Pro Gln Arg Arg Ser Ser
1 5 10
<210> 134
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 90
<400> 134
Gln Ala Lys Ala Ala Gln Thr Met Ser Thr Ser
1 5 10
<210> 135
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 91
<400> 135
Ile Tyr Ile Pro Phe Pro Glu Asp Asp Ser Asn Ser Thr Asn
1 5 10
<210> 136
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 92
<400> 136
Gln His Ser Pro Glu Ala Ala Cys Pro Pro Thr Ala Gly Thr
1 5 10
<210> 137
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 93
<400> 137
Ala Ser Pro Pro Arg Arg Ala Ser Ser Val Gly
1 5 10
<210> 138
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 94
<400> 138
Pro Glu Val Arg Cys Cys Val Asp Ala Val Asn
1 5 10
<210> 139
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 95
<400> 139
Pro Arg Leu Arg His Val Leu Leu Glu Leu Leu
1 5 10
<210> 140
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 96
<400> 140
Phe Ile Trp Asp Ser Ala Val Leu Glu Phe Glu Ala Ser Gln
1 5 10
<210> 141
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 97
<400> 141
Leu Phe Leu Gln Lys Leu Pro Lys Leu Leu Cys
1 5 10
<210> 142
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 98
<400> 142
Ser Ile Ile Val Thr Val Phe Val Ile Asn Val
1 5 10
<210> 143
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 99
<400> 143
Thr Leu Ser Ile Ile Val Thr Val Phe Val Ile
1 5 10
<210> 144
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 100
<400> 144
Leu Phe Glu Asn Ala Asp Gly Arg Phe Glu Gly Ser Leu
1 5 10
<210> 145
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 101
<400> 145
Gly Val Tyr Asn Gln Pro Pro Pro Gln Pro Phe Pro Gly Asp
1 5 10
<210> 146
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 102
<400> 146
Leu Glu Glu Asp Arg Glu Ala Val Arg Arg Glu Ala Glu Arg
1 5 10
<210> 147
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 103
<400> 147
Lys Phe Lys Thr Thr His Ala Pro Pro Gly Asp Thr Leu Val
1 5 10
<210> 148
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 104
<400> 148
Ala Gly Glu Ser Thr Phe Ala Asn Asn Lys Ser Ser Val Pro
1 5 10
<210> 149
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 105
<400> 149
Glu Met Ser Ala Gly Glu Ser Thr Phe Ala Asn Asn Lys Ser
1 5 10
<210> 150
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 106
<400> 150
Gly Asn Ile Glu Gly Asn Ala Ala Lys Arg Arg Lys Gln Gln
1 5 10
<210> 151
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 107
<400> 151
Leu Gly Ala Ala Met Ala Leu Ser Leu Ile Thr Phe Ile Cys
1 5 10
<210> 152
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 108
<400> 152
Ser Lys His Ser Gln Leu Ser Asp Leu Tyr Gly Lys Phe Ser
1 5 10
<210> 153
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 109
<400> 153
Ile Gly Thr Asp Ile Val Ala Thr Val Glu Asn Glu Glu Pro
1 5 10
<210> 154
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 110
<400> 154
Cys Tyr Phe Ile Gly Thr Asp Ile Val Ala Thr Val Glu Asn
1 5 10
<210> 155
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 111
<400> 155
Phe Gly Lys Phe Cys Pro His Arg Val Ala Cys Lys Arg Leu
1 5 10
<210> 156
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 112
<400> 156
Ala Gly Tyr Pro Ser Thr Val Ser Thr Val Glu
1 5 10
<210> 157
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 113
<400> 157
Phe Ala Gln Asp Pro Lys Phe Ile Glu Val Thr
1 5 10
<210> 158
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 114
<400> 158
Gly Gln Phe Ala Gln Asp Pro Lys Phe Ile Glu
1 5 10
<210> 159
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 115
<400> 159
Pro Gln Pro Val Pro Thr Leu Arg Leu Glu Gly Val Glu Ser
1 5 10
<210> 160
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 116
<400> 160
Gln Gly Ser Thr Thr Ala Thr Arg Pro Pro Arg
1 5 10
<210> 161
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 117
<400> 161
Ser Ser Asn Arg Glu Arg His Val Pro Met Cys Glu Asp Leu
1 5 10
<210> 162
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 118
<400> 162
Ala Leu Ala His Glu Asp Cys Pro Ala Ile Asp Gln Pro Ala
1 5 10
<210> 163
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 119
<400> 163
Gly Ala Ala His Val His Gly Ile Val Phe Glu Asp Asn Val
1 5 10
<210> 164
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 120
<400> 164
His Val His Gly Ile Val Phe Glu Asp Asn Val Asp Thr Glu
1 5 10
<210> 165
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 121
<400> 165
Pro His Met Gln Lys Ala Leu Glu Gly Val His Tyr Ile Ala
1 5 10
<210> 166
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 122
<400> 166
Glu Val Ala Ile Thr Gln Leu Ala Asn Val Asp Glu Val Asn
1 5 10
<210> 167
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 123
<400> 167
His Cys His Lys Ser Asn Glu Leu Ala Thr Ser
1 5 10
<210> 168
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 124
<400> 168
Val Asp Met Asn Asp Phe Trp Glu Asn Ser Glu
1 5 10
<210> 169
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 125
<400> 169
Trp Thr Tyr Asp Lys Ala Glu Ile Asp Leu Leu
1 5 10
<210> 170
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 126
<400> 170
Leu Gly Arg Ser Asn Thr Ile Gly Ser Ala Pro
1 5 10
<210> 171
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 127
<400> 171
Met Glu Pro Ser Ser Leu Pro Gln Glu Ile Ile
1 5 10
<210> 172
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 128
<400> 172
Leu Phe Pro Val Ala Phe Ala Gly Phe Asn Leu Val Tyr Trp
1 5 10
<210> 173
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 129
<400> 173
Arg Pro Gly Phe Gly Gly Ala Val Thr Glu Val Lys Thr Asp
1 5 10
<210> 174
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 130
<400> 174
Gly Ala Val Met Asn Lys Leu Leu Thr Met Gly
1 5 10
<210> 175
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 131
<400> 175
Arg Leu Thr Ile Ala Lys Gln Thr Val Ser Ser
1 5 10
<210> 176
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 132
<400> 176
Asp Met Asn Phe Asp Phe Asp Leu Tyr Ile Val Gly Asp Gly
1 5 10
<210> 177
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 133
<400> 177
Ile Glu His Pro Phe Val Phe Thr Arg Glu Val Asp Asp Glu
1 5 10
<210> 178
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 134
<400> 178
Tyr Glu Trp Lys Ser Pro Phe Gly Leu Thr Pro Lys Gly Arg
1 5 10
<210> 179
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 135
<400> 179
Ile Thr Ile Ile Phe Asn Lys Phe Ser His Phe Tyr Arg Arg
1 5 10
<210> 180
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 136
<400> 180
Asp Asp Glu Asp Leu Ala Ala Lys Arg Leu Gly Ile Glu Asp
1 5 10
<210> 181
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 137
<400> 181
Leu Ser Pro Pro Pro Arg Ala Pro Pro Leu Ser Pro Gly Pro
1 5 10
<210> 182
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 138
<400> 182
Glu Ser Glu Gly Glu Lys Glu Asn Ser Thr Asn Asp Pro Glu
1 5 10
<210> 183
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 139
<400> 183
Glu Ser Leu Cys Ser Ile Arg Arg Ala Ser Ser Val His Asp
1 5 10
<210> 184
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 140
<400> 184
Leu Ser Phe Glu Ser Glu Gly Glu Lys Glu Asn Ser Thr Asn
1 5 10
<210> 185
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 141
<400> 185
Arg Ser Arg Glu Ser Leu Cys Ser Ile Arg Arg Ala Ser Ser
1 5 10
<210> 186
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 142
<400> 186
Ser Pro Thr Lys Glu Ser Cys Ser Pro Ser Glu Ala Asp Asp
1 5 10
<210> 187
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 143
<400> 187
Thr Leu Ser Asp Asp Asp Tyr Val Asn Val Ala Ser Phe Asn
1 5 10
<210> 188
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 144
<400> 188
Asp Glu Glu Gly Arg Gly Gly Ala Gly Gly Gly Gly Ala Gly
1 5 10
<210> 189
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 145
<400> 189
Gly Gly Ala Gly Gly Gly Gly Asp Thr Glu Gly Gly Leu Cys
1 5 10
<210> 190
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 146
<400> 190
Gly Arg Gly Gly Ala Gly Gly Gly Gly Ala Gly
1 5 10
<210> 191
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 147
<400> 191
Arg Ser Pro Ser Trp Ala Ala Asp Arg Ser Lys Asp Pro Pro
1 5 10
<210> 192
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 148
<400> 192
Trp Gly Arg Ser Ala Ala Trp Ala Ser Arg Arg
1 5 10
<210> 193
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 149
<400> 193
Ala Ser Pro Ser Arg Asp Val Ser Pro Met Gly
1 5 10
<210> 194
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 150
<400> 194
Gly Ser Trp Thr Tyr Asn Gly Asn Gln Val Asp
1 5 10
<210> 195
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 151
<400> 195
Thr Asp Lys Val Leu Asn Val Thr Leu Gln Ile Thr Leu Ser
1 5 10
<210> 196
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 152
<400> 196
Val Leu Phe Val Tyr Asp Val Gly Glu Ser Cys Leu Ser
1 5 10
<210> 197
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 153
<400> 197
Phe Ser Arg Ser Tyr Ser Glu Leu Lys Glu Gln Gln Gln Arg
1 5 10
<210> 198
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 154
<400> 198
Phe Gln Ala Thr Trp Ala Val Asn Asn Gly Ile Asp Thr Thr
1 5 10
<210> 199
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 155
<400> 199
Lys Phe Phe Lys Asn Ala Leu Asn Leu Ile Asp Leu Met Ser
1 5 10
<210> 200
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 156
<400> 200
Pro Arg Arg His Arg Arg Pro Arg Arg Val Ile Ala Arg Tyr
1 5 10
<210> 201
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 157
<400> 201
Ser Arg Asp Ala Ser Pro Val Gly Ile Lys Gly Phe Asn Thr
1 5 10
<210> 202
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 158
<400> 202
Ile Leu Tyr Ala Gly Asn Asp Arg Trp Thr Ser Asp Pro Arg
1 5 10
<210> 203
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 159
<400> 203
Ser Trp Gly Ser Lys Ile Ala Pro Val Tyr Gln Gln Glu Glu
1 5 10
<210> 204
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 160
<400> 204
Phe Glu Gln Gly Lys Lys Ser Val Thr Ala Pro Lys Phe Ile
1 5 10
<210> 205
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 161
<400> 205
Gly Lys Lys Ser Val Thr Ala Pro Lys Phe Ile Ser Pro Ala
1 5 10
<210> 206
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 162
<400> 206
Ser Val Thr Ala Pro Lys Phe Ile Ser Pro Ala Ser Gln Leu
1 5 10
<210> 207
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 163
<400> 207
Ala Leu Met Ala His Glu Ser Gly Leu Lys Glu
1 5 10
<210> 208
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 164
<400> 208
Ala Arg Lys Pro Asp His Thr Thr Val Asp Ile
1 5 10
<210> 209
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 165
<400> 209
Ala Ser Val Ala Tyr Glu Asn Ala Leu Arg Val Phe Asn Ile
1 5 10
<210> 210
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 166
<400> 210
Asp Cys Arg Gly Lys Tyr Leu Leu Tyr Glu Lys Asn Glu Val
1 5 10
<210> 211
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 167
<400> 211
Gly Ala Asp Lys Gln Gln Met Asp Ala Glu Leu
1 5 10
<210> 212
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 168
<400> 212
Gly Lys Tyr Leu Leu Tyr Glu Lys Asn Glu Val
1 5 10
<210> 213
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 169
<400> 213
Gly Ser Tyr Leu Arg Asn Gly Trp Asn Val Met
1 5 10
<210> 214
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 170
<400> 214
His His Gly Tyr Tyr Arg Gly Ser Asp Tyr Asp
1 5 10
<210> 215
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 171
<400> 215
Leu Phe Ile Val Val Phe Ala Leu Leu Gly Met
1 5 10
<210> 216
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 172
<400> 216
Leu Gly Met Gln Leu Phe Gly Gly Gln Phe Asn
1 5 10
<210> 217
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 173
<400> 217
Leu Arg Leu Leu Arg Ile Phe Lys Val Thr Lys Tyr Trp Ala
1 5 10
<210> 218
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 174
<400> 218
Leu Ser Gly Glu Phe Ala Lys Glu Arg Glu Arg
1 5 10
<210> 219
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 175
<400> 219
Met Ala His Glu Ser Gly Leu Lys Glu Ser Pro
1 5 10
<210> 220
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 176
<400> 220
Asn Pro Asp Pro Leu Pro Lys Lys Glu Glu Glu
1 5 10
<210> 221
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 177
<400> 221
Asn Tyr Thr Leu Leu Asn Val Phe Leu Ala Ile Ala Val Asp
1 5 10
<210> 222
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 178
<400> 222
Gln Gly Gly Gln Pro Gly Ala Gln Arg Met Tyr
1 5 10
<210> 223
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 179
<400> 223
Arg Glu Ala Leu Tyr Asn Glu Met Asp Pro Asp
1 5 10
<210> 224
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 180
<400> 224
Arg Pro His Val Ser Tyr Ser Pro Val Ile Arg
1 5 10
<210> 225
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 181
<400> 225
Arg Thr Pro Leu Met Phe Gln Arg Met Glu Pro
1 5 10
<210> 226
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 182
<400> 226
Ser Ala Ala Pro His Gly Ser Leu Gly His Ala
1 5 10
<210> 227
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 183
<400> 227
Ser Gly Ile Leu Thr Arg Glu Cys Gly Asn Glu
1 5 10
<210> 228
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 184
<400> 228
Ser Leu Lys Asn Val Phe Asn Ile Leu Ile Val
1 5 10
<210> 229
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 185
<400> 229
Thr Pro Arg Pro His Val Ser Tyr Ser Pro Val
1 5 10
<210> 230
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 186
<400> 230
Thr Val Phe Gln Ile Leu Thr Gly Glu Asp Trp Asn Glu Val
1 5 10
<210> 231
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 187
<400> 231
Val Ile Leu Ala Glu Asp Glu Thr Asp Gly Glu
1 5 10
<210> 232
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 188
<400> 232
Tyr Leu Thr Arg Asp Ser Ser Ile Leu Gly Pro
1 5 10
<210> 233
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 189
<400> 233
Gly Gly Ala Leu Met Ala His Glu Ser Gly Leu Lys Glu Ser
1 5 10
<210> 234
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 190
<400> 234
Ala Ala Phe Met Ile Gln Glu Glu Tyr Val Asp Thr Val Ser
1 5 10
<210> 235
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 191
<400> 235
Ala Pro Thr Ser Arg Ser Leu Glu Asp Leu Ser Ser Cys Pro
1 5 10
<210> 236
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 192
<400> 236
Pro Leu Trp Ser Arg Tyr Gly Arg Phe Leu Gln Pro Val Asp
1 5 10
<210> 237
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 193
<400> 237
Pro Gln Pro Leu Pro Ser Pro Ala Tyr Pro Ala Pro Arg Pro
1 5 10
<210> 238
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 194
<400> 238
Gln Leu Gln Val Ile Phe Glu Val Leu Glu Glu Tyr Asp Trp
1 5 10
<210> 239
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 195
<400> 239
Val Ile Phe Glu Val Leu Glu Glu Tyr Asp Trp Thr Ser Phe
1 5 10
<210> 240
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 196
<400> 240
Tyr Thr Ala Asn Leu Ala Ala Phe Met Ile Gln Glu Glu Tyr
1 5 10
<210> 241
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 197
<400> 241
Glu Ser Gln Pro Leu Leu Gly Pro Gly Ala Gly Gly Ala Gly
1 5 10
<210> 242
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 198
<400> 242
Asp Pro Gln Ile Pro Leu Ala Glu Met Glu Ala Leu Ser Leu
1 5 10
<210> 243
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 199
<400> 243
Phe Ile Phe Ile Phe Ser Ile Leu Gly Met His Leu Phe Gly
1 5 10
<210> 244
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 200
<400> 244
Lys Gly Ala Ile Asn Phe Asp Asn Ile Gly Tyr
1 5 10
<210> 245
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 201
<400> 245
Asn His Asn Pro Trp Met Leu Leu Tyr Phe Ile Ser Phe Leu
1 5 10
<210> 246
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 202
<400> 246
Pro Cys Glu Gly Leu Gly Arg His Ala Thr Phe Arg Asn Phe
1 5 10
<210> 247
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 203
<400> 247
Pro Trp Met Leu Leu Tyr Phe Ile Ser Phe Leu Leu Ile Val
1 5 10
<210> 248
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 204
<400> 248
Pro Tyr Cys Ala Arg Ala Gly Ala Gly Glu Val
1 5 10
<210> 249
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 205
<400> 249
Ser Pro Ser Leu Asp Gly Asp Gly Asp Arg Lys Lys Cys Leu
1 5 10
<210> 250
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 206
<400> 250
Val His His Leu Val His His His His His His His His His
1 5 10
<210> 251
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 207
<400> 251
Val Arg Phe Leu Ser Asn Ala Ser Thr Leu Ala
1 5 10
<210> 252
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 208
<400> 252
Cys Gly Leu Asp Tyr Glu Ala Tyr Asn Ser Ser Ser Asn Thr
1 5 10
<210> 253
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 209
<400> 253
Gly Ala Ala Gly Gly Gly Gly Asp Gly Gly Gly Gly Gly Gly
1 5 10
<210> 254
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 210
<400> 254
Gly Gly Gly Gly Asp Gly Gly Gly Gly Gly Gly Gly Ala Ala
1 5 10
<210> 255
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 211
<400> 255
Lys Ala Arg Arg Ala Ala Gly Ala Ala Gly Gly Gly Gly Asp
1 5 10
<210> 256
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 212
<400> 256
Arg Ala Ala Gly Ala Ala Gly Gly Gly Gly Asp Gly Gly Gly
1 5 10
<210> 257
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 213
<400> 257
Tyr Gly Asp Lys Thr Pro Lys Thr Trp Glu Gly Arg Leu Ile
1 5 10
<210> 258
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 214
<400> 258
Phe Ala Arg Leu Pro Pro Tyr Arg Tyr Arg Phe Arg Arg Arg
1 5 10
<210> 259
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 215
<400> 259
Asp Phe Glu Leu Tyr Leu Val Gly Asp Gly Lys Tyr Gly Ala
1 5 10
<210> 260
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 216
<400> 260
Thr Gly Arg Leu Leu Met Asn Leu Trp Ala Ile Phe Cys Leu
1 5 10
<210> 261
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 217
<400> 261
Lys Glu Glu Thr Ala Glu Ala Glu Pro Ser Gly Pro Glu Val
1 5 10
<210> 262
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 218
<400> 262
Glu Lys Arg Leu Gly Thr Pro Pro Gly Gly Gly Gly Ala Gly
1 5 10
<210> 263
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 219
<400> 263
Phe Trp Ile Ile His Pro Tyr Ser Asp Phe Arg Phe Tyr Trp
1 5 10
<210> 264
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 220
<400> 264
Leu Gly Thr Pro Pro Gly Gly Gly Gly Ala Gly Ala Lys Glu
1 5 10
<210> 265
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 221
<400> 265
Leu Leu Gln Asp Phe Pro Pro Asp Cys Trp Val Ser Leu Asn
1 5 10
<210> 266
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 222
<400> 266
Leu Pro Ala Asp Met Arg Gln Lys Ile His Asp Tyr Tyr Glu
1 5 10
<210> 267
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 223
<400> 267
Met Val Gly Asn Leu Val Ile Ile Pro Val Gly Ile Thr Phe
1 5 10
<210> 268
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 224
<400> 268
Pro Ser Ala Ile Leu Ser Pro Cys Ser Tyr Thr Thr Ala Val
1 5 10
<210> 269
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 225
<400> 269
Thr Asn Leu Thr Arg Glu Val Arg Pro Leu Ser Ala Ser Gln
1 5 10
<210> 270
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 226
<400> 270
Thr Pro Gln Pro Ser Ala Ile Leu Ser Pro Cys Ser Tyr Thr
1 5 10
<210> 271
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 227
<400> 271
Tyr Glu His Arg Tyr Gln Gly Lys Ile Phe Asp Glu Glu Asn
1 5 10
<210> 272
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 228
<400> 272
Ile Gln His Gly Val Ala Gly Val Ile Thr Lys Ser Ser Lys
1 5 10
<210> 273
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 229
<400> 273
Cys Gly Gly Ile Leu Glu Thr Thr Leu Val Glu
1 5 10
<210> 274
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 230
<400> 274
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 275
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 231
<400> 275
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 276
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 232
<400> 276
Gly Ala Asp Met Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 277
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 233
<400> 277
His His Gly Gln Pro Val Trp Leu Thr Gln Ile Gln Glu Tyr
1 5 10
<210> 278
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 234
<400> 278
His Ser Ser Ala Ile Ser Val Val Lys Ile Leu Arg Val Leu
1 5 10
<210> 279
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 235
<400> 279
Ile Val Ala Tyr Gly Leu Val Leu His Pro Ser
1 5 10
<210> 280
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 236
<400> 280
Ile Val Asp Ile Ala Val Thr Glu Val Asn Asn
1 5 10
<210> 281
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 237
<400> 281
Leu Gly Met Gln Leu Phe Gly Gly Lys Phe Asn Phe Asp Gln
1 5 10
<210> 282
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 238
<400> 282
Leu Pro Ala Ser Asp Thr Gly Ser Met Thr Glu
1 5 10
<210> 283
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 239
<400> 283
Leu Tyr Ser Asp Glu Glu Ser Ile Leu Ser Arg Phe Asp Glu
1 5 10
<210> 284
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 240
<400> 284
Met Glu Glu Asp Leu Arg Gly Tyr Leu Asp Trp Ile Thr Gln
1 5 10
<210> 285
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 241
<400> 285
Met Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 286
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 242
<400> 286
Pro His Gln Tyr Arg Val Trp Ala Thr Val Asn
1 5 10
<210> 287
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 243
<400> 287
Gln Glu Asn Glu Gly Leu Val Pro Gly Val Glu Lys Glu Glu
1 5 10
<210> 288
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 244
<400> 288
Ser Ala Met Met Ala Leu Phe Thr Val Ser Thr Phe Glu Gly
1 5 10
<210> 289
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 245
<400> 289
Ser His Ala Ser Leu Pro Ala Ser Asp Thr Gly
1 5 10
<210> 290
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 246
<400> 290
Thr Cys Asp Thr Glu Glu Glu Glu Glu Glu Gly
1 5 10
<210> 291
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 247
<400> 291
Glu Gly Ser Gly Arg Val Ala Asp Val Ile Ala Gln Val Ala
1 5 10
<210> 292
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 248
<400> 292
Ala Glu Ser Leu Asp Pro Arg Pro Leu Arg Pro
1 5 10
<210> 293
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 249
<400> 293
Ala Ser Val Arg Thr Arg Lys His Thr Phe Gly Gln Arg Cys
1 5 10
<210> 294
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 250
<400> 294
Ala Thr Phe Cys Thr Leu Leu Met Leu Phe Ile Phe Ile Phe
1 5 10
<210> 295
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 251
<400> 295
Asp Asn Val Ala Thr Phe Cys Thr Leu Leu Met Leu Phe Ile
1 5 10
<210> 296
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 252
<400> 296
Asp Pro Tyr Glu Lys Ile Pro His Val Val Gly Glu His Gly
1 5 10
<210> 297
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 253
<400> 297
Asp Thr Gly Asp Thr Val Pro Asp Arg Lys Asn
1 5 10
<210> 298
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 254
<400> 298
Gly Val Pro Ser Gly Asp Pro Phe Leu Asp Gly
1 5 10
<210> 299
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 255
<400> 299
His Ala Tyr Leu Gln Ser Ser Trp Asn Leu Leu Asp Gly Leu
1 5 10
<210> 300
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 256
<400> 300
Lys Arg Arg Gly Leu Tyr Leu Thr Val Pro Gln Cys Pro Leu
1 5 10
<210> 301
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 257
<400> 301
Pro Gly Ser Pro Gln Arg Arg Ala Gln Gln Arg
1 5 10
<210> 302
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 258
<400> 302
Ala Glu Pro Ala Leu Gly Ala Arg Arg Lys Lys Lys Met Ser
1 5 10
<210> 303
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 259
<400> 303
Gly Ala Asp Glu Glu Gln Arg Val Pro Tyr Pro Ala Leu Ala
1 5 10
<210> 304
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 260
<400> 304
Ala Gly Leu Val Leu Gly Ser Glu His Glu Thr Arg Leu Val
1 5 10
<210> 305
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 261
<400> 305
Asp Glu Val Asn Gln Ile Val Thr Thr Asn Val
1 5 10
<210> 306
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 262
<400> 306
Gly Leu Gln Leu Ile Gln Leu Ile Asn Val Asp Glu Val Asn
1 5 10
<210> 307
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 263
<400> 307
Ile Gln Leu Ile Asn Val Asp Glu Val Asn Gln
1 5 10
<210> 308
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 264
<400> 308
Tyr Cys Glu Ile Ile Val Thr His Phe Pro Phe
1 5 10
<210> 309
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 265
<400> 309
His Ser Glu Glu Asn Lys Ala Pro Glu Ser Glu Glu Leu Glu
1 5 10
<210> 310
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 266
<400> 310
Pro Ala Lys Met Leu Leu Asp Pro Ala Ala Pro Ala Gln Glu
1 5 10
<210> 311
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 267
<400> 311
Ile Leu Ile Val Val Asn Ala
1 5
<210> 312
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 268
<400> 312
Ser His Phe Asp Asn Gly Asn Glu Glu Trp Phe Leu Val
1 5 10
<210> 313
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 269
<400> 313
Ala Ile Asn Cys Tyr Ala Asn Glu Thr Cys Cys Asp Phe Phe
1 5 10
<210> 314
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 270
<400> 314
Asp Asn Ile Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp
1 5 10
<210> 315
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 271
<400> 315
Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp
1 5 10
<210> 316
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 272
<400> 316
His Asp Val Thr Gln Glu Arg Asp Glu Val Trp
1 5 10
<210> 317
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 273
<400> 317
Ala Ile Thr Ser Pro Phe Lys Tyr Gln Ser Leu Leu Thr
1 5 10
<210> 318
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 274
<400> 318
Ile Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp Ser
1 5 10
<210> 319
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 275
<400> 319
Lys Tyr Gln Ser Leu Leu Thr
1 5
<210> 320
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 276
<400> 320
Asn Ile Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp
1 5 10
<210> 321
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 277
<400> 321
Asp Leu Ile Ile Gly Val Phe Ser Met Asn Leu
1 5 10
<210> 322
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 278
<400> 322
Ile Gly Val Phe Ser Met Asn Leu Tyr Thr Leu Tyr Thr Val
1 5 10
<210> 323
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 279
<400> 323
Ile Val Gly Val Arg Thr Val Glu Asp Gly Glu
1 5 10
<210> 324
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 280
<400> 324
Lys Ser Asp Ser Cys Thr Pro Thr Asn Thr Thr Val Glu Val
1 5 10
<210> 325
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 281
<400> 325
Met Asn Asn Ser Thr Asn Ser Ser Asn Asn Ser
1 5 10
<210> 326
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 282
<400> 326
Thr Ser Leu Gly His Ser Lys Asp Glu Asn Ser Lys Gln Thr
1 5 10
<210> 327
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 283
<400> 327
Met Asn Asn Ser Thr Asn Ser
1 5
<210> 328
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 284
<400> 328
Met Asn Asn Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala
1 5 10
<210> 329
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 285
<400> 329
Asn Asn Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala Leu
1 5 10
<210> 330
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 286
<400> 330
Thr Gln Asp Glu Asn Thr Val Ser Thr Ser Leu Gly His
1 5 10
<210> 331
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 287
<400> 331
Lys Glu Lys Lys Ala Lys Thr Leu Ala Phe Leu
1 5 10
<210> 332
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 288
<400> 332
Pro Ala Thr Glu Leu Ser Thr Thr Glu Ala Thr
1 5 10
<210> 333
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 289
<400> 333
Gly Ser Ala Thr Gln Asn Thr
1 5
<210> 334
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 290
<400> 334
Tyr Thr Val Tyr Ile Ile Lys Gly Tyr Trp Pro Leu Gly
1 5 10
<210> 335
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 291
<400> 335
Ala Pro Ala Pro Pro Pro Gly Pro Pro Arg Pro
1 5 10
<210> 336
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 292
<400> 336
Glu Arg Arg Phe Leu Gly Gly Pro Ala Arg Pro
1 5 10
<210> 337
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 293
<400> 337
Asn Gly Gly Ala Ala Ala Asp Ser Asp Ser Ser Leu Asp Glu
1 5 10
<210> 338
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 294
<400> 338
Tyr Asn Asp Pro Lys Cys Cys Asp Phe Val Thr
1 5 10
<210> 339
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 295
<400> 339
Ala Ile Thr Ser Pro Phe Arg Tyr Gln Ser Leu Leu Thr
1 5 10
<210> 340
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 296
<400> 340
Arg Tyr Gln Ser Leu Leu Thr
1 5
<210> 341
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 297
<400> 341
Asp Tyr Val Ala Ser Asn Ala Ser Val Met Asn Leu Leu Val
1 5 10
<210> 342
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 298
<400> 342
Glu Glu Thr Glu Glu Thr Phe Val Lys Ala Glu
1 5 10
<210> 343
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 299
<400> 343
Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu
1 5 10
<210> 344
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 300
<400> 344
Leu Val Gly Lys Arg Thr Val Pro Leu Asp Glu
1 5 10
<210> 345
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 301
<400> 345
Ala Glu Glu Thr Glu Glu Thr
1 5
<210> 346
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 302
<400> 346
Ala Glu Glu Thr Glu Glu Thr Phe Val Lys Ala Glu Thr
1 5 10
<210> 347
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 303
<400> 347
Cys Ser Ser Tyr Pro Ser Ser Glu Asp Glu Asp Lys Pro
1 5 10
<210> 348
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 304
<400> 348
Glu Glu Thr Glu Glu Thr Phe Val Lys Ala Glu Thr Glu
1 5 10
<210> 349
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 305
<400> 349
Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe
1 5 10
<210> 350
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 306
<400> 350
Leu Phe Arg Ser Cys Leu Arg Cys Pro Arg Pro Thr Leu
1 5 10
<210> 351
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 307
<400> 351
Leu Gly Tyr Trp Leu Cys Tyr Val Asn Ser Thr Val Asn
1 5 10
<210> 352
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 308
<400> 352
Ser Ala Glu Glu Thr Glu Glu
1 5
<210> 353
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 309
<400> 353
Thr Lys Ala Glu Lys Arg Lys Pro Ala His Arg Ala Leu
1 5 10
<210> 354
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 310
<400> 354
Tyr Pro Ser Ser Glu Asp Glu Asp Lys Pro Ala Thr Asp
1 5 10
<210> 355
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 311
<400> 355
Ile Tyr Leu Ala Leu Asp Val Leu Phe Cys Thr
1 5 10
<210> 356
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 312
<400> 356
Val Ala Thr Leu Val Ile Pro Phe Ser Leu Ala Asn Glu Val
1 5 10
<210> 357
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 313
<400> 357
Ala Ala Leu Gln Gly Ser Glu Thr Pro Gly Lys Gly Gly Gly
1 5 10
<210> 358
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 314
<400> 358
Glu Thr Glu Asn Arg Ala Arg Glu Leu Ala Ala Leu Gln Gly
1 5 10
<210> 359
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 315
<400> 359
Leu Val Leu Ile Ser Phe Lys Val Asn Thr Glu
1 5 10
<210> 360
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 316
<400> 360
Pro Arg Ser Ser Pro Asn Thr Val Lys Arg Pro
1 5 10
<210> 361
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 317
<400> 361
Gln Lys Pro Arg Gly Lys Glu Gln Leu Ala Lys
1 5 10
<210> 362
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 318
<400> 362
Pro Thr Lys Lys Gly Arg Asp
1 5
<210> 363
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 319
<400> 363
Pro Gly Ala Leu Leu Met Leu
1 5
<210> 364
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 320
<400> 364
Trp Thr Phe Ile Ile Phe Thr Ser Val Gly Thr Leu Val
1 5 10
<210> 365
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 321
<400> 365
Val Leu Val Trp Val Val Ser Ala Ala Val Ser
1 5 10
<210> 366
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 322
<400> 366
Tyr Gly Ala Leu Val Thr Lys
1 5
<210> 367
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 323
<400> 367
Gly Lys Thr Arg Thr Ser Leu Lys Thr Met Ser Arg Arg Lys
1 5 10
<210> 368
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 324
<400> 368
Asp Ile Val Ala Ile Ile Pro Tyr Phe Ile Thr Leu Gly Thr
1 5 10
<210> 369
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 325
<400> 369
Glu Asn Glu Phe Gln Arg Gln Val Trp Leu Leu Phe Glu Tyr
1 5 10
<210> 370
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 326
<400> 370
Glu Tyr Pro Glu Ser Ser Gly Pro Ala Arg Ile Ile Ala Ile
1 5 10
<210> 371
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 327
<400> 371
Ile Gly Val Ile Leu Phe Ser Ser Ala Val Tyr Phe Ala Glu
1 5 10
<210> 372
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 328
<400> 372
Gln Ser Thr Ser Phe Thr Asp Pro Phe Phe Ile Val Glu Thr
1 5 10
<210> 373
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 329
<400> 373
Gln Glu Gly Val Asn Asn Ser Asn Glu Asp Phe Arg Glu Glu
1 5 10
<210> 374
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 330
<400> 374
Thr Trp Thr Leu Lys Lys Leu Pro Leu Ser Leu Ser Phe Leu
1 5 10
<210> 375
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 331
<400> 375
Asn Asn Gly Gly Val Ser Arg Val Ser Pro Val Ser Arg Gly
1 5 10
<210> 376
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 332
<400> 376
Phe Arg Ser Trp Thr Tyr Asp Arg Thr Glu Ile Asp Leu Val
1 5 10
<210> 377
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 333
<400> 377
Leu Asp Asp Phe Thr Pro Ser Gly Glu Trp Asp Ile Val Ala
1 5 10
<210> 378
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 334
<400> 378
Leu Pro Pro Ala Ile Tyr Lys Ser Ala Cys Lys
1 5 10
<210> 379
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 335
<400> 379
Asn Val Trp Leu Thr Gln Glu Trp Glu Asp Tyr
1 5 10
<210> 380
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 336
<400> 380
Arg His His Cys Ala Arg Gln Arg Leu Arg Leu Arg Arg Arg
1 5 10
<210> 381
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 337
<400> 381
Trp Thr Tyr Asp Arg Thr Glu Ile Asp Leu Val
1 5 10
<210> 382
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 338
<400> 382
Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 383
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 339
<400> 383
Ala Ser Val Ala Ser Ala Arg Glu Val Asn Gly
1 5 10
<210> 384
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 340
<400> 384
Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 385
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 341
<400> 385
Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 386
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 342
<400> 386
Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 387
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 343
<400> 387
Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 388
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 344
<400> 388
Glu Glu Glu Cys Glu Pro Gln Ala Val Pro Val
1 5 10
<210> 389
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 345
<400> 389
Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu
1 5 10
<210> 390
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 346
<400> 390
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys
1 5 10
<210> 391
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 347
<400> 391
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu
1 5 10
<210> 392
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 348
<400> 392
Gly Gln Gly Gln Lys Glu Gly Val Cys Gly Ala
1 5 10
<210> 393
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 349
<400> 393
Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly
1 5 10
<210> 394
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 350
<400> 394
Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly Val
1 5 10
<210> 395
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 351
<400> 395
Ser Gly Gln Gly Gln Lys Glu Gly Val Cys Gly
1 5 10
<210> 396
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 352
<400> 396
Ser Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 397
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 353
<400> 397
Ala Ala Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly
1 5 10
<210> 398
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 354
<400> 398
Cys Ile Ile Leu Thr Val Trp Leu Ile Ala Ala Val Ile
1 5 10
<210> 399
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 355
<400> 399
Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly Val Cys
1 5 10
<210> 400
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 356
<400> 400
Pro Asn Ser Gly Gln Gly Gln Lys Glu Gly Val Cys Gly
1 5 10
<210> 401
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 357
<400> 401
Gln Gly Gln Lys Glu Gly Val
1 5
<210> 402
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 358
<400> 402
Ser Gly Gln Gly Gln Lys Glu
1 5
<210> 403
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 359
<400> 403
Ser Thr Gly Glu Lys Glu Glu
1 5
<210> 404
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 360
<400> 404
Ala Cys Met Met Asp Leu Arg Arg Tyr Pro Leu Asp Glu Gln
1 5 10
<210> 405
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 361
<400> 405
Glu Ile Arg Asn Glu Thr Ser Gly Ser Glu Val Leu Thr Ser
1 5 10
<210> 406
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 362
<400> 406
Ala Gln Ala Arg Glu Lys Arg Phe Thr Phe Val
1 5 10
<210> 407
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 363
<400> 407
Ala Ala Ala Leu Ala Val Ala
1 5
<210> 408
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 364
<400> 408
Ala Val Leu Thr Ser Arg Ala
1 5
<210> 409
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 365
<400> 409
Arg Arg Ser Phe Lys His Ile Leu Phe Arg Arg Arg Arg
1 5 10
<210> 410
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 366
<400> 410
Arg Ser Phe Lys His Ile Leu Phe Arg Arg Arg Arg Arg
1 5 10
<210> 411
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 367
<400> 411
Asp Ser Trp Asn Asn Asn Asp
1 5
<210> 412
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 368
<400> 412
Leu Gln Gln Gln Ser Met Lys Arg Ser Asn Arg Arg Lys
1 5 10
<210> 413
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 369
<400> 413
Val Val Pro Gly Asp His Leu Leu Glu Pro Glu Val Ala Asp
1 5 10
<210> 414
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 370
<400> 414
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly Arg Phe Tyr
1 5 10
<210> 415
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 371
<400> 415
Glu Ser Leu Cys Ala Lys Glu Glu Lys Cys Gln Gly Lys Gly
1 5 10
<210> 416
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 372
<400> 416
His Cys Ser Asp Leu Met Pro Ser Gly Ser Glu Glu Lys Ile
1 5 10
<210> 417
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 373
<400> 417
Lys Lys Gln Ile Trp Leu Leu Phe Glu Tyr Pro Glu Ser Ser
1 5 10
<210> 418
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 374
<400> 418
Ser Ser Ser Leu Gly Asp Lys Ser Glu Tyr Leu Glu Met Glu
1 5 10
<210> 419
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 375
<400> 419
His Asp Pro Gln Ser Ser Arg Gly Ser Arg Arg Arg Arg Arg
1 5 10
<210> 420
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 376
<400> 420
Gln Ser Ser Arg Gly Ser Arg Arg Arg Arg Arg Gln Arg Ser
1 5 10
<210> 421
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 377
<400> 421
Gly Pro Lys Glu Pro Ala Pro Lys Gly Arg Gly Ala Gln Arg
1 5 10
<210> 422
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 378
<400> 422
Leu Arg Tyr Phe Asp Pro Leu Arg Asn Glu Tyr Phe Phe Asp
1 5 10
<210> 423
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 379
<400> 423
Leu Tyr Ala Leu Cys Leu Asp Thr Ser Arg Glu Thr Asp Leu
1 5 10
<210> 424
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 380
<400> 424
Met Ala Val Cys Leu Leu Phe Val Phe Ser Ala Leu Leu Glu
1 5 10
<210> 425
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 381
<400> 425
Phe Thr Met Thr Leu Tyr Leu Arg His Tyr Trp Lys Asp Glu
1 5 10
<210> 426
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 382
<400> 426
Gly Val Asp Val Gln Val Glu Ser Leu Asp Ser Ile Ser Glu
1 5 10
<210> 427
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 383
<400> 427
Trp Lys Asp Glu Arg Leu Ser Phe Pro Ser Thr Asn Asn Leu
1 5 10
<210> 428
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 384
<400> 428
Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile Gln Ser Val
1 5 10
<210> 429
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 385
<400> 429
Glu Ala Arg Pro Leu Val Glu Phe Tyr Glu Glu
1 5 10
<210> 430
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 386
<400> 430
Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile
1 5 10
<210> 431
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 387
<400> 431
Glu Ile Gln Ser Val Glu Glu Thr Gln Ile Lys Glu Arg Lys
1 5 10
<210> 432
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 388
<400> 432
Phe Cys Leu Asn His Leu Glu Glu Ala Arg Pro Leu Val Glu
1 5 10
<210> 433
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 389
<400> 433
Leu Glu Glu Ala Arg Pro Leu Val Glu Phe Tyr
1 5 10
<210> 434
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 390
<400> 434
Leu Leu Leu Lys Ile Arg Gly Gly Lys Gln Phe Ile Leu Gln
1 5 10
<210> 435
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 391
<400> 435
Asn His Leu Glu Glu Ala Arg Pro Leu Val Glu Phe Tyr Glu
1 5 10
<210> 436
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 392
<400> 436
Gln Lys Tyr Pro Pro Pro Leu Ile Pro Pro Arg Gly Glu Val
1 5 10
<210> 437
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 393
<400> 437
Gln Ser Leu Leu Thr Met Glu Glu Ile Gln Ser
1 5 10
<210> 438
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 394
<400> 438
Gln Val Pro Pro Asp Leu Phe Gln Pro Tyr Ile Glu Glu Ile
1 5 10
<210> 439
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 395
<400> 439
Ser Asp Lys Phe Thr Arg Phe Cys Gln Trp Lys
1 5 10
<210> 440
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 396
<400> 440
Ser Leu Leu Thr Met Glu Glu Ile Gln Ser Val Glu Glu Thr
1 5 10
<210> 441
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 397
<400> 441
Thr Val Phe Asp Thr Ile Asn Ala Glu Thr Asp Arg Leu Glu
1 5 10
<210> 442
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 398
<400> 442
Ala Met Glu Lys Ser Lys Ala
1 5
<210> 443
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 399
<400> 443
Glu Ala Pro Gln Ser Leu Leu Thr Met Glu Glu Ile Gln
1 5 10
<210> 444
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 400
<400> 444
Glu Ile Gln Ser Val Glu Glu Thr Gln Ile Lys Glu Arg
1 5 10
<210> 445
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 401
<400> 445
Glu Thr Gln Ile Lys Glu Arg
1 5
<210> 446
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 402
<400> 446
Gly Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr Met Glu
1 5 10
<210> 447
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 403
<400> 447
Gln Ser Leu Leu Thr Met Glu
1 5
<210> 448
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 404
<400> 448
Arg Gly Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr Met
1 5 10
<210> 449
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 405
<400> 449
Ser Leu Leu Thr Met Glu Glu
1 5
<210> 450
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 406
<400> 450
Val His Arg Ile Ile Gly Arg Gly Gly Phe Gly Glu Val
1 5 10
<210> 451
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 407
<400> 451
Trp Arg Gly Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr
1 5 10
<210> 452
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 408
<400> 452
Ile Met Thr Glu Arg Lys Ala Ala Ala Ile Leu Ala Leu Leu
1 5 10
<210> 453
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 409
<400> 453
Leu Leu Lys Phe Ser Arg Glu Lys Lys Ala Ala Lys Thr Leu
1 5 10
<210> 454
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 410
<400> 454
Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg
1 5 10
<210> 455
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 411
<400> 455
Leu Leu Ser Val Ser Phe Glu Gly Pro Arg Pro Asp Ser Ser
1 5 10
<210> 456
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 412
<400> 456
Leu Arg Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg
1 5 10
<210> 457
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 413
<400> 457
Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp Arg
1 5 10
<210> 458
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 414
<400> 458
Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp Arg Val
1 5 10
<210> 459
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 415
<400> 459
Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro
1 5 10
<210> 460
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 416
<400> 460
Leu Arg Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg
1 5 10
<210> 461
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 417
<400> 461
Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp Arg
1 5 10
<210> 462
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 418
<400> 462
Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu
1 5 10
<210> 463
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 419
<400> 463
Arg Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg
1 5 10
<210> 464
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 420
<400> 464
Tyr Pro Ala Ile Met Thr Glu Arg Lys Ala Ala Ala Ile
1 5 10
<210> 465
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 421
<400> 465
Glu Ile Ile Pro Ser Ser Ser Lys Val Ile Pro Leu Ile Gly
1 5 10
<210> 466
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 422
<400> 466
Arg Ser His Val Asp Arg Tyr Phe Thr Gln Lys Glu Glu Thr
1 5 10
<210> 467
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 423
<400> 467
Leu Lys Gln Glu Trp Thr Asp Tyr Arg Leu Thr
1 5 10
<210> 468
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 424
<400> 468
Leu Met Thr Pro Thr Ala Ser Met Asp Asp Phe
1 5 10
<210> 469
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 425
<400> 469
Met Phe Val Cys Val Leu Gly Thr Val Gly Leu
1 5 10
<210> 470
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 426
<400> 470
Gln Leu Ser Leu Ala Gln Leu Ile Ser Val Asn
1 5 10
<210> 471
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 427
<400> 471
Arg Pro Ala Thr Ser Ser Ser Gln Leu Ile Ser
1 5 10
<210> 472
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 428
<400> 472
Ser Lys Ser Pro Ala Gly Ser Thr Pro Val Ala Ile Pro Arg
1 5 10
<210> 473
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 429
<400> 473
Ser Thr His Thr Met Ala Pro Trp Val Lys Arg Cys Phe Leu
1 5 10
<210> 474
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 430
<400> 474
Val Cys Val Leu Gly Thr Val Gly Leu Phe Leu
1 5 10
<210> 475
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 431
<400> 475
Tyr Glu Val Ser Val Tyr Thr Asn Leu Ile Val
1 5 10
<210> 476
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 432
<400> 476
Ser Glu Gly Pro Tyr Ala Ala
1 5
<210> 477
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 433
<400> 477
Ala Glu His Arg Leu Phe Glu Arg Leu Phe Glu Asp Tyr Asn
1 5 10
<210> 478
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 434
<400> 478
Glu Arg Leu Phe Glu Asp Tyr Asn Glu Ile Ile Arg Pro
1 5 10
<210> 479
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 435
<400> 479
Leu Asn Gln Tyr Asp Leu Leu Gly His Val Val Gly Thr Glu
1 5 10
<210> 480
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 436
<400> 480
Glu Thr Lys Thr Tyr Asn Ser Val Ser Lys Val Asp Lys Ile
1 5 10
<210> 481
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 437
<400> 481
Ala Ala Lys Thr Leu Gly Ile Val Val Gly Cys Phe Val Leu
1 5 10
<210> 482
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 438
<400> 482
Gly Gly Ser Gly Met Ala Ser Ala Lys Thr Lys
1 5 10
<210> 483
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 439
<400> 483
Ile Leu Leu Gly Val Ile Leu Gly Gly Leu Ile Leu Phe Gly
1 5 10
<210> 484
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 440
<400> 484
Thr Phe Tyr Arg Ile Ser Lys Thr Asp Gly Val
1 5 10
<210> 485
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 441
<400> 485
Tyr Arg Ile Ser Lys Thr Asp Gly Val Cys Glu
1 5 10
<210> 486
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 442
<400> 486
Asp Gln Ser Ser Cys Thr Thr Ala Arg Val Arg Ser Lys
1 5 10
<210> 487
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 443
<400> 487
Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 488
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 444
<400> 488
Leu Gly Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg
1 5 10
<210> 489
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 445
<400> 489
Leu Ser Leu Cys Ala Ile Ser Ile Asp Arg Tyr Ile Gly Val
1 5 10
<210> 490
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 446
<400> 490
Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 491
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 447
<400> 491
Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 492
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 448
<400> 492
Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu
1 5 10
<210> 493
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 449
<400> 493
Arg His Asp Ser Gly Pro Leu Phe Thr Phe Lys Leu Leu Thr
1 5 10
<210> 494
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 450
<400> 494
Gly Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg
1 5 10
<210> 495
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 451
<400> 495
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly Gly
1 5 10
<210> 496
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 452
<400> 496
Arg Arg Arg Arg Arg Arg Arg Leu Gly Gly Cys Ala Tyr
1 5 10
<210> 497
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 453
<400> 497
Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly Gly Cys Ala
1 5 10
<210> 498
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 454
<400> 498
Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly Gly Cys
1 5 10
<210> 499
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 455
<400> 499
Asp Glu Lys Asn Gln Val Leu Thr Thr Asn Ile
1 5 10
<210> 500
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 456
<400> 500
Ala Gln Glu Val Ala Ser Thr Leu Ala Ser Ser Pro Pro Ser
1 5 10
<210> 501
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 457
<400> 501
Gly Arg Gly Ala Gln Glu Val Ala Ser Thr Leu Ala Ser Ser
1 5 10
<210> 502
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 458
<400> 502
Glu Thr Ala Ala Glu Ile Leu Lys Gln Ile Leu Phe Met Gly
1 5 10
<210> 503
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 459
<400> 503
Gly Val Ser Cys Val Leu Phe Val Ile Ala Arg Phe Thr Pro
1 5 10
<210> 504
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 460
<400> 504
Lys Pro Leu Leu Lys Glu Met Lys Lys Gly Lys Glu Phe Tyr
1 5 10
<210> 505
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 461
<400> 505
Arg Ile Gly Gly Ile Phe Glu Thr Val Glu Asn Glu Pro Val
1 5 10
<210> 506
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 462
<400> 506
Ala Leu Val Thr Lys Thr Asn Arg Ile Ala Arg Ile Leu Ala
1 5 10
<210> 507
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 463
<400> 507
Met Glu Pro Pro Asp Ile Met His Asp Tyr Pro Ser Ile Arg
1 5 10
<210> 508
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 464
<400> 508
Cys Glu Lys Gly Gln Ile Lys Val Ile Arg Lys Gly Glu Val
1 5 10
<210> 509
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 465
<400> 509
Ala Asn Gln Phe Glu Gly Asn Asp Arg Tyr Glu Gly Tyr Cys
1 5 10
<210> 510
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 466
<400> 510
Phe Asn Ser Leu Trp Phe Ser Leu Gly Ala Phe Met Gln Gln
1 5 10
<210> 511
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 467
<400> 511
Gly Ile Arg Lys Ile Gly Tyr Trp Asn Glu Asp Asp Lys Phe
1 5 10
<210> 512
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 468
<400> 512
His Val Cys Phe Ile Thr Pro Ser Phe Pro Val Asp Thr Ser
1 5 10
<210> 513
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 469
<400> 513
Leu Thr Val Glu Arg Met Val Ser Pro Ile Glu Ser Ala Glu
1 5 10
<210> 514
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 470
<400> 514
Pro Cys Met Ser His Ser Ser Gly Met Pro Leu Gly Ala Thr
1 5 10
<210> 515
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 471
<400> 515
Arg Lys Ser Lys Gly Lys Tyr Ala Tyr Leu Leu Glu Ser Thr
1 5 10
<210> 516
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 472
<400> 516
Glu Arg Leu Val Val Val Asp Cys Glu Ser Glu Arg Leu Asn
1 5 10
<210> 517
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 473
<400> 517
Met Arg Ser Ala Glu Pro Ser Val Phe Val Arg Thr Thr Ala
1 5 10
<210> 518
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 474
<400> 518
Ser Arg Ala Glu Ala Lys Arg Met Lys Val Ala Lys Asn Ala
1 5 10
<210> 519
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 475
<400> 519
Ile Ala Val Tyr Glu Lys Met Trp Ser Tyr Met Lys Ser Ala
1 5 10
<210> 520
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 476
<400> 520
Lys Ile Ala Val Tyr Glu Lys Met Trp Ser Tyr Met Lys Ser
1 5 10
<210> 521
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 477
<400> 521
Pro Tyr Glu Trp His Leu Glu Asp Asn Asn Glu Glu Pro Arg
1 5 10
<210> 522
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 478
<400> 522
Trp Glu Lys Phe Val Tyr Leu Tyr Asp Thr Glu Arg Gly Phe
1 5 10
<210> 523
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 479
<400> 523
Asn Phe Lys Pro Ala Pro Ala Thr Asn Thr Gln Asn Tyr Ala
1 5 10
<210> 524
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 480
<400> 524
Arg Val Arg Lys Ser Lys Gly Lys Phe Ala Phe Leu Leu Glu
1 5 10
<210> 525
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 481
<400> 525
Leu His Arg Gln Asn Glu Glu Pro Val Phe Ser Lys Asp Gly
1 5 10
<210> 526
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 482
<400> 526
Leu Tyr Ser Ala Asn Thr Val Gly Asn Phe Asn Arg Gln Cys
1 5 10
<210> 527
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 483
<400> 527
Ala Pro Ser Arg Thr Ile Pro Thr Ala Cys Val Arg Pro Thr
1 5 10
<210> 528
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 484
<400> 528
Asp Pro Thr Asp Pro Val Asp Tyr Tyr Pro Leu Leu Asp Asp
1 5 10
<210> 529
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 485
<400> 529
Ser Ile Thr Asp Pro Thr Asp Pro Val Asp Tyr Tyr Pro Leu
1 5 10
<210> 530
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 486
<400> 530
Asp Gln Leu Pro Pro Gln Gln Pro Leu Glu Ala
1 5 10
<210> 531
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 487
<400> 531
Asp Val Val Leu Val Arg Phe Gly Leu Ser Ile Ala Gln Leu
1 5 10
<210> 532
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 488
<400> 532
His Ser Arg Val Asp Gln Leu Asp Phe Trp Glu
1 5 10
<210> 533
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 489
<400> 533
Pro Asp Gln Pro Ser Pro Cys Lys Cys Thr Cys
1 5 10
<210> 534
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 490
<400> 534
Arg Val Asp Gln Leu Asp Phe Trp Glu Ser Gly
1 5 10
<210> 535
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 491
<400> 535
Ser Ala Glu Leu Pro Pro Pro Asp Gln Pro Ser
1 5 10
<210> 536
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 492
<400> 536
Glu Leu Pro Pro Pro Asp Gln Pro Ser Pro Cys Lys Cys
1 5 10
<210> 537
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 493
<400> 537
Asn Thr His Ser Ala Glu Leu Pro Pro Pro Asp Gln Pro
1 5 10
<210> 538
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 494
<400> 538
Pro Pro Pro Asp Gln Pro Ser Pro Cys Lys Cys Thr Cys
1 5 10
<210> 539
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 495
<400> 539
Arg Ile Phe Leu Trp Met Phe Ile Ile Val Cys Leu Leu
1 5 10
<210> 540
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 496
<400> 540
Thr His Ser Ala Glu Leu Pro Pro Pro Asp Gln Pro Ser
1 5 10
<210> 541
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 497
<400> 541
Asn Met Gln Phe Leu Leu Phe Val Phe Leu Val Trp Asp Pro
1 5 10
<210> 542
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 498
<400> 542
Ser Val Gln Val Ala Pro Asp Gly Ser Arg Leu Asn Gln Tyr
1 5 10
<210> 543
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 499
<400> 543
Cys Ala Leu Ala Gly Val Leu Thr Ile Ala Met Pro Val Pro
1 5 10
<210> 544
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 500
<400> 544
His Phe Asp Tyr Asp Pro Arg Ala Asp Glu Phe Phe Phe Asp
1 5 10
<210> 545
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 501
<400> 545
Leu Ser Gly Leu Ser Ser Lys Ala Ala Lys Asp Val Leu Gly
1 5 10
<210> 546
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 502
<400> 546
Pro Val Pro Val Ile Val Asn Asn Phe Gly Met Tyr Tyr Ser
1 5 10
<210> 547
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 503
<400> 547
Val Phe Ala His Ile Leu Asn Tyr Tyr Arg Thr Gly Lys Leu
1 5 10
<210> 548
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 504
<400> 548
Trp Leu Ala Glu Pro Asp Ala His Ser His Phe Asp Tyr Asp
1 5 10
<210> 549
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 505
<400> 549
Cys Gln Ala Arg Gln Phe Arg Thr Phe His His Pro Thr Tyr
1 5 10
<210> 550
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 506
<400> 550
Lys Asp Asn Gly Val Thr Pro Gly Glu Lys Met Leu Thr Val
1 5 10
<210> 551
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 507
<400> 551
Thr Tyr Glu Gln Leu Thr Val Pro Arg Arg Gly Pro Asp Glu
1 5 10
<210> 552
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 508
<400> 552
Glu Arg Pro Thr Gly Trp Lys Cys Phe Val Tyr His Phe Ala
1 5 10
<210> 553
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 509
<400> 553
Lys Cys Phe Val Tyr His Phe Ala Val Phe Leu Ile Val Leu
1 5 10
<210> 554
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 510
<400> 554
Asn Phe Leu Glu Arg Pro Thr Gly Trp Lys Cys Phe Val Tyr
1 5 10
<210> 555
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 511
<400> 555
Thr Gly Trp Lys Cys Phe Val Tyr His Phe Ala Val Phe Leu
1 5 10
<210> 556
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 512
<400> 556
Ala Ala Ala Trp Ser Ile Leu Gln Gln Phe Leu
1 5 10
<210> 557
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 513
<400> 557
Gln Trp Arg Glu Asp Phe Ala Ser Asn Glu Val
1 5 10
<210> 558
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 514
<400> 558
Ser Cys Phe Gln His Leu Val Gln Ala Asn Val
1 5 10
<210> 559
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 515
<400> 559
Val Asp Val Ser Gly Ser Val Ser Gly Leu Thr
1 5 10
<210> 560
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 516
<400> 560
Tyr Asp Val Arg Arg Arg Pro Trp Tyr Ile Gln
1 5 10
<210> 561
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 517
<400> 561
Leu Glu Glu Thr Ile Thr Gln Ala Arg Tyr Ser Glu Thr Leu
1 5 10
<210> 562
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 518
<400> 562
Gly Ser Pro Leu Pro Pro Gly Ala Pro Leu Pro Gly Pro Gly
1 5 10
<210> 563
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 519
<400> 563
Pro Arg Thr Ser Ala Glu Asp Ala Pro Ser Glu Glu Val Ala
1 5 10
<210> 564
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 520
<400> 564
Ala Pro Arg Ala Glu Leu Val Ala Leu Thr Ala Val Gln Ser
1 5 10
<210> 565
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 521
<400> 565
Asp Ile Thr Ser Asp Tyr His Ser Pro Val Asp His Glu Asp
1 5 10
<210> 566
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 522
<400> 566
Ala Ala Glu Ala Pro Glu Gly Val Asp Pro Pro
1 5 10
<210> 567
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 523
<400> 567
Cys Leu Ser Pro Thr Asn Leu Leu Arg Arg Phe
1 5 10
<210> 568
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 524
<400> 568
Asp Phe Val Val Val Leu Thr Gly Ile Leu Ala Thr Ala Gly
1 5 10
<210> 569
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 525
<400> 569
Glu Met Asp Pro Glu Glu Arg Leu Arg Phe Ala
1 5 10
<210> 570
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 526
<400> 570
Phe Ile Met Ala Met Ile Ala Leu Asn Thr Val
1 5 10
<210> 571
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 527
<400> 571
Gly Pro Asp Gly Glu Pro Gln Pro Gly Leu Glu
1 5 10
<210> 572
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 528
<400> 572
Gly Pro Thr Gly Cys Arg Arg Glu Arg Glu Arg
1 5 10
<210> 573
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 529
<400> 573
Pro Gly Pro His Pro Gln Gly Ser Gly Ser Val
1 5 10
<210> 574
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 530
<400> 574
Gln Gly Pro Ser Pro Gly Tyr Arg Met Glu Leu
1 5 10
<210> 575
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 531
<400> 575
Arg Ala Arg Gly Gly Gly Ala Gly Gly Ala Gly
1 5 10
<210> 576
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 532
<400> 576
Arg Ala Arg Gly Gly Gly Ala Gly Gly Ala Gly Gly Pro Gly
1 5 10
<210> 577
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 533
<400> 577
Arg Gly Gly Gly Ala Gly Gly Ala Gly Gly Pro
1 5 10
<210> 578
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 534
<400> 578
Arg Gln Lys Ser Ser Thr Ser Leu Ser Asn Gly Gly Ala Ile
1 5 10
<210> 579
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 535
<400> 579
Arg Arg Gly Pro Asp Gly Glu Pro Gln Pro Gly
1 5 10
<210> 580
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 536
<400> 580
Thr Asp Ala Glu Pro Val Gly Asp Phe Pro Cys
1 5 10
<210> 581
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 537
<400> 581
Tyr Lys Arg Leu Val Arg Met Asn Met Pro Ile Ser Asn Glu
1 5 10
<210> 582
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 538
<400> 582
Tyr Ser Glu Met Asp Pro Glu Glu Arg Leu Arg
1 5 10
<210> 583
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 539
<400> 583
Gly Gly Glu Arg Ala Arg Gly Gly Gly Ala Gly Gly Ala Gly
1 5 10
<210> 584
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 540
<400> 584
Ala Cys Ile Ser Ile Val Glu Trp Lys Pro Phe
1 5 10
<210> 585
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 541
<400> 585
Ala Lys Ser Asn Pro Glu Glu Cys Arg Gly Leu
1 5 10
<210> 586
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 542
<400> 586
Ala Leu Leu Gly Asn His Val Asn His Val Asn
1 5 10
<210> 587
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 543
<400> 587
Glu Cys Leu Arg Arg Gln Ser Ser Gln Glu Glu
1 5 10
<210> 588
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 544
<400> 588
Glu Ile Arg Arg Ala Ile Ser Cys Asp Leu Gln Asp Asp Glu
1 5 10
<210> 589
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 545
<400> 589
Glu Ser Val Asn Thr Glu Asn Val Ser Gly Glu
1 5 10
<210> 590
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 546
<400> 590
Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ser
1 5 10
<210> 591
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 547
<400> 591
Gly Ala Leu Leu Gly Asn His Val Asn His Val Asn Ser Asp
1 5 10
<210> 592
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 548
<400> 592
Gly Leu Gly Arg Tyr Ala Arg Asp Pro Lys Phe Val Ser Ala
1 5 10
<210> 593
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 549
<400> 593
Gly Arg Tyr Ala Arg Asp Pro Lys Phe Val Ser
1 5 10
<210> 594
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 550
<400> 594
Ile Gly Val Gln Leu Phe Lys Gly Lys Phe Tyr Arg Cys Thr
1 5 10
<210> 595
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 551
<400> 595
Ile Ile Val Ala Phe Phe Met Met Asn Ile Phe Val Gly Phe
1 5 10
<210> 596
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 552
<400> 596
Ile Leu Leu Ala Ile Phe Ala Asn Cys Val Ala Leu Ala Ile
1 5 10
<210> 597
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 553
<400> 597
Leu Gly Asn His Val Asn His Val Asn Ser Asp
1 5 10
<210> 598
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 554
<400> 598
Leu Pro Tyr Val Ala Leu Leu Ile Ala Met Leu
1 5 10
<210> 599
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 555
<400> 599
Leu Thr Ile Ser Ser Glu His Tyr Asn Gln Pro Asp Trp Leu
1 5 10
<210> 600
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 556
<400> 600
Asn Leu Ala Asp Ala Glu Ser Leu Asn Thr Ala
1 5 10
<210> 601
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 557
<400> 601
Pro Phe Pro Glu Asp Asp Ser Asn Ser Thr Asn
1 5 10
<210> 602
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 558
<400> 602
Ser Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ser Gly Glu
1 5 10
<210> 603
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 559
<400> 603
Thr Ser Met Pro Thr Ser Glu Thr Glu Ser Val Asn Thr Glu
1 5 10
<210> 604
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 560
<400> 604
Phe Val Ile Val Thr Phe Gln Glu Gln Gly Glu Lys Glu Tyr
1 5 10
<210> 605
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 561
<400> 605
Pro Phe Pro Glu Asp Asp Ser Asn Ser Thr Asn His Asn Leu
1 5 10
<210> 606
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 562
<400> 606
Ser Arg Arg Trp Arg Arg Trp Asn Arg Phe Asn Arg Arg Arg
1 5 10
<210> 607
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 563
<400> 607
Trp Ser Glu Tyr Asp Pro Glu Ala Lys Gly Arg Ile Lys His
1 5 10
<210> 608
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 564
<400> 608
Ala Arg Gln Gly Ser Trp Glu Asp Glu Glu Glu
1 5 10
<210> 609
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 565
<400> 609
Glu Asp Glu Glu Glu Asp Tyr Glu Glu Glu Leu
1 5 10
<210> 610
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 566
<400> 610
Glu Glu Glu Asp Tyr Glu Glu Glu Leu Thr Asp
1 5 10
<210> 611
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 567
<400> 611
Gly Asp Asn Ser Ser Ser Ser Leu Gly Asp Val
1 5 10
<210> 612
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 568
<400> 612
Leu Gly Arg Asn Lys Asn Glu Leu Glu Gly Trp
1 5 10
<210> 613
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 569
<400> 613
Asn Ser Ala Tyr Thr Glu Leu Gly Asp Ser Cys
1 5 10
<210> 614
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 570
<400> 614
Pro Gly Ser Arg Asn Ser Ala Tyr Thr Glu Leu
1 5 10
<210> 615
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 571
<400> 615
Gln Gly Ser Trp Glu Asp Glu Glu Glu Asp Tyr
1 5 10
<210> 616
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 572
<400> 616
Ser Gln Glu Ile Pro Met Glu Val Phe Asp Pro
1 5 10
<210> 617
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 573
<400> 617
Ser Arg Asn Ser Ala Tyr Thr Glu Leu Gly Asp
1 5 10
<210> 618
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 574
<400> 618
Ser Arg Asn Ser Ala Tyr Thr Glu Leu Gly Asp Ser Cys Val
1 5 10
<210> 619
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 575
<400> 619
Ser Trp Glu Asp Glu Glu Glu Asp Tyr Glu Glu
1 5 10
<210> 620
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 576
<400> 620
Tyr Asn Pro Ser Pro Gly Asp Glu Val Pro Val
1 5 10
<210> 621
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 577
<400> 621
Tyr Pro Pro Ser Gln Glu Ile Pro Met Glu Val Phe Asp Pro
1 5 10
<210> 622
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 578
<400> 622
Cys Pro Ala Asp Val Cys Gly Pro Leu Phe Glu Glu Glu Leu
1 5 10
<210> 623
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 579
<400> 623
Ile Thr Ser Val His Phe Arg Arg Glu Val Glu Thr Glu Pro
1 5 10
<210> 624
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 580
<400> 624
Asn Lys Pro Pro Ser Lys Thr Cys Leu Lys Glu Glu Met Ala
1 5 10
<210> 625
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 581
<400> 625
Asp Asp Phe Gly Gly Ile Glu Thr Leu Arg Val
1 5 10
<210> 626
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 582
<400> 626
Gly Lys Thr Ile Asn Lys Ile Asp Ile Asp Thr Glu Ala Tyr
1 5 10
<210> 627
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 583
<400> 627
Ser Leu Asn Glu Lys Glu Glu Thr Leu Thr Thr
1 5 10
<210> 628
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 584
<400> 628
Lys Ile Gln Leu Asn Ala Thr Ser Val Thr His Lys Pro Asn
1 5 10
<210> 629
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 585
<400> 629
Pro Phe Gly Arg Phe Lys Val Asn Ser Glu Glu Glu Glu Glu
1 5 10
<210> 630
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 586
<400> 630
Val Pro Pro Tyr Ser His Gln Ser Ser Val Trp Phe Glu Met
1 5 10
<210> 631
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 587
<400> 631
Ile Pro Cys Leu Gly Leu Ser Phe Leu Thr Val Leu Val Phe
1 5 10
<210> 632
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 588
<400> 632
Ile Val Thr Val Phe Val Ile Asn Val His His
1 5 10
<210> 633
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 589
<400> 633
Cys Leu Phe Val Val Thr Pro Val Met Val Val
1 5 10
<210> 634
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 590
<400> 634
Gly Ala Asn Phe Ile Val Asn His Met Arg Asp
1 5 10
<210> 635
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 591
<400> 635
Asn Gln Pro Pro Pro Gln Pro Phe Pro Gly Asp
1 5 10
<210> 636
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 592
<400> 636
Pro Pro Pro Gln Pro Phe Pro Gly Asp Pro Tyr
1 5 10
<210> 637
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 593
<400> 637
Cys Leu Phe Val Val Thr Pro Val Met Val Val Gly Thr
1 5 10
<210> 638
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 594
<400> 638
Asp Val Ser Leu Glu Glu Asp Arg Glu Ala Val Arg Arg Glu
1 5 10
<210> 639
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 595
<400> 639
Glu Lys Phe Asn Asn Asp Trp Trp Ile Gly Arg
1 5 10
<210> 640
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 596
<400> 640
His Thr Pro Pro Tyr Asp Val Val Pro Ser Met Arg Pro Val
1 5 10
<210> 641
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 597
<400> 641
Tyr Val Glu Pro Lys Glu Asp Tyr Ser His Asp His Val Asp
1 5 10
<210> 642
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 598
<400> 642
Thr Thr Val Ile Tyr Asn Ser Asn Ile Phe Thr Asp Pro Phe
1 5 10
<210> 643
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 599
<400> 643
Ile Ala Glu Gln Glu Gly Asn Gln Lys Gly Glu Gln Ala Thr
1 5 10
<210> 644
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 600
<400> 644
Phe Met Ala Cys Glu Glu Leu Pro Pro Gly Ala Pro Glu Leu
1 5 10
<210> 645
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 601
<400> 645
Gly Glu Ser Pro Ser Ser Gly Pro Ser Ser Pro Glu Ser Ser
1 5 10
<210> 646
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 602
<400> 646
Leu Arg Leu Val Arg Val Ala Arg Lys Leu Asp Arg Tyr Ser
1 5 10
<210> 647
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 603
<400> 647
Lys Phe Ser Tyr Ile Pro Glu Ala Lys Ala Ser Cys Tyr Gly
1 5 10
<210> 648
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 604
<400> 648
Leu Leu Val Leu Pro Ala Leu Leu Val Trp Arg Gly Pro Ala
1 5 10
<210> 649
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 605
<400> 649
Asn Ser Thr Asn Glu Gly Met Asn Val Lys Lys Cys Cys Lys
1 5 10
<210> 650
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 606
<400> 650
Pro Ser Phe Thr Ile Gly Lys Ala Ile Trp Leu Leu Trp Gly
1 5 10
<210> 651
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 607
<400> 651
Pro Ser Gly Leu Ile Ser Val Ser Tyr Asp Asp Trp Asp Tyr
1 5 10
<210> 652
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 608
<400> 652
Leu Arg Ile Ser Arg Gln His Ser Tyr Asp Asn Ile Val Asp
1 5 10
<210> 653
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 609
<400> 653
His Ser Tyr Asp Asn Ile Val Asp Lys Pro Arg Glu Leu Asp
1 5 10
<210> 654
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 610
<400> 654
Lys Leu Ser Gly Lys Lys Ser Ser Leu Phe Pro Gln Gly Leu
1 5 10
<210> 655
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 611
<400> 655
Met Ser Leu Ile Lys Glu Ala His Trp Glu Gly Leu Thr Gly
1 5 10
<210> 656
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 612
<400> 656
Ile Pro Val Ser Phe Glu Trp Ser Asn Asp Ser Ser Val Ile
1 5 10
<210> 657
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 613
<400> 657
Ser Asp Arg Thr Pro Val Val Ser Ser Phe Leu Asp Asn Thr
1 5 10
<210> 658
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 614
<400> 658
Thr Ile Lys Asp Glu Ala Glu Asn Ala Phe Leu Leu Glu Glu
1 5 10
<210> 659
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 615
<400> 659
Ala Met Ala Leu Ser Leu Ile Thr Phe Ile Cys Glu His Leu
1 5 10
<210> 660
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 616
<400> 660
Ala Pro Trp Glu Lys Asn Leu Thr Asn Val Glu Trp Glu Asp
1 5 10
<210> 661
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 617
<400> 661
Ala Ser Val Met Leu Asn Ile Met Glu Glu Tyr Asp Trp Tyr
1 5 10
<210> 662
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 618
<400> 662
Glu Gly Asn Ala Ala Lys Arg Arg Lys Gln Gln Tyr Lys Asp
1 5 10
<210> 663
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 619
<400> 663
Glu Thr Glu Glu Gln Glu Asp Asp His Leu Ser Ile Val Thr
1 5 10
<210> 664
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 620
<400> 664
Phe Pro Thr Gly Leu Ile Ser Val Ser Tyr Asp Glu Trp Asp
1 5 10
<210> 665
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 621
<400> 665
Gly Val Pro Ala Pro Trp Glu Lys Asn Leu Thr Asn Val Glu
1 5 10
<210> 666
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 622
<400> 666
His Met Phe Glu Met Ser Ala Gly Glu Ser Thr Phe Ala Asn
1 5 10
<210> 667
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 623
<400> 667
Ile Glu Asn Ser Phe Val Gly Trp Glu Leu Glu Glu Val Leu
1 5 10
<210> 668
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 624
<400> 668
Gln Phe Gly Pro Ser Ile Glu Gln Gln Ala Ser Val Met Leu
1 5 10
<210> 669
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 625
<400> 669
Ser Arg Arg Glu Phe Asp Glu Ile Glu Leu Ala Tyr Arg Arg
1 5 10
<210> 670
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 626
<400> 670
Arg Glu Arg Leu Pro Lys Ala Arg Val Val Val Cys Phe Cys
1 5 10
<210> 671
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 627
<400> 671
Ser Ala Met Cys Tyr Ser Ala Leu Val Thr Lys Thr Asn Arg
1 5 10
<210> 672
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 628
<400> 672
Ala Asp Phe Pro Gly Asp Asp Glu Glu Asp Glu Pro Glu Ile
1 5 10
<210> 673
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 629
<400> 673
Asp Ile Val Ala Thr Val Glu Asn Glu Glu Pro
1 5 10
<210> 674
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 630
<400> 674
Phe Ile Gly Thr Asp Ile Val Ala Thr Val Glu
1 5 10
<210> 675
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 631
<400> 675
Gly Ser Leu Asp Gln His Gln Gly Ser Gln Glu
1 5 10
<210> 676
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 632
<400> 676
Gly Thr Asp Ile Val Ala Thr Val Glu Asn Glu
1 5 10
<210> 677
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 633
<400> 677
Ile Asp Glu Phe Glu Ser Asn Val Asn Glu Val
1 5 10
<210> 678
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 634
<400> 678
Lys Leu Cys Asp Pro Glu Ser Asp Tyr Ala Pro Gly Glu Glu
1 5 10
<210> 679
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 635
<400> 679
Lys Leu Met Ala Phe Lys Ala Arg Gly Tyr Phe Gly Asp Pro
1 5 10
<210> 680
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 636
<400> 680
Leu Leu Ile Gln Lys Ala Leu Val Arg Gly Gly Leu Gly Thr
1 5 10
<210> 681
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 637
<400> 681
Thr Asp Leu Ser Lys Met Thr Glu Glu Glu Cys
1 5 10
<210> 682
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 638
<400> 682
Thr Gly Gln Ala Leu Ala Asp Ala Cys Gln Met Glu Pro Glu
1 5 10
<210> 683
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 639
<400> 683
Thr Ser Met Lys Leu Leu Asp Gln Val Ile Pro Pro Ile Gly
1 5 10
<210> 684
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 640
<400> 684
Tyr Pro Ser Ala Asp Phe Pro Gly Asp Asp Glu Glu Asp Glu
1 5 10
<210> 685
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 641
<400> 685
Asp Ile Val Ala Thr Val Glu Asn Glu Glu Pro Ser Pro Cys
1 5 10
<210> 686
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 642
<400> 686
Pro Asp Lys Ser Glu Glu Glu Lys Ser Thr Met Ala Lys Lys
1 5 10
<210> 687
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 643
<400> 687
Ala Ala Ile Asp Ala Ala Arg Gln Ala Lys Leu Met Gly Ser
1 5 10
<210> 688
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 644
<400> 688
Asp Ala Ala Arg Gln Ala Lys Leu Met Gly Ser Ala Gly Asn
1 5 10
<210> 689
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 645
<400> 689
Glu Gly Leu Gly Gln Phe Ala Gln Asp Pro Lys Phe Ile Glu
1 5 10
<210> 690
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 646
<400> 690
Gly Gln Phe Ala Gln Asp Pro Lys Phe Ile Glu Val Thr Thr
1 5 10
<210> 691
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 647
<400> 691
Gly Trp Pro Pro Gln Pro Val Pro Thr Leu Arg
1 5 10
<210> 692
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 648
<400> 692
Gly Trp Pro Pro Gln Pro Val Pro Thr Leu Arg Leu Glu Gly
1 5 10
<210> 693
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 649
<400> 693
Ile Val Thr Phe Gln Glu Gln Gly Glu Gln Glu
1 5 10
<210> 694
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 650
<400> 694
Leu Glu Thr Gly His Gly Arg Gln Cys Gln Asn
1 5 10
<210> 695
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 651
<400> 695
Leu Arg Arg Asp Ser Gly Ser Ala Gly Thr Gln Ala His Cys
1 5 10
<210> 696
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 652
<400> 696
Pro Pro Gln Pro Val Pro Thr Leu Arg Leu Glu
1 5 10
<210> 697
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 653
<400> 697
Gln Asp Pro Lys Phe Ile Glu Val Thr Thr Gln
1 5 10
<210> 698
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 654
<400> 698
Gln Pro Val Pro Thr Leu Arg Leu Glu Gly Val
1 5 10
<210> 699
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 655
<400> 699
Ser Met Asn Ala Glu Glu Asn Ser Arg Ile Ser
1 5 10
<210> 700
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 656
<400> 700
Val Ala Cys Lys Arg Leu Val Ser Met Asn Met
1 5 10
<210> 701
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 657
<400> 701
Tyr Pro Ser Thr Val Ser Thr Val Glu Gly His
1 5 10
<210> 702
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 658
<400> 702
Pro Arg Pro Ala Gly Tyr Pro Ser Thr Val Ser Thr Val Glu
1 5 10
<210> 703
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 659
<400> 703
Tyr Ile Pro Phe Pro Glu Asp Asp Ser Asn Ala Thr Asn Ser
1 5 10
<210> 704
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 660
<400> 704
Phe Pro Glu Asp Asp Ser Asn Ala Thr Asn Ser Asn Leu Glu
1 5 10
<210> 705
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 661
<400> 705
Leu Leu Tyr Arg Ser Ile Asp Ser His Thr Glu Asp Lys Gly
1 5 10
<210> 706
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 662
<400> 706
Cys Pro Ala Ile Asp Gln Pro Ala Met Ser Pro Glu Asp Lys
1 5 10
<210> 707
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 663
<400> 707
Glu Asn Ile Thr Asn Val Glu Val Glu Thr Glu Pro Phe Leu
1 5 10
<210> 708
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 664
<400> 708
Glu Ser Pro Pro Pro Pro Pro Leu Pro Pro Gln Gln Gln Gln
1 5 10
<210> 709
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 665
<400> 709
His Glu Asp Cys Pro Ala Ile Asp Gln Pro Ala Met Ser Pro
1 5 10
<210> 710
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 666
<400> 710
Ile Pro Gly Ala Pro Pro Glu Asn Ile Thr Asn Val Glu Val
1 5 10
<210> 711
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 667
<400> 711
Pro Asn Tyr Cys Lys Pro Asp Pro Pro Pro Pro Pro Pro Pro
1 5 10
<210> 712
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 668
<400> 712
Glu Arg Ile Gly Ala Asp Pro Asp Asp Ile Leu Gly Ser Asn
1 5 10
<210> 713
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 669
<400> 713
Val Lys Ser Val Gln Pro Gly Glu Val Cys Cys Trp Leu Cys
1 5 10
<210> 714
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 670
<400> 714
Ala Glu Lys Asp Glu Asp Asp Thr Lys Phe Lys Ser Ile Pro
1 5 10
<210> 715
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 671
<400> 715
Phe Pro Gly Pro Cys Thr Trp Arg Arg Ile Ser Ser Leu Glu
1 5 10
<210> 716
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 672
<400> 716
Phe Val Ala Tyr Cys Ser Arg Glu Glu Ala Glu Val Leu Phe
1 5 10
<210> 717
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 673
<400> 717
Gly Ile Val Phe Glu Asp Asn Val Asp Thr Glu Ala Val Ala
1 5 10
<210> 718
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 674
<400> 718
Lys Arg Val Arg Gly Val Trp Asn Gly Met Ile Gly Glu Val
1 5 10
<210> 719
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 675
<400> 719
Leu Ala Ala Phe Met Ile Gln Glu Gln Tyr Ile Asp Thr Val
1 5 10
<210> 720
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 676
<400> 720
Pro Ala Thr Phe Pro Val Gly Leu Ile Ser Val Val Thr Glu
1 5 10
<210> 721
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 677
<400> 721
Pro Cys Thr Trp Arg Arg Ile Ser Ser Leu Glu Ser Glu Val
1 5 10
<210> 722
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 678
<400> 722
Pro Leu Glu Ile Gln Pro Leu Thr Val Gly Val Asn Thr Thr
1 5 10
<210> 723
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 679
<400> 723
Leu Glu Ile Gln Pro Leu Thr Val Gly Val Asn Thr Thr Asn
1 5 10
<210> 724
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 680
<400> 724
Val Glu Glu Glu Asp Arg Trp Ala Cys Ala Gly
1 5 10
<210> 725
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 681
<400> 725
Gly Ser Trp Thr Tyr Asp Lys Ala Glu Ile Asp
1 5 10
<210> 726
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 682
<400> 726
Ile Gly Ser Lys Val Asp Met Asn Asp Phe Trp
1 5 10
<210> 727
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 683
<400> 727
Lys Ser Ser Cys Pro Met Asp Ile Thr Phe Phe
1 5 10
<210> 728
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 684
<400> 728
Gln Leu Ala Asn Val Asp Glu Val Asn Gln Ile
1 5 10
<210> 729
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 685
<400> 729
Ser Lys Val Asp Met Asn Asp Phe Trp Glu Asn
1 5 10
<210> 730
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 686
<400> 730
Tyr Asn Cys Cys Glu Glu Ile Tyr Thr Asp Ile Thr Tyr Ser
1 5 10
<210> 731
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 687
<400> 731
Ala Pro Met Phe Gln Arg Met Glu Pro Ser Ser
1 5 10
<210> 732
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 688
<400> 732
Glu Glu Glu Thr Leu Thr Phe Glu Ala Ala Val
1 5 10
<210> 733
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 689
<400> 733
Gly Ser Ala Pro Pro Leu Arg His Ser Trp Gln Met Pro Asn
1 5 10
<210> 734
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 690
<400> 734
Gly Thr Asn Lys Gly Arg Asp Ile Lys Thr Ile
1 5 10
<210> 735
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 691
<400> 735
His Arg Ala Cys Phe Met Asn Asn Ser Gly Ile Leu Glu Gly
1 5 10
<210> 736
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 692
<400> 736
Ile Thr Met Glu Gly Trp Thr Thr Val Leu Tyr
1 5 10
<210> 737
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 693
<400> 737
Lys Asn Ala Pro Met Phe Gln Arg Met Glu Pro
1 5 10
<210> 738
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 694
<400> 738
Met Met Lys Tyr Tyr Ser Ala Pro Cys Thr Tyr Glu Leu Ala
1 5 10
<210> 739
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 695
<400> 739
Gln Cys Ile Thr Met Glu Gly Trp Thr Thr Val
1 5 10
<210> 740
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 696
<400> 740
Gln Glu Leu Thr Lys Asp Glu Gln Glu Glu Glu Glu Ala Phe
1 5 10
<210> 741
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 697
<400> 741
Gln Gln Glu Ala Gly Gly Gly Glu Ala Val Val
1 5 10
<210> 742
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 698
<400> 742
Arg Glu Arg Gly Arg Ser Lys Glu Arg Lys His Leu Leu Ser
1 5 10
<210> 743
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 699
<400> 743
Ser Pro Leu Lys Glu Ala Glu Ile Arg Glu Asp Glu Glu Glu
1 5 10
<210> 744
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 700
<400> 744
Thr Asp Pro Ser Ser Met Arg Arg Ser Phe Ser Thr Ile Arg
1 5 10
<210> 745
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 701
<400> 745
Pro Met Arg Leu Val Asn Phe Pro Met Asp Gly His Ala Cys
1 5 10
<210> 746
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 702
<400> 746
Ala Leu Ser Arg Gly His Gly Lys Tyr Phe Phe
1 5 10
<210> 747
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 703
<400> 747
Asp Gly Ala His Gly Leu Leu Asp Pro Tyr Asn
1 5 10
<210> 748
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 704
<400> 748
Glu Ser Leu Asn Lys Val Phe Val Asp Asn Phe
1 5 10
<210> 749
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 705
<400> 749
Ile Met Leu Ile Thr Asp Gly Ala Val Asp Thr Tyr Asp Thr
1 5 10
<210> 750
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 706
<400> 750
Pro Glu Leu Arg Leu Leu Tyr Glu Glu Gly Lys
1 5 10
<210> 751
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 707
<400> 751
Pro Gly Ile Lys Trp Glu Pro Asp Glu Asn Gly
1 5 10
<210> 752
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 708
<400> 752
Thr Ile Ala Lys Gln Thr Val Ser Ser Ile Leu
1 5 10
<210> 753
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 709
<400> 753
Thr Thr Val Ala Met Pro Val Phe Ser Lys Gln
1 5 10
<210> 754
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 710
<400> 754
Val Asp Lys Gly Lys Arg Val Leu Val Met Thr Asn Asp Tyr
1 5 10
<210> 755
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 711
<400> 755
Arg Ile Ala Lys Ile Asp Ser Tyr Ser Arg Ile Phe Phe Pro
1 5 10
<210> 756
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 712
<400> 756
Lys Phe Arg Ser Ala Arg Tyr Ser Arg Ser Leu Ser Thr Glu
1 5 10
<210> 757
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 713
<400> 757
Arg Thr Phe Glu Glu Pro Thr Ser Ser Leu Ala Ala Gln Ile
1 5 10
<210> 758
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 714
<400> 758
Phe Ile Met Asp Lys Ala Leu Leu Asp Tyr Glu Val Ser Ile
1 5 10
<210> 759
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 715
<400> 759
Ile Pro Ser Thr Met Asn Cys Met Glu Val Glu Thr Thr Asn
1 5 10
<210> 760
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 716
<400> 760
Gln Arg Leu His Arg Ala Ile Asn Thr Ser Phe Ile Glu Glu
1 5 10
<210> 761
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 717
<400> 761
Asp Ala Phe Ile Met Asp Lys Ala Leu Leu Asp Tyr Glu Val
1 5 10
<210> 762
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 718
<400> 762
Lys Thr Lys Arg Val Glu Lys Arg Ser Asn Val Gly Pro Arg
1 5 10
<210> 763
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 719
<400> 763
Glu Thr Glu Cys Phe Phe Val Glu Pro Asp Glu Pro Phe His
1 5 10
<210> 764
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 720
<400> 764
Gly Gly Gly Gly Gly Gly Gly Gly Gly Ala Gly
1 5 10
<210> 765
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 721
<400> 765
Gly Leu Ala Gly Ala Gly Gly Gly Gly Gly Gly Ala Val Gly
1 5 10
<210> 766
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 722
<400> 766
Ser Asn Ile Ile Gly Val Ile Val Tyr Ile Ser
1 5 10
<210> 767
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 723
<400> 767
Val Ala Ala Gly Leu Ala Gly Ala Gly Gly Gly Gly Gly Gly
1 5 10
<210> 768
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 724
<400> 768
Arg Leu Pro Ser Tyr Arg Phe Arg Tyr Arg Arg Arg Ser Arg
1 5 10
<210> 769
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 725
<400> 769
Phe Ser Ser Arg Glu Arg Arg Ser Phe Thr Glu Ile Asp Thr
1 5 10
<210> 770
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 726
<400> 770
Lys Glu Gln Met Asn Glu Glu Leu Arg Arg Glu Ala Glu Thr
1 5 10
<210> 771
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 727
<400> 771
Arg Ser Phe Thr Glu Ile Asp Thr Gly Asp Asp Glu Asp Phe
1 5 10
<210> 772
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 728
<400> 772
Ser Ala Asp Asp Asn His Leu Ser Pro Ser Arg Trp Lys Trp
1 5 10
<210> 773
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 729
<400> 773
Val Cys Asp Asp Tyr Asn Leu Asn Glu Asn Glu Tyr Phe Phe
1 5 10
<210> 774
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 730
<400> 774
Cys Asp Asp Tyr Asp Glu Ala Ala Arg Glu Phe Tyr Phe Asp
1 5 10
<210> 775
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 731
<400> 775
Leu Arg Ser Leu Gly Ala Thr Leu Lys His Ser Tyr Arg Glu
1 5 10
<210> 776
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 732
<400> 776
Val Ser Glu Ala Ser Leu Glu Thr Ser Arg Glu Thr Ser Gln
1 5 10
<210> 777
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 733
<400> 777
Val Tyr Cys Ser Asp Gly Phe Cys Glu Leu Ala Gly Phe Ala
1 5 10
<210> 778
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 734
<400> 778
Ile Arg Val Ser Arg Ser Asn Ser Pro Lys Thr Lys Gln Glu
1 5 10
<210> 779
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 735
<400> 779
Ser Pro Ile Cys Thr Arg Gly Ser Ser Ser Arg Asn Lys Lys
1 5 10
<210> 780
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 736
<400> 780
Thr Leu Pro Gly Thr Arg Leu Ala Leu Leu Ala Ser Ser Glu
1 5 10
<210> 781
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 737
<400> 781
Leu Glu Gly Lys Ala Asn Gly Gly Leu Val Asp Gly Glu Val
1 5 10
<210> 782
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 738
<400> 782
Cys Gly Pro Ser Val Arg Pro Val Pro Ala Trp
1 5 10
<210> 783
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 739
<400> 783
Asp Arg Phe Phe Leu Ala Ile Phe Phe Ser Met
1 5 10
<210> 784
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 740
<400> 784
Phe Phe Leu Ala Ile Phe Phe Ser Met Ala Leu
1 5 10
<210> 785
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 741
<400> 785
Gln Ser Arg Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser Pro
1 5 10
<210> 786
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 742
<400> 786
Arg Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser
1 5 10
<210> 787
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 743
<400> 787
Leu Ser Pro Ser Pro Gln Ser
1 5
<210> 788
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 744
<400> 788
Leu Tyr Leu Trp Ile Arg Gln
1 5
<210> 789
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 745
<400> 789
Gln Gly His Ala Ser Tyr Ile Leu Glu Ala Pro Ala Ser Asn
1 5 10
<210> 790
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 746
<400> 790
Gly Ser Gln Asn Ser Met Gly Ala Gly Pro Cys Ala Pro Gly
1 5 10
<210> 791
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 747
<400> 791
Leu Gly Pro Gln Phe Pro Ser Lys Gly Tyr Ser Leu Leu Gly
1 5 10
<210> 792
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 748
<400> 792
Tyr Ser Ala Ala Phe Leu Leu Ser Asp Gln Asp Glu Ser Arg
1 5 10
<210> 793
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 749
<400> 793
Lys Asp Arg Thr His Asn Val Thr Glu Lys Val Thr Gln Val
1 5 10
<210> 794
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 750
<400> 794
Glu Asn Ser Thr Asn Asp Pro Glu Asp Ser Ala Asp Thr Ile
1 5 10
<210> 795
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 751
<400> 795
Gly Glu Lys Glu Asn Ser Thr Asn Asp Pro Glu Asp Ser Ala
1 5 10
<210> 796
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 752
<400> 796
Arg Glu Cys Gly Tyr Ser Cys Ser Pro Leu Asn Val Val Asp
1 5 10
<210> 797
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 753
<400> 797
Tyr Ser Glu Tyr Gly Ala Ala Val Leu Met Leu Leu Met Cys
1 5 10
<210> 798
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 754
<400> 798
Ser Arg Pro Asp Val Met Gln Lys Pro Cys Thr Cys Asp Phe
1 5 10
<210> 799
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 755
<400> 799
Gly Arg Arg Thr Leu Arg Pro Ala Val Val Gly
1 5 10
<210> 800
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 756
<400> 800
Leu Asp Phe Leu Asp Ala Glu Leu Glu Asp Glu
1 5 10
<210> 801
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 757
<400> 801
Leu Asp Asn His Gly Tyr Val Phe Lys Pro Pro His Gln Asp
1 5 10
<210> 802
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 758
<400> 802
Arg Thr Leu Arg Pro Ala Val Val Gly Val Lys
1 5 10
<210> 803
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 759
<400> 803
Arg Thr Leu Val Lys Ser Leu Asp Glu Arg Tyr
1 5 10
<210> 804
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 760
<400> 804
Thr Arg Arg Pro Thr Ser Gly Pro Pro Arg Pro
1 5 10
<210> 805
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 761
<400> 805
Val Thr Leu Asp Phe Leu Asp Ala Glu Leu Glu Asp Glu Asn
1 5 10
<210> 806
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 762
<400> 806
Arg Glu Tyr Cys Lys Asp Leu Asn Ala Ser Asp Asn Asn Thr
1 5 10
<210> 807
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 763
<400> 807
Leu Tyr Gly Leu Ile Tyr His Ser Trp Phe Gln Ala Asp Pro
1 5 10
<210> 808
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 764
<400> 808
Asp Phe Phe Tyr His Pro Glu Thr Gln Gln Tyr Phe Phe Asp
1 5 10
<210> 809
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 765
<400> 809
Leu Ile Pro Glu Ile Ile Gly Asp Cys Cys Tyr Glu Glu Tyr
1 5 10
<210> 810
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 766
<400> 810
Arg Tyr Pro Asp Thr Leu Leu Gly Ser Ser Glu Arg Asp Phe
1 5 10
<210> 811
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 767
<400> 811
Val Thr Met Thr Thr Leu Gly Tyr Gly Asp Met Val Pro Lys
1 5 10
<210> 812
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 768
<400> 812
Ala Asn Arg Ser Tyr Ser Asp Glu Asp Gln Ser Ser Ser Asn
1 5 10
<210> 813
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 769
<400> 813
Asp Ala Thr Pro His Thr Leu Val Gln Pro Ile
1 5 10
<210> 814
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 770
<400> 814
Asp Asn Gly Ile Met Gly Cys His Glu Ile Pro
1 5 10
<210> 815
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 771
<400> 815
Asp Arg Gly Glu Asp Glu Glu Glu Ile Asp Tyr
1 5 10
<210> 816
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 772
<400> 816
Glu Leu Gly Lys Glu Glu Glu Glu Glu Glu Gln
1 5 10
<210> 817
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 773
<400> 817
Phe Tyr His Cys Leu Gly Val Asp Thr Arg Asn
1 5 10
<210> 818
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 774
<400> 818
Gly Gly Ala Gly Gly Gly Gly Ala Gly Ser Glu
1 5 10
<210> 819
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 775
<400> 819
Gly Lys Phe Tyr His Cys Leu Gly Val Asp Thr
1 5 10
<210> 820
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 776
<400> 820
Gly Met His Ile Phe Gly Cys Lys Phe Ser Leu
1 5 10
<210> 821
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 777
<400> 821
Gly Arg Gly Gly Ala Gly Gly Gly Gly Ala Gly Ser Glu His
1 5 10
<210> 822
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 778
<400> 822
Leu Phe Lys Gly Lys Phe Tyr His Cys Leu Gly Val Asp Thr
1 5 10
<210> 823
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 779
<400> 823
Asn Arg Val Pro Ser Met Arg Ile Leu Val Asn
1 5 10
<210> 824
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 780
<400> 824
Gln Glu Val Gln Leu Ala Glu Thr Glu Ala Phe
1 5 10
<210> 825
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 781
<400> 825
Gln Pro Ile Pro Ala Thr Leu Ala Ser Asp Pro
1 5 10
<210> 826
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 782
<400> 826
Arg Gln Ala Thr Gly Ser Asp Thr Ser Leu Asp
1 5 10
<210> 827
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 783
<400> 827
Arg Gln Ala Thr Gly Ser Asp Thr Ser Leu Asp Ala Ser Pro
1 5 10
<210> 828
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 784
<400> 828
Ser Leu Arg Gly Leu Arg Ala His Gln Arg Ser
1 5 10
<210> 829
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 785
<400> 829
Ser Met Arg Ile Leu Val Asn Leu Leu Leu Asp
1 5 10
<210> 830
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 786
<400> 830
Ser Pro Ser Ser Ser Ala Gly Ser Leu Gln Thr Thr Leu Glu
1 5 10
<210> 831
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 787
<400> 831
Thr Ala Val Ser Pro Asp Pro Glu Asn Phe Leu
1 5 10
<210> 832
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 788
<400> 832
Thr Gly Ser Asp Thr Ser Leu Asp Ala Ser Pro Ser Ser Ser
1 5 10
<210> 833
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 789
<400> 833
Leu Val Gln Pro Ile Pro Ala Thr Leu Ala Ser Asp Pro Ala
1 5 10
<210> 834
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 790
<400> 834
Pro Tyr Ala Arg Met Pro Ser Tyr Arg Tyr Arg Arg Arg Arg
1 5 10
<210> 835
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 791
<400> 835
Arg Met Pro Ser Tyr Arg Tyr Arg Arg Arg Arg Ser Arg Ser
1 5 10
<210> 836
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 792
<400> 836
Glu Trp Glu Val His Gly Met Pro Ala Val Lys Asn Val Ile
1 5 10
<210> 837
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 793
<400> 837
Leu Ser Asp Phe Ile Glu Asp Val Glu Trp Glu
1 5 10
<210> 838
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 794
<400> 838
Val Leu Asn Val Thr Leu Gln Ile Thr Leu Ser Gln Ile Lys
1 5 10
<210> 839
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 795
<400> 839
Val Leu Tyr Asn Lys Ala Asp Asp Glu Ser Ser Glu Pro Val
1 5 10
<210> 840
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 796
<400> 840
Asp Glu Ser Ser Glu Pro Val
1 5
<210> 841
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 797
<400> 841
Leu Leu Leu Lys Arg Arg Ser Ser Phe Tyr Ile Val Asn
1 5 10
<210> 842
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 798
<400> 842
Thr Phe Gly Ser Trp Thr Tyr Asn Gly Asn Gln Val Asp
1 5 10
<210> 843
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 799
<400> 843
Ala Ile Arg Asn Gly Val Asn Arg Asn Ser Ala Ile Ile Gly
1 5 10
<210> 844
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 800
<400> 844
Gly Asp Asn Ser Asp Tyr Asp Tyr Ser Ala Leu Ser Cys Thr
1 5 10
<210> 845
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 801
<400> 845
Gln Pro Glu Asp Arg Arg Arg Arg Ile Ile Ile Asn Val Gly
1 5 10
<210> 846
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 802
<400> 846
Ser Asp Tyr Asp Tyr Ser Ala Leu Ser Cys Thr Ser Asp Ala
1 5 10
<210> 847
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 803
<400> 847
Thr Arg Glu Phe Gly Leu Leu Leu Leu Phe Leu Cys Val Ala
1 5 10
<210> 848
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 804
<400> 848
Phe His Thr Phe Ser Arg Ser Tyr Ser Glu Leu Lys Glu Gln
1 5 10
<210> 849
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 805
<400> 849
Arg Leu Arg Ala Cys Arg Gly His Asp Asp Leu Leu Arg Val
1 5 10
<210> 850
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 806
<400> 850
Arg Val Cys Asp Asp Tyr Asp Val Ser Arg Asp Glu Phe Phe
1 5 10
<210> 851
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 807
<400> 851
Leu Gly Ala Gly Gly Gly Ser Ala Glu Val Asp Thr Ser Ser
1 5 10
<210> 852
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 808
<400> 852
Pro Asp Leu Ser Pro Arg Val Val Asp Gly Ile Glu Asp Gly
1 5 10
<210> 853
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 809
<400> 853
Thr Ala Pro Arg Pro Arg Leu Gly Gly Arg Gly Arg Pro Gly
1 5 10
<210> 854
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 810
<400> 854
Ser Ala Met Arg Ser Cys Asp Phe Gly Asp Gly Met Lys Glu
1 5 10
<210> 855
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 811
<400> 855
Arg Ser Cys Asp Phe Gly Asp Gly Met Lys Glu Val Pro Ser
1 5 10
<210> 856
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 812
<400> 856
Ile Leu Lys Phe Gln Val Gln Arg Glu Val Asn Ser Tyr Leu
1 5 10
<210> 857
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 813
<400> 857
Gln Pro Arg Arg His Arg Arg Pro Arg Arg Val Ile Ala Arg
1 5 10
<210> 858
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 814
<400> 858
Asp Leu Ser Pro Arg Ile Val Asp Gly Ile Glu Asp Ser Gly
1 5 10
<210> 859
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 815
<400> 859
Ile Glu Asp Ser Gly Ser Thr Ala Glu Ala Pro Ser Phe Arg
1 5 10
<210> 860
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 816
<400> 860
Asp Lys Thr Leu Pro Ser Ile Thr Glu Ala Glu Ser Gly Ala
1 5 10
<210> 861
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 817
<400> 861
Ala Ser Pro Val Gly Ile Lys Gly Phe Asn Thr Leu Pro Ser
1 5 10
<210> 862
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 818
<400> 862
Leu Ala Val His Met Phe Ile Asp Arg His Lys
1 5 10
<210> 863
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 819
<400> 863
Asp Ala Ser Pro Val Gly Ile Lys Gly Phe Asn Thr Leu Pro
1 5 10
<210> 864
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 820
<400> 864
Ala Val Asn Phe Asn Gly Ser Ala Gly Thr Pro Val Thr Phe
1 5 10
<210> 865
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 821
<400> 865
Cys Glu Gly Tyr Asn Tyr Gln Val Asp Glu Leu Ser Cys Glu
1 5 10
<210> 866
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 822
<400> 866
Cys Ser Arg Asp Thr Tyr Ala Leu Glu Gln Ser Leu Thr Phe
1 5 10
<210> 867
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 823
<400> 867
Glu Ser Gly Val Glu Ala Phe Thr Gln Ile Ser Arg Glu Ile
1 5 10
<210> 868
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 824
<400> 868
Phe Asn Gly Ser Ala Gly Thr Pro Val Thr Phe Asn Glu Asn
1 5 10
<210> 869
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 825
<400> 869
Gly His Phe Leu Trp Ile Gly Ser Asp Ser Trp Gly Ser Lys
1 5 10
<210> 870
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 826
<400> 870
Ile Ala Gln Ser Gln Lys Ile Pro Arg Glu Pro Arg Pro Gly
1 5 10
<210> 871
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 827
<400> 871
Ile Phe Glu Gln Gly Lys Lys Ser Val Thr Ala Pro Lys Phe
1 5 10
<210> 872
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 828
<400> 872
Ile Leu Pro Lys Arg Ala Ser Ile Asp Gly Phe Asp Arg Tyr
1 5 10
<210> 873
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 829
<400> 873
Lys Leu Ile Gln Lys Gly Asn Asp Arg Pro Asn Gly Glu Val
1 5 10
<210> 874
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 830
<400> 874
Lys Ser Val Thr Ala Pro Lys Phe Ile Ser Pro Ala Ser Gln
1 5 10
<210> 875
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 831
<400> 875
Asn Asn Arg Arg Asn Val Trp Phe Ala Glu Phe Trp Glu Glu
1 5 10
<210> 876
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 832
<400> 876
Asn Gln Ser Gly His Phe Leu Trp Ile Gly Ser Asp Ser Trp
1 5 10
<210> 877
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 833
<400> 877
Gln Gly Lys Lys Ser Val Thr Ala Pro Lys Phe Ile Ser Pro
1 5 10
<210> 878
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 834
<400> 878
Arg Met Ser Thr Ile Asp Gly Lys Glu Leu Leu Gly Tyr Ile
1 5 10
<210> 879
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 835
<400> 879
Ile Asp Gln Ile Asn Lys Asp Pro Asp Leu Leu Ser Asn Ile
1 5 10
<210> 880
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 836
<400> 880
Gln Ser Ala Glu Lys Met Tyr Ile Gln Thr Thr Thr Leu Thr
1 5 10
<210> 881
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 837
<400> 881
Ala Glu Val Gln Ser Glu Ile Glu Arg Ile Phe
1 5 10
<210> 882
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 838
<400> 882
Ala Lys Arg Ser Val Leu Asn Asn Pro Ser Lys
1 5 10
<210> 883
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 839
<400> 883
Ile Ser Ile Thr Arg Val Thr Ala Asp Ile Ser Leu Ala Lys
1 5 10
<210> 884
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 840
<400> 884
Arg Pro Ser Asp Ser Asp Val Ser Leu Glu Glu
1 5 10
<210> 885
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 841
<400> 885
Ser Glu Ile Glu Arg Ile Phe Glu Leu Ala Arg
1 5 10
<210> 886
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 842
<400> 886
Ser Leu Ala Glu Val Gln Ser Glu Ile Glu Arg
1 5 10
<210> 887
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 843
<400> 887
Tyr Pro Leu Val Glu Glu Asp Tyr Pro Asp Ser Tyr Gln Asp
1 5 10
<210> 888
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 844
<400> 888
Ala Ala Asn Gln Lys Leu Ala Leu Gln Lys Ala Lys Glu Val
1 5 10
<210> 889
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 845
<400> 889
Ala Gly Gly Ser Gly Pro Pro Gln Gln Gln Gln
1 5 10
<210> 890
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 846
<400> 890
Ala Gly Gly Ser Gly Pro Pro Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 891
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 847
<400> 891
Ala Lys Pro Leu Thr Arg His Met Pro Gln Asn
1 5 10
<210> 892
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 848
<400> 892
Ala Leu Glu Gln His Leu Pro Asp Asp Asp Lys Thr Pro Met
1 5 10
<210> 893
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 849
<400> 893
Ala Leu Tyr Asn Glu Met Asp Pro Asp Glu Arg
1 5 10
<210> 894
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 850
<400> 894
Ala Asn Ala Gln Glu Leu Thr Lys Asp Glu Gln Glu Glu Glu
1 5 10
<210> 895
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 851
<400> 895
Ala Arg Asp Arg Glu Trp Lys Lys Tyr Glu Phe His Tyr Asp
1 5 10
<210> 896
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 852
<400> 896
Ala Arg Gly Gly Glu Gly Glu Gly Glu Gly Pro
1 5 10
<210> 897
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 853
<400> 897
Ala Arg Thr Met Ala Leu Tyr Asn Pro Ile Pro Val Arg Gln
1 5 10
<210> 898
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 854
<400> 898
Ala Ser Glu Arg Ser Leu Gly Arg Tyr Thr Asp Val Asp Thr
1 5 10
<210> 899
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 855
<400> 899
Ala Ser Arg Glu Ala Leu Tyr Asn Glu Met Asp Pro Asp Glu
1 5 10
<210> 900
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 856
<400> 900
Ala Val Asp Asn Leu Ala Asn Ala Gln Glu Leu
1 5 10
<210> 901
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 857
<400> 901
Asp Glu Asp Ser Asp Glu Asp Glu Phe Gln Ile
1 5 10
<210> 902
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 858
<400> 902
Asp Glu Gly Thr Pro Pro Thr Asn Phe Asp Thr
1 5 10
<210> 903
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 859
<400> 903
Asp His His Ala Arg Glu Gly Ser Leu Glu Gln Pro Gly Phe
1 5 10
<210> 904
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 860
<400> 904
Asp Pro Gln Glu Asn Arg Asn Asn Asn Thr Asn
1 5 10
<210> 905
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 861
<400> 905
Asp Arg Ala Arg Asp Pro Ser Gly Ser Ala Gly Leu Asp Ala
1 5 10
<210> 906
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 862
<400> 906
Glu Glu Glu Lys Lys Glu Glu Glu Glu Asp Asp
1 5 10
<210> 907
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 863
<400> 907
Glu Glu Lys Lys Glu Glu Glu Glu Asp Asp Arg Gly Glu Asp
1 5 10
<210> 908
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 864
<400> 908
Glu Gly Pro Tyr Gly Arg Glu Ser Asp His His
1 5 10
<210> 909
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 865
<400> 909
Glu Pro Tyr Ser Glu Ser Asp Asp Asp Trp Cys
1 5 10
<210> 910
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 866
<400> 910
Glu Gln Asp Arg Thr Pro Leu Met Phe Gln Arg Met Glu Pro
1 5 10
<210> 911
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 867
<400> 911
Glu Gln Glu Glu Glu Glu Ala Ala Asn Gln Lys
1 5 10
<210> 912
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 868
<400> 912
Glu Gln Gly Pro Pro Thr Asp Met Pro Asn Ser
1 5 10
<210> 913
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 869
<400> 913
Glu Val Ala Glu Val Ser Pro Leu Ser Ala Ala
1 5 10
<210> 914
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 870
<400> 914
Glu Val Ile Leu Ala Glu Asp Glu Thr Asp Gly Glu Gln Arg
1 5 10
<210> 915
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 871
<400> 915
Glu Val Lys Ala Arg Asp Arg Glu Trp Lys Lys Tyr Glu Phe
1 5 10
<210> 916
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 872
<400> 916
Glu Tyr Leu Thr Arg Asp Ser Ser Ile Leu Gly
1 5 10
<210> 917
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 873
<400> 917
Phe Asp Thr Phe Pro Ala Ala Ile Met Thr Val
1 5 10
<210> 918
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 874
<400> 918
Phe Glu Lys Asp Cys Arg Gly Lys Tyr Leu Leu
1 5 10
<210> 919
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 875
<400> 919
Phe Glu Tyr Leu Thr Arg Asp Ser Ser Ile Leu
1 5 10
<210> 920
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 876
<400> 920
Phe Phe Ile Tyr Ala Ile Ile Gly Met Gln Val
1 5 10
<210> 921
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 877
<400> 921
Phe Leu Lys Leu Arg Arg Gln Gln Gln Ile Glu
1 5 10
<210> 922
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 878
<400> 922
Phe Val Ala Val Ile Met Asp Asn Phe Glu Tyr
1 5 10
<210> 923
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 879
<400> 923
Gly Ala Leu Met Ala His Glu Ser Gly Leu Lys Glu Ser Pro
1 5 10
<210> 924
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 880
<400> 924
Gly Pro Pro Gln Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 925
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 881
<400> 925
Gly Arg Glu Ser Asp His His Ala Arg Glu Gly
1 5 10
<210> 926
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 882
<400> 926
Gly Ser Asp Tyr Asp Glu Ala Asp Gly Pro Gly
1 5 10
<210> 927
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 883
<400> 927
Gly Ser Gly Pro Pro Gln Gln Gln Gln Gln Gln
1 5 10
<210> 928
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 884
<400> 928
Gly Ser Gly Val Pro Val Ser Gly Pro Asn Leu Ser Thr Thr
1 5 10
<210> 929
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 885
<400> 929
His His His His His His His His His His Pro Pro Pro Pro
1 5 10
<210> 930
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 886
<400> 930
His His His His His His His Pro Pro Pro Pro Asp Lys Asp
1 5 10
<210> 931
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 887
<400> 931
His His His His His His Pro Pro Pro Pro Asp
1 5 10
<210> 932
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 888
<400> 932
His His His His Pro Pro Pro Pro Asp Lys Asp
1 5 10
<210> 933
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 889
<400> 933
His His Leu Asp Glu Tyr Val Arg Val Trp Ala Glu Tyr Asp
1 5 10
<210> 934
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 890
<400> 934
His Tyr Leu Pro Met Glu Gly Gln Gly Arg Ala
1 5 10
<210> 935
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 891
<400> 935
Ile Asp Val Glu Asp Glu Asp Ser Asp Glu Asp
1 5 10
<210> 936
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 892
<400> 936
Ile Gln Gln Asp Leu Gly Arg Gln Asp Pro Pro
1 5 10
<210> 937
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 893
<400> 937
Lys Asp Glu Gln Glu Glu Glu Glu Ala Ala Asn
1 5 10
<210> 938
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 894
<400> 938
Lys Gly Gly Ala Asp Lys Gln Gln Met Asp Ala
1 5 10
<210> 939
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 895
<400> 939
Lys Gly Gly Ala Asp Lys Gln Gln Met Asp Ala Glu Leu Arg
1 5 10
<210> 940
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 896
<400> 940
Lys Lys Glu Glu Glu Lys Lys Glu Glu Glu Glu
1 5 10
<210> 941
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 897
<400> 941
Lys Pro Cys Asp Lys Asn Ser Gly Ile Leu Thr
1 5 10
<210> 942
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 898
<400> 942
Leu Ala Glu Asp Glu Thr Asp Gly Glu Gln Arg
1 5 10
<210> 943
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 899
<400> 943
Leu Phe Gly Asn Tyr Thr Leu Leu Asn Val Phe Leu Ala Ile
1 5 10
<210> 944
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 900
<400> 944
Leu Gly Val Leu Ser Gly Glu Phe Ala Lys Glu Arg Glu Arg
1 5 10
<210> 945
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 901
<400> 945
Leu Ile Phe Ala Ile Ile Gly Leu Glu Phe Tyr
1 5 10
<210> 946
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 902
<400> 946
Leu Arg Ala Leu Arg Leu Leu Arg Ile Phe Lys Val Thr Lys
1 5 10
<210> 947
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 903
<400> 947
Leu Arg Pro Leu Lys Thr Ile Lys Arg Leu Pro Lys Leu Lys
1 5 10
<210> 948
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 904
<400> 948
Leu Ser Thr Thr Arg Pro Ile Gln Gln Asp Leu
1 5 10
<210> 949
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 905
<400> 949
Leu Thr Lys Asp Glu Gln Glu Glu Glu Glu Ala
1 5 10
<210> 950
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 906
<400> 950
Leu Thr Arg Asp Ser Ser Ile Leu Gly Pro His
1 5 10
<210> 951
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 907
<400> 951
Met Ala Gly Ala Tyr Asp Ala Pro Pro Pro Val
1 5 10
<210> 952
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 908
<400> 952
Asn Ile Gly Ile Asp Val Glu Asp Glu Asp Ser Asp Glu Asp
1 5 10
<210> 953
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 909
<400> 953
Pro Leu Met Phe Gln Arg Met Glu Pro Pro Ser
1 5 10
<210> 954
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 910
<400> 954
Pro Leu Pro Lys Lys Glu Glu Glu Lys Lys Glu Glu Glu Glu
1 5 10
<210> 955
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 911
<400> 955
Pro Leu Ser Ala Ala Asn Met Ser Ile Ala Val
1 5 10
<210> 956
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 912
<400> 956
Pro Asn Ala Pro Arg Asn Asn Val Leu Arg Tyr Phe Asp Tyr
1 5 10
<210> 957
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 913
<400> 957
Pro Asn Ser Gln Ser Val Glu Met Arg Glu Met
1 5 10
<210> 958
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 914
<400> 958
Pro Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 959
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 915
<400> 959
Pro Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 960
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 916
<400> 960
Pro Thr Asn Phe Asp Thr Phe Pro Ala Ala Ile Met Thr Val
1 5 10
<210> 961
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 917
<400> 961
Pro Tyr Gly Arg Glu Ser Asp His His Ala Arg
1 5 10
<210> 962
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 918
<400> 962
Gln Ile Leu Thr Gly Glu Asp Trp Asn Glu Val Met Tyr Asp
1 5 10
<210> 963
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 919
<400> 963
Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Ala
1 5 10
<210> 964
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 920
<400> 964
Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 965
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 921
<400> 965
Arg Asp Gly Tyr Ser Asp Ser Glu His Tyr Leu Pro Met Glu
1 5 10
<210> 966
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 922
<400> 966
Arg Asp Arg Ser His Arg Ala Ser Glu Arg Ser
1 5 10
<210> 967
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 923
<400> 967
Arg Met Arg Phe Tyr Ile Arg Arg Met Val Lys
1 5 10
<210> 968
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 924
<400> 968
Arg Arg Met Arg Phe Tyr Ile Arg Arg Met Val Lys Thr Gln
1 5 10
<210> 969
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 925
<400> 969
Arg Arg Gln Gln Gln Ile Glu Arg Glu Leu Asn Gly Tyr Met
1 5 10
<210> 970
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 926
<400> 970
Arg Thr Pro Leu Met Phe Gln Arg Met Glu Pro Pro Ser Pro
1 5 10
<210> 971
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 927
<400> 971
Arg Tyr His Asp Arg Ala Arg Asp Pro Ser Gly Ser Ala Gly
1 5 10
<210> 972
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 928
<400> 972
Ser Asp Ser Glu His Tyr Leu Pro Met Glu Gly
1 5 10
<210> 973
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 929
<400> 973
Ser Glu His Tyr Leu Pro Met Glu Gly Gln Gly
1 5 10
<210> 974
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 930
<400> 974
Ser Gly Lys Pro Cys Asp Lys Asn Ser Gly Ile Leu Thr Arg
1 5 10
<210> 975
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 931
<400> 975
Ser Gly Leu Lys Glu Ser Pro Ser Trp Val Thr
1 5 10
<210> 976
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 932
<400> 976
Ser Gly Pro Pro Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln
1 5 10
<210> 977
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 933
<400> 977
Ser Leu Phe Ser Leu Glu Cys Val Leu Lys Val
1 5 10
<210> 978
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 934
<400> 978
Ser Pro Glu Gln Gly Pro Pro Thr Asp Met Pro
1 5 10
<210> 979
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 935
<400> 979
Ser Pro Leu Ser Ala Ala Asn Met Ser Ile Ala Val Lys Glu
1 5 10
<210> 980
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 936
<400> 980
Ser Thr Asp Pro Gly Pro Met Leu Ala Ile Pro Ala Met Ala
1 5 10
<210> 981
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 937
<400> 981
Thr Gly Thr Trp Ser Pro Glu Gln Gly Pro Pro Thr Asp Met
1 5 10
<210> 982
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 938
<400> 982
Thr Arg Pro Tyr Phe His Ser Ser Phe Asn Cys Phe Asp Cys
1 5 10
<210> 983
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 939
<400> 983
Val Glu Asp Glu Asp Ser Asp Glu Asp Glu Phe
1 5 10
<210> 984
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 940
<400> 984
Val Phe Gln Ile Leu Thr Gly Glu Asp Trp Asn Glu Val Met
1 5 10
<210> 985
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 941
<400> 985
Val Ile Lys Pro Gly Thr Ser Phe Gly Ile Ser Val Leu Arg
1 5 10
<210> 986
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 942
<400> 986
Trp Ala Glu Tyr Asp Pro Ala Ala Trp Gly Arg Met Pro Tyr
1 5 10
<210> 987
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 943
<400> 987
Tyr Asn Pro Ile Pro Val Arg Gln Asn Cys Leu Thr Val Asn
1 5 10
<210> 988
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 944
<400> 988
Tyr Arg Gly Ser Asp Tyr Asp Glu Ala Asp Gly
1 5 10
<210> 989
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 945
<400> 989
Tyr Ser Asp Ser Glu His Tyr Leu Pro Met Glu Gly Gln Gly
1 5 10
<210> 990
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 946
<400> 990
Asp Asn Phe Glu Tyr Leu Thr Arg Asp Ser Ser Ile Leu Gly
1 5 10
<210> 991
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 947
<400> 991
Asp Gly Pro Gly Ser Gly Gly Gly Glu Glu Ala Met Ala Gly
1 5 10
<210> 992
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 948
<400> 992
Asp Pro Gln Glu Asn Arg Asn Asn Asn Thr Asn Lys Ser Arg
1 5 10
<210> 993
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 949
<400> 993
Glu Asp Ser Asp Glu Asp Glu Phe Gln Ile Thr Glu His Asn
1 5 10
<210> 994
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 950
<400> 994
Gly Ile Asp Val Glu Asp Glu Asp Ser Asp Glu Asp Glu Phe
1 5 10
<210> 995
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 951
<400> 995
Gly Asn Ile Gly Ile Asp Val Glu Asp Glu Asp Ser Asp Glu
1 5 10
<210> 996
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 952
<400> 996
Leu Met Ala His Glu Ser Gly Leu Lys Glu Ser Pro Ser Trp
1 5 10
<210> 997
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 953
<400> 997
Leu Val Val Asp Pro Gln Glu Asn Arg Asn Asn Asn Thr Asn
1 5 10
<210> 998
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 954
<400> 998
Met Asp Asn Phe Glu Tyr Leu Thr Arg Asp Ser Ser Ile Leu
1 5 10
<210> 999
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 955
<400> 999
Asn Ala Gln Glu Leu Thr Lys Asp Glu Gln Glu Glu Glu Glu
1 5 10
<210> 1000
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 956
<400> 1000
Pro Lys Lys Glu Glu Glu Lys Lys Glu Glu Glu Glu Asp Asp
1 5 10
<210> 1001
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 957
<400> 1001
Val Glu Asp Glu Asp Ser Asp Glu Asp Glu Phe Gln Ile Thr
1 5 10
<210> 1002
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 958
<400> 1002
Gly Ile Cys Phe Ser Phe Val Phe Gly Ala Leu Leu Glu Tyr
1 5 10
<210> 1003
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 959
<400> 1003
Ser Thr Val Ala Cys Asp Met Asp Leu Ala Lys Tyr Pro Met
1 5 10
<210> 1004
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 960
<400> 1004
Asp Glu Gln Glu Cys Met Leu Asp Leu Glu Ser Tyr Gly Tyr
1 5 10
<210> 1005
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 961
<400> 1005
Lys Lys Gln Lys Ala Lys Val Lys Val Ser Arg Pro Arg Ala
1 5 10
<210> 1006
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 962
<400> 1006
Thr Thr Glu Leu Met Asn Phe Lys Ser Ala Gly Gln Phe Pro
1 5 10
<210> 1007
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 963
<400> 1007
Lys Asp Asn Lys Gly Tyr Cys Ala Gln Tyr Arg Gly Glu Val
1 5 10
<210> 1008
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 964
<400> 1008
Leu Tyr Cys Cys Arg Arg Arg Lys Gln Trp Lys Asn Lys Lys
1 5 10
<210> 1009
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 965
<400> 1009
Gln Glu Cys Ser Pro Gly Val Val Pro Thr Pro Ile Pro Ile
1 5 10
<210> 1010
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 966
<400> 1010
Glu Leu Leu Pro Gly Val Arg Leu Gly Ala Arg Leu Leu Asp
1 5 10
<210> 1011
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 967
<400> 1011
Ser Val Ile Asp Tyr Glu Glu Gln Arg Thr Val Asp Pro Glu
1 5 10
<210> 1012
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 968
<400> 1012
Ala Arg Glu Glu Ala Glu Pro Val Phe Arg Ala Ala Glu Glu
1 5 10
<210> 1013
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 969
<400> 1013
Asp Leu Ala Leu Leu Gln Phe Leu Gly Asp Asp Glu Ile Glu
1 5 10
<210> 1014
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 970
<400> 1014
Asp Asn Met Ala Gly Val Phe Tyr Met Leu Leu Val Ala Met
1 5 10
<210> 1015
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 971
<400> 1015
Glu Arg Ser Glu Ile Val Asp Phe Ser Val Pro Phe Val Glu
1 5 10
<210> 1016
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 972
<400> 1016
Gly Gly Ala Gly Gly Pro Gly Gly Gly Leu Gly Gly Ala Arg
1 5 10
<210> 1017
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 973
<400> 1017
Ile Arg Leu Leu Phe Cys Ala Arg Glu Glu Ala Glu Pro Val
1 5 10
<210> 1018
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 974
<400> 1018
Leu Ala Asp Gly Phe His Arg Tyr Tyr Gly Pro Ile Glu Pro
1 5 10
<210> 1019
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 975
<400> 1019
Leu Leu Gly Pro Gly Ala Gly Gly Ala Gly Gly Thr Gly Gly
1 5 10
<210> 1020
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 976
<400> 1020
Pro Gly Ala Gly Gly Ala Gly Gly Thr Gly Gly Ala Gly Gly
1 5 10
<210> 1021
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 977
<400> 1021
Pro Ser Pro Ser Asp Ser Glu Asp Ser Glu Ser Leu Gly Gly
1 5 10
<210> 1022
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 978
<400> 1022
Pro Trp Trp Phe Ala Asp Phe Pro Tyr Pro Tyr Ala Glu Arg
1 5 10
<210> 1023
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 979
<400> 1023
Ser Gln Pro Leu Leu Gly Pro Gly Ala Gly Gly Ala Gly Gly
1 5 10
<210> 1024
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 980
<400> 1024
Ser Arg Tyr Gly Arg Phe Leu Gln Pro Val Asp Asp Thr Gln
1 5 10
<210> 1025
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 981
<400> 1025
Ser Tyr Thr Ala Asn Leu Ala Ala Phe Met Ile Gln Glu Glu
1 5 10
<210> 1026
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 982
<400> 1026
Thr Glu Gln Gln Leu Gln Val Ile Phe Glu Val Leu Glu Glu
1 5 10
<210> 1027
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 983
<400> 1027
Thr Gln His Leu Thr Val Ala Thr Leu Glu Glu Arg Pro Phe
1 5 10
<210> 1028
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 984
<400> 1028
Ala Leu Leu Gln Phe Leu Gly Asp Asp Glu Ile Glu Met Leu
1 5 10
<210> 1029
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 985
<400> 1029
Gly Asp Asp Glu Ile Glu Met Leu Glu Arg Leu Trp Leu Ser
1 5 10
<210> 1030
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 986
<400> 1030
Gly Pro Gly Ala Gly Gly Ala Gly Gly Thr Gly Gly Ala Gly
1 5 10
<210> 1031
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 987
<400> 1031
Ile Asp Leu Ala Leu Leu Gln Phe Leu Gly Asp Asp Glu Ile
1 5 10
<210> 1032
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 988
<400> 1032
Lys Lys Ile Asp Gly Val Trp Asn Gly Met Ile Gly Glu Val
1 5 10
<210> 1033
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 989
<400> 1033
Pro Leu Leu Gly Pro Gly Ala Gly Gly Ala Gly Gly Thr Gly
1 5 10
<210> 1034
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 990
<400> 1034
Gln Phe Leu Gly Asp Asp Glu Ile Glu Met Leu Glu Arg Leu
1 5 10
<210> 1035
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 991
<400> 1035
Val Trp Val Met Met Phe Val Met Cys Leu Thr Val Val Ala
1 5 10
<210> 1036
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 992
<400> 1036
Asn Leu Phe Asp Thr Ala Glu Val Tyr Ala Ala Gly Lys Ala
1 5 10
<210> 1037
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 993
<400> 1037
Ala Asn Lys Ser Glu Ser Glu Pro Asp Phe Phe
1 5 10
<210> 1038
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 994
<400> 1038
Ala Gln Arg Pro Leu Arg Arg Gln Ala Ala Ile Arg Thr Asp
1 5 10
<210> 1039
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 995
<400> 1039
Ala Trp Ile Ala Ile Phe Gln Val Ile Thr Leu Glu Gly Trp
1 5 10
<210> 1040
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 996
<400> 1040
Cys Val Thr Leu Gly Met Phe Arg Pro Cys Glu Asp Ile Ala
1 5 10
<210> 1041
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 997
<400> 1041
Asp Phe Phe Ser Pro Ser Leu Asp Gly Asp Gly Asp Arg Lys
1 5 10
<210> 1042
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 998
<400> 1042
Asp Gly Asp Arg Lys Lys Cys Leu Ala Leu Val Ser Leu Gly
1 5 10
<210> 1043
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 999
<400> 1043
Asp Arg Lys Asn Phe Asp Ser Leu Leu Trp Ala Ile Val Thr
1 5 10
<210> 1044
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1000
<400> 1044
Asp Ser Cys Pro Tyr Cys Ala Arg Ala Gly Ala Gly Glu Val
1 5 10
<210> 1045
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1001
<400> 1045
Asp Ser Lys Asp Pro Leu Ala Ser Gly Pro Pro Asp Ser Met
1 5 10
<210> 1046
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1002
<400> 1046
Asp Thr Leu Pro Met Leu Gly Asn Val Leu Leu
1 5 10
<210> 1047
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1003
<400> 1047
Glu Ala Glu Leu Glu Ala Glu Leu Glu Leu Glu
1 5 10
<210> 1048
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1004
<400> 1048
Glu Leu Thr Asn Ala Leu Glu Ile Ser Asn Ile Val Phe Thr
1 5 10
<210> 1049
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1005
<400> 1049
Glu Asn Phe His Lys Cys Arg Gln His Gln Glu Glu Glu Glu
1 5 10
<210> 1050
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1006
<400> 1050
Glu Trp Glu Leu Lys Leu Met Asp Glu Leu Ala
1 5 10
<210> 1051
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1007
<400> 1051
Phe Ala Ala Leu Gly Val Glu Leu Phe Gly Asp Leu Glu Cys
1 5 10
<210> 1052
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1008
<400> 1052
Phe Ile Ile Phe Gly Ile Leu Gly Val Gln Leu Phe Lys Gly
1 5 10
<210> 1053
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1009
<400> 1053
Phe Val Leu Thr Ala Gln Phe Val Leu Val Asn
1 5 10
<210> 1054
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1010
<400> 1054
Phe Tyr His Ala Asp Cys His Leu Glu Pro Val
1 5 10
<210> 1055
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1011
<400> 1055
Gly Ala Gly Glu Val Glu Leu Ala Asp Arg Glu Met Pro Asp
1 5 10
<210> 1056
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1012
<400> 1056
Gly Asp Leu Leu Pro Pro Gly Gly Gln Glu Glu
1 5 10
<210> 1057
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1013
<400> 1057
Gly Glu Arg Arg Ser Leu Leu Ser Gly Glu Gly
1 5 10
<210> 1058
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1014
<400> 1058
Gly Gly Ser Asp Pro Gln Ile Pro Leu Ala Glu
1 5 10
<210> 1059
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1015
<400> 1059
Gly Ile Met Ile Ala Ile Leu Val Asn Thr Leu
1 5 10
<210> 1060
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1016
<400> 1060
Gly Leu Asp Tyr Glu Ala Tyr Asn Ser Ser Ser Asn Thr Thr
1 5 10
<210> 1061
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1017
<400> 1061
Gly Gln Glu Ser Gln Asp Glu Glu Glu Ser Ser Glu Glu Glu
1 5 10
<210> 1062
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1018
<400> 1062
His Pro Thr Asp Arg Gln Leu Phe Asp Thr Ile Ser Leu Leu
1 5 10
<210> 1063
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1019
<400> 1063
His Ser Pro Leu Gly Ser Pro Phe Leu Trp Pro Gly Val Glu
1 5 10
<210> 1064
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1020
<400> 1064
Ile Pro Leu Ala Glu Met Glu Ala Leu Ser Leu
1 5 10
<210> 1065
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1021
<400> 1065
Lys Glu Ala Lys Glu Glu Ala Glu Leu Glu Ala Glu Leu Glu
1 5 10
<210> 1066
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1022
<400> 1066
Lys Lys Arg Arg Asn Leu Met Leu Asp Asp Val Ile Ala Ser
1 5 10
<210> 1067
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1023
<400> 1067
Lys Leu Leu Lys Met Ala Val Gly Met Arg Ala Leu Leu Asp
1 5 10
<210> 1068
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1024
<400> 1068
Lys Met Ala Val Gly Met Arg Ala Leu Leu Asp Thr Val Met
1 5 10
<210> 1069
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1025
<400> 1069
Leu Ala Arg Ala Leu Arg Pro Asp Asp Pro Pro Leu Asp Gly
1 5 10
<210> 1070
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1026
<400> 1070
Leu Asp Gly Asp Gly Asp Arg Lys Lys Cys Leu Ala Leu Val
1 5 10
<210> 1071
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1027
<400> 1071
Leu Asp Tyr Glu Ala Tyr Asn Ser Ser Ser Asn
1 5 10
<210> 1072
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1028
<400> 1072
Leu Lys Tyr Leu Val Tyr Ile Leu Arg Lys Ala Ala Arg Arg
1 5 10
<210> 1073
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1029
<400> 1073
Leu Met Thr Phe Gly Asn Tyr Val Leu Phe Asn
1 5 10
<210> 1074
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1030
<400> 1074
Leu Asn Ile Pro Pro Gly Pro Tyr Ser Ser Met
1 5 10
<210> 1075
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1031
<400> 1075
Leu Pro Ala Cys Cys Leu Glu Arg Asp Ser Trp
1 5 10
<210> 1076
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1032
<400> 1076
Leu Val His His His His His His His His His Tyr His Leu
1 5 10
<210> 1077
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1033
<400> 1077
Leu Val Thr Leu Leu Leu Asp Thr Leu Pro Met
1 5 10
<210> 1078
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1034
<400> 1078
Met Asp Ala His Ser Phe Tyr Asn Phe Ile Tyr Phe Ile Leu
1 5 10
<210> 1079
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1035
<400> 1079
Met Phe Val Gly Val Val Val Glu Asn Phe His Lys Cys Arg
1 5 10
<210> 1080
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1036
<400> 1080
Met Arg Ile Leu Val Thr Leu Leu Leu Asp Thr Leu Pro Met
1 5 10
<210> 1081
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1037
<400> 1081
Asn Tyr Ile Phe Thr Ala Val Phe Leu Ala Glu
1 5 10
<210> 1082
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1038
<400> 1082
Pro Pro Glu Thr Arg Ser Ser Leu Glu Leu Asp
1 5 10
<210> 1083
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1039
<400> 1083
Pro Gln Ile Pro Leu Ala Glu Met Glu Ala Leu
1 5 10
<210> 1084
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1040
<400> 1084
Pro Ser Gly Glu Arg Arg Ser Leu Leu Ser Gly Glu Gly Gln
1 5 10
<210> 1085
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1041
<400> 1085
Pro Ser Leu Gly Gly Ser Asp Pro Gln Ile Pro Leu Ala Glu
1 5 10
<210> 1086
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1042
<400> 1086
Gln Glu Asp Trp Asn Lys Val Leu Tyr Asn Gly
1 5 10
<210> 1087
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1043
<400> 1087
Gln Ser Gly Ser Val Leu Ser Val His Ser Gln Pro Ala Asp
1 5 10
<210> 1088
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1044
<400> 1088
Arg Ala Arg Leu Pro Ala Cys Cys Leu Glu Arg Asp Ser Trp
1 5 10
<210> 1089
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1045
<400> 1089
Arg Leu Glu Lys Lys Arg Arg Asn Leu Met Leu Asp Asp Val
1 5 10
<210> 1090
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1046
<400> 1090
Arg Leu Arg Arg Leu Glu Lys Lys Arg Arg Asn Leu Met Leu
1 5 10
<210> 1091
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1047
<400> 1091
Arg Leu Ser Val His His Leu Val His His His His His His
1 5 10
<210> 1092
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1048
<400> 1092
Arg Gln His Gln Glu Glu Glu Glu Ala Arg Arg Arg Glu Glu
1 5 10
<210> 1093
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1049
<400> 1093
Ser Leu Glu Trp Glu Leu Lys Leu Met Asp Glu
1 5 10
<210> 1094
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1050
<400> 1094
Ser Pro Glu Ile Gln Asp Arg Asp Ala Asn Gly Ser Arg Arg
1 5 10
<210> 1095
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1051
<400> 1095
Ser Arg Phe Arg Leu Leu Val His His Leu Cys
1 5 10
<210> 1096
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1052
<400> 1096
Ser Val Leu Ser Val His Ser Gln Pro Ala Asp
1 5 10
<210> 1097
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1053
<400> 1097
Val Gly Ser Gly Lys Val Tyr Pro Thr Val His
1 5 10
<210> 1098
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1054
<400> 1098
Val Ile Asp Ile Leu Val Ser Met Val Ser Asp Ser Gly Thr
1 5 10
<210> 1099
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1055
<400> 1099
Val Leu Tyr Asn Gly Met Ala Ser Thr Ser Ser
1 5 10
<210> 1100
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1056
<400> 1100
Trp Ser Ala Tyr Ile Phe Pro Pro Gln Ser Arg
1 5 10
<210> 1101
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1057
<400> 1101
Tyr Glu Ala Tyr Asn Ser Ser Ser Asn Thr Thr
1 5 10
<210> 1102
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1058
<400> 1102
Ala Leu Gly Val Glu Leu Phe Gly Asp Leu Glu Cys Asp Glu
1 5 10
<210> 1103
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1059
<400> 1103
Ala Ser Gly Arg Leu Ala Arg Ala Leu Arg Pro Asp Asp Pro
1 5 10
<210> 1104
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1060
<400> 1104
Asp Tyr Glu Ala Tyr Asn Ser Ser Ser Asn Thr Thr Cys Val
1 5 10
<210> 1105
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1061
<400> 1105
Phe Phe Val Cys Gln Gly Glu Asp Thr Arg Asn Ile Thr Asn
1 5 10
<210> 1106
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1062
<400> 1106
Phe Gly Asp Leu Glu Cys Asp Glu Thr His Pro Cys Glu Gly
1 5 10
<210> 1107
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1063
<400> 1107
Phe Ile Leu Leu Ile Ile Val Gly Ser Phe Phe Met Ile Asn
1 5 10
<210> 1108
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1064
<400> 1108
Gly Asn Val Leu Leu Leu Cys Phe Phe Val Phe Phe Ile Phe
1 5 10
<210> 1109
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1065
<400> 1109
Lys Arg Leu Arg Arg Leu Glu Lys Lys Arg Arg Asn Leu Met
1 5 10
<210> 1110
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1066
<400> 1110
Leu Arg Ala Ile Asn Arg Val Pro Ser Met Arg Ile Leu Val
1 5 10
<210> 1111
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1067
<400> 1111
Asn Ile Gly Tyr Ala Trp Ile Ala Ile Phe Gln Val Ile Thr
1 5 10
<210> 1112
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1068
<400> 1112
Pro Ala Pro Cys Pro Gly Pro Glu Pro Asn Trp Gly Lys Gly
1 5 10
<210> 1113
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1069
<400> 1113
Arg Arg Arg Glu Glu Lys Arg Leu Arg Arg Leu Glu Lys Lys
1 5 10
<210> 1114
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1070
<400> 1114
Ser Glu Thr Lys Gln Arg Glu Ser Gln Leu Met Arg Glu Gln
1 5 10
<210> 1115
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1071
<400> 1115
Ala Ala Ala Gly Asp Glu Glu Arg Lys Val Gly Leu Ala Pro
1 5 10
<210> 1116
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1072
<400> 1116
Asp Ala Ile Glu Glu Ser Pro Ser Lys Glu Pro Lys Pro Val
1 5 10
<210> 1117
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1073
<400> 1117
Asp Arg Gly Tyr Gly Asn Asp Phe Pro Ile Glu Asp Met Ile
1 5 10
<210> 1118
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1074
<400> 1118
Asp Thr Asp Pro Phe Thr Pro Ser Gly Ser Met Pro Leu Ser
1 5 10
<210> 1119
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1075
<400> 1119
Glu Leu Glu Arg Ser Pro Ser Gly Phe Ser Ile Ser Gln Asp
1 5 10
<210> 1120
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1076
<400> 1120
Gly Asp Glu Glu Arg Lys Val Gly Leu Ala Pro Gly Asp Val
1 5 10
<210> 1121
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1077
<400> 1121
Gly Gly Gly Ala Ala Asn Pro Ala Gly Gly Asp Ala Ala Ala
1 5 10
<210> 1122
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1078
<400> 1122
Ser Ile Thr Arg Asp Ser Asp Thr Pro Leu Ser Leu Met Ser
1 5 10
<210> 1123
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1079
<400> 1123
Thr Ile Ile Cys Asn Tyr Ser Glu Thr Gly Pro Pro Glu Pro
1 5 10
<210> 1124
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1080
<400> 1124
Asp Gln Ser Met Met Gly Lys Phe Val Lys Val Glu Arg Gln
1 5 10
<210> 1125
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1081
<400> 1125
Glu Glu Leu Glu Arg Ser Pro Ser Gly Phe Ser Ile Ser Gln
1 5 10
<210> 1126
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1082
<400> 1126
Glu Val Asp Ala Gln Gly Glu Glu Met Lys Glu Glu Phe Glu
1 5 10
<210> 1127
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1083
<400> 1127
His Ala Leu Val Phe Leu Ile Val Leu Gly Cys Leu Ile Leu
1 5 10
<210> 1128
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1084
<400> 1128
Met Met Gly Lys Phe Val Lys Val Glu Arg Gln Val Gln Asp
1 5 10
<210> 1129
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1085
<400> 1129
Arg Tyr Lys Gly Trp Arg Gly Arg Leu Lys Phe Ala Arg Lys
1 5 10
<210> 1130
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1086
<400> 1130
Val Arg Ile Leu Gln Phe Arg Leu Tyr Lys Lys Lys Phe Lys
1 5 10
<210> 1131
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1087
<400> 1131
Asp Leu His Ser Thr Trp Gln Tyr Tyr Glu Arg Thr Val Thr
1 5 10
<210> 1132
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1088
<400> 1132
Gly Glu Asp Ile Val Asp Asp Lys Ser Cys Pro Cys Glu Phe
1 5 10
<210> 1133
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1089
<400> 1133
Ala Arg Leu Pro Pro Tyr Arg Tyr Arg Phe Arg Arg Arg Ser
1 5 10
<210> 1134
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1090
<400> 1134
Lys Glu Ser Leu His Asn Asn Pro Ala Asn Arg
1 5 10
<210> 1135
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1091
<400> 1135
Thr Phe Ala Arg Leu Pro Pro Tyr Arg Tyr Arg
1 5 10
<210> 1136
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1092
<400> 1136
Phe Pro Glu Asp Ala Asp Tyr Glu Gln Asp Thr Ala Glu Tyr
1 5 10
<210> 1137
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1093
<400> 1137
Ile Asp His Phe Pro Glu Asp Ala Asp Tyr Glu Gln Asp Thr
1 5 10
<210> 1138
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1094
<400> 1138
Tyr Arg Tyr Arg Phe Arg Arg Arg Ser Ser Ser Arg Ser Thr
1 5 10
<210> 1139
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1095
<400> 1139
Ala Glu Asp Thr Pro Phe Asp Phe Glu Leu Tyr Leu Val Gly
1 5 10
<210> 1140
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1096
<400> 1140
Ala Gln Val Gln Pro Lys Arg Ala Leu Leu Pro Ala Pro Val
1 5 10
<210> 1141
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1097
<400> 1141
Asp Leu Leu Glu Arg Leu Ala Glu Asp Thr Pro Phe Asp Phe
1 5 10
<210> 1142
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1098
<400> 1142
Glu Pro Ser Gly Pro Glu Val Glu Gln Gln Gln Gln Gln Gln
1 5 10
<210> 1143
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1099
<400> 1143
Glu Arg Leu Ala Glu Asp Thr Pro Phe Asp Phe Glu Leu Tyr
1 5 10
<210> 1144
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1100
<400> 1144
Phe Glu Glu Leu Ser Gly Ile His Asp Pro Lys Leu His His
1 5 10
<210> 1145
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1101
<400> 1145
Gly Glu His Ala Phe Phe Arg Leu Ala Leu Pro Arg Ile Arg
1 5 10
<210> 1146
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1102
<400> 1146
Gly Pro Glu Val Glu Gln Gln Gln Gln Gln Gln Asp Gln Pro
1 5 10
<210> 1147
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1103
<400> 1147
Lys Met Val Pro Cys Gly Lys Arg Val Phe Ala Val Thr Glu
1 5 10
<210> 1148
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1104
<400> 1148
Leu Val Arg Arg Gly Gln Leu Leu Ala Gln Leu Gly Asp Ser
1 5 10
<210> 1149
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1105
<400> 1149
Asn Ala Phe Ile Met Asp Lys Ser Leu Leu Asp Tyr Glu Val
1 5 10
<210> 1150
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1106
<400> 1150
Gln Pro Lys Arg Ala Leu Leu Pro Ala Pro Val Asn Cys Gly
1 5 10
<210> 1151
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1107
<400> 1151
Ser Tyr Thr Ala Asn Leu Ala Ala Val Met Val Gly Asp Lys
1 5 10
<210> 1152
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1108
<400> 1152
Thr Pro Phe Asp Phe Glu Leu Tyr Leu Val Gly Asp Gly Lys
1 5 10
<210> 1153
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1109
<400> 1153
Glu Gly Pro Val Trp Leu Cys Ser Tyr Gly Arg Pro Pro Ala
1 5 10
<210> 1154
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1110
<400> 1154
Glu Gly Ser Lys Glu Glu Thr Ala Glu Ala Glu Pro Ser Gly
1 5 10
<210> 1155
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1111
<400> 1155
Glu His Pro Phe Val Phe Ala Arg Asp Pro Asp Glu Asp Gly
1 5 10
<210> 1156
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1112
<400> 1156
Glu Pro Pro Glu Gly Ser Lys Glu Glu Thr Ala Glu Ala Glu
1 5 10
<210> 1157
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1113
<400> 1157
Leu Cys Gln Ala Leu Val Pro Pro Gly Val Ala Ala Leu Leu
1 5 10
<210> 1158
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1114
<400> 1158
Leu Arg Lys Cys Cys Tyr Gly Tyr Cys Ile Asp Leu Leu Glu
1 5 10
<210> 1159
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1115
<400> 1159
Gln Gln Gln Gln Gln Gln Asp Gln Pro Thr Ala Pro Glu Gly
1 5 10
<210> 1160
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1116
<400> 1160
Thr Ala Gly Leu Pro Pro Gly Leu Leu Ala Leu Gly Glu Val
1 5 10
<210> 1161
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1117
<400> 1161
Glu Asn Ile Leu Asn Glu Leu Asn Asp Pro Leu Arg Glu Glu
1 5 10
<210> 1162
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1118
<400> 1162
Glu Ser Ser Ser Val Leu Asn Thr Asp Pro Asp Ala Glu Lys
1 5 10
<210> 1163
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1119
<400> 1163
Gly Gly Gly Glu Glu Pro Ala Gly Gly Phe Glu Asp Ala Glu
1 5 10
<210> 1164
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1120
<400> 1164
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Glu Glu
1 5 10
<210> 1165
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1121
<400> 1165
Ile His Pro Tyr Ser Asp Phe Arg Phe Tyr Trp Asp Leu Ile
1 5 10
<210> 1166
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1122
<400> 1166
Lys Val Asp Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly
1 5 10
<210> 1167
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1123
<400> 1167
Leu Ile Met Met Val Gly Asn Leu Val Ile Ile Pro Val Gly
1 5 10
<210> 1168
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1124
<400> 1168
Leu Asn Asp Pro Leu Arg Glu Glu Ile Val Asn Phe Asn Cys
1 5 10
<210> 1169
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1125
<400> 1169
Leu Tyr Ser Leu Ser Val Asp Asn Phe Asn Glu Val Leu Glu
1 5 10
<210> 1170
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1126
<400> 1170
Arg Thr Gly Thr Val Asn Glu Asp Ser Ser Glu Ile Ile Leu
1 5 10
<210> 1171
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1127
<400> 1171
Arg Tyr Gln Gly Lys Ile Phe Asp Glu Glu Asn Ile Leu Asn
1 5 10
<210> 1172
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1128
<400> 1172
Ser Leu Ser His Ser Asn Leu His Ser Pro Ser Pro Ser Thr
1 5 10
<210> 1173
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1129
<400> 1173
Ser Gln Pro Pro Gln Thr Gln Pro Gln Gln Pro Ser Pro Gln
1 5 10
<210> 1174
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1130
<400> 1174
Ser Val Leu Asn Thr Asp Pro Asp Ala Glu Lys Pro Arg Phe
1 5 10
<210> 1175
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1131
<400> 1175
Thr Ala Gly Phe Trp Ile Ile His Pro Tyr Ser Asp Phe Arg
1 5 10
<210> 1176
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1132
<400> 1176
Thr Ala Thr Ser Leu Ser His Ser Asn Leu His Ser Pro Ser
1 5 10
<210> 1177
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1133
<400> 1177
Tyr Pro Met Met Arg Arg Ala Phe Glu Thr Val Ala Ile Asp
1 5 10
<210> 1178
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1134
<400> 1178
Asp Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Glu
1 5 10
<210> 1179
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1135
<400> 1179
Glu Gly Gly Gly Lys Pro Asn Ser Ser Ser Asn Ser Arg Asp
1 5 10
<210> 1180
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1136
<400> 1180
Phe Lys Val Asp Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly
1 5 10
<210> 1181
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1137
<400> 1181
Phe Arg Thr Gly Thr Val Asn Glu Asp Ser Ser Glu Ile Ile
1 5 10
<210> 1182
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1138
<400> 1182
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Glu Glu Pro Ala
1 5 10
<210> 1183
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1139
<400> 1183
Ile Phe Asp Glu Glu Asn Ile Leu Asn Glu Leu Asn Asp Pro
1 5 10
<210> 1184
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1140
<400> 1184
Gln Gly Lys Ile Phe Asp Glu Glu Asn Ile Leu Asn Glu Leu
1 5 10
<210> 1185
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1141
<400> 1185
Gln Ser Gln Pro Pro Gln Thr Gln Pro Gln Gln Pro Ser Pro
1 5 10
<210> 1186
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1142
<400> 1186
Ser Val Cys Phe Lys Val Asp Gly Gly Gly Gly Gly Gly Gly
1 5 10
<210> 1187
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1143
<400> 1187
Ala Asp Met Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1188
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1144
<400> 1188
Ala Leu Gly Val Tyr Ile Pro Phe Pro Glu Asp
1 5 10
<210> 1189
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1145
<400> 1189
Ala Leu Thr Cys Asp Thr Glu Glu Glu Glu Glu
1 5 10
<210> 1190
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1146
<400> 1190
Ala Ser Leu Pro Ala Ser Asp Thr Gly Ser Met
1 5 10
<210> 1191
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1147
<400> 1191
Cys Lys Arg Leu Val Ala Met Asn Met Pro Leu
1 5 10
<210> 1192
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1148
<400> 1192
Cys Val Ala Leu Gly Val Tyr Ile Pro Phe Pro Glu Asp Asp
1 5 10
<210> 1193
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1149
<400> 1193
Asp Glu Asp Glu Glu Glu Gly Ala Leu Ala Ser
1 5 10
<210> 1194
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1150
<400> 1194
Asp Glu Phe Lys Arg Ile Trp Ser Glu Tyr Asp
1 5 10
<210> 1195
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1151
<400> 1195
Asp Glu Val Ile Pro Pro Pro Asp Glu Glu Glu Val Thr Val
1 5 10
<210> 1196
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1152
<400> 1196
Asp Thr Glu Glu Glu Glu Glu Glu Gly Gln Glu
1 5 10
<210> 1197
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1153
<400> 1197
Asp Trp Ile Thr Gln Ala Glu Glu Leu Asp Met Glu Asp Pro
1 5 10
<210> 1198
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1154
<400> 1198
Asp Tyr Ala Phe Thr Ser Ile Phe Thr Val Glu
1 5 10
<210> 1199
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1155
<400> 1199
Glu Asp Glu Glu Val Pro Asp Arg Leu Ser Tyr
1 5 10
<210> 1200
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1156
<400> 1200
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly Ala
1 5 10
<210> 1201
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1157
<400> 1201
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly
1 5 10
<210> 1202
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1158
<400> 1202
Glu Glu Glu Glu Glu Glu Glu Glu Gly Ala Gly
1 5 10
<210> 1203
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1159
<400> 1203
Glu Glu Glu Glu Gly Gln Glu Gly Val Glu Glu
1 5 10
<210> 1204
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1160
<400> 1204
Glu Glu Glu Glu Gly Gln Glu Gly Val Glu Glu Glu Asp Glu
1 5 10
<210> 1205
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1161
<400> 1205
Glu Glu Gly Gln Glu Gly Val Glu Glu Glu Asp
1 5 10
<210> 1206
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1162
<400> 1206
Glu Glu Val Pro Asp Arg Leu Ser Tyr Leu Asp
1 5 10
<210> 1207
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1163
<400> 1207
Glu Gly Ala Asp Met Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1208
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1164
<400> 1208
Glu Leu Asp Lys Asn Gln Arg Gln Cys Val Glu Tyr Ala Leu
1 5 10
<210> 1209
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1165
<400> 1209
Glu Pro Ser Pro Ala Asn Gly Ala Gly Pro Gly Pro Glu Trp
1 5 10
<210> 1210
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1166
<400> 1210
Glu Gln Val Glu Tyr Val Phe Leu Val Ile Phe
1 5 10
<210> 1211
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1167
<400> 1211
Glu Ser Ile Leu Ser Arg Phe Asp Glu Glu Asp
1 5 10
<210> 1212
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1168
<400> 1212
Glu Thr Gln Gly Asp Glu Asp Glu Glu Glu Gly
1 5 10
<210> 1213
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1169
<400> 1213
Glu Val Ile Pro Pro Pro Asp Glu Glu Glu Val
1 5 10
<210> 1214
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1170
<400> 1214
Phe Ala Cys Ile Gly Val Gln Leu Phe Lys Gly Lys Phe Tyr
1 5 10
<210> 1215
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1171
<400> 1215
Phe Asp Asn Phe Phe Phe Ala Met Leu Thr Val Phe Gln Cys
1 5 10
<210> 1216
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1172
<400> 1216
Phe Asp Tyr Ala Phe Thr Ser Ile Phe Thr Val Glu Ile Leu
1 5 10
<210> 1217
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1173
<400> 1217
Gly Ile Leu Glu Thr Thr Leu Val Glu Val Gly
1 5 10
<210> 1218
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1174
<400> 1218
Gly Ser Ile Val Asp Ile Ala Val Thr Glu Val Asn Asn Gly
1 5 10
<210> 1219
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1175
<400> 1219
Gly Val Tyr Ile Pro Phe Pro Glu Asp Asp Ser
1 5 10
<210> 1220
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1176
<400> 1220
Gly Tyr Leu Asp Trp Ile Thr Gln Ala Glu Glu Leu Asp Met
1 5 10
<210> 1221
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1177
<400> 1221
Ile Met Lys Thr Arg Val Cys Arg Arg Leu Arg
1 5 10
<210> 1222
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1178
<400> 1222
Ile Pro Pro Pro Asp Glu Glu Glu Val Thr Val
1 5 10
<210> 1223
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1179
<400> 1223
Ile Thr Gln Ala Glu Glu Leu Asp Met Glu Asp
1 5 10
<210> 1224
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1180
<400> 1224
Lys Ile Lys Thr Glu Gly Asn Leu Glu Gln Ala
1 5 10
<210> 1225
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1181
<400> 1225
Lys Leu Leu Asp Glu Val Ile Pro Pro Pro Asp Glu Glu Glu
1 5 10
<210> 1226
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1182
<400> 1226
Lys Gln Glu Ile Ala Asp Ala Cys Arg Leu Thr
1 5 10
<210> 1227
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1183
<400> 1227
Lys Gln Gln Met Glu Glu Asp Leu Arg Gly Tyr Leu Asp Trp
1 5 10
<210> 1228
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1184
<400> 1228
Lys Arg Leu Val Ala Met Asn Met Pro Leu Asn
1 5 10
<210> 1229
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1185
<400> 1229
Leu Gly Ser Asp Met Glu Ala Glu Glu Asp Pro
1 5 10
<210> 1230
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1186
<400> 1230
Leu Ile Ser Phe Gly Ile His Ser Ser Ala Ile Ser Val Val
1 5 10
<210> 1231
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1187
<400> 1231
Leu Leu Val Leu Phe Val Ile Ile Ile Tyr Ala Ile Ile Gly
1 5 10
<210> 1232
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1188
<400> 1232
Leu Arg Ile Val Ile Lys Lys Ile Trp Lys Arg
1 5 10
<210> 1233
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1189
<400> 1233
Met Ala Leu Phe Thr Val Ser Thr Phe Glu Gly
1 5 10
<210> 1234
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1190
<400> 1234
Met Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1235
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1191
<400> 1235
Met Leu Cys Ala Phe Leu Ile Ile Asn Leu Phe Val Ala Val
1 5 10
<210> 1236
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1192
<400> 1236
Met Ser Glu Ser Glu Gly Gly Lys Asp Thr Thr Pro Glu Pro
1 5 10
<210> 1237
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1193
<400> 1237
Met Thr Glu Thr Gln Gly Asp Glu Asp Glu Glu
1 5 10
<210> 1238
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1194
<400> 1238
Asn Ala Thr Leu Phe Ala Leu Val Arg Thr Ser
1 5 10
<210> 1239
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1195
<400> 1239
Asn Leu Glu Gln Val Glu Tyr Val Phe Leu Val
1 5 10
<210> 1240
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1196
<400> 1240
Pro Phe Pro Glu Asp Asp Ser Asn Thr Ala Asn
1 5 10
<210> 1241
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1197
<400> 1241
Gln Ala Glu Glu Leu Asp Met Glu Asp Pro Ser
1 5 10
<210> 1242
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1198
<400> 1242
Gln Asp Ala Met Gly Tyr Glu Leu Pro Trp Val
1 5 10
<210> 1243
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1199
<400> 1243
Gln Gly Thr Ser Ser Leu Tyr Ser Asp Glu Glu
1 5 10
<210> 1244
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1200
<400> 1244
Gln Tyr Arg Val Trp Ala Thr Val Asn Ser Ala
1 5 10
<210> 1245
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1201
<400> 1245
Arg Leu Thr Leu Asp Glu Met Asp Asn Ala Ala Ser Asp Leu
1 5 10
<210> 1246
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1202
<400> 1246
Arg Asn Asn Asn Phe Gln Thr Phe Pro Gln Ala Val Leu Leu
1 5 10
<210> 1247
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1203
<400> 1247
Arg Arg Glu Gly Ala Asp Met Glu Glu Glu Glu
1 5 10
<210> 1248
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1204
<400> 1248
Arg Arg Glu Gly Ala Asp Met Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1249
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1205
<400> 1249
Arg Val Cys Arg Arg Leu Arg Arg Ala Asn Arg
1 5 10
<210> 1250
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1206
<400> 1250
Ser His Ala Ser Leu Pro Ala Ser Asp Thr Gly Ser Met Thr
1 5 10
<210> 1251
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1207
<400> 1251
Ser Leu Pro Ala Ser Asp Thr Gly Ser Met Thr Glu Thr Gln
1 5 10
<210> 1252
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1208
<400> 1252
Ser Thr Ser Ser His Ala Ser Leu Pro Ala Ser Asp Thr Gly
1 5 10
<210> 1253
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1209
<400> 1253
Thr Phe Glu Gly Trp Pro Ala Leu Leu Tyr Lys Ala Ile Asp
1 5 10
<210> 1254
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1210
<400> 1254
Thr Gly Ser Met Thr Glu Thr Gln Gly Asp Glu Asp Glu Glu
1 5 10
<210> 1255
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1211
<400> 1255
Thr Asn Arg Arg Arg Gly Arg Leu Arg Trp Phe
1 5 10
<210> 1256
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1212
<400> 1256
Thr Gln Ala Glu Glu Leu Asp Met Glu Asp Pro Ser Ala Asp
1 5 10
<210> 1257
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1213
<400> 1257
Thr Ser Ser Leu Tyr Ser Asp Glu Glu Ser Ile Leu Ser Arg
1 5 10
<210> 1258
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1214
<400> 1258
Val Ala Ser Ala Gln Arg Ser Pro Arg Ala Leu
1 5 10
<210> 1259
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1215
<400> 1259
Val Glu Tyr Val Phe Leu Val Ile Phe Thr Val Glu Thr Val
1 5 10
<210> 1260
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1216
<400> 1260
Val Val Pro Lys Glu Lys Val Val Pro Ile Pro
1 5 10
<210> 1261
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1217
<400> 1261
Trp Ala Thr Pro Pro Gln Arg Gly Arg Leu Leu
1 5 10
<210> 1262
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1218
<400> 1262
Tyr Phe Leu Gly Ser Asp Met Glu Ala Glu Glu
1 5 10
<210> 1263
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1219
<400> 1263
Tyr Ile Pro Phe Pro Glu Asp Asp Ser Asn Thr
1 5 10
<210> 1264
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1220
<400> 1264
Tyr Leu Asp Trp Ile Thr Gln Ala Glu Glu Leu
1 5 10
<210> 1265
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1221
<400> 1265
Tyr Leu Gly Arg Ser Ser Gly Pro Leu Arg Thr
1 5 10
<210> 1266
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1222
<400> 1266
Tyr Val Phe Leu Val Ile Phe Thr Val Glu Thr
1 5 10
<210> 1267
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1223
<400> 1267
Ala Arg Arg Glu Gly Ala Asp Met Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1268
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1224
<400> 1268
Asp Met Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1269
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1225
<400> 1269
Asp Thr Glu Glu Glu Glu Glu Glu Gly Gln Glu Gly Val Glu
1 5 10
<210> 1270
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1226
<400> 1270
Glu Glu Glu Glu Glu Glu Glu
1 5
<210> 1271
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1227
<400> 1271
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly
1 5 10
<210> 1272
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1228
<400> 1272
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly Ala Gly Gly
1 5 10
<210> 1273
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1229
<400> 1273
Glu Glu Glu Glu Glu Glu Glu Gly Ala Gly Gly Val Glu Leu
1 5 10
<210> 1274
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1230
<400> 1274
Glu Glu Glu Glu Glu Gly Gln Glu Gly Val Glu Glu Glu Asp
1 5 10
<210> 1275
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1231
<400> 1275
Glu Glu Gly Gln Glu Gly Val Glu Glu Glu Asp Glu Lys Asp
1 5 10
<210> 1276
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1232
<400> 1276
Glu Gly Ala Asp Met Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1277
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1233
<400> 1277
Phe Asp Glu Glu Asp Leu Gly Asp Glu Met Ala Cys Val His
1 5 10
<210> 1278
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1234
<400> 1278
Phe Tyr Ala Thr Phe Leu Ile Gln Asp Tyr Phe Arg Lys Phe
1 5 10
<210> 1279
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1235
<400> 1279
Leu Asp Trp Ile Thr Gln Ala Glu Glu Leu Asp Met Glu Asp
1 5 10
<210> 1280
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1236
<400> 1280
Leu Thr Cys Asp Thr Glu Glu Glu Glu Glu Glu Gly Gln Glu
1 5 10
<210> 1281
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1237
<400> 1281
Asn Thr Phe Asp Ala Leu Ile Val Val Gly Ser Ile Val Asp
1 5 10
<210> 1282
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1238
<400> 1282
Gln Cys Leu Gln Arg Gln Gly Ser Cys Glu Asp Leu Pro Ile
1 5 10
<210> 1283
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1239
<400> 1283
Arg Ile Val Ile Lys Lys Ile Trp Lys Arg Met Lys Gln Lys
1 5 10
<210> 1284
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1240
<400> 1284
Arg Leu Arg Arg Ala Asn Arg Val Leu Arg Ala Arg Cys Arg
1 5 10
<210> 1285
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1241
<400> 1285
Arg Gln Ala Leu Thr Cys Asp Thr Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1286
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1242
<400> 1286
Ser Asp Glu Glu Ser Ile Leu Ser Arg Phe Asp Glu Glu Asp
1 5 10
<210> 1287
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1243
<400> 1287
Val Tyr Ile Pro Phe Pro Glu Asp Asp Ser Asn Thr Ala Asn
1 5 10
<210> 1288
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1244
<400> 1288
Cys Asp Gly Asp Asn Asp Cys Glu Asp Asp Ser Asp Glu Gln
1 5 10
<210> 1289
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1245
<400> 1289
Cys Asp Gly Asp Asn Asp Cys Gly Asp His Ser Asp Glu Asp
1 5 10
<210> 1290
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1246
<400> 1290
Asp Asp Asp Cys Gly Asp Trp Ser Asp Glu Ser Asp Cys Ser
1 5 10
<210> 1291
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1247
<400> 1291
Asp Asn Asp Cys Glu Asp Asp Ser Asp Glu Gln Asp Cys Pro
1 5 10
<210> 1292
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1248
<400> 1292
Asp Asn Asp Cys Gly Asp His Ser Asp Glu Asp Gly Cys Ile
1 5 10
<210> 1293
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1249
<400> 1293
Lys Lys Glu Gly Gly Pro Asp His Asn Tyr Thr Lys Glu Lys
1 5 10
<210> 1294
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1250
<400> 1294
Asn Leu Asp Gly Ser Glu Arg Lys Val Leu Ile Asn Thr Asp
1 5 10
<210> 1295
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1251
<400> 1295
Gly Pro Gly Thr Leu His Thr Ile Asp Asn Ala Thr Thr Asn
1 5 10
<210> 1296
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1252
<400> 1296
Lys Tyr Val Arg Val Ser Gln Asp Thr Pro Ser Ser Val Ile
1 5 10
<210> 1297
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1253
<400> 1297
Leu Glu Asn Gly Val Gln Leu Lys Glu Phe Val Thr Trp Asp
1 5 10
<210> 1298
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1254
<400> 1298
Leu Glu Pro Leu Ser Thr Ile Gln Tyr Asn Val Val Asp Gly
1 5 10
<210> 1299
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1255
<400> 1299
Leu Ser Thr Ile Gln Tyr Asn Val Val Asp Gly Leu Arg Asp
1 5 10
<210> 1300
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1256
<400> 1300
Val Cys Glu Glu Met Arg Gln Leu Phe Tyr Asp Pro Asp Glu
1 5 10
<210> 1301
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1257
<400> 1301
Ala Asp Glu Glu Gln Arg Val Pro Tyr Pro Ala Leu Ala Ala
1 5 10
<210> 1302
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1258
<400> 1302
Ala Asp Gly Gly Leu Ser Val Leu Arg Thr Phe
1 5 10
<210> 1303
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1259
<400> 1303
Ala Glu Leu Asp Ala Glu Ile Glu Leu Glu Met
1 5 10
<210> 1304
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1260
<400> 1304
Ala Gly Thr Pro Leu Gly Ser Val Ala Ser Val
1 5 10
<210> 1305
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1261
<400> 1305
Ala Ile Val Leu Leu Ser Leu Met Gly Ile Thr Leu Glu Glu
1 5 10
<210> 1306
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1262
<400> 1306
Ala Ile Val Pro Leu Glu Pro Pro Glu Ser Glu Pro Pro Met
1 5 10
<210> 1307
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1263
<400> 1307
Ala Pro His Pro Arg Pro Leu Gln Glu Val Glu
1 5 10
<210> 1308
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1264
<400> 1308
Ala Ser Ala Pro His Pro Arg Pro Leu Gln Glu
1 5 10
<210> 1309
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1265
<400> 1309
Ala Thr Gly Met Arg Ala Leu Leu Asp Thr Val
1 5 10
<210> 1310
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1266
<400> 1310
Ala Thr Gly Met Arg Ala Leu Leu Asp Thr Val Val Gln Ala
1 5 10
<210> 1311
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1267
<400> 1311
Cys Glu Gly Pro Asp Thr Arg Asn Ile Ser Thr Lys Ala Gln
1 5 10
<210> 1312
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1268
<400> 1312
Cys Gly Glu Arg Glu Ser Leu Leu Ser Gly Glu
1 5 10
<210> 1313
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1269
<400> 1313
Cys Thr Leu Leu Met Leu Phe Ile Phe Ile Phe Ser Ile Leu
1 5 10
<210> 1314
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1270
<400> 1314
Asp Ala Glu Leu Asp Ala Glu Ile Glu Leu Glu Met Ala Gln
1 5 10
<210> 1315
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1271
<400> 1315
Asp Glu Asp Lys Thr Ser Val His Phe Glu Glu Asp Phe His
1 5 10
<210> 1316
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1272
<400> 1316
Asp Lys Thr Ser Val His Phe Glu Glu Asp Phe
1 5 10
<210> 1317
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1273
<400> 1317
Asp Leu Phe Ile Thr Phe Ile Ile Cys Val Asn
1 5 10
<210> 1318
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1274
<400> 1318
Asp Leu Gly Val Pro Ser Gly Asp Pro Phe Leu
1 5 10
<210> 1319
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1275
<400> 1319
Asp Pro Ala Glu Pro Gly Glu Lys Thr Pro Val
1 5 10
<210> 1320
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1276
<400> 1320
Glu Ala Glu Ala Ser Asp Pro Ala Asp Glu Glu
1 5 10
<210> 1321
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1277
<400> 1321
Glu Asp Ala Ala Glu Leu Asp Asp Asp Ser Glu Asp Ser Cys
1 5 10
<210> 1322
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1278
<400> 1322
Glu Gly Ser Gly Ala Gly Gly Asp Pro Ala Ala
1 5 10
<210> 1323
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1279
<400> 1323
Glu Pro Pro Glu Ser Glu Pro Pro Met Pro Val
1 5 10
<210> 1324
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1280
<400> 1324
Glu Pro Thr Glu Gly Ser Gly Ala Gly Gly Asp Pro Ala Ala
1 5 10
<210> 1325
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1281
<400> 1325
Glu Arg Arg Arg Arg Ser Thr Phe Pro Ser Pro
1 5 10
<210> 1326
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1282
<400> 1326
Glu Arg Val Phe Leu Ser Val Ser Asn Tyr Ile Phe Thr Ala
1 5 10
<210> 1327
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1283
<400> 1327
Glu Val Glu Met Glu Thr Tyr Gly Ala Gly Thr
1 5 10
<210> 1328
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1284
<400> 1328
Phe Phe Leu Arg Ile Asp Ser His Arg Glu Asp Ala Ala Glu
1 5 10
<210> 1329
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1285
<400> 1329
Phe Gly Ile Leu Gly Val Gln Leu Phe Lys Gly Lys Phe Tyr
1 5 10
<210> 1330
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1286
<400> 1330
Phe Ile Phe Leu Asn Cys Val Thr Ile Ala Leu Glu Arg Pro
1 5 10
<210> 1331
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1287
<400> 1331
Phe Leu Arg Pro Tyr Tyr Gln Thr Glu Glu Gly Glu Glu Asn
1 5 10
<210> 1332
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1288
<400> 1332
Phe Val Thr Phe Val Leu Val Ala Gln Phe Val Leu Val Asn
1 5 10
<210> 1333
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1289
<400> 1333
Gly Ala Ile Val Pro Leu Glu Pro Pro Glu Ser
1 5 10
<210> 1334
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1290
<400> 1334
Gly Glu Glu Asn Pro Phe Ile Cys Ser Ser Arg
1 5 10
<210> 1335
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1291
<400> 1335
Gly Ile Met Met Ala Ile Leu Val Asn Thr Leu
1 5 10
<210> 1336
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1292
<400> 1336
Gly Ser Glu Leu Gly Val Ser Pro Ser Glu Ser Pro Ala Ala
1 5 10
<210> 1337
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1293
<400> 1337
His Ala Asp Cys His Ile Glu Gly Pro Gln Glu Arg Ala Arg
1 5 10
<210> 1338
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1294
<400> 1338
His Asn Gly Ala Ile Asn Phe Asp Asn Ile Gly Tyr Ala Trp
1 5 10
<210> 1339
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1295
<400> 1339
Ile Leu Gly Met His Leu Phe Gly Cys Lys Phe Ser Leu Lys
1 5 10
<210> 1340
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1296
<400> 1340
Lys Arg Leu Arg Arg Leu Glu Arg Arg Arg Arg
1 5 10
<210> 1341
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1297
<400> 1341
Lys Thr Ser Val His Phe Glu Glu Asp Phe His Lys Leu Arg
1 5 10
<210> 1342
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1298
<400> 1342
Leu Asp Pro Ala Glu Pro Gly Glu Lys Thr Pro Val Arg Pro
1 5 10
<210> 1343
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1299
<400> 1343
Leu Gly Val Gln Leu Phe Lys Gly Lys Phe Tyr Tyr Cys Glu
1 5 10
<210> 1344
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1300
<400> 1344
Leu Gln Ser Ser Trp Asn Leu Leu Asp Gly Leu Leu Val Leu
1 5 10
<210> 1345
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1301
<400> 1345
Leu Ser Pro Pro Leu Ile Met Cys Thr Ala Ala Thr Pro Met
1 5 10
<210> 1346
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1302
<400> 1346
Leu Ser Pro Arg Gly Thr Ala Arg Ser Pro Ser
1 5 10
<210> 1347
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1303
<400> 1347
Met Cys Thr Ala Ala Thr Pro Met Pro Thr Pro
1 5 10
<210> 1348
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1304
<400> 1348
Met Phe Ala Leu Glu Met Leu Leu Lys Leu Leu Ala Cys Gly
1 5 10
<210> 1349
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1305
<400> 1349
Met Gly Arg Leu Trp Val Thr Phe Ser Gly Lys Leu Arg Arg
1 5 10
<210> 1350
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1306
<400> 1350
Met His Leu Phe Gly Cys Lys Phe Ser Leu Lys Thr Asp Thr
1 5 10
<210> 1351
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1307
<400> 1351
Pro Ala Glu Ser Cys Ala Ser Leu Gln Ile Pro Leu Ala Val
1 5 10
<210> 1352
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1308
<400> 1352
Pro Ala Ser Ala Pro His Pro Arg Pro Leu Gln Glu Val Glu
1 5 10
<210> 1353
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1309
<400> 1353
Pro Glu Ala Glu Pro Ala Leu Gly Ala Arg Arg Lys Lys Lys
1 5 10
<210> 1354
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1310
<400> 1354
Pro Glu Pro Gly Ala Cys Asp Thr Arg Leu Val Arg Ala Gly
1 5 10
<210> 1355
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1311
<400> 1355
Pro Leu Glu Pro Pro Glu Ser Glu Pro Pro Met Pro Val Gly
1 5 10
<210> 1356
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1312
<400> 1356
Pro Leu Ile Met Cys Thr Ala Ala Thr Pro Met Pro Thr Pro
1 5 10
<210> 1357
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1313
<400> 1357
Pro Ser Pro Gly Arg Gly Pro Pro Asp Ala Glu
1 5 10
<210> 1358
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1314
<400> 1358
Gln Glu Ser Pro Gly Ala Arg Asp Ala Pro Asn Leu Val Ala
1 5 10
<210> 1359
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1315
<400> 1359
Gln Val Val Ala Leu Pro Ser Asp Phe Phe Leu
1 5 10
<210> 1360
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1316
<400> 1360
Arg Ala Ser Ser Ser Gly Ala Ile Val Pro Leu Glu Pro Pro
1 5 10
<210> 1361
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1317
<400> 1361
Ser Ala Val Gln Gly Gln Gly Pro Gly His Arg Gln Arg Arg
1 5 10
<210> 1362
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1318
<400> 1362
Ser Cys Ala Ser Leu Gln Ile Pro Leu Ala Val Ser Ser Pro
1 5 10
<210> 1363
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1319
<400> 1363
Ser His Arg Glu Asp Ala Ala Glu Leu Asp Asp Asp Ser Glu
1 5 10
<210> 1364
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1320
<400> 1364
Ser Leu Gln Ile Pro Leu Ala Val Ser Ser Pro Ala Arg Ser
1 5 10
<210> 1365
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1321
<400> 1365
Ser Asn Pro His Asn Gly Ala Ile Asn Phe Asp Asn Ile Gly
1 5 10
<210> 1366
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1322
<400> 1366
Ser Pro Pro Ser Pro Gly Arg Gly Pro Pro Asp
1 5 10
<210> 1367
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1323
<400> 1367
Thr Leu Gly Met Phe Arg Pro Cys Glu Asp Val
1 5 10
<210> 1368
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1324
<400> 1368
Thr Arg Asn Ile Ser Thr Lys Ala Gln Cys Arg
1 5 10
<210> 1369
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1325
<400> 1369
Val Ala Leu Met Thr Phe Gly Asn Tyr Val Leu
1 5 10
<210> 1370
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1326
<400> 1370
Tyr Thr Gln Pro Gln Ala Glu Gly Val Gly Ala Ala Arg Asn
1 5 10
<210> 1371
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1327
<400> 1371
Ala Ala Glu Leu Asp Asp Asp Ser Glu Asp Ser Cys Cys Leu
1 5 10
<210> 1372
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1328
<400> 1372
Ala Gly Arg His Thr Ala Ser Val His His Leu Val Tyr His
1 5 10
<210> 1373
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1329
<400> 1373
Ala Pro Gly Glu Pro Gly Trp Met Gly Arg Leu Trp Val Thr
1 5 10
<210> 1374
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1330
<400> 1374
Ala Tyr Thr Gln Pro Gln Ala Glu Gly Val Gly Ala Ala Arg
1 5 10
<210> 1375
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1331
<400> 1375
Cys Lys Phe Ser Leu Lys Thr Asp Thr Gly Asp Thr Val Pro
1 5 10
<210> 1376
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1332
<400> 1376
Cys Ser Ser Arg Arg Asp Asn Gly Met Gln Lys Cys Ser His
1 5 10
<210> 1377
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1333
<400> 1377
Gly Met His Leu Phe Gly Cys Lys Phe Ser Leu Lys Thr Asp
1 5 10
<210> 1378
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1334
<400> 1378
Gly Pro Glu Ala Glu Pro Ala Leu Gly Ala Arg Arg Lys Lys
1 5 10
<210> 1379
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1335
<400> 1379
Leu Asp Leu Gly Val Pro Ser Gly Asp Pro Phe Leu Asp Gly
1 5 10
<210> 1380
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1336
<400> 1380
Leu Leu Lys Met Ala Thr Gly Met Arg Ala Leu Leu Asp Thr
1 5 10
<210> 1381
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1337
<400> 1381
Pro Asp Ser Arg Arg Gly Ser Ser Ser Ser Gly Asp Pro Pro
1 5 10
<210> 1382
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1338
<400> 1382
Gln Arg Cys Val Ser Ser Arg Pro Ala Ala Pro Gly Gly Glu
1 5 10
<210> 1383
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1339
<400> 1383
Gln Ser Arg Trp Arg Lys Lys Val Asp Pro Ser Ala Val Gln
1 5 10
<210> 1384
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1340
<400> 1384
Ser Ala Thr Pro Ala Pro Gly Gly Gly Ala Asp Asp Pro Val
1 5 10
<210> 1385
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1341
<400> 1385
Thr Phe Gly Gln Arg Cys Val Ser Ser Arg Pro Ala Ala Pro
1 5 10
<210> 1386
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1342
<400> 1386
Thr Ile Leu Pro Ser Gly Val Gly Ser Gly Lys Gly Ser Thr
1 5 10
<210> 1387
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1343
<400> 1387
Val Pro Leu Glu Pro Pro Glu Ser Glu Pro Pro Met Pro Val
1 5 10
<210> 1388
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1344
<400> 1388
Trp Asn Arg Leu Asp Phe Phe Ile Val Val Ala Gly Met Met
1 5 10
<210> 1389
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1345
<400> 1389
Tyr His His His His His His His His His Tyr His Phe Ser
1 5 10
<210> 1390
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1346
<400> 1390
Phe Leu Glu Asn Ile Val Arg Arg Ser Asn Asp Thr Asn Phe
1 5 10
<210> 1391
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1347
<400> 1391
Pro Tyr Asp Val Ile Asn Ala Phe Glu Asn Val Asp Glu Val
1 5 10
<210> 1392
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1348
<400> 1392
Ala Tyr Phe Leu Cys Leu Leu Ser Ala Leu Leu Leu Thr Glu
1 5 10
<210> 1393
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1349
<400> 1393
Asp His Ile Leu Leu Gly Val Phe Met Leu Val
1 5 10
<210> 1394
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1350
<400> 1394
Asp Gln Glu Ser Asn Asn Ala Ala Ala Glu Trp
1 5 10
<210> 1395
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1351
<400> 1395
Glu Ile Ile Val Thr His Phe Pro Phe Asp Glu
1 5 10
<210> 1396
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1352
<400> 1396
Glu Thr Met Lys Ser Asp Gln Glu Ser Asn Asn Ala Ala Ala
1 5 10
<210> 1397
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1353
<400> 1397
Gly Leu Val Leu Gly Ser Glu His Glu Thr Arg
1 5 10
<210> 1398
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1354
<400> 1398
Gly Ser Val Val Ala Ile Asn Pro Glu Ser Asp Gln Pro Asp
1 5 10
<210> 1399
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1355
<400> 1399
Lys Ser Asp Gln Glu Ser Asn Asn Ala Ala Ala
1 5 10
<210> 1400
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1356
<400> 1400
Lys Val Leu Leu Gln Tyr Thr Gly His Ile Thr
1 5 10
<210> 1401
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1357
<400> 1401
Leu Val Leu Tyr Asn Asn Ala Asp Gly Asp Phe Ala Ile Val
1 5 10
<210> 1402
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1358
<400> 1402
Asn Val Ile Ile Pro Cys Leu Leu Phe Ser Phe
1 5 10
<210> 1403
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1359
<400> 1403
Gln Asp Lys Lys Ile Phe Thr Glu Asp Ile Asp
1 5 10
<210> 1404
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1360
<400> 1404
Gln Leu Ile Gln Leu Ile Asn Val Asp Glu Val
1 5 10
<210> 1405
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1361
<400> 1405
Arg Pro Val Glu Asp His Arg Gln Val Val Glu
1 5 10
<210> 1406
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1362
<400> 1406
Ser Ala Gly Leu Val Leu Gly Ser Glu His Glu
1 5 10
<210> 1407
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1363
<400> 1407
Ser Ile Ile Ile Thr Val Ile Val Ile Asn Thr His His Arg
1 5 10
<210> 1408
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1364
<400> 1408
Ser Tyr Cys Glu Ile Ile Val Thr His Phe Pro Phe Asp Glu
1 5 10
<210> 1409
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1365
<400> 1409
Val Phe Val Ile Ala Ser Ile Ile Ile Thr Val
1 5 10
<210> 1410
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1366
<400> 1410
Val Ile Asn Thr His His Arg Ser Pro Ser Thr
1 5 10
<210> 1411
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1367
<400> 1411
Val Asn Val Ile Ile Pro Cys Leu Leu Phe Ser Phe Leu Thr
1 5 10
<210> 1412
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1368
<400> 1412
Val Pro Leu Phe Ser His Leu Gln Asn Glu Gln
1 5 10
<210> 1413
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1369
<400> 1413
Tyr Asn Asn Ala Asp Gly Asp Phe Ala Ile Val Lys Phe Thr
1 5 10
<210> 1414
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1370
<400> 1414
Cys Cys Pro Asp Thr Pro Tyr Leu Asp Ile Thr Tyr His
1 5 10
<210> 1415
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1371
<400> 1415
Cys Pro Asp Thr Pro Tyr Leu Asp Ile Thr Tyr His Phe
1 5 10
<210> 1416
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1372
<400> 1416
Phe Leu Leu Val Ile Val Glu
1 5
<210> 1417
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1373
<400> 1417
Gly Leu Gln Leu Ile Gln Leu Ile Asn Val Asp Glu Val
1 5 10
<210> 1418
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1374
<400> 1418
Gly Ser Val Val Ala Ile Asn Pro Glu Ser Asp Gln Pro
1 5 10
<210> 1419
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1375
<400> 1419
His Ser Val Thr Tyr Ser Cys Cys Pro Asp Thr Pro Tyr
1 5 10
<210> 1420
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1376
<400> 1420
Ile Asn Val Asp Glu Val Asn Gln Ile Val Thr Thr Asn
1 5 10
<210> 1421
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1377
<400> 1421
Lys Arg Pro Ser Arg Glu Lys Gln Asp Lys Lys Ile Phe
1 5 10
<210> 1422
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1378
<400> 1422
Leu Gln Leu Ile Gln Leu Ile Asn Val Asp Glu Val Asn
1 5 10
<210> 1423
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1379
<400> 1423
Leu Ser Asn Phe Met Glu Ser Gly Glu Trp Val Ile Lys
1 5 10
<210> 1424
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1380
<400> 1424
Asn Val Asp Glu Val Asn Gln Ile Val Thr Thr Asn Val
1 5 10
<210> 1425
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1381
<400> 1425
Asn Val Ile Ile Pro Cys Leu Leu Phe Ser Phe Leu Thr
1 5 10
<210> 1426
<211> 10
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1382
<400> 1426
Pro Asp Thr Pro Tyr Leu Asp Ile Thr Tyr
1 5 10
<210> 1427
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1383
<400> 1427
Ser Cys Cys Pro Asp Thr Pro Tyr Leu Asp Ile Thr Tyr
1 5 10
<210> 1428
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1384
<400> 1428
Ser Val Val Ala Ile Asn Pro Glu Ser Asp Gln Pro Asp
1 5 10
<210> 1429
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1385
<400> 1429
Thr Tyr Ser Cys Cys Pro Asp Thr Pro Tyr Leu Asp Ile
1 5 10
<210> 1430
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1386
<400> 1430
Val Cys Ile Ile Gly Thr Leu Ala Val Phe Ala Gly Arg
1 5 10
<210> 1431
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1387
<400> 1431
Val Thr Tyr Ser Cys Cys Pro Asp Thr Pro Tyr Leu Asp
1 5 10
<210> 1432
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1388
<400> 1432
Tyr Ser Cys Cys Pro Asp Thr Pro Tyr Leu Asp Ile Thr
1 5 10
<210> 1433
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1389
<400> 1433
Ala Ala Ala Ala Pro Leu Leu Val Ala Val Ala Ala Leu Leu
1 5 10
<210> 1434
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1390
<400> 1434
Ala Pro Glu Ser Glu Glu Leu Glu Met Glu Phe Glu Asp Met
1 5 10
<210> 1435
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1391
<400> 1435
Cys Ser Ile Ser Val Thr Tyr Phe Pro Phe Asp
1 5 10
<210> 1436
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1392
<400> 1436
Asp Gly Gln Thr Ile Glu Trp Ile Phe Ile Asp
1 5 10
<210> 1437
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1393
<400> 1437
Asp Pro Asn Leu Arg Pro Ala Glu Arg Asp Ser
1 5 10
<210> 1438
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1394
<400> 1438
Glu Glu Arg Leu Leu Ala Asp Leu Met Gln Asn
1 5 10
<210> 1439
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1395
<400> 1439
Phe Asp Asn Gly Asn Glu Glu Trp Phe Leu Val
1 5 10
<210> 1440
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1396
<400> 1440
Ile Phe Gln Ser Gln Thr Tyr Ser Thr Asn Glu Ile Asp Leu
1 5 10
<210> 1441
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1397
<400> 1441
Lys Met Leu Leu Asp Pro Ala Ala Pro Ala Gln
1 5 10
<210> 1442
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1398
<400> 1442
Leu Ala Val Cys Leu Gly Ala Gln Gly Arg Asn Gln Glu Glu
1 5 10
<210> 1443
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1399
<400> 1443
Leu Gly Ala Gln Gly Arg Asn Gln Glu Glu Arg
1 5 10
<210> 1444
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1400
<400> 1444
Leu Leu Asp Pro Ala Ala Pro Ala Gln Glu Ala
1 5 10
<210> 1445
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1401
<400> 1445
Leu Ser Gln Glu Asp Gly Gln Thr Ile Glu Trp
1 5 10
<210> 1446
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1402
<400> 1446
Leu Thr Asn Leu Ile Ser Leu Asn Glu Arg Glu Glu Ala Leu
1 5 10
<210> 1447
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1403
<400> 1447
Asn Gln Glu Glu Arg Leu Leu Ala Asp Leu Met
1 5 10
<210> 1448
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1404
<400> 1448
Asn Arg Val Pro Ala Leu Pro Phe Pro Gly Asp
1 5 10
<210> 1449
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1405
<400> 1449
Asn Tyr Asp Pro Asn Leu Arg Pro Ala Glu Arg
1 5 10
<210> 1450
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1406
<400> 1450
Pro Ala Lys Met Leu Leu Asp Pro Ala Ala Pro
1 5 10
<210> 1451
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1407
<400> 1451
Pro Asp Ile Val Leu Glu Asn Asn Val Asp Gly
1 5 10
<210> 1452
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1408
<400> 1452
Pro Asp Ile Val Leu Glu Asn Asn Val Asp Gly Val Phe Glu
1 5 10
<210> 1453
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1409
<400> 1453
Gln Thr Ile Glu Trp Ile Phe Ile Asp Pro Glu
1 5 10
<210> 1454
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1410
<400> 1454
Arg His Gln Gln Ser His Phe Asp Asn Gly Asn Glu Glu Trp
1 5 10
<210> 1455
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1411
<400> 1455
Ser His Phe Asp Asn Gly Asn Glu Glu Trp Phe
1 5 10
<210> 1456
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1412
<400> 1456
Ser Lys Tyr Leu Thr Phe Leu Leu Val Val Thr
1 5 10
<210> 1457
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1413
<400> 1457
Ser Gln Thr Tyr Ser Thr Asn Glu Ile Asp Leu
1 5 10
<210> 1458
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1414
<400> 1458
Val Asp Gly Val Phe Glu Val Ala Leu Tyr Cys
1 5 10
<210> 1459
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1415
<400> 1459
Val Pro Ala Leu Pro Phe Pro Gly Asp Pro Arg
1 5 10
<210> 1460
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1416
<400> 1460
Val Trp Arg Pro Asp Ile Val Leu Glu Asn Asn Val Asp Gly
1 5 10
<210> 1461
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1417
<400> 1461
Ala Ala Leu Glu Lys Leu Glu
1 5
<210> 1462
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1418
<400> 1462
Asp Ile Val Leu Glu Asn Asn Val Asp Gly Val Phe Glu
1 5 10
<210> 1463
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1419
<400> 1463
Glu Thr Ser Gln Ala Val Pro
1 5
<210> 1464
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1420
<400> 1464
Phe Gln Ser Gln Thr Tyr Ser Thr Asn Glu Ile Asp Leu
1 5 10
<210> 1465
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1421
<400> 1465
His Phe Asp Asn Gly Asn Glu Glu Trp Phe Leu Val Gly
1 5 10
<210> 1466
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1422
<400> 1466
His Tyr Asn Arg Val Pro Ala Leu Pro Phe Pro Gly Asp
1 5 10
<210> 1467
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1423
<400> 1467
Leu Leu Leu Ala Val Cys Leu Gly Ala Gln Gly Arg Asn
1 5 10
<210> 1468
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1424
<400> 1468
Leu Gln Leu Ser Gln Glu Asp Gly Gln Thr Ile Glu Trp
1 5 10
<210> 1469
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1425
<400> 1469
Leu Ser Leu Phe Ile Cys Gly
1 5
<210> 1470
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1426
<400> 1470
Leu Val Ala Lys Lys Val Pro Glu Thr Ser Gln Ala Val
1 5 10
<210> 1471
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1427
<400> 1471
Gln Trp Gln Arg Gln Gly Leu Val Ala Ala Ala Leu Glu
1 5 10
<210> 1472
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1428
<400> 1472
Arg Gln Gly Leu Val Ala Ala Ala Leu Glu Lys Leu Glu
1 5 10
<210> 1473
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1429
<400> 1473
Ser Thr Asn Glu Ile Asp Leu
1 5
<210> 1474
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1430
<400> 1474
Thr Ile Glu Trp Ile Phe Ile Asp Pro Glu Ala Phe Thr
1 5 10
<210> 1475
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1431
<400> 1475
Val Leu Glu Asn Asn Val Asp Gly Val Phe Glu Val Ala
1 5 10
<210> 1476
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1432
<400> 1476
Val Val Asn Ala Val Val Val
1 5
<210> 1477
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1433
<400> 1477
Trp Gln Arg Gln Gly Leu Val Ala Ala Ala Leu Glu Lys
1 5 10
<210> 1478
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1434
<400> 1478
Ala Pro Asp His Asp Val Thr Gln Glu Arg Asp Glu Val Trp
1 5 10
<210> 1479
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1435
<400> 1479
Cys Tyr Ala Asn Glu Thr Cys Cys Asp Phe Phe
1 5 10
<210> 1480
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1436
<400> 1480
Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp Ser Leu Leu
1 5 10
<210> 1481
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1437
<400> 1481
Phe Ala Ile Thr Ser Pro Phe Lys Tyr Gln Ser Leu Leu Thr
1 5 10
<210> 1482
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1438
<400> 1482
Asn Phe Trp Cys Glu Phe Trp Thr Ser Ile Asp Val Leu Cys
1 5 10
<210> 1483
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1439
<400> 1483
Asn Gly Tyr Ser Ser Asn Gly Asn Thr Gly Glu Gln Ser Gly
1 5 10
<210> 1484
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1440
<400> 1484
Gln Glu Lys Glu Asn Lys Leu Leu Cys Glu Asp Leu Pro Gly
1 5 10
<210> 1485
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1441
<400> 1485
Gln Gly Arg Asn Cys Ser Thr Asn Asp Ser Leu
1 5 10
<210> 1486
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1442
<400> 1486
Cys Leu Lys Glu His Lys Ala Leu Lys Thr Leu Gly Ile
1 5 10
<210> 1487
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1443
<400> 1487
Asp Asn Ile Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn
1 5 10
<210> 1488
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1444
<400> 1488
Asp Ser Gln Gly Arg Asn Cys Ser Thr Asn Asp Ser Leu
1 5 10
<210> 1489
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1445
<400> 1489
Phe Cys Leu Lys Glu His Lys Ala Leu Lys Thr Leu Gly
1 5 10
<210> 1490
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1446
<400> 1490
Gly Arg Asn Cys Ser Thr Asn
1 5
<210> 1491
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1447
<400> 1491
Ile Ala Ser Ser Ile Val Ser
1 5
<210> 1492
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1448
<400> 1492
Asn Cys Ser Thr Asn Asp Ser
1 5
<210> 1493
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1449
<400> 1493
Arg Asn Cys Ser Thr Asn Asp
1 5
<210> 1494
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1450
<400> 1494
Ser Leu Leu Thr Lys Asn Lys Ala Arg Val Ile Ile Leu
1 5 10
<210> 1495
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1451
<400> 1495
Thr Val Pro Ser Asp Asn Ile
1 5
<210> 1496
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1452
<400> 1496
Val Leu Ala Ile Val Phe Gly
1 5
<210> 1497
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1453
<400> 1497
Tyr Gln Ser Leu Leu Thr Lys
1 5
<210> 1498
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1454
<400> 1498
Ala Ile Ala Ala Phe Tyr Leu Pro Val Ile Ile Met Thr Val
1 5 10
<210> 1499
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1455
<400> 1499
Ala Pro Arg Asp Pro Val Thr Glu Asn Cys Val
1 5 10
<210> 1500
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1456
<400> 1500
Cys Ala Pro Cys Ile Pro Asn Thr Val Trp Thr
1 5 10
<210> 1501
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1457
<400> 1501
Asp Ser Cys Thr Pro Thr Asn Thr Thr Val Glu
1 5 10
<210> 1502
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1458
<400> 1502
Gly Arg Ile Val Lys Pro Asn Asn Asn Asn Met Pro Ser Ser
1 5 10
<210> 1503
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1459
<400> 1503
Ile Asn Thr Phe Cys Ala Pro Cys Ile Pro Asn Thr Val Trp
1 5 10
<210> 1504
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1460
<400> 1504
Ile Ser Phe Asp Arg Tyr Phe Cys Val Thr Lys Pro Leu Thr
1 5 10
<210> 1505
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1461
<400> 1505
Ile Val Lys Pro Asn Asn Asn Asn Met Pro Ser Ser Asp Asp
1 5 10
<210> 1506
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1462
<400> 1506
Lys Gln Asn Ile Val Ala Arg Lys Ile Val Lys Met Thr Lys
1 5 10
<210> 1507
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1463
<400> 1507
Lys Val Asn Arg His Leu Gln Thr Val Asn Asn
1 5 10
<210> 1508
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1464
<400> 1508
Leu Phe Trp Gln Phe Ile Val Gly Val Arg Thr Val Glu Asp
1 5 10
<210> 1509
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1465
<400> 1509
Leu Ile Ile Ser Phe Asp Arg Tyr Phe Cys Val
1 5 10
<210> 1510
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1466
<400> 1510
Leu Val Gln Gly Arg Ile Val Lys Pro Asn Asn Asn Asn Met
1 5 10
<210> 1511
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1467
<400> 1511
Met Asn Asn Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala Leu
1 5 10
<210> 1512
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1468
<400> 1512
Met Val Ser Ile Lys Val Asn Arg His Leu Gln Thr Val Asn
1 5 10
<210> 1513
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1469
<400> 1513
Asn Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala
1 5 10
<210> 1514
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1470
<400> 1514
Pro Ala Ile Leu Phe Trp Gln Phe Ile Val Gly
1 5 10
<210> 1515
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1471
<400> 1515
Pro Cys Ile Pro Asn Thr Val Trp Thr Ile Gly
1 5 10
<210> 1516
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1472
<400> 1516
Pro Val Thr Glu Asn Cys Val Gln Gly Glu Glu
1 5 10
<210> 1517
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1473
<400> 1517
Gln Phe Ile Val Gly Val Arg Thr Val Glu Asp
1 5 10
<210> 1518
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1474
<400> 1518
Gln Gly Arg Ile Val Lys Pro Asn Asn Asn Asn Met Pro Ser
1 5 10
<210> 1519
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1475
<400> 1519
Gln Asn Ile Val Ala Arg Lys Ile Val Lys Met Thr Lys Gln
1 5 10
<210> 1520
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1476
<400> 1520
Ser Arg Ile Lys Lys Asp Lys Lys Glu Pro Val
1 5 10
<210> 1521
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1477
<400> 1521
Ser Val Met Asn Leu Leu Ile Ile Ser Phe Asp
1 5 10
<210> 1522
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1478
<400> 1522
Thr Glu Asn Cys Val Gln Gly Glu Glu Lys Glu
1 5 10
<210> 1523
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1479
<400> 1523
Thr Glu Asn Cys Val Gln Gly Glu Glu Lys Glu Ser Ser Asn
1 5 10
<210> 1524
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1480
<400> 1524
Thr Phe Cys Ala Pro Cys Ile Pro Asn Thr Val Trp Thr Ile
1 5 10
<210> 1525
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1481
<400> 1525
Thr Pro Lys Ser Asp Ser Cys Thr Pro Thr Asn Thr Thr Val
1 5 10
<210> 1526
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1482
<400> 1526
Thr Val Glu Val Val Gly Ser Ser Gly Gln Asn Gly Asp Glu
1 5 10
<210> 1527
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1483
<400> 1527
Val Cys Asp Leu Trp Leu Ala Leu Asp Tyr Val
1 5 10
<210> 1528
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1484
<400> 1528
Val Leu Val Ala Gly Ser Leu Ser Leu Val Thr Ile Ile Gly
1 5 10
<210> 1529
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1485
<400> 1529
Val Ser Ile Lys Val Asn Arg His Leu Gln Thr Val Asn Asn
1 5 10
<210> 1530
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1486
<400> 1530
Trp Pro Leu Gly Pro Val Val Cys Asp Leu Trp
1 5 10
<210> 1531
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1487
<400> 1531
Ile Val Lys Met Thr Lys Gln Pro Ala Lys Lys Lys Pro
1 5 10
<210> 1532
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1488
<400> 1532
Lys Ile Val Lys Met Thr Lys Gln Pro Ala Lys Lys Lys
1 5 10
<210> 1533
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1489
<400> 1533
Leu Phe Trp Gln Phe Ile Val Gly Val Arg Thr Val Glu
1 5 10
<210> 1534
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1490
<400> 1534
Asn Asn Asn Asn Met Pro Ser Ser Asp Asp Gly Leu Glu
1 5 10
<210> 1535
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1491
<400> 1535
Asn Asn Ser Thr Asn Ser Ser
1 5
<210> 1536
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1492
<400> 1536
Asn Ser Thr Asn Ser Ser Asn
1 5
<210> 1537
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1493
<400> 1537
Asn Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala Leu Thr
1 5 10
<210> 1538
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1494
<400> 1538
Arg Lys Ile Val Lys Met Thr Lys Gln Pro Ala Lys Lys
1 5 10
<210> 1539
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1495
<400> 1539
Ser Arg Ala Ser Lys Ser Arg Ile Lys Lys Asp Lys Lys
1 5 10
<210> 1540
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1496
<400> 1540
Ser Thr Asn Ser Ser Asn Asn Ser Leu Ala Leu Thr Ser
1 5 10
<210> 1541
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1497
<400> 1541
Thr Asn Ser Ser Asn Asn Ser
1 5
<210> 1542
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1498
<400> 1542
Val Lys Pro Asn Asn Asn Asn Met Pro Ser Ser Asp Asp
1 5 10
<210> 1543
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1499
<400> 1543
Trp Thr Ile Gly Tyr Trp Leu
1 5
<210> 1544
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1500
<400> 1544
Tyr Ile Asn Ser Thr Ile Asn
1 5
<210> 1545
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1501
<400> 1545
Ala Phe Tyr Leu Pro Val Val Ile Met Thr Val
1 5 10
<210> 1546
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1502
<400> 1546
Ala Lys Thr Leu Ala Phe Leu Lys Ser Pro Leu
1 5 10
<210> 1547
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1503
<400> 1547
Glu Ala Thr Thr Pro Ala Met Pro Ala Pro Pro
1 5 10
<210> 1548
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1504
<400> 1548
Glu Met Val Phe Ile Ala Thr Val Thr Gly Ser
1 5 10
<210> 1549
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1505
<400> 1549
Glu Thr Val Glu Met Val Phe Ile Ala Thr Val Thr Gly Ser
1 5 10
<210> 1550
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1506
<400> 1550
Leu Ser Ile Lys Val Asn Arg Gln Leu Gln Thr Val Asn Asn
1 5 10
<210> 1551
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1507
<400> 1551
Leu Ser Thr Thr Glu Ala Thr Thr Pro Ala Met Pro Ala Pro
1 5 10
<210> 1552
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1508
<400> 1552
Asn Arg Tyr Glu Thr Val Glu Met Val Phe Ile Ala Thr Val
1 5 10
<210> 1553
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1509
<400> 1553
Thr Val Glu Met Val Phe Ile Ala Thr Val Thr
1 5 10
<210> 1554
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1510
<400> 1554
Val Asn Arg Gln Leu Gln Thr Val Asn Asn Tyr
1 5 10
<210> 1555
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1511
<400> 1555
Trp Thr Pro Tyr Asn Val Met Val Leu Val Asn
1 5 10
<210> 1556
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1512
<400> 1556
Ala Lys Thr Leu Ala Phe Leu
1 5
<210> 1557
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1513
<400> 1557
Asp Lys Asp Thr Ser Asn Glu
1 5
<210> 1558
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1514
<400> 1558
Lys Asp Thr Ser Asn Glu Ser
1 5
<210> 1559
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1515
<400> 1559
Leu Tyr Thr Val Tyr Ile Ile Lys Gly Tyr Trp Pro Leu
1 5 10
<210> 1560
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1516
<400> 1560
Arg Asn Gln Val Arg Lys Lys Arg Gln Met Ala Ala Arg
1 5 10
<210> 1561
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1517
<400> 1561
Arg Tyr Glu Thr Val Glu Met Val Phe Ile Ala Thr Val
1 5 10
<210> 1562
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1518
<400> 1562
Ser Ala Thr Gln Asn Thr Lys
1 5
<210> 1563
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1519
<400> 1563
Tyr Glu Thr Val Glu Met Val Phe Ile Ala Thr Val Thr
1 5 10
<210> 1564
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1520
<400> 1564
Glu Tyr Gly Ser Phe Phe Cys Glu Leu Trp Thr Ser Val Asp
1 5 10
<210> 1565
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1521
<400> 1565
Leu Ala Ile Thr Ser Pro Phe Arg Tyr Gln Ser Leu Leu Thr
1 5 10
<210> 1566
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1522
<400> 1566
Leu Val Ala Leu Arg Glu Gln Lys Ala Leu Lys
1 5 10
<210> 1567
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1523
<400> 1567
Pro Gly Ala Ala Ser Asp Asp Asp Asp Asp Asp
1 5 10
<210> 1568
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1524
<400> 1568
Pro Pro Ser Pro Ser Pro Ser Pro Val Pro Ala
1 5 10
<210> 1569
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1525
<400> 1569
Arg Ala Arg Ala Arg Gly Leu Val Cys Thr Val
1 5 10
<210> 1570
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1526
<400> 1570
Ser Phe Phe Cys Glu Leu Trp Thr Ser Val Asp
1 5 10
<210> 1571
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1527
<400> 1571
Val Trp Ala Ile Ser Ala Leu Val Ser Phe Leu
1 5 10
<210> 1572
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1528
<400> 1572
Trp Glu Tyr Gly Ser Phe Phe Cys Glu Leu Trp
1 5 10
<210> 1573
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1529
<400> 1573
Ala Arg Leu Leu Glu Pro Trp
1 5
<210> 1574
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1530
<400> 1574
Ala Arg Leu Leu Val Pro Ala
1 5
<210> 1575
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1531
<400> 1575
Asp Val Val Gly Ala Thr Pro Pro Ala Arg Leu Leu Glu
1 5 10
<210> 1576
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1532
<400> 1576
Leu Pro Pro Ala Ser Glu Ser
1 5
<210> 1577
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1533
<400> 1577
Pro Pro Ala Arg Leu Leu Glu
1 5
<210> 1578
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1534
<400> 1578
Gln Gln Trp Thr Ala Gly Met Gly Leu Leu Met Ala Leu
1 5 10
<210> 1579
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1535
<400> 1579
Arg Leu Leu Cys Cys Ala Arg Arg Ala Ala Arg Arg Arg
1 5 10
<210> 1580
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1536
<400> 1580
Ser Phe Phe Cys Glu Leu Trp Thr Ser Val Asp Val Leu
1 5 10
<210> 1581
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1537
<400> 1581
Arg Ala Ala Arg Phe Arg Ile Arg Lys Thr Val Lys Lys Val
1 5 10
<210> 1582
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1538
<400> 1582
Ala Gln Arg Glu Arg Asn Gln Ala Ser Trp Ser
1 5 10
<210> 1583
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1539
<400> 1583
Cys Leu Arg Cys Pro Arg Pro Thr Leu Ala Gln Arg Glu Arg
1 5 10
<210> 1584
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1540
<400> 1584
Cys Trp Gln Tyr Leu Val Gly Lys Arg Thr Val
1 5 10
<210> 1585
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1541
<400> 1585
Asp Ser Tyr His Asn Ala Thr Thr Val Asn Gly
1 5 10
<210> 1586
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1542
<400> 1586
Glu Asp Glu Asp Lys Pro Ala Thr Asp Pro Val
1 5 10
<210> 1587
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1543
<400> 1587
Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe Val
1 5 10
<210> 1588
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1544
<400> 1588
Gly Lys Arg Thr Val Pro Leu Asp Glu Cys Gln
1 5 10
<210> 1589
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1545
<400> 1589
Gly Thr Pro Val Asn His Gln Pro Leu Glu Arg
1 5 10
<210> 1590
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1546
<400> 1590
Lys Pro Ala Thr Asp Pro Val Leu Gln Val Val
1 5 10
<210> 1591
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1547
<400> 1591
Lys Arg Thr Lys Asp Leu Ala Asp Leu Gln Gly Ser Asp Ser
1 5 10
<210> 1592
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1548
<400> 1592
Leu Gly Tyr Trp Leu Cys Tyr Val Asn Ser Thr Val Asn Pro
1 5 10
<210> 1593
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1549
<400> 1593
Asn Leu Leu Val Ile Ser Phe Asp Arg Tyr Phe
1 5 10
<210> 1594
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1550
<400> 1594
Pro Ile Cys Tyr Ala Leu Cys Asn Arg Thr Phe
1 5 10
<210> 1595
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1551
<400> 1595
Gln Gly Lys Glu Ser Pro Gly Glu Glu Phe Ser Ala Glu Glu
1 5 10
<210> 1596
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1552
<400> 1596
Gln Tyr Leu Val Gly Lys Arg Thr Val Pro Leu Asp Glu Cys
1 5 10
<210> 1597
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1553
<400> 1597
Arg Lys Thr Phe Lys Met Leu Leu Leu Cys Arg Trp Lys Lys
1 5 10
<210> 1598
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1554
<400> 1598
Thr Glu Glu Thr Phe Val Lys Ala Glu Thr Glu
1 5 10
<210> 1599
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1555
<400> 1599
Thr Leu Ala Gln Arg Glu Arg Asn Gln Ala Ser
1 5 10
<210> 1600
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1556
<400> 1600
Thr Val Asn Gly Thr Pro Val Asn His Gln Pro Leu Glu Arg
1 5 10
<210> 1601
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1557
<400> 1601
Trp Ala Leu Gly Ser Leu Ala Cys Asp Leu Trp
1 5 10
<210> 1602
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1558
<400> 1602
Ala Glu Thr Glu Lys Ser Asp
1 5
<210> 1603
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1559
<400> 1603
Ala Leu Phe Arg Ser Cys Leu Arg Cys Pro Arg Pro Thr
1 5 10
<210> 1604
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1560
<400> 1604
Ala Ser Trp Ser Ser Ser Arg Arg Ser Thr Ser Thr Thr
1 5 10
<210> 1605
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1561
<400> 1605
Asp Pro Val Leu Gln Val Val
1 5
<210> 1606
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1562
<400> 1606
Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe Val
1 5 10
<210> 1607
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1563
<400> 1607
Glu Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe Val Lys
1 5 10
<210> 1608
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1564
<400> 1608
Phe Lys Met Leu Leu Leu Cys Arg Trp Lys Lys Lys Lys
1 5 10
<210> 1609
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1565
<400> 1609
Phe Arg Ser Cys Leu Arg Cys Pro Arg Pro Thr Leu Ala
1 5 10
<210> 1610
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1566
<400> 1610
Phe Ser Ala Glu Glu Thr Glu Glu Thr Phe Val Lys Ala
1 5 10
<210> 1611
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1567
<400> 1611
Gly Lys Arg Thr Val Pro Leu Asp Glu Cys Gln Ile Gln
1 5 10
<210> 1612
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1568
<400> 1612
Gly Tyr Trp Leu Cys Tyr Val Asn Ser Thr Val Asn Pro
1 5 10
<210> 1613
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1569
<400> 1613
Lys Met Leu Leu Leu Cys Arg Trp Lys Lys Lys Lys Val
1 5 10
<210> 1614
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1570
<400> 1614
Lys Pro Ala His Arg Ala Leu Phe Arg Ser Cys Leu Arg
1 5 10
<210> 1615
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1571
<400> 1615
Leu Tyr Thr Thr Tyr Ile Leu Met Gly Arg Trp Ala Leu
1 5 10
<210> 1616
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1572
<400> 1616
Ser Pro Gly Glu Glu Phe Ser Ala Glu Glu Thr Glu Glu
1 5 10
<210> 1617
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1573
<400> 1617
Ser Ser Tyr Pro Ser Ser Glu Asp Glu Asp Lys Pro Ala
1 5 10
<210> 1618
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1574
<400> 1618
Ser Tyr Pro Ser Ser Glu Asp Glu Asp Lys Pro Ala Thr
1 5 10
<210> 1619
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1575
<400> 1619
Thr Cys Ser Ser Tyr Pro Ser Ser Glu Asp Glu Asp Lys
1 5 10
<210> 1620
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1576
<400> 1620
Val Asn Ser Thr Val Asn Pro
1 5
<210> 1621
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1577
<400> 1621
Tyr Val Asn Ser Thr Val Asn
1 5
<210> 1622
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1578
<400> 1622
Tyr Trp Leu Cys Tyr Val Asn Ser Thr Val Asn Pro Ile
1 5 10
<210> 1623
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1579
<400> 1623
Ala Trp Cys Glu Ile Tyr Leu Ala Leu Asp Val
1 5 10
<210> 1624
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1580
<400> 1624
Asp Ser Leu Pro Arg Arg Gly Pro Gly Ala Thr
1 5 10
<210> 1625
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1581
<400> 1625
His Ala Glu Arg Pro Pro Gly Pro Arg Arg Pro Glu Arg Gly
1 5 10
<210> 1626
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1582
<400> 1626
Ile Ser Leu Asp Arg Tyr Trp Ser Ile Thr Gln Ala Ile Glu
1 5 10
<210> 1627
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1583
<400> 1627
Lys Phe Phe Phe Trp Phe Gly Tyr Cys Asn Ser Ser Leu Asn
1 5 10
<210> 1628
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1584
<400> 1628
Leu Ala Leu Asp Val Leu Phe Cys Thr Ser Ser Ile Val His
1 5 10
<210> 1629
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1585
<400> 1629
Pro Met Gly Ser Leu Gln Pro Asp Ala Gly Asn
1 5 10
<210> 1630
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1586
<400> 1630
Pro Pro Gly Gly Thr Glu Arg Arg Pro Asn Gly
1 5 10
<210> 1631
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1587
<400> 1631
Ser Ser Asp His Ala Glu Arg Pro Pro Gly Pro Arg Arg Pro
1 5 10
<210> 1632
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1588
<400> 1632
Ser Ser Ile Val His Leu Cys Ala Ile Ser Leu Asp Arg Tyr
1 5 10
<210> 1633
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1589
<400> 1633
Thr Glu Arg Arg Pro Asn Gly Leu Gly Pro Glu
1 5 10
<210> 1634
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1590
<400> 1634
Val His Leu Cys Ala Ile Ser Leu Asp Arg Tyr
1 5 10
<210> 1635
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1591
<400> 1635
Tyr Thr Ile Phe Asn His Asp Phe Arg Arg Ala
1 5 10
<210> 1636
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1592
<400> 1636
Ala Leu Asp Leu Glu Glu Ser
1 5
<210> 1637
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1593
<400> 1637
Ala Thr Leu Val Ile Pro Phe Ser Leu Ala Asn Glu Val
1 5 10
<210> 1638
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1594
<400> 1638
Asp Phe Arg Arg Ala Phe Lys
1 5
<210> 1639
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1595
<400> 1639
Phe Ser Leu Ala Asn Glu Val
1 5
<210> 1640
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1596
<400> 1640
Gly Ala Glu Ala Glu Pro Leu
1 5
<210> 1641
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1597
<400> 1641
Ala Tyr Ser Trp Lys Glu Glu Glu Glu Glu Asp
1 5 10
<210> 1642
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1598
<400> 1642
Cys Lys Asp Cys Val Pro Glu Thr Leu Trp Glu Leu Gly Tyr
1 5 10
<210> 1643
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1599
<400> 1643
Cys Val Pro Glu Thr Leu Trp Glu Leu Gly Tyr Trp Leu Cys
1 5 10
<210> 1644
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1600
<400> 1644
Gly Ser Glu Val Val Ile Lys Met Pro Met Val
1 5 10
<210> 1645
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1601
<400> 1645
Gly Tyr Trp Leu Cys Tyr Val Asn Ser Thr Ile Asn Pro Met
1 5 10
<210> 1646
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1602
<400> 1646
Lys Gln Pro Pro Arg Ser Ser Pro Asn Thr Val Lys Arg Pro
1 5 10
<210> 1647
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1603
<400> 1647
Leu Leu Gln Ala Tyr Ser Trp Lys Glu Glu Glu Glu Glu Asp
1 5 10
<210> 1648
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1604
<400> 1648
Leu Gln Ala Tyr Ser Trp Lys Glu Glu Glu Glu
1 5 10
<210> 1649
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1605
<400> 1649
Asn Leu Leu Val Leu Ile Ser Phe Lys Val Asn Thr Glu Leu
1 5 10
<210> 1650
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1606
<400> 1650
Ser Glu Gly Glu Glu Pro Gly Ser Glu Val Val
1 5 10
<210> 1651
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1607
<400> 1651
Ser Trp Lys Glu Glu Glu Glu Glu Asp Glu Gly
1 5 10
<210> 1652
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1608
<400> 1652
Glu Glu Glu Glu Glu Asp Glu
1 5
<210> 1653
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1609
<400> 1653
Glu Glu Glu Glu Glu Asp Glu Gly Ser Met Glu Ser Leu
1 5 10
<210> 1654
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1610
<400> 1654
Lys Glu Glu Glu Glu Glu Asp
1 5
<210> 1655
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1611
<400> 1655
Leu Leu Gln Ala Tyr Ser Trp
1 5
<210> 1656
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1612
<400> 1656
Gln Ala Tyr Ser Trp Lys Glu Glu Glu Glu Glu Asp Glu
1 5 10
<210> 1657
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1613
<400> 1657
Arg Pro Leu Ser Tyr Arg Ala Lys Arg Thr Pro Arg Arg
1 5 10
<210> 1658
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1614
<400> 1658
Ser Leu Thr Ser Ser Glu Gly
1 5
<210> 1659
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1615
<400> 1659
Trp Lys Glu Glu Glu Glu Glu
1 5
<210> 1660
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1616
<400> 1660
Gly Leu Gly Pro Asp Gly Gln Gly His Gln Glu
1 5 10
<210> 1661
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1617
<400> 1661
Leu Lys Arg Pro Lys Pro Glu Arg Asp Leu Met Pro Glu Pro
1 5 10
<210> 1662
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1618
<400> 1662
Tyr Leu Asp Leu Glu Trp Thr Asp Tyr Arg Leu Ser Trp Asp
1 5 10
<210> 1663
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1619
<400> 1663
Ala Val Ala Leu Leu Pro Glu Leu Arg Glu Val Val Ser
1 5 10
<210> 1664
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1620
<400> 1664
Cys Thr Met Val Phe Ser Ser
1 5
<210> 1665
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1621
<400> 1665
His Glu Gly Thr Phe Ile Glu
1 5
<210> 1666
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1622
<400> 1666
Leu Ala Pro Gly Val Arg Gly
1 5
<210> 1667
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1623
<400> 1667
Ser Tyr Ser Tyr Asp Ser Ser Glu Val Ser Leu Gln Thr
1 5 10
<210> 1668
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1624
<400> 1668
Thr Pro Gly Ala Leu Leu Met
1 5
<210> 1669
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1625
<400> 1669
Trp Thr Phe Ile Ile Phe Thr
1 5
<210> 1670
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1626
<400> 1670
Ala Thr Gly Cys Glu Leu Trp Thr Ser Val Asp
1 5 10
<210> 1671
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1627
<400> 1671
Gly Leu Ile Met Gly Thr Phe Thr Leu Cys Trp
1 5 10
<210> 1672
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1628
<400> 1672
Leu Pro Thr Leu Ala Pro Asn Thr Ala Asn Thr
1 5 10
<210> 1673
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1629
<400> 1673
Arg Ala Leu Gly Gly Pro Ser Leu Val Pro Gly
1 5 10
<210> 1674
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1630
<400> 1674
Ser Arg Ser Leu Ala Pro Ala Pro Val Gly Thr
1 5 10
<210> 1675
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1631
<400> 1675
Val Asp Arg Tyr Leu Ala Val Thr Asn Pro Leu
1 5 10
<210> 1676
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1632
<400> 1676
Val Gly Ala Asp Ala Glu Ala Gln Arg Cys His Ser Asn Pro
1 5 10
<210> 1677
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1633
<400> 1677
Arg Tyr Gly Ala Leu Val Thr
1 5
<210> 1678
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1634
<400> 1678
Ile Lys Ile Tyr Ile Val Leu Arg Arg Arg Arg Lys Arg Val
1 5 10
<210> 1679
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1635
<400> 1679
Leu Val Tyr Ile Lys Ile Tyr Ile Val Leu Arg Arg Arg Arg
1 5 10
<210> 1680
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1636
<400> 1680
His Gly Leu His Ser Thr Pro Asp Ser Pro Ala Lys Pro Glu
1 5 10
<210> 1681
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1637
<400> 1681
Ile Val Leu Arg Arg Arg Arg Lys Arg Val Asn Thr Lys Arg
1 5 10
<210> 1682
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1638
<400> 1682
Lys Ile Tyr Ile Val Leu Arg Arg Arg Arg Lys Arg Val Asn
1 5 10
<210> 1683
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1639
<400> 1683
Met Pro Asn Gly Lys Thr Arg Thr Ser Leu Lys Thr Met Ser
1 5 10
<210> 1684
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1640
<400> 1684
Arg Arg Arg Arg Lys Arg Val Asn Thr Lys Arg Ser Ser Arg
1 5 10
<210> 1685
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1641
<400> 1685
Val Tyr Ile Lys Ile Tyr Ile Val Leu Arg Arg Arg Arg Lys
1 5 10
<210> 1686
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1642
<400> 1686
Ala Val Cys Tyr Ala Phe Val Phe Ser Ala Leu Ile Glu Phe
1 5 10
<210> 1687
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1643
<400> 1687
Glu Cys Pro Met His Leu Glu Asp Phe Pro Met Asp Ala His
1 5 10
<210> 1688
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1644
<400> 1688
Lys Val Ala Tyr Ala Thr Ala Met Asp Trp Phe Ile Ala Val
1 5 10
<210> 1689
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1645
<400> 1689
Tyr Phe Val Ile Gln Thr Tyr Leu Pro Cys Ile Met Thr Val
1 5 10
<210> 1690
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1646
<400> 1690
Phe Thr Lys Arg Gly Tyr Ala Trp Asp Gly Lys Ser Val Val
1 5 10
<210> 1691
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1647
<400> 1691
Phe Asn Val Tyr Ile Glu Ser Asp Ala Trp Gln Glu Lys Asp
1 5 10
<210> 1692
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1648
<400> 1692
Ala Ile Leu Tyr Tyr Tyr Gln Ser Gly Gly Arg Leu Arg Arg
1 5 10
<210> 1693
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1649
<400> 1693
Asp Glu Asn Glu Asp Met His Gly Ser Gly Val Thr Phe His
1 5 10
<210> 1694
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1650
<400> 1694
Asp Tyr Met Glu Ile Gln Glu Gly Val Asn Asn Ser Asn Glu
1 5 10
<210> 1695
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1651
<400> 1695
Glu Asp Met His Gly Ser Gly Val Thr Phe His Thr Tyr Ser
1 5 10
<210> 1696
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1652
<400> 1696
Glu Gly Val Asn Asn Ser Asn Glu Asp Phe Arg Glu Glu Asn
1 5 10
<210> 1697
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1653
<400> 1697
Glu Ile Gln Glu Gly Val Asn Asn Ser Asn Glu Asp Phe Arg
1 5 10
<210> 1698
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1654
<400> 1698
Glu Met Phe Arg Glu Asp Glu Gly Tyr Ile Lys Glu Glu Glu
1 5 10
<210> 1699
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1655
<400> 1699
Phe Arg Ile Phe Lys Leu Ser Arg His Ser Lys Gly Leu Gln
1 5 10
<210> 1700
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1656
<400> 1700
Phe Tyr Glu Leu Gly Glu Glu Ala Met Glu Met Phe Arg Glu
1 5 10
<210> 1701
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1657
<400> 1701
Ile Ser Ile Val Ser Phe Cys Leu Glu Thr Leu Pro Ile Phe
1 5 10
<210> 1702
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1658
<400> 1702
Lys Leu Ser Arg His Ser Lys Gly Leu Gln Ile Leu Gly Gln
1 5 10
<210> 1703
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1659
<400> 1703
Pro Gln Asp Thr Tyr Asp Pro Glu Ala Asp His Glu Cys Cys
1 5 10
<210> 1704
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1660
<400> 1704
Met Glu Ile Gln Glu Gly Val Asn Asn Ser Asn Glu Asp Phe
1 5 10
<210> 1705
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1661
<400> 1705
Ser Asp Tyr Met Glu Ile Gln Glu Gly Val Asn Asn Ser Asn
1 5 10
<210> 1706
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1662
<400> 1706
Val Asn Asn Ser Asn Glu Asp Phe Arg Glu Glu Asn Leu Lys
1 5 10
<210> 1707
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1663
<400> 1707
Phe Leu His Leu Thr Arg Ala Asp Leu Ser Tyr Pro Ser His
1 5 10
<210> 1708
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1664
<400> 1708
Tyr Val Phe Phe Glu Glu Gln Glu Asp Glu Ile Ile Gly Phe
1 5 10
<210> 1709
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1665
<400> 1709
Glu Tyr Pro Glu Ser Ser Gly Pro Ala Arg Gly Ile Ala Ile
1 5 10
<210> 1710
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1666
<400> 1710
Gly Gly Ser Phe Phe Thr Asp Pro Phe Phe Leu Val Glu Thr
1 5 10
<210> 1711
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1667
<400> 1711
Gly Val Ser Arg Val Ser Pro Val Ser Arg Gly Ser Gln Glu
1 5 10
<210> 1712
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1668
<400> 1712
Leu Ala Ala Pro Gly Glu Val Arg Gly Pro Glu Gly Glu Gln
1 5 10
<210> 1713
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1669
<400> 1713
Leu Arg Ala Thr Asp Asn Gly Leu Gly Lys Pro Asp Phe Pro
1 5 10
<210> 1714
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1670
<400> 1714
Pro Val Ser Arg Gly Ser Gln Glu Glu Glu Glu Asp Glu Asp
1 5 10
<210> 1715
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1671
<400> 1715
Gln Glu Glu Glu Glu Asp Glu Asp Asp Ser Tyr Thr Phe His
1 5 10
<210> 1716
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1672
<400> 1716
Arg Glu Asp Glu Gly Cys Leu Pro Glu Gly Gly Glu Asp Glu
1 5 10
<210> 1717
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1673
<400> 1717
Arg Gly Ser Gln Glu Glu Glu Glu Asp Glu Asp Asp Ser Tyr
1 5 10
<210> 1718
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1674
<400> 1718
Ser Gln Pro Phe Gln Arg Gln Val Trp Leu Leu Phe Glu Tyr
1 5 10
<210> 1719
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1675
<400> 1719
Ser Thr Leu Gly Gly Ser Phe Phe Thr Asp Pro Phe Phe Leu
1 5 10
<210> 1720
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1676
<400> 1720
Glu Arg Leu Val Ile Asn Ile Ser Gly Leu Arg Phe Glu Thr
1 5 10
<210> 1721
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1677
<400> 1721
Arg Ser Glu Lys Ser Leu Thr Leu Ala Ala Pro Gly Glu Val
1 5 10
<210> 1722
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1678
<400> 1722
Ser Gln Glu Glu Glu Glu Asp Glu Asp Asp Ser Tyr Thr Phe
1 5 10
<210> 1723
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1679
<400> 1723
Tyr Phe Ala Glu Ala Asp Asp Asp Asp Ser Leu Phe Pro Ser
1 5 10
<210> 1724
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1680
<400> 1724
Ala Cys Lys Ile Glu Val Lys His Phe Pro Phe
1 5 10
<210> 1725
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1681
<400> 1725
Ala Gly Ala Phe Gly Ala Glu Pro Ala Pro Val
1 5 10
<210> 1726
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1682
<400> 1726
Cys Ala Arg Gln Arg Leu Arg Leu Arg Arg Arg
1 5 10
<210> 1727
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1683
<400> 1727
Cys Gly Glu Lys Met Thr Leu Cys Ile Ser Val
1 5 10
<210> 1728
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1684
<400> 1728
Glu Lys Met Thr Leu Cys Ile Ser Val Leu Leu
1 5 10
<210> 1729
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1685
<400> 1729
Gly Pro Val Ala Leu Leu Leu Gly Phe Gly Leu
1 5 10
<210> 1730
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1686
<400> 1730
Ile Ser Val His Glu Arg Glu Gln Ile Met Thr Thr Asn Val
1 5 10
<210> 1731
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1687
<400> 1731
Lys Val Arg Leu Pro Ser Lys His Ile Trp Leu Pro Asp Val
1 5 10
<210> 1732
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1688
<400> 1732
Met Thr Thr Asn Val Trp Leu Thr Gln Glu Trp Glu Asp Tyr
1 5 10
<210> 1733
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1689
<400> 1733
Pro Pro Ala Ile Tyr Lys Ser Ala Cys Lys Ile
1 5 10
<210> 1734
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1690
<400> 1734
Gln Arg Leu Arg Leu Arg Arg Arg Gln Arg Glu Arg Glu Gly
1 5 10
<210> 1735
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1691
<400> 1735
Arg Leu Arg Arg Arg Gln Arg Glu Arg Glu Gly
1 5 10
<210> 1736
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1692
<400> 1736
Arg Gln Arg Leu Arg Leu Arg Arg Arg Gln Arg
1 5 10
<210> 1737
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1693
<400> 1737
Arg Ser Trp Thr Tyr Asp Arg Thr Glu Ile Asp
1 5 10
<210> 1738
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1694
<400> 1738
Val Ala Ser Leu Asp Asp Phe Thr Pro Ser Gly Glu Trp Asp
1 5 10
<210> 1739
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1695
<400> 1739
Val His Glu Arg Glu Gln Ile Met Thr Thr Asn
1 5 10
<210> 1740
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1696
<400> 1740
Val Ser Leu Ala Gln Leu Ile Ser Val His Glu Arg Glu Gln
1 5 10
<210> 1741
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1697
<400> 1741
Trp Thr Tyr Asp Arg Thr Glu Ile Asp Leu Val Leu Lys Ser
1 5 10
<210> 1742
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1698
<400> 1742
Tyr Asp Arg Thr Glu Ile Asp Leu Val Leu Lys
1 5 10
<210> 1743
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1699
<400> 1743
Cys Ala Arg Gln Arg Leu Arg Leu Arg Arg Arg Gln Arg
1 5 10
<210> 1744
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1700
<400> 1744
Gly Ala Glu Pro Ala Pro Val
1 5
<210> 1745
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1701
<400> 1745
Gly Leu Ala Gly Ala Phe Gly Ala Glu Pro Ala Pro Val
1 5 10
<210> 1746
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1702
<400> 1746
His His Cys Ala Arg Gln Arg Leu Arg Leu Arg Arg Arg
1 5 10
<210> 1747
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1703
<400> 1747
Ile Ser Val His Glu Arg Glu Gln Ile Met Thr Thr Asn
1 5 10
<210> 1748
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1704
<400> 1748
Asn Ala Val Val Ser Tyr Asp
1 5
<210> 1749
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1705
<400> 1749
Arg His His Cys Ala Arg Gln Arg Leu Arg Leu Arg Arg
1 5 10
<210> 1750
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1706
<400> 1750
Ala Ala Ile Thr Phe Leu Ile Leu Phe Thr Ile
1 5 10
<210> 1751
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1707
<400> 1751
Ala Ser Pro Glu Asp Glu Ala Glu Glu Glu Glu
1 5 10
<210> 1752
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1708
<400> 1752
Cys Gly Ala Ser Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu
1 5 10
<210> 1753
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1709
<400> 1753
Glu Glu Glu Glu Glu Glu Cys Glu Pro Gln Ala Val Pro Val
1 5 10
<210> 1754
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1710
<400> 1754
Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro Gln
1 5 10
<210> 1755
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1711
<400> 1755
Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro
1 5 10
<210> 1756
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1712
<400> 1756
Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro Gln Ala
1 5 10
<210> 1757
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1713
<400> 1757
Gly Ala Ser Pro Glu Asp Glu Ala Glu Glu Glu
1 5 10
<210> 1758
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1714
<400> 1758
Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1759
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1715
<400> 1759
Ser Gly Gln Gly Gln Lys Glu Gly Val Cys Gly Ala Ser Pro
1 5 10
<210> 1760
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1716
<400> 1760
Ser Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu
1 5 10
<210> 1761
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1717
<400> 1761
Ser Thr Gly Glu Lys Glu Glu Gly Glu Thr Pro
1 5 10
<210> 1762
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1718
<400> 1762
Ala Glu Glu Glu Glu Glu Glu
1 5
<210> 1763
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1719
<400> 1763
Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1764
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1720
<400> 1764
Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1765
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1721
<400> 1765
Glu Ala Glu Glu Glu Glu Glu
1 5
<210> 1766
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1722
<400> 1766
Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1767
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1723
<400> 1767
Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1768
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1724
<400> 1768
Glu Glu Glu Glu Glu Cys Glu
1 5
<210> 1769
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1725
<400> 1769
Glu Glu Glu Glu Glu Glu Cys
1 5
<210> 1770
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1726
<400> 1770
Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro Gln Ala
1 5 10
<210> 1771
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1727
<400> 1771
Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro Gln
1 5 10
<210> 1772
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1728
<400> 1772
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu Pro
1 5 10
<210> 1773
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1729
<400> 1773
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys Glu
1 5 10
<210> 1774
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1730
<400> 1774
Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Cys
1 5 10
<210> 1775
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1731
<400> 1775
Gly Glu Lys Glu Glu Gly Glu
1 5
<210> 1776
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1732
<400> 1776
Gly Gln Lys Glu Gly Val Cys
1 5
<210> 1777
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1733
<400> 1777
Ile Ile Leu Thr Val Trp Leu Ile Ala Ala Val Ile Ser
1 5 10
<210> 1778
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1734
<400> 1778
Ile Tyr Thr Ile Phe Asn Gln
1 5
<210> 1779
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1735
<400> 1779
Asn Ser Gly Gln Gly Gln Lys Glu Gly Val Cys Gly Ala
1 5 10
<210> 1780
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1736
<400> 1780
Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1781
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1737
<400> 1781
Arg Ala Leu Pro Pro Ser Trp Ala Ala Leu Pro Asn Ser
1 5 10
<210> 1782
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1738
<400> 1782
Arg Ala Gln Leu Thr Arg Glu
1 5
<210> 1783
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1739
<400> 1783
Arg Gly Arg Pro Gln Cys Lys
1 5
<210> 1784
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1740
<400> 1784
Ser Pro Glu Asp Glu Ala Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1785
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1741
<400> 1785
Thr Gly Glu Lys Glu Glu Gly
1 5
<210> 1786
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1742
<400> 1786
Thr Ile Phe Asn Gln Asp Phe
1 5
<210> 1787
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1743
<400> 1787
Val Asn Gly His Ser Lys Ser Thr Gly Glu Lys Glu Glu
1 5 10
<210> 1788
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1744
<400> 1788
Trp Ala Ala Leu Pro Asn Ser Gly Gln Gly Gln Lys Glu
1 5 10
<210> 1789
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1745
<400> 1789
Glu Thr Leu Pro Lys Ile Pro Tyr Val Lys Ala Ile Asp Ile
1 5 10
<210> 1790
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1746
<400> 1790
Ile Asp Val Ala Ser Ile Asp Met Val Ser Glu Val Asn Met
1 5 10
<210> 1791
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1747
<400> 1791
Leu Arg Pro Asp Phe Gly Gly Pro Pro Val Asp Val Gly Met
1 5 10
<210> 1792
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1748
<400> 1792
Pro Leu Asp Glu Gln Asn Cys Thr Leu Glu Ile Glu Ser Tyr
1 5 10
<210> 1793
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1749
<400> 1793
Val Cys Cys Ala His Ser Thr Asn Glu Pro Ser Asn Met Ser
1 5 10
<210> 1794
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1750
<400> 1794
Ala Ala Arg Val Ala Leu Gly Ile Thr Thr Val Leu Thr Met
1 5 10
<210> 1795
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1751
<400> 1795
Gly Cys Phe Val Phe Val Phe Leu Ala Leu Leu Glu Tyr Ala
1 5 10
<210> 1796
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1752
<400> 1796
Tyr Asp Ile Arg Leu Arg Pro Asp Phe Gly Gly Pro Pro Val
1 5 10
<210> 1797
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1753
<400> 1797
Ala Thr His Leu Gln Glu Arg Asp Glu Glu Tyr Gly Tyr Glu
1 5 10
<210> 1798
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1754
<400> 1798
Asp Ala Glu Cys Gln Leu Gln Leu His Asn Phe Pro Met Asp
1 5 10
<210> 1799
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1755
<400> 1799
Asp Ala Val Pro Ala Arg Thr Ser Leu Gly Ile Thr Thr Val
1 5 10
<210> 1800
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1756
<400> 1800
Lys Lys Asn Pro Ala Pro Thr Ile Asp Ile Arg Pro Arg Ser
1 5 10
<210> 1801
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1757
<400> 1801
Lys Val Ser Tyr Val Thr Ala Met Asp Leu Phe Val Ser Val
1 5 10
<210> 1802
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1758
<400> 1802
Leu Asp Gly Lys Asp Cys Ala Ser Phe Phe Cys Cys Phe Glu
1 5 10
<210> 1803
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1759
<400> 1803
Leu Ile His Thr Asp Met Tyr Val Asn Ser Ile Gly Pro Val
1 5 10
<210> 1804
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1760
<400> 1804
Asn Phe Pro Met Asp Glu His Ser Cys Pro Leu Glu Phe Ser
1 5 10
<210> 1805
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1761
<400> 1805
Asn Thr Thr Glu Val Val Lys Thr Thr Ser Gly Asp Tyr Val
1 5 10
<210> 1806
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1762
<400> 1806
Ser Asn Arg Lys Pro Ser Lys Asp Lys Asp Lys Lys Lys Lys
1 5 10
<210> 1807
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1763
<400> 1807
Lys Pro Ser Lys Asp Lys Asp Lys Lys Lys Lys Asn Pro Ala
1 5 10
<210> 1808
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1764
<400> 1808
Val Leu Tyr Thr Leu Arg Leu Thr Ile Asp Ala Glu Cys Gln
1 5 10
<210> 1809
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1765
<400> 1809
Ala Ala Ala Gly Pro Asn Ala Ser Gly Ala Gly Glu Arg Gly
1 5 10
<210> 1810
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1766
<400> 1810
Ala Asp Val Glu Pro Asp Glu Ser Ser Ala Ala Ala Glu Arg
1 5 10
<210> 1811
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1767
<400> 1811
Ala Asn Ala Ser Gly Ala Ser Trp Gly Pro Pro Arg Gly Gln
1 5 10
<210> 1812
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1768
<400> 1812
Ala Pro Pro Pro Ala Asp Val Glu Pro Asp Glu
1 5 10
<210> 1813
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1769
<400> 1813
Gly Ala Ala Tyr Pro Gln Cys Gly Leu Asn Asp
1 5 10
<210> 1814
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1770
<400> 1814
His Cys Ala Pro Pro Pro Ala Asp Val Glu Pro Asp Glu Ser
1 5 10
<210> 1815
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1771
<400> 1815
Ile Ala Val Leu Thr Ser Arg Ala Leu Arg Ala
1 5 10
<210> 1816
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1772
<400> 1816
Ile Leu Phe Arg Arg Arg Arg Arg Gly Phe Arg
1 5 10
<210> 1817
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1773
<400> 1817
Ile Val Phe Thr Val Val Gly Asn Val Leu Val
1 5 10
<210> 1818
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1774
<400> 1818
Leu Ile Met Gly Leu Val Tyr Ala Arg Ile Tyr
1 5 10
<210> 1819
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1775
<400> 1819
Pro Ala Asp Val Glu Pro Asp Glu Ser Ser Ala
1 5 10
<210> 1820
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1776
<400> 1820
Pro Cys Leu Ile Met Gly Leu Val Tyr Ala Arg
1 5 10
<210> 1821
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1777
<400> 1821
Pro Asp Gly Ala Ala Tyr Pro Gln Cys Gly Leu Asn Asp Glu
1 5 10
<210> 1822
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1778
<400> 1822
Pro Phe Ser Leu Ala Asn Glu Leu Met Ala Tyr
1 5 10
<210> 1823
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1779
<400> 1823
Pro Pro Pro Ala Asp Val Glu Pro Asp Glu Ser
1 5 10
<210> 1824
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1780
<400> 1824
Pro Pro Pro Ala Asp Val Glu Pro Asp Glu Ser Ser Ala Ala
1 5 10
<210> 1825
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1781
<400> 1825
Arg Arg Gly Ala Leu Arg Arg Gly Gly Arg Arg
1 5 10
<210> 1826
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1782
<400> 1826
Ala Ala Ala Glu Arg Arg Arg Arg Arg Gly Ala Leu Arg
1 5 10
<210> 1827
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1783
<400> 1827
Ala Ala Glu Arg Arg Arg Arg Arg Gly Ala Leu Arg Arg
1 5 10
<210> 1828
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1784
<400> 1828
Ala Ala Gly Pro Asn Ala Ser
1 5
<210> 1829
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1785
<400> 1829
Ala Ala Val Val Gly Phe Leu
1 5
<210> 1830
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1786
<400> 1830
Ala Glu Arg Arg Arg Arg Arg
1 5
<210> 1831
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1787
<400> 1831
Ala Glu Arg Arg Arg Arg Arg Gly Ala Leu Arg Arg Gly
1 5 10
<210> 1832
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1788
<400> 1832
Ala Gly Glu Arg Gly Ser Gly
1 5
<210> 1833
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1789
<400> 1833
Phe Arg Arg Ser Phe Lys His Ile Leu Phe Arg Arg Arg
1 5 10
<210> 1834
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1790
<400> 1834
Gly Phe Leu Ile Val Phe Thr
1 5
<210> 1835
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1791
<400> 1835
Lys His Ile Leu Phe Arg Arg Arg Arg Arg Gly Phe Arg
1 5 10
<210> 1836
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1792
<400> 1836
Leu Phe Arg Arg Arg Arg Arg
1 5
<210> 1837
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1793
<400> 1837
Asn Ala Ser Gly Ala Gly Glu
1 5
<210> 1838
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1794
<400> 1838
Pro Phe Phe Phe Ser Tyr Ser Leu Tyr Gly Ile Cys Arg
1 5 10
<210> 1839
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1795
<400> 1839
Arg Arg Arg Gly Ala Leu Arg Arg Gly Gly Arg Arg Arg
1 5 10
<210> 1840
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1796
<400> 1840
Arg Arg Arg Arg Ala Arg Ser Ser Val Cys Arg Arg Lys
1 5 10
<210> 1841
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1797
<400> 1841
Arg Arg Arg Arg Gly Ala Leu Arg Arg Gly Gly Arg Arg
1 5 10
<210> 1842
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1798
<400> 1842
Arg Arg Arg Arg Arg Gly Ala Leu Arg Arg Gly Gly Arg
1 5 10
<210> 1843
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1799
<400> 1843
Ser Phe Lys His Ile Leu Phe Arg Arg Arg Arg Arg Gly
1 5 10
<210> 1844
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1800
<400> 1844
Ser Arg Ala Leu Arg Ala Pro
1 5
<210> 1845
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1801
<400> 1845
Ser Arg Arg Arg Arg Ala Arg Ser Ser Val Cys Arg Arg
1 5 10
<210> 1846
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1802
<400> 1846
Tyr Arg Val Ala Lys Leu Arg Thr Arg Thr Leu Ser Glu
1 5 10
<210> 1847
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1803
<400> 1847
Ala Ala Ser Leu Glu Asn Ser Ala Ser Ser Asp Glu Glu Asp
1 5 10
<210> 1848
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1804
<400> 1848
Cys Tyr Ile Asn Ser Thr Val Asn Pro Val Cys
1 5 10
<210> 1849
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1805
<400> 1849
Asp Asn Leu Gln Val Pro Glu Glu Glu Leu Gly
1 5 10
<210> 1850
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1806
<400> 1850
Phe Ser Lys Leu Pro Ile Gln Leu Glu Ser Ala Val Asp Thr
1 5 10
<210> 1851
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1807
<400> 1851
Leu Ala Cys Asp Leu Trp Leu Ala Ile Asp Tyr
1 5 10
<210> 1852
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1808
<400> 1852
Leu Glu Arg Lys Ala Asp Lys Leu Gln Ala Gln
1 5 10
<210> 1853
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1809
<400> 1853
Leu Gly Asn Leu Ala Cys Asp Leu Trp Leu Ala Ile Asp Tyr
1 5 10
<210> 1854
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1810
<400> 1854
Leu Pro Ile Gln Leu Glu Ser Ala Val Asp Thr
1 5 10
<210> 1855
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1811
<400> 1855
Leu Gln Val Pro Glu Glu Glu Leu Gly Met Val
1 5 10
<210> 1856
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1812
<400> 1856
Pro Leu Phe Pro Asn Ile Ser Ser Ser Trp Ile
1 5 10
<210> 1857
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1813
<400> 1857
Thr Ala Ile Ala Ala Phe Tyr Met Pro Val Thr
1 5 10
<210> 1858
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1814
<400> 1858
Thr Phe Gly Thr Ala Ile Ala Ala Phe Tyr Met Pro Val Thr
1 5 10
<210> 1859
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1815
<400> 1859
Thr Thr Lys Arg Ala Gly Val Met Ile Gly Leu Ala Trp Val
1 5 10
<210> 1860
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1816
<400> 1860
Val Asp Thr Ala Lys Thr Ser Asp Val Asn Ser
1 5 10
<210> 1861
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1817
<400> 1861
Trp Leu Cys Tyr Ile Asn Ser Thr Val Asn Pro
1 5 10
<210> 1862
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1818
<400> 1862
Glu Leu Ala Gly Leu Gln Ala
1 5
<210> 1863
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1819
<400> 1863
Ile Phe His Lys Arg Ala Pro
1 5
<210> 1864
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1820
<400> 1864
Ile Asn Ser Thr Val Asn Pro
1 5
<210> 1865
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1821
<400> 1865
Asn Ser Thr Val Asn Pro Val
1 5
<210> 1866
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1822
<400> 1866
Gln Gln Gln Ser Met Lys Arg Ser Asn Arg Arg Lys Tyr
1 5 10
<210> 1867
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1823
<400> 1867
Gln Ser Met Lys Arg Ser Asn
1 5
<210> 1868
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1824
<400> 1868
Arg Pro Leu Thr Tyr Arg Ala Lys Arg Thr Thr Lys Arg
1 5 10
<210> 1869
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1825
<400> 1869
Thr Lys Arg Lys Arg Met Ser Leu Val Lys Glu Lys Lys
1 5 10
<210> 1870
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1826
<400> 1870
Tyr Ile Asn Ser Thr Val Asn
1 5
<210> 1871
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1827
<400> 1871
Phe Lys Thr Gly Asn Ser Thr Ala Thr Cys Thr Thr Asn Asn
1 5 10
<210> 1872
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1828
<400> 1872
Gly Arg Glu Leu Pro Pro Asp Met Thr Val Val Pro Gly Asp
1 5 10
<210> 1873
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1829
<400> 1873
Ala Ala Ala Ala Ala Ala Val Ala Ala Ala Thr Ala Ala Val
1 5 10
<210> 1874
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1830
<400> 1874
Ala Thr Ala Ala Val Glu Gly Ser Gly Gly Ser Gly Gly Gly
1 5 10
<210> 1875
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1831
<400> 1875
Cys Thr Ser His Asp Pro Gln Ser Ser Arg Gly Ser Arg Arg
1 5 10
<210> 1876
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1832
<400> 1876
Glu Glu Glu Glu Glu Glu Glu Gly Arg Phe Tyr Tyr Ser Glu
1 5 10
<210> 1877
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1833
<400> 1877
Glu Glu Glu Glu Gly Arg Phe Tyr Tyr Ser Glu Asp Asp His
1 5 10
<210> 1878
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1834
<400> 1878
Phe Arg Glu Asp Glu Gly Phe Val Arg Glu Glu Glu Asp Arg
1 5 10
<210> 1879
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1835
<400> 1879
Phe Tyr Tyr Ser Glu Asp Asp His Gly Asp Glu Cys Ser Tyr
1 5 10
<210> 1880
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1836
<400> 1880
Gly Val Lys Glu Ser Leu Cys Ala Lys Glu Glu Lys Cys Gln
1 5 10
<210> 1881
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1837
<400> 1881
Lys Ile Leu Arg Glu Leu Ser Glu Glu Glu Glu Asp Glu Glu
1 5 10
<210> 1882
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1838
<400> 1882
Leu Leu Lys Phe Arg Glu Asp Glu Gly Phe Val Arg Glu Glu
1 5 10
<210> 1883
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1839
<400> 1883
Gln Leu Gly Glu Glu Ala Leu Leu Lys Phe Arg Glu Asp Glu
1 5 10
<210> 1884
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1840
<400> 1884
Ser Glu Glu Lys Ile Leu Arg Glu Leu Ser Glu Glu Glu Glu
1 5 10
<210> 1885
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1841
<400> 1885
Ser Phe Pro His Cys Ser Asp Leu Met Pro Ser Gly Ser Glu
1 5 10
<210> 1886
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1842
<400> 1886
Ser Gly His Thr Ile Phe Asn Asp Pro Phe Phe Ile Val Glu
1 5 10
<210> 1887
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1843
<400> 1887
Ser Ser Thr Ser Ser Ser Leu Gly Asp Lys Ser Glu Tyr Leu
1 5 10
<210> 1888
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1844
<400> 1888
Thr Ile Phe Asn Asp Pro Phe Phe Ile Val Glu Thr Val Cys
1 5 10
<210> 1889
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1845
<400> 1889
Thr Gln Tyr Phe Asp Pro Leu Arg Asn Glu Tyr Phe Phe Asp
1 5 10
<210> 1890
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1846
<400> 1890
Val Ser Gly Leu Arg Phe Glu Thr Gln Met Lys Thr Leu Ala
1 5 10
<210> 1891
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1847
<400> 1891
Glu Glu Asp Glu Glu Glu Glu Glu Glu Glu Glu Glu Glu Gly
1 5 10
<210> 1892
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1848
<400> 1892
Arg Glu Leu Ser Glu Glu Glu Glu Asp Glu Glu Glu Glu Glu
1 5 10
<210> 1893
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1849
<400> 1893
Ser Glu Glu Glu Glu Asp Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 1894
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1850
<400> 1894
Arg Gly Ser Arg Arg Arg Arg Arg Gln Arg Ser Glu Lys Lys
1 5 10
<210> 1895
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1851
<400> 1895
Arg Arg Arg Arg Arg Gln Arg Ser Glu Lys Lys Lys Ala His
1 5 10
<210> 1896
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1852
<400> 1896
Glu Leu Pro Arg Pro Arg Arg Pro Pro Pro Glu Asp Glu Glu
1 5 10
<210> 1897
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1853
<400> 1897
Glu Asn Gly Gly Ala Met Thr Val Arg Gly Gly Asp Glu Ala
1 5 10
<210> 1898
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1854
<400> 1898
Phe Asp Arg Asn Arg Pro Ser Phe Asp Gly Ile Leu Tyr Tyr
1 5 10
<210> 1899
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1855
<400> 1899
Leu Leu Pro Arg Thr Leu Ala Asp Pro Phe Phe Ile Val Glu
1 5 10
<210> 1900
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1856
<400> 1900
Leu Pro Pro Leu Pro Glu Glu Leu Pro Arg Pro Arg Arg Pro
1 5 10
<210> 1901
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1857
<400> 1901
Leu Ser Asp Gly Pro Lys Glu Pro Ala Pro Lys Gly Arg Gly
1 5 10
<210> 1902
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1858
<400> 1902
Pro Leu Glu Lys Cys Asn Val Lys Ala Lys Ser Asn Val Asp
1 5 10
<210> 1903
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1859
<400> 1903
Arg Glu Thr Asp His Glu Glu Pro Ala Val Leu Lys Glu Glu
1 5 10
<210> 1904
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1860
<400> 1904
Ser Leu Asp Val Phe Ala Asp Glu Ile Arg Phe Tyr Gln Leu
1 5 10
<210> 1905
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1861
<400> 1905
Thr Phe Glu Leu Leu Val Arg Phe Phe Ala Cys Pro Ser Lys
1 5 10
<210> 1906
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1862
<400> 1906
Thr Val Gly Tyr Gly Asp Met Arg Pro Ile Thr Val Gly Gly
1 5 10
<210> 1907
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1863
<400> 1907
Glu Glu Glu Glu Gly Asp Pro Gly Leu Gly Thr Val Glu Asp
1 5 10
<210> 1908
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1864
<400> 1908
Pro Glu Asp Glu Glu Glu Glu Gly Asp Pro Gly Leu Gly Thr
1 5 10
<210> 1909
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1865
<400> 1909
Val Asn Val Ser Leu Asp Val Phe Ala Asp Glu Ile Arg Phe
1 5 10
<210> 1910
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1866
<400> 1910
Ala Lys Asp Gly Ile Ser Val Lys Gly Ala Asn Asn Ser Asn
1 5 10
<210> 1911
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1867
<400> 1911
Ala Asn Asn Ser Asn Thr Thr Asn Pro Pro Pro Ala Pro Ser
1 5 10
<210> 1912
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1868
<400> 1912
Cys Leu Leu Phe Val Phe Ser Ala Leu Leu Glu Tyr Ala Ala
1 5 10
<210> 1913
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1869
<400> 1913
Gly Ile Ser Val Lys Gly Ala Asn Asn Ser Asn Thr Thr Asn
1 5 10
<210> 1914
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1870
<400> 1914
Val Lys Gly Ala Asn Asn Ser Asn Thr Thr Asn Pro Pro Pro
1 5 10
<210> 1915
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1871
<400> 1915
Asp Phe Ser Met Arg Pro Gly Phe Gly Gly Pro Ala Ile Pro
1 5 10
<210> 1916
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1872
<400> 1916
Asp Ser Leu Lys Thr Asp Glu Arg Ile Ser Leu Ser Gln Phe
1 5 10
<210> 1917
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1873
<400> 1917
Gly Phe Gly Gly Pro Ala Ile Pro Val Gly Val Asp Val Gln
1 5 10
<210> 1918
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1874
<400> 1918
Gly Lys Val Leu Tyr Ser Leu Arg Val Thr Val Thr Ala Met
1 5 10
<210> 1919
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1875
<400> 1919
Met Arg Pro Gly Phe Gly Gly Pro Ala Ile Pro Val Gly Val
1 5 10
<210> 1920
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1876
<400> 1920
Gln Pro Asp Gly Lys Val Leu Tyr Ser Leu Arg Val Thr Val
1 5 10
<210> 1921
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1877
<400> 1921
Thr Leu Tyr Leu Arg His Tyr Trp Lys Asp Glu Arg Leu Ser
1 5 10
<210> 1922
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1878
<400> 1922
Val Gln Val Glu Ser Leu Asp Ser Ile Ser Glu Val Asp Met
1 5 10
<210> 1923
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1879
<400> 1923
Trp Val Pro Asp Met Phe Phe Val His Ser Lys Arg Ser Phe
1 5 10
<210> 1924
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1880
<400> 1924
Cys Ser Leu Glu Ile Glu Ser Tyr Ala Tyr Thr Glu Asp Asp
1 5 10
<210> 1925
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1881
<400> 1925
Glu Arg Leu Ser Phe Pro Ser Thr Asn Asn Leu Ser Met Thr
1 5 10
<210> 1926
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1882
<400> 1926
Ser Leu Glu Glu Lys Gln Ser Cys Leu Lys Phe Lys Ala Asn
1 5 10
<210> 1927
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1883
<400> 1927
Ala Ala Asp Ala Phe Asp Ile Gly Ser Phe Asp Glu Glu Asp
1 5 10
<210> 1928
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1884
<400> 1928
Ala Phe Asp Ile Gly Ser Phe Asp Glu Glu Asp
1 5 10
<210> 1929
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1885
<400> 1929
Asp Leu Phe Gln Pro Tyr Ile Glu Glu Ile Cys
1 5 10
<210> 1930
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1886
<400> 1930
Asp Arg Leu Glu Ala Arg Lys Lys Ala Lys Asn
1 5 10
<210> 1931
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1887
<400> 1931
Glu Glu Ala Arg Pro Leu Val Glu Phe Tyr Glu Glu Ile Lys
1 5 10
<210> 1932
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1888
<400> 1932
Glu Glu Glu Arg Val Ala Arg Ser Arg Glu Ile Phe Asp Ser
1 5 10
<210> 1933
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1889
<400> 1933
Phe Gln Lys Phe Ile Glu Ser Asp Lys Phe Thr
1 5 10
<210> 1934
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1890
<400> 1934
Gly Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr
1 5 10
<210> 1935
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1891
<400> 1935
His Lys Thr Lys Asp Lys His Glu Ile Asp Arg
1 5 10
<210> 1936
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1892
<400> 1936
Leu Leu Thr Met Glu Glu Ile Gln Ser Val Glu
1 5 10
<210> 1937
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1893
<400> 1937
Leu Pro Asp Ser Phe Ser Pro Glu Leu Arg Ser Leu Leu Glu
1 5 10
<210> 1938
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1894
<400> 1938
Asn His Leu Glu Glu Ala Arg Pro Leu Val Glu
1 5 10
<210> 1939
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1895
<400> 1939
Gln Asn Leu Arg Gly Asp Val Phe Gln Lys Phe Ile Glu Ser
1 5 10
<210> 1940
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1896
<400> 1940
Gln Gln Glu Val Ala Glu Thr Val Phe Asp Thr Ile Asn Ala
1 5 10
<210> 1941
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1897
<400> 1941
Arg Pro Leu Val Glu Phe Tyr Glu Glu Ile Lys
1 5 10
<210> 1942
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1898
<400> 1942
Ser Phe Ser Pro Glu Leu Arg Ser Leu Leu Glu
1 5 10
<210> 1943
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1899
<400> 1943
Ser Val Glu Glu Thr Gln Ile Lys Glu Arg Lys
1 5 10
<210> 1944
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1900
<400> 1944
Thr Met Glu Glu Ile Gln Ser Val Glu Glu Thr
1 5 10
<210> 1945
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1901
<400> 1945
Trp Arg Gly Glu Gly Glu Ala Pro Gln Ser Leu Leu Thr Met
1 5 10
<210> 1946
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1902
<400> 1946
Tyr Leu Glu Asp Arg Gly Glu Val Thr Phe Glu
1 5 10
<210> 1947
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1903
<400> 1947
Ala Ala Glu Ile Ile Leu Gly
1 5
<210> 1948
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1904
<400> 1948
Ala Pro Gln Ser Leu Leu Thr
1 5
<210> 1949
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1905
<400> 1949
Glu Glu Glu Arg Val Ala Arg Ser Arg Glu Ile Phe Asp
1 5 10
<210> 1950
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1906
<400> 1950
Glu Ile Gln Ser Val Glu Glu
1 5
<210> 1951
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1907
<400> 1951
Glu Arg Val Ala Arg Ser Arg Glu Ile Phe Asp Ser Tyr
1 5 10
<210> 1952
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1908
<400> 1952
Gly Arg Gly Gly Phe Gly Glu
1 5
<210> 1953
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1909
<400> 1953
Gly Tyr Met Ala Pro Glu Val
1 5
<210> 1954
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1910
<400> 1954
His Pro Phe Ser Lys Ser Ala
1 5
<210> 1955
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1911
<400> 1955
Ile Gly Arg Gly Gly Phe Gly
1 5
<210> 1956
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1912
<400> 1956
Ile Pro Pro Arg Gly Glu Val
1 5
<210> 1957
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1913
<400> 1957
Ile Gln Ser Val Glu Glu Thr Gln Ile Lys Glu Arg Lys
1 5 10
<210> 1958
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1914
<400> 1958
Ile Ser Glu Arg Trp Gln Gln Glu Val Ala Glu Thr Val
1 5 10
<210> 1959
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1915
<400> 1959
Lys Tyr Pro Pro Pro Leu Ile Pro Pro Arg Gly Glu Val
1 5 10
<210> 1960
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1916
<400> 1960
Leu Glu Asp Arg Gly Glu Val
1 5
<210> 1961
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1917
<400> 1961
Leu Thr Met Asn Asp Phe Ser
1 5
<210> 1962
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1918
<400> 1962
Pro Gln Ser Leu Leu Thr Met
1 5
<210> 1963
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1919
<400> 1963
Gln Ser Val Glu Glu Thr Gln Ile Lys Glu Arg Lys Cys
1 5 10
<210> 1964
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1920
<400> 1964
Arg Gly Gly Phe Gly Glu Val
1 5
<210> 1965
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1921
<400> 1965
Arg Val Ala Arg Ser Arg Glu Ile Phe Asp Ser Tyr Ile
1 5 10
<210> 1966
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1922
<400> 1966
Ser Val Met Gln Lys Tyr Leu Glu Asp Arg Gly Glu Val
1 5 10
<210> 1967
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1923
<400> 1967
Ala Leu Thr Ala Leu Pro Asp Pro Asp Pro Glu
1 5 10
<210> 1968
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1924
<400> 1968
Ala Pro Ser Ser Gly Asp Ala Pro Pro Gly Ala Pro Leu Ala
1 5 10
<210> 1969
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1925
<400> 1969
Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro
1 5 10
<210> 1970
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1926
<400> 1970
Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp
1 5 10
<210> 1971
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1927
<400> 1971
Asp Pro Glu Pro Pro Gly Thr Pro Glu Met Gln Ala Pro Val
1 5 10
<210> 1972
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1928
<400> 1972
Glu Arg Gly Lys Ala Ser Glu Val Val Leu Arg
1 5 10
<210> 1973
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1929
<400> 1973
Phe Arg Asp Leu Leu Ser Val Ser Phe Glu Gly
1 5 10
<210> 1974
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1930
<400> 1974
Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg
1 5 10
<210> 1975
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1931
<400> 1975
Leu Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu
1 5 10
<210> 1976
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1932
<400> 1976
Met Gln Ala Pro Val Ala Ser Arg Arg Lys Pro Pro Ser Ala
1 5 10
<210> 1977
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1933
<400> 1977
Pro Leu Leu Gly Trp Lys Glu Pro Val Pro Pro Asp Glu Arg
1 5 10
<210> 1978
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1934
<400> 1978
Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu
1 5 10
<210> 1979
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1935
<400> 1979
Gln Asp Cys Ala Pro Ser Ser Gly Asp Ala Pro Pro Gly Ala
1 5 10
<210> 1980
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1936
<400> 1980
Arg Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 1981
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1937
<400> 1981
Trp Arg Ala Ser Thr Ser Gly Leu Arg Gln Asp Cys Ala Pro
1 5 10
<210> 1982
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1938
<400> 1982
Cys Gln Cys Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp
1 5 10
<210> 1983
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1939
<400> 1983
Cys Arg Arg Arg Arg Arg Arg
1 5
<210> 1984
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1940
<400> 1984
Glu Val Ala Glu Gly Ala Thr Cys Gln Ala Tyr Glu Leu
1 5 10
<210> 1985
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1941
<400> 1985
Phe Leu Arg Leu Leu Arg Cys Gln Cys Arg Arg Arg Arg
1 5 10
<210> 1986
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1942
<400> 1986
Phe Ser Arg Glu Lys Lys Ala Ala Lys Thr Leu Ala Ile
1 5 10
<210> 1987
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1943
<400> 1987
Gly Ala Thr Cys Gln Ala Tyr Glu Leu Ala Asp Tyr Ser
1 5 10
<210> 1988
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1944
<400> 1988
Leu Cys Cys Thr Ala Ser Ile Leu Ser Leu Cys Thr Ile
1 5 10
<210> 1989
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1945
<400> 1989
Pro Glu Met Gln Ala Pro Val
1 5
<210> 1990
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1946
<400> 1990
Arg Arg Arg Arg Arg Arg Pro Leu Trp Arg Val Tyr Gly
1 5 10
<210> 1991
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1947
<400> 1991
Arg Arg Arg Arg Arg Arg Arg
1 5
<210> 1992
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1948
<400> 1992
Arg Arg Arg Arg Arg Arg Arg Pro Leu Trp Arg Val Tyr
1 5 10
<210> 1993
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1949
<400> 1993
Ser Ala Thr Met Glu Val Leu
1 5
<210> 1994
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1950
<400> 1994
Val Ile Phe Trp Leu Gly Tyr
1 5
<210> 1995
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1951
<400> 1995
Val Leu Cys Trp Phe Pro Phe Phe Phe Val Leu Pro Leu
1 5 10
<210> 1996
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1952
<400> 1996
Val Val Cys Cys Ala Gln Ser Val Asn Asp Pro Gly Asn Met
1 5 10
<210> 1997
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1953
<400> 1997
Leu Tyr Trp Lys Asn Gly Asp Glu Ser Leu Lys Thr Asp Glu
1 5 10
<210> 1998
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1954
<400> 1998
Gln Thr Cys Ser Leu Glu Leu Glu Ser Tyr Ala Tyr Thr Asp
1 5 10
<210> 1999
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1955
<400> 1999
Cys Thr Ile Asp Val Thr Phe Phe Pro Phe Asp
1 5 10
<210> 2000
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1956
<400> 2000
Asp Gln Asp Val Asp Lys Arg Asp Phe Phe Asp
1 5 10
<210> 2001
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1957
<400> 2001
Gly Leu Ser Phe Leu Thr Val Leu Val Phe Tyr
1 5 10
<210> 2002
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1958
<400> 2002
His Glu Asp Ser Leu Leu Lys Asp Leu Phe Gln Asp Tyr Glu
1 5 10
<210> 2003
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1959
<400> 2003
Pro Ser Asp Ser Val Trp Thr Pro Asp Ile Val Leu Phe Asp
1 5 10
<210> 2004
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1960
<400> 2004
Gln Asp Val Asp Lys Arg Asp Phe Phe Asp Asn Gly Glu Trp
1 5 10
<210> 2005
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1961
<400> 2005
Gln Lys Glu Glu Thr Glu Ser Gly Ser Gly Pro
1 5 10
<210> 2006
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1962
<400> 2006
Arg Asp Phe Phe Asp Asn Gly Glu Trp Glu Ile
1 5 10
<210> 2007
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1963
<400> 2007
Ser Val Trp Thr Pro Asp Ile Val Leu Phe Asp Asn Ala Asp
1 5 10
<210> 2008
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1964
<400> 2008
Ser Trp Thr Tyr Asp Gly Ser Gln Val Asp Ile Ile Leu Glu
1 5 10
<210> 2009
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1965
<400> 2009
Thr Lys Thr Val Ile Arg Tyr Asn Gly Thr Val Thr Trp Thr
1 5 10
<210> 2010
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1966
<400> 2010
Ala Ile Ser Gln Leu Val Asp Val Asp Glu Lys Asn Gln
1 5 10
<210> 2011
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1967
<400> 2011
Arg Tyr Asn Gly Thr Val Thr
1 5
<210> 2012
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1968
<400> 2012
Thr Tyr Ser Phe Val Ile Lys Arg Leu Pro Leu Phe Tyr
1 5 10
<210> 2013
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1969
<400> 2013
Val Thr Tyr Ser Phe Val Ile Lys Arg Leu Pro Leu Phe
1 5 10
<210> 2014
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1970
<400> 2014
Asp Phe Ile Ile Lys Arg Lys Pro Leu Phe Tyr
1 5 10
<210> 2015
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1971
<400> 2015
Met Arg Arg Ala Pro Ser Leu Val Leu Phe Phe Leu Val Ala
1 5 10
<210> 2016
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1972
<400> 2016
Asn Glu Arg Glu Gln Ile Met Thr Thr Asn Val
1 5 10
<210> 2017
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1973
<400> 2017
Ser Leu Ala Gln Leu Ile Ser Val Asn Glu Arg
1 5 10
<210> 2018
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1974
<400> 2018
Thr Ser Pro Ser Asn Phe Tyr Gly Asn Ser Met
1 5 10
<210> 2019
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1975
<400> 2019
Val Phe Met Phe Val Cys Val Leu Gly Thr Val
1 5 10
<210> 2020
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1976
<400> 2020
Asp Phe Ile Ile Lys Arg Lys Pro Leu Phe Tyr Thr Ile
1 5 10
<210> 2021
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1977
<400> 2021
Ile Ser Val Asn Glu Arg Glu Gln Ile Met Thr Thr Asn
1 5 10
<210> 2022
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1978
<400> 2022
Leu Ile Ser Val Asn Glu Arg Glu Gln Ile Met Thr Thr
1 5 10
<210> 2023
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1979
<400> 2023
Glu Cys Pro Met Gln Leu Glu Asp Phe Pro Met Asp Ala His
1 5 10
<210> 2024
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1980
<400> 2024
Gly Met Phe Ser Gly Phe Ile Met Ile Lys Asn Leu Leu Leu
1 5 10
<210> 2025
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1981
<400> 2025
Ile Ser Ala Glu Cys Pro Met Gln Leu Glu Asp Phe Pro Met
1 5 10
<210> 2026
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1982
<400> 2026
Lys Lys Arg Glu Val Ile Leu Asn Lys Ser Thr Asn Ala Phe
1 5 10
<210> 2027
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1983
<400> 2027
Met Asn Leu Ser Ser His Phe Gly Phe Ser Gln Met Pro Thr
1 5 10
<210> 2028
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1984
<400> 2028
Ser Gly Phe Ile Met Ile Lys Asn Leu Leu Leu Phe Cys Ile
1 5 10
<210> 2029
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1985
<400> 2029
Asp Gly Lys Lys Ala Leu Glu Ala Ala Lys Ile Lys Lys Lys
1 5 10
<210> 2030
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1986
<400> 2030
Glu Val Ile Leu Asn Lys Ser Thr Asn Ala Phe Thr Thr Gly
1 5 10
<210> 2031
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1987
<400> 2031
Ala Ser Glu Ala Glu His Arg Leu Phe Glu Arg Leu Phe Glu
1 5 10
<210> 2032
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1988
<400> 2032
Asp Ile Lys Tyr Asn Cys Cys Glu Glu Ile Tyr
1 5 10
<210> 2033
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1989
<400> 2033
Glu Arg Leu Phe Glu Asp Tyr Asn Glu Ile Ile Arg Pro Val
1 5 10
<210> 2034
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1990
<400> 2034
His His Arg Arg Ile Lys Ile Ser Asn Phe Ser Ala Asn Leu
1 5 10
<210> 2035
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1991
<400> 2035
His Arg Leu Phe Glu Arg Leu Phe Glu Asp Tyr
1 5 10
<210> 2036
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1992
<400> 2036
Ile Arg Pro Val Ala Asn Val Ser Asp Pro Val
1 5 10
<210> 2037
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1993
<400> 2037
Lys Ile Asp Val Thr Tyr Phe Pro Phe Asp Tyr
1 5 10
<210> 2038
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1994
<400> 2038
Met Ser Gln Leu Val Lys Val Asp Glu Val Asn
1 5 10
<210> 2039
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1995
<400> 2039
Pro Val Ala Asn Val Ser Asp Pro Val Ile Ile His Phe Glu
1 5 10
<210> 2040
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1996
<400> 2040
Arg Leu Phe Glu Arg Leu Phe Glu Asp Tyr Asn Glu Ile Ile
1 5 10
<210> 2041
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1997
<400> 2041
Val Ala Arg Ala Ser Glu Ala Glu His Arg Leu Phe Glu Arg
1 5 10
<210> 2042
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1998
<400> 2042
Val Asp Glu Val Asn Gln Ile Met Glu Thr Asn
1 5 10
<210> 2043
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 1999
<400> 2043
Val Asp Glu Val Asn Gln Ile Met Glu Thr Asn Leu Trp Leu
1 5 10
<210> 2044
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2000
<400> 2044
Cys Cys Glu Glu Ile Tyr Pro Asp Ile Thr Tyr Ser Leu
1 5 10
<210> 2045
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2001
<400> 2045
Cys Glu Glu Ile Tyr Pro Asp Ile Thr Tyr Ser Leu Tyr
1 5 10
<210> 2046
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2002
<400> 2046
Asp Lys Thr Lys Ala Leu Leu Lys Tyr Thr Gly Glu Val
1 5 10
<210> 2047
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2003
<400> 2047
Glu Asn Met Lys Ala Gln Asn
1 5
<210> 2048
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2004
<400> 2048
Glu Val Ser Met Ser Gln Leu Val Lys Val Asp Glu Val
1 5 10
<210> 2049
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2005
<400> 2049
Ile Ala Glu Asn Met Lys Ala Gln Asn Glu Ala Lys Glu
1 5 10
<210> 2050
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2006
<400> 2050
Leu Phe Glu Arg Leu Phe Glu Asp Tyr Asn Glu Ile Ile
1 5 10
<210> 2051
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2007
<400> 2051
Leu Lys Tyr Thr Gly Glu Val
1 5
<210> 2052
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2008
<400> 2052
Arg Leu Phe Glu Asp Tyr Asn Glu Ile Ile Arg Pro Val
1 5 10
<210> 2053
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2009
<400> 2053
Tyr Ser Leu Tyr Ile Arg Arg Leu Pro Leu Phe Tyr Thr
1 5 10
<210> 2054
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2010
<400> 2054
Ala Glu Cys Pro Met His Leu Glu Asp Phe Pro Met Asp Val
1 5 10
<210> 2055
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2011
<400> 2055
Asp Ser Pro Thr Glu Thr Lys Thr Tyr Asn Ser Val Ser Lys
1 5 10
<210> 2056
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2012
<400> 2056
Ile Phe Thr Arg Ile Leu Asp Arg Leu Leu Asp Gly Tyr Asp
1 5 10
<210> 2057
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2013
<400> 2057
Leu Tyr Thr Met Arg Leu Thr Ile His Ala Glu Cys Pro Met
1 5 10
<210> 2058
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2014
<400> 2058
Pro Met His Leu Glu Asp Phe Pro Met Asp Val His Ala Cys
1 5 10
<210> 2059
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2015
<400> 2059
Thr Glu Thr Lys Thr Tyr Asn Ser Val Ser Lys Val Asp Lys
1 5 10
<210> 2060
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2016
<400> 2060
Val Val Gly Thr Glu Ile Ile Arg Ser Ser Thr Gly Glu Tyr
1 5 10
<210> 2061
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2017
<400> 2061
Gly Gln Gly Glu Ser Arg Arg Gln Glu Pro Gly Asp Phe Val
1 5 10
<210> 2062
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2018
<400> 2062
Ser Pro Thr Glu Thr Lys Thr Tyr Asn Ser Val Ser Lys Val
1 5 10
<210> 2063
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2019
<400> 2063
Gly Leu Cys Ile Ile Ser Ile Asp Arg Tyr Ile
1 5 10
<210> 2064
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2020
<400> 2064
Ile Asp Arg Tyr Ile Gly Val Ser Tyr Pro Leu
1 5 10
<210> 2065
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2021
<400> 2065
Ile Gly Pro Leu Phe Gly Trp Arg Gln Pro Ala Pro Glu Asp
1 5 10
<210> 2066
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2022
<400> 2066
Leu Lys Thr Asp Lys Ser Asp Ser Glu Gln Val Thr Leu Arg
1 5 10
<210> 2067
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2023
<400> 2067
Leu Thr Ser Thr Val Leu Pro Phe Ser Ala Ile Phe Glu Val
1 5 10
<210> 2068
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2024
<400> 2068
Val Leu Cys Trp Leu Pro Phe Phe Leu Val Met Pro Ile Gly
1 5 10
<210> 2069
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2025
<400> 2069
Ile Thr Val Ser Lys Asp Gln Ser Ser Cys Thr Thr Ala
1 5 10
<210> 2070
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2026
<400> 2070
Pro Ser Glu Thr Val Phe Lys
1 5
<210> 2071
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2027
<400> 2071
Ala Asn Gly Gln Pro Gly Phe Lys Ser Asn Met Pro Leu Ala
1 5 10
<210> 2072
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2028
<400> 2072
Ala Ser Ile Leu Ser Leu Cys Ala Ile Ser Ile Asp Arg Tyr
1 5 10
<210> 2073
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2029
<400> 2073
Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg
1 5 10
<210> 2074
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2030
<400> 2074
Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg
1 5 10
<210> 2075
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2031
<400> 2075
Asp Lys Glu Cys Gly Val Thr Glu Glu Pro Phe
1 5 10
<210> 2076
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2032
<400> 2076
Gly Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg Arg
1 5 10
<210> 2077
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2033
<400> 2077
Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 2078
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2034
<400> 2078
Gly Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly
1 5 10
<210> 2079
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2035
<400> 2079
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu
1 5 10
<210> 2080
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2036
<400> 2080
Leu Cys Trp Leu Pro Phe Phe Ile Ala Leu Pro Leu Gly Ser
1 5 10
<210> 2081
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2037
<400> 2081
Leu Ser Leu Cys Ala Ile Ser Ile Asp Arg Tyr
1 5 10
<210> 2082
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2038
<400> 2082
Pro Cys Ser Ser Lys Glu Phe Lys Arg Ala Phe Val Arg Ile
1 5 10
<210> 2083
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2039
<400> 2083
Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg Arg
1 5 10
<210> 2084
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2040
<400> 2084
Arg Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg
1 5 10
<210> 2085
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2041
<400> 2085
Arg Ile Leu Gly Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg
1 5 10
<210> 2086
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2042
<400> 2086
Arg Arg Arg Arg Arg Arg Arg Arg Arg Leu Gly
1 5 10
<210> 2087
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2043
<400> 2087
Ser Ile Asp Arg Tyr Ile Gly Val Arg Tyr Ser
1 5 10
<210> 2088
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2044
<400> 2088
Ala Asn Phe Thr Gly Pro Asn Gln Thr Ser Ser Asn Ser
1 5 10
<210> 2089
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2045
<400> 2089
Phe Thr Gly Pro Asn Gln Thr Ser Ser Asn Ser Thr Leu
1 5 10
<210> 2090
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2046
<400> 2090
Gly Arg Arg Arg Arg Arg Arg
1 5
<210> 2091
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2047
<400> 2091
Leu Gly Cys Gln Cys Arg Gly Arg Gly Arg Arg Arg Arg
1 5 10
<210> 2092
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2048
<400> 2092
Asn Phe Thr Gly Pro Asn Gln Thr Ser Ser Asn Ser Thr
1 5 10
<210> 2093
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2049
<400> 2093
Gln Thr Ser Ser Asn Ser Thr
1 5
<210> 2094
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2050
<400> 2094
Arg Arg Arg Arg Arg Arg Leu Gly Gly Cys Ala Tyr Thr
1 5 10
<210> 2095
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2051
<400> 2095
Ser Phe Thr Val Leu Pro Phe Ser Ala Ala Leu Glu Val
1 5 10
<210> 2096
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2052
<400> 2096
Thr Gly Pro Asn Gln Thr Ser Ser Asn Ser Thr Leu Pro
1 5 10
<210> 2097
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2053
<400> 2097
Cys Val Pro Thr Pro Asp Ser Gly Val Val Cys Gly Arg Met
1 5 10
<210> 2098
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2054
<400> 2098
Asp His Tyr Leu Gln Trp Asn Val Ser Glu Tyr
1 5 10
<210> 2099
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2055
<400> 2099
Asp Ile Ser Gly Tyr Ile Pro Asn Gly Glu Trp
1 5 10
<210> 2100
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2056
<400> 2100
Glu Gly Asp Pro Asp Leu Ala Lys Ile Leu Glu
1 5 10
<210> 2101
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2057
<400> 2101
Glu Leu Val Lys Asn Tyr Asn Pro Leu Glu Arg
1 5 10
<210> 2102
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2058
<400> 2102
Glu Val Arg Tyr Ile Ala Asn Arg Phe Arg Cys Gln Asp Glu
1 5 10
<210> 2103
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2059
<400> 2103
Phe Ser Leu Ser Leu Leu Gln Ile Met Asp Val Asp Glu Lys
1 5 10
<210> 2104
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2060
<400> 2104
Gly Glu Asp Lys Val Arg Pro Ala Cys Gln His Lys Gln Arg
1 5 10
<210> 2105
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2061
<400> 2105
Gly Ile Phe Lys Ser Ser Cys Tyr Ile Asp Val
1 5 10
<210> 2106
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2062
<400> 2106
His Gly Gly Gln Pro Pro Glu Gly Asp Pro Asp
1 5 10
<210> 2107
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2063
<400> 2107
Leu Glu Arg Pro Val Ala Asn Asp Ser Gln Pro
1 5 10
<210> 2108
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2064
<400> 2108
Leu His Gly Gly Gln Pro Pro Glu Gly Asp Pro Asp Leu Ala
1 5 10
<210> 2109
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2065
<400> 2109
Leu Gln Met Gln Glu Ala Asp Ile Ser Gly Tyr
1 5 10
<210> 2110
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2066
<400> 2110
Met Leu Leu Val Ala Glu Ile Met Pro Ala Thr
1 5 10
<210> 2111
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2067
<400> 2111
Met Ser Ala Pro Asn Phe Val Glu Ala Val Ser
1 5 10
<210> 2112
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2068
<400> 2112
Pro Ala Cys Gln His Lys Gln Arg Arg Cys Ser Leu Ala Ser
1 5 10
<210> 2113
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2069
<400> 2113
Ser Gly Tyr Ile Pro Asn Gly Glu Trp Asp Leu
1 5 10
<210> 2114
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2070
<400> 2114
Ser Leu Ser Leu Leu Gln Ile Met Asp Val Asp
1 5 10
<210> 2115
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2071
<400> 2115
Ser Val Pro Leu Ile Ala Gln Tyr Phe Ala Ser Thr Met Ile
1 5 10
<210> 2116
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2072
<400> 2116
Thr Val Tyr Phe Ser Leu Ser Leu Leu Gln Ile Met Asp Val
1 5 10
<210> 2117
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2073
<400> 2117
Val Lys Asn Tyr Asn Pro Leu Glu Arg Pro Val
1 5 10
<210> 2118
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2074
<400> 2118
Val Thr Val Ile Val Leu Gln Tyr His His His Asp Pro Asp
1 5 10
<210> 2119
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2075
<400> 2119
Tyr Ile Ala Asn Arg Phe Arg Cys Gln Asp Glu
1 5 10
<210> 2120
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2076
<400> 2120
Tyr Asn Pro Leu Glu Arg Pro Val Ala Asn Asp Ser Gln Pro
1 5 10
<210> 2121
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2077
<400> 2121
Asp Glu Lys Asn Gln Val Leu Thr Thr Asn Ile Trp Leu
1 5 10
<210> 2122
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2078
<400> 2122
Asp Ile Leu Leu Tyr Asn Ser
1 5
<210> 2123
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2079
<400> 2123
Glu Lys Ile Ser Leu Gly Ile
1 5
<210> 2124
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2080
<400> 2124
Glu Arg Phe Tyr Glu Cys Cys Lys Glu Pro Tyr Pro Asp
1 5 10
<210> 2125
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2081
<400> 2125
Ile Pro Gly Lys Arg Ser Glu
1 5
<210> 2126
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2082
<400> 2126
Lys Ile Ser Leu Gly Ile Thr
1 5
<210> 2127
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2083
<400> 2127
Lys Asn Tyr Asn Pro Leu Glu
1 5
<210> 2128
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2084
<400> 2128
Val Lys Thr Val Arg Phe Pro
1 5
<210> 2129
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2085
<400> 2129
Tyr Phe Ser Leu Ser Leu Leu Gln Ile Met Asp Val Asp
1 5 10
<210> 2130
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2086
<400> 2130
Pro Glu Pro Ala Ala Pro Gln Gln Pro Thr Ala Glu Glu Glu
1 5 10
<210> 2131
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2087
<400> 2131
Tyr Gly Asn Cys Tyr Thr Phe Asn Asp Lys Asn Asn Ser Asn
1 5 10
<210> 2132
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2088
<400> 2132
Ala Cys Asp Gln Leu Ala Leu Gly Val Ala Ala Leu Phe Gly
1 5 10
<210> 2133
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2089
<400> 2133
Ala Cys Leu Gly Val Ser Cys Val Leu Phe Val Ile Ala Arg
1 5 10
<210> 2134
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2090
<400> 2134
Ala Glu Ile Leu Lys Gln Ile Leu Phe Met Gly Met Met Thr
1 5 10
<210> 2135
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2091
<400> 2135
Ala Leu Ser Thr Arg Ile Val Gly Gly Ile Trp Trp Phe Phe
1 5 10
<210> 2136
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2092
<400> 2136
Phe Glu Ala Ser Arg Arg Ala Cys Asp Gln Leu Ala Leu Gly
1 5 10
<210> 2137
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2093
<400> 2137
Phe Gly Pro Ser His Ser Ser Ser Val Ser Ala Val Gln Ser
1 5 10
<210> 2138
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2094
<400> 2138
Gly Tyr Cys Leu Asp Leu Leu Lys Glu Leu Ser Asn Ile Leu
1 5 10
<210> 2139
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2095
<400> 2139
Ile Asp Asn Pro His Val Ser Ser Ile Ile Glu Lys Trp Ser
1 5 10
<210> 2140
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2096
<400> 2140
Ile Phe Glu Thr Val Glu Asn Glu Pro Val Asn Val Glu Glu
1 5 10
<210> 2141
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2097
<400> 2141
Leu Lys Glu Met Lys Lys Gly Lys Glu Phe Tyr Val Ile Phe
1 5 10
<210> 2142
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2098
<400> 2142
Leu Leu Met Glu Ser Thr Ser Ile Glu Tyr Val Thr Gln Arg
1 5 10
<210> 2143
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2099
<400> 2143
Leu Leu Asn Ile Asp Asn Pro His Val Ser Ser Ile Ile Glu
1 5 10
<210> 2144
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2100
<400> 2144
Leu Asn Ser Phe Trp Phe Gly Val Gly Ala Leu Met Gln Gln
1 5 10
<210> 2145
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2101
<400> 2145
Pro Leu Tyr Gly Asn Asp Arg Phe Glu Gly Tyr Cys Leu Asp
1 5 10
<210> 2146
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2102
<400> 2146
Gln Leu Ala Leu Gly Val Ala Ala Leu Phe Gly Pro Ser His
1 5 10
<210> 2147
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2103
<400> 2147
Ser Asp Lys Pro Leu Tyr Gly Asn Asp Arg Phe Glu Gly Tyr
1 5 10
<210> 2148
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2104
<400> 2148
Ser Leu Gln Cys His Arg His Lys Pro Trp Arg Leu Gly Pro
1 5 10
<210> 2149
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2105
<400> 2149
Thr Val Glu Asn Glu Pro Val Asn Val Glu Glu Leu Ala Phe
1 5 10
<210> 2150
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2106
<400> 2150
Gly Ile Phe Glu Thr Val Glu Asn Glu Pro Val Asn Val Glu
1 5 10
<210> 2151
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2107
<400> 2151
Asn Ile Lys Ile Lys Ile Arg Gln Leu Pro Ser Gly Asn Lys
1 5 10
<210> 2152
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2108
<400> 2152
Arg Leu Leu Asn Ile Asp Asn Pro His Val Ser Ser Ile Ile
1 5 10
<210> 2153
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2109
<400> 2153
Ala Arg Pro Arg Ser Pro Ser Pro Ile Ser Thr Leu Ser His
1 5 10
<210> 2154
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2110
<400> 2154
Cys Lys Glu Asn Glu Tyr Val Phe Asp Glu Tyr Thr Cys Lys
1 5 10
<210> 2155
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2111
<400> 2155
Cys Met Phe Val Pro Lys Val Tyr Ile Ile Leu Ala Lys Pro
1 5 10
<210> 2156
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2112
<400> 2156
Cys Trp Thr Cys Thr Pro Cys Lys Glu Asn Glu Tyr Val Phe
1 5 10
<210> 2157
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2113
<400> 2157
Glu Phe Ile Arg Asp Ser Leu Ile Ser Ser Glu Glu Glu Glu
1 5 10
<210> 2158
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2114
<400> 2158
Glu Ser Arg Gly Leu Gly Ala Gly Ala Gly Ala Gly Gly Ser
1 5 10
<210> 2159
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2115
<400> 2159
Phe Ser Val Ser Leu Ser Ala Thr Val Ala Leu Gly Cys Met
1 5 10
<210> 2160
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2116
<400> 2160
Gly Leu Gly Ala Gly Ala Gly Ala Gly Gly Ser Ala Gly Gly
1 5 10
<210> 2161
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2117
<400> 2161
Ile Lys Leu Gln Ser Pro Asp Val Lys Trp Phe Asp Asp Tyr
1 5 10
<210> 2162
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2118
<400> 2162
Ile Met Asn Phe Lys Glu Met Gly Lys Asp Tyr Phe Asp Tyr
1 5 10
<210> 2163
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2119
<400> 2163
Gln Ala Arg Ala Met Val Asp Ile Val Lys Arg Tyr Asn Trp
1 5 10
<210> 2164
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2120
<400> 2164
Arg Pro Glu Thr Asn His Arg Asn Pro Trp Phe Gln Glu Phe
1 5 10
<210> 2165
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2121
<400> 2165
Pro Cys Lys Glu Asn Glu Tyr Val Phe Asp Glu Tyr Thr Cys
1 5 10
<210> 2166
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2122
<400> 2166
Pro Gln Glu Asn Ser Lys Tyr Asn Lys Thr Cys Asn Ser Ser
1 5 10
<210> 2167
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2123
<400> 2167
Arg Ile Leu Ala Gly Ser Lys Lys Lys Ile Cys Thr Lys Lys
1 5 10
<210> 2168
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2124
<400> 2168
Arg Thr Asp Asp Asp Val Pro Ser Leu His Ser Glu Pro Val
1 5 10
<210> 2169
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2125
<400> 2169
Trp Pro Thr Asp Asp Leu Thr Gly Cys Asp Leu Ile Pro Val
1 5 10
<210> 2170
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2126
<400> 2170
Ala Ala Glu Lys Asn Trp Gln Val Thr Ala Val Asn Ile Leu
1 5 10
<210> 2171
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2127
<400> 2171
Ala Pro Leu Thr Ile Thr Leu Val Arg Glu Glu Val Ile Asp
1 5 10
<210> 2172
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2128
<400> 2172
Phe Glu Glu Gly Arg Asp Gln Thr Thr Ser Asp Gln Ser Asn
1 5 10
<210> 2173
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2129
<400> 2173
Gly Ala Phe Met Gln Gln Gly Cys Asp Ile Ser Pro Arg Ser
1 5 10
<210> 2174
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2130
<400> 2174
Lys Gly Lys Tyr Ala Tyr Leu Leu Glu Ser Thr Met Asn Glu
1 5 10
<210> 2175
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2131
<400> 2175
Lys His Asp Gly Ile Arg Lys Ile Gly Tyr Trp Asn Glu Asp
1 5 10
<210> 2176
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2132
<400> 2176
Lys Ile Gly Tyr Trp Asn Glu Asp Asp Lys Phe Val Pro Ala
1 5 10
<210> 2177
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2133
<400> 2177
Lys Lys Asn Ala Asn Gln Phe Glu Gly Asn Asp Arg Tyr Glu
1 5 10
<210> 2178
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2134
<400> 2178
Lys Tyr Ala Tyr Leu Leu Glu Ser Thr Met Asn Glu Tyr Ile
1 5 10
<210> 2179
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2135
<400> 2179
Leu Asn Lys Phe Lys Glu Ser Gly Ala Asn Val Thr Gly Phe
1 5 10
<210> 2180
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2136
<400> 2180
Pro Leu Thr Ile Thr Leu Val Arg Glu Glu Val Ile Asp Phe
1 5 10
<210> 2181
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2137
<400> 2181
Ser Ala Glu Pro Ser Val Phe Val Arg Thr Thr Glu Glu Gly
1 5 10
<210> 2182
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2138
<400> 2182
Ser Lys Gly Lys Tyr Ala Tyr Leu Leu Glu Ser Thr Met Asn
1 5 10
<210> 2183
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2139
<400> 2183
Ser Arg Phe Ser Pro Tyr Glu Trp His Ser Glu Glu Phe Glu
1 5 10
<210> 2184
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2140
<400> 2184
Val Arg Lys Ser Lys Gly Lys Tyr Ala Tyr Leu Leu Glu Ser
1 5 10
<210> 2185
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2141
<400> 2185
Tyr Ala Tyr Leu Leu Glu Ser Thr Met Asn Glu Tyr Ile Glu
1 5 10
<210> 2186
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2142
<400> 2186
Tyr Trp Asn Glu Asp Asp Lys Phe Val Pro Ala Ala Thr Asp
1 5 10
<210> 2187
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2143
<400> 2187
Glu His Ala Ala Phe Arg Phe Ala Leu Ser Gln Leu Thr Glu
1 5 10
<210> 2188
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2144
<400> 2188
Val Ile Asp Phe Ser Lys Pro Phe Met Ser Leu Gly Ile Ser
1 5 10
<210> 2189
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2145
<400> 2189
Ala Ile Phe Gly Phe Tyr Asp Lys Lys Ser Val Asn Thr Ile
1 5 10
<210> 2190
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2146
<400> 2190
Ile Glu Ser Ala Glu Asp Leu Ser Lys Gln Thr Glu Ile Ala
1 5 10
<210> 2191
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2147
<400> 2191
Ile Asn Pro Ser Ser Ser Gln Asn Ser Gln Asn Phe Ala Thr
1 5 10
<210> 2192
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2148
<400> 2192
Leu Lys Lys Glu Arg Arg Val Ile Leu Asp Cys Glu Arg Asp
1 5 10
<210> 2193
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2149
<400> 2193
Met Leu Val Ala Leu Ile Glu Phe Cys Tyr Lys Ser Arg Ala
1 5 10
<210> 2194
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2150
<400> 2194
Asn His Glu Met Leu Glu Gly Asn Glu Arg Tyr Glu Gly Tyr
1 5 10
<210> 2195
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2151
<400> 2195
Asn Pro Ala Val Pro Trp Gly Gln Gly Val Glu Ile Glu Arg
1 5 10
<210> 2196
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2152
<400> 2196
Pro Ile Glu Ser Ala Glu Asp Leu Ser Lys Gln Thr Glu Ile
1 5 10
<210> 2197
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2153
<400> 2197
Pro Tyr Glu Trp His Thr Glu Glu Phe Glu Asp Gly Arg Glu
1 5 10
<210> 2198
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2154
<400> 2198
Arg Phe Ser Pro Tyr Glu Trp His Thr Glu Glu Phe Glu Asp
1 5 10
<210> 2199
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2155
<400> 2199
Ala Leu His Thr Ser Phe Val Thr Pro Ser Phe Pro Thr Asp
1 5 10
<210> 2200
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2156
<400> 2200
Glu Arg Tyr Glu Gly Tyr Cys Val Asp Leu Ala Tyr Glu Ile
1 5 10
<210> 2201
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2157
<400> 2201
Phe Ala Phe Leu Leu Glu Ser Thr Met Asn Glu Tyr Ile Glu
1 5 10
<210> 2202
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2158
<400> 2202
Phe Val Tyr Leu Tyr Asp Thr Glu Arg Gly Phe Ser Ile Leu
1 5 10
<210> 2203
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2159
<400> 2203
Gly Phe Ser Ile Leu Gln Ala Ile Met Glu Ala Ala Val Gln
1 5 10
<210> 2204
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2160
<400> 2204
Leu Gly Leu Leu Gly His Ser His Gly Gly Phe Pro Asn Thr
1 5 10
<210> 2205
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2161
<400> 2205
Asn Ile Thr Gly Phe Gln Ile Val Asn Asn Glu Asn Pro Met
1 5 10
<210> 2206
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2162
<400> 2206
Pro Phe Ser Asp Gln Gln Ile Ser Asn Asp Ser Ala Ser Ser
1 5 10
<210> 2207
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2163
<400> 2207
Arg Ile Lys Tyr Lys Leu Ser Ile Val Gly Asp Gly Lys Tyr
1 5 10
<210> 2208
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2164
<400> 2208
Arg Lys Ser Lys Gly Lys Phe Ala Phe Leu Leu Glu Ser Thr
1 5 10
<210> 2209
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2165
<400> 2209
Arg Gln Glu Lys Arg Tyr Leu Ile Asp Cys Glu Val Glu Arg
1 5 10
<210> 2210
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2166
<400> 2210
Ser Ile Val Gly Asp Gly Lys Tyr Gly Ala Arg Asp Pro Glu
1 5 10
<210> 2211
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2167
<400> 2211
Ser Lys Gly Lys Phe Ala Phe Leu Leu Glu Ser Thr Met Asn
1 5 10
<210> 2212
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2168
<400> 2212
Ser Arg Gly Val Tyr Ala Ile Phe Gly Phe Tyr Asp Gln Met
1 5 10
<210> 2213
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2169
<400> 2213
Thr Gln Asn Phe Lys Pro Ala Pro Ala Thr Asn Thr Gln Asn
1 5 10
<210> 2214
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2170
<400> 2214
Val Thr Pro Ser Phe Pro Thr Asp Ala Asp Val Gln Phe Val
1 5 10
<210> 2215
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2171
<400> 2215
Tyr Lys Leu Ser Ile Val Gly Asp Gly Lys Tyr Gly Ala Arg
1 5 10
<210> 2216
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2172
<400> 2216
Lys Phe Ala Phe Leu Leu Glu Ser Thr Met Asn Glu Tyr Ile
1 5 10
<210> 2217
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2173
<400> 2217
Val Arg Lys Ser Lys Gly Lys Phe Ala Phe Leu Leu Glu Ser
1 5 10
<210> 2218
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2174
<400> 2218
Gly Lys Phe Ala Phe Leu Leu Glu Ser Thr Met Asn Glu Tyr
1 5 10
<210> 2219
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2175
<400> 2219
Asp Gly Arg Lys Phe Phe Phe Ile Arg Ala Ile Pro Gln Gly
1 5 10
<210> 2220
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2176
<400> 2220
Glu Asn Asp Leu Asp Glu Ser Gln Val Pro Asp Gln Pro Ser
1 5 10
<210> 2221
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2177
<400> 2221
Leu Asp Glu Ser Gln Val Pro Asp Gln Pro Ser Ser Leu His
1 5 10
<210> 2222
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2178
<400> 2222
Asn Pro Leu Leu Pro Pro Pro Met Ser Ala Ile Glu Pro Lys
1 5 10
<210> 2223
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2179
<400> 2223
Val Pro Asp Leu Ser Thr Pro Met Leu Pro Pro Val Gly Val
1 5 10
<210> 2224
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2180
<400> 2224
Ala Asp His Leu Lys Ala Glu Asp Thr Asp Phe
1 5 10
<210> 2225
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2181
<400> 2225
Cys Cys Ala Glu Ile Tyr Pro Asp Ile Thr Tyr
1 5 10
<210> 2226
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2182
<400> 2226
Asp Ala Val Gly Thr Tyr Asn Thr Arg Lys Tyr
1 5 10
<210> 2227
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2183
<400> 2227
Glu Asp Thr Asp Phe Ser Val Lys Glu Asp Trp
1 5 10
<210> 2228
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2184
<400> 2228
Phe Trp Glu Ser Gly Glu Trp Val Ile Val Asp
1 5 10
<210> 2229
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2185
<400> 2229
Gly Thr Tyr Asn Thr Arg Lys Tyr Glu Cys Cys Ala Glu Ile
1 5 10
<210> 2230
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2186
<400> 2230
Lys Lys Leu Phe Ser Gly Tyr Asn Lys Trp Ser Arg Pro Val
1 5 10
<210> 2231
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2187
<400> 2231
Lys Ser Pro Ser Asp Gln Leu Pro Pro Gln Gln Pro Leu Glu
1 5 10
<210> 2232
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2188
<400> 2232
Leu Asp Phe Trp Glu Ser Gly Glu Trp Val Ile
1 5 10
<210> 2233
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2189
<400> 2233
Leu Leu Leu Met Lys Arg Pro Ser Val Val Lys
1 5 10
<210> 2234
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2190
<400> 2234
Leu Met Lys Arg Pro Ser Val Val Lys Asp Asn
1 5 10
<210> 2235
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2191
<400> 2235
Asn Val Thr Ser Ile Arg Ile Pro Ser Glu Leu
1 5 10
<210> 2236
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2192
<400> 2236
Arg Lys Tyr Glu Cys Cys Ala Glu Ile Tyr Pro
1 5 10
<210> 2237
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2193
<400> 2237
Arg Ser Arg Ser Ile Gln Tyr Cys Val Pro Arg
1 5 10
<210> 2238
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2194
<400> 2238
Arg Trp Asp Pro Ala Asp Tyr Glu Asn Val Thr
1 5 10
<210> 2239
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2195
<400> 2239
Ser Cys Ser Ile Asp Val Thr Phe Phe Pro Phe Asp Gln Gln
1 5 10
<210> 2240
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2196
<400> 2240
Thr Gly Leu Leu Arg Ala Ser Ser His Val Glu Thr Arg Ala
1 5 10
<210> 2241
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2197
<400> 2241
Val Gly Leu Phe Leu Pro Pro Trp Leu Ala Gly
1 5 10
<210> 2242
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2198
<400> 2242
Tyr Glu Cys Cys Ala Glu Ile Tyr Pro Asp Ile
1 5 10
<210> 2243
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2199
<400> 2243
Tyr Asn Lys Trp Ser Arg Pro Val Ala Asn Ile Ser Asp Val
1 5 10
<210> 2244
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2200
<400> 2244
Ala Asp Gly Gln Ala Ala Gly Ala Leu Ala Ser Arg Asn
1 5 10
<210> 2245
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2201
<400> 2245
Leu Pro Pro Pro Asp Gln Pro
1 5
<210> 2246
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2202
<400> 2246
Leu Pro Pro Pro Asp Gln Pro Ser Pro Cys Lys Cys Thr
1 5 10
<210> 2247
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2203
<400> 2247
Pro Pro Pro Asp Gln Pro Ser
1 5
<210> 2248
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2204
<400> 2248
Ser Ile Gln Tyr Cys Val Pro Arg Asp Asp Ala Ala Pro
1 5 10
<210> 2249
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2205
<400> 2249
Thr Pro Pro Ala Ile Tyr Lys
1 5
<210> 2250
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2206
<400> 2250
Trp Asp Pro Ala Asp Tyr Glu
1 5
<210> 2251
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2207
<400> 2251
Asp Asp Gly Thr Leu Leu Tyr Thr Met Arg Leu Thr Val Gln
1 5 10
<210> 2252
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2208
<400> 2252
Gly Leu Gly Asp Ser Ile Thr Glu Val Phe Thr Asn Ile Tyr
1 5 10
<210> 2253
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2209
<400> 2253
Met His Leu Glu Asp Phe Pro Met Asp Ala His Ser Cys Pro
1 5 10
<210> 2254
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2210
<400> 2254
Ser Arg Leu Asn Gln Tyr Asp Leu Leu Gly Gln Ser Ile Gly
1 5 10
<210> 2255
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2211
<400> 2255
Val Met Ile Gln Asn Asn Ala Tyr Ala Val Ala Val Ala Asn
1 5 10
<210> 2256
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2212
<400> 2256
Val Gln Ala Glu Cys Pro Met His Leu Glu Asp Phe Pro Met
1 5 10
<210> 2257
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2213
<400> 2257
Ala Val Cys Ala Gln Ser Val Asn Asp Pro Ser Asn Met Ser
1 5 10
<210> 2258
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2214
<400> 2258
Leu Met Gly Cys Phe Val Phe Val Phe Met Ala Leu Leu Glu
1 5 10
<210> 2259
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2215
<400> 2259
Thr Leu Glu Ile Lys Asn Glu Met Ala Thr Ser Glu Ala Val
1 5 10
<210> 2260
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2216
<400> 2260
Val Asn Asp Pro Ser Asn Met Ser Leu Val Lys Glu Thr Val
1 5 10
<210> 2261
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2217
<400> 2261
Asp Leu Ala Arg Val Pro Ala Asn Ser Thr Ser Asn Ile Leu
1 5 10
<210> 2262
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2218
<400> 2262
Asp Ile Tyr Val Thr Ser Phe Gly Pro Val Ser Asp Val Glu
1 5 10
<210> 2263
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2219
<400> 2263
Asn Lys Glu Ser Val Pro Ala Arg Thr Val Phe Gly Ile Thr
1 5 10
<210> 2264
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2220
<400> 2264
Thr Gly Lys Leu Ser Ala Thr Pro Pro Pro Ser Ala Pro Pro
1 5 10
<210> 2265
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2221
<400> 2265
Val Cys Leu Asn Glu Ser Pro Gly Gln Asn Gln Lys Glu Glu
1 5 10
<210> 2266
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2222
<400> 2266
Ala Gly Val Leu Thr Ile Ala Met Pro Val Pro Val Ile Val
1 5 10
<210> 2267
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2223
<400> 2267
Ala His Ser His Phe Asp Tyr Asp Pro Arg Ala Asp Glu Phe
1 5 10
<210> 2268
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2224
<400> 2268
Ala Leu Ala Gly Val Leu Thr Ile Ala Met Pro Val Pro Val
1 5 10
<210> 2269
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2225
<400> 2269
Cys Pro Ala Asp Val Cys Gly Pro Leu Tyr Glu Glu Glu Leu
1 5 10
<210> 2270
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2226
<400> 2270
Asp Thr Cys Pro Leu Ala Gln Glu Glu Ile Leu Glu Ile Asn
1 5 10
<210> 2271
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2227
<400> 2271
Asp Val Cys Gly Pro Leu Tyr Glu Glu Glu Leu Ala Phe Trp
1 5 10
<210> 2272
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2228
<400> 2272
Glu Val Gly Leu Ser Gly Leu Ser Ser Lys Ala Ala Lys Asp
1 5 10
<210> 2273
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2229
<400> 2273
Gly Ala Leu Cys Ala Leu Ala Gly Val Leu Thr Ile Ala Met
1 5 10
<210> 2274
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2230
<400> 2274
His Ile Leu Asn Tyr Tyr Arg Thr Gly Lys Leu His Cys Pro
1 5 10
<210> 2275
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2231
<400> 2275
Lys Leu His Cys Pro Ala Asp Val Cys Gly Pro Leu Tyr Glu
1 5 10
<210> 2276
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2232
<400> 2276
Leu Ala Gly Val Leu Thr Ile Ala Met Pro Val Pro Val Ile
1 5 10
<210> 2277
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2233
<400> 2277
Leu Cys Ala Leu Ala Gly Val Leu Thr Ile Ala Met Pro Val
1 5 10
<210> 2278
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2234
<400> 2278
Ser Leu Ala Met Ala Lys Gln Lys Leu Pro Lys Lys Lys Lys
1 5 10
<210> 2279
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2235
<400> 2279
Lys Gln Lys Leu Pro Lys Lys Lys Lys Lys His Ile Pro Arg
1 5 10
<210> 2280
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2236
<400> 2280
Ser His Phe Asp Tyr Asp Pro Arg Ala Asp Glu Phe Phe Phe
1 5 10
<210> 2281
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2237
<400> 2281
Tyr Ser Leu Ala Met Ala Lys Gln Lys Leu Pro Lys Lys Lys
1 5 10
<210> 2282
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2238
<400> 2282
Phe Lys Gln Phe Lys Thr Gln Tyr Ser Thr Arg Val Val Thr
1 5 10
<210> 2283
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2239
<400> 2283
Arg Thr Glu Asn Gly Ser Glu Pro Gly Ala Ser Met Pro Pro
1 5 10
<210> 2284
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2240
<400> 2284
Thr Leu Gln Glu Met Leu Ser Phe Glu Glu Thr Val Pro Val
1 5 10
<210> 2285
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2241
<400> 2285
Glu Ile Thr Ile Gly Ala Glu Pro Lys Glu Thr Thr Glu Asp
1 5 10
<210> 2286
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2242
<400> 2286
Leu Phe Thr Met Gln Thr Asp Gln Ser Met Ile Cys Asn Leu
1 5 10
<210> 2287
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2243
<400> 2287
Gln Asp Ala Gly Trp Leu Val Gly Val Lys Glu Ser Asp Trp
1 5 10
<210> 2288
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2244
<400> 2288
Phe Arg Asn Phe Thr Ser Ala Thr Gln Ala Leu Thr Glu Trp
1 5 10
<210> 2289
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2245
<400> 2289
Gly Glu Pro Tyr Ser Pro Cys Thr Val Asn Gly Ser Glu Val
1 5 10
<210> 2290
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2246
<400> 2290
Asn Tyr Asp Ser Leu Arg Leu Gln Pro Leu Asp Val Ile Glu
1 5 10
<210> 2291
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2247
<400> 2291
Glu Glu Glu Tyr Asn Pro Phe Leu Val Ser Ser Thr Gly Ala
1 5 10
<210> 2292
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2248
<400> 2292
Gly Leu Gln Val Ile Leu Tyr Ile Asn Glu Glu Glu Tyr Asn
1 5 10
<210> 2293
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2249
<400> 2293
Ile Leu Tyr Ile Asn Glu Glu Glu Tyr Asn Pro Phe Leu Val
1 5 10
<210> 2294
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2250
<400> 2294
Ile Asn Glu Glu Glu Tyr Asn Pro Phe Leu Val Ser Ser Thr
1 5 10
<210> 2295
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2251
<400> 2295
Leu Gln Val Ile Leu Tyr Ile Asn Glu Glu Glu Tyr Asn Pro
1 5 10
<210> 2296
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2252
<400> 2296
Gln Val Pro Leu Glu Lys Lys Ile Asn Met Ser Tyr Ser Ala
1 5 10
<210> 2297
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2253
<400> 2297
Arg Pro Gly Ile Thr His Gly Val Gly Leu Val Leu Arg Val
1 5 10
<210> 2298
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2254
<400> 2298
Asp Ala Val Asn Glu Ser Gly Arg Val Glu Phe Gly Ser Tyr
1 5 10
<210> 2299
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2255
<400> 2299
Gly Ala Arg Leu Asn Arg Val Glu Asp Lys Val Thr Gln Leu
1 5 10
<210> 2300
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2256
<400> 2300
His Ile Thr Cys Asp Pro Pro Glu Glu Arg Arg Leu Asp His
1 5 10
<210> 2301
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2257
<400> 2301
Ser Tyr Ala Asp Ala Leu Trp Trp Gly Val Val Thr Val Thr
1 5 10
<210> 2302
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2258
<400> 2302
Pro Lys Lys Ser Val Val Val Lys Lys Lys Lys Phe Lys Leu
1 5 10
<210> 2303
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2259
<400> 2303
Ser Pro Lys Pro Lys Lys Ser Val Val Val Lys Lys Lys Lys
1 5 10
<210> 2304
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2260
<400> 2304
Phe Asn Arg Gln Ile Pro Ala Ala Ala Ser Leu Ile Gln Thr
1 5 10
<210> 2305
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2261
<400> 2305
Gln Lys His Phe Asn Arg Gln Ile Pro Ala Ala Ala Ser Leu
1 5 10
<210> 2306
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2262
<400> 2306
Gln Leu Glu Asp Ala Cys Glu His Leu Ala Glu Tyr Leu Glu
1 5 10
<210> 2307
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2263
<400> 2307
Gln Cys Pro Pro Glu Ser Phe Asp Val Ile Leu Asp Glu Asn
1 5 10
<210> 2308
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2264
<400> 2308
Cys Gly Asn Cys Ser Arg Ile Phe His Gly Glu Lys Leu Met
1 5 10
<210> 2309
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2265
<400> 2309
Cys Ser Arg Ile Phe His Gly Glu Lys Leu Met Asn Thr Asn
1 5 10
<210> 2310
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2266
<400> 2310
Asp Cys Lys Arg Asn Ser Asp Val Met Asp Cys
1 5 10
<210> 2311
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2267
<400> 2311
Asp Asp Phe Val Asn Val Ala Ser Phe Asn Ser
1 5 10
<210> 2312
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2268
<400> 2312
Asp Ile Lys Arg Leu Thr Pro Arg Phe Thr Leu
1 5 10
<210> 2313
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2269
<400> 2313
Glu Asn Pro Glu Thr Tyr Glu Asp Ser Phe Tyr
1 5 10
<210> 2314
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2270
<400> 2314
Phe Arg Thr Leu Val Lys Ser Gln Asp Glu Arg Tyr Ile Asp
1 5 10
<210> 2315
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2271
<400> 2315
Phe Thr Leu Cys Pro Asn Gly Tyr Tyr Phe Ala Ile Asp Pro
1 5 10
<210> 2316
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2272
<400> 2316
Gly Glu Lys Leu Met Asn Thr Asn Leu Ile Phe Ile Met Val
1 5 10
<210> 2317
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2273
<400> 2317
Gly Arg Phe Phe Gly Glu Ile Asp Pro Ser Leu
1 5 10
<210> 2318
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2274
<400> 2318
Ile Glu Asp Ala Asn Phe Gly Arg Gln Ile Ser
1 5 10
<210> 2319
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2275
<400> 2319
Ile Phe His Gly Glu Lys Leu Met Asn Thr Asn Leu Ile Phe
1 5 10
<210> 2320
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2276
<400> 2320
Ile Phe Ile Met Val Glu Ser Lys Gly Thr Cys Pro Cys Asp
1 5 10
<210> 2321
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2277
<400> 2321
Ile Pro Ser Ile Gly Ala Ile Arg Ile Asn Thr Gln Glu Tyr
1 5 10
<210> 2322
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2278
<400> 2322
Leu Cys Pro Asn Gly Tyr Tyr Phe Ala Ile Asp
1 5 10
<210> 2323
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2279
<400> 2323
Leu Ile Gly Pro Ser Ser Glu Glu Pro Phe Pro Ser Ala Val
1 5 10
<210> 2324
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2280
<400> 2324
Pro Asn Gly Tyr Tyr Phe Ala Ile Asp Pro Asn
1 5 10
<210> 2325
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2281
<400> 2325
Gln Glu Tyr Leu Asp Val Leu Gly Arg Pro Met
1 5 10
<210> 2326
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2282
<400> 2326
Gln Ile Gly Arg Phe Phe Gly Glu Ile Asp Pro
1 5 10
<210> 2327
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2283
<400> 2327
Arg Ile Lys Pro Val Phe Ile Glu Asp Ala Asn Phe Gly Arg
1 5 10
<210> 2328
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2284
<400> 2328
Ser Leu Ser Lys Gln Ser Cys Ile Thr Glu Gln
1 5 10
<210> 2329
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2285
<400> 2329
Ser Ser Glu Glu Pro Phe Pro Ser Ala Val Thr
1 5 10
<210> 2330
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2286
<400> 2330
Thr Leu Ser Asp Asp Asp Phe Val Asn Val Ala Ser Phe Asn
1 5 10
<210> 2331
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2287
<400> 2331
Thr Leu Thr Leu Phe Gln Ser Leu Leu Ile Gly
1 5 10
<210> 2332
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2288
<400> 2332
Thr Leu Val Lys Ser Gln Asp Glu Arg Tyr Ile
1 5 10
<210> 2333
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2289
<400> 2333
Val Cys Phe Asp Asn Asn Val Leu Glu Asp Tyr
1 5 10
<210> 2334
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2290
<400> 2334
Val Glu Met Glu Asp Asp Asp Phe Thr Ala Ser
1 5 10
<210> 2335
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2291
<400> 2335
Val Lys Ser Gln Asp Glu Arg Tyr Ile Asp Lys
1 5 10
<210> 2336
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2292
<400> 2336
Asp Tyr Cys Asn Asp Leu Lys Ile Ser Asp Asn Asn Thr Glu
1 5 10
<210> 2337
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2293
<400> 2337
His Gly Glu Lys Leu Met Asn Thr Asn Leu Ile Phe Ile Met
1 5 10
<210> 2338
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2294
<400> 2338
Pro Asp Asn Phe Glu Glu Ser Gly Tyr Thr Phe Ile Ala Pro
1 5 10
<210> 2339
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2295
<400> 2339
Thr Leu Lys Pro Asp Asn Phe Glu Glu Ser Gly Tyr Thr Phe
1 5 10
<210> 2340
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2296
<400> 2340
Val Leu Asn Glu Leu Asn Trp Thr Ser Ala Leu Asp Glu Val
1 5 10
<210> 2341
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2297
<400> 2341
Ala Leu Leu Gly Ile Ser Phe Phe Ala Leu Pro Ala Gly Ile
1 5 10
<210> 2342
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2298
<400> 2342
Cys Val Ile Asp Phe Ile Val Phe Val Ala Ser Val Ala Val
1 5 10
<210> 2343
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2299
<400> 2343
Glu Leu Val Ala Leu Thr Ala Val Gln Ser Glu Gln Gly Glu
1 5 10
<210> 2344
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2300
<400> 2344
His Gln Glu Leu Ala Asn Glu Cys Leu Leu Ile Leu Glu Phe
1 5 10
<210> 2345
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2301
<400> 2345
Leu Ala Asn Glu Cys Leu Leu Ile Leu Glu Phe Val Met Ile
1 5 10
<210> 2346
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2302
<400> 2346
Met Ile Val Val Phe Gly Leu Glu Tyr Ile Val Arg Val Trp
1 5 10
<210> 2347
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2303
<400> 2347
Pro Arg Ala Glu Leu Val Ala Leu Thr Ala Val Gln Ser Glu
1 5 10
<210> 2348
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2304
<400> 2348
Pro Ser Lys Gln His Leu Ala Pro Pro Thr Met Pro Thr Ser
1 5 10
<210> 2349
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2305
<400> 2349
Gln Thr Leu Ser Ile Ser Arg Ser Val Ser Thr Asn Met Asp
1 5 10
<210> 2350
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2306
<400> 2350
Arg Ile Arg Met Gly Ser Ser Gln Arg Arg Thr Gly Pro Ser
1 5 10
<210> 2351
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2307
<400> 2351
Tyr Gln Cys Glu Leu Thr Val Asp Asp Ile Met Pro Ala Val
1 5 10
<210> 2352
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2308
<400> 2352
Ala Glu Leu Val Ala Leu Thr Ala Val Gln Ser Glu Gln Gly
1 5 10
<210> 2353
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2309
<400> 2353
Val Ala Leu Thr Ala Val Gln Ser Glu Gln Gly Glu Ala Gly
1 5 10
<210> 2354
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2310
<400> 2354
Glu Tyr Phe Leu Glu Pro Glu Ile Asn Leu Val Thr Glu Asn
1 5 10
<210> 2355
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2311
<400> 2355
Leu Glu Pro Glu Ile Asn Leu Val Thr Glu Asn Thr Glu Asn
1 5 10
<210> 2356
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2312
<400> 2356
Cys Phe Val Phe Cys Phe Cys Ala Leu Leu Glu Phe Ala Val
1 5 10
<210> 2357
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2313
<400> 2357
Ile Ala Ile Cys Phe Val Phe Cys Phe Cys Ala Leu Leu Glu
1 5 10
<210> 2358
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2314
<400> 2358
Lys Cys Gln Lys Glu Ala Lys Arg Ser Ser Ala Asp Lys Gly
1 5 10
<210> 2359
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2315
<400> 2359
Lys Arg Ser Ser Ala Asp Lys Gly Val Ala Leu Ser Leu Asp
1 5 10
<210> 2360
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2316
<400> 2360
Ala Ala Glu Thr Gln Pro Val Thr Asp Ala Ser
1 5 10
<210> 2361
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2317
<400> 2361
Ala Ala Glu Thr Gln Pro Val Thr Asp Ala Ser Pro Met Lys
1 5 10
<210> 2362
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2318
<400> 2362
Ala Glu Glu Val Met Leu Ala Glu Glu Asp Arg Asn Ala Glu
1 5 10
<210> 2363
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2319
<400> 2363
Ala Gly Pro Arg Glu Ala Glu Ser Gly Glu Glu
1 5 10
<210> 2364
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2320
<400> 2364
Ala Leu Glu Gln His Leu Pro Asp Gly Asp Lys Thr Pro Met
1 5 10
<210> 2365
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2321
<400> 2365
Ala Ser Cys Glu Ala Leu Tyr Ser Glu Met Asp Pro Glu Glu
1 5 10
<210> 2366
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2322
<400> 2366
Cys Ala Val Gly Ser Pro Phe Ala Arg Ala Ser
1 5 10
<210> 2367
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2323
<400> 2367
Cys Glu Ala Leu Tyr Ser Glu Met Asp Pro Glu
1 5 10
<210> 2368
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2324
<400> 2368
Cys Arg Gly Gln Tyr Leu Asp Tyr Glu Lys Glu Glu Val Glu
1 5 10
<210> 2369
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2325
<400> 2369
Cys Arg Arg Glu Arg Glu Arg Arg Gln Glu Arg
1 5 10
<210> 2370
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2326
<400> 2370
Asp Glu Phe Ile Arg Val Trp Ala Glu Tyr Asp Pro Ala Ala
1 5 10
<210> 2371
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2327
<400> 2371
Glu Ala Thr Val Val Pro Ser Gly Asn Val Asp
1 5 10
<210> 2372
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2328
<400> 2372
Glu Thr Gln Pro Val Thr Asp Ala Ser Pro Met
1 5 10
<210> 2373
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2329
<400> 2373
Phe Tyr Asp Ala Pro Tyr Glu Tyr Glu Leu Met
1 5 10
<210> 2374
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2330
<400> 2374
Gly Pro Gly Gly Gly Glu Arg Ala Arg Gly Gly Gly Ala Gly
1 5 10
<210> 2375
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2331
<400> 2375
Gly Pro Leu Gly Glu Ala Thr Val Val Pro Ser
1 5 10
<210> 2376
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2332
<400> 2376
Ile Thr Arg Arg Gly Pro Asp Gly Glu Pro Gln
1 5 10
<210> 2377
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2333
<400> 2377
Lys Glu Leu Glu Arg Asp Cys Arg Gly Gln Tyr Leu Asp Tyr
1 5 10
<210> 2378
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2334
<400> 2378
Lys His Ser Val Asp Ala Thr Tyr Glu Glu Gln
1 5 10
<210> 2379
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2335
<400> 2379
Lys Gln Asn Cys Phe Thr Val Asn Arg Ser Leu Phe Val Phe
1 5 10
<210> 2380
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2336
<400> 2380
Leu Cys Glu Gly Asp Thr Glu Cys Arg Glu Tyr
1 5 10
<210> 2381
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2337
<400> 2381
Leu Phe Gly Gly Gln Phe Asn Phe Gln Asp Glu
1 5 10
<210> 2382
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2338
<400> 2382
Leu Gly Glu Ala Thr Val Val Pro Ser Gly Asn
1 5 10
<210> 2383
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2339
<400> 2383
Leu Pro Asp Gly Asp Lys Thr Pro Met Ser Glu
1 5 10
<210> 2384
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2340
<400> 2384
Leu Thr Phe Glu Glu Ala Val Ala Thr Asn Ser
1 5 10
<210> 2385
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2341
<400> 2385
Leu Thr Lys Asp Glu Glu Glu Met Glu Glu Ala
1 5 10
<210> 2386
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2342
<400> 2386
Met Lys Phe Tyr Asp Ala Pro Tyr Glu Tyr Glu
1 5 10
<210> 2387
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2343
<400> 2387
Met Pro Arg Leu Ala Ala Glu Thr Gln Pro Val
1 5 10
<210> 2388
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2344
<400> 2388
Asn Ala Gln Glu Leu Thr Lys Asp Glu Glu Glu
1 5 10
<210> 2389
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2345
<400> 2389
Pro Asp Glu Met Thr Val Gly Lys Val Tyr Ala
1 5 10
<210> 2390
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2346
<400> 2390
Pro Glu Ala Ala Glu Ala Pro Glu Gly Val Asp
1 5 10
<210> 2391
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2347
<400> 2391
Pro Leu Val Val Glu Leu Gly Arg Asp Gly Ala
1 5 10
<210> 2392
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2348
<400> 2392
Pro Val Gly Asp Phe Pro Cys Gly Lys Glu Ala
1 5 10
<210> 2393
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2349
<400> 2393
Arg Asp Cys Arg Gly Gln Tyr Leu Asp Tyr Glu
1 5 10
<210> 2394
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2350
<400> 2394
Arg Glu Pro Arg Arg His Arg Ala His Arg His
1 5 10
<210> 2395
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2351
<400> 2395
Arg Leu Cys Glu Gly Asp Thr Glu Cys Arg Glu Tyr Trp Pro
1 5 10
<210> 2396
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2352
<400> 2396
Arg Pro Pro Leu Glu Arg Gly His Ser Thr Glu Ile Pro Val
1 5 10
<210> 2397
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2353
<400> 2397
Arg Arg Gly Pro Asp Gly Glu Pro Gln Pro Gly Leu Glu Ser
1 5 10
<210> 2398
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2354
<400> 2398
Arg Val Ala Tyr Lys Arg Leu Val Arg Met Asn Met Pro Ile
1 5 10
<210> 2399
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2355
<400> 2399
Ser Ala Asp Met Asp Gly Ala Pro Ser Ser Ala
1 5 10
<210> 2400
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2356
<400> 2400
Ser Glu Arg Gly Arg Gly Pro Gly Pro Glu Gly
1 5 10
<210> 2401
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2357
<400> 2401
Ser Phe Tyr Phe Ile Val Leu Thr Leu Phe Gly Asn Tyr Thr
1 5 10
<210> 2402
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2358
<400> 2402
Ser Leu Glu Lys Gly Pro Ser Leu Ser Ala Asp
1 5 10
<210> 2403
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2359
<400> 2403
Ser Ser Ser Ser Ser Glu Lys Gln Arg Phe Tyr
1 5 10
<210> 2404
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2360
<400> 2404
Ser Val Ser Trp Gly Thr Gln Arg Thr Gln Asp
1 5 10
<210> 2405
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2361
<400> 2405
Thr Gly Cys Arg Arg Glu Arg Glu Arg Arg Gln
1 5 10
<210> 2406
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2362
<400> 2406
Thr His Leu Cys Ser Thr Thr Pro Asp Arg Pro
1 5 10
<210> 2407
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2363
<400> 2407
Val Phe Leu Arg Gln Lys Ser Ser Thr Ser Leu Ser Asn Gly
1 5 10
<210> 2408
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2364
<400> 2408
Val Leu Lys His Ser Val Asp Ala Thr Tyr Glu
1 5 10
<210> 2409
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2365
<400> 2409
Val Leu Met Met Lys Phe Tyr Asp Ala Pro Tyr Glu Tyr Glu
1 5 10
<210> 2410
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2366
<400> 2410
Val Met Leu Thr Gly Pro Leu Gly Glu Ala Thr Val Val Pro
1 5 10
<210> 2411
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2367
<400> 2411
Val Arg Phe Gly Asp Glu Leu Gly Gly Arg Tyr
1 5 10
<210> 2412
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2368
<400> 2412
Val Tyr Ala Ala Leu Met Ile Phe Asp Phe Tyr
1 5 10
<210> 2413
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2369
<400> 2413
Tyr Lys Arg Leu Val Arg Met Asn Met Pro Ile
1 5 10
<210> 2414
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2370
<400> 2414
Gly Gly Ala Ile Gln Asn Gln Glu Ser Gly Ile Lys Glu Ser
1 5 10
<210> 2415
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2371
<400> 2415
Gly Ile Lys Ile Ile Ala Leu Gly Phe Val Phe His Lys Gly
1 5 10
<210> 2416
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2372
<400> 2416
His His His Arg Cys His Arg Arg Arg Asp Arg Lys Gln Arg
1 5 10
<210> 2417
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2373
<400> 2417
Asn Leu Ala Asn Ala Gln Glu Leu Thr Lys Asp Glu Glu Glu
1 5 10
<210> 2418
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2374
<400> 2418
Gln Glu Arg Arg Gln Pro Ser Ser Ser Ser Ser Glu Lys Gln
1 5 10
<210> 2419
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2375
<400> 2419
Arg Asn Val Thr Arg Met Gly Ser Gln Pro Pro Asp Pro Asn
1 5 10
<210> 2420
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2376
<400> 2420
Ser Ser Ser Ser Ser Glu Lys Gln Arg Phe Tyr Ser Cys Asp
1 5 10
<210> 2421
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2377
<400> 2421
Ala Leu Ala Ile Tyr Ile Pro Phe Pro Glu Asp
1 5 10
<210> 2422
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2378
<400> 2422
Ala Asn Cys Val Ala Leu Ala Ile Tyr Ile Pro Phe Pro Glu
1 5 10
<210> 2423
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2379
<400> 2423
Cys Leu Ala Met Gln His Tyr Glu Gln Ser Lys Met Phe Asn
1 5 10
<210> 2424
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2380
<400> 2424
Cys Leu Gly Glu Gln Glu Tyr Phe Ser Ser Glu Glu Cys Tyr
1 5 10
<210> 2425
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2381
<400> 2425
Cys Gln Ala Ile Ser Lys Ser Lys Leu Ser Arg Arg Trp Arg
1 5 10
<210> 2426
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2382
<400> 2426
Cys Val Ala Leu Ala Ile Tyr Ile Pro Phe Pro Glu Asp Asp
1 5 10
<210> 2427
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2383
<400> 2427
Asp Ala Cys Asp Leu Thr Ile Asp Glu Met Glu
1 5 10
<210> 2428
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2384
<400> 2428
Asp Asp Asp Ser Pro Val Cys Tyr Asp Ser Arg Arg Ser Pro
1 5 10
<210> 2429
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2385
<400> 2429
Asp Asp Ser Asn Ser Thr Asn His Asn Leu Glu
1 5 10
<210> 2430
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2386
<400> 2430
Asp Asp Tyr Arg Glu Glu Asp Glu Asp Lys Asp
1 5 10
<210> 2431
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2387
<400> 2431
Asp Glu Glu Pro Asp Pro Gly Arg Asp Glu Glu Asp Leu Ala
1 5 10
<210> 2432
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2388
<400> 2432
Asp Phe Gly Pro Gly Tyr Ser Asp Glu Glu Pro
1 5 10
<210> 2433
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2389
<400> 2433
Asp Ile Phe Ile Leu Leu Ala Ile Phe Ala Asn Cys Val Ala
1 5 10
<210> 2434
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2390
<400> 2434
Asp Pro Glu Ser Asp Tyr Asn Pro Gly Glu Glu
1 5 10
<210> 2435
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2391
<400> 2435
Asp Pro Tyr Pro Pro Cys Asp Val Pro Val Gly Glu Glu Glu
1 5 10
<210> 2436
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2392
<400> 2436
Asp Val Pro Val Gly Glu Glu Glu Glu Glu Glu
1 5 10
<210> 2437
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2393
<400> 2437
Asp Val Pro Val Gly Glu Glu Glu Glu Glu Glu Glu Glu Asp
1 5 10
<210> 2438
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2394
<400> 2438
Glu Asp Lys Asp Pro Tyr Pro Pro Cys Asp Val Pro Val Gly
1 5 10
<210> 2439
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2395
<400> 2439
Glu Glu Glu Glu Glu Asp Glu Pro Glu Val Pro
1 5 10
<210> 2440
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2396
<400> 2440
Glu Glu Glu Glu Glu Glu Glu Asp Glu Pro Glu
1 5 10
<210> 2441
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2397
<400> 2441
Glu Glu Glu Glu Glu Glu Glu Asp Glu Pro Glu Val Pro Ala
1 5 10
<210> 2442
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2398
<400> 2442
Glu Glu Pro Asp Pro Gly Arg Asp Glu Glu Asp
1 5 10
<210> 2443
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2399
<400> 2443
Glu Lys Val Glu Tyr Ala Phe Leu Ile Ile Phe Thr Val Glu
1 5 10
<210> 2444
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2400
<400> 2444
Glu Pro Glu Glu Thr Lys Arg Glu Glu Glu Asp
1 5 10
<210> 2445
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2401
<400> 2445
Glu Gln Glu Tyr Phe Ser Ser Glu Glu Cys Tyr
1 5 10
<210> 2446
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2402
<400> 2446
Glu Gln Glu Tyr Phe Ser Ser Glu Glu Cys Tyr Glu Asp Asp
1 5 10
<210> 2447
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2403
<400> 2447
Glu Ser Asp Tyr Asn Pro Gly Glu Glu Tyr Thr
1 5 10
<210> 2448
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2404
<400> 2448
Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ser Gly Glu Gly
1 5 10
<210> 2449
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2405
<400> 2449
Glu Val Pro Ala Gly Pro Arg Pro Arg Arg Ile
1 5 10
<210> 2450
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2406
<400> 2450
Glu Tyr Phe Ser Ser Glu Glu Cys Tyr Glu Asp
1 5 10
<210> 2451
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2407
<400> 2451
Phe Gly Ile Gln Ser Ser Ala Ile Ser Val Val
1 5 10
<210> 2452
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2408
<400> 2452
Phe Leu Glu Asp Asp Asp Ser Pro Val Cys Tyr
1 5 10
<210> 2453
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2409
<400> 2453
Phe Asn Phe Glu Cys Leu Arg Arg Gln Ser Ser Gln Glu Glu
1 5 10
<210> 2454
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2410
<400> 2454
Phe Gln Cys Ile Thr Met Glu Gly Trp Thr Asp Val Leu Tyr
1 5 10
<210> 2455
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2411
<400> 2455
Phe Arg Asn Thr Ile Leu Gly Tyr Phe Asp Tyr
1 5 10
<210> 2456
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2412
<400> 2456
Gly Cys His Lys Leu Ile Asn His His Ile Phe
1 5 10
<210> 2457
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2413
<400> 2457
Gly Glu Glu Glu Glu Glu Glu Glu Glu Asp Glu
1 5 10
<210> 2458
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2414
<400> 2458
Gly Gly Glu Glu Gly Lys Arg Asn Thr Ser Met Pro Thr Ser
1 5 10
<210> 2459
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2415
<400> 2459
Gly Tyr Ser Asp Glu Glu Pro Asp Pro Gly Arg Asp Glu Glu
1 5 10
<210> 2460
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2416
<400> 2460
His Pro Gln Gly Phe Leu Glu Asp Asp Asp Ser
1 5 10
<210> 2461
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2417
<400> 2461
His Val Asn Ser Asp Arg Arg Asp Ser Leu Gln
1 5 10
<210> 2462
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2418
<400> 2462
Ile Ala Asp Ala Cys Asp Leu Thr Ile Asp Glu Met Glu Ser
1 5 10
<210> 2463
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2419
<400> 2463
Ile Leu Asn Met Val Phe Thr Gly Val Phe Thr Val Glu Met
1 5 10
<210> 2464
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2420
<400> 2464
Ile Leu Tyr Lys Asp Gly Asp Val Asp Ser Pro
1 5 10
<210> 2465
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2421
<400> 2465
Ile Pro Phe Pro Glu Asp Asp Ser Asn Ser Thr Asn His Asn
1 5 10
<210> 2466
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2422
<400> 2466
Ile Val Ala Glu Glu Asp Pro Ala Pro Cys Ala
1 5 10
<210> 2467
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2423
<400> 2467
Lys Gly Lys Phe Tyr Arg Cys Thr Asp Glu Ala Lys Ser Asn
1 5 10
<210> 2468
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2424
<400> 2468
Lys Gln Arg Ser Ala Asp Ser Leu Val Glu Ala
1 5 10
<210> 2469
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2425
<400> 2469
Lys Arg Gln Gln Tyr Ala Lys Ser Lys Lys Gln Gly Asn Ser
1 5 10
<210> 2470
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2426
<400> 2470
Lys Ser Lys Leu Ser Arg Arg Trp Arg Arg Trp
1 5 10
<210> 2471
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2427
<400> 2471
Lys Val Thr Ile Asp Asp Tyr Arg Glu Glu Asp
1 5 10
<210> 2472
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2428
<400> 2472
Leu Glu Glu Asp Leu Lys Gly Tyr Leu Asp Trp
1 5 10
<210> 2473
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2429
<400> 2473
Leu Phe Ile Leu Tyr Lys Asp Gly Asp Val Asp
1 5 10
<210> 2474
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2430
<400> 2474
Leu Lys Met Thr Thr Phe Gly Ala Phe Leu His
1 5 10
<210> 2475
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2431
<400> 2475
Leu Gln Asp Asp Glu Pro Glu Glu Thr Lys Arg Glu Glu Glu
1 5 10
<210> 2476
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2432
<400> 2476
Leu Gln Asp Phe Gly Pro Gly Tyr Ser Asp Glu Glu Pro Asp
1 5 10
<210> 2477
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2433
<400> 2477
Leu Arg Glu Lys Gln Gln Leu Glu Glu Asp Leu
1 5 10
<210> 2478
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2434
<400> 2478
Leu Ser Arg Arg Trp Arg Arg Trp Asn Arg Phe Asn Arg Arg
1 5 10
<210> 2479
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2435
<400> 2479
Leu Thr Ile Asp Glu Met Glu Ser Ala Ala Ser Thr Leu Leu
1 5 10
<210> 2480
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2436
<400> 2480
Met Met Lys Lys Met Gln His Gln Arg Gln Gln Gln Ala Asp
1 5 10
<210> 2481
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2437
<400> 2481
Met Pro Thr Ser Glu Thr Glu Ser Val Asn Thr Glu Asn Val
1 5 10
<210> 2482
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2438
<400> 2482
Met Val Phe Thr Gly Val Phe Thr Val Glu Met
1 5 10
<210> 2483
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2439
<400> 2483
Asn Lys Val Thr Ile Asp Asp Tyr Arg Glu Glu Asp Glu Asp
1 5 10
<210> 2484
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2440
<400> 2484
Asn Met Lys Glu Lys Ile Ala Pro Ile Pro Glu
1 5 10
<210> 2485
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2441
<400> 2485
Asn Met Lys Glu Lys Ile Ala Pro Ile Pro Glu Gly Ser Ala
1 5 10
<210> 2486
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2442
<400> 2486
Asn Ser Asp Arg Arg Asp Ser Leu Gln Gln Thr
1 5 10
<210> 2487
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2443
<400> 2487
Pro Cys Asp Val Pro Val Gly Glu Glu Glu Glu
1 5 10
<210> 2488
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2444
<400> 2488
Pro Asp Pro Gly Arg Asp Glu Glu Asp Leu Ala Asp Glu Met
1 5 10
<210> 2489
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2445
<400> 2489
Pro Glu Asp Asp Ser Asn Ser Thr Asn His Asn
1 5 10
<210> 2490
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2446
<400> 2490
Pro Glu Asp Asp Ser Asn Ser Thr Asn His Asn Leu Glu Lys
1 5 10
<210> 2491
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2447
<400> 2491
Pro Pro Ala Ser Asp Thr Glu Lys Pro Leu Phe Pro Pro Ala
1 5 10
<210> 2492
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2448
<400> 2492
Pro Pro Cys Asp Val Pro Val Gly Glu Glu Glu Glu Glu Glu
1 5 10
<210> 2493
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2449
<400> 2493
Pro Thr Ser Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ser
1 5 10
<210> 2494
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2450
<400> 2494
Pro Val Gly Glu Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 2495
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2451
<400> 2495
Gln Gly Phe Leu Glu Asp Asp Asp Ser Pro Val
1 5 10
<210> 2496
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2452
<400> 2496
Gln Lys Leu Arg Glu Lys Gln Gln Leu Glu Glu
1 5 10
<210> 2497
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2453
<400> 2497
Gln Leu Phe Lys Gly Lys Phe Tyr Arg Cys Thr Asp Glu Ala
1 5 10
<210> 2498
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2454
<400> 2498
Gln Thr Val Leu Ser Trp Gln Ala Ala Ile Asp
1 5 10
<210> 2499
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2455
<400> 2499
Gln Val Pro Thr Ser Thr Asn Ala Asn Leu Asn Asn Ala Asn
1 5 10
<210> 2500
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2456
<400> 2500
Arg Ala Val Ile Lys Lys Ile Trp Lys Lys Thr
1 5 10
<210> 2501
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2457
<400> 2501
Arg Gly Leu Phe Ile Leu Tyr Lys Asp Gly Asp Val Asp Ser
1 5 10
<210> 2502
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2458
<400> 2502
Arg Ser Asp Ser Gly Asp Glu Gln Leu Pro Thr
1 5 10
<210> 2503
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2459
<400> 2503
Ser Glu Leu Asn Met Lys Glu Lys Ile Ala Pro Ile Pro Glu
1 5 10
<210> 2504
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2460
<400> 2504
Ser Gln Arg Lys Arg Gln Gln Tyr Ala Lys Ser Lys Lys Gln
1 5 10
<210> 2505
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2461
<400> 2505
Ser Arg Arg Ser Pro Arg Arg Arg Leu Leu Pro
1 5 10
<210> 2506
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2462
<400> 2506
Ser Ser Lys Gln Thr Val Leu Ser Trp Gln Ala Ala Ile Asp
1 5 10
<210> 2507
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2463
<400> 2507
Thr Glu Ser Val Asn Thr Glu Asn Val Ser Gly Glu Gly Glu
1 5 10
<210> 2508
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2464
<400> 2508
Thr Glu Thr Ile Leu Val Glu Leu Glu Ile Met
1 5 10
<210> 2509
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2465
<400> 2509
Thr Ile Asp Asp Tyr Arg Glu Glu Asp Glu Asp
1 5 10
<210> 2510
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2466
<400> 2510
Thr Ser Glu Thr Glu Ser Val Asn Thr Glu Asn
1 5 10
<210> 2511
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2467
<400> 2511
Val Glu Thr Phe Leu Lys Ile Ile Ala Tyr Gly
1 5 10
<210> 2512
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2468
<400> 2512
Val Gly Glu Glu Glu Glu Glu Glu Glu Glu Asp Glu Pro Glu
1 5 10
<210> 2513
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2469
<400> 2513
Val Ile Lys Lys Ile Trp Lys Lys Thr Ser Met
1 5 10
<210> 2514
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2470
<400> 2514
Trp Ile Thr Gln Ala Glu Asp Ile Asp Pro Glu
1 5 10
<210> 2515
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2471
<400> 2515
Tyr Ala Phe Leu Ile Ile Phe Thr Val Glu Thr
1 5 10
<210> 2516
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2472
<400> 2516
Tyr Ala Phe Thr Ala Ile Phe Thr Val Glu Ile
1 5 10
<210> 2517
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2473
<400> 2517
Tyr Phe Asp Tyr Ala Phe Thr Ala Ile Phe Thr Val Glu Ile
1 5 10
<210> 2518
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2474
<400> 2518
Tyr Phe Arg Asp Pro His Cys Leu Gly Glu Gln Glu Tyr Phe
1 5 10
<210> 2519
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2475
<400> 2519
Ser Met Pro Thr Ser Glu Thr Glu Ser Val Asn Thr Glu Asn
1 5 10
<210> 2520
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2476
<400> 2520
Ala Glu Asp Ile Asp Pro Glu Asn Glu Glu Glu Gly Gly Glu
1 5 10
<210> 2521
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2477
<400> 2521
Cys Asp Leu Gln Asp Asp Glu Pro Glu Glu Thr Lys Arg Glu
1 5 10
<210> 2522
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2478
<400> 2522
Glu Asp Asp Ser Asn Ser Thr Asn His Asn Leu Glu Lys Val
1 5 10
<210> 2523
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2479
<400> 2523
Glu Ser Val Asn Thr Glu Asn Val Ser Gly Glu Gly Glu Asn
1 5 10
<210> 2524
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2480
<400> 2524
Gly Glu Glu Glu Glu Glu Glu Glu Glu Asp Glu Pro Glu Val
1 5 10
<210> 2525
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2481
<400> 2525
Ile Asp Asp Tyr Arg Glu Glu Asp Glu Asp Lys Asp Pro Tyr
1 5 10
<210> 2526
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2482
<400> 2526
Ile Thr Gln Ala Glu Asp Ile Asp Pro Glu Asn Glu Glu Glu
1 5 10
<210> 2527
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2483
<400> 2527
Leu Leu Asp Gln Val Val Pro Pro Ala Gly Asp Asp Glu Val
1 5 10
<210> 2528
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2484
<400> 2528
Pro Ala Ser Asp Thr Glu Lys Pro Leu Phe Pro Pro Ala Gly
1 5 10
<210> 2529
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2485
<400> 2529
Pro Cys Asp Val Pro Val Gly Glu Glu Glu Glu Glu Glu Glu
1 5 10
<210> 2530
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2486
<400> 2530
Gln Asp Phe Gly Pro Gly Tyr Ser Asp Glu Glu Pro Asp Pro
1 5 10
<210> 2531
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2487
<400> 2531
Gln Gly Phe Leu Glu Asp Asp Asp Ser Pro Val Cys Tyr Asp
1 5 10
<210> 2532
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2488
<400> 2532
Arg Leu Phe Arg Val Met Arg Leu Val Lys Leu Leu Ser Arg
1 5 10
<210> 2533
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2489
<400> 2533
Arg Gln Gln Tyr Ala Lys Ser Lys Lys Gln Gly Asn Ser Ser
1 5 10
<210> 2534
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2490
<400> 2534
Val Pro Pro Ala Gly Asp Asp Glu Val Thr Val Gly Lys Phe
1 5 10
<210> 2535
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2491
<400> 2535
Val Pro Val Gly Glu Glu Glu Glu Glu Glu Glu Glu Asp Glu
1 5 10
<210> 2536
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2492
<400> 2536
Gly Phe Leu Gln Glu Phe Ser Lys Glu Glu Arg Asp Pro Val
1 5 10
<210> 2537
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2493
<400> 2537
Gly Val Ser Ser Ser Glu Met Asn Val Thr Trp Glu Pro Val
1 5 10
<210> 2538
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2494
<400> 2538
Gln Leu Asn Leu Ala Ala Glu Asp Thr Arg Leu Phe Ala Pro
1 5 10
<210> 2539
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2495
<400> 2539
Ser Gly Leu Ser Gly Gly Gly Gly Ala Pro Gly Glu Leu Ile
1 5 10
<210> 2540
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2496
<400> 2540
Thr Phe Thr Trp Thr Leu Asp Asp Phe Pro Ile Asp Phe Asp
1 5 10
<210> 2541
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2497
<400> 2541
Ala Gln Cys Pro Pro Glu Met Phe Asp Ile Ile Leu Asp Glu
1 5 10
<210> 2542
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2498
<400> 2542
Asp Ala Cys Glu His Leu Ala Glu Tyr Leu Glu Ala Tyr Trp
1 5 10
<210> 2543
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2499
<400> 2543
Asp Met Glu Thr Asp Pro Ser Glu Gly Pro Gly
1 5 10
<210> 2544
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2500
<400> 2544
Glu Glu Asp Tyr Glu Glu Glu Leu Thr Asp Asn Arg Asn Arg
1 5 10
<210> 2545
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2501
<400> 2545
Glu Lys Leu Ala Gln Cys Pro Pro Glu Met Phe Asp Ile Ile
1 5 10
<210> 2546
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2502
<400> 2546
Gly Arg Phe Lys Arg Ser Asp Gly Ser Thr Ser Ser Asp Thr
1 5 10
<210> 2547
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2503
<400> 2547
Pro Pro Ala Arg Gln Gly Ser Trp Glu Asp Glu
1 5 10
<210> 2548
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2504
<400> 2548
Pro Gln Gly Lys Tyr Ser Lys Arg Lys Gly Arg Phe Lys Arg
1 5 10
<210> 2549
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2505
<400> 2549
Gln Gly Pro Tyr Leu Ala Ser Gly Asp Gln Pro Leu Glu Arg
1 5 10
<210> 2550
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2506
<400> 2550
Arg Gly Pro Tyr Pro Pro Ser Gln Glu Ile Pro Met Glu Val
1 5 10
<210> 2551
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2507
<400> 2551
Thr Pro Pro Ala Arg Gln Gly Ser Trp Glu Asp Glu Glu Glu
1 5 10
<210> 2552
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2508
<400> 2552
Tyr Leu Ala Ser Gly Asp Gln Pro Leu Glu Arg
1 5 10
<210> 2553
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2509
<400> 2553
Ala Arg Gln Gly Ser Trp Glu Asp Glu Glu Glu Asp Tyr Glu
1 5 10
<210> 2554
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2510
<400> 2554
Asp Ala Asp Thr Pro Gly Ser Arg Asn Ser Ala Tyr Thr Glu
1 5 10
<210> 2555
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2511
<400> 2555
Glu Asp Glu Glu Glu Asp Tyr Glu Glu Glu Leu Thr Asp Asn
1 5 10
<210> 2556
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2512
<400> 2556
Gly Ser Trp Glu Asp Glu Glu Glu Asp Tyr Glu Glu Glu Leu
1 5 10
<210> 2557
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2513
<400> 2557
Asn Val Gly Tyr Asn Pro Ser Pro Gly Asp Glu Val Pro Val
1 5 10
<210> 2558
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2514
<400> 2558
Arg Asn Lys Ala Arg Tyr Cys Ala Glu Gly Gly Gly Pro Val
1 5 10
<210> 2559
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2515
<400> 2559
Thr Pro Gly Ser Arg Asn Ser Ala Tyr Thr Glu Leu Gly Asp
1 5 10
<210> 2560
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2516
<400> 2560
Lys Arg Ser Asp Gly Ser Thr Ser Ser Asp Thr Thr Ser Asn
1 5 10
<210> 2561
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2517
<400> 2561
Ala Asp Val Cys Gly Pro Leu Phe Glu Glu Glu Leu Thr Phe
1 5 10
<210> 2562
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2518
<400> 2562
Leu Arg Asp Leu Pro Leu Gln His Ser Pro Glu Ala Ala Cys
1 5 10
<210> 2563
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2519
<400> 2563
Arg Arg Glu Val Glu Thr Glu Pro Ile Leu Thr Tyr Ile Glu
1 5 10
<210> 2564
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2520
<400> 2564
His Cys Pro Ala Asp Val Cys Gly Pro Leu Phe Glu Glu Glu
1 5 10
<210> 2565
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2521
<400> 2565
Cys Cys Pro Asp Thr Leu Asp Phe Val Lys Asn Leu Leu Asn
1 5 10
<210> 2566
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2522
<400> 2566
Asp His Thr Asp Phe Lys Asn Ile Pro Ile Gly Phe Trp Trp
1 5 10
<210> 2567
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2523
<400> 2567
Glu Glu Leu Thr Phe Trp Gly Ile Asp Glu Thr Asp Val Glu
1 5 10
<210> 2568
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2524
<400> 2568
Phe Leu Val Arg Ile Val Cys Cys Pro Asp Thr Leu Asp Phe
1 5 10
<210> 2569
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2525
<400> 2569
Lys Gln Lys Leu Pro Lys Lys Arg Lys Lys His Val Pro Arg
1 5 10
<210> 2570
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2526
<400> 2570
Leu Phe Glu Glu Glu Leu Thr Phe Trp Gly Ile Asp Glu Thr
1 5 10
<210> 2571
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2527
<400> 2571
Thr Leu Glu Phe Leu Val Arg Ile Val Cys Cys Pro Asp Thr
1 5 10
<210> 2572
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2528
<400> 2572
Ala Gly Gly Gln Lys Cys Thr Val Ser Ile Asn
1 5 10
<210> 2573
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2529
<400> 2573
Ala Leu Val Leu Phe Ser Val Gly Ser Ser Leu Ile Phe Leu
1 5 10
<210> 2574
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2530
<400> 2574
Ala Tyr Thr Glu Asn Gly Glu Trp Ala Ile Asp
1 5 10
<210> 2575
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2531
<400> 2575
Ala Tyr Thr Glu Asn Gly Glu Trp Ala Ile Asp Phe Cys Pro
1 5 10
<210> 2576
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2532
<400> 2576
Cys Cys Val Asp Ala Val Asn Phe Val Ala Glu
1 5 10
<210> 2577
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2533
<400> 2577
Asp Thr Glu Ala Tyr Thr Glu Asn Gly Glu Trp Ala Ile Asp
1 5 10
<210> 2578
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2534
<400> 2578
Ile Phe Arg Ser Gln Thr Tyr Asn Ala Glu Glu Val Glu Phe
1 5 10
<210> 2579
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2535
<400> 2579
Leu Gly Val Leu Leu Leu Leu Gly Leu Leu Gly
1 5 10
<210> 2580
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2536
<400> 2580
Asn Asn Tyr Asp Pro Gly Ser Arg Pro Val Arg Glu Pro Glu
1 5 10
<210> 2581
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2537
<400> 2581
Pro Pro Arg Arg Ala Ser Ser Val Gly Leu Leu
1 5 10
<210> 2582
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2538
<400> 2582
Ser Gln Thr Tyr Asn Ala Glu Glu Val Glu Phe
1 5 10
<210> 2583
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2539
<400> 2583
Thr Tyr Asn Ala Glu Glu Val Glu Phe Thr Phe
1 5 10
<210> 2584
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2540
<400> 2584
Val Cys Ala Val Glu Val Thr Tyr Phe Pro Phe Asp Trp Gln
1 5 10
<210> 2585
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2541
<400> 2585
Val Asp Ala Val Asn Phe Val Ala Glu Ser Thr
1 5 10
<210> 2586
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2542
<400> 2586
Val Gly Leu Leu Leu Arg Ala Glu Glu Leu Ile Leu Lys Lys
1 5 10
<210> 2587
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2543
<400> 2587
Val Arg Cys Cys Val Asp Ala Val Asn Phe Val
1 5 10
<210> 2588
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2544
<400> 2588
Val Arg Cys Cys Val Asp Ala Val Asn Phe Val Ala Glu Ser
1 5 10
<210> 2589
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2545
<400> 2589
Lys Lys Pro Arg Ser Glu Leu Val Phe Glu Gly Gln Arg
1 5 10
<210> 2590
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2546
<400> 2590
Leu Gly Ala Ala Ala Pro Glu Val Arg Cys Cys Val Asp
1 5 10
<210> 2591
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2547
<400> 2591
Leu Gly Leu Leu Gly Arg Gly Val Gly Lys Asn Glu Glu
1 5 10
<210> 2592
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2548
<400> 2592
Asn Ala Glu Glu Val Glu Phe Thr Phe Ala Val Asp Asn
1 5 10
<210> 2593
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2549
<400> 2593
Thr Glu Asn Gly Glu Trp Ala Ile Asp Phe Cys Pro Gly
1 5 10
<210> 2594
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2550
<400> 2594
Thr Leu Thr Thr Ser Val Trp
1 5
<210> 2595
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2551
<400> 2595
Tyr Ser Leu Ile Ile Arg Arg
1 5
<210> 2596
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2552
<400> 2596
Glu Arg Glu Ser Lys Ala Glu Lys Val Leu Gln Phe Asp Pro
1 5 10
<210> 2597
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2553
<400> 2597
Phe Ser Trp Gly Val Leu Leu Asn Ser Gly Ile Gly Glu Gly
1 5 10
<210> 2598
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2554
<400> 2598
Gly Glu Thr Glu Lys Pro Arg Gly Tyr Gln Met Ser Thr Arg
1 5 10
<210> 2599
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2555
<400> 2599
Gly Ile Asn Asp Pro Arg Leu Arg Asn Pro Ser Asp Lys Phe
1 5 10
<210> 2600
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2556
<400> 2600
Gly Ser Trp Lys Ile Gln Leu Asn Ala Thr Ser Val Thr His
1 5 10
<210> 2601
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2557
<400> 2601
Leu His Ala Phe Ile Trp Asp Ser Ala Val Leu Glu Phe Glu
1 5 10
<210> 2602
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2558
<400> 2602
Leu Leu Glu Glu Arg Glu Ser Lys Ala Glu Lys Val Leu Gln
1 5 10
<210> 2603
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2559
<400> 2603
Met Leu Tyr Leu Leu Asp Arg Phe Ser Pro Phe Gly Arg Phe
1 5 10
<210> 2604
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2560
<400> 2604
Asn Asp His Phe Thr Pro Thr Pro Val Ser Tyr Thr Ala Gly
1 5 10
<210> 2605
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2561
<400> 2605
Pro Leu Thr Ile Asn Asn Glu Arg Ala Gln Tyr Ile Glu Phe
1 5 10
<210> 2606
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2562
<400> 2606
Arg Phe Lys Val Asn Ser Glu Glu Glu Glu Glu Asp Ala Leu
1 5 10
<210> 2607
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2563
<400> 2607
Arg Arg Ser Ser Lys Asp Thr Ser Thr Gly Gly Gly Arg Gly
1 5 10
<210> 2608
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2564
<400> 2608
Ser Asp Asp His Glu Gly Arg Ala Ala Gln Lys Arg Leu Glu
1 5 10
<210> 2609
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2565
<400> 2609
Phe Asp Pro Gly Thr Lys Asn Val Thr Ala Leu Leu Met Glu
1 5 10
<210> 2610
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2566
<400> 2610
Lys Leu His Ala Phe Ile Trp Asp Ser Ala Val Leu Glu Phe
1 5 10
<210> 2611
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2567
<400> 2611
Ser Glu Glu Glu Glu Glu Asp Ala Leu Thr Leu Ser Ser Ala
1 5 10
<210> 2612
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2568
<400> 2612
Leu Pro Asp Phe Met Leu Val Leu Ile Val Leu
1 5 10
<210> 2613
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2569
<400> 2613
Ser Ser Ser Thr Tyr His Pro Met Ala Pro Trp
1 5 10
<210> 2614
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2570
<400> 2614
Thr Val Phe Val Ile Asn Val His His Arg Ser Ser Ser Thr
1 5 10
<210> 2615
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2571
<400> 2615
Val Leu Phe Glu Asn Ala Asp Gly Arg Phe Glu
1 5 10
<210> 2616
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2572
<400> 2616
Lys Glu Glu Ser Gln Pro Val
1 5
<210> 2617
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2573
<400> 2617
Leu Ile Val Leu Gly Ile Pro Ser Ser Ala Thr Thr Gly
1 5 10
<210> 2618
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2574
<400> 2618
Tyr Phe Gly Leu Lys Ile Ser Gln Leu Val Asp Val Asp
1 5 10
<210> 2619
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2575
<400> 2619
Ala Arg Arg Pro Pro Ala Ser Ser Glu Gln Ala Gln Gln Glu
1 5 10
<210> 2620
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2576
<400> 2620
Ile Ile Arg Arg Lys Pro Leu Phe Tyr Ile Ile
1 5 10
<210> 2621
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2577
<400> 2621
Leu Gly Tyr Ile Ser Lys Ala Glu Glu Tyr Phe
1 5 10
<210> 2622
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2578
<400> 2622
Asn Gln Pro Pro Pro Gln Pro Phe Pro Gly Asp Pro Tyr Ser
1 5 10
<210> 2623
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2579
<400> 2623
Asn Val Asp Pro Arg Ala Pro Leu Asp Ser Pro
1 5 10
<210> 2624
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2580
<400> 2624
Pro Ala Ser Ser Glu Gln Ala Gln Gln Glu Leu
1 5 10
<210> 2625
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2581
<400> 2625
Pro Pro Ala Ser Ser Glu Gln Ala Gln Gln Glu Leu Phe Asn
1 5 10
<210> 2626
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2582
<400> 2626
Pro Pro Gln Pro Phe Pro Gly Asp Pro Tyr Ser Tyr Asn Val
1 5 10
<210> 2627
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2583
<400> 2627
Pro Gln Pro Phe Pro Gly Asp Pro Tyr Ser Tyr
1 5 10
<210> 2628
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2584
<400> 2628
Pro Ser Pro Gly Ala Leu Val Arg Arg Ser Ser Ser Leu Gly
1 5 10
<210> 2629
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2585
<400> 2629
Gln Asn Cys Ser Leu Lys Phe Ser Ser Leu Lys
1 5 10
<210> 2630
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2586
<400> 2630
Arg Arg Lys Pro Leu Phe Tyr Ile Ile Asn Ile
1 5 10
<210> 2631
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2587
<400> 2631
Val Glu Trp Ile Ile Ile Asp Pro Glu Gly Phe
1 5 10
<210> 2632
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2588
<400> 2632
Val Arg Arg Ser Ser Ser Leu Gly Tyr Ile Ser Lys Ala Glu
1 5 10
<210> 2633
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2589
<400> 2633
Phe Ser Ser Leu Lys Tyr Thr
1 5
<210> 2634
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2590
<400> 2634
Ile Arg Arg Lys Pro Leu Phe Tyr Ile Ile Asn Ile Leu
1 5 10
<210> 2635
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2591
<400> 2635
Asn Tyr Asn Glu Glu Lys Asp Ser Trp Asn Arg Val Ala
1 5 10
<210> 2636
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2592
<400> 2636
Pro Phe Pro Gly Asp Pro Tyr Ser Tyr Asn Val Gln Asp
1 5 10
<210> 2637
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2593
<400> 2637
Val Tyr Asn Gln Pro Pro Pro Gln Pro Phe Pro Gly Asp
1 5 10
<210> 2638
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2594
<400> 2638
Ala Glu Glu Glu Pro Ser Val Glu Pro Val Lys
1 5 10
<210> 2639
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2595
<400> 2639
Asp Ala Cys Glu His Leu Ala Asp Tyr Leu Glu Ala Tyr Trp
1 5 10
<210> 2640
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2596
<400> 2640
Asp Arg Glu Ala Val Arg Arg Glu Ala Glu Arg Gln Ala Gln
1 5 10
<210> 2641
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2597
<400> 2641
Gly Thr Ser Arg Gly Leu Ser Arg Gln Glu Thr
1 5 10
<210> 2642
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2598
<400> 2642
His Lys Ser Lys Asp Arg Tyr Cys Glu Lys Asp Gly Glu Val
1 5 10
<210> 2643
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2599
<400> 2643
Gln Leu Glu Asp Ala Cys Glu His Leu Ala Asp Tyr Leu Glu
1 5 10
<210> 2644
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2600
<400> 2644
Arg Lys Ser Thr Pro Pro Ser Ser Ala Ile Asp
1 5 10
<210> 2645
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2601
<400> 2645
Arg Ser Gly Thr Ser Arg Gly Leu Ser Arg Gln
1 5 10
<210> 2646
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2602
<400> 2646
Ser Thr Pro Pro Ser Ser Ala Ile Asp Ile Asp
1 5 10
<210> 2647
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2603
<400> 2647
His Asp His Val Asp His Tyr Ala Ser His Arg Asp His Asn
1 5 10
<210> 2648
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2604
<400> 2648
Pro Thr Leu Ala Ser Asn Ser Gln Gly Ser Gln Gly Asp Gln
1 5 10
<210> 2649
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2605
<400> 2649
Val Asp His Tyr Ala Ser His Arg Asp His Asn His Arg Asp
1 5 10
<210> 2650
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2606
<400> 2650
Glu Leu Gly Glu Glu Ala Met Glu Lys Phe Arg Glu Asp Glu
1 5 10
<210> 2651
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2607
<400> 2651
Lys Ser Glu Tyr Met Glu Ile Glu Glu Asp Met Asn Asn Ser
1 5 10
<210> 2652
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2608
<400> 2652
Met Phe Ser Glu Glu Ile Lys Phe Tyr Glu Leu Gly Glu Glu
1 5 10
<210> 2653
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2609
<400> 2653
Met Ser Gly Glu Asn Val Asp Glu Ala Ser Ala Ala Pro Gly
1 5 10
<210> 2654
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2610
<400> 2654
Met Thr Val Met Ser Gly Glu Asn Val Asp Glu Ala Ser Ala
1 5 10
<210> 2655
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2611
<400> 2655
Pro Leu Asp Met Phe Ser Glu Glu Ile Lys Phe Tyr Glu Leu
1 5 10
<210> 2656
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2612
<400> 2656
Ser Ala Ala Pro Gly His Pro Gln Asp Gly Ser Tyr Pro Arg
1 5 10
<210> 2657
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2613
<400> 2657
Ser Asn Ile Phe Thr Asp Pro Phe Phe Ile Val Glu Thr Leu
1 5 10
<210> 2658
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2614
<400> 2658
Ala Ala Gln Ile Ala Gln Ala Leu Leu Gly Ala Glu Glu Arg
1 5 10
<210> 2659
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2615
<400> 2659
Ala Leu Leu Ala Leu Thr Ala Arg Glu Ser Ser Val Arg Ser
1 5 10
<210> 2660
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2616
<400> 2660
Cys Glu Leu Cys Gly Tyr Ser Arg Ala Glu Val Met Gln Arg
1 5 10
<210> 2661
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2617
<400> 2661
Glu Asn Cys Ala Val Ile Tyr Cys Asn Asp Gly Phe Cys Glu
1 5 10
<210> 2662
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2618
<400> 2662
Phe Asp Leu Leu Ile Phe Gly Ser Gly Ser Glu Glu Leu Ile
1 5 10
<210> 2663
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2619
<400> 2663
Phe Leu Cys Leu Val Asp Val Val Pro Val Lys Asn Glu Asp
1 5 10
<210> 2664
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2620
<400> 2664
Gly Glu Pro Leu Met Glu Asp Cys Glu Lys Ser Ser Asp Thr
1 5 10
<210> 2665
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2621
<400> 2665
Ile Pro Gly Ser Pro Gly Ser Thr Glu Leu Glu Gly Gly Phe
1 5 10
<210> 2666
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2622
<400> 2666
Lys Leu Pro Ala Leu Leu Ala Leu Thr Ala Arg Glu Ser Ser
1 5 10
<210> 2667
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2623
<400> 2667
Leu Ile Ala His Trp Leu Ala Cys Ile Trp Tyr Ala Ile Gly
1 5 10
<210> 2668
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2624
<400> 2668
Leu Gln Ala Asp Ile Cys Leu His Leu Asn Arg Ser Leu Leu
1 5 10
<210> 2669
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2625
<400> 2669
Leu Thr Ser Val Gly Phe Gly Asn Val Ser Pro Asn Thr Asn
1 5 10
<210> 2670
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2626
<400> 2670
Leu Val Arg Val Ala Arg Lys Leu Asp Arg Tyr Ser Glu Tyr
1 5 10
<210> 2671
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2627
<400> 2671
Arg Asp Asp Leu Leu Glu Val Leu Asp Met Tyr Pro Glu Phe
1 5 10
<210> 2672
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2628
<400> 2672
Arg Arg Arg Thr Asp Lys Asp Thr Glu Gln Pro Gly Glu Val
1 5 10
<210> 2673
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2629
<400> 2673
Ser Pro Gly Ser Thr Glu Leu Glu Gly Gly Phe Ser Arg Gln
1 5 10
<210> 2674
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2630
<400> 2674
Ser Ser Val Arg Ser Gly Gly Ala Gly Gly Ala Gly Ala Pro
1 5 10
<210> 2675
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2631
<400> 2675
Met Ile Pro Gly Ser Pro Gly Ser Thr Glu Leu Glu Gly Gly
1 5 10
<210> 2676
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2632
<400> 2676
Pro Ala Leu Leu Ala Leu Thr Ala Arg Glu Ser Ser Val Arg
1 5 10
<210> 2677
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2633
<400> 2677
Pro Gln Glu Gly Pro Thr Arg Arg Leu Ser Leu Pro Gly Gln
1 5 10
<210> 2678
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2634
<400> 2678
Pro Tyr Ser Ala Ala Phe Leu Leu Lys Glu Thr Glu Glu Gly
1 5 10
<210> 2679
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2635
<400> 2679
Ser Arg Gln Arg Lys Arg Lys Leu Ser Phe Arg Arg Arg Thr
1 5 10
<210> 2680
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2636
<400> 2680
Ala Ser Cys Tyr Gly Gln Met Glu Arg Pro Glu Val Pro Met
1 5 10
<210> 2681
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2637
<400> 2681
Asp Gln Tyr Lys Leu Tyr Ser Lys His Phe Thr Leu Lys Asp
1 5 10
<210> 2682
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2638
<400> 2682
Glu Ala Lys Ala Ser Cys Tyr Gly Gln Met Glu Arg Pro Glu
1 5 10
<210> 2683
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2639
<400> 2683
Phe Thr Gly Val Cys Ser Asp Arg Pro Gly Leu Leu Phe Ser
1 5 10
<210> 2684
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2640
<400> 2684
Gly Lys Ala Pro His Gly Pro Ser Phe Thr Ile Gly Lys Ala
1 5 10
<210> 2685
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2641
<400> 2685
Ile Tyr Asp Ala Ala Val Leu Asn Tyr Lys Ala Gly Arg Asp
1 5 10
<210> 2686
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2642
<400> 2686
Lys Ala Ile Trp Leu Leu Trp Gly Leu Val Phe Asn Asn Ser
1 5 10
<210> 2687
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2643
<400> 2687
Lys Glu Phe Pro Ser Gly Leu Ile Ser Val Ser Tyr Asp Asp
1 5 10
<210> 2688
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2644
<400> 2688
Lys Phe Val Lys Ile Asn Asn Ser Thr Asn Glu Gly Met Asn
1 5 10
<210> 2689
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2645
<400> 2689
Leu Ala Lys Gly Lys Ala Pro His Gly Pro Ser Phe Thr Ile
1 5 10
<210> 2690
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2646
<400> 2690
Leu Ala Leu Leu Gln Phe Val Gly Asp Gly Glu Met Glu Glu
1 5 10
<210> 2691
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2647
<400> 2691
Leu Ile Ser Val Ser Tyr Asp Asp Trp Asp Tyr Ser Leu Glu
1 5 10
<210> 2692
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2648
<400> 2692
Leu Trp Leu Thr Gly Ile Cys His Asn Glu Lys Asn Glu Val
1 5 10
<210> 2693
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2649
<400> 2693
Asn Ser Val Pro Val Gln Asn Pro Lys Gly Thr Thr Ser Lys
1 5 10
<210> 2694
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2650
<400> 2694
Pro His Gly Pro Ser Phe Thr Ile Gly Lys Ala Ile Trp Leu
1 5 10
<210> 2695
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2651
<400> 2695
Pro Val Gln Asn Pro Lys Gly Thr Thr Ser Lys Ile Met Val
1 5 10
<210> 2696
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2652
<400> 2696
Thr Ile Gly Lys Ala Ile Trp Leu Leu Trp Gly Leu Val Phe
1 5 10
<210> 2697
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2653
<400> 2697
Val Phe Asn Asn Ser Val Pro Val Gln Asn Pro Lys Gly Thr
1 5 10
<210> 2698
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2654
<400> 2698
Trp Gly Leu Val Phe Asn Asn Ser Val Pro Val Gln Asn Pro
1 5 10
<210> 2699
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2655
<400> 2699
Trp Leu Leu Trp Gly Leu Val Phe Asn Asn Ser Val Pro Val
1 5 10
<210> 2700
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2656
<400> 2700
Pro Cys Arg Lys Phe Val Lys Ile Asn Asn Ser Thr Asn Glu
1 5 10
<210> 2701
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2657
<400> 2701
Ala Ala Ala Met Ala Leu Ser Leu Ile Thr Phe Ile Trp Glu
1 5 10
<210> 2702
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2658
<400> 2702
Ser Asn Arg Arg Val Tyr Lys Lys Met Pro Ser Ile Glu Ser
1 5 10
<210> 2703
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2659
<400> 2703
Thr Leu Pro Glu Asn Val Asp Phe Pro Asp Pro Tyr Gln Asp
1 5 10
<210> 2704
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2660
<400> 2704
Gly Asn Gly Cys Pro Glu Glu Glu Ser Lys Glu Ala Ser Ala
1 5 10
<210> 2705
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2661
<400> 2705
Trp Trp Arg Gly Asn Gly Cys Pro Glu Glu Glu Ser Lys Glu
1 5 10
<210> 2706
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2662
<400> 2706
Phe Ala His Ile Glu Glu Glu Asn Phe Val Asn Glu Leu Leu
1 5 10
<210> 2707
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2663
<400> 2707
Phe Gly Ala His Leu Ala Ser Phe Ala His Ile Glu Glu Glu
1 5 10
<210> 2708
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2664
<400> 2708
Asp Glu Ala Glu Asn Ala Phe Leu Leu Glu Glu Leu Phe Ala
1 5 10
<210> 2709
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2665
<400> 2709
Ser Thr Val Leu Asp Ser Met Ser Phe Glu Ala Ala His Glu
1 5 10
<210> 2710
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2666
<400> 2710
Ala Lys Ser Arg Arg Glu Phe Asp Glu Ile Glu Leu Ala Tyr
1 5 10
<210> 2711
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2667
<400> 2711
Ala Leu Asp Phe Ile Arg Arg Glu Ser Ser Val Tyr Asp Ile
1 5 10
<210> 2712
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2668
<400> 2712
Cys Glu Glu Asn Leu Phe Ser Asp Tyr Ile Ser Glu Val Glu
1 5 10
<210> 2713
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2669
<400> 2713
Asp Gly Ile Ala Ile Ile Thr Thr Ala Ala Ser Asp Met Leu
1 5 10
<210> 2714
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2670
<400> 2714
Asp Ser Lys Ile Gln Asn Gln Leu Lys Lys Leu Gln Ser Pro
1 5 10
<210> 2715
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2671
<400> 2715
Glu Glu Gln Glu Asp Asp His Leu Ser Ile Val Thr Leu Glu
1 5 10
<210> 2716
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2672
<400> 2716
Glu Leu Glu Glu Val Leu Leu Leu Asp Met Ser Leu Asp Asp
1 5 10
<210> 2717
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2673
<400> 2717
Glu Gln Glu Asp Asp His Leu Ser Ile Val Thr Leu Glu Glu
1 5 10
<210> 2718
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2674
<400> 2718
Glu Ser Ser Met Phe Phe Gln Phe Gly Pro Ser Ile Glu Gln
1 5 10
<210> 2719
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2675
<400> 2719
Ile Asp Ile Leu Lys Lys Ile Ser Lys Ser Val Lys Phe Thr
1 5 10
<210> 2720
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2676
<400> 2720
Ile Leu Gln Leu Phe Gly Asp Gly Glu Met Glu Glu Leu Glu
1 5 10
<210> 2721
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2677
<400> 2721
Ile Arg Ser Asp Val Ser Asp Ile Ser Thr His Thr Val Thr
1 5 10
<210> 2722
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2678
<400> 2722
Lys Tyr Tyr Val Trp Pro Arg Met Cys Pro Glu Thr Glu Glu
1 5 10
<210> 2723
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2679
<400> 2723
Leu Phe Gly Asp Gly Glu Met Glu Glu Leu Glu Ala Leu Trp
1 5 10
<210> 2724
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2680
<400> 2724
Leu Ile Val Ser Ala Val Ala Val Phe Val Phe Glu Tyr Phe
1 5 10
<210> 2725
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2681
<400> 2725
Asn Leu Ala Ala Phe Met Ile Gln Glu Glu Tyr Val Asp Gln
1 5 10
<210> 2726
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2682
<400> 2726
Pro Thr Gly Leu Ile Ser Val Ser Tyr Asp Glu Trp Asp Tyr
1 5 10
<210> 2727
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2683
<400> 2727
Gln Ala Ser Val Met Leu Asn Ile Met Glu Glu Tyr Asp Trp
1 5 10
<210> 2728
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2684
<400> 2728
Ser Ala Lys Ser Arg Arg Glu Phe Asp Glu Ile Glu Leu Ala
1 5 10
<210> 2729
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2685
<400> 2729
Ser Glu His Ser Phe Ile Pro Glu Pro Lys Ser Ser Cys Tyr
1 5 10
<210> 2730
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2686
<400> 2730
Ser Phe Val Gly Trp Glu Leu Glu Glu Val Leu Leu Leu Asp
1 5 10
<210> 2731
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2687
<400> 2731
Ser Gly Val Pro Ala Pro Trp Glu Lys Asn Leu Thr Asn Val
1 5 10
<210> 2732
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2688
<400> 2732
Ser Pro Ser Ala Phe Leu Glu Pro Phe Ser Ala Asp Val Trp
1 5 10
<210> 2733
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2689
<400> 2733
Ser Gln Lys Ser Pro Pro Ser Ile Gly Ile Ala Val Ile Leu
1 5 10
<210> 2734
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2690
<400> 2734
Val Trp Pro Arg Met Cys Pro Glu Thr Glu Glu Gln Glu Asp
1 5 10
<210> 2735
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2691
<400> 2735
Trp Glu Lys Asn Leu Thr Asn Val Glu Trp Glu Asp Arg Ser
1 5 10
<210> 2736
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2692
<400> 2736
Tyr Asn Asn Pro Pro Cys Glu Glu Asn Leu Phe Ser Asp Tyr
1 5 10
<210> 2737
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2693
<400> 2737
Phe Ser Pro Val Gly Tyr Asn Arg Cys Leu Ala Asp Gly Arg
1 5 10
<210> 2738
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2694
<400> 2738
Ile Glu Leu Ala Tyr Arg Arg Arg Pro Pro Arg Ser Pro Asp
1 5 10
<210> 2739
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2695
<400> 2739
Glu Glu Thr Pro Leu Phe Leu Ala Glu Pro Ala Leu Pro Lys
1 5 10
<210> 2740
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2696
<400> 2740
Glu Asn Pro Asn Phe Lys Arg Ile Cys Thr Gly Asn Glu Ser
1 5 10
<210> 2741
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2697
<400> 2741
Gly Leu Arg Ser Leu Tyr Pro Pro Pro Pro Pro Pro Gln His
1 5 10
<210> 2742
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2698
<400> 2742
Lys Leu Gln Ser Pro Glu Val Arg Ser Phe Asp Asp Tyr Phe
1 5 10
<210> 2743
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2699
<400> 2743
Met Leu Asp Ile Val Lys Arg Tyr Asn Trp Thr Tyr Val Ser
1 5 10
<210> 2744
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2700
<400> 2744
Met Pro Ile Leu Ser Tyr Pro Ser Ile Lys Glu Val Tyr Leu
1 5 10
<210> 2745
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2701
<400> 2745
Pro Gly Asn Gly Leu Arg Ser Leu Tyr Pro Pro Pro Pro Pro
1 5 10
<210> 2746
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2702
<400> 2746
Ser Thr Lys Thr Leu Tyr Asn Val Glu Glu Glu Glu Asp Ala
1 5 10
<210> 2747
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2703
<400> 2747
Thr Ala Cys Lys Glu Asn Glu Tyr Val Gln Asp Glu Phe Thr
1 5 10
<210> 2748
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2704
<400> 2748
Val Gln Leu Thr Leu Val Val Thr Leu Ile Ile Met Glu Pro
1 5 10
<210> 2749
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2705
<400> 2749
Asn Thr Glu Glu Asp Glu Leu Glu Glu Glu Glu Glu Asp Leu
1 5 10
<210> 2750
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2706
<400> 2750
Arg Glu Gly Asn Thr Glu Glu Asp Glu Leu Glu Glu Glu Glu
1 5 10
<210> 2751
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2707
<400> 2751
Thr Leu Tyr Asn Val Glu Glu Glu Glu Asp Ala Gln Pro Ile
1 5 10
<210> 2752
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2708
<400> 2752
Cys Thr Tyr Tyr Ala Phe Lys Thr Arg Asn Val Pro Ala Asn
1 5 10
<210> 2753
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2709
<400> 2753
Asp Ile Pro Gln Ile Ala Tyr Ser Ala Thr Ser Ile Asp Leu
1 5 10
<210> 2754
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2710
<400> 2754
Glu Asp Glu Leu Glu Glu Glu Glu Glu Asp Leu Gln Ala Ala
1 5 10
<210> 2755
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2711
<400> 2755
Gly Leu Ser Ser Ala Met Cys Tyr Ser Ala Leu Val Thr Lys
1 5 10
<210> 2756
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2712
<400> 2756
Arg Lys Leu Arg Glu Arg Leu Pro Lys Ala Arg Val Val Val
1 5 10
<210> 2757
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2713
<400> 2757
Phe Asp Thr Ala Glu Val Tyr Ala Ala Gly Lys Ala Glu Val
1 5 10
<210> 2758
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2714
<400> 2758
Val Phe Ala Asn Arg Pro Asp Pro Asn Thr Pro Met Glu Glu
1 5 10
<210> 2759
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2715
<400> 2759
Gly Ala Ile Gln Val Leu Pro Lys Leu Ser Ser Ser Ile Ile
1 5 10
<210> 2760
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2716
<400> 2760
Pro Lys Leu Ser Ser Ser Ile Ile His Glu Ile Asp Ser Ile
1 5 10
<210> 2761
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2717
<400> 2761
Gln Val Leu Pro Lys Leu Ser Ser Ser Ile Ile His Glu Ile
1 5 10
<210> 2762
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2718
<400> 2762
Ser Ser Ser Ile Ile His Glu Ile Asp Ser Ile Leu Gly Asn
1 5 10
<210> 2763
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2719
<400> 2763
Val Asp Val Val Phe Ala Asn Arg Pro Asp Pro Asn Thr Pro
1 5 10
<210> 2764
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2720
<400> 2764
Ala Leu Ala Asp Ala Cys Gln Met Glu Pro Glu Glu Val Glu
1 5 10
<210> 2765
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2721
<400> 2765
Asp Ala Cys Gln Met Glu Pro Glu Glu Val Glu
1 5 10
<210> 2766
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2722
<400> 2766
Asp Phe Glu Asp Thr Glu Val Arg Arg Ser Asn Phe Asp Asn
1 5 10
<210> 2767
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2723
<400> 2767
Asp Ile Gly Phe Thr Ser Val Phe Thr Val Glu
1 5 10
<210> 2768
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2724
<400> 2768
Asp Val Ile Leu Ser Glu Ile Asp Thr Phe Leu
1 5 10
<210> 2769
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2725
<400> 2769
Glu Ala Ser Ser Phe Phe Ile Phe Ser Pro Thr Asn Lys Ile
1 5 10
<210> 2770
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2726
<400> 2770
Glu His Phe Arg Lys Phe Met Lys Arg Gln Glu Glu Tyr Tyr
1 5 10
<210> 2771
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2727
<400> 2771
Glu Ile Glu Met Glu Glu Met Glu Ser Pro Val
1 5 10
<210> 2772
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2728
<400> 2772
Glu Lys Ala Val Pro Ile Pro Glu Ala Ser Ser
1 5 10
<210> 2773
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2729
<400> 2773
Phe Ala Glu Ile Glu Met Glu Glu Met Glu Ser
1 5 10
<210> 2774
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2730
<400> 2774
Phe Arg Cys Thr Asp Leu Ser Lys Met Thr Glu Glu Glu Cys
1 5 10
<210> 2775
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2731
<400> 2775
Gly Phe Thr Ser Val Phe Thr Val Glu Ile Val
1 5 10
<210> 2776
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2732
<400> 2776
Gly Gly Leu Tyr Cys Leu Gly Gly Gly Cys Gly Asn Val Asp
1 5 10
<210> 2777
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2733
<400> 2777
His Phe Arg Lys Phe Met Lys Arg Gln Glu Glu
1 5 10
<210> 2778
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2734
<400> 2778
Ile Glu Met Glu Glu Met Glu Ser Pro Val Phe Leu Glu Asp
1 5 10
<210> 2779
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2735
<400> 2779
Ile Ile Leu Leu Thr Ile Phe Ala Asn Cys Val Ala Leu Ala
1 5 10
<210> 2780
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2736
<400> 2780
Lys Asp Pro Tyr Pro Ser Ala Asp Phe Pro Gly Asp Asp Glu
1 5 10
<210> 2781
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2737
<400> 2781
Lys Leu Leu Asp Gln Val Ile Pro Pro Ile Gly Asp Asp Glu
1 5 10
<210> 2782
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2738
<400> 2782
Leu Ala Asp Ala Cys Gln Met Glu Pro Glu Glu
1 5 10
<210> 2783
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2739
<400> 2783
Leu Asp Glu Phe Lys Ala Ile Trp Ala Glu Tyr Asp Pro Glu
1 5 10
<210> 2784
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2740
<400> 2784
Leu Gln Phe Ala Glu Ile Glu Met Glu Glu Met
1 5 10
<210> 2785
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2741
<400> 2785
Leu Arg His Arg Glu Trp Val His Ser Asp Phe His Phe Asp
1 5 10
<210> 2786
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2742
<400> 2786
Leu Arg Lys Ala Cys Ile Ser Ile Val Glu Trp Lys Pro Phe
1 5 10
<210> 2787
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2743
<400> 2787
Leu Ser Pro Arg Pro Arg Pro Leu Ala Glu Leu
1 5 10
<210> 2788
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2744
<400> 2788
Leu Tyr Cys Leu Gly Gly Gly Cys Gly Asn Val
1 5 10
<210> 2789
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2745
<400> 2789
Met Ser Trp Ile Thr Gln Gly Glu Val Met Asp Val Glu Asp
1 5 10
<210> 2790
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2746
<400> 2790
Asn Cys Val Ala Leu Ala Val Tyr Leu Pro Met Pro Glu Asp
1 5 10
<210> 2791
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2747
<400> 2791
Pro Leu Gln Phe Ala Glu Ile Glu Met Glu Glu Met Glu Ser
1 5 10
<210> 2792
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2748
<400> 2792
Gln Ala Leu Ala Asp Ala Cys Gln Met Glu Pro
1 5 10
<210> 2793
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2749
<400> 2793
Gln Val Ile Pro Pro Ile Gly Asp Asp Glu Val
1 5 10
<210> 2794
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2750
<400> 2794
Arg Cys Thr Asp Leu Ser Lys Met Thr Glu Glu
1 5 10
<210> 2795
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2751
<400> 2795
Arg Tyr Asp Phe Glu Asp Thr Glu Val Arg Arg
1 5 10
<210> 2796
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2752
<400> 2796
Ser Ala Asp Phe Pro Gly Asp Asp Glu Glu Asp
1 5 10
<210> 2797
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2753
<400> 2797
Ser Asp Tyr Ala Pro Gly Glu Glu Tyr Thr Cys Gly Thr Asn
1 5 10
<210> 2798
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2754
<400> 2798
Thr Phe Glu Gly Trp Pro Gln Leu Leu Tyr Lys Ala Ile Asp
1 5 10
<210> 2799
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2755
<400> 2799
Val Ala Thr Val Glu Asn Glu Glu Pro Ser Pro
1 5 10
<210> 2800
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2756
<400> 2800
Val Phe Ser Ser Val His Tyr Glu Arg Glu Phe
1 5 10
<210> 2801
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2757
<400> 2801
Val Thr Phe Gln Glu Gln Gly Glu Thr Glu Tyr
1 5 10
<210> 2802
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2758
<400> 2802
Trp Pro Gln Leu Leu Tyr Lys Ala Ile Asp Ser
1 5 10
<210> 2803
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2759
<400> 2803
Tyr Ala Pro Gly Glu Glu Tyr Thr Cys Gly Thr
1 5 10
<210> 2804
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2760
<400> 2804
Tyr Cys Leu Gly Gly Gly Cys Gly Asn Val Asp Pro Asp Glu
1 5 10
<210> 2805
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2761
<400> 2805
Asp Pro Glu Ser Asp Tyr Ala Pro Gly Glu Glu Tyr Thr Cys
1 5 10
<210> 2806
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2762
<400> 2806
Ala Thr Val Glu Asn Glu Glu Pro Ser Pro Cys Ala Arg Thr
1 5 10
<210> 2807
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2763
<400> 2807
Gly Lys Phe Phe Arg Cys Thr Asp Leu Ser Lys Met Thr Glu
1 5 10
<210> 2808
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2764
<400> 2808
Val His Tyr Glu Arg Glu Phe Pro Glu Glu Thr Glu Thr Pro
1 5 10
<210> 2809
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2765
<400> 2809
Ala Glu Ser Leu Thr Ser Ala Gln Lys Glu Glu Glu Glu Glu
1 5 10
<210> 2810
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2766
<400> 2810
Ala Gly Asn Ala Thr Ile Ser Thr Val Ser Ser
1 5 10
<210> 2811
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2767
<400> 2811
Ala Gly Tyr Pro Ser Thr Val Ser Thr Val Glu Gly His Gly
1 5 10
<210> 2812
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2768
<400> 2812
Ala Gln Asp Pro Lys Phe Ile Glu Val Thr Thr Gln Glu Leu
1 5 10
<210> 2813
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2769
<400> 2813
Cys Lys Gly Asn Tyr Ile Thr Tyr Lys Asp Gly Glu Val Asp
1 5 10
<210> 2814
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2770
<400> 2814
Cys Lys Arg Leu Val Ser Met Asn Met Pro Leu
1 5 10
<210> 2815
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2771
<400> 2815
Cys Leu Thr Leu Lys Asn Pro Ile Arg Arg Ala
1 5 10
<210> 2816
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2772
<400> 2816
Cys Ser Asp Ser Ser Lys Gln Thr Glu Ala Glu
1 5 10
<210> 2817
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2773
<400> 2817
Cys Val Arg Ala Arg Gly Arg Pro Ser Glu Glu Glu Leu Gln
1 5 10
<210> 2818
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2774
<400> 2818
Asp Met Thr Ile Glu Glu Met Glu Ser Ala Ala Asp Asn Ile
1 5 10
<210> 2819
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2775
<400> 2819
Glu Asp Glu Glu Glu Pro Glu Met Pro Val Gly
1 5 10
<210> 2820
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2776
<400> 2820
Glu Asp Glu Gly Met Asp Glu Glu Lys Pro Arg
1 5 10
<210> 2821
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2777
<400> 2821
Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ala
1 5 10
<210> 2822
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2778
<400> 2822
Phe Asp Ile Val Phe Thr Thr Ile Phe Thr Ile Glu Ile Ala
1 5 10
<210> 2823
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2779
<400> 2823
Gly Gly Pro Ser Phe Pro Gly Met Leu Val Cys Ile Tyr Phe
1 5 10
<210> 2824
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2780
<400> 2824
Gly Gly Ser Ser Ala Ala Arg Arg Val Arg Pro
1 5 10
<210> 2825
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2781
<400> 2825
Gly Ser Ala Gly Asn Ala Thr Ile Ser Thr Val
1 5 10
<210> 2826
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2782
<400> 2826
Gly Ser Ile Val Asp Ile Ala Ile Thr Glu Val Asn Pro Ala
1 5 10
<210> 2827
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2783
<400> 2827
Gly Ser Arg Gly Trp Pro Pro Gln Pro Val Pro Thr Leu Arg
1 5 10
<210> 2828
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2784
<400> 2828
His Arg Ile Ser Lys Ser Lys Phe Ser Arg Tyr Trp Arg Arg
1 5 10
<210> 2829
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2785
<400> 2829
Lys Leu Met Gly Ser Ala Gly Asn Ala Thr Ile Ser Thr Val
1 5 10
<210> 2830
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2786
<400> 2830
Leu Phe Thr Val Glu Met Ile Leu Lys Leu Ile Ala Phe Lys
1 5 10
<210> 2831
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2787
<400> 2831
Leu Thr Ile Phe Ala Asn Cys Val Ala Leu Ala Ile Tyr Ile
1 5 10
<210> 2832
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2788
<400> 2832
Leu Thr Ser Ala Gln Lys Glu Glu Glu Glu Glu
1 5 10
<210> 2833
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2789
<400> 2833
Met Asp Glu Glu Lys Pro Arg Asn Met Ser Met Pro Thr Ser
1 5 10
<210> 2834
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2790
<400> 2834
Met His Lys Thr Cys Tyr Asn Gln Glu Gly Ile Ala Asp Val
1 5 10
<210> 2835
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2791
<400> 2835
Met Val Pro Ser Gln Ala Gly Ala Pro Gly Arg Gln Phe His
1 5 10
<210> 2836
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2792
<400> 2836
Asn Tyr Ile Thr Tyr Lys Asp Gly Glu Val Asp
1 5 10
<210> 2837
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2793
<400> 2837
Pro Glu Asp Asp Ser Asn Ala Thr Asn Ser Asn
1 5 10
<210> 2838
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2794
<400> 2838
Pro Glu Thr Thr Gly Glu Glu Asp Glu Glu Glu
1 5 10
<210> 2839
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2795
<400> 2839
Pro His His Leu Asp Glu Phe Lys Arg Ile Trp Ala Glu Tyr
1 5 10
<210> 2840
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2796
<400> 2840
Pro Leu Ser Pro Ala Ile Arg Val Gln Glu Val Ala Trp Lys
1 5 10
<210> 2841
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2797
<400> 2841
Pro Val Gly Pro Arg Pro Arg Pro Leu Ser Glu
1 5 10
<210> 2842
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2798
<400> 2842
Gln Lys Glu Glu Glu Glu Glu Lys Glu Arg Lys
1 5 10
<210> 2843
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2799
<400> 2843
Gln Arg Lys Arg Gln Gln Tyr Gly Lys Pro Lys
1 5 10
<210> 2844
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2800
<400> 2844
Arg Asn Met Ser Met Pro Thr Ser Glu Thr Glu Ser Val Asn
1 5 10
<210> 2845
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2801
<400> 2845
Ser Ala Gln Lys Glu Glu Glu Glu Glu Lys Glu
1 5 10
<210> 2846
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2802
<400> 2846
Ser Ile Thr Ala Asp Gly Glu Ser Pro Pro Ala
1 5 10
<210> 2847
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2803
<400> 2847
Ser Lys Gln Thr Glu Ala Glu Cys Lys Gly Asn
1 5 10
<210> 2848
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2804
<400> 2848
Ser Arg Gly Trp Pro Pro Gln Pro Val Pro Thr
1 5 10
<210> 2849
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2805
<400> 2849
Ser Thr Glu Met Leu Ser Tyr Gln Asp Asp Glu Asn Arg Gln
1 5 10
<210> 2850
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2806
<400> 2850
Ser Thr Gly Ser Asn Ala Asn Ile Asn Asn Ala
1 5 10
<210> 2851
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2807
<400> 2851
Ser Thr Gln Arg Lys Arg Gln Gln Tyr Gly Lys
1 5 10
<210> 2852
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2808
<400> 2852
Thr Ala Asp Gly Glu Ser Pro Pro Ala Thr Lys
1 5 10
<210> 2853
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2809
<400> 2853
Thr Phe Asp Asn Phe Pro Gln Ser Leu Leu Thr
1 5 10
<210> 2854
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2810
<400> 2854
Thr Phe Thr Pro Ser Ser Tyr Ser Ser Thr Gly Ser Asn Ala
1 5 10
<210> 2855
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2811
<400> 2855
Thr Gly Glu Glu Asp Glu Glu Glu Pro Glu Met Pro Val Gly
1 5 10
<210> 2856
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2812
<400> 2856
Thr Ile Glu Ile Ala Leu Lys Ile Leu Gly Asn Ala Asp Tyr
1 5 10
<210> 2857
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2813
<400> 2857
Thr Ile Phe Thr Asn Leu Ile Leu Phe Phe Ile Leu Leu Ser
1 5 10
<210> 2858
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2814
<400> 2858
Thr Thr Gly Glu Glu Asp Glu Glu Glu Pro Glu
1 5 10
<210> 2859
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2815
<400> 2859
Val Glu Tyr Leu Phe Leu Ile Ile Phe Thr Val Glu Ala Phe
1 5 10
<210> 2860
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2816
<400> 2860
Val Gly Arg Asp Trp Pro Trp Ile Tyr Phe Val
1 5 10
<210> 2861
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2817
<400> 2861
Val Asn Ser Thr Tyr Phe Glu Tyr Leu Met Phe Val Leu Ile
1 5 10
<210> 2862
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2818
<400> 2862
Val Ser Leu Met Val Pro Ser Gln Ala Gly Ala Pro Gly Arg
1 5 10
<210> 2863
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2819
<400> 2863
Trp Asp Gly Pro Lys His Gly Ile Thr Asn Phe Asp Asn Phe
1 5 10
<210> 2864
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2820
<400> 2864
Tyr Phe Glu Tyr Leu Met Phe Val Leu Ile Leu
1 5 10
<210> 2865
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2821
<400> 2865
Tyr Phe Ser Asp Pro Trp Asn Val Phe Asp Phe
1 5 10
<210> 2866
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2822
<400> 2866
Tyr Lys Val Trp Tyr Val Val Asn Ser Thr Tyr Phe Glu Tyr
1 5 10
<210> 2867
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2823
<400> 2867
Tyr Leu Phe Leu Ile Ile Phe Thr Val Glu Ala
1 5 10
<210> 2868
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2824
<400> 2868
Tyr Pro Asn Pro Glu Thr Thr Gly Glu Glu Asp Glu Glu Glu
1 5 10
<210> 2869
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2825
<400> 2869
Tyr Thr Cys Ser Asp Ser Ser Lys Gln Thr Glu
1 5 10
<210> 2870
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2826
<400> 2870
Thr Glu Ser Val Asn Thr Glu Asn Val Ala Gly Gly Asp Ile
1 5 10
<210> 2871
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2827
<400> 2871
Thr Ser Glu Thr Glu Ser Val Asn Thr Glu Asn Val Ala Gly
1 5 10
<210> 2872
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2828
<400> 2872
Asp Asp Ser Asn Ala Thr Asn Ser Asn Leu Glu Arg Val Glu
1 5 10
<210> 2873
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2829
<400> 2873
Ala Pro Gly Glu Pro Cys Pro Leu Ala Gln Glu Glu Val Ile
1 5 10
<210> 2874
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2830
<400> 2874
Ala Ser Pro Ile Pro Gly Ala Pro Pro Glu Asn Ile Thr Asn
1 5 10
<210> 2875
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2831
<400> 2875
Cys Lys Pro Asp Pro Pro Pro Pro Pro Pro Pro His Pro His
1 5 10
<210> 2876
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2832
<400> 2876
Asp Gly Gly Leu Asp Asp Glu Ala Gly Ala Gly Gly Gly Gly
1 5 10
<210> 2877
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2833
<400> 2877
Asp Val Cys Gly Pro Leu Phe Glu Glu Glu Leu Gly Phe Trp
1 5 10
<210> 2878
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2834
<400> 2878
Leu Cys Phe Gln Asp Ala Gly Gly Gly Ala Gly Gly Pro Pro
1 5 10
<210> 2879
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2835
<400> 2879
Leu Asp Asp Glu Ala Gly Ala Gly Gly Gly Gly Leu Asp Gly
1 5 10
<210> 2880
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2836
<400> 2880
Leu Lys Arg Leu Cys Phe Gln Asp Ala Gly Gly Gly Ala Gly
1 5 10
<210> 2881
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2837
<400> 2881
Pro Asp Asp Ile Leu Gly Ser Asn His Thr Tyr Phe Lys Asn
1 5 10
<210> 2882
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2838
<400> 2882
Pro Pro Pro Gln Pro Pro Glu Ser Pro Pro Pro Pro Pro Leu
1 5 10
<210> 2883
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2839
<400> 2883
Arg Gly Arg Gln Gly Ala Ser Lys Gln Gln Pro Ala Pro Pro
1 5 10
<210> 2884
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2840
<400> 2884
Ser Asn His Thr Tyr Phe Lys Asn Ile Pro Ile Gly Phe Trp
1 5 10
<210> 2885
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2841
<400> 2885
Ala Pro Pro Glu Asn Ile Thr Asn Val Glu Val Glu Thr Glu
1 5 10
<210> 2886
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2842
<400> 2886
Asp Ala Glu Glu Ala Leu Asp Ser Phe Glu Ala Pro Asp Pro
1 5 10
<210> 2887
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2843
<400> 2887
Arg Phe Asp Tyr Asp Pro Gly Ala Asp Glu Phe Phe Phe Asp
1 5 10
<210> 2888
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2844
<400> 2888
Tyr Tyr Ala Glu Arg Ile Gly Ala Asp Pro Asp Asp Ile Leu
1 5 10
<210> 2889
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2845
<400> 2889
Phe Asp Ala Pro Phe Arg Pro Ala Asp Thr His Asn Glu Val
1 5 10
<210> 2890
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2846
<400> 2890
Gly Pro Ala Lys Lys Val Leu Thr Leu Glu Gly Asp Leu Val
1 5 10
<210> 2891
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2847
<400> 2891
Asp Ser Leu Leu Glu Val Cys Asp Asp Tyr Ser Leu Asp Asp
1 5 10
<210> 2892
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2848
<400> 2892
Asp Tyr Trp Gly Ile Asp Glu Ile Tyr Leu Glu Ser Cys Cys
1 5 10
<210> 2893
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2849
<400> 2893
Glu Ala Glu Thr Leu Arg Glu Arg Glu Gly Glu Glu Phe Asp
1 5 10
<210> 2894
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2850
<400> 2894
Glu Leu Gly Leu Leu Ile Leu Phe Leu Ala Met Gly Ile Met
1 5 10
<210> 2895
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2851
<400> 2895
Glu Met Cys Ala Leu Ser Phe Ser Gln Glu Leu Asp Tyr Trp
1 5 10
<210> 2896
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2852
<400> 2896
Glu Pro Met Glu Ile Val Arg Ser Lys Ala Cys Ser Arg Arg
1 5 10
<210> 2897
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2853
<400> 2897
Lys Gly Pro Ser Gly Gln Glu Lys Cys Lys Leu Glu Asn His
1 5 10
<210> 2898
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2854
<400> 2898
Met Asn Met Lys Asp Ala Phe Ala Arg Ser Ile Glu Met Met
1 5 10
<210> 2899
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2855
<400> 2899
Arg Asp Cys Asn Thr His Asp Ser Leu Leu Glu Val Cys Asp
1 5 10
<210> 2900
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2856
<400> 2900
Arg Leu Asn Val Gly Gly Leu Ala His Glu Val Leu Trp Arg
1 5 10
<210> 2901
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2857
<400> 2901
Ser Ala Ala Gln Ser Lys Pro Lys Glu Glu Leu Glu Met Glu
1 5 10
<210> 2902
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2858
<400> 2902
Ser Phe Trp Trp Ala Thr Ile Thr Met Thr Thr Val Gly Tyr
1 5 10
<210> 2903
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2859
<400> 2903
Ser Gly Gln Glu Lys Cys Lys Leu Glu Asn His Ile Ser Pro
1 5 10
<210> 2904
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2860
<400> 2904
Thr Ser Ser Leu Pro Pro Glu Pro Met Glu Ile Val Arg Ser
1 5 10
<210> 2905
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2861
<400> 2905
Val Glu Ala Val Cys Ile Ala Trp Phe Thr Met Glu Tyr Leu
1 5 10
<210> 2906
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2862
<400> 2906
Tyr Ser Leu Asp Asp Asn Glu Tyr Phe Phe Asp Arg His Pro
1 5 10
<210> 2907
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2863
<400> 2907
Cys Asp Asp Tyr Ser Leu Asp Asp Asn Glu Tyr Phe Phe Asp
1 5 10
<210> 2908
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2864
<400> 2908
Leu Glu Val Cys Asp Asp Tyr Ser Leu Asp Asp Asn Glu Tyr
1 5 10
<210> 2909
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2865
<400> 2909
Asp Val Val Phe Ala Asn Arg Pro Asp Ser Asn Thr Pro Met
1 5 10
<210> 2910
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2866
<400> 2910
Lys Met Thr Ser His Val Val Asn Glu Ile Asp Asn Ile Leu
1 5 10
<210> 2911
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2867
<400> 2911
Val Leu Pro Lys Met Thr Ser His Val Val Asn Glu Ile Asp
1 5 10
<210> 2912
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2868
<400> 2912
Phe Ala Asn Arg Pro Asp Ser Asn Thr Pro Met Glu Glu Ile
1 5 10
<210> 2913
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2869
<400> 2913
Pro Cys Cys Trp Thr Cys Glu Pro Cys Asp Gly Tyr Gln Tyr
1 5 10
<210> 2914
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2870
<400> 2914
Pro Glu Leu Asn Val Gln Lys Arg Lys Arg Ser Phe Lys Ala
1 5 10
<210> 2915
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2871
<400> 2915
Cys Trp Ile Cys Ile Pro Cys Glu Pro Tyr Glu Tyr Leu Ala
1 5 10
<210> 2916
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2872
<400> 2916
Phe Gly Asp Gly Met Gly Arg Tyr Asn Val Phe Asn Phe Gln
1 5 10
<210> 2917
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2873
<400> 2917
Ala Ala Leu Val Arg Arg Ala Pro Gln Pro Pro Gly Arg Pro
1 5 10
<210> 2918
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2874
<400> 2918
Ala Pro Val Phe Val Ala Tyr Cys Ser Arg Glu Glu Ala Glu
1 5 10
<210> 2919
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2875
<400> 2919
Cys Leu Thr Val Val Ala Ile Thr Val Phe Met Phe Glu Tyr
1 5 10
<210> 2920
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2876
<400> 2920
Asp Met Val Thr Thr Ala Gly Val Ser Ser Ser Leu Asp Arg
1 5 10
<210> 2921
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2877
<400> 2921
Phe Met Ile Gln Glu Gln Tyr Ile Asp Thr Val Ser Gly Leu
1 5 10
<210> 2922
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2878
<400> 2922
Ile Gln Pro Leu Thr Val Gly Val Asn Thr Thr Asn Pro Ser
1 5 10
<210> 2923
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2879
<400> 2923
Lys Leu Arg His Ser Val Pro Asn Ser Ser Gln Leu Asp Phe
1 5 10
<210> 2924
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2880
<400> 2924
Leu Thr Val Gly Val Asn Thr Thr Asn Pro Ser Ser Leu Leu
1 5 10
<210> 2925
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2881
<400> 2925
Asn Glu Lys Asn Glu Val Met Ser Ser Lys Leu Asp Ile Asp
1 5 10
<210> 2926
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2882
<400> 2926
Pro Ala Pro Ala Gly Asp Cys Arg Val His Pro Gly Pro Val
1 5 10
<210> 2927
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2883
<400> 2927
Pro Glu Pro Ser Pro Thr Gly Trp Gly Pro Pro Asp Gly Gly
1 5 10
<210> 2928
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2884
<400> 2928
Gln Leu Gln Val Leu Phe Lys Val Leu Glu Glu Tyr Asp Trp
1 5 10
<210> 2929
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2885
<400> 2929
Arg Leu Leu Asp Val Val Thr Leu Glu Leu Gly Pro Gly Gly
1 5 10
<210> 2930
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2886
<400> 2930
Arg Pro Phe Leu Pro Leu Phe Pro Glu Leu Glu Asp Leu Pro
1 5 10
<210> 2931
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2887
<400> 2931
Arg Ser Gly Arg Pro Phe Leu Pro Leu Phe Pro Glu Leu Glu
1 5 10
<210> 2932
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2888
<400> 2932
Ser Gln Thr His Val Pro Ile Leu Ser Ile Ser Gly Gly Ser
1 5 10
<210> 2933
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2889
<400> 2933
Ser Val Val Thr Glu Ser Trp Arg Leu Ser Leu Arg Gln Lys
1 5 10
<210> 2934
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2890
<400> 2934
Val Lys Phe Asn Gln Arg Ser Val Glu Asp Ala Leu Thr Ser
1 5 10
<210> 2935
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2891
<400> 2935
Ala Thr Phe Pro Val Gly Leu Ile Ser Val Val Thr Glu Ser
1 5 10
<210> 2936
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2892
<400> 2936
Phe Leu Gly Asp Gly Glu Thr Gln Lys Leu Glu Thr Val Trp
1 5 10
<210> 2937
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2893
<400> 2937
Gln Pro Leu Thr Val Gly Val Asn Thr Thr Asn Pro Ser Ser
1 5 10
<210> 2938
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2894
<400> 2938
Val Trp Leu Ser Gly Ile Cys Gln Asn Glu Lys Asn Glu Val
1 5 10
<210> 2939
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2895
<400> 2939
Ala Glu Glu Arg Glu Val Val Val Glu Glu Glu Asp Arg Trp
1 5 10
<210> 2940
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2896
<400> 2940
Ala Lys Ile Asp Leu Glu Gln Met Glu Gln Thr Val Asp Leu
1 5 10
<210> 2941
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2897
<400> 2941
Ala Leu Leu Gln Glu Gly Glu Leu Leu Leu Ser
1 5 10
<210> 2942
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2898
<400> 2942
Ala Ser Gly Pro Lys Ala Glu Ala Leu Leu Gln Glu Gly Glu
1 5 10
<210> 2943
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2899
<400> 2943
Cys Lys Met Lys Phe Gly Ser Trp Thr Tyr Asp
1 5 10
<210> 2944
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2900
<400> 2944
Phe Arg Gly Tyr Asn Arg Trp Ala Arg Pro Val
1 5 10
<210> 2945
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2901
<400> 2945
Ile Asp Leu Glu Gln Met Glu Gln Thr Val Asp
1 5 10
<210> 2946
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2902
<400> 2946
Leu Glu Ser Asn Val Asp Ala Glu Glu Arg Glu Val Val Val
1 5 10
<210> 2947
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2903
<400> 2947
Leu Met Asn Arg Pro Pro Pro Pro Val Glu Leu
1 5 10
<210> 2948
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2904
<400> 2948
Asn Val Asp Ala Glu Glu Arg Glu Val Val Val
1 5 10
<210> 2949
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2905
<400> 2949
Asn Val Asp Ala Glu Glu Arg Glu Val Val Val Glu Glu Glu
1 5 10
<210> 2950
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2906
<400> 2950
Arg Glu Val Val Val Glu Glu Glu Asp Arg Trp
1 5 10
<210> 2951
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2907
<400> 2951
Arg Trp Asn Pro Thr Asp Phe Gly Asn Ile Thr
1 5 10
<210> 2952
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2908
<400> 2952
Trp Leu Leu Met Asn Arg Pro Pro Pro Pro Val Glu Leu Cys
1 5 10
<210> 2953
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2909
<400> 2953
Ala Glu Ala Leu Leu Gln Glu
1 5
<210> 2954
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2910
<400> 2954
Ala Leu Leu Gln Glu Gly Glu
1 5
<210> 2955
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2911
<400> 2955
Ala Leu Leu Gln Glu Gly Glu Leu Leu Leu Ser Pro His
1 5 10
<210> 2956
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2912
<400> 2956
Gly Ala Ser Gly Pro Lys Ala Glu Ala Leu Leu Gln Glu
1 5 10
<210> 2957
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2913
<400> 2957
Val Pro Pro Ala Ile Tyr Lys Ser Ser Cys Ser Ile Asp
1 5 10
<210> 2958
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2914
<400> 2958
Cys Glu Glu Ile Tyr Thr Asp Ile Thr Tyr Ser
1 5 10
<210> 2959
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2915
<400> 2959
Cys Phe His Cys His Lys Ser Asn Glu Leu Ala
1 5 10
<210> 2960
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2916
<400> 2960
Asp Gly Ile Glu Thr Leu Arg Val Pro Ala Asp
1 5 10
<210> 2961
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2917
<400> 2961
Asp Leu Leu Ile Ile Gly Ser Lys Val Asp Met
1 5 10
<210> 2962
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2918
<400> 2962
Glu Ile Asp Leu Leu Ile Ile Gly Ser Lys Val
1 5 10
<210> 2963
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2919
<400> 2963
Ile Thr Gln Leu Ala Asn Val Asp Glu Val Asn
1 5 10
<210> 2964
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2920
<400> 2964
Ile Thr Gln Leu Ala Asn Val Asp Glu Val Asn Gln Ile Met
1 5 10
<210> 2965
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2921
<400> 2965
Leu Ala Asn Val Asp Glu Val Asn Gln Ile Met Glu Thr Asn
1 5 10
<210> 2966
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2922
<400> 2966
Leu Arg Trp Asp Pro Met Glu Tyr Asp Gly Ile
1 5 10
<210> 2967
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2923
<400> 2967
Asn Leu Trp Leu Arg His Ile Trp Asn Asp Tyr
1 5 10
<210> 2968
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2924
<400> 2968
Pro Ala Ile Phe Lys Ser Ser Cys Pro Met Asp Ile Thr Phe
1 5 10
<210> 2969
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2925
<400> 2969
Ser Glu His Ser Pro Glu Val Glu Asp Val Ile
1 5 10
<210> 2970
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2926
<400> 2970
Thr Leu Ser Ile Val Val Thr Val Phe Val Leu
1 5 10
<210> 2971
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2927
<400> 2971
Val His Phe Glu Val Ala Ile Thr Gln Leu Ala Asn Val Asp
1 5 10
<210> 2972
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2928
<400> 2972
Trp Thr Pro Pro Ala Ile Phe Lys Ser Ser Cys Pro Met Asp
1 5 10
<210> 2973
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2929
<400> 2973
Tyr Asp Lys Ala Glu Ile Asp Leu Leu Ile Ile
1 5 10
<210> 2974
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2930
<400> 2974
Tyr Lys Leu Arg Trp Asp Pro Met Glu Tyr Asp
1 5 10
<210> 2975
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2931
<400> 2975
Asp Met Asn Asp Phe Trp Glu Asn Ser Glu Trp Glu Ile
1 5 10
<210> 2976
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2932
<400> 2976
Glu Asn Val Ser Asp Pro Val
1 5
<210> 2977
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2933
<400> 2977
Glu Val Ala Ile Thr Gln Leu Ala Asn Val Asp Glu Val
1 5 10
<210> 2978
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2934
<400> 2978
Leu Ala Asn Val Asp Glu Val
1 5
<210> 2979
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2935
<400> 2979
Asn Leu Ile Ile Pro Cys Leu Phe Ile Ser Phe Leu Thr
1 5 10
<210> 2980
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2936
<400> 2980
Gln Phe Ile Arg Pro Val Glu Asn Val Ser Asp Pro Val
1 5 10
<210> 2981
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2937
<400> 2981
Val Ala Ile Thr Gln Leu Ala Asn Val Asp Glu Val Asn
1 5 10
<210> 2982
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2938
<400> 2982
Val Gln Phe Ile Ala Glu Asn
1 5
<210> 2983
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2939
<400> 2983
Ala Ala Val Ala Thr Ser Leu Gly Arg Ser Asn
1 5 10
<210> 2984
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2940
<400> 2984
Ala Cys Phe Met Asn Asn Ser Gly Ile Leu Glu
1 5 10
<210> 2985
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2941
<400> 2985
Ala Asp Asp Gly Gln Phe Gln Glu Arg Gln Ser Leu Glu Pro
1 5 10
<210> 2986
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2942
<400> 2986
Ala Glu Ile Arg Glu Asp Glu Glu Glu Val Glu
1 5 10
<210> 2987
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2943
<400> 2987
Ala Lys Glu Pro Thr Ile Gln Glu Glu Arg Ala Gln Asp Leu
1 5 10
<210> 2988
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2944
<400> 2988
Ala Lys Glu Val Ser Pro Met Ser Ala Pro Asn
1 5 10
<210> 2989
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2945
<400> 2989
Ala Leu Glu Gln His Leu Pro Glu Asp Asp Lys Thr Pro Met
1 5 10
<210> 2990
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2946
<400> 2990
Ala Leu Glu Val Leu Arg Arg Ala Thr Ile Lys
1 5 10
<210> 2991
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2947
<400> 2991
Ala Pro Asn Met Pro Ser Ile Glu Arg Asp Arg
1 5 10
<210> 2992
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2948
<400> 2992
Cys Glu Pro Asp Thr Thr Ala Pro Ser Gly Gln
1 5 10
<210> 2993
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2949
<400> 2993
Asp Glu Phe Val Arg Val Trp Ala Glu Tyr Asp
1 5 10
<210> 2994
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2950
<400> 2994
Asp Ser His Ala Ser Asp Cys Gly Glu Glu Glu
1 5 10
<210> 2995
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2951
<400> 2995
Glu Asp Glu Glu Glu Val Glu Lys Lys Lys Gln
1 5 10
<210> 2996
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2952
<400> 2996
Glu Pro Tyr Leu Ala Leu His Glu Asp Ser His
1 5 10
<210> 2997
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2953
<400> 2997
Glu Gln Gly Asp Lys Met Met Glu Glu Cys Ser
1 5 10
<210> 2998
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2954
<400> 2998
Phe Met Asn Asn Ser Gly Ile Leu Glu Gly Phe
1 5 10
<210> 2999
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2955
<400> 2999
Phe Arg Asp Leu Trp Asn Ile Leu Asp Phe Val
1 5 10
<210> 3000
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2956
<400> 3000
Phe Arg Pro Gly Thr Ser Phe Gly Ile Ser Val
1 5 10
<210> 3001
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2957
<400> 3001
Gly Asp Lys Met Met Glu Glu Cys Ser Leu Glu
1 5 10
<210> 3002
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2958
<400> 3002
Gly Asp Ser Asp Gln Ser Arg Asn Arg Gln Gly Thr Pro Val
1 5 10
<210> 3003
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2959
<400> 3003
Gly Gln Phe Gln Glu Arg Gln Ser Leu Glu Pro
1 5 10
<210> 3004
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2960
<400> 3004
Gly Trp Pro Gln Val Leu Gln His Ser Val Asp Val Thr Glu
1 5 10
<210> 3005
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2961
<400> 3005
His Gly Ala Lys Glu Pro Thr Ile Gln Glu Glu
1 5 10
<210> 3006
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2962
<400> 3006
His His Leu Asp Glu Phe Val Arg Val Trp Ala Glu Tyr Asp
1 5 10
<210> 3007
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2963
<400> 3007
His Asn Gln Pro Gln Trp Leu Thr His Leu Leu
1 5 10
<210> 3008
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2964
<400> 3008
Ile Ala Ala Ser Ser Ile Ala Leu Ala Ala Glu Asp Pro Val
1 5 10
<210> 3009
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2965
<400> 3009
Lys Asp Glu Gln Glu Glu Glu Glu Ala Phe Asn
1 5 10
<210> 3010
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2966
<400> 3010
Lys Glu Ala Glu Ile Arg Glu Asp Glu Glu Glu
1 5 10
<210> 3011
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2967
<400> 3011
Lys Glu Ala Glu Ile Arg Glu Asp Glu Glu Glu Val Glu Lys
1 5 10
<210> 3012
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2968
<400> 3012
Lys Arg Leu Val Leu Met Asn Met Pro Val Ala
1 5 10
<210> 3013
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2969
<400> 3013
Lys Val Ala Tyr Lys Arg Leu Val Leu Met Asn Met Pro Val
1 5 10
<210> 3014
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2970
<400> 3014
Lys Val Lys Lys Gln Arg Gln Gln Leu Glu Glu
1 5 10
<210> 3015
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2971
<400> 3015
Leu Gly Ala Thr Trp Asn Trp Leu Tyr Phe Ile
1 5 10
<210> 3016
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2972
<400> 3016
Leu Gly Leu Ala Leu Glu Lys Phe Glu Glu Glu
1 5 10
<210> 3017
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2973
<400> 3017
Leu Pro Tyr Leu Gln Gln Asp Pro Val Ser Gly
1 5 10
<210> 3018
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2974
<400> 3018
Leu Val Leu Met Asn Met Pro Val Ala Glu Asp
1 5 10
<210> 3019
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2975
<400> 3019
Met Ser Phe Leu Lys Leu Phe Arg Ala Ala Arg
1 5 10
<210> 3020
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2976
<400> 3020
Pro Asn Gly His Tyr Arg Arg Arg Arg Arg Gly Gly Pro Gly
1 5 10
<210> 3021
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2977
<400> 3021
Pro Pro Leu Arg His Ser Trp Gln Met Pro Asn
1 5 10
<210> 3022
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2978
<400> 3022
Pro Ser Leu Tyr Arg Arg Pro Arg Ala Ile Glu
1 5 10
<210> 3023
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2979
<400> 3023
Gln Pro Gln Trp Leu Thr His Leu Leu Tyr Tyr
1 5 10
<210> 3024
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2980
<400> 3024
Gln Ser Arg Ser Pro Ser Glu Gly Arg Ser Gln
1 5 10
<210> 3025
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2981
<400> 3025
Gln Trp Leu Thr His Leu Leu Tyr Tyr Ala Glu
1 5 10
<210> 3026
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2982
<400> 3026
Arg Ser Pro Ser Glu Gly Arg Ser Gln Thr Pro
1 5 10
<210> 3027
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2983
<400> 3027
Ser Pro Met Ser Ala Pro Asn Met Pro Ser Ile
1 5 10
<210> 3028
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2984
<400> 3028
Ser Pro Pro Leu Gly Leu Gly Lys Arg Cys Pro
1 5 10
<210> 3029
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2985
<400> 3029
Thr Thr Glu Ser Thr Ser Val Thr Val Ala Ile Pro Asp Val
1 5 10
<210> 3030
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2986
<400> 3030
Val His His Asn Gln Pro Gln Trp Leu Thr His
1 5 10
<210> 3031
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2987
<400> 3031
Val Leu Thr Glu Gln Glu Pro Glu Gly Ser Ser
1 5 10
<210> 3032
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2988
<400> 3032
Val Gln Pro Ser Asn His Gly Ile Tyr Leu Pro
1 5 10
<210> 3033
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2989
<400> 3033
Trp His Phe Val Val Ser Pro Ser Phe Glu Tyr
1 5 10
<210> 3034
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2990
<400> 3034
Tyr Lys Arg Leu Val Leu Met Asn Met Pro Val Ala Glu Asp
1 5 10
<210> 3035
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2991
<400> 3035
Glu Gln Lys Asn Ala Pro Met Phe Gln Arg Met Glu Pro Ser
1 5 10
<210> 3036
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2992
<400> 3036
Ala Ile Pro Asp Val Asp Pro Leu Val Asp Ser Thr Val Val
1 5 10
<210> 3037
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2993
<400> 3037
His Arg Gln Ser Gln Arg Arg Ser Arg His Arg Arg Val Arg
1 5 10
<210> 3038
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2994
<400> 3038
Ile Phe Asp Phe Ile Thr Val Ile Gly Ser Ile Thr Glu Ile
1 5 10
<210> 3039
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2995
<400> 3039
Leu Ala Glu Glu Asn Lys Asn Ala Gly Thr Ser Ala Leu Glu
1 5 10
<210> 3040
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2996
<400> 3040
Gln Ala Leu Glu Ser Asn Asn Ala Cys Leu Thr Glu Ser Ser
1 5 10
<210> 3041
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2997
<400> 3041
Arg Ala Arg His Arg Gln Ser Gln Arg Arg Ser Arg His Arg
1 5 10
<210> 3042
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2998
<400> 3042
Thr Glu Gln Glu Pro Glu Gly Ser Ser Glu Gln Ala Leu Leu
1 5 10
<210> 3043
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 2999
<400> 3043
Ala Asp Cys Pro Met Arg Leu Val Asn Phe Pro Met Asp Gly
1 5 10
<210> 3044
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3000
<400> 3044
Ala Gly Phe Asn Leu Val Tyr Trp Val Val Tyr Leu Ser Lys
1 5 10
<210> 3045
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3001
<400> 3045
Ile Lys Ser Asn Thr Gly Glu Tyr Val Ile Met Thr Val Tyr
1 5 10
<210> 3046
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3002
<400> 3046
Trp Leu Cys Ile Ile Leu Trp Leu Glu Asn Ala Leu Gly Lys
1 5 10
<210> 3047
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3003
<400> 3047
Arg Ala Pro Ile Leu Gln Ser Thr Pro Val Thr Pro Pro Pro
1 5 10
<210> 3048
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3004
<400> 3048
Ile Phe Phe Glu Ala Leu Asn Tyr Glu Thr Ile Glu Gln Lys
1 5 10
<210> 3049
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3005
<400> 3049
Thr Ile Glu Gln Lys Lys Ala Tyr Glu Val Ala Ala Leu Leu
1 5 10
<210> 3050
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3006
<400> 3050
Thr Ile Ser His Thr Val Asn Val Pro Leu Gln Thr Thr Leu
1 5 10
<210> 3051
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3007
<400> 3051
Asp Ser Thr Thr Tyr Ala His Phe Leu Phe Asn Ala Phe Asp
1 5 10
<210> 3052
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3008
<400> 3052
Tyr Ala Gln Asn Ser Thr Lys Arg Ser Ile Lys Glu Arg Leu
1 5 10
<210> 3053
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3009
<400> 3053
Ile Ser Ser Lys Val Pro Lys Ala Glu Tyr Ile Pro Thr Ile
1 5 10
<210> 3054
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3010
<400> 3054
Ser Leu Val Ser Asn Gly Cys Tyr Glu Gly Ser Leu Ser Glu
1 5 10
<210> 3055
<211> 12
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3011
<400> 3055
Ala Gly Tyr Trp Asn Glu Tyr Glu Arg Phe Val Pro
1 5 10
<210> 3056
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3012
<400> 3056
Phe Ser Pro Tyr Glu Trp His Leu Glu Asp Asn Asn Glu Glu
1 5 10
<210> 3057
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3013
<400> 3057
Tyr Glu Trp His Leu Glu Asp Asn Asn Glu Glu Pro Arg Asp
1 5 10
<210> 3058
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3014
<400> 3058
Asn Tyr Asn Ser Val Asp Leu Ser Glu Val Glu Trp Glu Asp
1 5 10
<210> 3059
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3015
<400> 3059
Ala His Gly Leu Leu Asp Pro Tyr Asn Ala Phe
1 5 10
<210> 3060
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3016
<400> 3060
Asp Gln Gly Pro Val Leu Met Thr Thr Val Ala Met Pro Val
1 5 10
<210> 3061
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3017
<400> 3061
Asp Thr Leu Gly Asp Asp Asp Phe Phe Asn Ile Ile Ala Tyr
1 5 10
<210> 3062
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3018
<400> 3062
Asp Val Leu Arg Asn Ala Met Val Asn Arg Lys
1 5 10
<210> 3063
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3019
<400> 3063
Glu Phe Asp Ala Asp Leu Gln Tyr Glu Tyr Phe
1 5 10
<210> 3064
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3020
<400> 3064
Glu Pro Asp Glu Asn Gly Val Ile Ala Phe Asp Cys Arg Asn
1 5 10
<210> 3065
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3021
<400> 3065
Phe Phe Asn Ile Ile Ala Tyr Asn Glu Glu Leu
1 5 10
<210> 3066
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3022
<400> 3066
Phe Arg Gly Asn Val Thr Ile Glu Glu Gly Leu
1 5 10
<210> 3067
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3023
<400> 3067
Gly Asp Asp Asp Phe Phe Asn Ile Ile Ala Tyr Asn Glu Glu
1 5 10
<210> 3068
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3024
<400> 3068
Gly Ser Phe Val Tyr Ser Ile Pro Phe Ser Thr Gly Pro Val
1 5 10
<210> 3069
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3025
<400> 3069
Ile Met Leu Ile Thr Asp Gly Ala Val Asp Thr
1 5 10
<210> 3070
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3026
<400> 3070
Lys Glu Tyr Glu Lys Asp Val Ala Ile Glu Glu
1 5 10
<210> 3071
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3027
<400> 3071
Lys Glu Tyr Glu Lys Asp Val Ala Ile Glu Glu Ile Asp Gly
1 5 10
<210> 3072
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3028
<400> 3072
Leu Ala Leu Asn Lys Ser Glu Asn Ser Asp Lys
1 5 10
<210> 3073
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3029
<400> 3073
Leu Pro Gln Ala Gln Lys Leu Thr Asp Asp Gln Gly Pro Val
1 5 10
<210> 3074
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3030
<400> 3074
Leu Arg Asn Ala Met Val Asn Arg Lys Thr Gly
1 5 10
<210> 3075
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3031
<400> 3075
Leu Val Asp Val Ser Gly Ser Met Lys Gly Leu Arg Leu Thr
1 5 10
<210> 3076
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3032
<400> 3076
Asn Glu Arg Asp Lys Asp Gly Asn Phe Leu Glu
1 5 10
<210> 3077
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3033
<400> 3077
Asn Ile Ile Ala Tyr Asn Glu Glu Leu His Tyr Val Glu Pro
1 5 10
<210> 3078
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3034
<400> 3078
Asn Asn Leu Pro Val Asn Ile Ser Leu Ser Asp
1 5 10
<210> 3079
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3035
<400> 3079
Asn Tyr Ser Ser Val Asp Leu Ser Glu Val Glu
1 5 10
<210> 3080
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3036
<400> 3080
Pro Val Leu Met Thr Thr Val Ala Met Pro Val
1 5 10
<210> 3081
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3037
<400> 3081
Gln Leu Val Lys Lys Leu Ala Lys Asn Met Glu Glu Met Phe
1 5 10
<210> 3082
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3038
<400> 3082
Gln Tyr Pro Gly Ile Lys Trp Glu Pro Asp Glu
1 5 10
<210> 3083
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3039
<400> 3083
Ser Ile Leu Asp Thr Leu Gly Asp Asp Asp Phe Phe Asn Ile
1 5 10
<210> 3084
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3040
<400> 3084
Ser Gln Ala Ile Met Leu Ile Thr Asp Gly Ala Val Asp Thr
1 5 10
<210> 3085
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3041
<400> 3085
Thr His Pro Glu Leu Arg Leu Leu Tyr Glu Glu
1 5 10
<210> 3086
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3042
<400> 3086
Thr Ser Leu Ala Leu Asn Lys Ser Glu Asn Ser
1 5 10
<210> 3087
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3043
<400> 3087
Thr Val Ser Ser Ile Leu Asp Thr Leu Gly Asp Asp Asp Phe
1 5 10
<210> 3088
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3044
<400> 3088
Val Ile Asp Gln Glu His Asp Val Val Trp Thr Glu Ala Tyr
1 5 10
<210> 3089
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3045
<400> 3089
Val Ser Glu Asp Tyr Thr Gln Thr Gly Asp Phe
1 5 10
<210> 3090
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3046
<400> 3090
Tyr Trp Thr Ser Leu Ala Leu Asn Lys Ser Glu Asn Ser Asp
1 5 10
<210> 3091
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3047
<400> 3091
Glu Ala Tyr Trp Thr Ser Leu Ala Leu Asn Lys Ser Glu Asn
1 5 10
<210> 3092
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3048
<400> 3092
Leu Ala Leu Asn Lys Ser Glu Asn Ser Asp Lys Gly Val Glu
1 5 10
<210> 3093
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3049
<400> 3093
Trp Thr Ser Leu Ala Leu Asn Lys Ser Glu Asn Ser Asp Lys
1 5 10
<210> 3094
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3050
<400> 3094
Ala Glu Cys Tyr Leu Gln Leu His Asn Phe Pro Met Asp Glu
1 5 10
<210> 3095
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3051
<400> 3095
Gly Asn Cys Val Asp Lys Ala Asp Asp Glu Asp Asp Glu Asp
1 5 10
<210> 3096
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3052
<400> 3096
Leu His Leu Gly Asn Cys Val Asp Lys Ala Asp Asp Glu Asp
1 5 10
<210> 3097
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3053
<400> 3097
Thr Ile Ser Gly Asp Tyr Val Ile Met Thr Ile Phe Phe Asp
1 5 10
<210> 3098
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3054
<400> 3098
Tyr Leu Gln Leu His Asn Phe Pro Met Asp Glu His Ser Cys
1 5 10
<210> 3099
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3055
<400> 3099
Val Asp Lys Ala Asp Asp Glu Asp Asp Glu Asp Leu Thr Val
1 5 10
<210> 3100
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3056
<400> 3100
Cys Ala Ser Thr Leu Pro Asp Trp Arg Asn Ala Ala Ala Asp
1 5 10
<210> 3101
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3057
<400> 3101
Leu Glu Val Cys Asp Asp Tyr Asp Arg Glu Arg Asn Glu Tyr
1 5 10
<210> 3102
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3058
<400> 3102
Arg Asp Val Leu Glu Val Cys Asp Asp Tyr Asp Arg Glu Arg
1 5 10
<210> 3103
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3059
<400> 3103
Arg Met Arg Arg Thr Phe Glu Glu Pro Thr Ser Ser Leu Ala
1 5 10
<210> 3104
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3060
<400> 3104
Arg Ser Glu Arg Asp Val Leu Glu Val Cys Asp Asp Tyr Asp
1 5 10
<210> 3105
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3061
<400> 3105
Cys Asp Asp Tyr Asp Arg Glu Arg Asn Glu Tyr Phe Phe Asp
1 5 10
<210> 3106
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3062
<400> 3106
Ser Ala Arg Tyr Ser Arg Ser Leu Ser Thr Glu Phe Leu Asn
1 5 10
<210> 3107
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3063
<400> 3107
Ile Phe Glu Ile Thr Thr Gln Phe Gly Val Met Pro Pro Glu
1 5 10
<210> 3108
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3064
<400> 3108
Ile Pro Leu Pro Pro Arg Arg Arg Glu Leu Pro Ala Leu Arg
1 5 10
<210> 3109
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3065
<400> 3109
Leu Asp Ala Phe Ile Met Asp Lys Ala Leu Leu Asp Tyr Glu
1 5 10
<210> 3110
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3066
<400> 3110
Asn Asn Phe Phe Ile Trp Asn Leu Gln His Asp Pro Met Gly
1 5 10
<210> 3111
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3067
<400> 3111
Pro Phe Val Phe Thr Arg Glu Val Asp Asp Glu Gly Leu Cys
1 5 10
<210> 3112
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3068
<400> 3112
Gln Glu Leu Gln Leu Ala Val Ser Arg Lys Thr Glu Leu Glu
1 5 10
<210> 3113
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3069
<400> 3113
Gln Leu Gly Ile Arg Ile His Gln Asp Ile Pro Leu Pro Pro
1 5 10
<210> 3114
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3070
<400> 3114
Arg Ser Gln Val Ile Asp Phe Thr Ser Pro Phe Phe Ser Thr
1 5 10
<210> 3115
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3071
<400> 3115
Arg Trp Val Leu Gly Asp Ser Gln Asn Val Glu Glu Leu Arg
1 5 10
<210> 3116
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3072
<400> 3116
Thr Met Asn Cys Met Glu Val Glu Thr Thr Asn Leu Thr Ser
1 5 10
<210> 3117
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3073
<400> 3117
Thr Asn Gly Lys Ala Asp Ser Leu Asn Val Ser Arg Asn Ser
1 5 10
<210> 3118
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3074
<400> 3118
Ala Asp Ser Leu Asn Val Ser Arg Asn Ser Val Met Gln Glu
1 5 10
<210> 3119
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3075
<400> 3119
Asn Gly Lys Ala Asp Ser Leu Asn Val Ser Arg Asn Ser Val
1 5 10
<210> 3120
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3076
<400> 3120
Asp Ile Asp Pro Glu Ile Glu Thr Glu Cys Phe Phe Val Glu
1 5 10
<210> 3121
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3077
<400> 3121
Glu Cys Leu Phe Ser Leu Ile Asn Gly Asp Asp Met Phe Ala
1 5 10
<210> 3122
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3078
<400> 3122
Cys Asp Asp Tyr Asp Glu Asp Ser Gln Glu Phe Phe Phe Asp
1 5 10
<210> 3123
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3079
<400> 3123
Glu Glu Ile Val Gln Leu Cys Asp Asp Tyr Asp Glu Asp Ser
1 5 10
<210> 3124
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3080
<400> 3124
Asp Leu Arg Arg Phe Ala Arg Ser Ala Leu Asn Leu Val Asp
1 5 10
<210> 3125
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3081
<400> 3125
Glu Glu Asp Glu Asp Gly Glu Glu Glu Asp Gln Trp Lys Asp
1 5 10
<210> 3126
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3082
<400> 3126
Lys Asp Asp Leu Ala Glu Glu Asp Gln Gln Ala Gly Glu Val
1 5 10
<210> 3127
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3083
<400> 3127
Arg Arg Ser Trp Ser Tyr Arg Pro Trp Asn Thr Thr Glu Asn
1 5 10
<210> 3128
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3084
<400> 3128
Ala Ala Gly Gly Ala Gly Gly Gly Gly Gly Gly Gly Gly Gly
1 5 10
<210> 3129
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3085
<400> 3129
Ala Gly Leu Ala Gly Ala Gly Gly Gly Gly Gly
1 5 10
<210> 3130
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3086
<400> 3130
Asp Thr Asp Tyr Asp His Asp Ser Ala Glu Tyr
1 5 10
<210> 3131
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3087
<400> 3131
Phe Gly Gly Ala Ala Gly Gly Ala Gly Gly Gly Gly Gly Gly
1 5 10
<210> 3132
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3088
<400> 3132
Gly Ala Gly Gly Gly Gly Gly Gly Ala Val Gly
1 5 10
<210> 3133
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3089
<400> 3133
Gly Ala Gly Gly Gly Gly Gly Gly Gly Gly Gly Ala Gly Ala
1 5 10
<210> 3134
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3090
<400> 3134
Gly Gly Gly Gly Gly Ala Gly Ala Glu Arg Asp
1 5 10
<210> 3135
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3091
<400> 3135
Gly Gly Gly Gly Gly Gly Gly Gly Ala Gly Ala Glu Arg Asp
1 5 10
<210> 3136
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3092
<400> 3136
His Phe Pro Glu Asp Thr Asp Tyr Asp His Asp
1 5 10
<210> 3137
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3093
<400> 3137
Ile Asn His Phe Pro Glu Asp Thr Asp Tyr Asp
1 5 10
<210> 3138
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3094
<400> 3138
Leu Tyr Thr Arg Ala Leu Ile Cys Asn Thr Thr Asn Leu Thr
1 5 10
<210> 3139
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3095
<400> 3139
Asn His Phe Pro Glu Asp Thr Asp Tyr Asp His Asp Ser Ala
1 5 10
<210> 3140
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3096
<400> 3140
Pro Ser Tyr Arg Phe Arg Tyr Arg Arg Arg Ser
1 5 10
<210> 3141
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3097
<400> 3141
Arg Ala Leu Ile Cys Asn Thr Thr Asn Leu Thr
1 5 10
<210> 3142
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3098
<400> 3142
Arg Gly Val Cys Val Lys Ile Asn His Phe Pro
1 5 10
<210> 3143
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3099
<400> 3143
Arg Leu Pro Ser Tyr Arg Phe Arg Tyr Arg Arg
1 5 10
<210> 3144
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3100
<400> 3144
Ser Asp Leu Leu Lys Ala Gly Gly Gly Ala Gly
1 5 10
<210> 3145
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3101
<400> 3145
Val Thr Val Thr Val Thr Gly Pro Pro Ala Pro
1 5 10
<210> 3146
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3102
<400> 3146
Tyr Arg Phe Arg Tyr Arg Arg Arg Ser Arg Ser
1 5 10
<210> 3147
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3103
<400> 3147
Tyr Thr Arg Ala Leu Ile Cys Asn Thr Thr Asn
1 5 10
<210> 3148
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3104
<400> 3148
Ala Ile Leu Arg Leu Pro Ser Tyr Arg Phe Arg Tyr Arg Arg
1 5 10
<210> 3149
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3105
<400> 3149
Glu Pro Gly Pro Lys Arg Asp Glu Glu Lys Lys Asn His Tyr
1 5 10
<210> 3150
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3106
<400> 3150
Phe Arg Tyr Arg Arg Arg Ser Arg Ser Ser Ser Arg Ser Ser
1 5 10
<210> 3151
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3107
<400> 3151
His Phe Pro Glu Asp Thr Asp Tyr Asp His Asp Ser Ala Glu
1 5 10
<210> 3152
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3108
<400> 3152
Lys Ile Asn His Phe Pro Glu Asp Thr Asp Tyr Asp His Asp
1 5 10
<210> 3153
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3109
<400> 3153
Ser Tyr Arg Phe Arg Tyr Arg Arg Arg Ser Arg Ser Ser Ser
1 5 10
<210> 3154
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3110
<400> 3154
Cys Asn Thr His Glu Ser Leu Leu Glu Val Cys Asp Asp Tyr
1 5 10
<210> 3155
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3111
<400> 3155
Asp Asp Glu Asp Phe Leu Glu Leu Pro Gly Ala Arg Glu Glu
1 5 10
<210> 3156
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3112
<400> 3156
Asp Gly Thr Leu Glu Tyr Ala Pro Val Asp Ile Thr Val Asn
1 5 10
<210> 3157
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3113
<400> 3157
Glu Arg Pro Ser Ala Tyr Glu Glu Glu Ile Glu Met Glu Glu
1 5 10
<210> 3158
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3114
<400> 3158
His Gln Lys Lys Glu Gln Met Asn Glu Glu Leu Arg Arg Glu
1 5 10
<210> 3159
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3115
<400> 3159
Leu Phe Pro Phe Ser Ser Arg Glu Arg Arg Ser Phe Thr Glu
1 5 10
<210> 3160
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3116
<400> 3160
Asn Phe Lys Glu Asn Arg Gly Ser Ala Pro Gln Thr Pro Pro
1 5 10
<210> 3161
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3117
<400> 3161
Arg Glu Arg Arg Ser Phe Thr Glu Ile Asp Thr Gly Asp Asp
1 5 10
<210> 3162
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3118
<400> 3162
Ser Ala Tyr Glu Glu Glu Ile Glu Met Glu Glu Val Val Cys
1 5 10
<210> 3163
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3119
<400> 3163
Thr Glu Ile Asp Thr Gly Asp Asp Glu Asp Phe Leu Glu Leu
1 5 10
<210> 3164
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3120
<400> 3164
Cys Asp Asp Tyr Asn Leu Asn Glu Asn Glu Tyr Phe Phe Asp
1 5 10
<210> 3165
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3121
<400> 3165
Ser Phe Thr Ser Cys Ala Thr Asp Phe Thr Glu Thr Glu Arg
1 5 10
<210> 3166
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3122
<400> 3166
Ser Ile Asp Ser Phe Thr Ser Cys Ala Thr Asp Phe Thr Glu
1 5 10
<210> 3167
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3123
<400> 3167
Ala Ser Glu Glu Gln Ala Arg Arg Leu Cys Asp Asp Tyr Asp
1 5 10
<210> 3168
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3124
<400> 3168
Ala Val Arg Asn Ser Asn His Gln Glu Phe Glu Asp Leu Leu
1 5 10
<210> 3169
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3125
<400> 3169
Phe Glu Asp Leu Leu Ser Ser Ile Asp Gly Val Ser Glu Ala
1 5 10
<210> 3170
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3126
<400> 3170
Arg Arg Leu Cys Asp Asp Tyr Asp Glu Ala Ala Arg Glu Phe
1 5 10
<210> 3171
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3127
<400> 3171
Ala Arg Tyr Gly Ala Ala Arg Cys Gly Arg Leu Arg Arg Arg
1 5 10
<210> 3172
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3128
<400> 3172
Ala Ser Leu Glu Thr Ser Arg Glu Thr Ser Gln Glu Gly Gln
1 5 10
<210> 3173
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3129
<400> 3173
Ile Asp Gly Val Ser Glu Ala Ser Leu Glu Thr Ser Arg Glu
1 5 10
<210> 3174
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3130
<400> 3174
Asp Glu Glu Glu Glu Glu Glu Gly Glu Glu Glu Glu Ala Val
1 5 10
<210> 3175
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3131
<400> 3175
Asp Leu Ser Pro Arg Ile Val Asp Gly Ile Glu Asp Gly Asn
1 5 10
<210> 3176
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3132
<400> 3176
Glu Glu Glu Glu Gly Glu Glu Glu Glu Ala Val Ser Leu Ser
1 5 10
<210> 3177
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3133
<400> 3177
His Gln Pro Cys Leu His Leu Gln Thr Gly Gly Ala Ala Tyr
1 5 10
<210> 3178
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3134
<400> 3178
Ile Glu Asp Gly Asn Ser Ser Glu Glu Ser Gln Thr Phe Asp
1 5 10
<210> 3179
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3135
<400> 3179
Ile Val Glu Asp Glu Glu Glu Glu Glu Glu Gly Glu Glu Glu
1 5 10
<210> 3180
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3136
<400> 3180
Leu Glu Tyr Phe Gln Thr Thr Trp Ser Val Asn Asn Gly Ile
1 5 10
<210> 3181
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3137
<400> 3181
Leu Pro Ser Ile Val Glu Asp Glu Glu Glu Glu Glu Glu Gly
1 5 10
<210> 3182
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3138
<400> 3182
Met Gln Lys Ser Cys Ser Cys Lys Phe Leu Phe Gly Val Glu
1 5 10
<210> 3183
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3139
<400> 3183
Asn Lys Arg Leu Pro Ser Ile Val Glu Asp Glu Glu Glu Glu
1 5 10
<210> 3184
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3140
<400> 3184
Asn Asn Thr Leu Gly Gly Pro Ser Ile Arg Ser Ala Tyr Ile
1 5 10
<210> 3185
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3141
<400> 3185
Pro Glu Tyr Ala His Lys Phe Val Glu Asp Ile Gln His Asp
1 5 10
<210> 3186
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3142
<400> 3186
Pro Arg Ile Val Asp Gly Ile Glu Asp Gly Asn Ser Ser Glu
1 5 10
<210> 3187
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3143
<400> 3187
Arg Leu Leu Arg Leu Leu Gln Lys Leu Asp Arg Tyr Ser Gln
1 5 10
<210> 3188
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3144
<400> 3188
Ser Cys Ser Cys Lys Phe Leu Phe Gly Val Glu Thr Asn Glu
1 5 10
<210> 3189
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3145
<400> 3189
Ser Ser Leu Thr Ser Val Gly Phe Gly Asn Val Ser Ala Asn
1 5 10
<210> 3190
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3146
<400> 3190
Val Asp Gly Ile Glu Asp Gly Asn Ser Ser Glu Glu Ser Gln
1 5 10
<210> 3191
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3147
<400> 3191
Val Ser Arg Ser Asn Ser Pro Lys Thr Lys Gln Glu Ile Asp
1 5 10
<210> 3192
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3148
<400> 3192
Glu Glu Glu Glu Glu Glu Gly Glu Glu Glu Glu Ala Val Ser
1 5 10
<210> 3193
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3149
<400> 3193
Gly Ser Trp Asn Gln Glu Gly Met Ala Ser Ala Ser Thr Lys
1 5 10
<210> 3194
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3150
<400> 3194
Lys Ile Phe Ser Ile Cys Thr Met Leu Ile Gly Ala Leu Met
1 5 10
<210> 3195
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3151
<400> 3195
Asn Leu Pro Gly Ser Trp Asn Gln Glu Gly Met Ala Ser Ala
1 5 10
<210> 3196
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3152
<400> 3196
Pro Ser Ile Val Glu Asp Glu Glu Glu Glu Glu Glu Gly Glu
1 5 10
<210> 3197
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3153
<400> 3197
Ser Leu Thr Ser Val Gly Phe Gly Asn Val Ser Ala Asn Thr
1 5 10
<210> 3198
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3154
<400> 3198
Ser Val Gly Phe Gly Asn Val Ser Ala Asn Thr Asp Ala Glu
1 5 10
<210> 3199
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3155
<400> 3199
Val Glu Asp Glu Glu Glu Glu Glu Glu Gly Glu Glu Glu Glu
1 5 10
<210> 3200
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3156
<400> 3200
Ala Asp Val Cys Gly Pro Leu Phe Glu Glu Glu Leu Ala Phe
1 5 10
<210> 3201
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3157
<400> 3201
Ala Pro Pro Leu Ser Pro Gly Pro Gly Gly Cys Phe Glu Gly
1 5 10
<210> 3202
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3158
<400> 3202
Asp Leu Ala Ala Lys Arg Leu Gly Ile Glu Asp Ala Ala Gly
1 5 10
<210> 3203
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3159
<400> 3203
Pro Leu Phe Glu Glu Glu Leu Ala Phe Trp Gly Ile Asp Glu
1 5 10
<210> 3204
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3160
<400> 3204
Pro Ser Pro Pro Pro Leu Ser Pro Pro Pro Arg Ala Pro Pro
1 5 10
<210> 3205
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3161
<400> 3205
Gln Tyr Glu Ile Glu Thr Asp Pro Ala Leu Thr Tyr Val Glu
1 5 10
<210> 3206
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3162
<400> 3206
Thr Pro Asp Leu Ile Gly Gly Asp Pro Gly Asp Asp Glu Asp
1 5 10
<210> 3207
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3163
<400> 3207
Leu Arg Phe Glu Thr Arg Ala Arg Thr Leu Gly Arg Phe Pro
1 5 10
<210> 3208
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3164
<400> 3208
Tyr Trp Gln Glu Phe Glu Asp Thr Cys Val Tyr Glu Cys Leu
1 5 10
<210> 3209
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3165
<400> 3209
Asp Ser Thr Asp Ala Ser Ser Ile Glu Asp Asn Glu Asp Ile
1 5 10
<210> 3210
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3166
<400> 3210
Ser Glu Phe Gln Asn Glu Asp Gly Glu Val Asp Asp Pro Val
1 5 10
<210> 3211
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3167
<400> 3211
Cys His Glu Asp Trp Lys Arg Leu Ala Arg Val
1 5 10
<210> 3212
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3168
<400> 3212
His Tyr Cys Gly Pro Ser Val Arg Pro Val Pro
1 5 10
<210> 3213
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3169
<400> 3213
Ile Leu Ile Met Asn Leu His Tyr Cys Gly Pro Ser Val Arg
1 5 10
<210> 3214
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3170
<400> 3214
Pro Glu Leu Ser Pro Ser Pro Gln Ser Pro Glu
1 5 10
<210> 3215
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3171
<400> 3215
Pro Val Pro Ala Trp Ala Arg Ala Leu Leu Leu
1 5 10
<210> 3216
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3172
<400> 3216
Gln Glu Ala Leu Leu His His Val Ala Thr Ile Ala Asn Thr
1 5 10
<210> 3217
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3173
<400> 3217
Arg Gly Ala Ala Ala Ser Leu Ala Asp Phe Val
1 5 10
<210> 3218
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3174
<400> 3218
Arg Gly Glu Pro Cys Gly Gln Ser Arg Pro Pro Glu Leu Ser
1 5 10
<210> 3219
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3175
<400> 3219
Thr Leu Tyr Leu Trp Ile Arg Gln Glu Trp Thr
1 5 10
<210> 3220
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3176
<400> 3220
Ile Leu Ile Met Asn Leu His Tyr Cys Gly Pro Ser Val
1 5 10
<210> 3221
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3177
<400> 3221
Met Asp Glu Arg Asn Gln Val
1 5
<210> 3222
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3178
<400> 3222
Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser Pro Glu Gly
1 5 10
<210> 3223
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3179
<400> 3223
Gln Ser Arg Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser
1 5 10
<210> 3224
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3180
<400> 3224
Arg Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser Pro Glu
1 5 10
<210> 3225
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3181
<400> 3225
Arg Pro Val Pro Ala Trp Ala Arg Ala Leu Leu Leu Gly
1 5 10
<210> 3226
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3182
<400> 3226
Arg Arg Arg Ala Ala Ala Tyr
1 5
<210> 3227
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3183
<400> 3227
Ser Pro Ser Pro Gln Ser Pro
1 5
<210> 3228
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3184
<400> 3228
Ser Arg Pro Pro Glu Leu Ser Pro Ser Pro Gln Ser Pro
1 5 10
<210> 3229
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3185
<400> 3229
Thr Tyr Gly Cys Cys Ser Glu Pro Tyr Pro Asp Val Thr
1 5 10
<210> 3230
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3186
<400> 3230
Val Arg Pro Arg Gly Ala Ala
1 5
<210> 3231
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3187
<400> 3231
Val Arg Pro Val Pro Ala Trp Ala Arg Ala Leu Leu Leu
1 5 10
<210> 3232
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3188
<400> 3232
Trp Ala Arg Ala Leu Leu Leu
1 5
<210> 3233
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3189
<400> 3233
Tyr Leu Trp Ile Arg Gln Glu
1 5
<210> 3234
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3190
<400> 3234
Arg Val Ser Ser Asp Leu Ser Arg Ile Leu Gln Leu Leu Gln
1 5 10
<210> 3235
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3191
<400> 3235
Ser Asn Asp Leu Ala Leu Val Pro Ile Ala Ser Glu Thr Thr
1 5 10
<210> 3236
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3192
<400> 3236
Val Phe Thr Pro Tyr Ser Ala Ala Phe Leu Leu Ser Asp Gln
1 5 10
<210> 3237
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3193
<400> 3237
Ala Val Ser Arg Leu Ala Gln Ala Leu Leu Gly Ala Glu Glu
1 5 10
<210> 3238
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3194
<400> 3238
Phe Thr Pro Tyr Ser Ala Ala Phe Leu Leu Ser Asp Gln Asp
1 5 10
<210> 3239
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3195
<400> 3239
Lys His Arg Ser Ser Ser Thr Thr Glu Ile Glu Ile Ile Ala
1 5 10
<210> 3240
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3196
<400> 3240
Val Ala Ile Leu Gly Lys Asn Asp Ile Phe Gly Glu Pro Val
1 5 10
<210> 3241
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3197
<400> 3241
Gln Ser His Pro Glu Thr Leu Phe Lys Ser Ile Pro Gln Ser
1 5 10
<210> 3242
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3198
<400> 3242
Val Leu Ala Ile Leu Pro Phe Tyr Val Ser Leu Thr Leu Thr
1 5 10
<210> 3243
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3199
<400> 3243
Ile Arg Ile Met Lys Phe His Val Ala Lys Arg Lys Phe Lys
1 5 10
<210> 3244
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3200
<400> 3244
Pro Phe Glu Cys Glu Gln Thr Ser Asp Tyr Gln Ser Pro Val
1 5 10
<210> 3245
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3201
<400> 3245
Ala Phe Arg Gly Ala Ser Lys Gly Cys Leu Arg Ala Leu Ala
1 5 10
<210> 3246
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3202
<400> 3246
Asp Leu His Lys Ile Gln Arg Glu Asp Leu Leu Glu Val Leu
1 5 10
<210> 3247
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3203
<400> 3247
Glu Asp Pro Asp Val Val Val Ile Asp Ser Ser Lys His Ser
1 5 10
<210> 3248
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3204
<400> 3248
Phe Asn His Ile Lys Ser Ser Leu Leu Gly Ser Thr Ser Asp
1 5 10
<210> 3249
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3205
<400> 3249
Gly Ile Gly Lys Ala Ser Gly Leu Asp Phe Glu Glu Thr Val
1 5 10
<210> 3250
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3206
<400> 3250
Gly Leu Asp Phe Glu Glu Thr Val Pro Thr Ser Gly Arg Met
1 5 10
<210> 3251
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3207
<400> 3251
Gly Leu His Arg His Val Ser Asp Pro Gly Leu Pro Gly Lys
1 5 10
<210> 3252
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3208
<400> 3252
Gly Thr Ile Ile Arg Lys Phe Glu Gly Gln Asn Lys Lys Phe
1 5 10
<210> 3253
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3209
<400> 3253
Ile Ile Ala Pro Lys Val Lys Asp Arg Thr His Asn Val Thr
1 5 10
<210> 3254
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3210
<400> 3254
Lys Ala Ser Gly Leu Asp Phe Glu Glu Thr Val Pro Thr Ser
1 5 10
<210> 3255
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3211
<400> 3255
Leu Asp Arg Tyr Ser Glu Tyr Gly Ala Ala Val Leu Met Leu
1 5 10
<210> 3256
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3212
<400> 3256
Leu Gln Lys Gln Thr Thr Val Val Pro Pro Ala Tyr Ser Met
1 5 10
<210> 3257
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3213
<400> 3257
Leu Gln Leu Leu Gln Lys Gln Thr Thr Val Val Pro Pro Ala
1 5 10
<210> 3258
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3214
<400> 3258
Asn Phe Arg Thr Thr Tyr Val Asn Gln Asn Glu Glu Val Val
1 5 10
<210> 3259
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3215
<400> 3259
Gln Thr Thr Val Val Pro Pro Ala Tyr Ser Met Val Thr Ala
1 5 10
<210> 3260
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3216
<400> 3260
Arg Glu Asp Leu Leu Glu Val Leu Asp Met Tyr Pro Glu Phe
1 5 10
<210> 3261
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3217
<400> 3261
Arg Arg Ala Ser Ser Val His Asp Ile Glu Gly Phe Gly Val
1 5 10
<210> 3262
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3218
<400> 3262
Ser Ser Ser Phe Ile Ser Ser Ile Asp Asp Glu Gln Lys Pro
1 5 10
<210> 3263
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3219
<400> 3263
Val Asn Ile Ser Gly Pro Leu Asp His Ser Ser Pro Lys Arg
1 5 10
<210> 3264
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3220
<400> 3264
Val Val Pro Pro Ala Tyr Ser Met Val Thr Ala Gly Ser Glu
1 5 10
<210> 3265
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3221
<400> 3265
Tyr Cys Asn Asp Gly Phe Cys Glu Met Thr Gly Phe Ser Arg
1 5 10
<210> 3266
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3222
<400> 3266
Gly Ile Ser Glu Thr Glu Ser Asp Leu Thr Tyr Gly Glu Val
1 5 10
<210> 3267
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3223
<400> 3267
Lys Lys Asn Ser Ser Pro Pro Ser Ser Asp Lys Thr Ile Ile
1 5 10
<210> 3268
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3224
<400> 3268
Lys Ser Arg Ser Ser Ser Phe Ile Ser Ser Ile Asp Asp Glu
1 5 10
<210> 3269
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3225
<400> 3269
Ile Ala Gln Ile Ala Gln Ala Leu Leu Gly Ser Glu Glu Arg
1 5 10
<210> 3270
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3226
<400> 3270
Gln Glu Gln Leu Asn Arg Leu Glu Ser Gln Met Thr Thr Asp
1 5 10
<210> 3271
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3227
<400> 3271
Glu Glu Asn Phe Lys Gln Ile Tyr Ser Gln Phe Phe Pro Gln
1 5 10
<210> 3272
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3228
<400> 3272
Gly Arg Lys Glu Ser Leu Ser Asp Ser Arg Asp Leu Asp Gly
1 5 10
<210> 3273
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3229
<400> 3273
Ser Leu Ser Gly Val Leu Val Ile Ala Leu Pro Val Pro Val
1 5 10
<210> 3274
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3230
<400> 3274
Leu Gly Tyr Thr Leu Lys Ser Cys Ala Ser Glu Leu Gly Phe
1 5 10
<210> 3275
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3231
<400> 3275
Ser Leu Leu Ser Ser Cys Cys Pro Arg Arg Ala Lys Arg Arg
1 5 10
<210> 3276
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3232
<400> 3276
Ala Arg Thr Cys Gly Ala Ser Arg Pro Gly Pro
1 5 10
<210> 3277
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3233
<400> 3277
Asp Ala Glu Leu Asp Asp Pro Glu Ser Glu Asp
1 5 10
<210> 3278
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3234
<400> 3278
Asp Ala Leu Leu Arg Pro Leu Glu Leu Glu Asn
1 5 10
<210> 3279
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3235
<400> 3279
Asp Asp Asp Tyr Val Asn Val Ala Ser Phe Asn
1 5 10
<210> 3280
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3236
<400> 3280
Asp Met Val Ile Ile Val Asp Val Ser Gly Ser
1 5 10
<210> 3281
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3237
<400> 3281
Glu Asp Val Glu Arg Gly Ser Lys Ala Ser Thr Leu Arg Leu
1 5 10
<210> 3282
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3238
<400> 3282
Glu Leu Asp Asp Pro Glu Ser Glu Asp Val Glu
1 5 10
<210> 3283
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3239
<400> 3283
Phe Glu Lys Tyr Asn Trp Pro Asn Arg Thr Val
1 5 10
<210> 3284
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3240
<400> 3284
His Ala Gln Arg Leu Thr Asn Thr Asn Leu Leu
1 5 10
<210> 3285
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3241
<400> 3285
His Gln Asp Ala Leu Leu Arg Pro Leu Glu Leu
1 5 10
<210> 3286
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3242
<400> 3286
Lys Ala Asp Ala Glu Leu Asp Asp Pro Glu Ser
1 5 10
<210> 3287
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3243
<400> 3287
Lys Ala His Arg Trp Gln Asp Asn Ile Lys Glu Glu Asp Ile
1 5 10
<210> 3288
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3244
<400> 3288
Leu Gly Ala Asn Gly Tyr Val Phe Ala Ile Asp
1 5 10
<210> 3289
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3245
<400> 3289
Pro Thr Val Ala Asp Phe Leu Asn Leu Ala Trp Trp Thr Ser
1 5 10
<210> 3290
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3246
<400> 3290
Gln Ile Pro Thr Asp Ile Tyr Lys Gly Ser Thr Val Ile Leu
1 5 10
<210> 3291
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3247
<400> 3291
Arg Trp Gln Asp Asn Ile Lys Glu Glu Asp Ile Val Tyr Tyr
1 5 10
<210> 3292
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3248
<400> 3292
Ser Ser Pro Lys Asp Met Val Ile Ile Val Asp Val Ser Gly
1 5 10
<210> 3293
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3249
<400> 3293
Thr Cys Gly Ala Ser Arg Pro Gly Pro Ala Arg
1 5 10
<210> 3294
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3250
<400> 3294
Trp Ala Arg Arg Leu Glu Gln Glu Val Asp Gly
1 5 10
<210> 3295
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3251
<400> 3295
Tyr Arg Arg Gly Pro His Ile Cys Phe Asp Tyr
1 5 10
<210> 3296
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3252
<400> 3296
Tyr Val Phe Lys Pro Pro His Gln Asp Ala Leu
1 5 10
<210> 3297
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3253
<400> 3297
Tyr Val Asn Val Ala Ser Phe Asn Glu Lys Ala Gln Pro Val
1 5 10
<210> 3298
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3254
<400> 3298
Cys Lys Asp Leu Asn Ala Ser Asp Asn Asn Thr Glu Phe Leu
1 5 10
<210> 3299
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3255
<400> 3299
Thr Leu Val Lys Ser Leu Asp Glu Arg Tyr Ile Asp Glu Val
1 5 10
<210> 3300
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3256
<400> 3300
Leu Glu Asp Leu Gln Asp Leu Asp Ser Leu Asp Thr Glu Lys
1 5 10
<210> 3301
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3257
<400> 3301
Asp Thr Leu Leu Gly Ser Ser Glu Arg Asp Phe Phe Tyr His
1 5 10
<210> 3302
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3258
<400> 3302
Glu Gln Val Phe Glu Glu Ser Cys Met Glu Val Ala Thr Val
1 5 10
<210> 3303
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3259
<400> 3303
Glu Thr Gln Gln Tyr Phe Phe Asp Arg Asp Pro Asp Ile Phe
1 5 10
<210> 3304
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3260
<400> 3304
Phe Glu Glu Ser Cys Met Glu Val Ala Thr Val Asn Arg Pro
1 5 10
<210> 3305
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3261
<400> 3305
His Glu Cys Ile Ser Ala Tyr Asp Glu Glu Leu Ala Phe Phe
1 5 10
<210> 3306
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3262
<400> 3306
Lys Thr Thr Asn His Glu Phe Val Asp Glu Gln Val Phe Glu
1 5 10
<210> 3307
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3263
<400> 3307
Asn His Glu Phe Val Asp Glu Gln Val Phe Glu Glu Ser Cys
1 5 10
<210> 3308
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3264
<400> 3308
Pro Phe Ala Arg Ala Ala Ala Ile Gly Trp Met Pro Val Ala
1 5 10
<210> 3309
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3265
<400> 3309
Tyr His Pro Glu Thr Gln Gln Tyr Phe Phe Asp Arg Asp Pro
1 5 10
<210> 3310
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3266
<400> 3310
Tyr Pro Arg His Glu Cys Ile Ser Ala Tyr Asp Glu Glu Leu
1 5 10
<210> 3311
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3267
<400> 3311
Tyr Val Thr Thr Ala Ile Ile Ser Ile Pro Thr Pro Pro Val
1 5 10
<210> 3312
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3268
<400> 3312
Lys Arg Arg Ala Gln Lys Lys Ala Arg Leu Ala Arg Ile Arg
1 5 10
<210> 3313
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3269
<400> 3313
Leu Asp Thr Ala Cys Val Met Ile Phe Thr Val Glu Tyr Leu
1 5 10
<210> 3314
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3270
<400> 3314
Leu Val Met Thr Asp Asn Glu Asp Val Ser Gly Ala Phe Val
1 5 10
<210> 3315
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3271
<400> 3315
Tyr Ile Gly Leu Val Met Thr Asp Asn Glu Asp Val Ser Gly
1 5 10
<210> 3316
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3272
<400> 3316
Ala Gly Gly Gly Gly Ala Gly Ser Glu His Ser
1 5 10
<210> 3317
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3273
<400> 3317
Ala Asn Tyr Arg Trp Val His His Lys Tyr Asn
1 5 10
<210> 3318
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3274
<400> 3318
Asp Ala Thr Pro His Thr Leu Val Gln Pro Ile Pro Ala Thr
1 5 10
<210> 3319
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3275
<400> 3319
Asp Glu Glu Glu Ile Asp Tyr Thr Leu Cys Phe
1 5 10
<210> 3320
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3276
<400> 3320
Asp Glu Gly Arg His Leu Gly Ser Arg His Cys Gln Thr Leu
1 5 10
<210> 3321
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3277
<400> 3321
Asp Asn Arg Asp Ser Val Asp Leu Ala Glu Leu Val Pro Ala
1 5 10
<210> 3322
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3278
<400> 3322
Asp Arg Gly Asp Arg Gly Glu Asp Glu Glu Glu Ile Asp Tyr
1 5 10
<210> 3323
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3279
<400> 3323
Asp Arg Gly Glu Asp Glu Glu Glu Ile Asp Tyr Thr Leu Cys
1 5 10
<210> 3324
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3280
<400> 3324
Asp Ser Ser Gln Ala Pro Pro Ser Pro Phe Ser
1 5 10
<210> 3325
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3281
<400> 3325
Asp Val Tyr Lys Pro Asp Trp Cys Glu Val Arg Glu Asp Trp
1 5 10
<210> 3326
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3282
<400> 3326
Glu Cys Cys Leu Ser Lys Asp Asp Val Tyr Asp
1 5 10
<210> 3327
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3283
<400> 3327
Glu Asp Gly Ala Ser Ser Glu Leu Gly Lys Glu Glu Glu Glu
1 5 10
<210> 3328
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3284
<400> 3328
Glu Asp Gln Ser Ser Ser Asn Ile Glu Glu Phe
1 5 10
<210> 3329
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3285
<400> 3329
Glu Glu Glu Glu Glu Glu Gln Ala Asp Gly Ala
1 5 10
<210> 3330
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3286
<400> 3330
Phe Asn Pro Val Arg Ser Trp Leu Lys His Asp Ser Ser Gln
1 5 10
<210> 3331
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3287
<400> 3331
Gly Ala Gly Gly Gly Gly Ala Gly Ser Glu His Ser Glu Thr
1 5 10
<210> 3332
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3288
<400> 3332
Gly Ala Ser Ser Glu Leu Gly Lys Glu Glu Glu
1 5 10
<210> 3333
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3289
<400> 3333
Gly Glu Asp Glu Glu Glu Ile Asp Tyr Thr Leu
1 5 10
<210> 3334
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3290
<400> 3334
Gly Lys Glu Glu Glu Glu Glu Glu Gln Ala Asp
1 5 10
<210> 3335
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3291
<400> 3335
Gly Lys Phe Tyr His Cys Leu Gly Val Asp Thr Arg Asn Ile
1 5 10
<210> 3336
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3292
<400> 3336
Gly Ser Leu Gln Thr Thr Leu Glu Asp Ser Leu Thr Leu Ser
1 5 10
<210> 3337
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3293
<400> 3337
Gly Ser Ser Ala Gly Gly Glu Asp Glu Ala Asp
1 5 10
<210> 3338
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3294
<400> 3338
Lys Asp Pro Pro Gly Arg Ala Pro Leu Pro Met
1 5 10
<210> 3339
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3295
<400> 3339
Lys Glu Ala Gln Glu Asp Ala Glu Met Asp Ala Glu Leu Glu
1 5 10
<210> 3340
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3296
<400> 3340
Lys Phe Ser Leu Arg Thr Asp Thr Gly Asp Thr Val Pro Asp
1 5 10
<210> 3341
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3297
<400> 3341
Lys Met Gly Asp Arg Gly Asp Arg Gly Glu Asp Glu Glu Glu
1 5 10
<210> 3342
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3298
<400> 3342
Leu Asp Ala Val Ala Val Asp Gln Gln Pro Val
1 5 10
<210> 3343
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3299
<400> 3343
Leu Asp Ser Ser Gly Asp Pro Lys Leu Cys Pro Ile Pro Met
1 5 10
<210> 3344
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3300
<400> 3344
Leu Glu Gly Glu Leu Thr Ile Ile Asp Asn Leu
1 5 10
<210> 3345
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3301
<400> 3345
Leu Glu Arg Pro Gln Ile Glu Ala Gly Ser Thr Glu Arg Ile
1 5 10
<210> 3346
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3302
<400> 3346
Leu Thr Ser Leu Phe Cys Pro Pro Pro Pro Pro
1 5 10
<210> 3347
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3303
<400> 3347
Leu Val Ala Leu Gly Ser Arg Lys Ser Ser Val
1 5 10
<210> 3348
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3304
<400> 3348
Met Lys His Leu Asp Asp Ser Asn Lys Glu Ala
1 5 10
<210> 3349
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3305
<400> 3349
Met Arg Val Gly Asp Leu Gly Glu Cys Phe Phe Pro Leu Ser
1 5 10
<210> 3350
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3306
<400> 3350
Asn Phe Leu Cys Glu Met Glu Glu Ile Pro Phe
1 5 10
<210> 3351
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3307
<400> 3351
Pro Ala Pro Gly His Glu Asp Cys Asn Gly Arg Met Pro Ser
1 5 10
<210> 3352
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3308
<400> 3352
Pro Asp Ala Ser Ser Pro Leu Leu Pro Met Pro Ala Glu Phe
1 5 10
<210> 3353
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3309
<400> 3353
Pro Glu Asn Phe Leu Cys Glu Met Glu Glu Ile
1 5 10
<210> 3354
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3310
<400> 3354
Pro Gly Leu Glu Glu Pro Leu Asp Gly Ala Asp
1 5 10
<210> 3355
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3311
<400> 3355
Pro Arg Arg Ala Leu Gly Pro Pro Ala Pro Ala
1 5 10
<210> 3356
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3312
<400> 3356
Pro Ser Pro Phe Ser Pro Asp Ala Ser Ser Pro
1 5 10
<210> 3357
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3313
<400> 3357
Gln Glu Asp Ala Glu Met Asp Ala Glu Leu Glu Leu Glu Met
1 5 10
<210> 3358
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3314
<400> 3358
Arg Gly Leu Arg Ala His Gln Arg Ser His Ser
1 5 10
<210> 3359
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3315
<400> 3359
Arg Gly Pro Gly Gly Ala Gly Gly Gly Gly Asp
1 5 10
<210> 3360
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3316
<400> 3360
Arg Ile Leu Val Asn Leu Leu Leu Asp Thr Leu
1 5 10
<210> 3361
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3317
<400> 3361
Arg Ser Ala Ala Trp Ala Ser Arg Arg Ser Ser
1 5 10
<210> 3362
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3318
<400> 3362
Ser Ala Glu Arg Gly Gly Gly Ala Arg Val Cys
1 5 10
<210> 3363
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3319
<400> 3363
Ser Asp Arg Ser Ser Ser Ile Leu Leu Gly Asp
1 5 10
<210> 3364
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3320
<400> 3364
Ser Gly Asp Pro Lys Leu Cys Pro Ile Pro Met Thr Pro Asn
1 5 10
<210> 3365
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3321
<400> 3365
Ser Leu Phe Cys Pro Pro Pro Pro Pro Pro Ala
1 5 10
<210> 3366
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3322
<400> 3366
Ser Leu Thr Ser Leu Phe Cys Pro Pro Pro Pro Pro Pro Ala
1 5 10
<210> 3367
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3323
<400> 3367
Ser Pro Asp Ala Ser Ser Pro Leu Leu Pro Met
1 5 10
<210> 3368
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3324
<400> 3368
Ser Ser Glu Leu Gly Lys Glu Glu Glu Glu Glu
1 5 10
<210> 3369
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3325
<400> 3369
Ser Ser Pro Leu Leu Pro Met Pro Ala Glu Phe
1 5 10
<210> 3370
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3326
<400> 3370
Thr Pro His Thr Leu Val Gln Pro Ile Pro Ala
1 5 10
<210> 3371
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3327
<400> 3371
Thr Val Ala Ser Tyr Ala Glu Pro Gly Asp Cys Tyr Glu Glu
1 5 10
<210> 3372
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3328
<400> 3372
Val Ile Phe Gln Val Ile Thr Leu Glu Gly Trp Val Glu Ile
1 5 10
<210> 3373
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3329
<400> 3373
Val Thr Leu Gly Met Tyr Gln Pro Cys Asp Asp Met Asp Cys
1 5 10
<210> 3374
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3330
<400> 3374
Val Tyr Asp Phe Gly Ala Gly Arg Gln Asp Leu
1 5 10
<210> 3375
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3331
<400> 3375
Tyr Asn Gly Leu Asp Ala Val Ala Val Asp Gln Gln Pro Val
1 5 10
<210> 3376
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3332
<400> 3376
Ala Ser Ser Glu Leu Gly Lys Glu Glu Glu Glu Glu Glu Gln
1 5 10
<210> 3377
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3333
<400> 3377
Leu Asn Ser Asp Arg Ser Ser Ser Ile Leu Leu Gly Asp Asp
1 5 10
<210> 3378
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3334
<400> 3378
Ser Tyr Ser Asp Glu Asp Gln Ser Ser Ser Asn Ile Glu Glu
1 5 10
<210> 3379
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3335
<400> 3379
Ala Phe Ser Leu Asn Ser Asp Arg Ser Ser Ser Ile Leu Leu
1 5 10
<210> 3380
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3336
<400> 3380
Asp Asn Leu Ser Gly Ser Ile Phe His His Tyr Ser Ser Pro
1 5 10
<210> 3381
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3337
<400> 3381
Asp Arg Ser Ser Ser Ile Leu Leu Gly Asp Asp Leu Ser Leu
1 5 10
<210> 3382
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3338
<400> 3382
His Asp Lys Gln Glu Val Gln Leu Ala Glu Thr Glu Ala Phe
1 5 10
<210> 3383
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3339
<400> 3383
Met His Ile Phe Gly Cys Lys Phe Ser Leu Arg Thr Asp Thr
1 5 10
<210> 3384
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3340
<400> 3384
Ser Gly Ser Ile Phe His His Tyr Ser Ser Pro Ala Gly Cys
1 5 10
<210> 3385
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3341
<400> 3385
Ala His Ile Cys Asn Gly Thr Asn Leu Thr Met
1 5 10
<210> 3386
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3342
<400> 3386
Phe Gly Ala Leu Ser Phe Ile Val Ala Glu Thr Val Gly Val
1 5 10
<210> 3387
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3343
<400> 3387
Gly His Cys Phe Arg Ile Asn His Phe Pro Glu
1 5 10
<210> 3388
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3344
<400> 3388
Leu Thr Thr Ala Gly Ala Phe Ala Ala Phe Ser
1 5 10
<210> 3389
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3345
<400> 3389
Leu Tyr Ser Ser Ala His Ile Cys Asn Gly Thr Asn Leu Thr
1 5 10
<210> 3390
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3346
<400> 3390
Asn His Phe Pro Glu Asp Asn Asp Tyr Asp His
1 5 10
<210> 3391
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3347
<400> 3391
Pro Ser Arg Asp Val Ser Pro Met Gly Leu Lys
1 5 10
<210> 3392
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3348
<400> 3392
Arg Met Pro Ser Tyr Arg Tyr Arg Arg Arg Arg
1 5 10
<210> 3393
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3349
<400> 3393
Val Ala Glu Thr Val Gly Val Leu Ala Val Asn
1 5 10
<210> 3394
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3350
<400> 3394
Tyr Trp Leu Tyr Ser Ser Ala His Ile Cys Asn
1 5 10
<210> 3395
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3351
<400> 3395
Glu Asp Asn Asp Tyr Asp His Asp Ser Ser Glu Tyr Leu Leu
1 5 10
<210> 3396
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3352
<400> 3396
His Phe Pro Glu Asp Asn Asp Tyr Asp His Asp Ser Ser Glu
1 5 10
<210> 3397
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3353
<400> 3397
Arg Ile Asn His Phe Pro Glu Asp Asn Asp Tyr Asp His Asp
1 5 10
<210> 3398
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3354
<400> 3398
Ser Tyr Arg Tyr Arg Arg Arg Arg Ser Arg Ser Ser Ser Arg
1 5 10
<210> 3399
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3355
<400> 3399
Ser Phe Ala Phe Ala Ala Ile Ser Phe Leu Leu Thr Glu Ser
1 5 10
<210> 3400
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3356
<400> 3400
Ser Ser Glu Ala Ser Leu Gln Met Asn Ser Asn Tyr Pro Ala
1 5 10
<210> 3401
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3357
<400> 3401
Ala Tyr Leu Thr Trp Asp Arg Asp Gln Tyr Asp
1 5 10
<210> 3402
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3358
<400> 3402
Cys Leu Ser Pro His His Ser Arg Glu Arg Asp
1 5 10
<210> 3403
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3359
<400> 3403
Asp Phe Ile Glu Asp Val Glu Trp Glu Val His
1 5 10
<210> 3404
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3360
<400> 3404
Asp Phe Ile Glu Asp Val Glu Trp Glu Val His Gly Met Pro
1 5 10
<210> 3405
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3361
<400> 3405
Asp Ile Val Leu Tyr Asn Lys Ala Asp Asp Glu
1 5 10
<210> 3406
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3362
<400> 3406
Asp Leu Ser Asp Phe Ile Glu Asp Val Glu Trp Glu Val His
1 5 10
<210> 3407
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3363
<400> 3407
Asp Leu Val Trp Arg Pro Asp Ile Val Leu Tyr
1 5 10
<210> 3408
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3364
<400> 3408
Asp Ser Gly Asp Leu Ser Asp Phe Ile Glu Asp
1 5 10
<210> 3409
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3365
<400> 3409
Asp Ser Gly Asp Leu Ser Asp Phe Ile Glu Asp Val Glu Trp
1 5 10
<210> 3410
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3366
<400> 3410
Glu Asp Tyr Ser Asn Ala Leu Arg Pro Val Glu Asp Thr Asp
1 5 10
<210> 3411
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3367
<400> 3411
Phe Gln Leu Met Val Ala Glu Ile Met Pro Ala
1 5 10
<210> 3412
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3368
<400> 3412
Gly Asp Leu Ser Asp Phe Ile Glu Asp Val Glu
1 5 10
<210> 3413
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3369
<400> 3413
Ile Ala Thr Met Ala Leu Ile Thr Ala Ser Thr Ala Leu Thr
1 5 10
<210> 3414
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3370
<400> 3414
Leu Thr Lys Val Tyr Ser Lys Leu Pro Glu Ser Asn Leu Lys
1 5 10
<210> 3415
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3371
<400> 3415
Pro Ala Ile Thr Lys Ser Ser Cys Val Val Asp
1 5 10
<210> 3416
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3372
<400> 3416
Pro His Trp Ala Arg Val Val Ile Leu Lys Tyr
1 5 10
<210> 3417
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3373
<400> 3417
Gln Lys Leu Phe Asn Asp Leu Phe Glu Asp Tyr
1 5 10
<210> 3418
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3374
<400> 3418
Arg Asp His Leu Thr Lys Val Tyr Ser Lys Leu Pro Glu Ser
1 5 10
<210> 3419
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3375
<400> 3419
Thr Val Phe Gln Leu Met Val Ala Glu Ile Met Pro Ala Ser
1 5 10
<210> 3420
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3376
<400> 3420
Val His Gly Met Pro Ala Val Lys Asn Val Ile Ser Tyr Gly
1 5 10
<210> 3421
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3377
<400> 3421
Val Leu Arg Tyr Asp Gly Leu Ile Thr Trp Asp
1 5 10
<210> 3422
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3378
<400> 3422
Val Val Asp Val Thr Tyr Phe Pro Phe Asp Asn
1 5 10
<210> 3423
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3379
<400> 3423
Ala Ile Thr Lys Ser Ser Cys
1 5
<210> 3424
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3380
<400> 3424
Asp Phe Ile Glu Asp Val Glu
1 5
<210> 3425
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3381
<400> 3425
Asp Leu Ser Asp Phe Ile Glu Asp Val Glu Trp Glu Val
1 5 10
<210> 3426
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3382
<400> 3426
Asp Ser Gly Asp Leu Ser Asp Phe Ile Glu Asp Val Glu
1 5 10
<210> 3427
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3383
<400> 3427
Gly Ala Glu Ala Arg Pro Val
1 5
<210> 3428
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3384
<400> 3428
Gly Asp Leu Ser Asp Phe Ile Glu Asp Val Glu Trp Glu
1 5 10
<210> 3429
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3385
<400> 3429
Leu Thr Phe Gly Ser Trp Thr Tyr Asn Gly Asn Gln Val
1 5 10
<210> 3430
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3386
<400> 3430
Leu Tyr Asn Lys Ala Asp Asp Glu Ser Ser Glu Pro Val
1 5 10
<210> 3431
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3387
<400> 3431
Ser Phe Leu Ala Pro Leu Ser
1 5
<210> 3432
<211> 13
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3388
<400> 3432
Ser Gly Asp Leu Ser Asp Phe Ile Glu Asp Val Glu Trp
1 5 10
<210> 3433
<211> 7
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3389
<400> 3433
Tyr Asn Gly Asn Gln Val Asp
1 5
<210> 3434
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3390
<400> 3434
Ala Ser Met Asp Gln Ile Ser Ala Ile Thr Asp Ser Ala Glu
1 5 10
<210> 3435
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3391
<400> 3435
Asp Gln Ile Ser Ala Ile Thr Asp Ser Ala Glu Tyr Cys Glu
1 5 10
<210> 3436
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3392
<400> 3436
His Thr Ser Val Met Thr Gly Ser Leu Leu Asp Asp His His
1 5 10
<210> 3437
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3393
<400> 3437
Ile Tyr Gly His Thr Ser Val Met Thr Gly Ser Leu Leu Asp
1 5 10
<210> 3438
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3394
<400> 3438
Leu Pro Tyr Arg Phe Arg Asn Lys Lys Met Lys Thr Leu Lys
1 5 10
<210> 3439
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3395
<400> 3439
Met Gln Ala Ala Pro Arg Ala Gly Cys Gly Ala Ala Leu Leu
1 5 10
<210> 3440
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3396
<400> 3440
Asn Gly Val Asn Arg Asn Ser Ala Ile Ile Gly Gly Val Ile
1 5 10
<210> 3441
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3397
<400> 3441
Ser Ser Arg Val Asp Asn Ala Pro Asp Gln Gln Asn Ser His
1 5 10
<210> 3442
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3398
<400> 3442
Val Asp Asn Ala Pro Asp Gln Gln Asn Ser His Pro Asp Leu
1 5 10
<210> 3443
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3399
<400> 3443
Val Tyr Ser Ala Ser Met Asp Gln Ile Ser Ala Ile Thr Asp
1 5 10
<210> 3444
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3400
<400> 3444
Cys Asp Asp Tyr Asp Val Thr Cys Asn Glu Phe Phe Phe Asp
1 5 10
<210> 3445
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3401
<400> 3445
Asp Ala Ser Phe His Pro Ala Phe Leu Pro Gln Arg Gln Ala
1 5 10
<210> 3446
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3402
<400> 3446
Glu Glu Phe Ala Glu Met Val Glu Arg Glu Glu Glu Asp Asp
1 5 10
<210> 3447
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3403
<400> 3447
Leu Leu Pro Gly Asp Asn Ser Asp Tyr Asp Tyr Ser Ala Leu
1 5 10
<210> 3448
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3404
<400> 3448
Leu Leu Arg Glu Met Cys Ala Leu Ser Phe Gln Glu Glu Leu
1 5 10
<210> 3449
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3405
<400> 3449
Leu Asn Val Cys Asp Asp Tyr Asp Val Thr Cys Asn Glu Phe
1 5 10
<210> 3450
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3406
<400> 3450
Met Val Glu Arg Pro His Ser Gly Leu Pro Gly Lys Val Phe
1 5 10
<210> 3451
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3407
<400> 3451
Asn Leu Ser Val Ser Thr Leu Pro Ser Leu Arg Glu Glu Glu
1 5 10
<210> 3452
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3408
<400> 3452
Thr Asn Phe Asp Asp Ile Leu Asn Val Cys Asp Asp Tyr Asp
1 5 10
<210> 3453
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3409
<400> 3453
Thr Pro Gly Gln Val Val Ala Leu Ser Ser Ile Leu Ser Gly
1 5 10
<210> 3454
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3410
<400> 3454
Glu Glu Glu Glu Gln Gly His Cys Ser Gln Met Cys His Asn
1 5 10
<210> 3455
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3411
<400> 3455
Glu Phe Pro Leu Thr Arg Leu Gly Gln Leu Lys Ala Cys Thr
1 5 10
<210> 3456
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3412
<400> 3456
Met Val Glu Arg Glu Glu Glu Asp Asp Ala Leu Asp Ser Glu
1 5 10
<210> 3457
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3413
<400> 3457
Arg Val Met Phe Arg Arg Ala Gln Phe Leu Ile Lys Thr Lys
1 5 10
<210> 3458
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3414
<400> 3458
Asp Asp Tyr Asp Val Ser Arg Asp Glu Phe Phe Phe Asp Arg
1 5 10
<210> 3459
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3415
<400> 3459
Glu Cys Ser Pro Lys Cys Arg Ser Leu Phe Val Leu Glu Thr
1 5 10
<210> 3460
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3416
<400> 3460
Gly His Asp Asp Leu Leu Arg Val Cys Asp Asp Tyr Asp Val
1 5 10
<210> 3461
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3417
<400> 3461
His Ser Ala Thr Ala Thr Glu Asp Ser Ser Gln Gly Pro Asp
1 5 10
<210> 3462
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3418
<400> 3462
Pro Leu Ala Arg Leu Glu Arg Leu Arg Ala Cys Arg Gly His
1 5 10
<210> 3463
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3419
<400> 3463
Thr Glu Arg Gly Ala Gln Gly Ser Pro Ala Arg Ala Leu Gly
1 5 10
<210> 3464
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3420
<400> 3464
Leu Leu Leu Phe Leu Cys Val Ala Met Ala Leu Phe Ala Pro
1 5 10
<210> 3465
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3421
<400> 3465
Arg Ala Leu Gly Pro Arg Gly Arg Leu Gln Arg Gly Arg Arg
1 5 10
<210> 3466
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3422
<400> 3466
Arg Arg Cys Ala Arg Glu Phe Gly Leu Leu Leu Leu Phe Leu
1 5 10
<210> 3467
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3423
<400> 3467
Val Cys Asp Asp Tyr Asp Val Ser Arg Asp Glu Phe Phe Phe
1 5 10
<210> 3468
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3424
<400> 3468
Ala Ser Thr Ser Gly Leu Leu Gln Pro Leu Cys Val Asp Thr
1 5 10
<210> 3469
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3425
<400> 3469
Phe Asp Leu Leu His Ala Phe Lys Val Asn Val Tyr Phe Gly
1 5 10
<210> 3470
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3426
<400> 3470
Phe Trp Cys Leu Leu Asp Val Ile Pro Ile Lys Asn Glu Lys
1 5 10
<210> 3471
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3427
<400> 3471
Gly Ile Glu Asp Gly Cys Gly Ser Asp Gln Pro Lys Phe Ser
1 5 10
<210> 3472
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3428
<400> 3472
Asn Thr Leu Met Ser Thr Leu Glu Glu Lys Glu Thr Asp Gly
1 5 10
<210> 3473
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3429
<400> 3473
Pro Arg Arg Thr Ala Pro Arg Pro Arg Leu Gly Gly Arg Gly
1 5 10
<210> 3474
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3430
<400> 3474
Arg Arg Arg Tyr Gly Arg Ala Arg Ser Lys Gly Phe Asn Ala
1 5 10
<210> 3475
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3431
<400> 3475
Arg Thr Thr Phe Val Ser Lys Ser Gly Gln Val Val Phe Ala
1 5 10
<210> 3476
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3432
<400> 3476
Thr Val Ser Pro Ala Pro Ala Asp Glu Pro Ser Ser Pro Leu
1 5 10
<210> 3477
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3433
<400> 3477
Thr Trp Ala Val Asn Asn Gly Ile Asp Thr Thr Glu Leu Leu
1 5 10
<210> 3478
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3434
<400> 3478
Val Cys Asp Leu Ala Val Glu Val Leu Phe Ile Leu Asp Ile
1 5 10
<210> 3479
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3435
<400> 3479
Val Val Asp Gly Ile Glu Asp Gly Cys Gly Ser Asp Gln Pro
1 5 10
<210> 3480
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3436
<400> 3480
Tyr Ile Thr Ser Leu Tyr Phe Ala Leu Ser Ser Leu Thr Ser
1 5 10
<210> 3481
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3437
<400> 3481
Leu Leu Asp Val Ile Pro Ile Lys Asn Glu Lys Gly Glu Val
1 5 10
<210> 3482
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3438
<400> 3482
Asp Leu Cys Ser Glu Pro Ser Thr Pro Ala Ser Pro Pro Pro
1 5 10
<210> 3483
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3439
<400> 3483
Lys His Lys Leu Asn Lys Gly Val Phe Gly Glu Lys Pro Asn
1 5 10
<210> 3484
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3440
<400> 3484
Leu Asn Phe Arg Thr Thr Phe Val Ser Lys Ser Gly Gln Val
1 5 10
<210> 3485
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3441
<400> 3485
Ala Thr Val Ser Met Thr Thr Val Gly Tyr Gly Asp Val Val
1 5 10
<210> 3486
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3442
<400> 3486
Ala Tyr Thr Ile Glu Lys Glu Glu Asn Glu Gly Leu Ala Thr
1 5 10
<210> 3487
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3443
<400> 3487
Phe Gln Ile Pro Asp Ser Gln Gly Asn Pro Gly Glu Asp Pro
1 5 10
<210> 3488
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3444
<400> 3488
Gly Asn Phe Arg Arg Gln Leu Trp Leu Ala Leu Asp Asn Pro
1 5 10
<210> 3489
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3445
<400> 3489
His Ser Arg Glu Ala Ile Leu Glu Leu Cys Asp Asp Tyr Asp
1 5 10
<210> 3490
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3446
<400> 3490
Ser Thr Thr Ser Ser Phe Asp Glu Ile Leu Ala Phe Tyr Asn
1 5 10
<210> 3491
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3447
<400> 3491
Val Phe Ser Phe Ser Gln Glu Ile Glu Tyr Trp Gly Ile Asn
1 5 10
<210> 3492
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3448
<400> 3492
Cys Asp Asp Tyr Asp Asp Val Gln Arg Glu Phe Tyr Phe Asp
1 5 10
<210> 3493
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3449
<400> 3493
Leu Glu Leu Cys Asp Asp Tyr Asp Asp Val Gln Arg Glu Phe
1 5 10
<210> 3494
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3450
<400> 3494
Ala Cys Ser Leu Asp Leu His Lys Phe Pro Met Asp Lys Gln
1 5 10
<210> 3495
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3451
<400> 3495
Ala Gln Ala Pro Leu Ala Ser Pro Glu Ser Leu Gly Ser Leu
1 5 10
<210> 3496
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3452
<400> 3496
Phe Tyr Ser Arg Gly Pro Arg Arg Gln Pro Arg Arg His Arg
1 5 10
<210> 3497
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3453
<400> 3497
Ile Leu Val Cys Leu Phe Phe Val Phe Leu Ser Leu Leu Glu
1 5 10
<210> 3498
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3454
<400> 3498
Lys Cys Asp Thr Asn Ser Thr Trp Gly Leu Asn Asp Asp Glu
1 5 10
<210> 3499
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3455
<400> 3499
Arg Gly Pro Arg Arg Gln Pro Arg Arg His Arg Arg Pro Arg
1 5 10
<210> 3500
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3456
<400> 3500
Pro Arg Arg Gln Pro Arg Arg His Arg Arg Pro Arg Arg Val
1 5 10
<210> 3501
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3457
<400> 3501
Gln Arg Glu Val Asn Ser Tyr Leu Val Gln Val Tyr Trp Pro
1 5 10
<210> 3502
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3458
<400> 3502
Cys Ile Trp Tyr Val Ile Gly Arg Arg Glu Met Glu Ala Asn
1 5 10
<210> 3503
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3459
<400> 3503
Glu Ile Cys Phe Tyr Arg Lys Asp Gly Ser Ala Phe Trp Cys
1 5 10
<210> 3504
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3460
<400> 3504
Glu Leu Arg His Ile Met Gly Leu Leu Gln Ala Arg Leu Gly
1 5 10
<210> 3505
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3461
<400> 3505
His Lys Ala Leu Glu Gly His Gln Glu His Arg Ala Glu Ile
1 5 10
<210> 3506
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3462
<400> 3506
Lys Thr Leu Pro Ser Ile Thr Glu Ala Glu Ser Gly Ala Glu
1 5 10
<210> 3507
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3463
<400> 3507
Leu Glu Gly His Gln Glu His Arg Ala Glu Ile Cys Phe Tyr
1 5 10
<210> 3508
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3464
<400> 3508
Leu Pro Arg Pro Leu Lys Gln Arg Met Leu Glu Tyr Phe Gln
1 5 10
<210> 3509
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3465
<400> 3509
Asn Leu Arg Gln Gly Ser Asp Thr Ser Gly Leu Ser Arg Phe
1 5 10
<210> 3510
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3466
<400> 3510
Pro Ser Ile Thr Glu Ala Glu Ser Gly Ala Glu Pro Gly Gly
1 5 10
<210> 3511
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3467
<400> 3511
Arg Glu Ile Leu Gln Leu Pro Leu Phe Gly Ala Ala Ser Arg
1 5 10
<210> 3512
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3468
<400> 3512
Arg Pro Ser Pro Glu Leu Ala Ser Glu Ala Glu Glu Val Lys
1 5 10
<210> 3513
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3469
<400> 3513
Val Asp Gly Ile Glu Asp Ser Gly Ser Thr Ala Glu Ala Pro
1 5 10
<210> 3514
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3470
<400> 3514
Val His Arg Leu Pro Arg Pro Leu Lys Gln Arg Met Leu Glu
1 5 10
<210> 3515
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3471
<400> 3515
Gly Asp Ala Leu Gln Ala His Tyr Tyr Val Cys Ser Gly Ser
1 5 10
<210> 3516
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3472
<400> 3516
Leu Pro Ser Ile Thr Glu Ala Glu Ser Gly Ala Glu Pro Gly
1 5 10
<210> 3517
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3473
<400> 3517
Pro Tyr Asn Val Cys Phe Ser Gly Asp Asp Asp Thr Pro Ile
1 5 10
<210> 3518
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3474
<400> 3518
Ser Asp Ile Ala Val Glu Met Leu Phe Ile Leu Asp Ile Ile
1 5 10
<210> 3519
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3475
<400> 3519
Ser Gln Pro Arg Ser Glu Ser Leu Gly Ser Ser Ser Asp Lys
1 5 10
<210> 3520
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3476
<400> 3520
Gly Ser Asp Ser Ser Asp Ser Glu Leu Glu Leu Ser Thr Val
1 5 10
<210> 3521
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3477
<400> 3521
Ser Ser Thr Ala Pro Gln Gly Ser Asp Ser Ser Asp Ser Glu
1 5 10
<210> 3522
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3478
<400> 3522
Ala Ser Pro Val Gly Ile Lys Gly Phe Asn Thr
1 5 10
<210> 3523
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3479
<400> 3523
Phe Tyr Phe Gly Ala Leu Ser Phe Ile Ile Ala
1 5 10
<210> 3524
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3480
<400> 3524
Gly Ile Lys Gly Phe Asn Thr Leu Pro Ser Thr
1 5 10
<210> 3525
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3481
<400> 3525
Lys Gly Phe Asn Thr Leu Pro Ser Thr Glu Ile Ser Met Tyr
1 5 10
<210> 3526
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3482
<400> 3526
Leu Leu Phe Met Gly Gly Leu Cys Ile Ala Ala Ser Glu Phe
1 5 10
<210> 3527
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3483
<400> 3527
Pro Glu Asp Ala Asp Tyr Glu Ala Asp Thr Ala Glu Tyr Phe
1 5 10
<210> 3528
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3484
<400> 3528
Arg Ile Pro Ser Tyr Arg Tyr Arg Tyr Gln Arg Arg Ser Arg
1 5 10
<210> 3529
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3485
<400> 3529
Ser Leu His Ser Asn Thr Ala Asn Arg Arg Thr
1 5 10
<210> 3530
<211> 11
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3486
<400> 3530
Val His Met Phe Ile Asp Arg His Lys Gln Leu
1 5 10
<210> 3531
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3487
<400> 3531
Val Leu Ala Val His Met Phe Ile Asp Arg His Lys Gln Leu
1 5 10
<210> 3532
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3488
<400> 3532
Trp Leu Tyr Ser Arg Gly Val Cys Lys Thr Lys Ser Val Ser
1 5 10
<210> 3533
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3489
<400> 3533
Ile Lys Gly Phe Asn Thr Leu Pro Ser Thr Glu Ile Ser Met
1 5 10
<210> 3534
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3490
<400> 3534
Leu Leu Thr Thr Val Gly Ala Phe Ala Ala Phe Ser Leu Met
1 5 10
<210> 3535
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3491
<400> 3535
Pro Val Gly Ile Lys Gly Phe Asn Thr Leu Pro Ser Thr Glu
1 5 10
<210> 3536
<211> 14
<212> PRT
<213> Homo sapiens
<220>
<223> peptide 3492
<400> 3536
Ser Phe Tyr Phe Gly Ala Leu Ser Phe Ile Ile Ala Glu Met
1 5 10
Claims (16)
- 화합물로서,
생물중합체(biopolymer) 스캐폴드 및 6-13개 아미노산의 서열 길이를 갖는 적어도 2개의 펩타이드를 포함하되,
여기서 각각의 펩타이드는 독립적으로 다음:
P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1, A0A0G2JKS1, A5X5Y0, A6NL88, A8MPY1, B4DS77, B8ZZ34, O00222, O00591, O14490, O14764, O15303, O15399, O43424, O43653, O60359, O60391, O60403, O60404, O60936, O75311, O75916, O76027, O94772, O95264, O95502, O95868, O95886, P01579, P05026, P05067, P06850, P07196, P07384, P0C7T3, P0C8F1, P0DP57, P0DP58, P12931, P13500, P14416, P14867, P15382, P16066, P17342, P18505, P18507, P19634, P20594, P21452, P21728, P21917, P21918, P23415, P23416, P24046, P24387, P25021, P25101, P28221, P28222, P28223, P28335, P28472, P28476, P28566, P29274, P29275, P29323, P30411, P30542, P30556, P30939, P31644, P32418, P34903, P34969, P35367, P35372, P35462, P35609, P37288, P39086, P41594, P41595, P41597, P42261, P42262, P42263, P43119, P46098, P47869, P47870, P47898, P47901, P47972, P48058, P48067, P48167, P48169, P48549, P49354, P50052, P50406, P53355, P55000, P62955, P63252, P78334, P78352, P78509, Q00535, Q05586, Q06413, Q07699, Q12879, Q12959, Q13002, Q13003, Q13224, Q13255, Q13387, Q13639, Q13702, Q13936, Q13972, Q14289, Q14416, Q14500, Q14571, Q14573, Q14643, Q14831, Q14832, Q14833, Q14957, Q15700, Q15818, Q16099, Q16445, Q16478, Q16553, Q16602, Q401N2, Q494W8, Q5SQ64, Q6PI25, Q6TFL4, Q6UXU4, Q6ZSJ9, Q70Z44, Q86Y78, Q86YM7, Q8N1C3, Q8N2G4, Q8N2Q7, Q8N4C8, Q8NC67, Q8NFZ4, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC8, Q8NGC9, Q8NGG2, Q8NGG3, Q8NGH5, Q8NGH8, Q8NGN1, Q8NGS4, Q8NGY7, Q8NHC4, Q8NI32, Q8TBE1, Q8TCU5, Q8TDF5, Q8WXA2, Q8WXA8, Q8WXS5, Q92736, Q92796, Q96G91, Q96NW7, Q96P66, Q99928, Q99996, Q9BUH8, Q9BXM7, Q9BYB0, Q9GZV3, Q9H3N8, Q9NPA1, Q9NZ94, Q9P1A6, Q9UBK2, Q9UBN1, Q9UBS5, Q9UF02, Q9ULK0, Q9UN88, Q9UPX8, Q9Y2H0, Q9Y4A9, Q9Y566, Q9Y5N1, Q9Y691, Q9Y698, P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, P48664, A6NGN9, O00305, O00555, O15146, O43448, O43497, O43525, O43526, O60840, O75096, O95180, O95259, O95970, P06213, P16389, P16473, P17658, P22001, P22459, P22460, P24530, P42658, P43146, P48547, P49418, P51787, P54284, P54289, P56696, Q00975, Q01668, Q02246, Q02641, Q03721, Q05329, Q06432, Q08289, Q09470, Q12809, Q13018, Q13303, Q13698, Q14003, Q14721, Q14722, Q15878, Q6PIL6, Q6PIU1, Q6X4W1, Q7Z3S7, Q7Z429, Q8IZS8, Q8NCM2, Q8TAE7, Q8TDN1, Q8TDN2, Q8WWG9, Q92953, Q96KK3, Q96L42, Q96PR1, Q96RP8, Q9BQ31, Q9BXT2, Q9H252, Q9H3M0, Q9NR82, Q9NS40, Q9NS61, Q9NSA2, Q9NY47, Q9NZI2, Q9NZV8, Q9P0X4, Q9UHC6, Q9UIX4, Q9UJ90, Q9UJ96, Q9UK17, Q9ULD8, Q9ULS6, Q9UQ05, Q9Y2W7, Q9Y6H6, Q9Y6J6, P48058, P55087, Q9BPU6, P52799, P15328, Q05329, Q16653, Q9Y4C0, Q5F0I5, Q99719, P17600, Q13148, P01266, P07202, 및 Q9Y6A1으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는, 신경수용체의 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더욱 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 더욱 더 바람직하게는 11-, 훨씬 더 바람직하게는 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고,
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
- 제1 항에 있어서,
여기서 상기 아미노산 서열은 다음:
P02708, P07510, P07550, P08172, P08173, P08588, P08908, P08912, P08913, P11229, P11230, P13945, P17787, P18089, P18825, P20309, P25098, P25100, P30532, P30926, P32297, P35348, P35368, P35626, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1; P37088, P51168, P51170, P51172, O94759, Q16515, O60741, Q9NZQ8, P78348, Q8TDD5, Q9NY37, Q13002, P39086, 및 P48664으로 구성된 군으로부터 선택된 UniProt 접근 코드에 의해 식별되는, 자율신경계의 신경수용체의 아미노산 서열인, 화합물.
- 제1항 또는 제2항에 있어서,
여기서 상기 아미노산 서열은 무스카린성 및 니코틴성 콜린성 수용체, 알파- 및 베타-아드레날린성 수용체, 세로토닌 수용체, 안지오텐신- 및 엔도텔린 수용체로 구성된 군으로부터 선택되는 신경수용체의 아미노산 서열인, 화합물.
- 제1항 내지 제3항에 있어서,
여기서 상기 아미노산 서열은 P08588, P07550, P20309 및 P08173으로 구성된 군으로부터 선택된 UniProt 접근 코드로 식별되며, 베타-1 아드레날린성 수용체, 베타-2 아드레날린성 수용체, M3 무스카린성 아세틸콜린 수용체 및 M4 무스카린성 아세틸콜린 수용체로 구성된 군으로부터 선택된 신경수용체의 아미노산 서열인, 화합물.
- 제1항 내지 제4항 중 어느 한 항에 있어서,
여기서 적어도 하나의 펩타이드에 대해, 상기 아미노산 단편은 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고,
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
- 제1항 내지 제5항 중 어느 한 항에 있어서,
여기서 상기 적어도 2개의 펩타이드는 펩타이드 P1 및 펩타이드 P2를 포함하고, 여기서 P1 및 P2는 독립적으로 제1항 내지 제4항 중 어느 한 항에 정의된 아미노산 서열 중 6-아미노산 단편, 바람직하게는 7-, 더 바람직하게는 8-, 더 바람직하게는 9-, 더욱 더 바람직하게는 10-, 훨씬 더 바람직하게는 11-, 특히 12-, 가장 바람직하게는 13-아미노산 단편을 포함하고, 여기서 P1 및 P2는 펩타이드 이량체 P 1 - S - P 2 의 형태로 존재하며, 여기서 S는 비-펩타이드 스페이서이고, 여기서 상기 펩타이드 이량체는 바람직하게는 링커를 통해 생물중합체 스캐폴드에 공유 결합되고;
바람직하게는 여기서, 펩타이드 P1 및/또는 펩타이드 P2에 대하여, 상기 아미노산 단편은 서열번호 45-3536 중 어느 하나, 바람직하게는 서열번호 45-863 중 어느 하나, 특히 서열번호 45-201 중 어느 하나로 식별되는 서열 중 적어도 4개, 바람직하게는 적어도 5 또는 심지어 적어도 6, 더 바람직하게는 적어도 7 또는 심지어 적어도 8, 더욱 더 바람직하게는 적어도 9, 훨씬 더 바람직하게는 적어도 10, 훨씬 더 바람직하게는 적어도 11, 특히 적어도 12 또는 심지어 13개의 연속적인 아미노산을 포함하고,
임의로 여기서 최대 3개, 바람직하게는 최대 2개, 보다 바람직하게는 최대 1개의 아미노산이 임의의 다른 아미노산에 의해 독립적으로 치환되는, 화합물.
- 제1항 내지 제6항 중 어느 한 항에 있어서,
상기 생물중합체 스캐폴드는 인간 글로불린 및 인간 알부민으로부터 선택되는 것인, 화합물.
- 제1항 내지 제7항 중 어느 한 항에 있어서,
여기서 적어도 2개의 펩타이드 중 적어도 하나, 바람직하게는 적어도 2개의 펩타이드 각각은 환형화되는, 화합물.
- 제1항 내지 제8항 중 어느 한 항에 있어서,
상기 화합물은 인간에서 비면역원성인, 화합물.
- 제1항 내지 제9항 중 어느 한 항에 있어서,
상기 생물중합체 스캐폴드는 인간 트랜스페린인, 화합물.
- 제1항 내지 제10항 중 어느 한 항의 화합물 및 적어도 하나의 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물.
- 제11항에 있어서,
여기서 조성물 중 펩타이드 대 스캐폴드의 몰비는 2:1 내지 100:1, 바람직하게는 3:1 내지 90:1, 보다 바람직하게는 4:1 내지 80:1, 보다 더 바람직하게는 5:1 내지 70:1, 훨씬 더 바람직하게는 6:1 내지 60:1, 특히 7:1 내지 50:1 또는 심지어 8:10 내지 40:1인, 약제학적 조성물.
- 제11항 또는 제12항에 있어서,
개체에서, 바람직하게는 근육통성 뇌척수염/만성 피로 증후군(ME/CFS), 체위 기립성 빈맥 증후군 (POTS), 자가면역 자율신경절병증(AAG), 특발성 확장성 심근병증(IDC) 및 만성 샤가스 심장병(cChHD) 또는 변연계 뇌염(limbic encephalitis), 또는 부종양 선조체 뇌염(paraneoplastic striatal encephalitis), 또는 항-mGluR1 뇌염, 또는 항-mGluR5 뇌염, 또는 급성 파종성 뇌척수염(ADEM), 또는 NMDAR 뇌염과 같은 뇌염, 부종양 증후군(paraneoplastic syndrome), 강직 증후군(stiff man syndrome), 자가 면역 채널 병증(autoimmune channelopathies), 시신경 척수염(neuromyelitis optica), 신경 근육 긴장(neuromyotonia), 모르반증후군(Morvan's syndrome), 신경병성 통증, 척수염, 시신경염, 망막염, 파킨슨증, 무도병(chorea), 정신병, 디스토니아(dystonia), 무언증(mutism), 운동 장애, 착란(confusion), 환각, 전구 설사(prodromal diarrhoea), 기억 상실, 과흥분(hyperexcitability), 뇌염 정신과 증후군(encephalitis psychiatric syndrome), 기면증, 자폐 스펙트럼 장애(autism spectrum disorders), 발작, 간질 발작 상태, 만성 간질, 근간대 경련(myoclonus), 뇌척수염(encephalomyelitis), 근간대 경련(myoclonus), 사건수면증(parasomnia), 수면 무호흡증(sleep apnoea), 인지 장애, 보행 이상, 안면팔 근육 긴장 이상 발작(faciobrachial dystonic seizures), 부종양 증후군(paraneoplastic syndrome), 소뇌 운동 실조증(cerebellar ataxia), 자폐증, 뚜렛, ADHD, 소뇌 운동 실조증(cerebellar ataxia), 진동시(oscillopsia), 근 위축성 측삭 경화증 (ALS), 갑상선 장애 및 신경학적 결손 및 림프구증가증(HaNDL)을 동반한 두통으로부터 선택되는 자가항체-매개 병태의 예방 또는 치료에 사용하기 위한, 약제학적 조성물.
- 제13항에 있어서,
상기 조성물은 개체의 체중 kg당 화합물 1-1000 mg, 바람직하게는 2-500 mg, 보다 바람직하게는 3-250 mg, 훨씬 더 바람직하게는 4-100 mg, 특히 5-50 mg의 용량으로 투여되는, 약제학적 조성물.
- 제13항 또는 제14항에 있어서,
상기 조성물은 복강내, 피하, 근육내 또는 정맥내로 투여되는, 약제학적 조성물.
- 이를 필요로 하는 개체에서 자가면역 질환 또는 자가항체-매개 병태, 바람직하게는 ME/CFS를 개선 또는 치료하는 방법으로서,
제11항 또는 제12항에 정의된 약제학적 조성물을 수득하는 단계; 및
상기 약제학적 조성물의 유효량을 상기 개체에 투여하는 단계;
를 포함하는, 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20197934.1 | 2020-09-23 | ||
EP20197934 | 2020-09-23 | ||
PCT/EP2021/076176 WO2022063882A1 (en) | 2020-09-23 | 2021-09-23 | Compound for the prevention or treatment of autoantibody-mediated conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230074641A true KR20230074641A (ko) | 2023-05-30 |
Family
ID=72644088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020237013947A KR20230074641A (ko) | 2020-09-23 | 2021-09-23 | 자가항체-매개 병태의 예방 또는 치료를 위한 화합물 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230355784A1 (ko) |
EP (1) | EP4217402A1 (ko) |
JP (1) | JP2023542389A (ko) |
KR (1) | KR20230074641A (ko) |
CN (1) | CN116635081A (ko) |
AU (1) | AU2021347581A1 (ko) |
BR (1) | BR112023005257A2 (ko) |
CA (1) | CA3192740A1 (ko) |
IL (1) | IL301332A (ko) |
MX (1) | MX2023003376A (ko) |
WO (1) | WO2022063882A1 (ko) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022544A (en) | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5372933A (en) | 1988-10-03 | 1994-12-13 | The Scripps Research Institute | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
US5268454A (en) | 1991-02-08 | 1993-12-07 | La Jolla Pharmaceutical Company | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
US6897287B1 (en) | 1990-01-31 | 2005-05-24 | Oklahoma Medical Research Foundation | Ro/SSA peptide reagents for diagnosis of autoantibodies |
US7888458B1 (en) | 1993-11-30 | 2011-02-15 | John B. Harley | Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
JP2002531531A (ja) | 1998-12-09 | 2002-09-24 | ラ ホヤ ファーマシューティカル カンパニー | 循環している抗体を減少させるための方法および処方物 |
DE60140069D1 (de) | 2000-10-16 | 2009-11-12 | Cytoguide Aps | Funktion eines haptoglobin-hämoglobin-rezeptors und anwendungszwecke dafür |
WO2004067549A2 (de) | 2003-01-31 | 2004-08-12 | Max-Delbrück-Centrum für Molekulare Medizin | Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung |
WO2004089422A2 (en) | 2003-03-30 | 2004-10-21 | La Jolla Pharmaceutical Co. | Methods of treating and monitoring systemic lupus erythematosus in individuals |
CA2697108C (en) * | 2007-08-24 | 2018-05-22 | Julius-Maximilians-Universitaet Wuerzburg | Mutant double cyclized receptor peptides inhibiting .beta.1-adrenoceptor antibodies |
GB0917044D0 (en) | 2009-09-29 | 2009-11-18 | Cytoguide As | Agents, uses and methods |
BR112012026003B1 (pt) | 2010-04-13 | 2022-03-15 | Medimmune, Llc | Estrutura multimérica recombinante específica trail r2, seu uso, bem como composição |
EP2402016A1 (en) | 2010-06-29 | 2012-01-04 | Charité - Universitätsmedizin Berlin | Aptamers that inhibit interaction between antibody and 1st or 2nd extracellular loop of human beta-1-adrenergic receptor |
EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
EP3059244B1 (en) | 2013-10-15 | 2020-08-26 | The University of Tokyo | C-met protein agonist |
PL3116887T3 (pl) | 2014-03-13 | 2021-09-06 | Universität Basel | Ligandy węglowodanowe, które wiążą się z przeciwciałami igm przeciwko glikoproteinie związanej z mieliną |
WO2015181393A1 (en) | 2014-05-30 | 2015-12-03 | Per-Johan Jakobsson | Novel sfti and cyclotide based peptides |
EP2982756A1 (en) | 2014-08-04 | 2016-02-10 | Berlin Cures Holding AG | Aptamers for use against autoantibody-associated diseases |
US11091591B2 (en) | 2015-09-16 | 2021-08-17 | Universität Basel | Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids |
AU2017366674A1 (en) | 2016-12-02 | 2019-06-20 | The Texas A&M University System | Fusion proteins for selectively depleting antigen-specific antibodies |
US20190374650A1 (en) * | 2017-02-22 | 2019-12-12 | The Regents Of The University Of Michigan | Compositions and methods for delivery of polymer/biomacromolecule conjugates |
-
2021
- 2021-09-23 JP JP2023518816A patent/JP2023542389A/ja active Pending
- 2021-09-23 KR KR1020237013947A patent/KR20230074641A/ko unknown
- 2021-09-23 CN CN202180075991.8A patent/CN116635081A/zh active Pending
- 2021-09-23 BR BR112023005257A patent/BR112023005257A2/pt unknown
- 2021-09-23 CA CA3192740A patent/CA3192740A1/en active Pending
- 2021-09-23 EP EP21777810.9A patent/EP4217402A1/en active Pending
- 2021-09-23 US US18/246,110 patent/US20230355784A1/en active Pending
- 2021-09-23 AU AU2021347581A patent/AU2021347581A1/en active Pending
- 2021-09-23 MX MX2023003376A patent/MX2023003376A/es unknown
- 2021-09-23 WO PCT/EP2021/076176 patent/WO2022063882A1/en active Application Filing
- 2021-09-23 IL IL301332A patent/IL301332A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN116635081A (zh) | 2023-08-22 |
JP2023542389A (ja) | 2023-10-06 |
WO2022063882A1 (en) | 2022-03-31 |
CA3192740A1 (en) | 2022-03-31 |
BR112023005257A2 (pt) | 2023-04-25 |
AU2021347581A9 (en) | 2024-06-27 |
AU2021347581A1 (en) | 2023-05-18 |
MX2023003376A (es) | 2023-03-31 |
EP4217402A1 (en) | 2023-08-02 |
IL301332A (en) | 2023-05-01 |
US20230355784A1 (en) | 2023-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12011484B2 (en) | Compound for the sequestration of undesirable antibodies in a patient | |
US20230355747A1 (en) | Compound for increasing efficacy of viral vectors | |
KR20230074641A (ko) | 자가항체-매개 병태의 예방 또는 치료를 위한 화합물 | |
KR20230074552A (ko) | 중증 근무력증의 예방 또는 치료용 화합물 | |
US20230365655A1 (en) | Compound for increasing the efficacy of factor viii replacement therapy | |
US20230381334A1 (en) | Compound for the sequestration of undesirable antibodies in a patient | |
US11986536B2 (en) | Compound for the sequestration of undesirable antibodies in a patient | |
WO2020193487A1 (en) | Compound for the prevention or treatment of myasthenia gravis |